drug_name,drug_id,ind_name,ind_id,NCT,status,phase,DetailedStatus,drug_name_lower
Lepirudin,DB00001,Heparin-induced thrombocytopenia with thrombosis,C0272275,NA,Approved,NA,NA,lepirudin
Cetuximab,DB00002,Squamous cell carcinoma of mouth,C0585362,NA,Approved,NA,NA,cetuximab
Cetuximab,DB00002,Squamous cell carcinoma of nose,C3163899,NA,Approved,NA,NA,cetuximab
Cetuximab,DB00002,Squamous cell carcinoma of pharynx,C1319317,NA,Approved,NA,NA,cetuximab
Cetuximab,DB00002,Laryngeal Squamous Cell Carcinoma,C0280324,NA,Approved,NA,NA,cetuximab
Cetuximab,DB00002,Malignant tumor of colon,C0007102,NA,Approved,NA,NA,cetuximab
Dornase alfa,DB00003,Cystic Fibrosis,C0010674,NA,Approved,NA,NA,dornase alfa
Denileukin diftitox,DB00004,"Lymphoma, T-Cell, Cutaneous",C0079773,NA,Approved,NA,NA,denileukin diftitox
Etanercept,DB00005,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,etanercept
Etanercept,DB00005,Juvenile arthritis,C3495559,NA,Approved,NA,NA,etanercept
Etanercept,DB00005,"Arthritis, Psoriatic",C0003872,NA,Approved,NA,NA,etanercept
Etanercept,DB00005,Ankylosing spondylitis,C0038013,NA,Approved,NA,NA,etanercept
Etanercept,DB00005,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,etanercept
Leuprolide,DB00007,Precocious Puberty,C0034013,NA,Approved,NA,NA,leuprolide
Leuprolide,DB00007,Endometriosis,C0014175,NA,Approved,NA,NA,leuprolide
Peginterferon alfa-2a,DB00008,"Hepatitis C, Chronic",C0524910,NA,Approved,NA,NA,peginterferon alfa-2a
Peginterferon alfa-2a,DB00008,"Hepatitis B, Chronic",C0524909,NA,Approved,NA,NA,peginterferon alfa-2a
Alteplase,DB00009,Ischemic stroke,C0948008,NA,Approved,NA,NA,alteplase
Alteplase,DB00009,Acute myocardial infarction,C0155626,NA,Approved,NA,NA,alteplase
Alteplase,DB00009,Pulmonary Embolism,C0034065,NA,Approved,NA,NA,alteplase
Sermorelin,DB00010,Pituitary dwarfism,C0013338,NA,Approved,NA,NA,sermorelin
Urokinase,DB00013,Pulmonary Embolism,C0034065,NA,Approved,NA,NA,urokinase
Goserelin,DB00014,Hormone receptor positive malignant neoplasm of breast,C1562029,NA,Approved,NA,NA,goserelin
Goserelin,DB00014,Endometriosis,C0014175,NA,Approved,NA,NA,goserelin
Reteplase,DB00015,Acute myocardial infarction,C0155626,NA,Approved,NA,NA,reteplase
Erythropoietin,DB00016,Anemia in chronic kidney disease,C1561828,NA,Approved,NA,NA,erythropoietin
Erythropoietin,DB00016,Anemia due to chemotherapy,C1998329,NA,Approved,NA,NA,erythropoietin
Salmon Calcitonin,DB00017,"Osteoporosis, Postmenopausal",C0029458,NA,Approved,NA,NA,salmon calcitonin
Salmon Calcitonin,DB00017,Osteitis Deformans,C0029401,NA,Approved,NA,NA,salmon calcitonin
Pegfilgrastim,DB00019,Chemotherapy-induced neutropenia,C1827687,NA,Approved,NA,NA,pegfilgrastim
Sargramostim,DB00020,Chemotherapy-induced neutropenia,C1827687,NA,Approved,NA,NA,sargramostim
Peginterferon alfa-2b,DB00022,"Hepatitis C, Chronic",C0524910,NA,Approved,NA,NA,peginterferon alfa-2b
Asparaginase,DB00023,Acute lymphocytic leukemia,C0023449,NA,Approved,NA,NA,asparaginase
Anakinra,DB00026,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,anakinra
Anakinra,DB00026,Cryopyrin-Associated Periodic Syndromes,C2316212,NA,Approved,NA,NA,anakinra
Anakinra,DB00026,"Chronic Infantile Neurological, Cutaneous, and Articular Syndrome",C0409818,NA,Approved,NA,NA,anakinra
Gramicidin D,DB00027,Bacterial conjunctivitis,C0009768,NA,Approved,NA,NA,gramicidin d
Gramicidin D,DB00027,Infective blepharitis,C0729587,NA,Approved,NA,NA,gramicidin d
Gramicidin D,DB00027,Blepharoconjunctivitis,C0005743,NA,Approved,NA,NA,gramicidin d
Gramicidin D,DB00027,Bacterial keratitis,C0854211,NA,Approved,NA,NA,gramicidin d
Insulin Human,DB00030,"Diabetes Mellitus, Insulin-Dependent",C0011854,NA,Approved,NA,NA,insulin human
Insulin Human,DB00030,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,insulin human
Insulin Human,DB00030,Diabetes Mellitus,C0011849,NA,Approved,NA,NA,insulin human
Tenecteplase,DB00031,Acute myocardial infarction,C0155626,NA,Approved,NA,NA,tenecteplase
Desmopressin,DB00035,Hemophilia A,C0019069,NA,Approved,NA,NA,desmopressin
Desmopressin,DB00035,von Willebrand Disease,C0042974,NA,Approved,NA,NA,desmopressin
Desmopressin,DB00035,Bedwetting,C0270327,NA,Approved,NA,NA,desmopressin
Coagulation factor VIIa Recombinant Human,DB00036,Hemophilia A,C0019069,NA,Approved,NA,NA,coagulation factor viia recombinant human
Coagulation factor VIIa Recombinant Human,DB00036,Hemophilia B,C0008533,NA,Approved,NA,NA,coagulation factor viia recombinant human
Coagulation factor VIIa Recombinant Human,DB00036,Thrombasthenia,C0040015,NA,Approved,NA,NA,coagulation factor viia recombinant human
Coagulation factor VIIa Recombinant Human,DB00036,Factor VII Deficiency,C0015503,NA,Approved,NA,NA,coagulation factor viia recombinant human
Oprelvekin,DB00038,Thrombocytopenia,C0040034,NA,Approved,NA,NA,oprelvekin
Palifermin,DB00039,Mucositis following radiation therapy,C0392190,NA,Approved,NA,NA,palifermin
Palifermin,DB00039,Drug-induced mucositis,C1274988,NA,Approved,NA,NA,palifermin
Glucagon recombinant,DB00040,Hypoglycemia,C0020615,NA,Approved,NA,NA,glucagon recombinant
Aldesleukin,DB00041,"Leukemia, Myelocytic, Acute",C0023467,NA,Approved,NA,NA,aldesleukin
Aldesleukin,DB00041,Metastatic Renal Cell Cancer,C0278678,NA,Approved,NA,NA,aldesleukin
Aldesleukin,DB00041,"Malignant melanoma, metastatic",C0860594,NA,Approved,NA,NA,aldesleukin
Omalizumab,DB00043,Asthma,C0004096,NA,Approved,NA,NA,omalizumab
Omalizumab,DB00043,Chronic idiopathic urticaria,C0578870,NA,Approved,NA,NA,omalizumab
Insulin Lispro,DB00046,"Diabetes Mellitus, Insulin-Dependent",C0011854,NA,Approved,NA,NA,insulin lispro
Insulin Lispro,DB00046,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,insulin lispro
Insulin Glargine,DB00047,"Diabetes Mellitus, Insulin-Dependent",C0011854,NA,Approved,NA,NA,insulin glargine
Insulin Glargine,DB00047,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,insulin glargine
Collagenase clostridium histolyticum,DB00048,"Dupuytren's disease of finger, with contracture",C0410065,NA,Approved,NA,NA,collagenase clostridium histolyticum
Collagenase clostridium histolyticum,DB00048,Peyronie Disease,C0030848,NA,Approved,NA,NA,collagenase clostridium histolyticum
Rasburicase,DB00049,Hyperuricemia,C0740394,NA,Approved,NA,NA,rasburicase
Adalimumab,DB00051,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,adalimumab
Adalimumab,DB00051,Juvenile arthritis,C3495559,NA,Approved,NA,NA,adalimumab
Adalimumab,DB00051,"Arthritis, Psoriatic",C0003872,NA,Approved,NA,NA,adalimumab
Adalimumab,DB00051,Ankylosing spondylitis,C0038013,NA,Approved,NA,NA,adalimumab
Adalimumab,DB00051,Crohn Disease,C0010346,NA,Approved,NA,NA,adalimumab
Adalimumab,DB00051,Ulcerative Colitis,C0009324,NA,Approved,NA,NA,adalimumab
Adalimumab,DB00051,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,adalimumab
Adalimumab,DB00051,Hidradenitis Suppurativa,C0162836,NA,Approved,NA,NA,adalimumab
Somatropin recombinant,DB00052,Growth retardation,C0151686,NA,Approved,NA,NA,somatropin recombinant
Somatropin recombinant,DB00052,Prader-Willi Syndrome,C0032897,NA,Approved,NA,NA,somatropin recombinant
Somatropin recombinant,DB00052,Pituitary dwarfism,C0013338,NA,Approved,NA,NA,somatropin recombinant
Somatropin recombinant,DB00052,Turner Syndrome,C0041408,NA,Approved,NA,NA,somatropin recombinant
Imiglucerase,DB00053,Gaucher Disease,C0017205,NA,Approved,NA,NA,imiglucerase
Gemtuzumab ozogamicin,DB00056,"Leukemia, Myelocytic, Acute",C0023467,NA,Approved,NA,NA,gemtuzumab ozogamicin
Pegaspargase,DB00059,Acute lymphocytic leukemia,C0023449,NA,Approved,NA,NA,pegaspargase
Interferon beta-1a,DB00060,"Multiple Sclerosis, Relapsing-Remitting",C0751967,NA,Approved,NA,NA,interferon beta-1a
Eptifibatide,DB00063,Acute Coronary Syndrome,C0948089,NA,Approved,NA,NA,eptifibatide
Infliximab,DB00065,Crohn Disease,C0010346,NA,Approved,NA,NA,infliximab
Infliximab,DB00065,Ulcerative Colitis,C0009324,NA,Approved,NA,NA,infliximab
Infliximab,DB00065,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,infliximab
Infliximab,DB00065,Ankylosing spondylitis,C0038013,NA,Approved,NA,NA,infliximab
Infliximab,DB00065,"Arthritis, Psoriatic",C0003872,NA,Approved,NA,NA,infliximab
Infliximab,DB00065,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,infliximab
Vasopressin,DB00067,Bedwetting,C0270327,NA,Approved,NA,NA,vasopressin
Vasopressin,DB00067,von Willebrand Disease,C0042974,NA,Approved,NA,NA,vasopressin
Vasopressin,DB00067,Hemophilia A,C0019069,NA,Approved,NA,NA,vasopressin
Interferon beta-1b,DB00068,"Multiple Sclerosis, Relapsing-Remitting",C0751967,NA,Approved,NA,NA,interferon beta-1b
Trastuzumab,DB00072,HER2-positive carcinoma of breast,C1960398,NA,Approved,NA,NA,trastuzumab
Trastuzumab,DB00072,Secondary malignant neoplasm of female breast,C0346993,NA,Approved,NA,NA,trastuzumab
Trastuzumab,DB00072,Secondary malignant neoplasm of stomach,C0686068,NA,Approved,NA,NA,trastuzumab
Rituximab,DB00073,"Lymphoma, Non-Hodgkin",C0024305,NA,Approved,NA,NA,rituximab
Rituximab,DB00073,Chronic Lymphocytic Leukemia,C0023434,NA,Approved,NA,NA,rituximab
Rituximab,DB00073,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,rituximab
Basiliximab,DB00074,Renal transplant rejection,C0238217,NA,Approved,NA,NA,basiliximab
Ibritumomab tiuxetan,DB00078,"Lymphoma, Follicular",C0024301,NA,Approved,NA,NA,ibritumomab tiuxetan
Daptomycin,DB00080,Right-sided Staphylococcus aureus endocarditis,C1960924,NA,Approved,NA,NA,daptomycin
Daptomycin,DB00080,Sepsis due to Staphylococcus aureus,C2887088,NA,Approved,NA,NA,daptomycin
Pegvisomant,DB00082,Acromegaly,C0001206,NA,Approved,NA,NA,pegvisomant
Pancrelipase,DB00085,Exocrine pancreatic insufficiency,C0267963,NA,Approved,NA,NA,pancrelipase
Alemtuzumab,DB00087,"Multiple Sclerosis, Relapsing-Remitting",C0751967,NA,Approved,NA,NA,alemtuzumab
Alglucerase,DB00088,"Gaucher Disease, Type 1",C1961835,NA,Approved,NA,NA,alglucerase
Laronidase,DB00090,Mucopolysaccharidosis I,C0023786,NA,Approved,NA,NA,laronidase
Cyclosporine,DB00091,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,cyclosporine
Cyclosporine,DB00091,Dry Eye Syndromes,C0013238,NA,Approved,NA,NA,cyclosporine
Cyclosporine,DB00091,Keratoconjunctivitis Sicca,C0022575,NA,Approved,NA,NA,cyclosporine
Alefacept,DB00092,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,alefacept
Efalizumab,DB00095,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,efalizumab
Filgrastim,DB00099,Chemotherapy-induced neutropenia,C1827687,NA,Approved,NA,NA,filgrastim
Filgrastim,DB00099,Congenital neutropenia,C0340970,NA,Approved,NA,NA,filgrastim
Filgrastim,DB00099,Cyclic neutropenia,C0221023,NA,Approved,NA,NA,filgrastim
Filgrastim,DB00099,Chronic idiopathic neutropenia,C2267231,NA,Approved,NA,NA,filgrastim
Coagulation Factor IX,DB00100,Hemophilia B,C0008533,NA,Approved,NA,NA,coagulation factor ix
Becaplermin,DB00102,Neuropathic diabetic ulcer - foot,C0406526,NA,Approved,NA,NA,becaplermin
Agalsidase beta,DB00103,Fabry Disease,C0002986,NA,Approved,NA,NA,agalsidase beta
Octreotide,DB00104,Acromegaly,C0001206,NA,Approved,NA,NA,octreotide
Octreotide,DB00104,Malignant Carcinoid Syndrome,C0024586,NA,Approved,NA,NA,octreotide
Abarelix,DB00106,Ischemic priapism,C2711256,NA,Approved,NA,NA,abarelix
Oxytocin,DB00107,Unspecified Abortion,C0156543,NA,Approved,NA,NA,oxytocin
Oxytocin,DB00107,Postpartum Hemorrhage,C0032797,NA,Approved,NA,NA,oxytocin
Oxytocin,DB00107,Incomplete spontaneous abortion,C0000810,NA,Approved,NA,NA,oxytocin
Natalizumab,DB00108,Multiple Sclerosis,C0026769,NA,Approved,NA,NA,natalizumab
Natalizumab,DB00108,Crohn Disease,C0010346,NA,Approved,NA,NA,natalizumab
Enfuvirtide,DB00109,HIV Infections,C0019693,NA,Approved,NA,NA,enfuvirtide
Palivizumab,DB00110,Respiratory Syncytial Virus Infections,C0035235,NA,Approved,NA,NA,palivizumab
Daclizumab,DB00111,Renal transplant rejection,C0238217,NA,Approved,NA,NA,daclizumab
Daclizumab,DB00111,"Multiple Sclerosis, Relapsing-Remitting",C0751967,NA,Approved,NA,NA,daclizumab
Bevacizumab,DB00112,Secondary malignant neoplasm of colon,C0346974,NA,Approved,NA,NA,bevacizumab
Bevacizumab,DB00112,Nonsquamous nonsmall cell neoplasm of lung,C2585890,NA,Approved,NA,NA,bevacizumab
Bevacizumab,DB00112,Glioblastoma Multiforme,C1621958,NA,Approved,NA,NA,bevacizumab
Bevacizumab,DB00112,Metastatic Renal Cell Cancer,C0278678,NA,Approved,NA,NA,bevacizumab
Bevacizumab,DB00112,Cervix carcinoma,C0302592,NA,Approved,NA,NA,bevacizumab
Bevacizumab,DB00112,Malignant tumor of peritoneum,C0153467,NA,Approved,NA,NA,bevacizumab
Bevacizumab,DB00112,Malignant epithelial tumor of ovary,C0346161,NA,Approved,NA,NA,bevacizumab
Bevacizumab,DB00112,Malignant neoplasm of fallopian tube,C0153579,NA,Approved,NA,NA,bevacizumab
Cyanocobalamin,DB00115,Megaloblastic anemia due to folate deficiency,C0151482,NA,Approved,NA,NA,cyanocobalamin
Cyanocobalamin,DB00115,"Anemia, Pernicious",C0002892,NA,Approved,NA,NA,cyanocobalamin
Cyanocobalamin,DB00115,Iron deficiency anemia,C0162316,NA,Approved,NA,NA,cyanocobalamin
Cyanocobalamin,DB00115,Vitamin Deficiency,C1510471,NA,Approved,NA,NA,cyanocobalamin
Cyanocobalamin,DB00115,Vitamin B 12 Deficiency,C0042847,NA,Approved,NA,NA,cyanocobalamin
Biotin,DB00121,Biotin deficiency disease,C2937225,NA,Approved,NA,NA,biotin
Choline,DB00122,Sleeplessness,C0917801,NA,Approved,NA,NA,choline
Vitamin C,DB00126,Breastfeeding (mother),C1623040,NA,Approved,NA,NA,vitamin c
Vitamin C,DB00126,Vitamin Deficiency,C1510471,NA,Approved,NA,NA,vitamin c
L-Aspartic Acid,DB00128,Hypokalemia,C0020621,NA,Approved,NA,NA,l-aspartic acid
L-Glutamine,DB00130,Short Bowel Syndrome,C0036992,NA,Approved,NA,NA,l-glutamine
Adenosine monophosphate,DB00131,Pulmonary Cystic Fibrosis,C0392164,NA,Approved,NA,NA,adenosine monophosphate
L-Serine,DB00133,"Glaucoma, Open-Angle",C0017612,NA,Approved,NA,NA,l-serine
L-Serine,DB00133,Bacterial urinary infection,C0729524,NA,Approved,NA,NA,l-serine
L-Serine,DB00133,"Tuberculosis, Pulmonary",C0041327,NA,Approved,NA,NA,l-serine
L-Serine,DB00133,Acute tuberculosis,C0275959,NA,Approved,NA,NA,l-serine
L-Serine,DB00133,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,l-serine
Calcitriol,DB00136,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,calcitriol
Calcitriol,DB00136,Hypocalcemia,C0020598,NA,Approved,NA,NA,calcitriol
Calcitriol,DB00136,Hypophosphatemia,C0085682,NA,Approved,NA,NA,calcitriol
Calcitriol,DB00136,Renal Osteodystrophy,C0035086,NA,Approved,NA,NA,calcitriol
Calcitriol,DB00136,Hypoparathyroidism,C0020626,NA,Approved,NA,NA,calcitriol
Xanthophyll,DB00137,Age related macular degeneration,C0242383,NA,Approved,NA,NA,xanthophyll
Xanthophyll,DB00137,Dry Eye Syndromes,C0013238,NA,Approved,NA,NA,xanthophyll
Xanthophyll,DB00137,Meibomian gland dysfunction,C1275684,NA,Approved,NA,NA,xanthophyll
Succinic acid,DB00139,Iron deficiency anemia,C0162316,NA,Approved,NA,NA,succinic acid
Riboflavin,DB00140,Mineral deficiency,C0687148,NA,Approved,NA,NA,riboflavin
Riboflavin,DB00140,Vitamin Deficiency,C1510471,NA,Approved,NA,NA,riboflavin
Glycine,DB00145,Rhinorrhea,C1260880,NA,Approved,NA,NA,glycine
Glycine,DB00145,Coughing,C0010200,NA,Approved,NA,NA,glycine
Glycine,DB00145,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,glycine
Glycine,DB00145,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,glycine
Glycine,DB00145,Rhinitis,C0035455,NA,Approved,NA,NA,glycine
Glycine,DB00145,Common Cold,C0009443,NA,Approved,NA,NA,glycine
Calcidiol,DB00146,Hypocalcemia,C0020598,NA,Approved,NA,NA,calcidiol
Calcidiol,DB00146,Renal Osteodystrophy,C0035086,NA,Approved,NA,NA,calcidiol
Calcidiol,DB00146,Rickets,C0035579,NA,Approved,NA,NA,calcidiol
Calcidiol,DB00146,Hypophosphatemia,C0085682,NA,Approved,NA,NA,calcidiol
L-Cysteine,DB00151,Bronchitis,C0006277,NA,Approved,NA,NA,l-cysteine
L-Cysteine,DB00151,Poisoning by acetaminophen,C0237963,NA,Approved,NA,NA,l-cysteine
L-Cysteine,DB00151,Amyloidosis,C0002726,NA,Approved,NA,NA,l-cysteine
L-Cysteine,DB00151,Pulmonary Cystic Fibrosis,C0392164,NA,Approved,NA,NA,l-cysteine
L-Cysteine,DB00151,Bronchiectasis,C0006267,NA,Approved,NA,NA,l-cysteine
Thiamine,DB00152,Vitamin B 12 Deficiency,C0042847,NA,Approved,NA,NA,thiamine
Thiamine,DB00152,Wernicke-Korsakoff Syndrome,C0349464,NA,Approved,NA,NA,thiamine
Thiamine,DB00152,Vitamin Deficiency,C1510471,NA,Approved,NA,NA,thiamine
Thiamine,DB00152,"Anemia, Pernicious",C0002892,NA,Approved,NA,NA,thiamine
Thiamine,DB00152,Thiamine Deficiency,C0039841,NA,Approved,NA,NA,thiamine
Thiamine,DB00152,Mineral deficiency,C0687148,NA,Approved,NA,NA,thiamine
Ergocalciferol,DB00153,Vitamin D Deficiency,C0042870,NA,Approved,NA,NA,ergocalciferol
Ergocalciferol,DB00153,Osteomalacia,C0029442,NA,Approved,NA,NA,ergocalciferol
Ergocalciferol,DB00153,Rickets,C0035579,NA,Approved,NA,NA,ergocalciferol
Ergocalciferol,DB00153,Vitamin D-dependent rickets,C0221468,NA,Approved,NA,NA,ergocalciferol
Ergocalciferol,DB00153,Vitamin Deficiency,C1510471,NA,Approved,NA,NA,ergocalciferol
Ergocalciferol,DB00153,Osteoporosis,C0029456,NA,Approved,NA,NA,ergocalciferol
Ergocalciferol,DB00153,Hypocalcemia,C0020598,NA,Approved,NA,NA,ergocalciferol
Ergocalciferol,DB00153,"Osteoporosis, Postmenopausal",C0029458,NA,Approved,NA,NA,ergocalciferol
Ergocalciferol,DB00153,"Vitamin D-Resistant Rickets, X-Linked",C3536984,NA,Approved,NA,NA,ergocalciferol
Ergocalciferol,DB00153,Hypoparathyroidism,C0020626,NA,Approved,NA,NA,ergocalciferol
Folic Acid,DB00158,Megaloblastic anemia due to folate deficiency,C0151482,NA,Approved,NA,NA,folic acid
Folic Acid,DB00158,Mineral deficiency,C0687148,NA,Approved,NA,NA,folic acid
Folic Acid,DB00158,Breastfeeding (mother),C1623040,NA,Approved,NA,NA,folic acid
Folic Acid,DB00158,Iron deficiency anemia,C0162316,NA,Approved,NA,NA,folic acid
Folic Acid,DB00158,Folic Acid Deficiency,C0016412,NA,Approved,NA,NA,folic acid
Folic Acid,DB00158,Vitamin Deficiency,C1510471,NA,Approved,NA,NA,folic acid
Icosapent,DB00159,Breastfeeding (mother),C1623040,NA,Approved,NA,NA,icosapent
Icosapent,DB00159,Hypertriglyceridemia,C0020557,NA,Approved,NA,NA,icosapent
Vitamin A,DB00162,Mineral deficiency,C0687148,NA,Approved,NA,NA,vitamin a
Vitamin A,DB00162,Vitamin Deficiency,C1510471,NA,Approved,NA,NA,vitamin a
Vitamin A,DB00162,Vitamin A Deficiency,C0042842,NA,Approved,NA,NA,vitamin a
Vitamin E,DB00163,Vitamin E Deficiency,C0042875,NA,Approved,NA,NA,vitamin e
Pyridoxine,DB00165,Breastfeeding (mother),C1623040,NA,Approved,NA,NA,pyridoxine
Pyridoxine,DB00165,"EPILEPSY, PYRIDOXINE-DEPENDENT",C1849508,NA,Approved,NA,NA,pyridoxine
Pyridoxine,DB00165,Vitamin B 6 Deficiency,C0936215,NA,Approved,NA,NA,pyridoxine
Lipoic Acid,DB00166,Diabetic peripheral neuropathy,C0740447,NA,Approved,NA,NA,lipoic acid
Cholecalciferol,DB00169,"Osteoporosis, Postmenopausal",C0029458,NA,Approved,NA,NA,cholecalciferol
Cholecalciferol,DB00169,Hypoparathyroidism,C0020626,NA,Approved,NA,NA,cholecalciferol
Cholecalciferol,DB00169,Rickets,C0035579,NA,Approved,NA,NA,cholecalciferol
Cholecalciferol,DB00169,Hypocalcemia,C0020598,NA,Approved,NA,NA,cholecalciferol
Cholecalciferol,DB00169,Vitamin Deficiency,C1510471,NA,Approved,NA,NA,cholecalciferol
Cholecalciferol,DB00169,Osteomalacia,C0029442,NA,Approved,NA,NA,cholecalciferol
Cholecalciferol,DB00169,Vitamin D-dependent rickets,C0221468,NA,Approved,NA,NA,cholecalciferol
Cholecalciferol,DB00169,Osteoporosis,C0029456,NA,Approved,NA,NA,cholecalciferol
Pravastatin,DB00175,Cerebrovascular accident,C0038454,NA,Approved,NA,NA,pravastatin
Pravastatin,DB00175,Hyperlipoproteinemia Type III,C0020479,NA,Approved,NA,NA,pravastatin
Pravastatin,DB00175,Familial hypercholesterolemia - heterozygous,C0342882,NA,Approved,NA,NA,pravastatin
Pravastatin,DB00175,Hypercholesterolemia,C0020443,NA,Approved,NA,NA,pravastatin
Pravastatin,DB00175,Hypertriglyceridemia,C0020557,NA,Approved,NA,NA,pravastatin
Pravastatin,DB00175,"Hyperlipidemia, Familial Combined",C0020474,NA,Approved,NA,NA,pravastatin
Pravastatin,DB00175,Arteriosclerosis,C0003850,NA,Approved,NA,NA,pravastatin
Fluvoxamine,DB00176,Obsessive-Compulsive Disorder,C0028768,NA,Approved,NA,NA,fluvoxamine
Fluvoxamine,DB00176,"Phobia, Social",C0031572,NA,Approved,NA,NA,fluvoxamine
Valsartan,DB00177,Chronic heart failure,C0264716,NA,Approved,NA,NA,valsartan
Valsartan,DB00177,Hypertensive disease,C0020538,NA,Approved,NA,NA,valsartan
Ramipril,DB00178,Cerebrovascular accident,C0038454,NA,Approved,NA,NA,ramipril
Ramipril,DB00178,Chronic heart failure,C0264716,NA,Approved,NA,NA,ramipril
Ramipril,DB00178,Hypertensive disease,C0020538,NA,Approved,NA,NA,ramipril
Masoprocol,DB00179,Actinic keratosis,C0022602,NA,Approved,NA,NA,masoprocol
Flunisolide,DB00180,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,flunisolide
Flunisolide,DB00180,Asthma,C0004096,NA,Approved,NA,NA,flunisolide
Baclofen,DB00181,Muscle spasticity of spinal origin,C1562430,NA,Approved,NA,NA,baclofen
Amphetamine,DB00182,Obesity,C0028754,NA,Approved,NA,NA,amphetamine
Amphetamine,DB00182,Attention deficit hyperactivity disorder,C1263846,NA,Approved,NA,NA,amphetamine
Amphetamine,DB00182,Narcolepsy,C0027404,NA,Approved,NA,NA,amphetamine
Nicotine,DB00184,Pellagra,C0030783,NA,Approved,NA,NA,nicotine
Nicotine,DB00184,Nicotine Dependence,C0028043,NA,Approved,NA,NA,nicotine
Lorazepam,DB00186,Lennox-Gastaut syndrome,C0238111,NA,Approved,NA,NA,lorazepam
Lorazepam,DB00186,Absence Epilepsy,C0014553,NA,Approved,NA,NA,lorazepam
Lorazepam,DB00186,"Epilepsies, Myoclonic",C0014550,NA,Approved,NA,NA,lorazepam
Lorazepam,DB00186,Epileptic drop attack,C0270846,NA,Approved,NA,NA,lorazepam
Lorazepam,DB00186,Anxiety,C0003467,NA,Approved,NA,NA,lorazepam
Lorazepam,DB00186,Status Epilepticus,C0038220,NA,Approved,NA,NA,lorazepam
Lorazepam,DB00186,Panic Disorder,C0030319,NA,Approved,NA,NA,lorazepam
Esmolol,DB00187,Atrial Fibrillation,C0004238,NA,Approved,NA,NA,esmolol
Esmolol,DB00187,Supraventricular tachycardia,C0039240,NA,Approved,NA,NA,esmolol
Esmolol,DB00187,Perioperative hypertension,C3661921,NA,Approved,NA,NA,esmolol
Bortezomib,DB00188,Multiple Myeloma,C0026764,NA,Approved,NA,NA,bortezomib
Bortezomib,DB00188,"Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse",C0334634,NA,Approved,NA,NA,bortezomib
Ethchlorvynol,DB00189,Sleeplessness,C0917801,NA,Approved,NA,NA,ethchlorvynol
Carbidopa,DB00190,Parkinson Disease,C0030567,NA,Approved,NA,NA,carbidopa
Carbidopa,DB00190,Parkinsonian Disorders,C0242422,NA,Approved,NA,NA,carbidopa
Carbidopa,DB00190,"Parkinson Disease, Postencephalitic",C0030568,NA,Approved,NA,NA,carbidopa
Phentermine,DB00191,Hypotension,C0020649,NA,Approved,NA,NA,phentermine
Phentermine,DB00191,Obesity,C0028754,NA,Approved,NA,NA,phentermine
Tramadol,DB00193,Chronic pain,C0150055,NA,Approved,NA,NA,tramadol
Tramadol,DB00193,Degenerative polyarthritis,C0029408,NA,Approved,NA,NA,tramadol
Tramadol,DB00193,Pain,C0030193,NA,Approved,NA,NA,tramadol
Vidarabine,DB00194,"Keratitis, Dendritic",C0022570,NA,Approved,NA,NA,vidarabine
Vidarabine,DB00194,"Keratitis, Herpetic",C0019357,NA,Approved,NA,NA,vidarabine
Betaxolol,DB00195,Hypertensive disease,C0020538,NA,Approved,NA,NA,betaxolol
Betaxolol,DB00195,Ocular Hypertension,C0028840,NA,Approved,NA,NA,betaxolol
Betaxolol,DB00195,"Glaucoma, Open-Angle",C0017612,NA,Approved,NA,NA,betaxolol
Fluconazole,DB00196,Oropharyngeal candidiasis,C0919659,NA,Approved,NA,NA,fluconazole
Fluconazole,DB00196,Septicemia candida,C0349009,NA,Approved,NA,NA,fluconazole
Fluconazole,DB00196,"Candidiasis, Vulvovaginal",C0700345,NA,Approved,NA,NA,fluconazole
Fluconazole,DB00196,Oral candidiasis,C0006849,NA,Approved,NA,NA,fluconazole
Fluconazole,DB00196,Mucocutaneous candidiasis,C0006848,NA,Approved,NA,NA,fluconazole
Fluconazole,DB00196,Candidiasis of the esophagus,C0239295,NA,Approved,NA,NA,fluconazole
Fluconazole,DB00196,"Meningitis, Cryptococcal",C0085436,NA,Approved,NA,NA,fluconazole
Fluconazole,DB00196,Candidemia,C0877445,NA,Approved,NA,NA,fluconazole
Fluconazole,DB00196,Systemic candidiasis,C0153252,NA,Approved,NA,NA,fluconazole
Oseltamivir,DB00198,Influenza,C0021400,NA,Approved,NA,NA,oseltamivir
Erythromycin,DB00199,Diphtheria,C0012546,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Ophthalmia Neonatorum,C0029076,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Infective otitis media,C0729586,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Acute bacterial sinusitis,C0275556,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Acute gonococcal endometritis,C0153196,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Neonatal pneumonia,C0339968,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Chlamydial urethritis,C1278807,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Gonorrhea of rectum,C0275665,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Pneumococcal pharyngitis,C0275761,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Acute gonococcal urethritis,C0275652,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Legionnaires' Disease,C0023241,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,non-gonococcal urethritis (NGU),C1112709,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Listeriosis,C0023860,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Inclusion conjunctivitis,C0009770,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Chlamydial cervicitis,C0341834,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Pertussis,C0043167,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Erythrasma,C0014752,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Streptococcal pneumonia,C0155862,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Syphilis,C0039128,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Chlamydial pneumonia,C0339959,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Acute gonococcal cervicitis,C0153195,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Acne Vulgaris,C0001144,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Acute otitis media,C0271429,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Mycoplasma pneumonia,C0032302,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Gonorrhea,C0018081,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Meningitis,C0025289,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Cholangitis,C0008311,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Bacterial sepsis,C0684256,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Hepatic Coma,C0019147,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Infection of bone,C2242472,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Urinary tract infection,C0042029,NA,Approved,NA,NA,erythromycin
Erythromycin,DB00199,Arthropathy associated with infection,C0157749,NA,Approved,NA,NA,erythromycin
Hydroxocobalamin,DB00200,Vitamin B 12 Deficiency,C0042847,NA,Approved,NA,NA,hydroxocobalamin
Hydroxocobalamin,DB00200,Toxic effect of cyanide,C0238080,NA,Approved,NA,NA,hydroxocobalamin
Hydroxocobalamin,DB00200,"Anemia, Pernicious",C0002892,NA,Approved,NA,NA,hydroxocobalamin
Caffeine,DB00201,Headache Disorders,C0393735,NA,Approved,NA,NA,caffeine
Caffeine,DB00201,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,caffeine
Caffeine,DB00201,Pain,C0030193,NA,Approved,NA,NA,caffeine
Caffeine,DB00201,Vascular Headaches,C0042376,NA,Approved,NA,NA,caffeine
Caffeine,DB00201,Back Pain,C0004604,NA,Approved,NA,NA,caffeine
Caffeine,DB00201,Cluster Headache,C0009088,NA,Approved,NA,NA,caffeine
Caffeine,DB00201,Arthralgia,C0003862,NA,Approved,NA,NA,caffeine
Caffeine,DB00201,Influenza-like symptoms,C0392171,NA,Approved,NA,NA,caffeine
Caffeine,DB00201,Common Cold,C0009443,NA,Approved,NA,NA,caffeine
Caffeine,DB00201,Muscle Spasticity,C0026838,NA,Approved,NA,NA,caffeine
Caffeine,DB00201,Rhinorrhea,C1260880,NA,Approved,NA,NA,caffeine
Caffeine,DB00201,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,caffeine
Caffeine,DB00201,Sinus headache,C0037195,NA,Approved,NA,NA,caffeine
Caffeine,DB00201,Dysmenorrhea,C0013390,NA,Approved,NA,NA,caffeine
Caffeine,DB00201,Tension Headache,C0033893,NA,Approved,NA,NA,caffeine
Caffeine,DB00201,Migraine Disorders,C0149931,NA,Approved,NA,NA,caffeine
Caffeine,DB00201,Apnea in the newborn,C0232058,NA,Approved,NA,NA,caffeine
Sildenafil,DB00203,Pulmonary arterial hypertension,C2973725,NA,Approved,NA,NA,sildenafil
Sildenafil,DB00203,Erectile dysfunction,C0242350,NA,Approved,NA,NA,sildenafil
Pyrimethamine,DB00205,Malaria,C0024530,NA,Approved,NA,NA,pyrimethamine
Pyrimethamine,DB00205,Toxoplasmosis associated with AIDS,C1720498,NA,Approved,NA,NA,pyrimethamine
Pyrimethamine,DB00205,Toxoplasmosis,C0040558,NA,Approved,NA,NA,pyrimethamine
Reserpine,DB00206,Psychotic Disorders,C0033975,NA,Approved,NA,NA,reserpine
Reserpine,DB00206,Hypertensive disease,C0020538,NA,Approved,NA,NA,reserpine
Azithromycin,DB00207,Pulmonary Mycobacterium avium complex infection,C2733595,NA,Approved,NA,NA,azithromycin
Azithromycin,DB00207,Streptococcal tonsillitis,C0275804,NA,Approved,NA,NA,azithromycin
Azithromycin,DB00207,Pneumonia due to Staphylococcus aureus,C2349530,NA,Approved,NA,NA,azithromycin
Azithromycin,DB00207,Acute bacterial bronchitis,C0339933,NA,Approved,NA,NA,azithromycin
Azithromycin,DB00207,Infective otitis media,C0729586,NA,Approved,NA,NA,azithromycin
Azithromycin,DB00207,Chlamydial pneumonia,C0339959,NA,Approved,NA,NA,azithromycin
Azithromycin,DB00207,Chlamydial urethritis,C1278807,NA,Approved,NA,NA,azithromycin
Azithromycin,DB00207,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,azithromycin
Azithromycin,DB00207,Acute gonococcal cervicitis,C0153195,NA,Approved,NA,NA,azithromycin
Azithromycin,DB00207,Legionella pneumophila pneumonia,C0857846,NA,Approved,NA,NA,azithromycin
Azithromycin,DB00207,Acute gonococcal urethritis,C0275652,NA,Approved,NA,NA,azithromycin
Azithromycin,DB00207,Chancroids,C0007947,NA,Approved,NA,NA,azithromycin
Azithromycin,DB00207,Bacterial conjunctivitis,C0009768,NA,Approved,NA,NA,azithromycin
Azithromycin,DB00207,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,azithromycin
Azithromycin,DB00207,Chlamydial pelvic inflammatory disease,C0520777,NA,Approved,NA,NA,azithromycin
Azithromycin,DB00207,Chlamydial cervicitis,C0341834,NA,Approved,NA,NA,azithromycin
Azithromycin,DB00207,Streptococcal pneumonia,C0155862,NA,Approved,NA,NA,azithromycin
Azithromycin,DB00207,Mycoplasma pneumonia,C0032302,NA,Approved,NA,NA,azithromycin
Azithromycin,DB00207,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,azithromycin
Azithromycin,DB00207,Moraxella catarrhalis pneumonia,C0857831,NA,Approved,NA,NA,azithromycin
Azithromycin,DB00207,Acute bacterial sinusitis,C0275556,NA,Approved,NA,NA,azithromycin
Azithromycin,DB00207,Pelvic inflammatory disease due to Mycoplasma hominis,C1261256,NA,Approved,NA,NA,azithromycin
Azithromycin,DB00207,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,azithromycin
Azithromycin,DB00207,Acute exacerbation of chronic bronchitis,C0856695,NA,Approved,NA,NA,azithromycin
Ticlopidine,DB00208,Cerebrovascular Occlusion,C0596298,NA,Approved,NA,NA,ticlopidine
Trospium,DB00209,Urge Incontinence,C0150045,NA,Approved,NA,NA,trospium
Trospium,DB00209,Bladder muscle dysfunction - overactive,C0403643,NA,Approved,NA,NA,trospium
Trospium,DB00209,Increased frequency of micturition,C0042023,NA,Approved,NA,NA,trospium
Trospium,DB00209,Urgency of micturition,C0085606,NA,Approved,NA,NA,trospium
Adapalene,DB00210,Acne Vulgaris,C0001144,NA,Approved,NA,NA,adapalene
Midodrine,DB00211,"Hypotension, Orthostatic",C0020651,NA,Approved,NA,NA,midodrine
Pantoprazole,DB00213,Erosive esophagitis,C0267055,NA,Approved,NA,NA,pantoprazole
Pantoprazole,DB00213,Zollinger-Ellison syndrome,C0043515,NA,Approved,NA,NA,pantoprazole
Pantoprazole,DB00213,Gastroesophageal reflux disease,C0017168,NA,Approved,NA,NA,pantoprazole
Pantoprazole,DB00213,Multiple Endocrine Neoplasia,C0027662,NA,Approved,NA,NA,pantoprazole
Pantoprazole,DB00213,Peptic Ulcer,C0030920,NA,Approved,NA,NA,pantoprazole
Torasemide,DB00214,Hypertensive disease,C0020538,NA,Approved,NA,NA,torasemide
Torasemide,DB00214,Edema,C0013604,NA,Approved,NA,NA,torasemide
Torasemide,DB00214,Decompensated cardiac failure,C0581377,NA,Approved,NA,NA,torasemide
Torasemide,DB00214,Renal disease with edema NOS,C0866125,NA,Approved,NA,NA,torasemide
Citalopram,DB00215,Generalized Anxiety Disorder,C0270549,NA,Approved,NA,NA,citalopram
Citalopram,DB00215,Major Depressive Disorder,C1269683,NA,Approved,NA,NA,citalopram
Citalopram,DB00215,Depressive disorder,C0011581,NA,Approved,NA,NA,citalopram
Eletriptan,DB00216,Migraine Disorders,C0149931,NA,Approved,NA,NA,eletriptan
Moxifloxacin,DB00218,Chlamydial pneumonia,C0339959,NA,Approved,NA,NA,moxifloxacin
Moxifloxacin,DB00218,Acute bacterial sinusitis,C0275556,NA,Approved,NA,NA,moxifloxacin
Moxifloxacin,DB00218,Acute exacerbation of chronic bronchitis,C0856695,NA,Approved,NA,NA,moxifloxacin
Moxifloxacin,DB00218,Moraxella catarrhalis pneumonia,C0857831,NA,Approved,NA,NA,moxifloxacin
Moxifloxacin,DB00218,Bacterial infection due to Klebsiella pneumoniae,C0343402,NA,Approved,NA,NA,moxifloxacin
Moxifloxacin,DB00218,Mycoplasma pneumonia,C0032302,NA,Approved,NA,NA,moxifloxacin
Moxifloxacin,DB00218,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,moxifloxacin
Moxifloxacin,DB00218,Enterobacteriaceae Infections,C0014347,NA,Approved,NA,NA,moxifloxacin
Moxifloxacin,DB00218,Abdominal Abscess,C0243001,NA,Approved,NA,NA,moxifloxacin
Moxifloxacin,DB00218,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,moxifloxacin
Moxifloxacin,DB00218,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,moxifloxacin
Moxifloxacin,DB00218,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,moxifloxacin
Moxifloxacin,DB00218,Staphylococcal Pneumonia,C0032308,NA,Approved,NA,NA,moxifloxacin
Moxifloxacin,DB00218,Peritonitis,C0031154,NA,Approved,NA,NA,moxifloxacin
Moxifloxacin,DB00218,Pneumonia due to Klebsiella pneumoniae,C0519030,NA,Approved,NA,NA,moxifloxacin
Moxifloxacin,DB00218,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,moxifloxacin
Moxifloxacin,DB00218,Streptococcal pneumonia,C0155862,NA,Approved,NA,NA,moxifloxacin
Moxifloxacin,DB00218,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,moxifloxacin
Moxifloxacin,DB00218,Bacterial conjunctivitis,C0009768,NA,Approved,NA,NA,moxifloxacin
Moxifloxacin,DB00218,Rhinoscleroma,C0035468,NA,Approved,NA,NA,moxifloxacin
Moxifloxacin,DB00218,Pneumonic Plague,C0524688,NA,Approved,NA,NA,moxifloxacin
Moxifloxacin,DB00218,"Plague, Septicemic",C0152936,NA,Approved,NA,NA,moxifloxacin
Nelfinavir,DB00220,HIV Infections,C0019693,NA,Approved,NA,NA,nelfinavir
Glimepiride,DB00222,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,glimepiride
Diflorasone,DB00223,Pruritus Ani,C0033775,NA,Approved,NA,NA,diflorasone
Diflorasone,DB00223,Granuloma Annulare,C0085074,NA,Approved,NA,NA,diflorasone
Diflorasone,DB00223,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,diflorasone
Diflorasone,DB00223,Exanthema,C0015230,NA,Approved,NA,NA,diflorasone
Diflorasone,DB00223,Pruritus of genital organs,C0033777,NA,Approved,NA,NA,diflorasone
Diflorasone,DB00223,"Lymphoma, T-Cell, Cutaneous",C0079773,NA,Approved,NA,NA,diflorasone
Diflorasone,DB00223,"Lupus Erythematosus, Discoid",C0024138,NA,Approved,NA,NA,diflorasone
Diflorasone,DB00223,Lichen Simplex Chronicus,C0149922,NA,Approved,NA,NA,diflorasone
Diflorasone,DB00223,Contact Dermatitis,C0011616,NA,Approved,NA,NA,diflorasone
Diflorasone,DB00223,Scalp psoriasis,C0406326,NA,Approved,NA,NA,diflorasone
Diflorasone,DB00223,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,diflorasone
Diflorasone,DB00223,"Dermatitis, Atopic",C0011615,NA,Approved,NA,NA,diflorasone
Indinavir,DB00224,HIV Infections,C0019693,NA,Approved,NA,NA,indinavir
Guanadrel,DB00226,Hypertensive disease,C0020538,NA,Approved,NA,NA,guanadrel
Lovastatin,DB00227,Familial hypercholesterolemia - heterozygous,C0342882,NA,Approved,NA,NA,lovastatin
Lovastatin,DB00227,Hyperlipidemia,C0020473,NA,Approved,NA,NA,lovastatin
Lovastatin,DB00227,Hypercholesterolemia,C0020443,NA,Approved,NA,NA,lovastatin
Lovastatin,DB00227,Hypoalphalipoproteinemias,C0473527,NA,Approved,NA,NA,lovastatin
Lovastatin,DB00227,"Hyperlipidemia, Familial Combined",C0020474,NA,Approved,NA,NA,lovastatin
Lovastatin,DB00227,Hypertriglyceridemia,C0020557,NA,Approved,NA,NA,lovastatin
Lovastatin,DB00227,Arteriosclerosis,C0003850,NA,Approved,NA,NA,lovastatin
Pregabalin,DB00230,Diabetic peripheral neuropathy,C0740447,NA,Approved,NA,NA,pregabalin
Pregabalin,DB00230,Fibromyalgia,C0016053,NA,Approved,NA,NA,pregabalin
Pregabalin,DB00230,Postherpetic neuralgia,C0032768,NA,Approved,NA,NA,pregabalin
Pregabalin,DB00230,Generalized Anxiety Disorder,C0270549,NA,Approved,NA,NA,pregabalin
Temazepam,DB00231,Sleeplessness,C0917801,NA,Approved,NA,NA,temazepam
Methyclothiazide,DB00232,Hypertensive disease,C0020538,NA,Approved,NA,NA,methyclothiazide
Methyclothiazide,DB00232,Renal disease with edema NOS,C0866125,NA,Approved,NA,NA,methyclothiazide
Methyclothiazide,DB00232,Edema,C0013604,NA,Approved,NA,NA,methyclothiazide
Aminosalicylic Acid,DB00233,Acute tuberculosis,C0275959,NA,Approved,NA,NA,aminosalicylic acid
Aminosalicylic Acid,DB00233,"Tuberculosis, Pulmonary",C0041327,NA,Approved,NA,NA,aminosalicylic acid
Reboxetine,DB00234,Major Depressive Disorder,C1269683,NA,Approved,NA,NA,reboxetine
Milrinone,DB00235,Decompensated cardiac failure,C0581377,NA,Approved,NA,NA,milrinone
Butabarbital,DB00237,Severe anxiety (panic),C0231403,NA,Approved,NA,NA,butabarbital
Butabarbital,DB00237,Dysuria,C0013428,NA,Approved,NA,NA,butabarbital
Butabarbital,DB00237,Sleeplessness,C0917801,NA,Approved,NA,NA,butabarbital
Nevirapine,DB00238,HIV Infections,C0019693,NA,Approved,NA,NA,nevirapine
Oxiconazole,DB00239,Tinea corporis (disorder),C0040252,NA,Approved,NA,NA,oxiconazole
Oxiconazole,DB00239,Tinea Versicolor,C0040262,NA,Approved,NA,NA,oxiconazole
Oxiconazole,DB00239,Tinea cruris,C1384589,NA,Approved,NA,NA,oxiconazole
Oxiconazole,DB00239,Tinea Pedis,C0040259,NA,Approved,NA,NA,oxiconazole
Alclometasone,DB00240,Contact Dermatitis,C0011616,NA,Approved,NA,NA,alclometasone
Alclometasone,DB00240,Exanthema,C0015230,NA,Approved,NA,NA,alclometasone
Alclometasone,DB00240,"Lymphoma, T-Cell, Cutaneous",C0079773,NA,Approved,NA,NA,alclometasone
Alclometasone,DB00240,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,alclometasone
Alclometasone,DB00240,Pruritus Ani,C0033775,NA,Approved,NA,NA,alclometasone
Alclometasone,DB00240,Lichen Simplex Chronicus,C0149922,NA,Approved,NA,NA,alclometasone
Alclometasone,DB00240,"Dermatitis, Atopic",C0011615,NA,Approved,NA,NA,alclometasone
Alclometasone,DB00240,Granuloma Annulare,C0085074,NA,Approved,NA,NA,alclometasone
Alclometasone,DB00240,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,alclometasone
Alclometasone,DB00240,Scalp psoriasis,C0406326,NA,Approved,NA,NA,alclometasone
Alclometasone,DB00240,"Lupus Erythematosus, Discoid",C0024138,NA,Approved,NA,NA,alclometasone
Alclometasone,DB00240,Pruritus of genital organs,C0033777,NA,Approved,NA,NA,alclometasone
Butalbital,DB00241,Tension Headache,C0033893,NA,Approved,NA,NA,butalbital
Cladribine,DB00242,Hairy Cell Leukemia,C0023443,NA,Approved,NA,NA,cladribine
Ranolazine,DB00243,Angina Pectoris,C0002962,NA,Approved,NA,NA,ranolazine
Mesalazine,DB00244,Chronic ulcerative proctitis,C2937222,NA,Approved,NA,NA,mesalazine
Mesalazine,DB00244,Ulcerative Colitis,C0009324,NA,Approved,NA,NA,mesalazine
Mesalazine,DB00244,Ulcerative colitis in remission,C3697010,NA,Approved,NA,NA,mesalazine
Mesalazine,DB00244,Chronic ulcerative rectosigmoiditis,C0267390,NA,Approved,NA,NA,mesalazine
Benzatropine,DB00245,Extrapyramidal Disorders,C0015371,NA,Approved,NA,NA,benzatropine
Benzatropine,DB00245,"Parkinson Disease, Postencephalitic",C0030568,NA,Approved,NA,NA,benzatropine
Benzatropine,DB00245,Parkinson Disease,C0030567,NA,Approved,NA,NA,benzatropine
Benzatropine,DB00245,Parkinsonian Disorders,C0242422,NA,Approved,NA,NA,benzatropine
Ziprasidone,DB00246,Bipolar disorder in remission,C0270425,NA,Approved,NA,NA,ziprasidone
Ziprasidone,DB00246,Schizophrenia,C0036341,NA,Approved,NA,NA,ziprasidone
Ziprasidone,DB00246,Mixed bipolar I disorder,C0236780,NA,Approved,NA,NA,ziprasidone
Ziprasidone,DB00246,"Bipolar affective disorder, current episode manic",C0338873,NA,Approved,NA,NA,ziprasidone
Cabergoline,DB00248,Hyperprolactinemia,C0020514,NA,Approved,NA,NA,cabergoline
Idoxuridine,DB00249,"Keratitis, Herpetic",C0019357,NA,Approved,NA,NA,idoxuridine
Dapsone,DB00250,Acne Vulgaris,C0001144,NA,Approved,NA,NA,dapsone
Dapsone,DB00250,Leprosy,C0023343,NA,Approved,NA,NA,dapsone
Dapsone,DB00250,Dermatitis Herpetiformis,C0011608,NA,Approved,NA,NA,dapsone
Terconazole,DB00251,"Candidiasis, Vulvovaginal",C0700345,NA,Approved,NA,NA,terconazole
Phenytoin,DB00252,Status Epilepticus,C0038220,NA,Approved,NA,NA,phenytoin
Phenytoin,DB00252,Epilepsy characterized by intractable complex partial seizures,C2711653,NA,Approved,NA,NA,phenytoin
Phenytoin,DB00252,Epilepsy,C0014544,NA,Approved,NA,NA,phenytoin
Phenytoin,DB00252,Motor cortex epilepsy,C0234978,NA,Approved,NA,NA,phenytoin
Phenytoin,DB00252,"Epilepsies, Partial",C0014547,NA,Approved,NA,NA,phenytoin
Phenytoin,DB00252,Tonic - clonic seizures,C0494475,NA,Approved,NA,NA,phenytoin
Phenytoin,DB00252,Lennox-Gastaut syndrome,C0238111,NA,Approved,NA,NA,phenytoin
Phenytoin,DB00252,Tonic-Clonic Epilepsy,C0014549,NA,Approved,NA,NA,phenytoin
Phenytoin,DB00252,Bipolar disorder in remission,C0270425,NA,Approved,NA,NA,phenytoin
Phenytoin,DB00252,Simple Partial Seizures,C0234974,NA,Approved,NA,NA,phenytoin
Medrysone,DB00253,Rosacea,C0035854,NA,Approved,NA,NA,medrysone
Medrysone,DB00253,Iritis,C0022081,NA,Approved,NA,NA,medrysone
Medrysone,DB00253,Punctate keratopathy,C0423234,NA,Approved,NA,NA,medrysone
Medrysone,DB00253,Iridocyclitis,C0022073,NA,Approved,NA,NA,medrysone
Medrysone,DB00253,Corneal abrasion,C0010032,NA,Approved,NA,NA,medrysone
Medrysone,DB00253,Uveitis,C0042164,NA,Approved,NA,NA,medrysone
Medrysone,DB00253,Herpes zoster keratitis,C1275687,NA,Approved,NA,NA,medrysone
Medrysone,DB00253,Corneal Ulcer,C0010043,NA,Approved,NA,NA,medrysone
Medrysone,DB00253,Cyclitis,C0010543,NA,Approved,NA,NA,medrysone
Medrysone,DB00253,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,medrysone
Doxycycline,DB00254,Acne Vulgaris,C0001144,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Brucellosis,C0006309,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Scrub Typhus,C0036472,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Lymphogranuloma Venereum,C0024286,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Rocky Mountain Spotted Fever,C0035793,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Acute gonococcal cervicitis,C0153195,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Chlamydia trachomatis infection of genital structure,C1997322,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Cutaneous anthrax,C0003177,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Q Fever,C0034362,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Acute gonococcal urethritis,C0275652,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Actinomycosis,C0001261,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Endemic Flea-Borne Typhus,C0041472,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,TYPHUS,C0041471,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Anthrax disease,C0003175,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Cholera,C0008354,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Tularemia,C0041351,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Chancroids,C0007947,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,GONOCOCCAL INFECTION DISSEMINATED,C0744451,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,non-gonococcal urethritis (NGU),C1112709,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Pharyngitis,C0031350,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Sinusitis,C0037199,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Trachoma,C0040592,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Boutonneuse Fever,C0006060,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Gonorrhea of rectum,C0275665,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Yaws,C0043388,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Q fever endocarditis,C0340354,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Gonorrhea,C0018081,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Brill-Zinsser Disease,C0006181,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Listeriosis,C0023860,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Rickettsia Infections,C0035585,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Gonorrhea of pharynx,C0149966,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,"Typhus, Epidemic Louse-Borne",C0041473,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Rickettsialpox,C0035597,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Acute gonococcal endometritis,C0153196,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Acute gonococcal epididymo-orchitis,C0153193,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Inhalational anthrax,C0155866,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Gastrointestinal anthrax,C0152945,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Syphilis,C0039128,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Granuloma Inguinale,C0018190,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Mycoplasma pneumonia,C0032302,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Bronchitis,C0006277,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Bartonella Infections,C0004771,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Psittacosis,C0029291,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Relapsing Fever,C0035021,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,doxycycline
Doxycycline,DB00254,Chlamydia Infections,C0008149,NA,Approved,NA,NA,doxycycline
Clotrimazole,DB00257,"Candidiasis, Vulvovaginal",C0700345,NA,Approved,NA,NA,clotrimazole
Clotrimazole,DB00257,Diaper Rash,C0011974,NA,Approved,NA,NA,clotrimazole
Clotrimazole,DB00257,Oropharyngeal candidiasis,C0919659,NA,Approved,NA,NA,clotrimazole
Clotrimazole,DB00257,Tinea corporis (disorder),C0040252,NA,Approved,NA,NA,clotrimazole
Clotrimazole,DB00257,Cutaneous Candidiasis,C0006846,NA,Approved,NA,NA,clotrimazole
Clotrimazole,DB00257,Oral candidiasis,C0006849,NA,Approved,NA,NA,clotrimazole
Clotrimazole,DB00257,Tinea cruris,C1384589,NA,Approved,NA,NA,clotrimazole
Clotrimazole,DB00257,Tinea Pedis,C0040259,NA,Approved,NA,NA,clotrimazole
Clotrimazole,DB00257,Tinea Versicolor,C0040262,NA,Approved,NA,NA,clotrimazole
Calcium Acetate,DB00258,Disorder of electrolytes,C1704431,NA,Approved,NA,NA,calcium acetate
Calcium Acetate,DB00258,Hypermagnesemia,C0151714,NA,Approved,NA,NA,calcium acetate
Calcium Acetate,DB00258,Cardiac Arrest,C0018790,NA,Approved,NA,NA,calcium acetate
Calcium Acetate,DB00258,Hypocalcemia,C0020598,NA,Approved,NA,NA,calcium acetate
Calcium Acetate,DB00258,Hyperkalemia,C0020461,NA,Approved,NA,NA,calcium acetate
Calcium Acetate,DB00258,Hypocalcemic tetany,C0151940,NA,Approved,NA,NA,calcium acetate
Sulfanilamide,DB00259,Vulvovaginitis,C0042998,NA,Approved,NA,NA,sulfanilamide
Sulfanilamide,DB00259,"Candidiasis, Vulvovaginal",C0700345,NA,Approved,NA,NA,sulfanilamide
Cycloserine,DB00260,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,cycloserine
Cycloserine,DB00260,"Tuberculosis, Pulmonary",C0041327,NA,Approved,NA,NA,cycloserine
Cycloserine,DB00260,Acute tuberculosis,C0275959,NA,Approved,NA,NA,cycloserine
Cycloserine,DB00260,Bacterial urinary infection,C0729524,NA,Approved,NA,NA,cycloserine
Anagrelide,DB00261,"Thrombocythemia, Essential",C0040028,NA,Approved,NA,NA,anagrelide
Carmustine,DB00262,Malignant neoplasm of brain,C0153633,NA,Approved,NA,NA,carmustine
Carmustine,DB00262,Multiple Myeloma,C0026764,NA,Approved,NA,NA,carmustine
Carmustine,DB00262,Hodgkin Disease,C0019829,NA,Approved,NA,NA,carmustine
Carmustine,DB00262,Diffuse Large B-Cell Lymphoma,C0079744,NA,Approved,NA,NA,carmustine
Carmustine,DB00262,"Lymphoma, Non-Hodgkin",C0024305,NA,Approved,NA,NA,carmustine
Carmustine,DB00262,Malignant Glioma,C0555198,NA,Approved,NA,NA,carmustine
Carmustine,DB00262,Glioblastoma multiforme of brain,C0349543,NA,Approved,NA,NA,carmustine
Sulfisoxazole,DB00263,Chlamydial cervicitis,C0341834,NA,Approved,NA,NA,sulfisoxazole
Sulfisoxazole,DB00263,Infective otitis media,C0729586,NA,Approved,NA,NA,sulfisoxazole
Sulfisoxazole,DB00263,Chancroids,C0007947,NA,Approved,NA,NA,sulfisoxazole
Sulfisoxazole,DB00263,Meningococcal meningitis,C0025294,NA,Approved,NA,NA,sulfisoxazole
Sulfisoxazole,DB00263,Acute otitis media,C0271429,NA,Approved,NA,NA,sulfisoxazole
Sulfisoxazole,DB00263,Nocardia Infections,C0028242,NA,Approved,NA,NA,sulfisoxazole
Sulfisoxazole,DB00263,"Malaria, Falciparum",C0024535,NA,Approved,NA,NA,sulfisoxazole
Sulfisoxazole,DB00263,Trachoma,C0040592,NA,Approved,NA,NA,sulfisoxazole
Sulfisoxazole,DB00263,Inclusion conjunctivitis,C0009770,NA,Approved,NA,NA,sulfisoxazole
Sulfisoxazole,DB00263,Chlamydial urethritis,C1278807,NA,Approved,NA,NA,sulfisoxazole
Sulfisoxazole,DB00263,Urinary tract infection,C0042029,NA,Approved,NA,NA,sulfisoxazole
Metoprolol,DB00264,Hypertensive disease,C0020538,NA,Approved,NA,NA,metoprolol
Metoprolol,DB00264,Myocardial Infarction,C0027051,NA,Approved,NA,NA,metoprolol
Metoprolol,DB00264,Acute Coronary Syndrome,C0948089,NA,Approved,NA,NA,metoprolol
Metoprolol,DB00264,Angina Pectoris,C0002962,NA,Approved,NA,NA,metoprolol
Metoprolol,DB00264,Chronic heart failure,C0264716,NA,Approved,NA,NA,metoprolol
Crotamiton,DB00265,Scabies <infestation>,C0036262,NA,Approved,NA,NA,crotamiton
Crotamiton,DB00265,Pruritus,C0033774,NA,Approved,NA,NA,crotamiton
Dicoumarol,DB00266,Myocardial Infarction,C0027051,NA,Approved,NA,NA,dicoumarol
Dicoumarol,DB00266,Thromboembolism,C0040038,NA,Approved,NA,NA,dicoumarol
Dicoumarol,DB00266,Thrombosis,C0040053,NA,Approved,NA,NA,dicoumarol
Dicoumarol,DB00266,Cerebral Embolism,C0007780,NA,Approved,NA,NA,dicoumarol
Ropinirole,DB00268,Parkinson Disease,C0030567,NA,Approved,NA,NA,ropinirole
Ropinirole,DB00268,Restless Legs Syndrome,C0035258,NA,Approved,NA,NA,ropinirole
Isradipine,DB00270,Hypertensive disease,C0020538,NA,Approved,NA,NA,isradipine
Topiramate,DB00273,Tonic-Clonic Epilepsy,C0014549,NA,Approved,NA,NA,topiramate
Topiramate,DB00273,Epilepsy characterized by intractable complex partial seizures,C2711653,NA,Approved,NA,NA,topiramate
Topiramate,DB00273,Lennox-Gastaut syndrome,C0238111,NA,Approved,NA,NA,topiramate
Topiramate,DB00273,Simple Partial Seizures,C0234974,NA,Approved,NA,NA,topiramate
Cefmetazole,DB00274,Pneumonia,C0032285,NA,Approved,NA,NA,cefmetazole
Cefmetazole,DB00274,Staphylococcal Pneumonia,C0032308,NA,Approved,NA,NA,cefmetazole
Cefmetazole,DB00274,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,cefmetazole
Cefmetazole,DB00274,Pneumonia due to Escherichia coli,C0276089,NA,Approved,NA,NA,cefmetazole
Cefmetazole,DB00274,Urinary tract infection,C0042029,NA,Approved,NA,NA,cefmetazole
Cefmetazole,DB00274,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,cefmetazole
Cefmetazole,DB00274,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,cefmetazole
Cefmetazole,DB00274,Lower respiratory tract infection,C0149725,NA,Approved,NA,NA,cefmetazole
Olmesartan,DB00275,Hypertensive disease,C0020538,NA,Approved,NA,NA,olmesartan
Theophylline,DB00277,Lung diseases,C0024115,NA,Approved,NA,NA,theophylline
Theophylline,DB00277,Status Asthmaticus,C0038218,NA,Approved,NA,NA,theophylline
Theophylline,DB00277,Asthma night-time symptoms,C1273489,NA,Approved,NA,NA,theophylline
Theophylline,DB00277,Asthma,C0004096,NA,Approved,NA,NA,theophylline
Theophylline,DB00277,Bronchitis,C0006277,NA,Approved,NA,NA,theophylline
Theophylline,DB00277,Pulmonary Emphysema,C0034067,NA,Approved,NA,NA,theophylline
Theophylline,DB00277,Asthma-chronic obstructive pulmonary disease overlap syndrome,C4038730,NA,Approved,NA,NA,theophylline
Theophylline,DB00277,Bronchial Spasm,C0006266,NA,Approved,NA,NA,theophylline
Theophylline,DB00277,Asthma attack,C0347950,NA,Approved,NA,NA,theophylline
Argatroban,DB00278,Heparin-induced thrombocytopenia with thrombosis,C0272275,NA,Approved,NA,NA,argatroban
Liothyronine,DB00279,Malignant neoplasm of thyroid,C0007115,NA,Approved,NA,NA,liothyronine
Liothyronine,DB00279,Endemic goiter,C0018022,NA,Approved,NA,NA,liothyronine
Liothyronine,DB00279,Myxedema,C0027145,NA,Approved,NA,NA,liothyronine
Liothyronine,DB00279,Congenital Hypothyroidism,C0010308,NA,Approved,NA,NA,liothyronine
Liothyronine,DB00279,Goiter,C0018021,NA,Approved,NA,NA,liothyronine
Liothyronine,DB00279,Hypothyroidism,C0020676,NA,Approved,NA,NA,liothyronine
Liothyronine,DB00279,Myxedema coma,C0238298,NA,Approved,NA,NA,liothyronine
Disopyramide,DB00280,Ventricular arrhythmia,C0085612,NA,Approved,NA,NA,disopyramide
Lidocaine,DB00281,Ventricular arrhythmia,C0085612,NA,Approved,NA,NA,lidocaine
Lidocaine,DB00281,Scabies <infestation>,C0036262,NA,Approved,NA,NA,lidocaine
Lidocaine,DB00281,Infestation by Phthirus pubis,C0030759,NA,Approved,NA,NA,lidocaine
Lidocaine,DB00281,Pruritus Ani,C0033775,NA,Approved,NA,NA,lidocaine
Lidocaine,DB00281,Pruritus,C0033774,NA,Approved,NA,NA,lidocaine
Lidocaine,DB00281,Postherpetic neuralgia,C0032768,NA,Approved,NA,NA,lidocaine
Lidocaine,DB00281,Skin irritation,C0152030,NA,Approved,NA,NA,lidocaine
Lidocaine,DB00281,Hemorrhoids,C0019112,NA,Approved,NA,NA,lidocaine
Lidocaine,DB00281,Urethritis,C0041976,NA,Approved,NA,NA,lidocaine
Lidocaine,DB00281,Pediculus capitis infestation,C0030757,NA,Approved,NA,NA,lidocaine
Lidocaine,DB00281,Neuralgia,C0027796,NA,Approved,NA,NA,lidocaine
Lidocaine,DB00281,Mouth irritation,C0235339,NA,Approved,NA,NA,lidocaine
Lidocaine,DB00281,Premature Ejaculation,C0033038,NA,Approved,NA,NA,lidocaine
Pamidronate,DB00282,Humoral hypercalcemia of malignancy (disorder),C0149911,NA,Approved,NA,NA,pamidronate
Pamidronate,DB00282,Osteolytic Lesions of Multiple Myeloma,C3898069,NA,Approved,NA,NA,pamidronate
Pamidronate,DB00282,Osteitis Deformans,C0029401,NA,Approved,NA,NA,pamidronate
Clemastine,DB00283,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,clemastine
Clemastine,DB00283,Symptomatic dermographism,C0343065,NA,Approved,NA,NA,clemastine
Clemastine,DB00283,Sneezing,C0037383,NA,Approved,NA,NA,clemastine
Clemastine,DB00283,Urticaria,C0042109,NA,Approved,NA,NA,clemastine
Clemastine,DB00283,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,clemastine
Clemastine,DB00283,Pruritus,C0033774,NA,Approved,NA,NA,clemastine
Clemastine,DB00283,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,clemastine
Clemastine,DB00283,Rhinorrhea,C1260880,NA,Approved,NA,NA,clemastine
Clemastine,DB00283,"Rhinitis, Vasomotor",C0035460,NA,Approved,NA,NA,clemastine
Acarbose,DB00284,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,acarbose
Venlafaxine,DB00285,"Phobia, Social",C0031572,NA,Approved,NA,NA,venlafaxine
Venlafaxine,DB00285,Major Depressive Disorder,C1269683,NA,Approved,NA,NA,venlafaxine
Venlafaxine,DB00285,Generalized Anxiety Disorder,C0270549,NA,Approved,NA,NA,venlafaxine
Venlafaxine,DB00285,Panic Disorder,C0030319,NA,Approved,NA,NA,venlafaxine
Conjugated Estrogens,DB00286,Hot flushes,C0600142,NA,Approved,NA,NA,conjugated estrogens
Conjugated Estrogens,DB00286,Dyspareunia,C1384606,NA,Approved,NA,NA,conjugated estrogens
Travoprost,DB00287,Ocular Hypertension,C0028840,NA,Approved,NA,NA,travoprost
Travoprost,DB00287,"Glaucoma, Open-Angle",C0017612,NA,Approved,NA,NA,travoprost
Amcinonide,DB00288,Granuloma Annulare,C0085074,NA,Approved,NA,NA,amcinonide
Amcinonide,DB00288,Contact Dermatitis,C0011616,NA,Approved,NA,NA,amcinonide
Amcinonide,DB00288,Pruritus Ani,C0033775,NA,Approved,NA,NA,amcinonide
Amcinonide,DB00288,"Lymphoma, T-Cell, Cutaneous",C0079773,NA,Approved,NA,NA,amcinonide
Amcinonide,DB00288,Scalp psoriasis,C0406326,NA,Approved,NA,NA,amcinonide
Amcinonide,DB00288,Lichen Simplex Chronicus,C0149922,NA,Approved,NA,NA,amcinonide
Amcinonide,DB00288,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,amcinonide
Amcinonide,DB00288,Pruritus of genital organs,C0033777,NA,Approved,NA,NA,amcinonide
Amcinonide,DB00288,"Dermatitis, Atopic",C0011615,NA,Approved,NA,NA,amcinonide
Amcinonide,DB00288,Exanthema,C0015230,NA,Approved,NA,NA,amcinonide
Amcinonide,DB00288,"Lupus Erythematosus, Discoid",C0024138,NA,Approved,NA,NA,amcinonide
Amcinonide,DB00288,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,amcinonide
Atomoxetine,DB00289,Attention deficit hyperactivity disorder,C1263846,NA,Approved,NA,NA,atomoxetine
Bleomycin,DB00290,Squamous cell carcinoma,C0007137,NA,Approved,NA,NA,bleomycin
Bleomycin,DB00290,"Lymphoma, Non-Hodgkin",C0024305,NA,Approved,NA,NA,bleomycin
Bleomycin,DB00290,Malignant tumor of cervix,C0007847,NA,Approved,NA,NA,bleomycin
Bleomycin,DB00290,Diffuse Large B-Cell Lymphoma,C0079744,NA,Approved,NA,NA,bleomycin
Bleomycin,DB00290,"Lymphoma, Follicular",C0024301,NA,Approved,NA,NA,bleomycin
Bleomycin,DB00290,"Pleural Effusion, Malignant",C0080032,NA,Approved,NA,NA,bleomycin
Bleomycin,DB00290,Cancer of Head and Neck,C0278996,NA,Approved,NA,NA,bleomycin
Bleomycin,DB00290,Testicular Germ Cell Tumor,C1336708,NA,Approved,NA,NA,bleomycin
Bleomycin,DB00290,Malignant neoplasm of penis,C0153601,NA,Approved,NA,NA,bleomycin
Bleomycin,DB00290,FIGO stage finding for vulvar carcinoma,C1272826,NA,Approved,NA,NA,bleomycin
Bleomycin,DB00290,Hodgkin Disease,C0019829,NA,Approved,NA,NA,bleomycin
Chlorambucil,DB00291,"Lymphoma, Follicular",C0024301,NA,Approved,NA,NA,chlorambucil
Chlorambucil,DB00291,Hodgkin Disease,C0019829,NA,Approved,NA,NA,chlorambucil
Chlorambucil,DB00291,Chronic Lymphocytic Leukemia,C0023434,NA,Approved,NA,NA,chlorambucil
Morphine,DB00295,Chronic pain,C0150055,NA,Approved,NA,NA,morphine
Morphine,DB00295,Acute postoperative pain,C2215257,NA,Approved,NA,NA,morphine
Morphine,DB00295,Pain,C0030193,NA,Approved,NA,NA,morphine
Morphine,DB00295,Severe pain,C0278140,NA,Approved,NA,NA,morphine
Morphine,DB00295,Diarrhea,C0011991,NA,Approved,NA,NA,morphine
Bupivacaine,DB00297,Skin irritation,C0152030,NA,Approved,NA,NA,bupivacaine
Bupivacaine,DB00297,Pruritus,C0033774,NA,Approved,NA,NA,bupivacaine
Penciclovir,DB00299,Herpes zoster disease,C0019360,NA,Approved,NA,NA,penciclovir
Penciclovir,DB00299,Recurrent genital herpes simplex,C1274323,NA,Approved,NA,NA,penciclovir
Penciclovir,DB00299,Recurrent herpes simplex labialis,C1274321,NA,Approved,NA,NA,penciclovir
Penciclovir,DB00299,Herpes Labialis,C0019345,NA,Approved,NA,NA,penciclovir
Tenofovir,DB00300,"Hepatitis B, Chronic",C0524909,NA,Approved,NA,NA,tenofovir
Tenofovir,DB00300,HIV Infections,C0019693,NA,Approved,NA,NA,tenofovir
Tranexamic Acid,DB00302,Female hypogonadism syndrome,C0271578,NA,Approved,NA,NA,tranexamic acid
Tranexamic Acid,DB00302,Menorrhagia,C0025323,NA,Approved,NA,NA,tranexamic acid
Tranexamic Acid,DB00302,Endometriosis,C0014175,NA,Approved,NA,NA,tranexamic acid
Ertapenem,DB00303,Miscarriage with sepsis,C0269398,NA,Approved,NA,NA,ertapenem
Ertapenem,DB00303,Acute bacterial peritonitis,C0275550,NA,Approved,NA,NA,ertapenem
Ertapenem,DB00303,Diabetic foot infection,C0744130,NA,Approved,NA,NA,ertapenem
Ertapenem,DB00303,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,ertapenem
Ertapenem,DB00303,Peptostreptococcus infection,C1096562,NA,Approved,NA,NA,ertapenem
Ertapenem,DB00303,Abdominal Abscess,C0243001,NA,Approved,NA,NA,ertapenem
Ertapenem,DB00303,PYELONEPHRITIS E COLI,C0748196,NA,Approved,NA,NA,ertapenem
Ertapenem,DB00303,Streptococcal pneumonia,C0155862,NA,Approved,NA,NA,ertapenem
Ertapenem,DB00303,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,ertapenem
Ertapenem,DB00303,Female genital tract infection,C1263758,NA,Approved,NA,NA,ertapenem
Ertapenem,DB00303,Moraxella catarrhalis pneumonia,C0857831,NA,Approved,NA,NA,ertapenem
Ertapenem,DB00303,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,ertapenem
Mitomycin,DB00305,Adenocarcinoma of pancreas,C0281361,NA,Approved,NA,NA,mitomycin
Mitomycin,DB00305,Malignant neoplasm of stomach stage IV,C0278498,NA,Approved,NA,NA,mitomycin
Talbutal,DB00306,Sleeplessness,C0917801,NA,Approved,NA,NA,talbutal
Bexarotene,DB00307,"Lymphoma, T-Cell, Cutaneous",C0079773,NA,Approved,NA,NA,bexarotene
Vindesine,DB00309,Malignant neoplasm of lung,C0242379,NA,Approved,NA,NA,vindesine
Vindesine,DB00309,"Myeloid Leukemia, Chronic",C0023473,NA,Approved,NA,NA,vindesine
Vindesine,DB00309,melanoma,C0025202,NA,Approved,NA,NA,vindesine
Vindesine,DB00309,Acute lymphocytic leukemia,C0023449,NA,Approved,NA,NA,vindesine
Chlorthalidone,DB00310,Edema,C0013604,NA,Approved,NA,NA,chlorthalidone
Chlorthalidone,DB00310,Hypertensive disease,C0020538,NA,Approved,NA,NA,chlorthalidone
Pentobarbital,DB00312,Epilepsy,C0014544,NA,Approved,NA,NA,pentobarbital
Pentobarbital,DB00312,Status Epilepticus,C0038220,NA,Approved,NA,NA,pentobarbital
Pentobarbital,DB00312,Cerebral Ischemia,C0917798,NA,Approved,NA,NA,pentobarbital
Pentobarbital,DB00312,Sleeplessness,C0917801,NA,Approved,NA,NA,pentobarbital
Pentobarbital,DB00312,Severe anxiety (panic),C0231403,NA,Approved,NA,NA,pentobarbital
Valproic Acid,DB00313,"Bipolar affective disorder, current episode manic",C0338873,NA,Approved,NA,NA,valproic acid
Valproic Acid,DB00313,Epilepsy characterized by intractable complex partial seizures,C2711653,NA,Approved,NA,NA,valproic acid
Valproic Acid,DB00313,Epilepsy,C0014544,NA,Approved,NA,NA,valproic acid
Valproic Acid,DB00313,Absence Epilepsy,C0014553,NA,Approved,NA,NA,valproic acid
Capreomycin,DB00314,Acute tuberculosis,C0275959,NA,Approved,NA,NA,capreomycin
Capreomycin,DB00314,"Tuberculosis, Pulmonary",C0041327,NA,Approved,NA,NA,capreomycin
Zolmitriptan,DB00315,Migraine Disorders,C0149931,NA,Approved,NA,NA,zolmitriptan
Acetaminophen,DB00316,Pain,C0030193,NA,Approved,NA,NA,acetaminophen
Acetaminophen,DB00316,Tension Headache,C0033893,NA,Approved,NA,NA,acetaminophen
Acetaminophen,DB00316,Back Pain,C0004604,NA,Approved,NA,NA,acetaminophen
Acetaminophen,DB00316,Migraine Disorders,C0149931,NA,Approved,NA,NA,acetaminophen
Acetaminophen,DB00316,Headache Disorders,C0393735,NA,Approved,NA,NA,acetaminophen
Acetaminophen,DB00316,Arthritic pains,C0857177,NA,Approved,NA,NA,acetaminophen
Acetaminophen,DB00316,Arthralgia,C0003862,NA,Approved,NA,NA,acetaminophen
Acetaminophen,DB00316,Fever,C0015967,NA,Approved,NA,NA,acetaminophen
Acetaminophen,DB00316,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,acetaminophen
Acetaminophen,DB00316,Sinus headache,C0037195,NA,Approved,NA,NA,acetaminophen
Acetaminophen,DB00316,Influenza-like symptoms,C0392171,NA,Approved,NA,NA,acetaminophen
Acetaminophen,DB00316,Toothache,C0040460,NA,Approved,NA,NA,acetaminophen
Acetaminophen,DB00316,Common Cold,C0009443,NA,Approved,NA,NA,acetaminophen
Gefitinib,DB00317,Non-Small Cell Lung Carcinoma,C0007131,NA,Approved,NA,NA,gefitinib
Gefitinib,DB00317,Epidermal growth factor receptor positive non-small cell lung cancer,C1960925,NA,Approved,NA,NA,gefitinib
Codeine,DB00318,Sneezing,C0037383,NA,Approved,NA,NA,codeine
Codeine,DB00318,Coughing,C0010200,NA,Approved,NA,NA,codeine
Codeine,DB00318,Common Cold,C0009443,NA,Approved,NA,NA,codeine
Codeine,DB00318,Fever,C0015967,NA,Approved,NA,NA,codeine
Codeine,DB00318,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,codeine
Codeine,DB00318,Sore Throat,C0242429,NA,Approved,NA,NA,codeine
Codeine,DB00318,Rhinitis,C0035455,NA,Approved,NA,NA,codeine
Codeine,DB00318,Headache Disorders,C0393735,NA,Approved,NA,NA,codeine
Codeine,DB00318,Rhinorrhea,C1260880,NA,Approved,NA,NA,codeine
Codeine,DB00318,Pain,C0030193,NA,Approved,NA,NA,codeine
Codeine,DB00318,Influenza-like symptoms,C0392171,NA,Approved,NA,NA,codeine
Codeine,DB00318,Tension Headache,C0033893,NA,Approved,NA,NA,codeine
Codeine,DB00318,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,codeine
Piperacillin,DB00319,Enterobacter pneumonia,C1096258,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Infection due to Pseudomonas aeruginosa,C0276075,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Proteus septicemia,C0577690,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Acute gonococcal endometritis,C0153196,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Bacterial sepsis,C0684256,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Proteus urinary tract infection,C0577709,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Acute gonococcal cervicitis,C0153195,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Abdominal Abscess,C0243001,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,URINARY TRACT INFECTION ENTEROCOCCUS,C0749958,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Escherichia coli septicemia,C0276088,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Nosocomial pneumonia,C0949083,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Lower respiratory tract infection,C0149725,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Pneumonia due to Escherichia coli,C0276089,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Infection of bone,C2242472,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Arthropathy associated with infection,C0157749,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Escherichia coli Infections,C0014836,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Streptococcal sepsis,C0152964,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Pelvic Inflammatory Disease,C0242172,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Septicemia due to enterococcus,C0588233,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Appendicitis,C0003615,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Enterobacteriaceae Infections,C0014347,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Sepsis due to Pseudomonas,C2887096,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Postoperative infection,C0392618,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Acute gonococcal urethritis,C0275652,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Peritonitis,C0031154,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Sepsis due to Gram negative bacteria,C3163829,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Pneumonia due to Pseudomonas,C0155860,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Rhinoscleroma,C0035468,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Diabetic foot infection,C0744130,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Bacterial infection due to Klebsiella pneumoniae,C0343402,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Gonorrhea,C0018081,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Serratia Infections,C0085394,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Septicemia due to Bacteroides,C0276064,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Serratia sepsis,C0152973,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Urinary tract infection,C0042029,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Klebsiella cystitis,C0520775,NA,Approved,NA,NA,piperacillin
Piperacillin,DB00319,Female genital tract infection,C1263758,NA,Approved,NA,NA,piperacillin
Dihydroergotamine,DB00320,Cluster Headache,C0009088,NA,Approved,NA,NA,dihydroergotamine
Dihydroergotamine,DB00320,Vascular Headaches,C0042376,NA,Approved,NA,NA,dihydroergotamine
Dihydroergotamine,DB00320,Migraine Disorders,C0149931,NA,Approved,NA,NA,dihydroergotamine
Amitriptyline,DB00321,Mixed anxiety and depressive disorder,C0338908,NA,Approved,NA,NA,amitriptyline
Amitriptyline,DB00321,Depressive disorder,C0011581,NA,Approved,NA,NA,amitriptyline
Floxuridine,DB00322,Malignant neoplasm of liver,C0345904,NA,Approved,NA,NA,floxuridine
Floxuridine,DB00322,Primary malignant neoplasm of gastrointestinal tract,C1306632,NA,Approved,NA,NA,floxuridine
Tolcapone,DB00323,Parkinson Disease,C0030567,NA,Approved,NA,NA,tolcapone
Fluorometholone,DB00324,Uveitis,C0042164,NA,Approved,NA,NA,fluorometholone
Fluorometholone,DB00324,Herpes zoster keratitis,C1275687,NA,Approved,NA,NA,fluorometholone
Fluorometholone,DB00324,Cyclitis,C0010543,NA,Approved,NA,NA,fluorometholone
Fluorometholone,DB00324,Iridocyclitis,C0022073,NA,Approved,NA,NA,fluorometholone
Fluorometholone,DB00324,Punctate keratopathy,C0423234,NA,Approved,NA,NA,fluorometholone
Fluorometholone,DB00324,Corneal Ulcer,C0010043,NA,Approved,NA,NA,fluorometholone
Fluorometholone,DB00324,Corneal abrasion,C0010032,NA,Approved,NA,NA,fluorometholone
Fluorometholone,DB00324,Rosacea,C0035854,NA,Approved,NA,NA,fluorometholone
Fluorometholone,DB00324,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,fluorometholone
Fluorometholone,DB00324,Iritis,C0022081,NA,Approved,NA,NA,fluorometholone
Nitroprusside,DB00325,Hypertensive urgency,C0745138,NA,Approved,NA,NA,nitroprusside
Nitroprusside,DB00325,Decompensated cardiac failure,C0581377,NA,Approved,NA,NA,nitroprusside
Nitroprusside,DB00325,Hypertensive disease,C0020538,NA,Approved,NA,NA,nitroprusside
Nitroprusside,DB00325,Malignant essential hypertension,C0024588,NA,Approved,NA,NA,nitroprusside
Calcium Gluceptate,DB00326,Hypermagnesemia,C0151714,NA,Approved,NA,NA,calcium gluceptate
Calcium Gluceptate,DB00326,Hyperkalemia,C0020461,NA,Approved,NA,NA,calcium gluceptate
Calcium Gluceptate,DB00326,Hypocalcemia,C0020598,NA,Approved,NA,NA,calcium gluceptate
Calcium Gluceptate,DB00326,Disorder of electrolytes,C1704431,NA,Approved,NA,NA,calcium gluceptate
Calcium Gluceptate,DB00326,Hypocalcemic tetany,C0151940,NA,Approved,NA,NA,calcium gluceptate
Calcium Gluceptate,DB00326,Cardiac Arrest,C0018790,NA,Approved,NA,NA,calcium gluceptate
Hydromorphone,DB00327,Common Cold,C0009443,NA,Approved,NA,NA,hydromorphone
Hydromorphone,DB00327,Coughing,C0010200,NA,Approved,NA,NA,hydromorphone
Hydromorphone,DB00327,Acute postoperative pain,C2215257,NA,Approved,NA,NA,hydromorphone
Hydromorphone,DB00327,Pain,C0030193,NA,Approved,NA,NA,hydromorphone
Hydromorphone,DB00327,Severe pain,C0278140,NA,Approved,NA,NA,hydromorphone
Indomethacin,DB00328,Tenosynovitis,C0039520,NA,Approved,NA,NA,indomethacin
Indomethacin,DB00328,Bursitis,C0006444,NA,Approved,NA,NA,indomethacin
Indomethacin,DB00328,shoulder bursitis,C0262399,NA,Approved,NA,NA,indomethacin
Indomethacin,DB00328,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,indomethacin
Indomethacin,DB00328,Ankylosing spondylitis,C0038013,NA,Approved,NA,NA,indomethacin
Indomethacin,DB00328,Patent ductus arteriosus,C0013274,NA,Approved,NA,NA,indomethacin
Indomethacin,DB00328,Shoulder tendinitis,C0262633,NA,Approved,NA,NA,indomethacin
Indomethacin,DB00328,Synovitis,C0039103,NA,Approved,NA,NA,indomethacin
Indomethacin,DB00328,Degenerative polyarthritis,C0029408,NA,Approved,NA,NA,indomethacin
Indomethacin,DB00328,Tendinitis,C0039503,NA,Approved,NA,NA,indomethacin
Indomethacin,DB00328,Gout,C0018099,NA,Approved,NA,NA,indomethacin
Indomethacin,DB00328,Rheumatism,C0035435,NA,Approved,NA,NA,indomethacin
Ethambutol,DB00330,Acute tuberculosis,C0275959,NA,Approved,NA,NA,ethambutol
Ethambutol,DB00330,"Tuberculosis, Pulmonary",C0041327,NA,Approved,NA,NA,ethambutol
Metformin,DB00331,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,metformin
Ipratropium bromide,DB00332,Bronchial Spasm,C0006266,NA,Approved,NA,NA,ipratropium bromide
Ipratropium bromide,DB00332,Rhinorrhea,C1260880,NA,Approved,NA,NA,ipratropium bromide
Ipratropium bromide,DB00332,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,ipratropium bromide
Ipratropium bromide,DB00332,Chronic Obstructive Airway Disease,C0024117,NA,Approved,NA,NA,ipratropium bromide
Ipratropium bromide,DB00332,Pulmonary Emphysema,C0034067,NA,Approved,NA,NA,ipratropium bromide
Ipratropium bromide,DB00332,Bronchitis,C0006277,NA,Approved,NA,NA,ipratropium bromide
Methadone,DB00333,Opioid withdrawal,C0029104,NA,Approved,NA,NA,methadone
Methadone,DB00333,Severe pain,C0278140,NA,Approved,NA,NA,methadone
Olanzapine,DB00334,"Depression, Bipolar",C0005587,NA,Approved,NA,NA,olanzapine
Olanzapine,DB00334,Bipolar disorder in remission,C0270425,NA,Approved,NA,NA,olanzapine
Olanzapine,DB00334,Major Depressive Disorder,C1269683,NA,Approved,NA,NA,olanzapine
Olanzapine,DB00334,Mixed bipolar I disorder,C0236780,NA,Approved,NA,NA,olanzapine
Olanzapine,DB00334,"Bipolar affective disorder, current episode manic",C0338873,NA,Approved,NA,NA,olanzapine
Olanzapine,DB00334,Schizophrenia,C0036341,NA,Approved,NA,NA,olanzapine
Atenolol,DB00335,Myocardial Infarction,C0027051,NA,Approved,NA,NA,atenolol
Atenolol,DB00335,Angina Pectoris,C0002962,NA,Approved,NA,NA,atenolol
Atenolol,DB00335,Hypertensive disease,C0020538,NA,Approved,NA,NA,atenolol
Nitrofural,DB00336,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,nitrofural
Nitrofural,DB00336,Klebsiella cystitis,C0520775,NA,Approved,NA,NA,nitrofural
Nitrofural,DB00336,URINARY TRACT INFECTION ENTEROCOCCUS,C0749958,NA,Approved,NA,NA,nitrofural
Omeprazole,DB00338,Erosive esophagitis,C0267055,NA,Approved,NA,NA,omeprazole
Omeprazole,DB00338,Zollinger-Ellison syndrome,C0043515,NA,Approved,NA,NA,omeprazole
Omeprazole,DB00338,Peptic Esophagitis,C0014869,NA,Approved,NA,NA,omeprazole
Omeprazole,DB00338,Gastroesophageal reflux disease,C0017168,NA,Approved,NA,NA,omeprazole
Omeprazole,DB00338,Peptic Ulcer,C0030920,NA,Approved,NA,NA,omeprazole
Omeprazole,DB00338,Gastric ulcer,C0038358,NA,Approved,NA,NA,omeprazole
Omeprazole,DB00338,Duodenal Ulcer,C0013295,NA,Approved,NA,NA,omeprazole
Pyrazinamide,DB00339,Acute tuberculosis,C0275959,NA,Approved,NA,NA,pyrazinamide
Pyrazinamide,DB00339,"Tuberculosis, Pulmonary",C0041327,NA,Approved,NA,NA,pyrazinamide
Pyrazinamide,DB00339,"Tuberculosis, Meningeal",C0041318,NA,Approved,NA,NA,pyrazinamide
Metixene,DB00340,Parkinsonian Disorders,C0242422,NA,Approved,NA,NA,metixene
Cetirizine,DB00341,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,cetirizine
Cetirizine,DB00341,Hay fever,C0018621,NA,Approved,NA,NA,cetirizine
Cetirizine,DB00341,Rhinorrhea,C1260880,NA,Approved,NA,NA,cetirizine
Cetirizine,DB00341,Common Cold,C0009443,NA,Approved,NA,NA,cetirizine
Cetirizine,DB00341,Chronic idiopathic urticaria,C0578870,NA,Approved,NA,NA,cetirizine
Cetirizine,DB00341,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,cetirizine
Cetirizine,DB00341,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,cetirizine
Cetirizine,DB00341,"Rhinitis, Vasomotor",C0035460,NA,Approved,NA,NA,cetirizine
Cetirizine,DB00341,Sneezing,C0037383,NA,Approved,NA,NA,cetirizine
Diltiazem,DB00343,"Angina Pectoris, Variant",C0002963,NA,Approved,NA,NA,diltiazem
Diltiazem,DB00343,Hypertensive disease,C0020538,NA,Approved,NA,NA,diltiazem
Diltiazem,DB00343,Paroxysmal supraventricular tachycardia,C0030590,NA,Approved,NA,NA,diltiazem
Diltiazem,DB00343,Angina Pectoris,C0002962,NA,Approved,NA,NA,diltiazem
Diltiazem,DB00343,Atrial Fibrillation,C0004238,NA,Approved,NA,NA,diltiazem
Protriptyline,DB00344,Depressive disorder,C0011581,NA,Approved,NA,NA,protriptyline
Alfuzosin,DB00346,Prostatic Hypertrophy,C1739363,NA,Approved,NA,NA,alfuzosin
Trimethadione,DB00347,Epilepsy,C0014544,NA,Approved,NA,NA,trimethadione
Trimethadione,DB00347,Absence Epilepsy,C0014553,NA,Approved,NA,NA,trimethadione
Nitisinone,DB00348,"Tyrosinemia, Type I",C0268490,NA,Approved,NA,NA,nitisinone
Clobazam,DB00349,Lennox-Gastaut syndrome,C0238111,NA,Approved,NA,NA,clobazam
Minoxidil,DB00350,Hypertensive disease,C0020538,NA,Approved,NA,NA,minoxidil
Minoxidil,DB00350,Alopecia,C0002170,NA,Approved,NA,NA,minoxidil
Megestrol acetate,DB00351,Nutritional deficiency associated with AIDS,C0276587,NA,Approved,NA,NA,megestrol acetate
Megestrol acetate,DB00351,Endometrial Carcinoma,C0476089,NA,Approved,NA,NA,megestrol acetate
Megestrol acetate,DB00351,Hormone receptor positive malignant neoplasm of breast,C1562029,NA,Approved,NA,NA,megestrol acetate
Tioguanine,DB00352,"Leukemia, Myelocytic, Acute",C0023467,NA,Approved,NA,NA,tioguanine
Methylergometrine,DB00353,Postpartum Hemorrhage,C0032797,NA,Approved,NA,NA,methylergometrine
Buclizine,DB00354,Motion Sickness,C0026603,NA,Approved,NA,NA,buclizine
Aztreonam,DB00355,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,aztreonam
Aztreonam,DB00355,Serratia Infections,C0085394,NA,Approved,NA,NA,aztreonam
Aztreonam,DB00355,Enterobacter pneumonia,C1096258,NA,Approved,NA,NA,aztreonam
Aztreonam,DB00355,URINARY TRACT INFECTION CITROBACTER,C0749955,NA,Approved,NA,NA,aztreonam
Aztreonam,DB00355,Bacterial urinary infection,C0729524,NA,Approved,NA,NA,aztreonam
Aztreonam,DB00355,Klebsiella cystitis,C0520775,NA,Approved,NA,NA,aztreonam
Aztreonam,DB00355,Sepsis due to Pseudomonas,C2887096,NA,Approved,NA,NA,aztreonam
Aztreonam,DB00355,Pelvic Inflammatory Disease,C0242172,NA,Approved,NA,NA,aztreonam
Aztreonam,DB00355,Rhinoscleroma,C0035468,NA,Approved,NA,NA,aztreonam
Aztreonam,DB00355,Infection due to Pseudomonas aeruginosa,C0276075,NA,Approved,NA,NA,aztreonam
Aztreonam,DB00355,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,aztreonam
Aztreonam,DB00355,Proteus urinary tract infection,C0577709,NA,Approved,NA,NA,aztreonam
Aztreonam,DB00355,Enterobacteriaceae Infections,C0014347,NA,Approved,NA,NA,aztreonam
Aztreonam,DB00355,Bacterial peritonitis,C0341503,NA,Approved,NA,NA,aztreonam
Aztreonam,DB00355,Pneumonia due to Escherichia coli,C0276089,NA,Approved,NA,NA,aztreonam
Aztreonam,DB00355,Escherichia coli Infections,C0014836,NA,Approved,NA,NA,aztreonam
Aztreonam,DB00355,Peritonitis,C0031154,NA,Approved,NA,NA,aztreonam
Aztreonam,DB00355,Endometritis,C0014179,NA,Approved,NA,NA,aztreonam
Aztreonam,DB00355,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,aztreonam
Aztreonam,DB00355,Escherichia coli septicemia,C0276088,NA,Approved,NA,NA,aztreonam
Aztreonam,DB00355,Female genital tract infection,C1263758,NA,Approved,NA,NA,aztreonam
Aztreonam,DB00355,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,aztreonam
Aztreonam,DB00355,Serratia sepsis,C0152973,NA,Approved,NA,NA,aztreonam
Aztreonam,DB00355,Pneumonia due to Pseudomonas,C0155860,NA,Approved,NA,NA,aztreonam
Aztreonam,DB00355,Bacterial infection due to Klebsiella pneumoniae,C0343402,NA,Approved,NA,NA,aztreonam
Aztreonam,DB00355,Proteus septicemia,C0577690,NA,Approved,NA,NA,aztreonam
Aztreonam,DB00355,Lower respiratory tract infection,C0149725,NA,Approved,NA,NA,aztreonam
Aztreonam,DB00355,Sepsis due to Gram negative bacteria,C3163829,NA,Approved,NA,NA,aztreonam
Aztreonam,DB00355,Urinary tract infection,C0042029,NA,Approved,NA,NA,aztreonam
Aztreonam,DB00355,Proteus pneumonia,C1260917,NA,Approved,NA,NA,aztreonam
Chlorzoxazone,DB00356,Muscle Spasticity,C0026838,NA,Approved,NA,NA,chlorzoxazone
Aminoglutethimide,DB00357,Secondary malignant neoplasm of female breast,C0346993,NA,Approved,NA,NA,aminoglutethimide
Mefloquine,DB00358,"Malaria, Vivax",C0024537,NA,Approved,NA,NA,mefloquine
Sulfadiazine,DB00359,Toxoplasmosis,C0040558,NA,Approved,NA,NA,sulfadiazine
Sulfadiazine,DB00359,Chorioretinitis,C0008513,NA,Approved,NA,NA,sulfadiazine
Sulfadiazine,DB00359,Ulcerative Colitis,C0009324,NA,Approved,NA,NA,sulfadiazine
Sulfadiazine,DB00359,Toxoplasmosis associated with AIDS,C1720498,NA,Approved,NA,NA,sulfadiazine
Sulfadiazine,DB00359,Skin Ulcer,C0037299,NA,Approved,NA,NA,sulfadiazine
Sulfadiazine,DB00359,"Toxoplasmosis, Congenital",C0040560,NA,Approved,NA,NA,sulfadiazine
Sapropterin,DB00360,Classical phenylketonuria,C0751434,NA,Approved,NA,NA,sapropterin
Vinorelbine,DB00361,Non-Small Cell Lung Carcinoma,C0007131,NA,Approved,NA,NA,vinorelbine
Anidulafungin,DB00362,Candidiasis of the esophagus,C0239295,NA,Approved,NA,NA,anidulafungin
Anidulafungin,DB00362,candidal peritonitis,C2062982,NA,Approved,NA,NA,anidulafungin
Anidulafungin,DB00362,Candidemia,C0877445,NA,Approved,NA,NA,anidulafungin
Clozapine,DB00363,Treatment-resistant schizophrenia,C3544321,NA,Approved,NA,NA,clozapine
Sucralfate,DB00364,Duodenal Ulcer,C0013295,NA,Approved,NA,NA,sucralfate
Doxylamine,DB00366,Pruritus,C0033774,NA,Approved,NA,NA,doxylamine
Doxylamine,DB00366,Influenza-like symptoms,C0392171,NA,Approved,NA,NA,doxylamine
Doxylamine,DB00366,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,doxylamine
Doxylamine,DB00366,"Rhinitis, Vasomotor",C0035460,NA,Approved,NA,NA,doxylamine
Doxylamine,DB00366,Common Cold,C0009443,NA,Approved,NA,NA,doxylamine
Doxylamine,DB00366,Hay fever,C0018621,NA,Approved,NA,NA,doxylamine
Doxylamine,DB00366,Sneezing,C0037383,NA,Approved,NA,NA,doxylamine
Doxylamine,DB00366,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,doxylamine
Doxylamine,DB00366,Urticaria,C0042109,NA,Approved,NA,NA,doxylamine
Doxylamine,DB00366,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,doxylamine
Doxylamine,DB00366,Rhinorrhea,C1260880,NA,Approved,NA,NA,doxylamine
Doxylamine,DB00366,Symptomatic dermographism,C0343065,NA,Approved,NA,NA,doxylamine
Levonorgestrel,DB00367,Menorrhagia,C0025323,NA,Approved,NA,NA,levonorgestrel
Levonorgestrel,DB00367,Hot flushes,C0600142,NA,Approved,NA,NA,levonorgestrel
Norepinephrine,DB00368,Asthma attack,C0347950,NA,Approved,NA,NA,norepinephrine
Norepinephrine,DB00368,Bronchitis,C0006277,NA,Approved,NA,NA,norepinephrine
Norepinephrine,DB00368,Asthma,C0004096,NA,Approved,NA,NA,norepinephrine
Norepinephrine,DB00368,Hypotension,C0020649,NA,Approved,NA,NA,norepinephrine
Norepinephrine,DB00368,Bronchiectasis,C0006267,NA,Approved,NA,NA,norepinephrine
Norepinephrine,DB00368,Pulmonary Emphysema,C0034067,NA,Approved,NA,NA,norepinephrine
Norepinephrine,DB00368,Parkinson Disease,C0030567,NA,Approved,NA,NA,norepinephrine
Mirtazapine,DB00370,Major Depressive Disorder,C1269683,NA,Approved,NA,NA,mirtazapine
Meprobamate,DB00371,Anxiety,C0003467,NA,Approved,NA,NA,meprobamate
Timolol,DB00373,Ocular Hypertension,C0028840,NA,Approved,NA,NA,timolol
Timolol,DB00373,"Glaucoma, Open-Angle",C0017612,NA,Approved,NA,NA,timolol
Timolol,DB00373,Hypertensive disease,C0020538,NA,Approved,NA,NA,timolol
Treprostinil,DB00374,Pulmonary arterial hypertension,C2973725,NA,Approved,NA,NA,treprostinil
Colestipol,DB00375,Hypercholesterolemia,C0020443,NA,Approved,NA,NA,colestipol
Colestipol,DB00375,Hyperlipidemia,C0020473,NA,Approved,NA,NA,colestipol
Trihexyphenidyl,DB00376,Extrapyramidal Disorders,C0015371,NA,Approved,NA,NA,trihexyphenidyl
Trihexyphenidyl,DB00376,Parkinsonian Disorders,C0242422,NA,Approved,NA,NA,trihexyphenidyl
Trihexyphenidyl,DB00376,Parkinson Disease,C0030567,NA,Approved,NA,NA,trihexyphenidyl
Trihexyphenidyl,DB00376,"Parkinson Disease, Postencephalitic",C0030568,NA,Approved,NA,NA,trihexyphenidyl
Palonosetron,DB00377,Chemotherapy-induced nausea and vomiting,C0401160,NA,Approved,NA,NA,palonosetron
Mexiletine,DB00379,Ventricular arrhythmia,C0085612,NA,Approved,NA,NA,mexiletine
Amlodipine,DB00381,"Angina Pectoris, Variant",C0002963,NA,Approved,NA,NA,amlodipine
Amlodipine,DB00381,Cerebrovascular accident,C0038454,NA,Approved,NA,NA,amlodipine
Amlodipine,DB00381,Hypertensive disease,C0020538,NA,Approved,NA,NA,amlodipine
Amlodipine,DB00381,Angina Pectoris,C0002962,NA,Approved,NA,NA,amlodipine
Oxyphencyclimine,DB00383,Peptic Ulcer,C0030920,NA,Approved,NA,NA,oxyphencyclimine
Triamterene,DB00384,Hypertensive disease,C0020538,NA,Approved,NA,NA,triamterene
Triamterene,DB00384,Edema,C0013604,NA,Approved,NA,NA,triamterene
Valrubicin,DB00385,Malignant neoplasm of urinary bladder,C0005684,NA,Approved,NA,NA,valrubicin
Procyclidine,DB00387,Parkinson Disease,C0030567,NA,Approved,NA,NA,procyclidine
Procyclidine,DB00387,Parkinsonian Disorders,C0242422,NA,Approved,NA,NA,procyclidine
Procyclidine,DB00387,Extrapyramidal Disorders,C0015371,NA,Approved,NA,NA,procyclidine
Procyclidine,DB00387,"Parkinson Disease, Postencephalitic",C0030568,NA,Approved,NA,NA,procyclidine
Phenylephrine,DB00388,Coughing,C0010200,NA,Approved,NA,NA,phenylephrine
Phenylephrine,DB00388,Sneezing,C0037383,NA,Approved,NA,NA,phenylephrine
Phenylephrine,DB00388,Rhinorrhea,C1260880,NA,Approved,NA,NA,phenylephrine
Phenylephrine,DB00388,Fever,C0015967,NA,Approved,NA,NA,phenylephrine
Phenylephrine,DB00388,Redness of eye,C0235267,NA,Approved,NA,NA,phenylephrine
Phenylephrine,DB00388,Rectal pain,C0034886,NA,Approved,NA,NA,phenylephrine
Phenylephrine,DB00388,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,phenylephrine
Phenylephrine,DB00388,Headache Disorders,C0393735,NA,Approved,NA,NA,phenylephrine
Phenylephrine,DB00388,Rhinitis,C0035455,NA,Approved,NA,NA,phenylephrine
Phenylephrine,DB00388,Sinus headache,C0037195,NA,Approved,NA,NA,phenylephrine
Phenylephrine,DB00388,Proctitis,C0033246,NA,Approved,NA,NA,phenylephrine
Phenylephrine,DB00388,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,phenylephrine
Phenylephrine,DB00388,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,phenylephrine
Phenylephrine,DB00388,Hemorrhoids,C0019112,NA,Approved,NA,NA,phenylephrine
Phenylephrine,DB00388,Hay fever,C0018621,NA,Approved,NA,NA,phenylephrine
Phenylephrine,DB00388,"Rhinitis, Vasomotor",C0035460,NA,Approved,NA,NA,phenylephrine
Phenylephrine,DB00388,Influenza-like symptoms,C0392171,NA,Approved,NA,NA,phenylephrine
Phenylephrine,DB00388,Mydriasis,C0026961,NA,Approved,NA,NA,phenylephrine
Phenylephrine,DB00388,Common Cold,C0009443,NA,Approved,NA,NA,phenylephrine
Phenylephrine,DB00388,Pruritus Ani,C0033775,NA,Approved,NA,NA,phenylephrine
Carbimazole,DB00389,Hyperthyroidism,C0020550,NA,Approved,NA,NA,carbimazole
Carbimazole,DB00389,Graves Disease,C0018213,NA,Approved,NA,NA,carbimazole
Digoxin,DB00390,Atrial Fibrillation,C0004238,NA,Approved,NA,NA,digoxin
Digoxin,DB00390,Poisoning by digitalis glycoside,C0274726,NA,Approved,NA,NA,digoxin
Digoxin,DB00390,Chronic heart failure,C0264716,NA,Approved,NA,NA,digoxin
Sulpiride,DB00391,Schizophrenia,C0036341,NA,Approved,NA,NA,sulpiride
Nimodipine,DB00393,Subarachnoid Hemorrhage,C0038525,NA,Approved,NA,NA,nimodipine
Beclomethasone dipropionate,DB00394,Rhinitis,C0035455,NA,Approved,NA,NA,beclomethasone dipropionate
Beclomethasone dipropionate,DB00394,Nasal Polyps,C0027430,NA,Approved,NA,NA,beclomethasone dipropionate
Beclomethasone dipropionate,DB00394,Asthma,C0004096,NA,Approved,NA,NA,beclomethasone dipropionate
Beclomethasone dipropionate,DB00394,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,beclomethasone dipropionate
Beclomethasone dipropionate,DB00394,"Rhinitis, Vasomotor",C0035460,NA,Approved,NA,NA,beclomethasone dipropionate
Carisoprodol,DB00395,Back Pain,C0004604,NA,Approved,NA,NA,carisoprodol
Carisoprodol,DB00395,Muscle Spasticity,C0026838,NA,Approved,NA,NA,carisoprodol
Progesterone,DB00396,Hot flushes,C0600142,NA,Approved,NA,NA,progesterone
Progesterone,DB00396,Endometrial Carcinoma,C0476089,NA,Approved,NA,NA,progesterone
Progesterone,DB00396,Secondary malignant neoplasm of kidney,C0153685,NA,Approved,NA,NA,progesterone
Progesterone,DB00396,Endometriosis,C0014175,NA,Approved,NA,NA,progesterone
Progesterone,DB00396,Metrorrhagia,C0025874,NA,Approved,NA,NA,progesterone
Progesterone,DB00396,Atrophic Vaginitis,C0221392,NA,Approved,NA,NA,progesterone
Progesterone,DB00396,Secondary physiologic amenorrhea,C0232940,NA,Approved,NA,NA,progesterone
Phenylpropanolamine,DB00397,Influenza-like symptoms,C0392171,NA,Approved,NA,NA,phenylpropanolamine
Phenylpropanolamine,DB00397,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,phenylpropanolamine
Phenylpropanolamine,DB00397,"Rhinitis, Vasomotor",C0035460,NA,Approved,NA,NA,phenylpropanolamine
Phenylpropanolamine,DB00397,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,phenylpropanolamine
Phenylpropanolamine,DB00397,Coughing,C0010200,NA,Approved,NA,NA,phenylpropanolamine
Phenylpropanolamine,DB00397,Hay fever,C0018621,NA,Approved,NA,NA,phenylpropanolamine
Phenylpropanolamine,DB00397,Rhinorrhea,C1260880,NA,Approved,NA,NA,phenylpropanolamine
Phenylpropanolamine,DB00397,Common Cold,C0009443,NA,Approved,NA,NA,phenylpropanolamine
Phenylpropanolamine,DB00397,Sneezing,C0037383,NA,Approved,NA,NA,phenylpropanolamine
Phenylpropanolamine,DB00397,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,phenylpropanolamine
Phenylpropanolamine,DB00397,Sinus headache,C0037195,NA,Approved,NA,NA,phenylpropanolamine
Phenylpropanolamine,DB00397,Rhinitis,C0035455,NA,Approved,NA,NA,phenylpropanolamine
Sorafenib,DB00398,Renal Cell Carcinoma,C0007134,NA,Approved,NA,NA,sorafenib
Sorafenib,DB00398,Liver carcinoma,C2239176,NA,Approved,NA,NA,sorafenib
Sorafenib,DB00398,Malignant epithelial neoplasm of thyroid,C3163939,NA,Approved,NA,NA,sorafenib
Zoledronic acid,DB00399,Osteoporosis,C0029456,NA,Approved,NA,NA,zoledronic acid
Zoledronic acid,DB00399,Humoral hypercalcemia of malignancy (disorder),C0149911,NA,Approved,NA,NA,zoledronic acid
Zoledronic acid,DB00399,Osteitis Deformans,C0029401,NA,Approved,NA,NA,zoledronic acid
Zoledronic acid,DB00399,Osteolytic Lesions of Multiple Myeloma,C3898069,NA,Approved,NA,NA,zoledronic acid
Zoledronic acid,DB00399,"Osteoporosis, Postmenopausal",C0029458,NA,Approved,NA,NA,zoledronic acid
Griseofulvin,DB00400,Tinea corporis (disorder),C0040252,NA,Approved,NA,NA,griseofulvin
Griseofulvin,DB00400,Tinea cruris,C1384589,NA,Approved,NA,NA,griseofulvin
Griseofulvin,DB00400,Tinea Capitis,C0040250,NA,Approved,NA,NA,griseofulvin
Griseofulvin,DB00400,Onychomycosis,C0040261,NA,Approved,NA,NA,griseofulvin
Griseofulvin,DB00400,Tinea barbae,C2349994,NA,Approved,NA,NA,griseofulvin
Griseofulvin,DB00400,Tinea Pedis,C0040259,NA,Approved,NA,NA,griseofulvin
Nisoldipine,DB00401,Hypertensive disease,C0020538,NA,Approved,NA,NA,nisoldipine
Eszopiclone,DB00402,Sleeplessness,C0917801,NA,Approved,NA,NA,eszopiclone
Alprazolam,DB00404,Anxiety,C0003467,NA,Approved,NA,NA,alprazolam
Alprazolam,DB00404,Mixed anxiety and depressive disorder,C0338908,NA,Approved,NA,NA,alprazolam
Alprazolam,DB00404,Generalized Anxiety Disorder,C0270549,NA,Approved,NA,NA,alprazolam
Alprazolam,DB00404,Panic Disorder,C0030319,NA,Approved,NA,NA,alprazolam
Dexbrompheniramine,DB00405,Symptomatic dermographism,C0343065,NA,Approved,NA,NA,dexbrompheniramine
Dexbrompheniramine,DB00405,"Rhinitis, Vasomotor",C0035460,NA,Approved,NA,NA,dexbrompheniramine
Dexbrompheniramine,DB00405,Influenza-like symptoms,C0392171,NA,Approved,NA,NA,dexbrompheniramine
Dexbrompheniramine,DB00405,Hay fever,C0018621,NA,Approved,NA,NA,dexbrompheniramine
Dexbrompheniramine,DB00405,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,dexbrompheniramine
Dexbrompheniramine,DB00405,Pruritus,C0033774,NA,Approved,NA,NA,dexbrompheniramine
Dexbrompheniramine,DB00405,Urticaria,C0042109,NA,Approved,NA,NA,dexbrompheniramine
Dexbrompheniramine,DB00405,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,dexbrompheniramine
Gentian Violet,DB00406,"Candidiasis, Vulvovaginal",C0700345,NA,Approved,NA,NA,gentian violet
Loxapine,DB00408,Schizophrenia,C0036341,NA,Approved,NA,NA,loxapine
Loxapine,DB00408,Bipolar Disorder,C0005586,NA,Approved,NA,NA,loxapine
Mupirocin,DB00410,Impetigo,C0021099,NA,Approved,NA,NA,mupirocin
Carbachol,DB00411,"Glaucoma, Open-Angle",C0017612,NA,Approved,NA,NA,carbachol
Pramipexole,DB00413,Restless Legs Syndrome,C0035258,NA,Approved,NA,NA,pramipexole
Pramipexole,DB00413,Parkinson Disease,C0030567,NA,Approved,NA,NA,pramipexole
Ampicillin,DB00415,Acute otitis media,C0271429,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Acute bacterial epiglottitis,C0275555,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Escherichia coli septicemia,C0276088,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Cholangitis,C0008311,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,"Meningitis, Escherichia coli",C0338395,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Acute exacerbation of chronic bronchitis,C0856695,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Acute epiglottitis,C0155814,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,pharyngitis due to Haemophilus influenzae,C2062475,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Septicemia due to enterococcus,C0588233,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Streptococcal pneumonia,C0155862,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Acute gonococcal cervicitis,C0153195,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Gonorrhea of rectum,C0275665,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Bacterial peritonitis,C0341503,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Female genital tract infection,C1263758,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Bacterial Endocarditis,C0014121,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Infective otitis media,C0729586,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Sepsis due to Staphylococcus aureus,C2887088,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Salmonella sepsis,C0152486,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Staphylococcal endocarditis,C0520767,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Streptococcal endocarditis,C3665800,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Bacterial sepsis,C0684256,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Streptococcal sepsis,C0152964,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Sinusitis,C0037199,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Staphylococcal Pneumonia,C0032308,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Acute gonococcal urethritis,C0275652,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,"Meningitis, Bacterial",C0085437,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Dysentery,C0013369,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Gonorrhea,C0018081,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Acute gonococcal endometritis,C0153196,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,"Meningitis, Pneumococcal",C0025295,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Shigella Infections,C0013371,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Meningococcal meningitis,C0025294,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Acute bacterial sinusitis,C0275556,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,URINARY TRACT INFECTION ENTEROCOCCUS,C0749958,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Pharyngitis,C0031350,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Urinary tract infection,C0042029,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Proteus septicemia,C0577690,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Pneumococcal pharyngitis,C0275761,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Escherichia coli Infections,C0014836,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Proteus urinary tract infection,C0577709,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Streptococcal tonsillitis,C0275804,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Genitourinary tract infection,C1279247,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Pelvic Inflammatory Disease,C0242172,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Enterobacteriaceae Infections,C0014347,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Paratyphoid Fever,C0030528,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Rhinoscleroma,C0035468,NA,Approved,NA,NA,ampicillin
Ampicillin,DB00415,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,ampicillin
Phenoxymethylpenicillin,DB00417,Pharyngitis,C0031350,NA,Approved,NA,NA,phenoxymethylpenicillin
Phenoxymethylpenicillin,DB00417,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,phenoxymethylpenicillin
Phenoxymethylpenicillin,DB00417,Fusospirochetal pharyngitis,C1318559,NA,Approved,NA,NA,phenoxymethylpenicillin
Phenoxymethylpenicillin,DB00417,Acute otitis media,C0271429,NA,Approved,NA,NA,phenoxymethylpenicillin
Phenoxymethylpenicillin,DB00417,Erysipelas,C0014733,NA,Approved,NA,NA,phenoxymethylpenicillin
Phenoxymethylpenicillin,DB00417,Infective otitis media,C0729586,NA,Approved,NA,NA,phenoxymethylpenicillin
Phenoxymethylpenicillin,DB00417,Upper Respiratory Infections,C0041912,NA,Approved,NA,NA,phenoxymethylpenicillin
Phenoxymethylpenicillin,DB00417,Gingivostomatitis,C0149704,NA,Approved,NA,NA,phenoxymethylpenicillin
Phenoxymethylpenicillin,DB00417,Streptococcal tonsillitis,C0275804,NA,Approved,NA,NA,phenoxymethylpenicillin
Phenoxymethylpenicillin,DB00417,Scarlet Fever,C0036285,NA,Approved,NA,NA,phenoxymethylpenicillin
Phenoxymethylpenicillin,DB00417,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,phenoxymethylpenicillin
Secobarbital,DB00418,Epilepsy,C0014544,NA,Approved,NA,NA,secobarbital
Secobarbital,DB00418,Status Epilepticus,C0038220,NA,Approved,NA,NA,secobarbital
Secobarbital,DB00418,Severe anxiety (panic),C0231403,NA,Approved,NA,NA,secobarbital
Secobarbital,DB00418,Sleeplessness,C0917801,NA,Approved,NA,NA,secobarbital
Miglustat,DB00419,Gaucher Disease,C0017205,NA,Approved,NA,NA,miglustat
Miglustat,DB00419,"Niemann-Pick Disease, Type C",C0220756,NA,Approved,NA,NA,miglustat
Promazine,DB00420,"Bipolar affective disorder, current episode manic",C0338873,NA,Approved,NA,NA,promazine
Promazine,DB00420,Angioedema,C0002994,NA,Approved,NA,NA,promazine
Promazine,DB00420,Vomiting,C0042963,NA,Approved,NA,NA,promazine
Promazine,DB00420,Symptomatic dermographism,C0343065,NA,Approved,NA,NA,promazine
Promazine,DB00420,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,promazine
Promazine,DB00420,Pruritus,C0033774,NA,Approved,NA,NA,promazine
Promazine,DB00420,Urticaria,C0042109,NA,Approved,NA,NA,promazine
Promazine,DB00420,Nausea and vomiting,C0027498,NA,Approved,NA,NA,promazine
Promazine,DB00420,Intractable hiccups,C0744896,NA,Approved,NA,NA,promazine
Promazine,DB00420,Acute intermittent porphyria,C0162565,NA,Approved,NA,NA,promazine
Promazine,DB00420,Sneezing,C0037383,NA,Approved,NA,NA,promazine
Promazine,DB00420,Disruptive Behavior Disorder,C0012734,NA,Approved,NA,NA,promazine
Promazine,DB00420,Psychotic Disorders,C0033975,NA,Approved,NA,NA,promazine
Promazine,DB00420,Rhinorrhea,C1260880,NA,Approved,NA,NA,promazine
Promazine,DB00420,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,promazine
Promazine,DB00420,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,promazine
Promazine,DB00420,Nausea,C0027497,NA,Approved,NA,NA,promazine
Promazine,DB00420,Schizophrenia,C0036341,NA,Approved,NA,NA,promazine
Spironolactone,DB00421,Hypertensive disease,C0020538,NA,Approved,NA,NA,spironolactone
Spironolactone,DB00421,Ascites,C0003962,NA,Approved,NA,NA,spironolactone
Spironolactone,DB00421,Edema,C0013604,NA,Approved,NA,NA,spironolactone
Spironolactone,DB00421,Chronic heart failure,C0264716,NA,Approved,NA,NA,spironolactone
Spironolactone,DB00421,Hyperaldosteronism,C0020428,NA,Approved,NA,NA,spironolactone
Methylphenidate,DB00422,Attention deficit hyperactivity disorder,C1263846,NA,Approved,NA,NA,methylphenidate
Methylphenidate,DB00422,Narcolepsy,C0027404,NA,Approved,NA,NA,methylphenidate
Methocarbamol,DB00423,Muscle Spasticity,C0026838,NA,Approved,NA,NA,methocarbamol
Hyoscyamine,DB00424,Sinus bradycardia,C0085610,NA,Approved,NA,NA,hyoscyamine
Hyoscyamine,DB00424,Sialorrhea,C0037036,NA,Approved,NA,NA,hyoscyamine
Hyoscyamine,DB00424,Dysuria,C0013428,NA,Approved,NA,NA,hyoscyamine
Hyoscyamine,DB00424,Peptic Ulcer,C0030920,NA,Approved,NA,NA,hyoscyamine
Zolpidem,DB00425,Sleeplessness,C0917801,NA,Approved,NA,NA,zolpidem
Zolpidem,DB00425,Initial insomnia,C0393760,NA,Approved,NA,NA,zolpidem
Famciclovir,DB00426,Herpes zoster disease,C0019360,NA,Approved,NA,NA,famciclovir
Famciclovir,DB00426,Recurrent genital herpes simplex,C1274323,NA,Approved,NA,NA,famciclovir
Famciclovir,DB00426,Recurrent herpes simplex labialis,C1274321,NA,Approved,NA,NA,famciclovir
Triprolidine,DB00427,Hay fever,C0018621,NA,Approved,NA,NA,triprolidine
Triprolidine,DB00427,Rhinorrhea,C1260880,NA,Approved,NA,NA,triprolidine
Triprolidine,DB00427,"Rhinitis, Vasomotor",C0035460,NA,Approved,NA,NA,triprolidine
Triprolidine,DB00427,Common Cold,C0009443,NA,Approved,NA,NA,triprolidine
Triprolidine,DB00427,Urticaria,C0042109,NA,Approved,NA,NA,triprolidine
Triprolidine,DB00427,Pruritus,C0033774,NA,Approved,NA,NA,triprolidine
Triprolidine,DB00427,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,triprolidine
Triprolidine,DB00427,Symptomatic dermographism,C0343065,NA,Approved,NA,NA,triprolidine
Triprolidine,DB00427,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,triprolidine
Carboprost Tromethamine,DB00429,Postpartum Hemorrhage,C0032797,NA,Approved,NA,NA,carboprost tromethamine
Carboprost Tromethamine,DB00429,Unspecified Abortion,C0156543,NA,Approved,NA,NA,carboprost tromethamine
Lindane,DB00431,Scabies <infestation>,C0036262,NA,Approved,NA,NA,lindane
Lindane,DB00431,Pediculus capitis infestation,C0030757,NA,Approved,NA,NA,lindane
Lindane,DB00431,Infestation by Phthirus pubis,C0030759,NA,Approved,NA,NA,lindane
Trifluridine,DB00432,Herpes simplex keratoconjunctivitis,C0276228,NA,Approved,NA,NA,trifluridine
Trifluridine,DB00432,"Keratitis, Herpetic",C0019357,NA,Approved,NA,NA,trifluridine
Trifluridine,DB00432,Malignant tumor of colon,C0007102,NA,Approved,NA,NA,trifluridine
Prochlorperazine,DB00433,Schizophrenia,C0036341,NA,Approved,NA,NA,prochlorperazine
Prochlorperazine,DB00433,Nausea and vomiting,C0027498,NA,Approved,NA,NA,prochlorperazine
Cyproheptadine,DB00434,Rhinorrhea,C1260880,NA,Approved,NA,NA,cyproheptadine
Cyproheptadine,DB00434,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,cyproheptadine
Cyproheptadine,DB00434,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,cyproheptadine
Cyproheptadine,DB00434,Urticaria,C0042109,NA,Approved,NA,NA,cyproheptadine
Cyproheptadine,DB00434,Sneezing,C0037383,NA,Approved,NA,NA,cyproheptadine
Cyproheptadine,DB00434,Symptomatic dermographism,C0343065,NA,Approved,NA,NA,cyproheptadine
Cyproheptadine,DB00434,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,cyproheptadine
Cyproheptadine,DB00434,Pruritus,C0033774,NA,Approved,NA,NA,cyproheptadine
Nitric Oxide,DB00435,Persistent Fetal Circulation Syndrome,C0031190,NA,Approved,NA,NA,nitric oxide
Nitric Oxide,DB00435,Pulmonary Hypertension,C0020542,NA,Approved,NA,NA,nitric oxide
Bendroflumethiazide,DB00436,Hypertensive disease,C0020538,NA,Approved,NA,NA,bendroflumethiazide
Allopurinol,DB00437,Calcium renal calculus,C1959799,NA,Approved,NA,NA,allopurinol
Allopurinol,DB00437,Gout,C0018099,NA,Approved,NA,NA,allopurinol
Allopurinol,DB00437,"Arthritis, Gouty",C0003868,NA,Approved,NA,NA,allopurinol
Allopurinol,DB00437,Hyperuricemia,C0740394,NA,Approved,NA,NA,allopurinol
Allopurinol,DB00437,Uric acid renal calculus,C0558595,NA,Approved,NA,NA,allopurinol
Ceftazidime,DB00438,Sepsis due to Pseudomonas,C2887096,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Infection of bone,C2242472,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Meningococcal meningitis,C0025294,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Pneumonia due to Pseudomonas,C0155860,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Proteus urinary tract infection,C0577709,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Bacterial infection due to Klebsiella pneumoniae,C0343402,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Escherichia coli Infections,C0014836,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Escherichia coli septicemia,C0276088,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Peritonitis,C0031154,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Arthropathy associated with infection,C0157749,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Proteus pneumonia,C1260917,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Ecthyma gangrenosum,C0276085,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Enterobacter pneumonia,C1096258,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Staphylococcal Pneumonia,C0032308,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Bacterial urinary infection,C0729524,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Sepsis due to Staphylococcus aureus,C2887088,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Osteomyelitis due to Staphylococcus aureus,C1997728,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Neonatal meningitis,C0456107,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,"Meningitis, Bacterial",C0085437,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Bacterial sepsis,C0684256,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Lower respiratory tract infection,C0149725,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Endometritis,C0014179,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Serratia sepsis,C0152973,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Rhinoscleroma,C0035468,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Pneumonia due to Escherichia coli,C0276089,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Enterobacteriaceae Infections,C0014347,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Klebsiella cystitis,C0520775,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Haemophilus sepsis,C0854324,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Gonococcal meningitis,C0153225,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Pelvic Inflammatory Disease,C0242172,NA,Approved,NA,NA,ceftazidime
Ceftazidime,DB00438,Streptococcal sepsis,C0152964,NA,Approved,NA,NA,ceftazidime
Trimethoprim,DB00440,Urinary tract infection,C0042029,NA,Approved,NA,NA,trimethoprim
Trimethoprim,DB00440,Bacterial conjunctivitis,C0009768,NA,Approved,NA,NA,trimethoprim
Trimethoprim,DB00440,Proteus urinary tract infection,C0577709,NA,Approved,NA,NA,trimethoprim
Trimethoprim,DB00440,Shigella Infections,C0013371,NA,Approved,NA,NA,trimethoprim
Trimethoprim,DB00440,Blepharoconjunctivitis,C0005743,NA,Approved,NA,NA,trimethoprim
Trimethoprim,DB00440,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,trimethoprim
Trimethoprim,DB00440,Klebsiella cystitis,C0520775,NA,Approved,NA,NA,trimethoprim
Trimethoprim,DB00440,Bacterial urinary infection,C0729524,NA,Approved,NA,NA,trimethoprim
Trimethoprim,DB00440,Acute exacerbation of chronic bronchitis,C0856695,NA,Approved,NA,NA,trimethoprim
Trimethoprim,DB00440,Infective otitis media,C0729586,NA,Approved,NA,NA,trimethoprim
Trimethoprim,DB00440,Acute otitis media,C0271429,NA,Approved,NA,NA,trimethoprim
Gemcitabine,DB00441,Non-Small Cell Lung Carcinoma,C0007131,NA,Approved,NA,NA,gemcitabine
Gemcitabine,DB00441,Adenocarcinoma of pancreas,C0281361,NA,Approved,NA,NA,gemcitabine
Gemcitabine,DB00441,Malignant neoplasm of ovary,C1140680,NA,Approved,NA,NA,gemcitabine
Gemcitabine,DB00441,Carcinoma breast stage IV,C0278488,NA,Approved,NA,NA,gemcitabine
Entecavir,DB00442,"Hepatitis B, Chronic",C0524909,NA,Approved,NA,NA,entecavir
Betamethasone,DB00443,Transplanted organ rejection,C0345468,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Disorder of eye,C0015397,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Nephrotic Syndrome,C0027726,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,"Lupus Erythematosus, Systemic",C0024141,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Sarcoidosis,C0036202,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Inflammatory Bowel Diseases,C0021390,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Cerebral Edema,C0006114,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Serum Sickness,C0036830,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Hodgkin Disease,C0019829,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Congenital adrenal hyperplasia,C0001627,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Bursitis,C0006444,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Asthma,C0004096,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Erythema Multiforme,C0014742,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Dermatologic disorders,C0037274,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Angioedema,C0002994,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Crohn Disease,C0010346,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Status Asthmaticus,C0038218,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Adrenal cortical hypofunction,C0405580,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Acquired thrombocytopenia,C0154301,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,"Lymphoma, Follicular",C0024301,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Humoral hypercalcemia of malignancy (disorder),C0149911,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Tendinitis,C0039503,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Exfoliative dermatitis,C0011606,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Synovitis,C0039103,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Laryngeal Edema,C0023052,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,"Lymphoma, T-Cell, Cutaneous",C0079773,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Cooley's anemia,C0002875,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Scalp psoriasis,C0406326,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Tinea Pedis,C0040259,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Lichen Simplex Chronicus,C0149922,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Pemphigus,C0030807,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Contact Dermatitis,C0011616,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Mycosis Fungoides,C0026948,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Autoimmune Diseases,C0004364,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,"Dermatitis, Atopic",C0011615,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Multiple Sclerosis,C0026769,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Simple Pulmonary Eosinophilia,C0242459,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,"Lupus Erythematosus, Discoid",C0024138,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Epicondylitis,C0014488,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Trichinellosis,C0040896,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Autoimmune hemolytic anemia,C0002880,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Acute lymphocytic leukemia,C0023449,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Addisonian crisis,C0151467,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Pruritus Ani,C0033775,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,"Tuberculosis, Miliary",C0041321,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Scalp Dermatoses,C0036271,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Addison Disease,C0001403,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,"Arthritis, Psoriatic",C0003872,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Tinea cruris,C1384589,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Rheumatic Heart Disease,C0035439,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,"Anemia, Diamond-Blackfan",C1260899,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Aspiration pneumonitis,C1761609,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Psoriasis,C0033860,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Dermatitis Herpetiformis,C0011608,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Post traumatic osteoarthritis,C2894027,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,"Arthritis, Gouty",C0003868,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Tinea corporis (disorder),C0040252,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Granuloma Annulare,C0085074,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Berylliosis,C0005138,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Ankylosing spondylitis,C0038013,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Adrenogenital disorder,C0701163,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Musculoskeletal Diseases,C0026857,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Thyroiditis,C0040147,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,"Lymphoma, Non-Hodgkin",C0024305,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Exanthema,C0015230,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Tenosynovitis,C0039520,NA,Approved,NA,NA,betamethasone
Betamethasone,DB00443,Pruritus of genital organs,C0033777,NA,Approved,NA,NA,betamethasone
Teniposide,DB00444,Acute lymphocytic leukemia,C0023449,NA,Approved,NA,NA,teniposide
Epirubicin,DB00445,Breast Carcinoma,C0678222,NA,Approved,NA,NA,epirubicin
Chloramphenicol,DB00446,Meningococcal meningitis,C0025294,NA,Approved,NA,NA,chloramphenicol
Chloramphenicol,DB00446,Streptococcal meningitis,C0154639,NA,Approved,NA,NA,chloramphenicol
Chloramphenicol,DB00446,Rickettsia Infections,C0035585,NA,Approved,NA,NA,chloramphenicol
Chloramphenicol,DB00446,Boutonneuse Fever,C0006060,NA,Approved,NA,NA,chloramphenicol
Chloramphenicol,DB00446,Typhoid Fever,C0041466,NA,Approved,NA,NA,chloramphenicol
Chloramphenicol,DB00446,Otitis Externa,C0029878,NA,Approved,NA,NA,chloramphenicol
Chloramphenicol,DB00446,Paratyphoid Fever,C0030528,NA,Approved,NA,NA,chloramphenicol
Chloramphenicol,DB00446,Salmonella infections,C0036117,NA,Approved,NA,NA,chloramphenicol
Lansoprazole,DB00448,Duodenal Ulcer,C0013295,NA,Approved,NA,NA,lansoprazole
Lansoprazole,DB00448,Gastric ulcer,C0038358,NA,Approved,NA,NA,lansoprazole
Lansoprazole,DB00448,Zollinger-Ellison syndrome,C0043515,NA,Approved,NA,NA,lansoprazole
Lansoprazole,DB00448,Erosive esophagitis,C0267055,NA,Approved,NA,NA,lansoprazole
Lansoprazole,DB00448,Gastroesophageal reflux disease,C0017168,NA,Approved,NA,NA,lansoprazole
Lansoprazole,DB00448,Peptic Ulcer,C0030920,NA,Approved,NA,NA,lansoprazole
Dipivefrin,DB00449,"Glaucoma, Open-Angle",C0017612,NA,Approved,NA,NA,dipivefrin
Levothyroxine,DB00451,Myxedema,C0027145,NA,Approved,NA,NA,levothyroxine
Levothyroxine,DB00451,Malignant neoplasm of thyroid,C0007115,NA,Approved,NA,NA,levothyroxine
Levothyroxine,DB00451,Hyperlipidemia,C0020473,NA,Approved,NA,NA,levothyroxine
Levothyroxine,DB00451,Congenital Hypothyroidism,C0010308,NA,Approved,NA,NA,levothyroxine
Levothyroxine,DB00451,Hypothyroidism,C0020676,NA,Approved,NA,NA,levothyroxine
Levothyroxine,DB00451,Hashimoto Disease,C0677607,NA,Approved,NA,NA,levothyroxine
Levothyroxine,DB00451,Goiter,C0018021,NA,Approved,NA,NA,levothyroxine
Pethidine,DB00454,Severe pain,C0278140,NA,Approved,NA,NA,pethidine
Pethidine,DB00454,Pain,C0030193,NA,Approved,NA,NA,pethidine
Pethidine,DB00454,Labor Pain,C0474368,NA,Approved,NA,NA,pethidine
Loratadine,DB00455,Sneezing,C0037383,NA,Approved,NA,NA,loratadine
Loratadine,DB00455,Rhinorrhea,C1260880,NA,Approved,NA,NA,loratadine
Loratadine,DB00455,"Rhinitis, Vasomotor",C0035460,NA,Approved,NA,NA,loratadine
Loratadine,DB00455,Hay fever,C0018621,NA,Approved,NA,NA,loratadine
Loratadine,DB00455,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,loratadine
Loratadine,DB00455,Common Cold,C0009443,NA,Approved,NA,NA,loratadine
Loratadine,DB00455,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,loratadine
Loratadine,DB00455,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,loratadine
Loratadine,DB00455,Chronic idiopathic urticaria,C0578870,NA,Approved,NA,NA,loratadine
Cefalotin,DB00456,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,cefalotin
Cefalotin,DB00456,Bacterial infection due to Klebsiella pneumoniae,C0343402,NA,Approved,NA,NA,cefalotin
Cefalotin,DB00456,Infection of bone,C2242472,NA,Approved,NA,NA,cefalotin
Cefalotin,DB00456,Arthropathy associated with infection,C0157749,NA,Approved,NA,NA,cefalotin
Cefalotin,DB00456,Female genital tract infection,C1263758,NA,Approved,NA,NA,cefalotin
Cefalotin,DB00456,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,cefalotin
Cefalotin,DB00456,Genitourinary tract infection,C1279247,NA,Approved,NA,NA,cefalotin
Cefalotin,DB00456,Pneumonia,C0032285,NA,Approved,NA,NA,cefalotin
Cefalotin,DB00456,Urinary tract infection,C0042029,NA,Approved,NA,NA,cefalotin
Cefalotin,DB00456,Lower respiratory tract infection,C0149725,NA,Approved,NA,NA,cefalotin
Cefalotin,DB00456,Bacterial sepsis,C0684256,NA,Approved,NA,NA,cefalotin
Prazosin,DB00457,Hypertensive disease,C0020538,NA,Approved,NA,NA,prazosin
Imipramine,DB00458,Depressive disorder,C0011581,NA,Approved,NA,NA,imipramine
Imipramine,DB00458,Bedwetting,C0270327,NA,Approved,NA,NA,imipramine
Acitretin,DB00459,Psoriasis,C0033860,NA,Approved,NA,NA,acitretin
Verteporfin,DB00460,Choroidal retinal neovascularization,C0271066,NA,Approved,NA,NA,verteporfin
Verteporfin,DB00460,Choroidal Neovascularization,C0600518,NA,Approved,NA,NA,verteporfin
Verteporfin,DB00460,Ocular histoplasmosis syndrome,C1562543,NA,Approved,NA,NA,verteporfin
Verteporfin,DB00460,Exudative age-related macular degeneration,C0271084,NA,Approved,NA,NA,verteporfin
Nabumetone,DB00461,Degenerative polyarthritis,C0029408,NA,Approved,NA,NA,nabumetone
Nabumetone,DB00461,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,nabumetone
Methylscopolamine bromide,DB00462,Coughing,C0010200,NA,Approved,NA,NA,methylscopolamine bromide
Methylscopolamine bromide,DB00462,Peptic Ulcer,C0030920,NA,Approved,NA,NA,methylscopolamine bromide
Methylscopolamine bromide,DB00462,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,methylscopolamine bromide
Methylscopolamine bromide,DB00462,Common Cold,C0009443,NA,Approved,NA,NA,methylscopolamine bromide
Methylscopolamine bromide,DB00462,Rhinorrhea,C1260880,NA,Approved,NA,NA,methylscopolamine bromide
Methylscopolamine bromide,DB00462,Irritable Bowel Syndrome,C0022104,NA,Approved,NA,NA,methylscopolamine bromide
Methylscopolamine bromide,DB00462,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,methylscopolamine bromide
Methylscopolamine bromide,DB00462,"Rhinitis, Vasomotor",C0035460,NA,Approved,NA,NA,methylscopolamine bromide
Sodium Tetradecyl Sulfate,DB00464,Varicosity,C0042345,NA,Approved,NA,NA,sodium tetradecyl sulfate
Ketorolac,DB00465,Acute postoperative pain,C2215257,NA,Approved,NA,NA,ketorolac
Ketorolac,DB00465,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,ketorolac
Ketorolac,DB00465,Severe pain,C0278140,NA,Approved,NA,NA,ketorolac
Enoxacin,DB00467,Acute gonococcal cervicitis,C0153195,NA,Approved,NA,NA,enoxacin
Enoxacin,DB00467,Gonorrhea,C0018081,NA,Approved,NA,NA,enoxacin
Enoxacin,DB00467,Acute gonococcal urethritis,C0275652,NA,Approved,NA,NA,enoxacin
Enoxacin,DB00467,Gonorrhea of rectum,C0275665,NA,Approved,NA,NA,enoxacin
Enoxacin,DB00467,Gonorrhea of pharynx,C0149966,NA,Approved,NA,NA,enoxacin
Enoxacin,DB00467,Urinary tract infection,C0042029,NA,Approved,NA,NA,enoxacin
Quinine,DB00468,"Malaria, Falciparum",C0024535,NA,Approved,NA,NA,quinine
Tenoxicam,DB00469,Arthritis,C0003864,NA,Approved,NA,NA,tenoxicam
Montelukast,DB00471,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,montelukast
Montelukast,DB00471,Allergic asthma,C0155877,NA,Approved,NA,NA,montelukast
Montelukast,DB00471,Intrinsic asthma,C0155880,NA,Approved,NA,NA,montelukast
Fluoxetine,DB00472,Depressive disorder,C0011581,NA,Approved,NA,NA,fluoxetine
Fluoxetine,DB00472,Bulimia Nervosa,C2267227,NA,Approved,NA,NA,fluoxetine
Fluoxetine,DB00472,Obsessive-Compulsive Disorder,C0028768,NA,Approved,NA,NA,fluoxetine
Fluoxetine,DB00472,Major Depressive Disorder,C1269683,NA,Approved,NA,NA,fluoxetine
Fluoxetine,DB00472,Premenstrual Dysphoric Disorder,C0520676,NA,Approved,NA,NA,fluoxetine
Fluoxetine,DB00472,Panic Disorder,C0030319,NA,Approved,NA,NA,fluoxetine
Fluoxetine,DB00472,"Depression, Bipolar",C0005587,NA,Approved,NA,NA,fluoxetine
Chlordiazepoxide,DB00475,Anxiety,C0003467,NA,Approved,NA,NA,chlordiazepoxide
Chlordiazepoxide,DB00475,Severe anxiety (panic),C0231403,NA,Approved,NA,NA,chlordiazepoxide
Chlordiazepoxide,DB00475,Alcohol Withdrawal Delirium,C0001957,NA,Approved,NA,NA,chlordiazepoxide
Chlordiazepoxide,DB00475,Peptic Ulcer,C0030920,NA,Approved,NA,NA,chlordiazepoxide
Chlordiazepoxide,DB00475,Irritable Bowel Syndrome,C0022104,NA,Approved,NA,NA,chlordiazepoxide
Chlordiazepoxide,DB00475,Mixed anxiety and depressive disorder,C0338908,NA,Approved,NA,NA,chlordiazepoxide
Chlordiazepoxide,DB00475,Alcohol withdrawal syndrome,C0236663,NA,Approved,NA,NA,chlordiazepoxide
Duloxetine,DB00476,Generalized Anxiety Disorder,C0270549,NA,Approved,NA,NA,duloxetine
Duloxetine,DB00476,Diabetic peripheral neuropathy,C0740447,NA,Approved,NA,NA,duloxetine
Duloxetine,DB00476,MUSCULOSKELETAL PAIN CHRONIC,C0746683,NA,Approved,NA,NA,duloxetine
Duloxetine,DB00476,Fibromyalgia,C0016053,NA,Approved,NA,NA,duloxetine
Duloxetine,DB00476,Major Depressive Disorder,C1269683,NA,Approved,NA,NA,duloxetine
Duloxetine,DB00476,Female stress incontinence,C0038437,NA,Approved,NA,NA,duloxetine
Chlorpromazine,DB00477,Schizophrenia,C0036341,NA,Approved,NA,NA,chlorpromazine
Chlorpromazine,DB00477,"Bipolar affective disorder, current episode manic",C0338873,NA,Approved,NA,NA,chlorpromazine
Chlorpromazine,DB00477,Nausea and vomiting,C0027498,NA,Approved,NA,NA,chlorpromazine
Chlorpromazine,DB00477,Acute intermittent porphyria,C0162565,NA,Approved,NA,NA,chlorpromazine
Chlorpromazine,DB00477,Intractable hiccups,C0744896,NA,Approved,NA,NA,chlorpromazine
Chlorpromazine,DB00477,Psychotic Disorders,C0033975,NA,Approved,NA,NA,chlorpromazine
Chlorpromazine,DB00477,Disruptive Behavior Disorder,C0012734,NA,Approved,NA,NA,chlorpromazine
Rimantadine,DB00478,Influenza due to Influenza A virus,C2711180,NA,Approved,NA,NA,rimantadine
Amikacin,DB00479,Enterobacteriaceae Infections,C0014347,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Diverticulitis of gastrointestinal tract,C0349774,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Infection due to Pseudomonas aeruginosa,C0276075,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Proteus septicemia,C0577690,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Escherichia coli septicemia,C0276088,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Neonatal pneumonia,C0339968,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Klebsiella sepsis,C0745528,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Nosocomial pneumonia,C0949083,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Bacterial infection due to Klebsiella pneumoniae,C0343402,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,"Meningitis, Bacterial",C0085437,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Infection of bone,C2242472,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Staphylococcal Pneumonia,C0032308,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Pseudomonas aeruginosa meningitis,C3665869,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Neonatal meningitis,C0456107,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Arthropathy associated with infection,C0157749,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Rhinoscleroma,C0035468,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Cholangitis,C0008311,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Staphylococcal bacteraemia,C0152965,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Osteomyelitis,C0029443,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Pneumonia due to Pseudomonas,C0155860,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Sepsis due to Pseudomonas,C2887096,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Meningitis due to Klebsiella mobilis,C1719906,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Pneumonia due to Escherichia coli,C0276089,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Staphylococcal meningitis,C0154640,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Serratia Infections,C0085394,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Escherichia coli Infections,C0014836,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Sepsis due to Gram negative bacteria,C3163829,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Proteus pneumonia,C1260917,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Proteus meningitis,C0338396,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,"Meningitis, Escherichia coli",C0338395,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Serratia sepsis,C0152973,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Sepsis of the newborn,C0456103,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Bacterial meningitis due to Gram-negative bacteria,C0854215,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Pneumonia due to Gram negative bacteria,C0854248,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Enterobacter pneumonia,C1096258,NA,Approved,NA,NA,amikacin
Amikacin,DB00479,Bacterial sepsis,C0684256,NA,Approved,NA,NA,amikacin
Lenalidomide,DB00480,Multiple Myeloma,C0026764,NA,Approved,NA,NA,lenalidomide
Lenalidomide,DB00480,"Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse",C0334634,NA,Approved,NA,NA,lenalidomide
Raloxifene,DB00481,"Osteoporosis, Postmenopausal",C0029458,NA,Approved,NA,NA,raloxifene
Celecoxib,DB00482,Acute postoperative pain,C2215257,NA,Approved,NA,NA,celecoxib
Celecoxib,DB00482,Dysmenorrhea,C0013390,NA,Approved,NA,NA,celecoxib
Celecoxib,DB00482,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,celecoxib
Celecoxib,DB00482,Ankylosing spondylitis,C0038013,NA,Approved,NA,NA,celecoxib
Celecoxib,DB00482,Degenerative polyarthritis,C0029408,NA,Approved,NA,NA,celecoxib
Brimonidine,DB00484,"Glaucoma, Open-Angle",C0017612,NA,Approved,NA,NA,brimonidine
Brimonidine,DB00484,Ocular Hypertension,C0028840,NA,Approved,NA,NA,brimonidine
Dicloxacillin,DB00485,Staphylococcal Pneumonia,C0032308,NA,Approved,NA,NA,dicloxacillin
Dicloxacillin,DB00485,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,dicloxacillin
Dicloxacillin,DB00485,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,dicloxacillin
Altretamine,DB00488,Malignant neoplasm of ovary,C1140680,NA,Approved,NA,NA,altretamine
Buspirone,DB00490,Generalized Anxiety Disorder,C0270549,NA,Approved,NA,NA,buspirone
Miglitol,DB00491,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,miglitol
Fosinopril,DB00492,Chronic heart failure,C0264716,NA,Approved,NA,NA,fosinopril
Fosinopril,DB00492,Hypertensive disease,C0020538,NA,Approved,NA,NA,fosinopril
Cefotaxime,DB00493,Sepsis due to Staphylococcus aureus,C2887088,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,Ophthalmia Neonatorum,C0029076,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,Neonatal meningitis,C0456107,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,Streptococcal meningitis,C0154639,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,Infection of bone,C2242472,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,Haemophilus influenzae type b infection,C2028293,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,Pneumonia due to Pseudomonas,C0155860,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,Proteus urinary tract infection,C0577709,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,Klebsiella cystitis,C0520775,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,Serratia sepsis,C0152973,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,Sepsis of the newborn,C0456103,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,"Meningitis, Bacterial",C0085437,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,Serratia Infections,C0085394,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,Bacterial urinary infection,C0729524,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,Escherichia coli septicemia,C0276088,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,Haemophilus parainfluenzae pneumonia,C0877633,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,Female genital tract infection,C1263758,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,Peritonitis,C0031154,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,Staphylococcal Pneumonia,C0032308,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,Bacterial sepsis,C0684256,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,Proteus pneumonia,C1260917,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,Meningitis due to Klebsiella mobilis,C1719906,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,URINARY TRACT INFECTION ENTEROCOCCUS,C0749958,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,Enterobacter pneumonia,C1096258,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,"Arthritis, Bacterial",C1692886,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,Lower respiratory tract infection,C0149725,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,Bacterial infection due to Klebsiella pneumoniae,C0343402,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,URINARY TRACT INFECTION CITROBACTER,C0749955,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,"Meningitis, Escherichia coli",C0338395,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,Neonatal pneumonia,C0339968,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,Streptococcal sepsis,C0152964,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,Meningococcal meningitis,C0025294,NA,Approved,NA,NA,cefotaxime
Cefotaxime,DB00493,Pneumonia due to Escherichia coli,C0276089,NA,Approved,NA,NA,cefotaxime
Entacapone,DB00494,Parkinson Disease,C0030567,NA,Approved,NA,NA,entacapone
Zidovudine,DB00495,HIV Infections,C0019693,NA,Approved,NA,NA,zidovudine
Darifenacin,DB00496,Bladder muscle dysfunction - overactive,C0403643,NA,Approved,NA,NA,darifenacin
Darifenacin,DB00496,Urge Incontinence,C0150045,NA,Approved,NA,NA,darifenacin
Darifenacin,DB00496,Urgency of micturition,C0085606,NA,Approved,NA,NA,darifenacin
Darifenacin,DB00496,Increased frequency of micturition,C0042023,NA,Approved,NA,NA,darifenacin
Oxycodone,DB00497,Acute postoperative pain,C2215257,NA,Approved,NA,NA,oxycodone
Oxycodone,DB00497,Severe pain,C0278140,NA,Approved,NA,NA,oxycodone
Flutamide,DB00499,Prostatic Neoplasms,C0033578,NA,Approved,NA,NA,flutamide
Tolmetin,DB00500,Degenerative polyarthritis,C0029408,NA,Approved,NA,NA,tolmetin
Tolmetin,DB00500,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,tolmetin
Cimetidine,DB00501,Duodenal Ulcer,C0013295,NA,Approved,NA,NA,cimetidine
Cimetidine,DB00501,Upper gastrointestinal hemorrhage,C0041909,NA,Approved,NA,NA,cimetidine
Cimetidine,DB00501,Dyspepsia,C0013395,NA,Approved,NA,NA,cimetidine
Cimetidine,DB00501,Gastroesophageal reflux disease,C0017168,NA,Approved,NA,NA,cimetidine
Cimetidine,DB00501,Zollinger-Ellison syndrome,C0043515,NA,Approved,NA,NA,cimetidine
Cimetidine,DB00501,Heartburn,C0018834,NA,Approved,NA,NA,cimetidine
Cimetidine,DB00501,"Mastocytosis, Systemic",C0221013,NA,Approved,NA,NA,cimetidine
Cimetidine,DB00501,Multiple Endocrine Neoplasia,C0027662,NA,Approved,NA,NA,cimetidine
Cimetidine,DB00501,Gastric ulcer,C0038358,NA,Approved,NA,NA,cimetidine
Haloperidol,DB00502,Chronic schizophrenia,C0221765,NA,Approved,NA,NA,haloperidol
Haloperidol,DB00502,Gilles de la Tourette syndrome,C0040517,NA,Approved,NA,NA,haloperidol
Haloperidol,DB00502,Schizophrenia,C0036341,NA,Approved,NA,NA,haloperidol
Haloperidol,DB00502,Psychotic Disorders,C0033975,NA,Approved,NA,NA,haloperidol
Ritonavir,DB00503,HIV Infections,C0019693,NA,Approved,NA,NA,ritonavir
Ritonavir,DB00503,"Hepatitis C, Chronic",C0524910,NA,Approved,NA,NA,ritonavir
Nitazoxanide,DB00507,Giardiasis,C0017536,NA,Approved,NA,NA,nitazoxanide
Nitazoxanide,DB00507,Cryptosporidiosis,C0010418,NA,Approved,NA,NA,nitazoxanide
Triflupromazine,DB00508,Psychotic Disorders,C0033975,NA,Approved,NA,NA,triflupromazine
Triflupromazine,DB00508,Nausea,C0027497,NA,Approved,NA,NA,triflupromazine
Triflupromazine,DB00508,Vomiting,C0042963,NA,Approved,NA,NA,triflupromazine
Triflupromazine,DB00508,Nausea and vomiting,C0027498,NA,Approved,NA,NA,triflupromazine
Dextrothyroxine,DB00509,Hyperlipidemia,C0020473,NA,Approved,NA,NA,dextrothyroxine
Vancomycin,DB00512,Bacterial Endocarditis,C0014121,NA,Approved,NA,NA,vancomycin
Vancomycin,DB00512,Neonatal pneumonia,C0339968,NA,Approved,NA,NA,vancomycin
Vancomycin,DB00512,Bacterial sepsis,C0684256,NA,Approved,NA,NA,vancomycin
Vancomycin,DB00512,Staphylococcal Pneumonia,C0032308,NA,Approved,NA,NA,vancomycin
Vancomycin,DB00512,Sepsis of the newborn,C0456103,NA,Approved,NA,NA,vancomycin
Vancomycin,DB00512,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,vancomycin
Vancomycin,DB00512,Streptococcal endocarditis,C3665800,NA,Approved,NA,NA,vancomycin
Vancomycin,DB00512,Staphylococcal bacteraemia,C0152965,NA,Approved,NA,NA,vancomycin
Vancomycin,DB00512,Staphylococcal Infections,C0038160,NA,Approved,NA,NA,vancomycin
Vancomycin,DB00512,"Enterocolitis, Pseudomembranous",C0014358,NA,Approved,NA,NA,vancomycin
Vancomycin,DB00512,Staphylococcal enterocolitis,C0038157,NA,Approved,NA,NA,vancomycin
Vancomycin,DB00512,Infection of bone,C2242472,NA,Approved,NA,NA,vancomycin
Vancomycin,DB00512,Arthropathy associated with infection,C0157749,NA,Approved,NA,NA,vancomycin
Vancomycin,DB00512,Staphylococcal endocarditis,C0520767,NA,Approved,NA,NA,vancomycin
Vancomycin,DB00512,Osteomyelitis due to Staphylococcus aureus,C1997728,NA,Approved,NA,NA,vancomycin
Dextromethorphan,DB00514,Sneezing,C0037383,NA,Approved,NA,NA,dextromethorphan
Dextromethorphan,DB00514,Mouth irritation,C0235339,NA,Approved,NA,NA,dextromethorphan
Dextromethorphan,DB00514,Headache Disorders,C0393735,NA,Approved,NA,NA,dextromethorphan
Dextromethorphan,DB00514,Influenza-like symptoms,C0392171,NA,Approved,NA,NA,dextromethorphan
Dextromethorphan,DB00514,Pseudobulbar affect,C2316460,NA,Approved,NA,NA,dextromethorphan
Dextromethorphan,DB00514,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,dextromethorphan
Dextromethorphan,DB00514,"Rhinitis, Vasomotor",C0035460,NA,Approved,NA,NA,dextromethorphan
Dextromethorphan,DB00514,Coughing,C0010200,NA,Approved,NA,NA,dextromethorphan
Dextromethorphan,DB00514,Common Cold,C0009443,NA,Approved,NA,NA,dextromethorphan
Dextromethorphan,DB00514,Fever,C0015967,NA,Approved,NA,NA,dextromethorphan
Dextromethorphan,DB00514,Sore Throat,C0242429,NA,Approved,NA,NA,dextromethorphan
Dextromethorphan,DB00514,Rhinorrhea,C1260880,NA,Approved,NA,NA,dextromethorphan
Dextromethorphan,DB00514,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,dextromethorphan
Dextromethorphan,DB00514,Rhinitis,C0035455,NA,Approved,NA,NA,dextromethorphan
Cisplatin,DB00515,Malignant neoplasm of ovary,C1140680,NA,Approved,NA,NA,cisplatin
Cisplatin,DB00515,Testicular Germ Cell Tumor,C1336708,NA,Approved,NA,NA,cisplatin
Anisotropine Methylbromide,DB00517,Gastric ulcer,C0038358,NA,Approved,NA,NA,anisotropine methylbromide
Anisotropine Methylbromide,DB00517,Peptic Ulcer,C0030920,NA,Approved,NA,NA,anisotropine methylbromide
Albendazole,DB00518,Echinococcus granulosus infection of liver,C0153289,NA,Approved,NA,NA,albendazole
Albendazole,DB00518,Echinococcus granulosus infection of lung,C0153290,NA,Approved,NA,NA,albendazole
Albendazole,DB00518,Neurocysticercosis,C0338437,NA,Approved,NA,NA,albendazole
Albendazole,DB00518,Echinococcus granulosus infection,C0152068,NA,Approved,NA,NA,albendazole
Trandolapril,DB00519,Chronic heart failure,C0264716,NA,Approved,NA,NA,trandolapril
Trandolapril,DB00519,Hypertensive disease,C0020538,NA,Approved,NA,NA,trandolapril
Caspofungin,DB00520,candidal peritonitis,C2062982,NA,Approved,NA,NA,caspofungin
Caspofungin,DB00520,Candidiasis of the esophagus,C0239295,NA,Approved,NA,NA,caspofungin
Caspofungin,DB00520,Candidemia,C0877445,NA,Approved,NA,NA,caspofungin
Carteolol,DB00521,"Glaucoma, Open-Angle",C0017612,NA,Approved,NA,NA,carteolol
Carteolol,DB00521,Hypertensive disease,C0020538,NA,Approved,NA,NA,carteolol
Carteolol,DB00521,Ocular Hypertension,C0028840,NA,Approved,NA,NA,carteolol
Metolazone,DB00524,Hypertensive disease,C0020538,NA,Approved,NA,NA,metolazone
Metolazone,DB00524,Renal disease with edema NOS,C0866125,NA,Approved,NA,NA,metolazone
Tolnaftate,DB00525,Tinea cruris,C1384589,NA,Approved,NA,NA,tolnaftate
Tolnaftate,DB00525,Tinea manus,C0153246,NA,Approved,NA,NA,tolnaftate
Tolnaftate,DB00525,Tinea Versicolor,C0040262,NA,Approved,NA,NA,tolnaftate
Tolnaftate,DB00525,Tinea corporis (disorder),C0040252,NA,Approved,NA,NA,tolnaftate
Tolnaftate,DB00525,Tinea Capitis,C0040250,NA,Approved,NA,NA,tolnaftate
Tolnaftate,DB00525,Tinea Pedis,C0040259,NA,Approved,NA,NA,tolnaftate
Tolnaftate,DB00525,Tinea barbae,C2349994,NA,Approved,NA,NA,tolnaftate
Oxaliplatin,DB00526,Metastasis from malignant tumor of colon,C1282500,NA,Approved,NA,NA,oxaliplatin
Cinchocaine,DB00527,Skin irritation,C0152030,NA,Approved,NA,NA,cinchocaine
Cinchocaine,DB00527,Pruritus,C0033774,NA,Approved,NA,NA,cinchocaine
Lercanidipine,DB00528,Hypertensive disease,C0020538,NA,Approved,NA,NA,lercanidipine
Erlotinib,DB00530,Non-Small Cell Lung Carcinoma,C0007131,NA,Approved,NA,NA,erlotinib
Erlotinib,DB00530,Adenocarcinoma of pancreas,C0281361,NA,Approved,NA,NA,erlotinib
Cyclophosphamide,DB00531,Lymphoma,C0024299,NA,Approved,NA,NA,cyclophosphamide
Cyclophosphamide,DB00531,Multiple Myeloma,C0026764,NA,Approved,NA,NA,cyclophosphamide
Cyclophosphamide,DB00531,Mycosis Fungoides,C0026948,NA,Approved,NA,NA,cyclophosphamide
Cyclophosphamide,DB00531,Neuroblastoma,C0027819,NA,Approved,NA,NA,cyclophosphamide
Cyclophosphamide,DB00531,Retinoblastoma,C0035335,NA,Approved,NA,NA,cyclophosphamide
Cefdinir,DB00535,Moraxella catarrhalis pneumonia,C0857831,NA,Approved,NA,NA,cefdinir
Cefdinir,DB00535,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,cefdinir
Cefdinir,DB00535,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,cefdinir
Cefdinir,DB00535,Acute Moraxella catarrhalis bronchitis,C0339932,NA,Approved,NA,NA,cefdinir
Cefdinir,DB00535,Streptococcal tonsillitis,C0275804,NA,Approved,NA,NA,cefdinir
Cefdinir,DB00535,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,cefdinir
Cefdinir,DB00535,Haemophilus parainfluenzae pneumonia,C0877633,NA,Approved,NA,NA,cefdinir
Cefdinir,DB00535,Infective otitis media,C0729586,NA,Approved,NA,NA,cefdinir
Guanidine,DB00536,Lambert-Eaton Myasthenic Syndrome,C0022972,NA,Approved,NA,NA,guanidine
Ciprofloxacin,DB00537,Acute gonococcal urethritis,C0275652,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Infective otitis externa,C0021355,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Enterobacteriaceae Infections,C0014347,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Acute Moraxella catarrhalis bronchitis,C0339932,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Escherichia coli septicemia,C0276088,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Typhoid Fever,C0041466,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Bacterial conjunctivitis,C0009768,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Pneumonia due to Pseudomonas,C0155860,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Infection of bone,C2242472,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Anthrax disease,C0003175,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Infective cystitis,C0600041,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Haemophilus parainfluenzae pneumonia,C0877633,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Malignant otitis externa due to Pseudomonas aeruginosa,C0395818,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Enterobacter pneumonia,C1096258,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Rhinoscleroma,C0035468,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Nosocomial pneumonia,C0949083,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Arthropathy associated with infection,C0157749,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,URINARY TRACT INFECTION CITROBACTER,C0749955,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Acute gonococcal cervicitis,C0153195,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Chancroids,C0007947,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,URINARY TRACT INFECTION ENTEROCOCCUS,C0749958,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Cystitis,C0010692,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Traveler's diarrhea,C0277528,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Acute osteomyelitis,C0158371,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,prostatitis,C0033581,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Proteus urinary tract infection,C0577709,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Lower respiratory tract infection,C0149725,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Bacterial urinary infection,C0729524,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Cystitis escherichia,C0853852,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Klebsiella cystitis,C0520775,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Escherichia coli Infections,C0014836,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Abdominal Abscess,C0243001,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Chronic Bacterial Prostatitis,C1720797,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Shigella Infections,C0013371,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Acute maxillary sinusitis,C0155804,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Pneumonia due to Escherichia coli,C0276089,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Otitis Externa,C0029878,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,PYELONEPHRITIS E COLI,C0748196,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Proteus pneumonia,C1260917,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Bacterial infection due to Klebsiella pneumoniae,C0343402,NA,Approved,NA,NA,ciprofloxacin
Ciprofloxacin,DB00537,Enteric campylobacteriosis,C0275982,NA,Approved,NA,NA,ciprofloxacin
Toremifene,DB00539,Carcinoma breast stage IV,C0278488,NA,Approved,NA,NA,toremifene
Nortriptyline,DB00540,Depressive disorder,C0011581,NA,Approved,NA,NA,nortriptyline
Vincristine,DB00541,Rhabdomyosarcoma,C0035412,NA,Approved,NA,NA,vincristine
Vincristine,DB00541,Nephroblastoma,C0027708,NA,Approved,NA,NA,vincristine
Vincristine,DB00541,"Lymphoma, Follicular",C0024301,NA,Approved,NA,NA,vincristine
Vincristine,DB00541,Acute lymphocytic leukemia,C0023449,NA,Approved,NA,NA,vincristine
Vincristine,DB00541,Diffuse Large B-Cell Lymphoma,C0079744,NA,Approved,NA,NA,vincristine
Vincristine,DB00541,Burkitt Lymphoma,C0006413,NA,Approved,NA,NA,vincristine
Vincristine,DB00541,Hodgkin Disease,C0019829,NA,Approved,NA,NA,vincristine
Vincristine,DB00541,Neuroblastoma,C0027819,NA,Approved,NA,NA,vincristine
Vincristine,DB00541,"Lymphoma, Non-Hodgkin",C0024305,NA,Approved,NA,NA,vincristine
Benazepril,DB00542,Hypertensive disease,C0020538,NA,Approved,NA,NA,benazepril
Amoxapine,DB00543,Depressive disorder,C0011581,NA,Approved,NA,NA,amoxapine
Fluorouracil,DB00544,Adenocarcinoma of pancreas,C0281361,NA,Approved,NA,NA,fluorouracil
Fluorouracil,DB00544,Malignant tumor of colon,C0007102,NA,Approved,NA,NA,fluorouracil
Fluorouracil,DB00544,Superficial basal cell carcinoma,C0862889,NA,Approved,NA,NA,fluorouracil
Fluorouracil,DB00544,Metastasis from malignant tumor of colon,C1282500,NA,Approved,NA,NA,fluorouracil
Fluorouracil,DB00544,Actinic keratosis,C0022602,NA,Approved,NA,NA,fluorouracil
Fluorouracil,DB00544,Carcinoma breast stage IV,C0278488,NA,Approved,NA,NA,fluorouracil
Fluorouracil,DB00544,Malignant neoplasm of stomach,C0024623,NA,Approved,NA,NA,fluorouracil
Pyridostigmine,DB00545,Myasthenia Gravis,C0026896,NA,Approved,NA,NA,pyridostigmine
Desoximetasone,DB00547,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,desoximetasone
Desoximetasone,DB00547,Pruritus of genital organs,C0033777,NA,Approved,NA,NA,desoximetasone
Desoximetasone,DB00547,Contact Dermatitis,C0011616,NA,Approved,NA,NA,desoximetasone
Desoximetasone,DB00547,Granuloma Annulare,C0085074,NA,Approved,NA,NA,desoximetasone
Desoximetasone,DB00547,Exanthema,C0015230,NA,Approved,NA,NA,desoximetasone
Desoximetasone,DB00547,"Lymphoma, T-Cell, Cutaneous",C0079773,NA,Approved,NA,NA,desoximetasone
Desoximetasone,DB00547,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,desoximetasone
Desoximetasone,DB00547,Pruritus Ani,C0033775,NA,Approved,NA,NA,desoximetasone
Desoximetasone,DB00547,Scalp psoriasis,C0406326,NA,Approved,NA,NA,desoximetasone
Desoximetasone,DB00547,"Lupus Erythematosus, Discoid",C0024138,NA,Approved,NA,NA,desoximetasone
Desoximetasone,DB00547,"Dermatitis, Atopic",C0011615,NA,Approved,NA,NA,desoximetasone
Desoximetasone,DB00547,Lichen Simplex Chronicus,C0149922,NA,Approved,NA,NA,desoximetasone
Azelaic Acid,DB00548,Acne Vulgaris,C0001144,NA,Approved,NA,NA,azelaic acid
Zafirlukast,DB00549,Asthma,C0004096,NA,Approved,NA,NA,zafirlukast
Propylthiouracil,DB00550,Thyroid Crisis,C0040127,NA,Approved,NA,NA,propylthiouracil
Propylthiouracil,DB00550,Hyperthyroidism,C0020550,NA,Approved,NA,NA,propylthiouracil
Acetohydroxamic Acid,DB00551,Urinary tract infection,C0042029,NA,Approved,NA,NA,acetohydroxamic acid
Pentostatin,DB00552,Hairy Cell Leukemia,C0023443,NA,Approved,NA,NA,pentostatin
Methoxsalen,DB00553,"Lymphoma, T-Cell, Cutaneous",C0079773,NA,Approved,NA,NA,methoxsalen
Methoxsalen,DB00553,Vitiligo,C0042900,NA,Approved,NA,NA,methoxsalen
Piroxicam,DB00554,Degenerative polyarthritis,C0029408,NA,Approved,NA,NA,piroxicam
Piroxicam,DB00554,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,piroxicam
Lamotrigine,DB00555,Epilepsy,C0014544,NA,Approved,NA,NA,lamotrigine
Lamotrigine,DB00555,Lennox-Gastaut syndrome,C0238111,NA,Approved,NA,NA,lamotrigine
Lamotrigine,DB00555,Simple Partial Seizures,C0234974,NA,Approved,NA,NA,lamotrigine
Lamotrigine,DB00555,Epilepsy characterized by intractable complex partial seizures,C2711653,NA,Approved,NA,NA,lamotrigine
Lamotrigine,DB00555,Tonic - clonic seizures,C0494475,NA,Approved,NA,NA,lamotrigine
Lamotrigine,DB00555,Bipolar disorder in remission,C0270425,NA,Approved,NA,NA,lamotrigine
Hydroxyzine,DB00557,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,hydroxyzine
Hydroxyzine,DB00557,Rhinorrhea,C1260880,NA,Approved,NA,NA,hydroxyzine
Hydroxyzine,DB00557,Urticaria,C0042109,NA,Approved,NA,NA,hydroxyzine
Hydroxyzine,DB00557,Symptomatic dermographism,C0343065,NA,Approved,NA,NA,hydroxyzine
Hydroxyzine,DB00557,Pruritus,C0033774,NA,Approved,NA,NA,hydroxyzine
Hydroxyzine,DB00557,"Dermatitis, Atopic",C0011615,NA,Approved,NA,NA,hydroxyzine
Hydroxyzine,DB00557,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,hydroxyzine
Zanamivir,DB00558,Influenza,C0021400,NA,Approved,NA,NA,zanamivir
Bosentan,DB00559,Pulmonary arterial hypertension,C2973725,NA,Approved,NA,NA,bosentan
Bosentan,DB00559,Pulmonary Hypertension,C0020542,NA,Approved,NA,NA,bosentan
Bosentan,DB00559,Scleroderma,C0011644,NA,Approved,NA,NA,bosentan
Tigecycline,DB00560,Complicated appendicitis,C1632842,NA,Approved,NA,NA,tigecycline
Tigecycline,DB00560,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,tigecycline
Tigecycline,DB00560,Abdominal Abscess,C0243001,NA,Approved,NA,NA,tigecycline
Tigecycline,DB00560,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,tigecycline
Tigecycline,DB00560,Legionella pneumophila pneumonia,C0857846,NA,Approved,NA,NA,tigecycline
Doxapram,DB00561,Respiratory Depression,C0235063,NA,Approved,NA,NA,doxapram
Methotrexate,DB00563,Psoriasis,C0033860,NA,Approved,NA,NA,methotrexate
Methotrexate,DB00563,Malignant epithelial neoplasm of female breast,C3163805,NA,Approved,NA,NA,methotrexate
Methotrexate,DB00563,Cancer of Head and Neck,C0278996,NA,Approved,NA,NA,methotrexate
Methotrexate,DB00563,Gestational Trophoblastic Neoplasms,C1135868,NA,Approved,NA,NA,methotrexate
Methotrexate,DB00563,Mycosis Fungoides,C0026948,NA,Approved,NA,NA,methotrexate
Methotrexate,DB00563,"Lymphoma, Non-Hodgkin",C0024305,NA,Approved,NA,NA,methotrexate
Methotrexate,DB00563,Meningeal Leukemia,C0948840,NA,Approved,NA,NA,methotrexate
Methotrexate,DB00563,Acute lymphocytic leukemia,C0023449,NA,Approved,NA,NA,methotrexate
Methotrexate,DB00563,Malignant neoplasm of lung,C0242379,NA,Approved,NA,NA,methotrexate
Methotrexate,DB00563,Burkitt Lymphoma,C0006413,NA,Approved,NA,NA,methotrexate
Methotrexate,DB00563,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,methotrexate
Methotrexate,DB00563,Osteosarcoma of bone,C0585442,NA,Approved,NA,NA,methotrexate
Carbamazepine,DB00564,Epilepsy,C0014544,NA,Approved,NA,NA,carbamazepine
Carbamazepine,DB00564,Tonic - clonic seizures,C0494475,NA,Approved,NA,NA,carbamazepine
Carbamazepine,DB00564,Epilepsy characterized by intractable complex partial seizures,C2711653,NA,Approved,NA,NA,carbamazepine
Carbamazepine,DB00564,Simple Partial Seizures,C0234974,NA,Approved,NA,NA,carbamazepine
Carbamazepine,DB00564,Lennox-Gastaut syndrome,C0238111,NA,Approved,NA,NA,carbamazepine
Carbamazepine,DB00564,Glossopharyngeal Neuralgia,C0154731,NA,Approved,NA,NA,carbamazepine
Carbamazepine,DB00564,Mixed bipolar I disorder,C0236780,NA,Approved,NA,NA,carbamazepine
Carbamazepine,DB00564,Tonic-Clonic Epilepsy,C0014549,NA,Approved,NA,NA,carbamazepine
Carbamazepine,DB00564,"Bipolar affective disorder, current episode manic",C0338873,NA,Approved,NA,NA,carbamazepine
Carbamazepine,DB00564,Bipolar disorder in remission,C0270425,NA,Approved,NA,NA,carbamazepine
Carbamazepine,DB00564,"Epilepsies, Partial",C0014547,NA,Approved,NA,NA,carbamazepine
Carbamazepine,DB00564,mixed; epileptic,C1398376,NA,Approved,NA,NA,carbamazepine
Carbamazepine,DB00564,Trigeminal Neuralgia,C0040997,NA,Approved,NA,NA,carbamazepine
Succimer,DB00566,Accidental poisoning by lead and its compounds and fumes,C0261486,NA,Approved,NA,NA,succimer
Cephalexin,DB00567,Infective otitis media,C0729586,NA,Approved,NA,NA,cephalexin
Cephalexin,DB00567,prostatitis,C0033581,NA,Approved,NA,NA,cephalexin
Cephalexin,DB00567,Klebsiella cystitis,C0520775,NA,Approved,NA,NA,cephalexin
Cephalexin,DB00567,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,cephalexin
Cephalexin,DB00567,Arthropathy associated with infection,C0157749,NA,Approved,NA,NA,cephalexin
Cephalexin,DB00567,Acute otitis media,C0271429,NA,Approved,NA,NA,cephalexin
Cephalexin,DB00567,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,cephalexin
Cephalexin,DB00567,Proteus urinary tract infection,C0577709,NA,Approved,NA,NA,cephalexin
Cephalexin,DB00567,Osteomyelitis due to Staphylococcus aureus,C1997728,NA,Approved,NA,NA,cephalexin
Cephalexin,DB00567,Streptococcal tonsillitis,C0275804,NA,Approved,NA,NA,cephalexin
Cephalexin,DB00567,Infection of bone,C2242472,NA,Approved,NA,NA,cephalexin
Cephalexin,DB00567,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,cephalexin
Cephalexin,DB00567,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,cephalexin
Cinnarizine,DB00568,Vertigo,C0042571,NA,Approved,NA,NA,cinnarizine
Cinnarizine,DB00568,Nausea,C0027497,NA,Approved,NA,NA,cinnarizine
Cinnarizine,DB00568,Motion Sickness,C0026603,NA,Approved,NA,NA,cinnarizine
Fondaparinux sodium,DB00569,Pulmonary Thromboembolisms,C0524702,NA,Approved,NA,NA,fondaparinux sodium
Fondaparinux sodium,DB00569,Deep Vein Thrombosis,C0149871,NA,Approved,NA,NA,fondaparinux sodium
Vinblastine,DB00570,Gestational Trophoblastic Neoplasms,C1135868,NA,Approved,NA,NA,vinblastine
Vinblastine,DB00570,Hodgkin Disease,C0019829,NA,Approved,NA,NA,vinblastine
Vinblastine,DB00570,Carcinoma breast stage IV,C0278488,NA,Approved,NA,NA,vinblastine
Vinblastine,DB00570,Letterer-Siwe Disease,C0023381,NA,Approved,NA,NA,vinblastine
Vinblastine,DB00570,Malignant neoplasm of testis,C0153594,NA,Approved,NA,NA,vinblastine
Vinblastine,DB00570,"Lymphoma, Non-Hodgkin",C0024305,NA,Approved,NA,NA,vinblastine
Vinblastine,DB00570,Mycosis Fungoides,C0026948,NA,Approved,NA,NA,vinblastine
Vinblastine,DB00570,Kaposi Sarcoma,C0036220,NA,Approved,NA,NA,vinblastine
Vinblastine,DB00570,Malignant epithelial neoplasm of female breast,C3163805,NA,Approved,NA,NA,vinblastine
Propranolol,DB00571,Idiopathic hypertrophic subaortic stenosis,C0700053,NA,Approved,NA,NA,propranolol
Propranolol,DB00571,Atrial Fibrillation,C0004238,NA,Approved,NA,NA,propranolol
Propranolol,DB00571,Supraventricular tachycardia,C0039240,NA,Approved,NA,NA,propranolol
Propranolol,DB00571,Angina Pectoris,C0002962,NA,Approved,NA,NA,propranolol
Propranolol,DB00571,Hypertrophic Cardiomyopathy,C0007194,NA,Approved,NA,NA,propranolol
Propranolol,DB00571,Hypertensive disease,C0020538,NA,Approved,NA,NA,propranolol
Propranolol,DB00571,Hemangioma,C0018916,NA,Approved,NA,NA,propranolol
Fenoprofen,DB00573,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,fenoprofen
Fenoprofen,DB00573,Degenerative polyarthritis,C0029408,NA,Approved,NA,NA,fenoprofen
Fenoprofen,DB00573,Pain,C0030193,NA,Approved,NA,NA,fenoprofen
Clonidine,DB00575,"Glaucoma, Open-Angle",C0017612,NA,Approved,NA,NA,clonidine
Clonidine,DB00575,Attention deficit hyperactivity disorder,C1263846,NA,Approved,NA,NA,clonidine
Clonidine,DB00575,Hypertensive disease,C0020538,NA,Approved,NA,NA,clonidine
Clonidine,DB00575,Severe pain,C0278140,NA,Approved,NA,NA,clonidine
Sulfamethizole,DB00576,Proteus urinary tract infection,C0577709,NA,Approved,NA,NA,sulfamethizole
Sulfamethizole,DB00576,Klebsiella cystitis,C0520775,NA,Approved,NA,NA,sulfamethizole
Sulfamethizole,DB00576,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,sulfamethizole
Sulfamethizole,DB00576,Bacterial urinary infection,C0729524,NA,Approved,NA,NA,sulfamethizole
Sulfamethizole,DB00576,Infective otitis media,C0729586,NA,Approved,NA,NA,sulfamethizole
Sulfamethizole,DB00576,Acute otitis media,C0271429,NA,Approved,NA,NA,sulfamethizole
Sulfamethizole,DB00576,Shigella Infections,C0013371,NA,Approved,NA,NA,sulfamethizole
Valaciclovir,DB00577,Herpes zoster disease,C0019360,NA,Approved,NA,NA,valaciclovir
Valaciclovir,DB00577,Recurrent genital herpes simplex,C1274323,NA,Approved,NA,NA,valaciclovir
Valaciclovir,DB00577,Herpes Labialis,C0019345,NA,Approved,NA,NA,valaciclovir
Valaciclovir,DB00577,Chickenpox,C0008049,NA,Approved,NA,NA,valaciclovir
Valaciclovir,DB00577,Genital Herpes,C0019342,NA,Approved,NA,NA,valaciclovir
Carbenicillin,DB00578,prostatitis,C0033581,NA,Approved,NA,NA,carbenicillin
Carbenicillin,DB00578,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,carbenicillin
Carbenicillin,DB00578,Proteus urinary tract infection,C0577709,NA,Approved,NA,NA,carbenicillin
Carbenicillin,DB00578,Urinary tract infection,C0042029,NA,Approved,NA,NA,carbenicillin
Carbenicillin,DB00578,URINARY TRACT INFECTION ENTEROCOCCUS,C0749958,NA,Approved,NA,NA,carbenicillin
Carbenicillin,DB00578,Bacterial urinary infection,C0729524,NA,Approved,NA,NA,carbenicillin
Mazindol,DB00579,Obesity,C0028754,NA,Approved,NA,NA,mazindol
Lactulose,DB00581,Hepatic Encephalopathy,C0019151,NA,Approved,NA,NA,lactulose
Lactulose,DB00581,Hyperammonemia,C0220994,NA,Approved,NA,NA,lactulose
Lactulose,DB00581,Constipation,C0009806,NA,Approved,NA,NA,lactulose
Voriconazole,DB00582,Fusariosis,C0276758,NA,Approved,NA,NA,voriconazole
Voriconazole,DB00582,Systemic candidiasis,C0153252,NA,Approved,NA,NA,voriconazole
Voriconazole,DB00582,Candidiasis of the esophagus,C0239295,NA,Approved,NA,NA,voriconazole
Voriconazole,DB00582,Invasive Pulmonary Aspergillosis,C0276653,NA,Approved,NA,NA,voriconazole
Voriconazole,DB00582,Candidemia,C0877445,NA,Approved,NA,NA,voriconazole
L-Carnitine,DB00583,Carnitine deficiency,C1142132,NA,Approved,NA,NA,l-carnitine
Enalapril,DB00584,Asymptomatic left ventricular systolic dysfunction,C3698411,NA,Approved,NA,NA,enalapril
Enalapril,DB00584,Hypertensive disease,C0020538,NA,Approved,NA,NA,enalapril
Enalapril,DB00584,Congestive heart failure,C0018802,NA,Approved,NA,NA,enalapril
Nizatidine,DB00585,Erosive esophagitis,C0267055,NA,Approved,NA,NA,nizatidine
Nizatidine,DB00585,Peptic Esophagitis,C0014869,NA,Approved,NA,NA,nizatidine
Nizatidine,DB00585,Dyspepsia,C0013395,NA,Approved,NA,NA,nizatidine
Nizatidine,DB00585,Duodenal Ulcer,C0013295,NA,Approved,NA,NA,nizatidine
Nizatidine,DB00585,Peptic Ulcer,C0030920,NA,Approved,NA,NA,nizatidine
Nizatidine,DB00585,Heartburn,C0018834,NA,Approved,NA,NA,nizatidine
Nizatidine,DB00585,Gastroesophageal reflux disease,C0017168,NA,Approved,NA,NA,nizatidine
Nizatidine,DB00585,Gastric ulcer,C0038358,NA,Approved,NA,NA,nizatidine
Diclofenac,DB00586,Degenerative polyarthritis,C0029408,NA,Approved,NA,NA,diclofenac
Diclofenac,DB00586,Actinic keratosis,C0022602,NA,Approved,NA,NA,diclofenac
Diclofenac,DB00586,"Osteoarthritis, Knee",C0409959,NA,Approved,NA,NA,diclofenac
Diclofenac,DB00586,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,diclofenac
Diclofenac,DB00586,Dysmenorrhea,C0013390,NA,Approved,NA,NA,diclofenac
Diclofenac,DB00586,Sprains and Strains,C0038048,NA,Approved,NA,NA,diclofenac
Diclofenac,DB00586,Ankylosing spondylitis,C0038013,NA,Approved,NA,NA,diclofenac
Diclofenac,DB00586,Pain,C0030193,NA,Approved,NA,NA,diclofenac
Fluticasone Propionate,DB00588,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,fluticasone propionate
Fluticasone Propionate,DB00588,Pruritus of genital organs,C0033777,NA,Approved,NA,NA,fluticasone propionate
Fluticasone Propionate,DB00588,Exanthema,C0015230,NA,Approved,NA,NA,fluticasone propionate
Fluticasone Propionate,DB00588,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,fluticasone propionate
Fluticasone Propionate,DB00588,Allergic asthma,C0155877,NA,Approved,NA,NA,fluticasone propionate
Fluticasone Propionate,DB00588,Granuloma Annulare,C0085074,NA,Approved,NA,NA,fluticasone propionate
Fluticasone Propionate,DB00588,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,fluticasone propionate
Fluticasone Propionate,DB00588,"Lymphoma, T-Cell, Cutaneous",C0079773,NA,Approved,NA,NA,fluticasone propionate
Fluticasone Propionate,DB00588,Lichen Simplex Chronicus,C0149922,NA,Approved,NA,NA,fluticasone propionate
Fluticasone Propionate,DB00588,Intrinsic asthma,C0155880,NA,Approved,NA,NA,fluticasone propionate
Fluticasone Propionate,DB00588,Scalp psoriasis,C0406326,NA,Approved,NA,NA,fluticasone propionate
Fluticasone Propionate,DB00588,"Lupus Erythematosus, Discoid",C0024138,NA,Approved,NA,NA,fluticasone propionate
Fluticasone Propionate,DB00588,Pruritus Ani,C0033775,NA,Approved,NA,NA,fluticasone propionate
Fluticasone Propionate,DB00588,Contact Dermatitis,C0011616,NA,Approved,NA,NA,fluticasone propionate
Fluticasone Propionate,DB00588,Pulmonary Emphysema,C0034067,NA,Approved,NA,NA,fluticasone propionate
Fluticasone Propionate,DB00588,"Dermatitis, Atopic",C0011615,NA,Approved,NA,NA,fluticasone propionate
Lisuride,DB00589,Migraine Disorders,C0149931,NA,Approved,NA,NA,lisuride
Lisuride,DB00589,Amenorrhea,C0002453,NA,Approved,NA,NA,lisuride
Lisuride,DB00589,Acromegaly,C0001206,NA,Approved,NA,NA,lisuride
Doxazosin,DB00590,Hypertensive disease,C0020538,NA,Approved,NA,NA,doxazosin
Doxazosin,DB00590,Prostatic Hypertrophy,C1739363,NA,Approved,NA,NA,doxazosin
Fluocinolone Acetonide,DB00591,"Lymphoma, T-Cell, Cutaneous",C0079773,NA,Approved,NA,NA,fluocinolone acetonide
Fluocinolone Acetonide,DB00591,Exanthema,C0015230,NA,Approved,NA,NA,fluocinolone acetonide
Fluocinolone Acetonide,DB00591,Pruritus Ani,C0033775,NA,Approved,NA,NA,fluocinolone acetonide
Fluocinolone Acetonide,DB00591,"Lupus Erythematosus, Discoid",C0024138,NA,Approved,NA,NA,fluocinolone acetonide
Fluocinolone Acetonide,DB00591,Contact Dermatitis,C0011616,NA,Approved,NA,NA,fluocinolone acetonide
Fluocinolone Acetonide,DB00591,Lichen Simplex Chronicus,C0149922,NA,Approved,NA,NA,fluocinolone acetonide
Fluocinolone Acetonide,DB00591,Granuloma Annulare,C0085074,NA,Approved,NA,NA,fluocinolone acetonide
Fluocinolone Acetonide,DB00591,Chloasma,C0025218,NA,Approved,NA,NA,fluocinolone acetonide
Fluocinolone Acetonide,DB00591,"Dermatitis, Atopic",C0011615,NA,Approved,NA,NA,fluocinolone acetonide
Fluocinolone Acetonide,DB00591,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,fluocinolone acetonide
Fluocinolone Acetonide,DB00591,Scalp psoriasis,C0406326,NA,Approved,NA,NA,fluocinolone acetonide
Fluocinolone Acetonide,DB00591,Choroiditis,C0008526,NA,Approved,NA,NA,fluocinolone acetonide
Fluocinolone Acetonide,DB00591,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,fluocinolone acetonide
Fluocinolone Acetonide,DB00591,Pruritus of genital organs,C0033777,NA,Approved,NA,NA,fluocinolone acetonide
Fluocinolone Acetonide,DB00591,Scurfiness of scalp,C0423775,NA,Approved,NA,NA,fluocinolone acetonide
Piperazine,DB00592,Enterobiasis,C0086227,NA,Approved,NA,NA,piperazine
Piperazine,DB00592,Ascariasis,C0003950,NA,Approved,NA,NA,piperazine
Ethosuximide,DB00593,Absence Epilepsy,C0014553,NA,Approved,NA,NA,ethosuximide
Amiloride,DB00594,Edema,C0013604,NA,Approved,NA,NA,amiloride
Amiloride,DB00594,Hypertensive disease,C0020538,NA,Approved,NA,NA,amiloride
Oxytetracycline,DB00595,Bacterial keratitis,C0854211,NA,Approved,NA,NA,oxytetracycline
Oxytetracycline,DB00595,Rocky Mountain Spotted Fever,C0035793,NA,Approved,NA,NA,oxytetracycline
Oxytetracycline,DB00595,Lymphogranuloma Venereum,C0024286,NA,Approved,NA,NA,oxytetracycline
Oxytetracycline,DB00595,TYPHUS,C0041471,NA,Approved,NA,NA,oxytetracycline
Oxytetracycline,DB00595,Acute gonococcal urethritis,C0275652,NA,Approved,NA,NA,oxytetracycline
Oxytetracycline,DB00595,Bacterial conjunctivitis,C0009768,NA,Approved,NA,NA,oxytetracycline
Oxytetracycline,DB00595,Brucellosis,C0006309,NA,Approved,NA,NA,oxytetracycline
Oxytetracycline,DB00595,Relapsing Fever,C0035021,NA,Approved,NA,NA,oxytetracycline
Oxytetracycline,DB00595,Actinomycosis,C0001261,NA,Approved,NA,NA,oxytetracycline
Oxytetracycline,DB00595,Chlamydia trachomatis infection of genital structure,C1997322,NA,Approved,NA,NA,oxytetracycline
Oxytetracycline,DB00595,Syphilis,C0039128,NA,Approved,NA,NA,oxytetracycline
Oxytetracycline,DB00595,Acute gonococcal cervicitis,C0153195,NA,Approved,NA,NA,oxytetracycline
Oxytetracycline,DB00595,Infective otitis media,C0729586,NA,Approved,NA,NA,oxytetracycline
Oxytetracycline,DB00595,Pharyngitis,C0031350,NA,Approved,NA,NA,oxytetracycline
Oxytetracycline,DB00595,Psittacosis,C0029291,NA,Approved,NA,NA,oxytetracycline
Oxytetracycline,DB00595,Trachoma,C0040592,NA,Approved,NA,NA,oxytetracycline
Oxytetracycline,DB00595,Gingivostomatitis,C0149704,NA,Approved,NA,NA,oxytetracycline
Oxytetracycline,DB00595,Bronchitis,C0006277,NA,Approved,NA,NA,oxytetracycline
Oxytetracycline,DB00595,Granuloma Inguinale,C0018190,NA,Approved,NA,NA,oxytetracycline
Oxytetracycline,DB00595,Sinusitis,C0037199,NA,Approved,NA,NA,oxytetracycline
Oxytetracycline,DB00595,Acute gonococcal epididymo-orchitis,C0153193,NA,Approved,NA,NA,oxytetracycline
Oxytetracycline,DB00595,Gonorrhea of rectum,C0275665,NA,Approved,NA,NA,oxytetracycline
Oxytetracycline,DB00595,Gonorrhea of pharynx,C0149966,NA,Approved,NA,NA,oxytetracycline
Oxytetracycline,DB00595,Acute gonococcal endometritis,C0153196,NA,Approved,NA,NA,oxytetracycline
Oxytetracycline,DB00595,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,oxytetracycline
Oxytetracycline,DB00595,Rickettsialpox,C0035597,NA,Approved,NA,NA,oxytetracycline
Oxytetracycline,DB00595,Pneumonia,C0032285,NA,Approved,NA,NA,oxytetracycline
Oxytetracycline,DB00595,Urinary tract infection,C0042029,NA,Approved,NA,NA,oxytetracycline
Oxytetracycline,DB00595,Q Fever,C0034362,NA,Approved,NA,NA,oxytetracycline
Oxytetracycline,DB00595,Yaws,C0043388,NA,Approved,NA,NA,oxytetracycline
Ulobetasol,DB00596,Granuloma Annulare,C0085074,NA,Approved,NA,NA,ulobetasol
Ulobetasol,DB00596,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,ulobetasol
Ulobetasol,DB00596,Lichen Simplex Chronicus,C0149922,NA,Approved,NA,NA,ulobetasol
Ulobetasol,DB00596,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,ulobetasol
Ulobetasol,DB00596,Scalp psoriasis,C0406326,NA,Approved,NA,NA,ulobetasol
Ulobetasol,DB00596,"Lupus Erythematosus, Discoid",C0024138,NA,Approved,NA,NA,ulobetasol
Ulobetasol,DB00596,"Lymphoma, T-Cell, Cutaneous",C0079773,NA,Approved,NA,NA,ulobetasol
Ulobetasol,DB00596,Pruritus of genital organs,C0033777,NA,Approved,NA,NA,ulobetasol
Ulobetasol,DB00596,Contact Dermatitis,C0011616,NA,Approved,NA,NA,ulobetasol
Ulobetasol,DB00596,Exanthema,C0015230,NA,Approved,NA,NA,ulobetasol
Ulobetasol,DB00596,Pruritus Ani,C0033775,NA,Approved,NA,NA,ulobetasol
Labetalol,DB00598,Hypertensive disease,C0020538,NA,Approved,NA,NA,labetalol
Thiopental,DB00599,Epilepsy,C0014544,NA,Approved,NA,NA,thiopental
Thiopental,DB00599,Pseudotumor Cerebri,C0033845,NA,Approved,NA,NA,thiopental
Linezolid,DB00601,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,linezolid
Linezolid,DB00601,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,linezolid
Linezolid,DB00601,Staphylococcal Pneumonia,C0032308,NA,Approved,NA,NA,linezolid
Ivermectin,DB00602,Onchocerciasis,C0029001,NA,Approved,NA,NA,ivermectin
Ivermectin,DB00602,Strongyloidiasis,C0038463,NA,Approved,NA,NA,ivermectin
Medroxyprogesterone acetate,DB00603,Secondary malignant neoplasm of kidney,C0153685,NA,Approved,NA,NA,medroxyprogesterone acetate
Medroxyprogesterone acetate,DB00603,Metrorrhagia,C0025874,NA,Approved,NA,NA,medroxyprogesterone acetate
Medroxyprogesterone acetate,DB00603,Endometriosis,C0014175,NA,Approved,NA,NA,medroxyprogesterone acetate
Medroxyprogesterone acetate,DB00603,Endometrial Carcinoma,C0476089,NA,Approved,NA,NA,medroxyprogesterone acetate
Medroxyprogesterone acetate,DB00603,Hot flushes,C0600142,NA,Approved,NA,NA,medroxyprogesterone acetate
Medroxyprogesterone acetate,DB00603,Secondary physiologic amenorrhea,C0232940,NA,Approved,NA,NA,medroxyprogesterone acetate
Medroxyprogesterone acetate,DB00603,Atrophic Vaginitis,C0221392,NA,Approved,NA,NA,medroxyprogesterone acetate
Cisapride,DB00604,Gastroesophageal reflux disease,C0017168,NA,Approved,NA,NA,cisapride
Sulindac,DB00605,Ankylosing spondylitis,C0038013,NA,Approved,NA,NA,sulindac
Sulindac,DB00605,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,sulindac
Sulindac,DB00605,Degenerative polyarthritis,C0029408,NA,Approved,NA,NA,sulindac
Sulindac,DB00605,"Arthritis, Gouty",C0003868,NA,Approved,NA,NA,sulindac
Sulindac,DB00605,Bursitis,C0006444,NA,Approved,NA,NA,sulindac
Sulindac,DB00605,Tendinitis,C0039503,NA,Approved,NA,NA,sulindac
Nafcillin,DB00607,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,nafcillin
Nafcillin,DB00607,Sepsis due to Staphylococcus aureus,C2887088,NA,Approved,NA,NA,nafcillin
Nafcillin,DB00607,Osteomyelitis due to Staphylococcus aureus,C1997728,NA,Approved,NA,NA,nafcillin
Nafcillin,DB00607,Staphylococcal meningitis,C0154640,NA,Approved,NA,NA,nafcillin
Nafcillin,DB00607,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,nafcillin
Nafcillin,DB00607,Staphylococcal Pneumonia,C0032308,NA,Approved,NA,NA,nafcillin
Nafcillin,DB00607,Staphylococcal Infections,C0038160,NA,Approved,NA,NA,nafcillin
Nafcillin,DB00607,Infection of bone,C2242472,NA,Approved,NA,NA,nafcillin
Nafcillin,DB00607,Staphylococcal endocarditis,C0520767,NA,Approved,NA,NA,nafcillin
Chloroquine,DB00608,Quartan malaria,C0024536,NA,Approved,NA,NA,chloroquine
Chloroquine,DB00608,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,chloroquine
Chloroquine,DB00608,"Malaria, Falciparum",C0024535,NA,Approved,NA,NA,chloroquine
Chloroquine,DB00608,"Lupus Erythematosus, Systemic",C0024141,NA,Approved,NA,NA,chloroquine
Chloroquine,DB00608,"Lupus Erythematosus, Discoid",C0024138,NA,Approved,NA,NA,chloroquine
Chloroquine,DB00608,Ovale malaria,C0152072,NA,Approved,NA,NA,chloroquine
Chloroquine,DB00608,"Malaria, Vivax",C0024537,NA,Approved,NA,NA,chloroquine
Ethionamide,DB00609,Acute tuberculosis,C0275959,NA,Approved,NA,NA,ethionamide
Ethionamide,DB00609,"Tuberculosis, Pulmonary",C0041327,NA,Approved,NA,NA,ethionamide
Butorphanol,DB00611,Pain,C0030193,NA,Approved,NA,NA,butorphanol
Butorphanol,DB00611,Labor Pain,C0474368,NA,Approved,NA,NA,butorphanol
Bisoprolol,DB00612,Hypertensive disease,C0020538,NA,Approved,NA,NA,bisoprolol
Rifabutin,DB00615,Pulmonary Mycobacterium avium complex infection,C2733595,NA,Approved,NA,NA,rifabutin
Paramethadione,DB00617,Epilepsy,C0014544,NA,Approved,NA,NA,paramethadione
Paramethadione,DB00617,Absence Epilepsy,C0014553,NA,Approved,NA,NA,paramethadione
Demeclocycline,DB00618,Trachoma,C0040592,NA,Approved,NA,NA,demeclocycline
Demeclocycline,DB00618,Gonorrhea,C0018081,NA,Approved,NA,NA,demeclocycline
Demeclocycline,DB00618,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,demeclocycline
Demeclocycline,DB00618,Chancroids,C0007947,NA,Approved,NA,NA,demeclocycline
Demeclocycline,DB00618,Acute gonococcal urethritis,C0275652,NA,Approved,NA,NA,demeclocycline
Demeclocycline,DB00618,Sinusitis,C0037199,NA,Approved,NA,NA,demeclocycline
Demeclocycline,DB00618,Urinary tract infection,C0042029,NA,Approved,NA,NA,demeclocycline
Demeclocycline,DB00618,Infective otitis media,C0729586,NA,Approved,NA,NA,demeclocycline
Demeclocycline,DB00618,Acute gonococcal endometritis,C0153196,NA,Approved,NA,NA,demeclocycline
Demeclocycline,DB00618,Actinomycosis,C0001261,NA,Approved,NA,NA,demeclocycline
Demeclocycline,DB00618,Q Fever,C0034362,NA,Approved,NA,NA,demeclocycline
Demeclocycline,DB00618,Gonorrhea of pharynx,C0149966,NA,Approved,NA,NA,demeclocycline
Demeclocycline,DB00618,Yaws,C0043388,NA,Approved,NA,NA,demeclocycline
Demeclocycline,DB00618,Lymphogranuloma Venereum,C0024286,NA,Approved,NA,NA,demeclocycline
Demeclocycline,DB00618,Pharyngitis,C0031350,NA,Approved,NA,NA,demeclocycline
Demeclocycline,DB00618,Rocky Mountain Spotted Fever,C0035793,NA,Approved,NA,NA,demeclocycline
Demeclocycline,DB00618,Rickettsialpox,C0035597,NA,Approved,NA,NA,demeclocycline
Demeclocycline,DB00618,Brucellosis,C0006309,NA,Approved,NA,NA,demeclocycline
Demeclocycline,DB00618,Psittacosis,C0029291,NA,Approved,NA,NA,demeclocycline
Demeclocycline,DB00618,TYPHUS,C0041471,NA,Approved,NA,NA,demeclocycline
Demeclocycline,DB00618,Gingivostomatitis,C0149704,NA,Approved,NA,NA,demeclocycline
Demeclocycline,DB00618,Gonorrhea of rectum,C0275665,NA,Approved,NA,NA,demeclocycline
Demeclocycline,DB00618,Syphilis,C0039128,NA,Approved,NA,NA,demeclocycline
Demeclocycline,DB00618,Acute gonococcal cervicitis,C0153195,NA,Approved,NA,NA,demeclocycline
Demeclocycline,DB00618,Klebsiella cystitis,C0520775,NA,Approved,NA,NA,demeclocycline
Demeclocycline,DB00618,Pneumonia,C0032285,NA,Approved,NA,NA,demeclocycline
Demeclocycline,DB00618,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,demeclocycline
Demeclocycline,DB00618,Bronchitis,C0006277,NA,Approved,NA,NA,demeclocycline
Demeclocycline,DB00618,pharyngitis due to Haemophilus influenzae,C2062475,NA,Approved,NA,NA,demeclocycline
Demeclocycline,DB00618,Relapsing Fever,C0035021,NA,Approved,NA,NA,demeclocycline
Demeclocycline,DB00618,Granuloma Inguinale,C0018190,NA,Approved,NA,NA,demeclocycline
Imatinib,DB00619,"Leukemia, Myeloid, Accelerated Phase",C0023472,NA,Approved,NA,NA,imatinib
Imatinib,DB00619,"Mastocytosis, Systemic",C0221013,NA,Approved,NA,NA,imatinib
Imatinib,DB00619,"Leukemia, Myeloid, Chronic-Phase",C0023474,NA,Approved,NA,NA,imatinib
Imatinib,DB00619,Blast Phase,C0005699,NA,Approved,NA,NA,imatinib
Imatinib,DB00619,Philadelphia chromosome positive chronic myelogenous leukemia,C0279543,NA,Approved,NA,NA,imatinib
Imatinib,DB00619,Chronic eosinophilic leukemia,C0346421,NA,Approved,NA,NA,imatinib
Imatinib,DB00619,Philadelphia chromosome-positive acute lymphoblastic leukemia,C1960397,NA,Approved,NA,NA,imatinib
Imatinib,DB00619,Dermatofibrosarcoma Protuberans,C0392784,NA,Approved,NA,NA,imatinib
Imatinib,DB00619,Idiopathic Hypereosinophilic Syndrome,C0206141,NA,Approved,NA,NA,imatinib
Imatinib,DB00619,Gastrointestinal Stromal Tumors,C0238198,NA,Approved,NA,NA,imatinib
Triamcinolone,DB00620,Scalp psoriasis,C0406326,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Tendinitis,C0039503,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,"Lymphoma, Non-Hodgkin",C0024305,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Inflammatory Bowel Diseases,C0021390,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Giant Cell Arteritis,C0039483,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Granuloma Annulare,C0085074,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Uveitis,C0042164,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Aphthous Stomatitis,C0038363,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Keloid,C0022548,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Cooley's anemia,C0002875,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Gingival Diseases,C0017563,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Status Asthmaticus,C0038218,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Simple Pulmonary Eosinophilia,C0242459,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Exanthema,C0015230,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Erythema Multiforme,C0014742,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Contact Dermatitis,C0011616,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,"Arthritis, Gouty",C0003868,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Autoimmune Diseases,C0004364,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Post traumatic osteoarthritis,C2894027,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Lichen Simplex Chronicus,C0149922,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Laryngeal Edema,C0023052,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Autoimmune hemolytic anemia,C0002880,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Bursitis,C0006444,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Exfoliative dermatitis,C0011606,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Crohn Disease,C0010346,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Asthma,C0004096,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Acute lymphocytic leukemia,C0023449,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Adrenogenital disorder,C0701163,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Disorder of eye,C0015397,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Thyroiditis,C0040147,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Pemphigus,C0030807,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Aspiration pneumonitis,C1761609,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Sarcoidosis,C0036202,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Pruritus Ani,C0033775,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Multiple Sclerosis,C0026769,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Alopecia Areata,C0002171,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,"Arthritis, Psoriatic",C0003872,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Cutaneous Candidiasis,C0006846,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Epicondylitis,C0014488,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Trichinellosis,C0040896,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Addisonian crisis,C0151467,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Berylliosis,C0005138,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Lichen Planus,C0023646,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,"Ophthalmia, Sympathetic",C0029077,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Acquired thrombocytopenia,C0154301,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Mycosis Fungoides,C0026948,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Synovitis,C0039103,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Serum Sickness,C0036830,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,"Dermatitis, Atopic",C0011615,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,"Lupus Erythematosus, Systemic",C0024141,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Nephrotic Syndrome,C0027726,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Rheumatic Heart Disease,C0035439,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Pruritus of genital organs,C0033777,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Tenosynovitis,C0039520,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,"Lymphoma, T-Cell, Cutaneous",C0079773,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Transplanted organ rejection,C0345468,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Humoral hypercalcemia of malignancy (disorder),C0149911,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Hodgkin Disease,C0019829,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Dermatitis Herpetiformis,C0011608,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Psoriasis,C0033860,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Angioedema,C0002994,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,"Lupus Erythematosus, Discoid",C0024138,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Adrenal cortical hypofunction,C0405580,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Ankylosing spondylitis,C0038013,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Cerebral Edema,C0006114,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Subacute bursitis,C1290159,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Hay fever,C0018621,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,"Tuberculosis, Miliary",C0041321,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Dermatologic disorders,C0037274,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,"Anemia, Diamond-Blackfan",C1260899,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Addison Disease,C0001403,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Congenital adrenal hyperplasia,C0001627,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Musculoskeletal Diseases,C0026857,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,"Lymphoma, Follicular",C0024301,NA,Approved,NA,NA,triamcinolone
Triamcinolone,DB00620,Necrobiosis Lipoidica Diabeticorum,C0392445,NA,Approved,NA,NA,triamcinolone
Nicardipine,DB00622,Hypertensive disease,C0020538,NA,Approved,NA,NA,nicardipine
Fluphenazine,DB00623,Schizophrenia,C0036341,NA,Approved,NA,NA,fluphenazine
Fluphenazine,DB00623,Psychotic Disorders,C0033975,NA,Approved,NA,NA,fluphenazine
Testosterone,DB00624,Primary hypogonadism,C0948896,NA,Approved,NA,NA,testosterone
Testosterone,DB00624,Hypogonadotropic hypogonadism,C0271623,NA,Approved,NA,NA,testosterone
Testosterone,DB00624,Cryptorchidism,C0010417,NA,Approved,NA,NA,testosterone
Testosterone,DB00624,Klinefelter Syndrome,C0022735,NA,Approved,NA,NA,testosterone
Testosterone,DB00624,Delayed Puberty,C0034012,NA,Approved,NA,NA,testosterone
Testosterone,DB00624,Testicular hypogonadism,C0151721,NA,Approved,NA,NA,testosterone
Testosterone,DB00624,Deficiency of testosterone biosynthesis,C0342527,NA,Approved,NA,NA,testosterone
Testosterone,DB00624,Hormone receptor positive malignant neoplasm of breast,C1562029,NA,Approved,NA,NA,testosterone
Testosterone,DB00624,Hot flushes,C0600142,NA,Approved,NA,NA,testosterone
Testosterone,DB00624,Hypopituitarism,C0020635,NA,Approved,NA,NA,testosterone
Efavirenz,DB00625,HIV Infections,C0019693,NA,Approved,NA,NA,efavirenz
Bacitracin,DB00626,Corneal abrasion,C0010032,NA,Approved,NA,NA,bacitracin
Bacitracin,DB00626,Bacterial keratitis,C0854211,NA,Approved,NA,NA,bacitracin
Bacitracin,DB00626,Keratitis,C0022568,NA,Approved,NA,NA,bacitracin
Bacitracin,DB00626,Blepharoconjunctivitis,C0005743,NA,Approved,NA,NA,bacitracin
Bacitracin,DB00626,Infective blepharitis,C0729587,NA,Approved,NA,NA,bacitracin
Niacin,DB00627,Hypercholesterolemia,C0020443,NA,Approved,NA,NA,niacin
Niacin,DB00627,Hypertriglyceridemia,C0020557,NA,Approved,NA,NA,niacin
Niacin,DB00627,Familial hypercholesterolemia - heterozygous,C0342882,NA,Approved,NA,NA,niacin
Niacin,DB00627,"Hyperlipidemia, Familial Combined",C0020474,NA,Approved,NA,NA,niacin
Niacin,DB00627,Vitamin Deficiency,C1510471,NA,Approved,NA,NA,niacin
Niacin,DB00627,Hyperlipidemia,C0020473,NA,Approved,NA,NA,niacin
Clorazepate,DB00628,Anxiety,C0003467,NA,Approved,NA,NA,clorazepate
Clorazepate,DB00628,Alcohol withdrawal syndrome,C0236663,NA,Approved,NA,NA,clorazepate
Guanabenz,DB00629,Hypertensive disease,C0020538,NA,Approved,NA,NA,guanabenz
Alendronic acid,DB00630,"Osteoporosis, Postmenopausal",C0029458,NA,Approved,NA,NA,alendronic acid
Alendronic acid,DB00630,Osteitis Deformans,C0029401,NA,Approved,NA,NA,alendronic acid
Clofarabine,DB00631,Acute lymphocytic leukemia,C0023449,NA,Approved,NA,NA,clofarabine
Docosanol,DB00632,Herpes Labialis,C0019345,NA,Approved,NA,NA,docosanol
Sulfacetamide,DB00634,Trachoma,C0040592,NA,Approved,NA,NA,sulfacetamide
Sulfacetamide,DB00634,Blepharoconjunctivitis,C0005743,NA,Approved,NA,NA,sulfacetamide
Sulfacetamide,DB00634,Infective blepharitis,C0729587,NA,Approved,NA,NA,sulfacetamide
Sulfacetamide,DB00634,Acne Vulgaris,C0001144,NA,Approved,NA,NA,sulfacetamide
Sulfacetamide,DB00634,Inclusion conjunctivitis,C0009770,NA,Approved,NA,NA,sulfacetamide
Sulfacetamide,DB00634,Bacterial conjunctivitis,C0009768,NA,Approved,NA,NA,sulfacetamide
Sulfacetamide,DB00634,Amebiasis,C0002438,NA,Approved,NA,NA,sulfacetamide
Sulfacetamide,DB00634,Iridocyclitis,C0022073,NA,Approved,NA,NA,sulfacetamide
Sulfacetamide,DB00634,Vulvovaginitis,C0042998,NA,Approved,NA,NA,sulfacetamide
Sulfacetamide,DB00634,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,sulfacetamide
Sulfacetamide,DB00634,Scurfiness of scalp,C0423775,NA,Approved,NA,NA,sulfacetamide
Prednisone,DB00635,Exfoliative dermatitis,C0011606,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Acute lymphocytic leukemia,C0023449,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Crohn Disease,C0010346,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,"Lymphoma, Non-Hodgkin",C0024305,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Mycosis Fungoides,C0026948,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Contact Dermatitis,C0011616,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Simple Pulmonary Eosinophilia,C0242459,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Pemphigus,C0030807,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Nephrotic Syndrome,C0027726,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Trichinellosis,C0040896,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Autoimmune hemolytic anemia,C0002880,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,"Lymphoma, Follicular",C0024301,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Asthma,C0004096,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Berylliosis,C0005138,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Laryngeal Edema,C0023052,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Chronic Lymphocytic Leukemia,C0023434,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Thyroiditis,C0040147,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Hodgkin Disease,C0019829,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,"Lupus Erythematosus, Systemic",C0024141,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Erythema Multiforme,C0014742,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Adrenogenital disorder,C0701163,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Transplanted organ rejection,C0345468,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Humoral hypercalcemia of malignancy (disorder),C0149911,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Adrenal cortical hypofunction,C0405580,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Dermatologic disorders,C0037274,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Angioedema,C0002994,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Musculoskeletal Diseases,C0026857,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,"Lymphoma, T-Cell, Cutaneous",C0079773,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Dermatitis Herpetiformis,C0011608,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Rheumatic Heart Disease,C0035439,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Psoriasis,C0033860,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Multiple Sclerosis,C0026769,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,"Anemia, Diamond-Blackfan",C1260899,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Cooley's anemia,C0002875,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Addison Disease,C0001403,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Exacerbation of asthma,C0349790,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Diffuse Large B-Cell Lymphoma,C0079744,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,"Arthritis, Psoriatic",C0003872,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Serum Sickness,C0036830,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Acquired thrombocytopenia,C0154301,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Sarcoidosis,C0036202,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Ankylosing spondylitis,C0038013,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,"Arthritis, Gouty",C0003868,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Epicondylitis,C0014488,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Autoimmune Diseases,C0004364,NA,Approved,NA,NA,prednisone
Prednisone,DB00635,Inflammatory Bowel Diseases,C0021390,NA,Approved,NA,NA,prednisone
Clofibrate,DB00636,Hyperlipidemia,C0020473,NA,Approved,NA,NA,clofibrate
Astemizole,DB00637,Sneezing,C0037383,NA,Approved,NA,NA,astemizole
Astemizole,DB00637,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,astemizole
Astemizole,DB00637,Chronic idiopathic urticaria,C0578870,NA,Approved,NA,NA,astemizole
Astemizole,DB00637,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,astemizole
Butoconazole,DB00639,"Candidiasis, Vulvovaginal",C0700345,NA,Approved,NA,NA,butoconazole
Adenosine,DB00640,Pulmonary Cystic Fibrosis,C0392164,NA,Approved,NA,NA,adenosine
Adenosine,DB00640,Paroxysmal supraventricular tachycardia,C0030590,NA,Approved,NA,NA,adenosine
Simvastatin,DB00641,Hypoalphalipoproteinemias,C0473527,NA,Approved,NA,NA,simvastatin
Simvastatin,DB00641,Hyperlipoproteinemia Type III,C0020479,NA,Approved,NA,NA,simvastatin
Simvastatin,DB00641,Cerebrovascular accident,C0038454,NA,Approved,NA,NA,simvastatin
Simvastatin,DB00641,Arteriosclerosis,C0003850,NA,Approved,NA,NA,simvastatin
Simvastatin,DB00641,Familial hypercholesterolemia - heterozygous,C0342882,NA,Approved,NA,NA,simvastatin
Simvastatin,DB00641,Hypercholesterolemia,C0020443,NA,Approved,NA,NA,simvastatin
Simvastatin,DB00641,Familial hypercholesterolemia - homozygous,C0342881,NA,Approved,NA,NA,simvastatin
Simvastatin,DB00641,Hypertriglyceridemia,C0020557,NA,Approved,NA,NA,simvastatin
Simvastatin,DB00641,"Hyperlipidemia, Familial Combined",C0020474,NA,Approved,NA,NA,simvastatin
Pemetrexed,DB00642,Malignant Pleural Mesothelioma,C0812413,NA,Approved,NA,NA,pemetrexed
Pemetrexed,DB00642,Non-Small Cell Lung Carcinoma,C0007131,NA,Approved,NA,NA,pemetrexed
Mebendazole,DB00643,Enterobiasis,C0086227,NA,Approved,NA,NA,mebendazole
Mebendazole,DB00643,Ascariasis,C0003950,NA,Approved,NA,NA,mebendazole
Mebendazole,DB00643,Infection by Trichuris trichiura,C0040954,NA,Approved,NA,NA,mebendazole
Gonadorelin,DB00644,Amenorrhea,C0002453,NA,Approved,NA,NA,gonadorelin
Dyclonine,DB00645,Skin irritation,C0152030,NA,Approved,NA,NA,dyclonine
Dyclonine,DB00645,Pruritus,C0033774,NA,Approved,NA,NA,dyclonine
Dyclonine,DB00645,Mouth irritation,C0235339,NA,Approved,NA,NA,dyclonine
Nystatin,DB00646,"Candidiasis, Vulvovaginal",C0700345,NA,Approved,NA,NA,nystatin
Nystatin,DB00646,Mucocutaneous candidiasis,C0006848,NA,Approved,NA,NA,nystatin
Nystatin,DB00646,Gastrointestinal candidiasis,C0343886,NA,Approved,NA,NA,nystatin
Nystatin,DB00646,Oral candidiasis,C0006849,NA,Approved,NA,NA,nystatin
Nystatin,DB00646,Cutaneous Candidiasis,C0006846,NA,Approved,NA,NA,nystatin
Dextropropoxyphene,DB00647,Pain,C0030193,NA,Approved,NA,NA,dextropropoxyphene
Mitotane,DB00648,Carcinoma in situ of adrenal cortex,C0686510,NA,Approved,NA,NA,mitotane
Stavudine,DB00649,HIV Infections,C0019693,NA,Approved,NA,NA,stavudine
Leucovorin,DB00650,Poisoning by pyrimethamine,C0274478,NA,Approved,NA,NA,leucovorin
Leucovorin,DB00650,Methotrexate poisoning,C0568062,NA,Approved,NA,NA,leucovorin
Leucovorin,DB00650,"Anemia, Megaloblastic",C0002888,NA,Approved,NA,NA,leucovorin
Leucovorin,DB00650,Folic Acid Deficiency,C0016412,NA,Approved,NA,NA,leucovorin
Leucovorin,DB00650,Poisoning by sulfadiazine,C0274462,NA,Approved,NA,NA,leucovorin
Dyphylline,DB00651,Pulmonary Emphysema,C0034067,NA,Approved,NA,NA,dyphylline
Dyphylline,DB00651,Asthma,C0004096,NA,Approved,NA,NA,dyphylline
Dyphylline,DB00651,Bronchial Spasm,C0006266,NA,Approved,NA,NA,dyphylline
Dyphylline,DB00651,Asthma night-time symptoms,C1273489,NA,Approved,NA,NA,dyphylline
Dyphylline,DB00651,"Bronchitis, Chronic",C0008677,NA,Approved,NA,NA,dyphylline
Dyphylline,DB00651,Asthma-chronic obstructive pulmonary disease overlap syndrome,C4038730,NA,Approved,NA,NA,dyphylline
Pentazocine,DB00652,Labor Pain,C0474368,NA,Approved,NA,NA,pentazocine
Pentazocine,DB00652,Pain,C0030193,NA,Approved,NA,NA,pentazocine
Magnesium Sulfate,DB00653,Eclampsia in pregnancy,C0156677,NA,Approved,NA,NA,magnesium sulfate
Magnesium Sulfate,DB00653,Hypomagnesemia,C0151723,NA,Approved,NA,NA,magnesium sulfate
Magnesium Sulfate,DB00653,Mild pre-eclampsia,C0269658,NA,Approved,NA,NA,magnesium sulfate
Magnesium Sulfate,DB00653,Severe pre-eclampsia,C0341950,NA,Approved,NA,NA,magnesium sulfate
Magnesium Sulfate,DB00653,Incomplete passage of stool,C0426639,NA,Approved,NA,NA,magnesium sulfate
Magnesium Sulfate,DB00653,Constipation,C0009806,NA,Approved,NA,NA,magnesium sulfate
Latanoprost,DB00654,Ocular Hypertension,C0028840,NA,Approved,NA,NA,latanoprost
Latanoprost,DB00654,"Glaucoma, Open-Angle",C0017612,NA,Approved,NA,NA,latanoprost
Estrone,DB00655,Acne Vulgaris,C0001144,NA,Approved,NA,NA,estrone
Estrone,DB00655,Chemotherapy-induced nausea and vomiting,C0401160,NA,Approved,NA,NA,estrone
Estrone,DB00655,Atrophic Vaginitis,C0221392,NA,Approved,NA,NA,estrone
Trazodone,DB00656,Major Depressive Disorder,C1269683,NA,Approved,NA,NA,trazodone
Mecamylamine,DB00657,Hypertensive disease,C0020538,NA,Approved,NA,NA,mecamylamine
Acamprosate,DB00659,"Alcoholic Intoxication, Chronic",C0001973,NA,Approved,NA,NA,acamprosate
Metaxalone,DB00660,Muscle Spasticity,C0026838,NA,Approved,NA,NA,metaxalone
Verapamil,DB00661,Atrial Fibrillation,C0004238,NA,Approved,NA,NA,verapamil
Verapamil,DB00661,Hypertensive disease,C0020538,NA,Approved,NA,NA,verapamil
Verapamil,DB00661,"Angina Pectoris, Variant",C0002963,NA,Approved,NA,NA,verapamil
Verapamil,DB00661,Paroxysmal supraventricular tachycardia,C0030590,NA,Approved,NA,NA,verapamil
Verapamil,DB00661,Angina Pectoris,C0002962,NA,Approved,NA,NA,verapamil
Trimethobenzamide,DB00662,Vomiting,C0042963,NA,Approved,NA,NA,trimethobenzamide
Trimethobenzamide,DB00662,Nausea,C0027497,NA,Approved,NA,NA,trimethobenzamide
Trimethobenzamide,DB00662,Nausea and vomiting,C0027498,NA,Approved,NA,NA,trimethobenzamide
Flumethasone,DB00663,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,flumethasone
Flumethasone,DB00663,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,flumethasone
Flumethasone,DB00663,"Lupus Erythematosus, Discoid",C0024138,NA,Approved,NA,NA,flumethasone
Flumethasone,DB00663,Pruritus of genital organs,C0033777,NA,Approved,NA,NA,flumethasone
Flumethasone,DB00663,Exanthema,C0015230,NA,Approved,NA,NA,flumethasone
Flumethasone,DB00663,"Lymphoma, T-Cell, Cutaneous",C0079773,NA,Approved,NA,NA,flumethasone
Flumethasone,DB00663,Granuloma Annulare,C0085074,NA,Approved,NA,NA,flumethasone
Flumethasone,DB00663,Scalp psoriasis,C0406326,NA,Approved,NA,NA,flumethasone
Flumethasone,DB00663,Contact Dermatitis,C0011616,NA,Approved,NA,NA,flumethasone
Flumethasone,DB00663,Lichen Simplex Chronicus,C0149922,NA,Approved,NA,NA,flumethasone
Flumethasone,DB00663,Pruritus Ani,C0033775,NA,Approved,NA,NA,flumethasone
Flumethasone,DB00663,"Dermatitis, Atopic",C0011615,NA,Approved,NA,NA,flumethasone
Nilutamide,DB00665,Metastatic Prostate Carcinoma,C0936223,NA,Approved,NA,NA,nilutamide
Nafarelin,DB00666,Precocious Puberty,C0034013,NA,Approved,NA,NA,nafarelin
Nafarelin,DB00666,Endometriosis,C0014175,NA,Approved,NA,NA,nafarelin
Histamine Phosphate,DB00667,Degenerative polyarthritis,C0029408,NA,Approved,NA,NA,histamine phosphate
Epinephrine,DB00668,anaphylaxis,C0002792,NA,Approved,NA,NA,epinephrine
Epinephrine,DB00668,Hypotension,C0020649,NA,Approved,NA,NA,epinephrine
Epinephrine,DB00668,Bronchiectasis,C0006267,NA,Approved,NA,NA,epinephrine
Epinephrine,DB00668,Asthma attack,C0347950,NA,Approved,NA,NA,epinephrine
Epinephrine,DB00668,"Glaucoma, Open-Angle",C0017612,NA,Approved,NA,NA,epinephrine
Epinephrine,DB00668,Dyspnea,C0013404,NA,Approved,NA,NA,epinephrine
Epinephrine,DB00668,Bronchitis,C0006277,NA,Approved,NA,NA,epinephrine
Epinephrine,DB00668,Wheezing,C0043144,NA,Approved,NA,NA,epinephrine
Epinephrine,DB00668,Exacerbation of asthma,C0349790,NA,Approved,NA,NA,epinephrine
Epinephrine,DB00668,Asthma,C0004096,NA,Approved,NA,NA,epinephrine
Epinephrine,DB00668,Pulmonary Emphysema,C0034067,NA,Approved,NA,NA,epinephrine
Sumatriptan,DB00669,Migraine Disorders,C0149931,NA,Approved,NA,NA,sumatriptan
Sumatriptan,DB00669,Cluster Headache,C0009088,NA,Approved,NA,NA,sumatriptan
Pirenzepine,DB00670,Peptic Ulcer,C0030920,NA,Approved,NA,NA,pirenzepine
Cefixime,DB00671,Acute otitis media,C0271429,NA,Approved,NA,NA,cefixime
Cefixime,DB00671,Acute exacerbation of chronic bronchitis,C0856695,NA,Approved,NA,NA,cefixime
Cefixime,DB00671,Upper Respiratory Infections,C0041912,NA,Approved,NA,NA,cefixime
Cefixime,DB00671,Acute gonococcal urethritis,C0275652,NA,Approved,NA,NA,cefixime
Cefixime,DB00671,Streptococcal tonsillitis,C0275804,NA,Approved,NA,NA,cefixime
Cefixime,DB00671,Pharyngitis,C0031350,NA,Approved,NA,NA,cefixime
Cefixime,DB00671,Proteus urinary tract infection,C0577709,NA,Approved,NA,NA,cefixime
Cefixime,DB00671,Acute gonococcal cervicitis,C0153195,NA,Approved,NA,NA,cefixime
Cefixime,DB00671,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,cefixime
Cefixime,DB00671,Infective otitis media,C0729586,NA,Approved,NA,NA,cefixime
Cefixime,DB00671,Bronchitis,C0006277,NA,Approved,NA,NA,cefixime
Cefixime,DB00671,Urinary tract infection,C0042029,NA,Approved,NA,NA,cefixime
Cefixime,DB00671,Tonsillitis,C0040425,NA,Approved,NA,NA,cefixime
Cefixime,DB00671,Gonorrhea,C0018081,NA,Approved,NA,NA,cefixime
Chlorpropamide,DB00672,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,chlorpropamide
Aprepitant,DB00673,Chemotherapy-induced nausea and vomiting,C0401160,NA,Approved,NA,NA,aprepitant
Galantamine,DB00674,Alzheimer's Disease,C0002395,NA,Approved,NA,NA,galantamine
Tamoxifen,DB00675,Malignant epithelial neoplasm of female breast,C3163805,NA,Approved,NA,NA,tamoxifen
Tamoxifen,DB00675,Invasive Ductal Breast Carcinoma,C1134719,NA,Approved,NA,NA,tamoxifen
Losartan,DB00678,Diabetic Nephropathy,C0011881,NA,Approved,NA,NA,losartan
Losartan,DB00678,Hypertensive urgency,C0745138,NA,Approved,NA,NA,losartan
Losartan,DB00678,Hypertensive disease,C0020538,NA,Approved,NA,NA,losartan
Thioridazine,DB00679,Treatment-resistant schizophrenia,C3544321,NA,Approved,NA,NA,thioridazine
Moricizine,DB00680,Ventricular arrhythmia,C0085612,NA,Approved,NA,NA,moricizine
Amphotericin B,DB00681,Aspergillosis,C0004030,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Candidiasis of the esophagus,C0239295,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Yaws,C0043388,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Brucellosis,C0006309,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Rhinocerebral phycomycosis,C1636205,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Invasive Pulmonary Aspergillosis,C0276653,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Coccidioidomycosis,C0009186,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Infective otitis media,C0729586,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Fungal infection of lung,C0151874,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,"Meningitis, Fungal",C0085438,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Acute gonococcal cervicitis,C0153195,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Gonorrhea of rectum,C0275665,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Histoplasmosis,C0019655,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Mucormycosis,C0026718,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Relapsing Fever,C0035021,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Granuloma Inguinale,C0018190,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Gonorrhea of pharynx,C0149966,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Bronchitis,C0006277,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Psittacosis,C0029291,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Rocky Mountain Spotted Fever,C0035793,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Pulmonary cryptococcosis,C0276688,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Sinusitis,C0037199,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,"Leishmaniasis, Visceral",C0023290,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Q Fever,C0034362,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Gonorrhea,C0018081,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Chlamydia trachomatis infection of genital structure,C1997322,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Syphilis,C0039128,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Septicemia candida,C0349009,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Fungal septicemia,C2960008,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Cutaneous Candidiasis,C0006846,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Infection by Cryptococcus neoformans,C0010414,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Blastomycosis,C0005716,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Lymphogranuloma Venereum,C0024286,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Systemic candidiasis,C0153252,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Candidal meningitis,C0153256,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Candidal endocarditis,C0153254,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Candidiasis,C0006840,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Disseminated sporotrichosis,C0276725,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Acne Vulgaris,C0001144,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Mycotic endocarditis,C0276648,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Urinary tract infection,C0042029,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Pharyngitis,C0031350,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Pelvic Inflammatory Disease,C0242172,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Pneumonia,C0032285,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Acute gonococcal urethritis,C0275652,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Candidemia,C0877445,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Diaper Rash,C0011974,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Actinomycosis,C0001261,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Leishmaniasis,C0023281,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,candidal peritonitis,C2062982,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Urinary tract infection fungal,C0877131,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,TYPHUS,C0041471,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Oral candidiasis,C0006849,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Trachoma,C0040592,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Gingivostomatitis,C0149704,NA,Approved,NA,NA,amphotericin b
Amphotericin B,DB00681,Rickettsialpox,C0035597,NA,Approved,NA,NA,amphotericin b
Warfarin,DB00682,Thrombosis,C0040053,NA,Approved,NA,NA,warfarin
Warfarin,DB00682,Thromboembolism,C0040038,NA,Approved,NA,NA,warfarin
Warfarin,DB00682,Cerebral Embolism,C0007780,NA,Approved,NA,NA,warfarin
Warfarin,DB00682,Deep Vein Thrombosis,C0149871,NA,Approved,NA,NA,warfarin
Midazolam,DB00683,Agitation,C0085631,NA,Approved,NA,NA,midazolam
Midazolam,DB00683,Anxiety,C0003467,NA,Approved,NA,NA,midazolam
Tobramycin,DB00684,Enterobacteriaceae Infections,C0014347,NA,Approved,NA,NA,tobramycin
Tobramycin,DB00684,Bacterial infection due to Klebsiella pneumoniae,C0343402,NA,Approved,NA,NA,tobramycin
Tobramycin,DB00684,Pneumonia due to Pseudomonas,C0155860,NA,Approved,NA,NA,tobramycin
Tobramycin,DB00684,Bacterial sepsis,C0684256,NA,Approved,NA,NA,tobramycin
Tobramycin,DB00684,Punctate keratitis,C0259799,NA,Approved,NA,NA,tobramycin
Tobramycin,DB00684,Serratia Infections,C0085394,NA,Approved,NA,NA,tobramycin
Tobramycin,DB00684,Dacryocystitis,C0010930,NA,Approved,NA,NA,tobramycin
Tobramycin,DB00684,Anterior uveitis,C0042165,NA,Approved,NA,NA,tobramycin
Tobramycin,DB00684,Bacterial conjunctivitis,C0009768,NA,Approved,NA,NA,tobramycin
Tobramycin,DB00684,Sepsis due to Pseudomonas,C2887096,NA,Approved,NA,NA,tobramycin
Tobramycin,DB00684,Escherichia coli septicemia,C0276088,NA,Approved,NA,NA,tobramycin
Tobramycin,DB00684,Neonatal meningitis,C0456107,NA,Approved,NA,NA,tobramycin
Tobramycin,DB00684,Osteomyelitis due to Staphylococcus aureus,C1997728,NA,Approved,NA,NA,tobramycin
Tobramycin,DB00684,Corneal Perforation,C0339293,NA,Approved,NA,NA,tobramycin
Tobramycin,DB00684,Bacterial peritonitis,C0341503,NA,Approved,NA,NA,tobramycin
Tobramycin,DB00684,"Meningitis, Bacterial",C0085437,NA,Approved,NA,NA,tobramycin
Tobramycin,DB00684,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,tobramycin
Tobramycin,DB00684,Rhinoscleroma,C0035468,NA,Approved,NA,NA,tobramycin
Tobramycin,DB00684,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,tobramycin
Tobramycin,DB00684,Herpes zoster keratitis,C1275687,NA,Approved,NA,NA,tobramycin
Tobramycin,DB00684,Blepharoconjunctivitis,C0005743,NA,Approved,NA,NA,tobramycin
Tobramycin,DB00684,Infection of bone,C2242472,NA,Approved,NA,NA,tobramycin
Tobramycin,DB00684,Sepsis of the newborn,C0456103,NA,Approved,NA,NA,tobramycin
Tobramycin,DB00684,Rosacea,C0035854,NA,Approved,NA,NA,tobramycin
Tobramycin,DB00684,Meibomianitis,C0549398,NA,Approved,NA,NA,tobramycin
Tobramycin,DB00684,Pneumonia due to Escherichia coli,C0276089,NA,Approved,NA,NA,tobramycin
Tobramycin,DB00684,Enterobacter pneumonia,C1096258,NA,Approved,NA,NA,tobramycin
Tobramycin,DB00684,Escherichia coli Infections,C0014836,NA,Approved,NA,NA,tobramycin
Tobramycin,DB00684,Keratoconjunctivitis,C0022573,NA,Approved,NA,NA,tobramycin
Tobramycin,DB00684,Corneal abrasion,C0010032,NA,Approved,NA,NA,tobramycin
Tobramycin,DB00684,Staphylococcal Pneumonia,C0032308,NA,Approved,NA,NA,tobramycin
Tobramycin,DB00684,Nosocomial pneumonia,C0949083,NA,Approved,NA,NA,tobramycin
Tobramycin,DB00684,Infective blepharitis,C0729587,NA,Approved,NA,NA,tobramycin
Trovafloxacin,DB00685,Female genital tract infection,C1263758,NA,Approved,NA,NA,trovafloxacin
Trovafloxacin,DB00685,Postoperative infection,C0392618,NA,Approved,NA,NA,trovafloxacin
Trovafloxacin,DB00685,Urinary tract infection,C0042029,NA,Approved,NA,NA,trovafloxacin
Trovafloxacin,DB00685,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,trovafloxacin
Trovafloxacin,DB00685,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,trovafloxacin
Trovafloxacin,DB00685,Pneumonia due to Pseudomonas,C0155860,NA,Approved,NA,NA,trovafloxacin
Trovafloxacin,DB00685,Acute Moraxella catarrhalis bronchitis,C0339932,NA,Approved,NA,NA,trovafloxacin
Trovafloxacin,DB00685,Mycoplasma pneumonia,C0032302,NA,Approved,NA,NA,trovafloxacin
Trovafloxacin,DB00685,Acute gonococcal cervicitis,C0153195,NA,Approved,NA,NA,trovafloxacin
Trovafloxacin,DB00685,Gonorrhea of rectum,C0275665,NA,Approved,NA,NA,trovafloxacin
Trovafloxacin,DB00685,Acute gonococcal urethritis,C0275652,NA,Approved,NA,NA,trovafloxacin
Trovafloxacin,DB00685,Chronic Bacterial Prostatitis,C1720797,NA,Approved,NA,NA,trovafloxacin
Trovafloxacin,DB00685,Staphylococcal Pneumonia,C0032308,NA,Approved,NA,NA,trovafloxacin
Trovafloxacin,DB00685,Acute gonococcal endometritis,C0153196,NA,Approved,NA,NA,trovafloxacin
Trovafloxacin,DB00685,Bacterial infection due to Klebsiella pneumoniae,C0343402,NA,Approved,NA,NA,trovafloxacin
Trovafloxacin,DB00685,Legionella pneumophila pneumonia,C0857846,NA,Approved,NA,NA,trovafloxacin
Trovafloxacin,DB00685,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,trovafloxacin
Trovafloxacin,DB00685,Moraxella catarrhalis pneumonia,C0857831,NA,Approved,NA,NA,trovafloxacin
Trovafloxacin,DB00685,Acute bacterial sinusitis,C0275556,NA,Approved,NA,NA,trovafloxacin
Trovafloxacin,DB00685,Pneumonia due to Escherichia coli,C0276089,NA,Approved,NA,NA,trovafloxacin
Trovafloxacin,DB00685,Chlamydial pneumonia,C0339959,NA,Approved,NA,NA,trovafloxacin
Trovafloxacin,DB00685,Chlamydial cervicitis,C0341834,NA,Approved,NA,NA,trovafloxacin
Trovafloxacin,DB00685,Chlamydial pelvic inflammatory disease,C0520777,NA,Approved,NA,NA,trovafloxacin
Trovafloxacin,DB00685,Endomyometritis,C0269050,NA,Approved,NA,NA,trovafloxacin
Trovafloxacin,DB00685,Female pelvic cellulitis,C0349734,NA,Approved,NA,NA,trovafloxacin
Trovafloxacin,DB00685,Miscarriage with sepsis,C0269398,NA,Approved,NA,NA,trovafloxacin
Trovafloxacin,DB00685,Postnatal infection,C1278797,NA,Approved,NA,NA,trovafloxacin
Pentosan Polysulfate,DB00686,Bladder pain,C0232849,NA,Approved,NA,NA,pentosan polysulfate
Pentosan Polysulfate,DB00686,Interstitial Cystitis,C0282488,NA,Approved,NA,NA,pentosan polysulfate
Fludrocortisone,DB00687,Adrenogenital disorder,C0701163,NA,Approved,NA,NA,fludrocortisone
Fludrocortisone,DB00687,Addison Disease,C0001403,NA,Approved,NA,NA,fludrocortisone
Flurazepam,DB00690,Sleeplessness,C0917801,NA,Approved,NA,NA,flurazepam
Moexipril,DB00691,Hypertensive disease,C0020538,NA,Approved,NA,NA,moexipril
Phentolamine,DB00692,Peripheral Vascular Diseases,C0085096,NA,Approved,NA,NA,phentolamine
Phentolamine,DB00692,Hypertensive emergency,C0745136,NA,Approved,NA,NA,phentolamine
Phentolamine,DB00692,Pheochromocytoma,C0031511,NA,Approved,NA,NA,phentolamine
Phentolamine,DB00692,Cerebral Ischemia,C0917798,NA,Approved,NA,NA,phentolamine
Phentolamine,DB00692,Paroxysmal hypertension,C0221154,NA,Approved,NA,NA,phentolamine
Daunorubicin,DB00694,Acute lymphocytic leukemia,C0023449,NA,Approved,NA,NA,daunorubicin
Daunorubicin,DB00694,Acute Promyelocytic Leukemia,C0023487,NA,Approved,NA,NA,daunorubicin
Daunorubicin,DB00694,Acute monocytic leukemia,C0023465,NA,Approved,NA,NA,daunorubicin
Daunorubicin,DB00694,"Leukemia, Myelocytic, Acute",C0023467,NA,Approved,NA,NA,daunorubicin
Daunorubicin,DB00694,Acute Erythroblastic Leukemia,C0023440,NA,Approved,NA,NA,daunorubicin
Daunorubicin,DB00694,Kaposi Sarcoma,C0036220,NA,Approved,NA,NA,daunorubicin
Furosemide,DB00695,Decompensated cardiac failure,C0581377,NA,Approved,NA,NA,furosemide
Furosemide,DB00695,Edema,C0013604,NA,Approved,NA,NA,furosemide
Furosemide,DB00695,Acute pulmonary edema,C0155919,NA,Approved,NA,NA,furosemide
Furosemide,DB00695,Hypertensive disease,C0020538,NA,Approved,NA,NA,furosemide
Ergotamine,DB00696,Migraine Disorders,C0149931,NA,Approved,NA,NA,ergotamine
Ergotamine,DB00696,Vascular Headaches,C0042376,NA,Approved,NA,NA,ergotamine
Ergotamine,DB00696,Cluster Headache,C0009088,NA,Approved,NA,NA,ergotamine
Tizanidine,DB00697,Muscle spasticity of spinal origin,C1562430,NA,Approved,NA,NA,tizanidine
Tizanidine,DB00697,Muscle Spasticity,C0026838,NA,Approved,NA,NA,tizanidine
Nitrofurantoin,DB00698,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,nitrofurantoin
Nitrofurantoin,DB00698,Klebsiella cystitis,C0520775,NA,Approved,NA,NA,nitrofurantoin
Nitrofurantoin,DB00698,URINARY TRACT INFECTION ENTEROCOCCUS,C0749958,NA,Approved,NA,NA,nitrofurantoin
Eplerenone,DB00700,Hypertensive disease,C0020538,NA,Approved,NA,NA,eplerenone
Amprenavir,DB00701,HIV Infections,C0019693,NA,Approved,NA,NA,amprenavir
Methazolamide,DB00703,Angle Closure Glaucoma,C0017605,NA,Approved,NA,NA,methazolamide
Methazolamide,DB00703,Secondary glaucoma,C0149893,NA,Approved,NA,NA,methazolamide
Methazolamide,DB00703,"Glaucoma, Open-Angle",C0017612,NA,Approved,NA,NA,methazolamide
Naltrexone,DB00704,Drug-induced constipation,C0267511,NA,Approved,NA,NA,naltrexone
Naltrexone,DB00704,Chronic pain,C0150055,NA,Approved,NA,NA,naltrexone
Naltrexone,DB00704,"Alcoholic Intoxication, Chronic",C0001973,NA,Approved,NA,NA,naltrexone
Naltrexone,DB00704,Severe pain,C0278140,NA,Approved,NA,NA,naltrexone
Naltrexone,DB00704,Obesity,C0028754,NA,Approved,NA,NA,naltrexone
Delavirdine,DB00705,HIV Infections,C0019693,NA,Approved,NA,NA,delavirdine
Tamsulosin,DB00706,Prostatic Hypertrophy,C1739363,NA,Approved,NA,NA,tamsulosin
Porfimer,DB00707,Non-Small Cell Lung Carcinoma,C0007131,NA,Approved,NA,NA,porfimer
Porfimer,DB00707,Malignant neoplasm of esophagus,C0546837,NA,Approved,NA,NA,porfimer
Sufentanil,DB00708,"Pain, Postoperative",C0030201,NA,Approved,NA,NA,sufentanil
Lamivudine,DB00709,HIV Infections,C0019693,NA,Approved,NA,NA,lamivudine
Lamivudine,DB00709,"Hepatitis B, Chronic",C0524909,NA,Approved,NA,NA,lamivudine
Ibandronate,DB00710,"Osteoporosis, Postmenopausal",C0029458,NA,Approved,NA,NA,ibandronate
Ibandronate,DB00710,Hypercalcemia,C0020437,NA,Approved,NA,NA,ibandronate
Diethylcarbamazine,DB00711,Eosinophilic Pneumonia,C1527407,NA,Approved,NA,NA,diethylcarbamazine
Diethylcarbamazine,DB00711,Loiasis,C0023968,NA,Approved,NA,NA,diethylcarbamazine
Diethylcarbamazine,DB00711,Onchocerciasis,C0029001,NA,Approved,NA,NA,diethylcarbamazine
Diethylcarbamazine,DB00711,Elephantiasis,C0013882,NA,Approved,NA,NA,diethylcarbamazine
Flurbiprofen,DB00712,Degenerative polyarthritis,C0029408,NA,Approved,NA,NA,flurbiprofen
Flurbiprofen,DB00712,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,flurbiprofen
Oxacillin,DB00713,Staphylococcal Pneumonia,C0032308,NA,Approved,NA,NA,oxacillin
Oxacillin,DB00713,Staphylococcal Infections,C0038160,NA,Approved,NA,NA,oxacillin
Oxacillin,DB00713,Infection of bone,C2242472,NA,Approved,NA,NA,oxacillin
Oxacillin,DB00713,Sepsis due to Staphylococcus aureus,C2887088,NA,Approved,NA,NA,oxacillin
Oxacillin,DB00713,Lower respiratory tract infection,C0149725,NA,Approved,NA,NA,oxacillin
Oxacillin,DB00713,Osteomyelitis due to Staphylococcus aureus,C1997728,NA,Approved,NA,NA,oxacillin
Oxacillin,DB00713,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,oxacillin
Oxacillin,DB00713,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,oxacillin
Oxacillin,DB00713,Staphylococcal endocarditis,C0520767,NA,Approved,NA,NA,oxacillin
Oxacillin,DB00713,Sinusitis,C0037199,NA,Approved,NA,NA,oxacillin
Oxacillin,DB00713,Staphylococcal meningitis,C0154640,NA,Approved,NA,NA,oxacillin
Oxacillin,DB00713,Pharyngitis,C0031350,NA,Approved,NA,NA,oxacillin
Oxacillin,DB00713,Staphylococcal bacteraemia,C0152965,NA,Approved,NA,NA,oxacillin
Apomorphine,DB00714,Parkinson Disease,C0030567,NA,Approved,NA,NA,apomorphine
Paroxetine,DB00715,Major Depressive Disorder,C1269683,NA,Approved,NA,NA,paroxetine
Paroxetine,DB00715,Obsessive-Compulsive Disorder,C0028768,NA,Approved,NA,NA,paroxetine
Paroxetine,DB00715,Panic Disorder,C0030319,NA,Approved,NA,NA,paroxetine
Paroxetine,DB00715,"Phobia, Social",C0031572,NA,Approved,NA,NA,paroxetine
Paroxetine,DB00715,Post-Traumatic Stress Disorder,C0038436,NA,Approved,NA,NA,paroxetine
Paroxetine,DB00715,Premenstrual Dysphoric Disorder,C0520676,NA,Approved,NA,NA,paroxetine
Paroxetine,DB00715,Generalized Anxiety Disorder,C0270549,NA,Approved,NA,NA,paroxetine
Paroxetine,DB00715,Depressive disorder,C0011581,NA,Approved,NA,NA,paroxetine
Paroxetine,DB00715,Hot flushes,C0600142,NA,Approved,NA,NA,paroxetine
Nedocromil,DB00716,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,nedocromil
Nedocromil,DB00716,Asthma,C0004096,NA,Approved,NA,NA,nedocromil
Nedocromil,DB00716,Itching of eye,C0022281,NA,Approved,NA,NA,nedocromil
Norethisterone,DB00717,Atrophic Vaginitis,C0221392,NA,Approved,NA,NA,norethisterone
Norethisterone,DB00717,Secondary physiologic amenorrhea,C0232940,NA,Approved,NA,NA,norethisterone
Norethisterone,DB00717,Menorrhagia,C0025323,NA,Approved,NA,NA,norethisterone
Norethisterone,DB00717,Female hypogonadism syndrome,C0271578,NA,Approved,NA,NA,norethisterone
Norethisterone,DB00717,Hot flushes,C0600142,NA,Approved,NA,NA,norethisterone
Norethisterone,DB00717,Atrophy of vulva,C0156393,NA,Approved,NA,NA,norethisterone
Norethisterone,DB00717,Metrorrhagia,C0025874,NA,Approved,NA,NA,norethisterone
Norethisterone,DB00717,Acne Vulgaris,C0001144,NA,Approved,NA,NA,norethisterone
Norethisterone,DB00717,Endometriosis,C0014175,NA,Approved,NA,NA,norethisterone
Adefovir Dipivoxil,DB00718,"Hepatitis B, Chronic",C0524909,NA,Approved,NA,NA,adefovir dipivoxil
Azatadine,DB00719,Pruritus,C0033774,NA,Approved,NA,NA,azatadine
Azatadine,DB00719,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,azatadine
Azatadine,DB00719,Sneezing,C0037383,NA,Approved,NA,NA,azatadine
Azatadine,DB00719,Common Cold,C0009443,NA,Approved,NA,NA,azatadine
Azatadine,DB00719,Urticaria,C0042109,NA,Approved,NA,NA,azatadine
Azatadine,DB00719,"Rhinitis, Vasomotor",C0035460,NA,Approved,NA,NA,azatadine
Azatadine,DB00719,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,azatadine
Azatadine,DB00719,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,azatadine
Azatadine,DB00719,Rhinorrhea,C1260880,NA,Approved,NA,NA,azatadine
Azatadine,DB00719,Hay fever,C0018621,NA,Approved,NA,NA,azatadine
Azatadine,DB00719,Symptomatic dermographism,C0343065,NA,Approved,NA,NA,azatadine
Lisinopril,DB00722,Myocardial Infarction,C0027051,NA,Approved,NA,NA,lisinopril
Lisinopril,DB00722,Chronic heart failure,C0264716,NA,Approved,NA,NA,lisinopril
Lisinopril,DB00722,Hypertensive disease,C0020538,NA,Approved,NA,NA,lisinopril
Methoxamine,DB00723,Paroxysmal supraventricular tachycardia,C0030590,NA,Approved,NA,NA,methoxamine
Imiquimod,DB00724,Condylomata Acuminata,C0009663,NA,Approved,NA,NA,imiquimod
Imiquimod,DB00724,Superficial basal cell carcinoma,C0862889,NA,Approved,NA,NA,imiquimod
Imiquimod,DB00724,Actinic keratosis,C0022602,NA,Approved,NA,NA,imiquimod
Imiquimod,DB00724,Common wart,C0043037,NA,Approved,NA,NA,imiquimod
Homatropine Methylbromide,DB00725,Coughing,C0010200,NA,Approved,NA,NA,homatropine methylbromide
Homatropine Methylbromide,DB00725,Irritable Bowel Syndrome,C0022104,NA,Approved,NA,NA,homatropine methylbromide
Homatropine Methylbromide,DB00725,Peptic Ulcer,C0030920,NA,Approved,NA,NA,homatropine methylbromide
Trimipramine,DB00726,Depressive disorder,C0011581,NA,Approved,NA,NA,trimipramine
Nitroglycerin,DB00727,Perioperative hypertension,C3661921,NA,Approved,NA,NA,nitroglycerin
Thiabendazole,DB00730,"Larva Migrans, Cutaneous",C0546999,NA,Approved,NA,NA,thiabendazole
Thiabendazole,DB00730,Infection by Uncinaria,C0041648,NA,Approved,NA,NA,thiabendazole
Thiabendazole,DB00730,Toxocariasis,C0040553,NA,Approved,NA,NA,thiabendazole
Thiabendazole,DB00730,Enterobiasis,C0086227,NA,Approved,NA,NA,thiabendazole
Thiabendazole,DB00730,Trichinellosis,C0040896,NA,Approved,NA,NA,thiabendazole
Thiabendazole,DB00730,Ascariasis,C0003950,NA,Approved,NA,NA,thiabendazole
Thiabendazole,DB00730,Infection by Trichuris trichiura,C0040954,NA,Approved,NA,NA,thiabendazole
Thiabendazole,DB00730,Strongyloidiasis,C0038463,NA,Approved,NA,NA,thiabendazole
Nateglinide,DB00731,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,nateglinide
Pralidoxime,DB00733,Organophosphate poisoning,C0700359,NA,Approved,NA,NA,pralidoxime
Risperidone,DB00734,Schizophrenia,C0036341,NA,Approved,NA,NA,risperidone
Risperidone,DB00734,Bipolar disorder in remission,C0270425,NA,Approved,NA,NA,risperidone
Risperidone,DB00734,Autistic Disorder,C0004352,NA,Approved,NA,NA,risperidone
Risperidone,DB00734,Mixed bipolar I disorder,C0236780,NA,Approved,NA,NA,risperidone
Risperidone,DB00734,"Bipolar affective disorder, current episode manic",C0338873,NA,Approved,NA,NA,risperidone
Naftifine,DB00735,Tinea Pedis,C0040259,NA,Approved,NA,NA,naftifine
Naftifine,DB00735,Tinea corporis (disorder),C0040252,NA,Approved,NA,NA,naftifine
Naftifine,DB00735,Tinea cruris,C1384589,NA,Approved,NA,NA,naftifine
Esomeprazole,DB00736,Erosive esophagitis,C0267055,NA,Approved,NA,NA,esomeprazole
Esomeprazole,DB00736,Zollinger-Ellison syndrome,C0043515,NA,Approved,NA,NA,esomeprazole
Esomeprazole,DB00736,Peptic Esophagitis,C0014869,NA,Approved,NA,NA,esomeprazole
Esomeprazole,DB00736,Gastroesophageal reflux disease,C0017168,NA,Approved,NA,NA,esomeprazole
Esomeprazole,DB00736,Peptic Ulcer,C0030920,NA,Approved,NA,NA,esomeprazole
Meclizine,DB00737,Vertigo,C0042571,NA,Approved,NA,NA,meclizine
Meclizine,DB00737,Motion Sickness,C0026603,NA,Approved,NA,NA,meclizine
Pentamidine,DB00738,African Trypanosomiasis,C0041228,NA,Approved,NA,NA,pentamidine
Riluzole,DB00740,Amyotrophic Lateral Sclerosis,C0002736,NA,Approved,NA,NA,riluzole
Hydrocortisone,DB00741,Blepharoconjunctivitis,C0005743,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Bacterial keratitis,C0854211,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Cerebral Edema,C0006114,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Rheumatic Heart Disease,C0035439,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Laryngeal Edema,C0023052,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Nephrotic Syndrome,C0027726,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Recurrent herpes simplex labialis,C1274321,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Corneal abrasion,C0010032,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Crohn Disease,C0010346,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Proctitis,C0033246,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Lichen Simplex Chronicus,C0149922,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,"Lupus Erythematosus, Systemic",C0024141,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Transplanted organ rejection,C0345468,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Uveitis,C0042164,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Inflammatory Bowel Diseases,C0021390,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Keratitis,C0022568,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Infective blepharitis,C0729587,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Exanthema,C0015230,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Synovitis,C0039103,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Herpes zoster keratitis,C1275687,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Aphthous Stomatitis,C0038363,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Angioedema,C0002994,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Humoral hypercalcemia of malignancy (disorder),C0149911,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Corneal Ulcer,C0010043,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,"Anemia, Diamond-Blackfan",C1260899,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Cooley's anemia,C0002875,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Multiple Sclerosis,C0026769,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Psoriasis,C0033860,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Aspiration pneumonitis,C1761609,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Adrenogenital disorder,C0701163,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Iridocyclitis,C0022073,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,"Lupus Erythematosus, Discoid",C0024138,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Pemphigus,C0030807,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Dermatitis Herpetiformis,C0011608,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Tenosynovitis,C0039520,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Acne Vulgaris,C0001144,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Trichinellosis,C0040896,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Acute lymphocytic leukemia,C0023449,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Tinea Pedis,C0040259,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Malignant otitis externa due to Pseudomonas aeruginosa,C0395818,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Rosacea,C0035854,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Granuloma Annulare,C0085074,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Serum Sickness,C0036830,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Hodgkin Disease,C0019829,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Infective otitis externa,C0021355,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Exfoliative dermatitis,C0011606,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,"Lymphoma, Non-Hodgkin",C0024305,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Acquired thrombocytopenia,C0154301,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Simple Pulmonary Eosinophilia,C0242459,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Thyroiditis,C0040147,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,"Dermatitis, Atopic",C0011615,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Bursitis,C0006444,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Asthma,C0004096,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Erythema Multiforme,C0014742,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,"Arthritis, Gouty",C0003868,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Tinea cruris,C1384589,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Itching of ear,C0849907,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Hemorrhoids,C0019112,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,"Arthritis, Psoriatic",C0003872,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Addisonian crisis,C0151467,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Pruritus of genital organs,C0033777,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Adrenal cortical hypofunction,C0405580,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,"Lymphoma, T-Cell, Cutaneous",C0079773,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Iritis,C0022081,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Tinea corporis (disorder),C0040252,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Post traumatic osteoarthritis,C2894027,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Cyclitis,C0010543,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Scalp psoriasis,C0406326,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Addison Disease,C0001403,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Mycosis Fungoides,C0026948,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Inflammatory dermatosis,C3875321,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Status Asthmaticus,C0038218,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Autoimmune Diseases,C0004364,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Chronic ulcerative proctitis,C2937222,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Contact Dermatitis,C0011616,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Otitis Externa,C0029878,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Gingival Diseases,C0017563,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Ulcerative Colitis,C0009324,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Tendinitis,C0039503,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Autoimmune hemolytic anemia,C0002880,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Disorder of eye,C0015397,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Sarcoidosis,C0036202,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Berylliosis,C0005138,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Musculoskeletal Diseases,C0026857,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Ankylosing spondylitis,C0038013,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Punctate keratopathy,C0423234,NA,Approved,NA,NA,hydrocortisone
Hydrocortisone,DB00741,Pruritus Ani,C0033775,NA,Approved,NA,NA,hydrocortisone
Mannitol,DB00742,Ocular Hypertension,C0028840,NA,Approved,NA,NA,mannitol
Mannitol,DB00742,Edema,C0013604,NA,Approved,NA,NA,mannitol
Mannitol,DB00742,Pseudotumor Cerebri,C0033845,NA,Approved,NA,NA,mannitol
Mannitol,DB00742,Cerebral Edema,C0006114,NA,Approved,NA,NA,mannitol
Mannitol,DB00742,Cystic Fibrosis,C0010674,NA,Approved,NA,NA,mannitol
Zileuton,DB00744,Allergic asthma,C0155877,NA,Approved,NA,NA,zileuton
Zileuton,DB00744,Intrinsic asthma,C0155880,NA,Approved,NA,NA,zileuton
Modafinil,DB00745,Narcolepsy,C0027404,NA,Approved,NA,NA,modafinil
Deferoxamine,DB00746,Chronic iron overload,C1739382,NA,Approved,NA,NA,deferoxamine
Deferoxamine,DB00746,Poisoning by iron AND/OR its compounds,C0412842,NA,Approved,NA,NA,deferoxamine
Scopolamine,DB00747,Rhinorrhea,C1260880,NA,Approved,NA,NA,scopolamine
Scopolamine,DB00747,Posterior synechiae,C0152253,NA,Approved,NA,NA,scopolamine
Scopolamine,DB00747,"Rhinitis, Vasomotor",C0035460,NA,Approved,NA,NA,scopolamine
Scopolamine,DB00747,Uveitis,C0042164,NA,Approved,NA,NA,scopolamine
Scopolamine,DB00747,Peptic Ulcer,C0030920,NA,Approved,NA,NA,scopolamine
Scopolamine,DB00747,Mydriasis,C0026961,NA,Approved,NA,NA,scopolamine
Scopolamine,DB00747,Irritable Bowel Syndrome,C0022104,NA,Approved,NA,NA,scopolamine
Scopolamine,DB00747,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,scopolamine
Scopolamine,DB00747,Cycloplegia,C0235238,NA,Approved,NA,NA,scopolamine
Scopolamine,DB00747,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,scopolamine
Scopolamine,DB00747,Coughing,C0010200,NA,Approved,NA,NA,scopolamine
Scopolamine,DB00747,Iridocyclitis,C0022073,NA,Approved,NA,NA,scopolamine
Scopolamine,DB00747,Motion Sickness,C0026603,NA,Approved,NA,NA,scopolamine
Scopolamine,DB00747,Common Cold,C0009443,NA,Approved,NA,NA,scopolamine
Carbinoxamine,DB00748,Symptomatic dermographism,C0343065,NA,Approved,NA,NA,carbinoxamine
Carbinoxamine,DB00748,Hay fever,C0018621,NA,Approved,NA,NA,carbinoxamine
Carbinoxamine,DB00748,Pruritus,C0033774,NA,Approved,NA,NA,carbinoxamine
Carbinoxamine,DB00748,Urticaria,C0042109,NA,Approved,NA,NA,carbinoxamine
Carbinoxamine,DB00748,"Rhinitis, Vasomotor",C0035460,NA,Approved,NA,NA,carbinoxamine
Carbinoxamine,DB00748,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,carbinoxamine
Carbinoxamine,DB00748,Common Cold,C0009443,NA,Approved,NA,NA,carbinoxamine
Carbinoxamine,DB00748,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,carbinoxamine
Carbinoxamine,DB00748,Rhinorrhea,C1260880,NA,Approved,NA,NA,carbinoxamine
Etodolac,DB00749,Pain,C0030193,NA,Approved,NA,NA,etodolac
Etodolac,DB00749,Degenerative polyarthritis,C0029408,NA,Approved,NA,NA,etodolac
Etodolac,DB00749,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,etodolac
Prilocaine,DB00750,Premature Ejaculation,C0033038,NA,Approved,NA,NA,prilocaine
Epinastine,DB00751,Itching of eye,C0022281,NA,Approved,NA,NA,epinastine
Epinastine,DB00751,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,epinastine
Tranylcypromine,DB00752,Major Depressive Disorder,C1269683,NA,Approved,NA,NA,tranylcypromine
Ethotoin,DB00754,Tonic-Clonic Epilepsy,C0014549,NA,Approved,NA,NA,ethotoin
Ethotoin,DB00754,Epilepsy characterized by intractable complex partial seizures,C2711653,NA,Approved,NA,NA,ethotoin
Tretinoin,DB00755,Acute Promyelocytic Leukemia,C0023487,NA,Approved,NA,NA,tretinoin
Tretinoin,DB00755,Acne Vulgaris,C0001144,NA,Approved,NA,NA,tretinoin
Tretinoin,DB00755,Hyperkeratosis,C0870082,NA,Approved,NA,NA,tretinoin
Tretinoin,DB00755,Senile lentigo,C0036651,NA,Approved,NA,NA,tretinoin
Tretinoin,DB00755,Chloasma,C0025218,NA,Approved,NA,NA,tretinoin
Dolasetron,DB00757,Chemotherapy-induced nausea and vomiting,C0401160,NA,Approved,NA,NA,dolasetron
Clopidogrel,DB00758,Acute ST segment elevation myocardial infarction (disorder),C1303258,NA,Approved,NA,NA,clopidogrel
Clopidogrel,DB00758,Acute Coronary Syndrome,C0948089,NA,Approved,NA,NA,clopidogrel
Clopidogrel,DB00758,Non-Q wave myocardial infarction,C0542269,NA,Approved,NA,NA,clopidogrel
Clopidogrel,DB00758,Cerebral Embolism,C0007780,NA,Approved,NA,NA,clopidogrel
Tetracycline,DB00759,Lymphogranuloma Venereum,C0024286,NA,Approved,NA,NA,tetracycline
Tetracycline,DB00759,Relapsing Fever,C0035021,NA,Approved,NA,NA,tetracycline
Tetracycline,DB00759,Acute gonococcal urethritis,C0275652,NA,Approved,NA,NA,tetracycline
Tetracycline,DB00759,Gonorrhea,C0018081,NA,Approved,NA,NA,tetracycline
Tetracycline,DB00759,Sinusitis,C0037199,NA,Approved,NA,NA,tetracycline
Tetracycline,DB00759,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,tetracycline
Tetracycline,DB00759,Rickettsialpox,C0035597,NA,Approved,NA,NA,tetracycline
Tetracycline,DB00759,Pelvic Inflammatory Disease,C0242172,NA,Approved,NA,NA,tetracycline
Tetracycline,DB00759,Actinomycosis,C0001261,NA,Approved,NA,NA,tetracycline
Tetracycline,DB00759,Gonorrhea of pharynx,C0149966,NA,Approved,NA,NA,tetracycline
Tetracycline,DB00759,Pneumonia,C0032285,NA,Approved,NA,NA,tetracycline
Tetracycline,DB00759,Rocky Mountain Spotted Fever,C0035793,NA,Approved,NA,NA,tetracycline
Tetracycline,DB00759,Chlamydia trachomatis infection of genital structure,C1997322,NA,Approved,NA,NA,tetracycline
Tetracycline,DB00759,Ophthalmia Neonatorum,C0029076,NA,Approved,NA,NA,tetracycline
Tetracycline,DB00759,Bacterial keratitis,C0854211,NA,Approved,NA,NA,tetracycline
Tetracycline,DB00759,Psittacosis,C0029291,NA,Approved,NA,NA,tetracycline
Tetracycline,DB00759,TYPHUS,C0041471,NA,Approved,NA,NA,tetracycline
Tetracycline,DB00759,Acute gonococcal epididymo-orchitis,C0153193,NA,Approved,NA,NA,tetracycline
Tetracycline,DB00759,Brucellosis,C0006309,NA,Approved,NA,NA,tetracycline
Tetracycline,DB00759,Trachoma,C0040592,NA,Approved,NA,NA,tetracycline
Tetracycline,DB00759,Bacterial conjunctivitis,C0009768,NA,Approved,NA,NA,tetracycline
Tetracycline,DB00759,Urinary tract infection,C0042029,NA,Approved,NA,NA,tetracycline
Tetracycline,DB00759,Syphilis,C0039128,NA,Approved,NA,NA,tetracycline
Tetracycline,DB00759,Infective otitis media,C0729586,NA,Approved,NA,NA,tetracycline
Tetracycline,DB00759,Pharyngitis,C0031350,NA,Approved,NA,NA,tetracycline
Tetracycline,DB00759,Q Fever,C0034362,NA,Approved,NA,NA,tetracycline
Tetracycline,DB00759,Acute gonococcal endometritis,C0153196,NA,Approved,NA,NA,tetracycline
Tetracycline,DB00759,Granuloma Inguinale,C0018190,NA,Approved,NA,NA,tetracycline
Tetracycline,DB00759,Gonorrhea of rectum,C0275665,NA,Approved,NA,NA,tetracycline
Tetracycline,DB00759,Bronchitis,C0006277,NA,Approved,NA,NA,tetracycline
Tetracycline,DB00759,Yaws,C0043388,NA,Approved,NA,NA,tetracycline
Tetracycline,DB00759,Gingivostomatitis,C0149704,NA,Approved,NA,NA,tetracycline
Tetracycline,DB00759,Acne Vulgaris,C0001144,NA,Approved,NA,NA,tetracycline
Tetracycline,DB00759,Acute gonococcal cervicitis,C0153195,NA,Approved,NA,NA,tetracycline
Meropenem,DB00760,Infection due to Pseudomonas aeruginosa,C0276075,NA,Approved,NA,NA,meropenem
Meropenem,DB00760,Complicated appendicitis,C1632842,NA,Approved,NA,NA,meropenem
Meropenem,DB00760,Meningococcal meningitis,C0025294,NA,Approved,NA,NA,meropenem
Meropenem,DB00760,Peritonitis,C0031154,NA,Approved,NA,NA,meropenem
Meropenem,DB00760,"Meningitis, Bacterial",C0085437,NA,Approved,NA,NA,meropenem
Meropenem,DB00760,"Meningitis, Pneumococcal",C0025295,NA,Approved,NA,NA,meropenem
Meropenem,DB00760,Streptococcal meningitis,C0154639,NA,Approved,NA,NA,meropenem
Meropenem,DB00760,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,meropenem
Meropenem,DB00760,Abdominal Abscess,C0243001,NA,Approved,NA,NA,meropenem
Potassium Chloride,DB00761,Constipation,C0009806,NA,Approved,NA,NA,potassium chloride
Potassium Chloride,DB00761,Incomplete passage of stool,C0426639,NA,Approved,NA,NA,potassium chloride
Potassium Chloride,DB00761,Hypokalemia,C0020621,NA,Approved,NA,NA,potassium chloride
Irinotecan,DB00762,Metastasis from malignant tumor of colon,C1282500,NA,Approved,NA,NA,irinotecan
Irinotecan,DB00762,Secondary malignant neoplasm of pancreas,C0346976,NA,Approved,NA,NA,irinotecan
Methimazole,DB00763,Hyperthyroidism,C0020550,NA,Approved,NA,NA,methimazole
Mometasone,DB00764,Pruritus of genital organs,C0033777,NA,Approved,NA,NA,mometasone
Mometasone,DB00764,"Lymphoma, T-Cell, Cutaneous",C0079773,NA,Approved,NA,NA,mometasone
Mometasone,DB00764,Lichen Simplex Chronicus,C0149922,NA,Approved,NA,NA,mometasone
Mometasone,DB00764,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,mometasone
Mometasone,DB00764,Asthma,C0004096,NA,Approved,NA,NA,mometasone
Mometasone,DB00764,Scalp psoriasis,C0406326,NA,Approved,NA,NA,mometasone
Mometasone,DB00764,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,mometasone
Mometasone,DB00764,Pruritus Ani,C0033775,NA,Approved,NA,NA,mometasone
Mometasone,DB00764,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,mometasone
Mometasone,DB00764,Exanthema,C0015230,NA,Approved,NA,NA,mometasone
Mometasone,DB00764,Contact Dermatitis,C0011616,NA,Approved,NA,NA,mometasone
Mometasone,DB00764,Allergic asthma,C0155877,NA,Approved,NA,NA,mometasone
Mometasone,DB00764,Granuloma Annulare,C0085074,NA,Approved,NA,NA,mometasone
Mometasone,DB00764,Intrinsic asthma,C0155880,NA,Approved,NA,NA,mometasone
Mometasone,DB00764,"Lupus Erythematosus, Discoid",C0024138,NA,Approved,NA,NA,mometasone
Metyrosine,DB00765,Pheochromocytoma,C0031511,NA,Approved,NA,NA,metyrosine
Clavulanate,DB00766,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,clavulanate
Clavulanate,DB00766,Pneumonia due to Klebsiella pneumoniae,C0519030,NA,Approved,NA,NA,clavulanate
Clavulanate,DB00766,Klebsiella cystitis,C0520775,NA,Approved,NA,NA,clavulanate
Clavulanate,DB00766,Bacterial sepsis,C0684256,NA,Approved,NA,NA,clavulanate
Clavulanate,DB00766,Bacterial infection due to Klebsiella pneumoniae,C0343402,NA,Approved,NA,NA,clavulanate
Clavulanate,DB00766,Rhinoscleroma,C0035468,NA,Approved,NA,NA,clavulanate
Clavulanate,DB00766,Streptococcal pneumonia,C0155862,NA,Approved,NA,NA,clavulanate
Clavulanate,DB00766,Sepsis due to Staphylococcus aureus,C2887088,NA,Approved,NA,NA,clavulanate
Clavulanate,DB00766,Haemophilus parainfluenzae pneumonia,C0877633,NA,Approved,NA,NA,clavulanate
Clavulanate,DB00766,Osteomyelitis due to Staphylococcus aureus,C1997728,NA,Approved,NA,NA,clavulanate
Clavulanate,DB00766,Bacterial urinary infection,C0729524,NA,Approved,NA,NA,clavulanate
Clavulanate,DB00766,Acute bacterial sinusitis,C0275556,NA,Approved,NA,NA,clavulanate
Clavulanate,DB00766,Pneumonia due to Staphylococcus aureus,C2349530,NA,Approved,NA,NA,clavulanate
Clavulanate,DB00766,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,clavulanate
Clavulanate,DB00766,Infective otitis media,C0729586,NA,Approved,NA,NA,clavulanate
Clavulanate,DB00766,Moraxella catarrhalis pneumonia,C0857831,NA,Approved,NA,NA,clavulanate
Clavulanate,DB00766,Sepsis due to Pseudomonas,C2887096,NA,Approved,NA,NA,clavulanate
Clavulanate,DB00766,Escherichia coli septicemia,C0276088,NA,Approved,NA,NA,clavulanate
Clavulanate,DB00766,Escherichia coli Infections,C0014836,NA,Approved,NA,NA,clavulanate
Clavulanate,DB00766,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,clavulanate
Clavulanate,DB00766,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,clavulanate
Clavulanate,DB00766,URINARY TRACT INFECTION CITROBACTER,C0749955,NA,Approved,NA,NA,clavulanate
Clavulanate,DB00766,Urinary tract infection,C0042029,NA,Approved,NA,NA,clavulanate
Clavulanate,DB00766,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,clavulanate
Clavulanate,DB00766,Staphylococcal Pneumonia,C0032308,NA,Approved,NA,NA,clavulanate
Olopatadine,DB00768,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,olopatadine
Olopatadine,DB00768,Hay fever,C0018621,NA,Approved,NA,NA,olopatadine
Olopatadine,DB00768,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,olopatadine
Alprostadil,DB00770,Congenital atresia of pulmonary valve,C0242855,NA,Approved,NA,NA,alprostadil
Alprostadil,DB00770,Tricuspid Atresia,C0243002,NA,Approved,NA,NA,alprostadil
Alprostadil,DB00770,Aortic coarctation,C0003492,NA,Approved,NA,NA,alprostadil
Alprostadil,DB00770,Tetralogy of Fallot,C0039685,NA,Approved,NA,NA,alprostadil
Alprostadil,DB00770,Erectile dysfunction,C0242350,NA,Approved,NA,NA,alprostadil
Clidinium,DB00771,Irritable Bowel Syndrome,C0022104,NA,Approved,NA,NA,clidinium
Clidinium,DB00771,Enterocolitis,C0014356,NA,Approved,NA,NA,clidinium
Malathion,DB00772,Pediculus capitis infestation,C0030757,NA,Approved,NA,NA,malathion
Etoposide,DB00773,Small cell carcinoma of lung,C0149925,NA,Approved,NA,NA,etoposide
Hydroflumethiazide,DB00774,Hypertensive disease,C0020538,NA,Approved,NA,NA,hydroflumethiazide
Hydroflumethiazide,DB00774,Edema,C0013604,NA,Approved,NA,NA,hydroflumethiazide
Tirofiban,DB00775,Non-Q wave myocardial infarction,C0542269,NA,Approved,NA,NA,tirofiban
Tirofiban,DB00775,Acute Coronary Syndrome,C0948089,NA,Approved,NA,NA,tirofiban
Oxcarbazepine,DB00776,Epilepsy characterized by intractable complex partial seizures,C2711653,NA,Approved,NA,NA,oxcarbazepine
Oxcarbazepine,DB00776,"Epilepsies, Partial",C0014547,NA,Approved,NA,NA,oxcarbazepine
Oxcarbazepine,DB00776,Simple Partial Seizures,C0234974,NA,Approved,NA,NA,oxcarbazepine
Phenelzine,DB00780,Depressive disorder,C0011581,NA,Approved,NA,NA,phenelzine
Polymyxin B Sulfate,DB00781,Infective blepharitis,C0729587,NA,Approved,NA,NA,polymyxin b sulfate
Polymyxin B Sulfate,DB00781,Blepharoconjunctivitis,C0005743,NA,Approved,NA,NA,polymyxin b sulfate
Polymyxin B Sulfate,DB00781,Uveitis,C0042164,NA,Approved,NA,NA,polymyxin b sulfate
Polymyxin B Sulfate,DB00781,Corneal abrasion,C0010032,NA,Approved,NA,NA,polymyxin b sulfate
Polymyxin B Sulfate,DB00781,Urinary tract infection,C0042029,NA,Approved,NA,NA,polymyxin b sulfate
Polymyxin B Sulfate,DB00781,Bacterial conjunctivitis,C0009768,NA,Approved,NA,NA,polymyxin b sulfate
Polymyxin B Sulfate,DB00781,Otitis Externa,C0029878,NA,Approved,NA,NA,polymyxin b sulfate
Polymyxin B Sulfate,DB00781,Keratitis,C0022568,NA,Approved,NA,NA,polymyxin b sulfate
Polymyxin B Sulfate,DB00781,Bacterial keratitis,C0854211,NA,Approved,NA,NA,polymyxin b sulfate
Polymyxin B Sulfate,DB00781,Bacterial sepsis,C0684256,NA,Approved,NA,NA,polymyxin b sulfate
Propantheline,DB00782,Peptic Ulcer,C0030920,NA,Approved,NA,NA,propantheline
Estradiol,DB00783,Carcinoma breast stage IV,C0278488,NA,Approved,NA,NA,estradiol
Estradiol,DB00783,Atrophic Vaginitis,C0221392,NA,Approved,NA,NA,estradiol
Estradiol,DB00783,Urethral atrophy,C0520577,NA,Approved,NA,NA,estradiol
Estradiol,DB00783,Premenstrual Dysphoric Disorder,C0520676,NA,Approved,NA,NA,estradiol
Estradiol,DB00783,Acne Vulgaris,C0001144,NA,Approved,NA,NA,estradiol
Estradiol,DB00783,Atrophy of vulva,C0156393,NA,Approved,NA,NA,estradiol
Estradiol,DB00783,Female hypogonadism syndrome,C0271578,NA,Approved,NA,NA,estradiol
Estradiol,DB00783,Hot flushes,C0600142,NA,Approved,NA,NA,estradiol
Estradiol,DB00783,Metastatic Prostate Carcinoma,C0936223,NA,Approved,NA,NA,estradiol
Mefenamic acid,DB00784,Dysmenorrhea,C0013390,NA,Approved,NA,NA,mefenamic acid
Mefenamic acid,DB00784,Pain,C0030193,NA,Approved,NA,NA,mefenamic acid
Aciclovir,DB00787,Chickenpox,C0008049,NA,Approved,NA,NA,aciclovir
Aciclovir,DB00787,Herpes simplex infection of skin,C0349719,NA,Approved,NA,NA,aciclovir
Aciclovir,DB00787,Recurrent genital herpes simplex,C1274323,NA,Approved,NA,NA,aciclovir
Aciclovir,DB00787,Herpes Labialis,C0019345,NA,Approved,NA,NA,aciclovir
Aciclovir,DB00787,Herpes zoster disease,C0019360,NA,Approved,NA,NA,aciclovir
Aciclovir,DB00787,Herpes encephalitis,C0276226,NA,Approved,NA,NA,aciclovir
Aciclovir,DB00787,Herpes Simplex Infections,C0019348,NA,Approved,NA,NA,aciclovir
Aciclovir,DB00787,Genital Herpes,C0019342,NA,Approved,NA,NA,aciclovir
Aciclovir,DB00787,Recurrent herpes simplex labialis,C1274321,NA,Approved,NA,NA,aciclovir
Naproxen,DB00788,Arthralgia,C0003862,NA,Approved,NA,NA,naproxen
Naproxen,DB00788,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,naproxen
Naproxen,DB00788,Sinus headache,C0037195,NA,Approved,NA,NA,naproxen
Naproxen,DB00788,Dysmenorrhea,C0013390,NA,Approved,NA,NA,naproxen
Naproxen,DB00788,Rhinorrhea,C1260880,NA,Approved,NA,NA,naproxen
Naproxen,DB00788,Headache Disorders,C0393735,NA,Approved,NA,NA,naproxen
Naproxen,DB00788,Migraine Disorders,C0149931,NA,Approved,NA,NA,naproxen
Naproxen,DB00788,Degenerative polyarthritis,C0029408,NA,Approved,NA,NA,naproxen
Naproxen,DB00788,Fever,C0015967,NA,Approved,NA,NA,naproxen
Naproxen,DB00788,Bursitis,C0006444,NA,Approved,NA,NA,naproxen
Naproxen,DB00788,Myalgia,C0231528,NA,Approved,NA,NA,naproxen
Naproxen,DB00788,Pain,C0030193,NA,Approved,NA,NA,naproxen
Naproxen,DB00788,Gout,C0018099,NA,Approved,NA,NA,naproxen
Naproxen,DB00788,Tendinitis,C0039503,NA,Approved,NA,NA,naproxen
Naproxen,DB00788,Ankylosing spondylitis,C0038013,NA,Approved,NA,NA,naproxen
Naproxen,DB00788,Toothache,C0040460,NA,Approved,NA,NA,naproxen
Perindopril,DB00790,Hypertensive disease,C0020538,NA,Approved,NA,NA,perindopril
Uracil mustard,DB00791,"Lymphoma, Non-Hodgkin",C0024305,NA,Approved,NA,NA,uracil mustard
Uracil mustard,DB00791,Polycythemia Vera,C0032463,NA,Approved,NA,NA,uracil mustard
Uracil mustard,DB00791,"Myeloid Leukemia, Chronic",C0023473,NA,Approved,NA,NA,uracil mustard
Uracil mustard,DB00791,Chronic Lymphocytic Leukemia,C0023434,NA,Approved,NA,NA,uracil mustard
Tripelennamine,DB00792,Pruritus,C0033774,NA,Approved,NA,NA,tripelennamine
Tripelennamine,DB00792,Symptomatic dermographism,C0343065,NA,Approved,NA,NA,tripelennamine
Tripelennamine,DB00792,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,tripelennamine
Tripelennamine,DB00792,Rhinorrhea,C1260880,NA,Approved,NA,NA,tripelennamine
Tripelennamine,DB00792,Urticaria,C0042109,NA,Approved,NA,NA,tripelennamine
Tripelennamine,DB00792,"Rhinitis, Vasomotor",C0035460,NA,Approved,NA,NA,tripelennamine
Tripelennamine,DB00792,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,tripelennamine
Tripelennamine,DB00792,Sneezing,C0037383,NA,Approved,NA,NA,tripelennamine
Tripelennamine,DB00792,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,tripelennamine
Haloprogin,DB00793,Tinea cruris,C1384589,NA,Approved,NA,NA,haloprogin
Haloprogin,DB00793,Tinea corporis (disorder),C0040252,NA,Approved,NA,NA,haloprogin
Haloprogin,DB00793,Tinea Pedis,C0040259,NA,Approved,NA,NA,haloprogin
Primidone,DB00794,Simple Partial Seizures,C0234974,NA,Approved,NA,NA,primidone
Primidone,DB00794,Epilepsy characterized by intractable complex partial seizures,C2711653,NA,Approved,NA,NA,primidone
Primidone,DB00794,Bipolar disorder in remission,C0270425,NA,Approved,NA,NA,primidone
Primidone,DB00794,Epilepsy,C0014544,NA,Approved,NA,NA,primidone
Primidone,DB00794,Tonic - clonic seizures,C0494475,NA,Approved,NA,NA,primidone
Primidone,DB00794,Tonic-Clonic Epilepsy,C0014549,NA,Approved,NA,NA,primidone
Primidone,DB00794,Lennox-Gastaut syndrome,C0238111,NA,Approved,NA,NA,primidone
Primidone,DB00794,"Epilepsies, Partial",C0014547,NA,Approved,NA,NA,primidone
Sulfasalazine,DB00795,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,sulfasalazine
Sulfasalazine,DB00795,Ulcerative Colitis,C0009324,NA,Approved,NA,NA,sulfasalazine
Candesartan,DB00796,Hypertensive disease,C0020538,NA,Approved,NA,NA,candesartan
Candesartan,DB00796,Chronic heart failure,C0264716,NA,Approved,NA,NA,candesartan
Tolazoline,DB00797,Cerebrovascular Disorders,C0007820,NA,Approved,NA,NA,tolazoline
Tolazoline,DB00797,Persistent Fetal Circulation Syndrome,C0031190,NA,Approved,NA,NA,tolazoline
Tolazoline,DB00797,Vascular Diseases,C0042373,NA,Approved,NA,NA,tolazoline
Gentamicin,DB00798,Pneumonia due to Escherichia coli,C0276089,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Sepsis due to Gram negative bacteria,C3163829,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Pseudomonas aeruginosa meningitis,C3665869,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,"Meningitis, Bacterial",C0085437,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Serratia sepsis,C0152973,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Serratia Infections,C0085394,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Pneumonia due to Pseudomonas,C0155860,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Infection of bone,C2242472,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Enterobacter pneumonia,C1096258,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Bacterial sepsis,C0684256,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Bacterial conjunctivitis,C0009768,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Cholangitis,C0008311,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Bacterial keratitis,C0854211,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Rhinoscleroma,C0035468,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Escherichia coli septicemia,C0276088,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Dacryocystitis,C0010930,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Folliculitis,C0016436,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Blepharoconjunctivitis,C0005743,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Meibomianitis,C0549398,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Sepsis due to Pseudomonas,C2887096,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Peritonitis,C0031154,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Neonatal meningitis,C0456107,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Citrobacter sepsis,C1096254,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Escherichia coli Infections,C0014836,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Enterobacteriaceae Infections,C0014347,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Infection due to Pseudomonas aeruginosa,C0276075,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Neonatal pneumonia,C0339968,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Arthropathy associated with infection,C0157749,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Paronychia Inflammation,C0030578,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Sepsis of the newborn,C0456103,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Proteus septicemia,C0577690,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Infective blepharitis,C0729587,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Bacterial infection due to Klebsiella pneumoniae,C0343402,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Proteus pneumonia,C1260917,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Klebsiella sepsis,C0745528,NA,Approved,NA,NA,gentamicin
Gentamicin,DB00798,Furunculosis,C0016867,NA,Approved,NA,NA,gentamicin
Tazarotene,DB00799,Acne Vulgaris,C0001144,NA,Approved,NA,NA,tazarotene
Tazarotene,DB00799,Psoriasis,C0033860,NA,Approved,NA,NA,tazarotene
Tazarotene,DB00799,Facial hyperpigmentation,C2677857,NA,Approved,NA,NA,tazarotene
Fenoldopam,DB00800,Hypertensive urgency,C0745138,NA,Approved,NA,NA,fenoldopam
Fenoldopam,DB00800,Malignant essential hypertension,C0024588,NA,Approved,NA,NA,fenoldopam
Halazepam,DB00801,Anxiety,C0003467,NA,Approved,NA,NA,halazepam
Colistin,DB00803,Pseudomonas aeruginosa infection,C0854135,NA,Approved,NA,NA,colistin
Colistin,DB00803,Infection caused by Enterobacter,C0948205,NA,Approved,NA,NA,colistin
Colistin,DB00803,Klebsiella Infections,C0022729,NA,Approved,NA,NA,colistin
Colistin,DB00803,Otitis Externa,C0029878,NA,Approved,NA,NA,colistin
Dicyclomine,DB00804,Irritable Bowel Syndrome,C0022104,NA,Approved,NA,NA,dicyclomine
Pentoxifylline,DB00806,Peripheral Vascular Diseases,C0085096,NA,Approved,NA,NA,pentoxifylline
Indapamide,DB00808,Hypertensive disease,C0020538,NA,Approved,NA,NA,indapamide
Indapamide,DB00808,Edema,C0013604,NA,Approved,NA,NA,indapamide
Tropicamide,DB00809,Mydriasis,C0026961,NA,Approved,NA,NA,tropicamide
Tropicamide,DB00809,Cycloplegia,C0235238,NA,Approved,NA,NA,tropicamide
Biperiden,DB00810,Extrapyramidal Disorders,C0015371,NA,Approved,NA,NA,biperiden
Biperiden,DB00810,Parkinsonian Disorders,C0242422,NA,Approved,NA,NA,biperiden
Biperiden,DB00810,Parkinson Disease,C0030567,NA,Approved,NA,NA,biperiden
Biperiden,DB00810,"Parkinson Disease, Postencephalitic",C0030568,NA,Approved,NA,NA,biperiden
Ribavirin,DB00811,"Hepatitis C, Chronic",C0524910,NA,Approved,NA,NA,ribavirin
Ribavirin,DB00811,Respiratory Syncytial Virus Infections,C0035235,NA,Approved,NA,NA,ribavirin
Fentanyl,DB00813,Acute postoperative pain,C2215257,NA,Approved,NA,NA,fentanyl
Fentanyl,DB00813,Pain,C0030193,NA,Approved,NA,NA,fentanyl
Meloxicam,DB00814,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,meloxicam
Meloxicam,DB00814,Degenerative polyarthritis,C0029408,NA,Approved,NA,NA,meloxicam
Orciprenaline,DB00816,Bronchitis,C0006277,NA,Approved,NA,NA,orciprenaline
Orciprenaline,DB00816,Pulmonary Emphysema,C0034067,NA,Approved,NA,NA,orciprenaline
Orciprenaline,DB00816,Asthma attack,C0347950,NA,Approved,NA,NA,orciprenaline
Orciprenaline,DB00816,Asthma,C0004096,NA,Approved,NA,NA,orciprenaline
Acetazolamide,DB00819,Malignant glaucoma,C0271152,NA,Approved,NA,NA,acetazolamide
Acetazolamide,DB00819,Absence Epilepsy,C0014553,NA,Approved,NA,NA,acetazolamide
Acetazolamide,DB00819,"Glaucoma, Open-Angle",C0017612,NA,Approved,NA,NA,acetazolamide
Acetazolamide,DB00819,Peripheral edema,C0085649,NA,Approved,NA,NA,acetazolamide
Acetazolamide,DB00819,Secondary glaucoma,C0149893,NA,Approved,NA,NA,acetazolamide
Acetazolamide,DB00819,Edema,C0013604,NA,Approved,NA,NA,acetazolamide
Acetazolamide,DB00819,Angle Closure Glaucoma,C0017605,NA,Approved,NA,NA,acetazolamide
Acetazolamide,DB00819,Altitude Sickness,C0002351,NA,Approved,NA,NA,acetazolamide
Tadalafil,DB00820,Pulmonary Hypertension,C0020542,NA,Approved,NA,NA,tadalafil
Tadalafil,DB00820,Erectile dysfunction,C0242350,NA,Approved,NA,NA,tadalafil
Tadalafil,DB00820,Prostatic Hypertrophy,C1739363,NA,Approved,NA,NA,tadalafil
Disulfiram,DB00822,"Alcoholic Intoxication, Chronic",C0001973,NA,Approved,NA,NA,disulfiram
Menthol,DB00825,Tinea Versicolor,C0040262,NA,Approved,NA,NA,menthol
Menthol,DB00825,Skin irritation,C0152030,NA,Approved,NA,NA,menthol
Menthol,DB00825,Pruritus,C0033774,NA,Approved,NA,NA,menthol
Menthol,DB00825,Scurfiness of scalp,C0423775,NA,Approved,NA,NA,menthol
Menthol,DB00825,Sprains and Strains,C0038048,NA,Approved,NA,NA,menthol
Menthol,DB00825,Arthritic pains,C0857177,NA,Approved,NA,NA,menthol
Menthol,DB00825,Mouth irritation,C0235339,NA,Approved,NA,NA,menthol
Menthol,DB00825,Diaper Rash,C0011974,NA,Approved,NA,NA,menthol
Menthol,DB00825,Back Pain,C0004604,NA,Approved,NA,NA,menthol
Menthol,DB00825,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,menthol
Natamycin,DB00826,Fungal conjunctivitis,C0339170,NA,Approved,NA,NA,natamycin
Natamycin,DB00826,Fungal keratitis,C1262117,NA,Approved,NA,NA,natamycin
Cinoxacin,DB00827,Urinary tract infection,C0042029,NA,Approved,NA,NA,cinoxacin
Fosfomycin,DB00828,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,fosfomycin
Fosfomycin,DB00828,Urinary tract infection,C0042029,NA,Approved,NA,NA,fosfomycin
Fosfomycin,DB00828,URINARY TRACT INFECTION ENTEROCOCCUS,C0749958,NA,Approved,NA,NA,fosfomycin
Diazepam,DB00829,Alcohol Withdrawal Delirium,C0001957,NA,Approved,NA,NA,diazepam
Diazepam,DB00829,Status Epilepticus,C0038220,NA,Approved,NA,NA,diazepam
Diazepam,DB00829,Anxiety,C0003467,NA,Approved,NA,NA,diazepam
Diazepam,DB00829,Alcohol withdrawal syndrome,C0236663,NA,Approved,NA,NA,diazepam
Diazepam,DB00829,Muscle Spasticity,C0026838,NA,Approved,NA,NA,diazepam
Diazepam,DB00829,Tetanus,C0039614,NA,Approved,NA,NA,diazepam
Phenmetrazine,DB00830,Obesity,C0028754,NA,Approved,NA,NA,phenmetrazine
Trifluoperazine,DB00831,Schizophrenia,C0036341,NA,Approved,NA,NA,trifluoperazine
Trifluoperazine,DB00831,Anxiety,C0003467,NA,Approved,NA,NA,trifluoperazine
Phensuximide,DB00832,Epilepsy,C0014544,NA,Approved,NA,NA,phensuximide
Phensuximide,DB00832,Absence Epilepsy,C0014553,NA,Approved,NA,NA,phensuximide
Cefaclor,DB00833,Acute Moraxella catarrhalis bronchitis,C0339932,NA,Approved,NA,NA,cefaclor
Cefaclor,DB00833,Tonsillitis,C0040425,NA,Approved,NA,NA,cefaclor
Cefaclor,DB00833,Streptococcal tonsillitis,C0275804,NA,Approved,NA,NA,cefaclor
Cefaclor,DB00833,Upper Respiratory Infections,C0041912,NA,Approved,NA,NA,cefaclor
Cefaclor,DB00833,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,cefaclor
Cefaclor,DB00833,Pneumonia,C0032285,NA,Approved,NA,NA,cefaclor
Cefaclor,DB00833,Lower respiratory tract infection,C0149725,NA,Approved,NA,NA,cefaclor
Cefaclor,DB00833,Urinary tract infection,C0042029,NA,Approved,NA,NA,cefaclor
Cefaclor,DB00833,Pharyngitis,C0031350,NA,Approved,NA,NA,cefaclor
Cefaclor,DB00833,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,cefaclor
Cefaclor,DB00833,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,cefaclor
Cefaclor,DB00833,Infective otitis media,C0729586,NA,Approved,NA,NA,cefaclor
Mifepristone,DB00834,Unspecified Abortion,C0156543,NA,Approved,NA,NA,mifepristone
Brompheniramine,DB00835,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,brompheniramine
Brompheniramine,DB00835,Influenza-like symptoms,C0392171,NA,Approved,NA,NA,brompheniramine
Brompheniramine,DB00835,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,brompheniramine
Brompheniramine,DB00835,Hay fever,C0018621,NA,Approved,NA,NA,brompheniramine
Brompheniramine,DB00835,Urticaria,C0042109,NA,Approved,NA,NA,brompheniramine
Brompheniramine,DB00835,Pruritus,C0033774,NA,Approved,NA,NA,brompheniramine
Brompheniramine,DB00835,Symptomatic dermographism,C0343065,NA,Approved,NA,NA,brompheniramine
Brompheniramine,DB00835,Rhinorrhea,C1260880,NA,Approved,NA,NA,brompheniramine
Brompheniramine,DB00835,"Rhinitis, Vasomotor",C0035460,NA,Approved,NA,NA,brompheniramine
Loperamide,DB00836,Traveler's diarrhea,C0277528,NA,Approved,NA,NA,loperamide
Loperamide,DB00836,Diarrhea,C0011991,NA,Approved,NA,NA,loperamide
Clocortolone,DB00838,Scalp psoriasis,C0406326,NA,Approved,NA,NA,clocortolone
Clocortolone,DB00838,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,clocortolone
Clocortolone,DB00838,Pruritus Ani,C0033775,NA,Approved,NA,NA,clocortolone
Clocortolone,DB00838,Lichen Simplex Chronicus,C0149922,NA,Approved,NA,NA,clocortolone
Clocortolone,DB00838,Contact Dermatitis,C0011616,NA,Approved,NA,NA,clocortolone
Clocortolone,DB00838,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,clocortolone
Clocortolone,DB00838,"Lymphoma, T-Cell, Cutaneous",C0079773,NA,Approved,NA,NA,clocortolone
Clocortolone,DB00838,Pruritus of genital organs,C0033777,NA,Approved,NA,NA,clocortolone
Clocortolone,DB00838,"Lupus Erythematosus, Discoid",C0024138,NA,Approved,NA,NA,clocortolone
Clocortolone,DB00838,Exanthema,C0015230,NA,Approved,NA,NA,clocortolone
Clocortolone,DB00838,Granuloma Annulare,C0085074,NA,Approved,NA,NA,clocortolone
Tolazamide,DB00839,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,tolazamide
Dobutamine,DB00841,"Shock, Cardiogenic",C0036980,NA,Approved,NA,NA,dobutamine
Dobutamine,DB00841,Decompensated cardiac failure,C0581377,NA,Approved,NA,NA,dobutamine
Dobutamine,DB00841,Heart Decompensation,C1961112,NA,Approved,NA,NA,dobutamine
Oxazepam,DB00842,Anxiety,C0003467,NA,Approved,NA,NA,oxazepam
Oxazepam,DB00842,Alcohol Withdrawal Delirium,C0001957,NA,Approved,NA,NA,oxazepam
Donepezil,DB00843,Alzheimer's Disease,C0002395,NA,Approved,NA,NA,donepezil
Nalbuphine,DB00844,Pain,C0030193,NA,Approved,NA,NA,nalbuphine
Nalbuphine,DB00844,Labor Pain,C0474368,NA,Approved,NA,NA,nalbuphine
Clofazimine,DB00845,Dapsone resistant mycobacterium leprae disease,C1563054,NA,Approved,NA,NA,clofazimine
Clofazimine,DB00845,Pyoderma Gangrenosum,C0085652,NA,Approved,NA,NA,clofazimine
Clofazimine,DB00845,Erythema nodosum leprosum,C0343467,NA,Approved,NA,NA,clofazimine
Clofazimine,DB00845,Leprosy,C0023343,NA,Approved,NA,NA,clofazimine
Clofazimine,DB00845,"Leprosy, Multibacillary",C1562585,NA,Approved,NA,NA,clofazimine
Flurandrenolide,DB00846,"Lupus Erythematosus, Discoid",C0024138,NA,Approved,NA,NA,flurandrenolide
Flurandrenolide,DB00846,Pruritus of genital organs,C0033777,NA,Approved,NA,NA,flurandrenolide
Flurandrenolide,DB00846,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,flurandrenolide
Flurandrenolide,DB00846,Scalp psoriasis,C0406326,NA,Approved,NA,NA,flurandrenolide
Flurandrenolide,DB00846,Exanthema,C0015230,NA,Approved,NA,NA,flurandrenolide
Flurandrenolide,DB00846,Contact Dermatitis,C0011616,NA,Approved,NA,NA,flurandrenolide
Flurandrenolide,DB00846,Granuloma Annulare,C0085074,NA,Approved,NA,NA,flurandrenolide
Flurandrenolide,DB00846,Lichen Simplex Chronicus,C0149922,NA,Approved,NA,NA,flurandrenolide
Flurandrenolide,DB00846,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,flurandrenolide
Flurandrenolide,DB00846,Pruritus Ani,C0033775,NA,Approved,NA,NA,flurandrenolide
Flurandrenolide,DB00846,"Lymphoma, T-Cell, Cutaneous",C0079773,NA,Approved,NA,NA,flurandrenolide
Flurandrenolide,DB00846,"Dermatitis, Atopic",C0011615,NA,Approved,NA,NA,flurandrenolide
Cysteamine,DB00847,Nephropathic cystinosis,C2931187,NA,Approved,NA,NA,cysteamine
Methylphenobarbital,DB00849,apprehension,C0233485,NA,Approved,NA,NA,methylphenobarbital
Methylphenobarbital,DB00849,Tonic-Clonic Epilepsy,C0014549,NA,Approved,NA,NA,methylphenobarbital
Methylphenobarbital,DB00849,Tension,C0233494,NA,Approved,NA,NA,methylphenobarbital
Methylphenobarbital,DB00849,Epilepsy,C0014544,NA,Approved,NA,NA,methylphenobarbital
Methylphenobarbital,DB00849,Anxiety,C0003467,NA,Approved,NA,NA,methylphenobarbital
Perphenazine,DB00850,Nausea and vomiting,C0027498,NA,Approved,NA,NA,perphenazine
Perphenazine,DB00850,Schizophrenia,C0036341,NA,Approved,NA,NA,perphenazine
Perphenazine,DB00850,Mixed anxiety and depressive disorder,C0338908,NA,Approved,NA,NA,perphenazine
Dacarbazine,DB00851,Hodgkin Disease,C0019829,NA,Approved,NA,NA,dacarbazine
Dacarbazine,DB00851,"Malignant melanoma, metastatic",C0860594,NA,Approved,NA,NA,dacarbazine
Pseudoephedrine,DB00852,Headache Disorders,C0393735,NA,Approved,NA,NA,pseudoephedrine
Pseudoephedrine,DB00852,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,pseudoephedrine
Pseudoephedrine,DB00852,Rhinorrhea,C1260880,NA,Approved,NA,NA,pseudoephedrine
Pseudoephedrine,DB00852,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,pseudoephedrine
Pseudoephedrine,DB00852,Hay fever,C0018621,NA,Approved,NA,NA,pseudoephedrine
Pseudoephedrine,DB00852,"Rhinitis, Vasomotor",C0035460,NA,Approved,NA,NA,pseudoephedrine
Pseudoephedrine,DB00852,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,pseudoephedrine
Pseudoephedrine,DB00852,Influenza-like symptoms,C0392171,NA,Approved,NA,NA,pseudoephedrine
Pseudoephedrine,DB00852,Sinus headache,C0037195,NA,Approved,NA,NA,pseudoephedrine
Pseudoephedrine,DB00852,Rhinitis,C0035455,NA,Approved,NA,NA,pseudoephedrine
Pseudoephedrine,DB00852,Common Cold,C0009443,NA,Approved,NA,NA,pseudoephedrine
Temozolomide,DB00853,Anaplastic astrocytoma,C0334579,NA,Approved,NA,NA,temozolomide
Temozolomide,DB00853,Glioblastoma multiforme of brain,C0349543,NA,Approved,NA,NA,temozolomide
Levorphanol,DB00854,Pain,C0030193,NA,Approved,NA,NA,levorphanol
Aminolevulinic acid,DB00855,Actinic keratosis,C0022602,NA,Approved,NA,NA,aminolevulinic acid
Chlorphenesin,DB00856,Muscle Spasticity,C0026838,NA,Approved,NA,NA,chlorphenesin
Terbinafine,DB00857,Onychomycosis,C0040261,NA,Approved,NA,NA,terbinafine
Terbinafine,DB00857,Tinea Pedis,C0040259,NA,Approved,NA,NA,terbinafine
Terbinafine,DB00857,Tinea Versicolor,C0040262,NA,Approved,NA,NA,terbinafine
Terbinafine,DB00857,Onychomycosis of toenails,C1274470,NA,Approved,NA,NA,terbinafine
Terbinafine,DB00857,Tinea Capitis,C0040250,NA,Approved,NA,NA,terbinafine
Terbinafine,DB00857,Tinea cruris,C1384589,NA,Approved,NA,NA,terbinafine
Terbinafine,DB00857,Onychomycosis of fingernails,C1274469,NA,Approved,NA,NA,terbinafine
Terbinafine,DB00857,Tinea corporis (disorder),C0040252,NA,Approved,NA,NA,terbinafine
Drostanolone,DB00858,Corneal Ulcer,C0010043,NA,Approved,NA,NA,drostanolone
Drostanolone,DB00858,Iritis,C0022081,NA,Approved,NA,NA,drostanolone
Drostanolone,DB00858,Rosacea,C0035854,NA,Approved,NA,NA,drostanolone
Drostanolone,DB00858,"Anemia, Diamond-Blackfan",C1260899,NA,Approved,NA,NA,drostanolone
Drostanolone,DB00858,Uveitis,C0042164,NA,Approved,NA,NA,drostanolone
Drostanolone,DB00858,Aplastic Anemia,C0002874,NA,Approved,NA,NA,drostanolone
Drostanolone,DB00858,Punctate keratopathy,C0423234,NA,Approved,NA,NA,drostanolone
Drostanolone,DB00858,Iridocyclitis,C0022073,NA,Approved,NA,NA,drostanolone
Drostanolone,DB00858,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,drostanolone
Drostanolone,DB00858,Herpes zoster keratitis,C1275687,NA,Approved,NA,NA,drostanolone
Drostanolone,DB00858,Corneal abrasion,C0010032,NA,Approved,NA,NA,drostanolone
Drostanolone,DB00858,Cyclitis,C0010543,NA,Approved,NA,NA,drostanolone
Drostanolone,DB00858,Hypoplastic anemia,C0178416,NA,Approved,NA,NA,drostanolone
Penicillamine,DB00859,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,penicillamine
Penicillamine,DB00859,Hepatolenticular Degeneration,C0019202,NA,Approved,NA,NA,penicillamine
Penicillamine,DB00859,Cystinuria,C0010691,NA,Approved,NA,NA,penicillamine
Prednisolone,DB00860,Bacterial conjunctivitis,C0009768,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Blepharoconjunctivitis,C0005743,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Iridocyclitis,C0022073,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Infective blepharitis,C0729587,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,"Dermatitis, Atopic",C0011615,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Pruritus of genital organs,C0033777,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Pruritus Ani,C0033775,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,"Lupus Erythematosus, Discoid",C0024138,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Lichen Simplex Chronicus,C0149922,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,"Lymphoma, T-Cell, Cutaneous",C0079773,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Contact Dermatitis,C0011616,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Granuloma Annulare,C0085074,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Exanthema,C0015230,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Scalp psoriasis,C0406326,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,"Ophthalmia, Sympathetic",C0029077,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Mycosis Fungoides,C0026948,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Ulcerative Colitis,C0009324,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Eosinophilic Pneumonia,C1527407,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Addison Disease,C0001403,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Musculoskeletal Diseases,C0026857,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,"Arthritis, Gouty",C0003868,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Addisonian crisis,C0151467,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Disorder of eye,C0015397,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Synovitis,C0039103,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Bacterial keratitis,C0854211,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Serum Sickness,C0036830,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Multiple Sclerosis,C0026769,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Sjogren's Syndrome,C1527336,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Nephrotic Syndrome,C0027726,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Exacerbation of asthma,C0349790,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,"Arthritis, Psoriatic",C0003872,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Stevens-Johnson Syndrome,C0038325,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Rheumatic Heart Disease,C0035439,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Cyclitis,C0010543,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,"Lymphoma, Follicular",C0024301,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Inflammatory Bowel Diseases,C0021390,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Keratitis,C0022568,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Ankylosing spondylitis,C0038013,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Punctate keratopathy,C0423234,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Crohn Disease,C0010346,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Cooley's anemia,C0002875,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Psoriasis,C0033860,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Status Asthmaticus,C0038218,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Simple Pulmonary Eosinophilia,C0242459,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Corneal abrasion,C0010032,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Uveitis,C0042164,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,"Lymphoma, Non-Hodgkin",C0024305,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Acute lymphocytic leukemia,C0023449,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Erythema Multiforme,C0014742,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,"Lupus Erythematosus, Systemic",C0024141,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Adrenal cortical hypofunction,C0405580,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Adrenogenital disorder,C0701163,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Exfoliative dermatitis,C0011606,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Pemphigus,C0030807,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Ocular Rosacea,C0406486,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Berylliosis,C0005138,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,"Anemia, Diamond-Blackfan",C1260899,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Bursitis,C0006444,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Epicondylitis,C0014488,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Meibomianitis,C0549398,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Acquired thrombocytopenia,C0154301,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Giant Cell Arteritis,C0039483,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Herpes zoster keratitis,C1275687,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Sarcoidosis,C0036202,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,"Aspergillosis, Allergic Bronchopulmonary",C0004031,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Post traumatic osteoarthritis,C2894027,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Transplanted organ rejection,C0345468,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Autoimmune Diseases,C0004364,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Asthma,C0004096,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Corneal Ulcer,C0010043,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Rosacea,C0035854,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Extrinsic allergic alveolitis,C0002390,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Thyroiditis,C0040147,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Dermatitis Herpetiformis,C0011608,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Polymyalgia Rheumatica,C0032533,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Dacryocystitis,C0010930,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Angioedema,C0002994,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Autoimmune hemolytic anemia,C0002880,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Dermatologic disorders,C0037274,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Congenital adrenal hyperplasia,C0001627,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Tenosynovitis,C0039520,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Iritis,C0022081,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Cerebral Edema,C0006114,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Humoral hypercalcemia of malignancy (disorder),C0149911,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,"Tuberculosis, Miliary",C0041321,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Tendinitis,C0039503,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Hodgkin Disease,C0019829,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Pulmonary Fibrosis,C0034069,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Aspiration pneumonitis,C1761609,NA,Approved,NA,NA,prednisolone
Prednisolone,DB00860,Laryngeal Edema,C0023052,NA,Approved,NA,NA,prednisolone
Diflunisal,DB00861,Degenerative polyarthritis,C0029408,NA,Approved,NA,NA,diflunisal
Diflunisal,DB00861,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,diflunisal
Diflunisal,DB00861,Pain,C0030193,NA,Approved,NA,NA,diflunisal
Diflunisal,DB00861,Chronic pain,C0150055,NA,Approved,NA,NA,diflunisal
Vardenafil,DB00862,Erectile dysfunction,C0242350,NA,Approved,NA,NA,vardenafil
Ranitidine,DB00863,Erosive esophagitis,C0267055,NA,Approved,NA,NA,ranitidine
Ranitidine,DB00863,Duodenal Ulcer,C0013295,NA,Approved,NA,NA,ranitidine
Ranitidine,DB00863,Zollinger-Ellison syndrome,C0043515,NA,Approved,NA,NA,ranitidine
Ranitidine,DB00863,Dyspepsia,C0013395,NA,Approved,NA,NA,ranitidine
Ranitidine,DB00863,Gastroesophageal reflux disease,C0017168,NA,Approved,NA,NA,ranitidine
Ranitidine,DB00863,Heartburn,C0018834,NA,Approved,NA,NA,ranitidine
Ranitidine,DB00863,Gastric ulcer,C0038358,NA,Approved,NA,NA,ranitidine
Tacrolimus,DB00864,Transplanted organ rejection,C0345468,NA,Approved,NA,NA,tacrolimus
Tacrolimus,DB00864,Renal transplant rejection,C0238217,NA,Approved,NA,NA,tacrolimus
Tacrolimus,DB00864,Liver transplant rejection,C0400968,NA,Approved,NA,NA,tacrolimus
Benzphetamine,DB00865,Obesity,C0028754,NA,Approved,NA,NA,benzphetamine
Ritodrine,DB00867,Premature Obstetric Labor,C0022876,NA,Approved,NA,NA,ritodrine
Benzonatate,DB00868,Coughing,C0010200,NA,Approved,NA,NA,benzonatate
Dorzolamide,DB00869,"Glaucoma, Open-Angle",C0017612,NA,Approved,NA,NA,dorzolamide
Dorzolamide,DB00869,Ocular Hypertension,C0028840,NA,Approved,NA,NA,dorzolamide
Terbutaline,DB00871,Pulmonary Emphysema,C0034067,NA,Approved,NA,NA,terbutaline
Terbutaline,DB00871,Pruritus,C0033774,NA,Approved,NA,NA,terbutaline
Terbutaline,DB00871,Dry Eye Syndromes,C0013238,NA,Approved,NA,NA,terbutaline
Terbutaline,DB00871,Asthma,C0004096,NA,Approved,NA,NA,terbutaline
Terbutaline,DB00871,Skin irritation,C0152030,NA,Approved,NA,NA,terbutaline
Terbutaline,DB00871,Bronchitis,C0006277,NA,Approved,NA,NA,terbutaline
Terbutaline,DB00871,Asthma attack,C0347950,NA,Approved,NA,NA,terbutaline
Conivaptan,DB00872,Hyponatremia,C0020625,NA,Approved,NA,NA,conivaptan
Loteprednol,DB00873,Iritis,C0022081,NA,Approved,NA,NA,loteprednol
Loteprednol,DB00873,Herpes zoster keratoconjunctivitis,C0153027,NA,Approved,NA,NA,loteprednol
Loteprednol,DB00873,Corneal abrasion,C0010032,NA,Approved,NA,NA,loteprednol
Loteprednol,DB00873,Corneal Perforation,C0339293,NA,Approved,NA,NA,loteprednol
Loteprednol,DB00873,Punctate keratitis,C0259799,NA,Approved,NA,NA,loteprednol
Loteprednol,DB00873,Rosacea,C0035854,NA,Approved,NA,NA,loteprednol
Loteprednol,DB00873,Herpes zoster keratitis,C1275687,NA,Approved,NA,NA,loteprednol
Loteprednol,DB00873,Iridocyclitis,C0022073,NA,Approved,NA,NA,loteprednol
Loteprednol,DB00873,Anterior uveitis,C0042165,NA,Approved,NA,NA,loteprednol
Loteprednol,DB00873,Ocular Rosacea,C0406486,NA,Approved,NA,NA,loteprednol
Loteprednol,DB00873,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,loteprednol
Guaifenesin,DB00874,Headache Disorders,C0393735,NA,Approved,NA,NA,guaifenesin
Guaifenesin,DB00874,Fever,C0015967,NA,Approved,NA,NA,guaifenesin
Guaifenesin,DB00874,Rhinitis,C0035455,NA,Approved,NA,NA,guaifenesin
Guaifenesin,DB00874,Common Cold,C0009443,NA,Approved,NA,NA,guaifenesin
Guaifenesin,DB00874,Influenza-like symptoms,C0392171,NA,Approved,NA,NA,guaifenesin
Guaifenesin,DB00874,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,guaifenesin
Guaifenesin,DB00874,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,guaifenesin
Guaifenesin,DB00874,Rhinorrhea,C1260880,NA,Approved,NA,NA,guaifenesin
Guaifenesin,DB00874,Sinus headache,C0037195,NA,Approved,NA,NA,guaifenesin
Guaifenesin,DB00874,Coughing,C0010200,NA,Approved,NA,NA,guaifenesin
Flupentixol,DB00875,Schizophrenia,C0036341,NA,Approved,NA,NA,flupentixol
Eprosartan,DB00876,Hypertensive disease,C0020538,NA,Approved,NA,NA,eprosartan
Sirolimus,DB00877,Renal Cell Carcinoma,C0007134,NA,Approved,NA,NA,sirolimus
Sirolimus,DB00877,"Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse",C0334634,NA,Approved,NA,NA,sirolimus
Sirolimus,DB00877,Pulmonary lymphangioleiomyomatosis,C0349649,NA,Approved,NA,NA,sirolimus
Chlorhexidine,DB00878,Gingivitis,C0017574,NA,Approved,NA,NA,chlorhexidine
Emtricitabine,DB00879,HIV Infections,C0019693,NA,Approved,NA,NA,emtricitabine
Chlorothiazide,DB00880,Edema,C0013604,NA,Approved,NA,NA,chlorothiazide
Chlorothiazide,DB00880,Hypertensive urgency,C0745138,NA,Approved,NA,NA,chlorothiazide
Chlorothiazide,DB00880,Hypertensive disease,C0020538,NA,Approved,NA,NA,chlorothiazide
Chlorothiazide,DB00880,Chronic heart failure,C0264716,NA,Approved,NA,NA,chlorothiazide
Quinapril,DB00881,Hypertensive disease,C0020538,NA,Approved,NA,NA,quinapril
Quinapril,DB00881,Chronic heart failure,C0264716,NA,Approved,NA,NA,quinapril
Clomifene,DB00882,Female infertility,C0021361,NA,Approved,NA,NA,clomifene
Isosorbide Dinitrate,DB00883,Chronic heart failure,C0264716,NA,Approved,NA,NA,isosorbide dinitrate
Isosorbide Dinitrate,DB00883,Angina Pectoris,C0002962,NA,Approved,NA,NA,isosorbide dinitrate
Risedronate,DB00884,Osteitis Deformans,C0029401,NA,Approved,NA,NA,risedronate
Risedronate,DB00884,"Osteoporosis, Postmenopausal",C0029458,NA,Approved,NA,NA,risedronate
Risedronate,DB00884,Osteoporosis,C0029456,NA,Approved,NA,NA,risedronate
Pemirolast,DB00885,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,pemirolast
Pemirolast,DB00885,Asthma,C0004096,NA,Approved,NA,NA,pemirolast
Pemirolast,DB00885,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,pemirolast
Bumetanide,DB00887,Renal disease with edema NOS,C0866125,NA,Approved,NA,NA,bumetanide
Bumetanide,DB00887,Edema,C0013604,NA,Approved,NA,NA,bumetanide
Mechlorethamine,DB00888,Hodgkin Disease,C0019829,NA,Approved,NA,NA,mechlorethamine
Mechlorethamine,DB00888,Malignant neoplasm of lung,C0242379,NA,Approved,NA,NA,mechlorethamine
Mechlorethamine,DB00888,"Lymphoma, Non-Hodgkin",C0024305,NA,Approved,NA,NA,mechlorethamine
Mechlorethamine,DB00888,Malignant pericardial effusion,C0220655,NA,Approved,NA,NA,mechlorethamine
Mechlorethamine,DB00888,"Lymphoma, T-Cell, Cutaneous",C0079773,NA,Approved,NA,NA,mechlorethamine
Mechlorethamine,DB00888,Chronic Lymphocytic Leukemia,C0023434,NA,Approved,NA,NA,mechlorethamine
Mechlorethamine,DB00888,"Myeloid Leukemia, Chronic",C0023473,NA,Approved,NA,NA,mechlorethamine
Mechlorethamine,DB00888,"Pleural Effusion, Malignant",C0080032,NA,Approved,NA,NA,mechlorethamine
Mechlorethamine,DB00888,Malignant ascites,C0220656,NA,Approved,NA,NA,mechlorethamine
Mechlorethamine,DB00888,Mycosis Fungoides,C0026948,NA,Approved,NA,NA,mechlorethamine
Granisetron,DB00889,Chemotherapy-induced nausea and vomiting,C0401160,NA,Approved,NA,NA,granisetron
Dienestrol,DB00890,Dyspareunia,C1384606,NA,Approved,NA,NA,dienestrol
Dienestrol,DB00890,Atrophy of vulva,C0156393,NA,Approved,NA,NA,dienestrol
Dienestrol,DB00890,Atrophic Vaginitis,C0221392,NA,Approved,NA,NA,dienestrol
Sulfapyridine,DB00891,Dermatitis Herpetiformis,C0011608,NA,Approved,NA,NA,sulfapyridine
Testolactone,DB00894,Malignant epithelial neoplasm of female breast,C3163805,NA,Approved,NA,NA,testolactone
Rimexolone,DB00896,Uveitis,C0042164,NA,Approved,NA,NA,rimexolone
Triazolam,DB00897,Sleeplessness,C0917801,NA,Approved,NA,NA,triazolam
Remifentanil,DB00899,Acute postoperative pain,C2215257,NA,Approved,NA,NA,remifentanil
Didanosine,DB00900,HIV Infections,C0019693,NA,Approved,NA,NA,didanosine
Methdilazine,DB00902,Pruritus,C0033774,NA,Approved,NA,NA,methdilazine
Methdilazine,DB00902,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,methdilazine
Methdilazine,DB00902,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,methdilazine
Methdilazine,DB00902,Angioedema,C0002994,NA,Approved,NA,NA,methdilazine
Methdilazine,DB00902,Symptomatic dermographism,C0343065,NA,Approved,NA,NA,methdilazine
Methdilazine,DB00902,Rhinorrhea,C1260880,NA,Approved,NA,NA,methdilazine
Methdilazine,DB00902,Urticaria,C0042109,NA,Approved,NA,NA,methdilazine
Methdilazine,DB00902,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,methdilazine
Methdilazine,DB00902,Sneezing,C0037383,NA,Approved,NA,NA,methdilazine
Etacrynic acid,DB00903,Edema,C0013604,NA,Approved,NA,NA,etacrynic acid
Ondansetron,DB00904,Chemotherapy-induced nausea and vomiting,C0401160,NA,Approved,NA,NA,ondansetron
Bimatoprost,DB00905,"Glaucoma, Open-Angle",C0017612,NA,Approved,NA,NA,bimatoprost
Bimatoprost,DB00905,Ocular Hypertension,C0028840,NA,Approved,NA,NA,bimatoprost
Bimatoprost,DB00905,Hypertrichosis of eyelid,C0155213,NA,Approved,NA,NA,bimatoprost
Tiagabine,DB00906,Epilepsy characterized by intractable complex partial seizures,C2711653,NA,Approved,NA,NA,tiagabine
Tiagabine,DB00906,Simple Partial Seizures,C0234974,NA,Approved,NA,NA,tiagabine
Quinidine,DB00908,Pseudobulbar affect,C2316460,NA,Approved,NA,NA,quinidine
Tinidazole,DB00911,Acute amebiasis,C0152499,NA,Approved,NA,NA,tinidazole
Tinidazole,DB00911,Trichomonas Infections,C0040921,NA,Approved,NA,NA,tinidazole
Tinidazole,DB00911,Bacterial Vaginosis,C0085166,NA,Approved,NA,NA,tinidazole
Tinidazole,DB00911,"Liver Abscess, Amebic",C0023886,NA,Approved,NA,NA,tinidazole
Tinidazole,DB00911,Giardiasis,C0017536,NA,Approved,NA,NA,tinidazole
Repaglinide,DB00912,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,repaglinide
Amantadine,DB00915,Extrapyramidal Disorders,C0015371,NA,Approved,NA,NA,amantadine
Amantadine,DB00915,Parkinson Disease,C0030567,NA,Approved,NA,NA,amantadine
Amantadine,DB00915,Parkinsonian Disorders,C0242422,NA,Approved,NA,NA,amantadine
Amantadine,DB00915,Influenza due to Influenza A virus,C2711180,NA,Approved,NA,NA,amantadine
Amantadine,DB00915,"Parkinson Disease, Postencephalitic",C0030568,NA,Approved,NA,NA,amantadine
Metronidazole,DB00916,"Liver Abscess, Amebic",C0023886,NA,Approved,NA,NA,metronidazole
Metronidazole,DB00916,Bacteroides empyema,C2062454,NA,Approved,NA,NA,metronidazole
Metronidazole,DB00916,Infection due to anaerobic bacteria,C0854328,NA,Approved,NA,NA,metronidazole
Metronidazole,DB00916,Bacterial sepsis,C0684256,NA,Approved,NA,NA,metronidazole
Metronidazole,DB00916,Acute amebiasis,C0152499,NA,Approved,NA,NA,metronidazole
Metronidazole,DB00916,Female genital tract infection,C1263758,NA,Approved,NA,NA,metronidazole
Metronidazole,DB00916,Arthropathy associated with infection,C0157749,NA,Approved,NA,NA,metronidazole
Metronidazole,DB00916,Trichomonas Infections,C0040921,NA,Approved,NA,NA,metronidazole
Metronidazole,DB00916,Liver Abscess,C0023885,NA,Approved,NA,NA,metronidazole
Metronidazole,DB00916,Lower respiratory tract infection,C0149725,NA,Approved,NA,NA,metronidazole
Metronidazole,DB00916,Tubo-ovarian abscess,C0041343,NA,Approved,NA,NA,metronidazole
Metronidazole,DB00916,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,metronidazole
Metronidazole,DB00916,Peritonitis,C0031154,NA,Approved,NA,NA,metronidazole
Metronidazole,DB00916,Bacterial Vaginosis,C0085166,NA,Approved,NA,NA,metronidazole
Metronidazole,DB00916,Infection of bone,C2242472,NA,Approved,NA,NA,metronidazole
Metronidazole,DB00916,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,metronidazole
Metronidazole,DB00916,Giardiasis,C0017536,NA,Approved,NA,NA,metronidazole
Metronidazole,DB00916,Brain Abscess,C0006105,NA,Approved,NA,NA,metronidazole
Metronidazole,DB00916,Meningitis due to Bacteroides,C0865436,NA,Approved,NA,NA,metronidazole
Metronidazole,DB00916,Septicemia due to Bacteroides,C0276064,NA,Approved,NA,NA,metronidazole
Metronidazole,DB00916,Abdominal Abscess,C0243001,NA,Approved,NA,NA,metronidazole
Metronidazole,DB00916,Endometritis,C0014179,NA,Approved,NA,NA,metronidazole
Dinoprostone,DB00917,"Hydatidiform mole, benign",C0549315,NA,Approved,NA,NA,dinoprostone
Dinoprostone,DB00917,Unspecified Abortion,C0156543,NA,Approved,NA,NA,dinoprostone
Dinoprostone,DB00917,Incomplete spontaneous abortion,C0000810,NA,Approved,NA,NA,dinoprostone
Almotriptan,DB00918,Migraine Disorders,C0149931,NA,Approved,NA,NA,almotriptan
Spectinomycin,DB00919,GONOCOCCAL INFECTION DISSEMINATED,C0744451,NA,Approved,NA,NA,spectinomycin
Spectinomycin,DB00919,Gonorrhea of rectum,C0275665,NA,Approved,NA,NA,spectinomycin
Spectinomycin,DB00919,Gonorrhea,C0018081,NA,Approved,NA,NA,spectinomycin
Spectinomycin,DB00919,Acute gonococcal cervicitis,C0153195,NA,Approved,NA,NA,spectinomycin
Spectinomycin,DB00919,Acute gonococcal urethritis,C0275652,NA,Approved,NA,NA,spectinomycin
Ketotifen,DB00920,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,ketotifen
Buprenorphine,DB00921,Opiate Addiction,C0524662,NA,Approved,NA,NA,buprenorphine
Buprenorphine,DB00921,Chronic pain,C0150055,NA,Approved,NA,NA,buprenorphine
Buprenorphine,DB00921,Acute postoperative pain,C2215257,NA,Approved,NA,NA,buprenorphine
Buprenorphine,DB00921,Severe pain,C0278140,NA,Approved,NA,NA,buprenorphine
Levosimendan,DB00922,Congestive heart failure,C0018802,NA,Approved,NA,NA,levosimendan
Cyclobenzaprine,DB00924,Muscle Spasticity,C0026838,NA,Approved,NA,NA,cyclobenzaprine
Phenoxybenzamine,DB00925,Pheochromocytoma,C0031511,NA,Approved,NA,NA,phenoxybenzamine
Famotidine,DB00927,Peptic Esophagitis,C0014869,NA,Approved,NA,NA,famotidine
Famotidine,DB00927,Duodenal Ulcer,C0013295,NA,Approved,NA,NA,famotidine
Famotidine,DB00927,Zollinger-Ellison syndrome,C0043515,NA,Approved,NA,NA,famotidine
Famotidine,DB00927,Dyspepsia,C0013395,NA,Approved,NA,NA,famotidine
Famotidine,DB00927,Heartburn,C0018834,NA,Approved,NA,NA,famotidine
Famotidine,DB00927,Erosive esophagitis,C0267055,NA,Approved,NA,NA,famotidine
Famotidine,DB00927,Gastric ulcer,C0038358,NA,Approved,NA,NA,famotidine
Famotidine,DB00927,Gastroesophageal reflux disease,C0017168,NA,Approved,NA,NA,famotidine
Misoprostol,DB00929,Postpartum Hemorrhage,C0032797,NA,Approved,NA,NA,misoprostol
Colesevelam,DB00930,Hypercholesterolemia,C0020443,NA,Approved,NA,NA,colesevelam
Methacycline,DB00931,Bacterial enteritis,C0152516,NA,Approved,NA,NA,methacycline
Tipranavir,DB00932,HIV Infections,C0019693,NA,Approved,NA,NA,tipranavir
Mesoridazine,DB00933,Schizophrenia,C0036341,NA,Approved,NA,NA,mesoridazine
Maprotiline,DB00934,Mixed anxiety and depressive disorder,C0338908,NA,Approved,NA,NA,maprotiline
Maprotiline,DB00934,Depressive disorder,C0011581,NA,Approved,NA,NA,maprotiline
Oxymetazoline,DB00935,Rhinorrhea,C1260880,NA,Approved,NA,NA,oxymetazoline
Oxymetazoline,DB00935,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,oxymetazoline
Oxymetazoline,DB00935,Redness of eye,C0235267,NA,Approved,NA,NA,oxymetazoline
Salicylic acid,DB00936,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,salicylic acid
Salicylic acid,DB00936,Degenerative polyarthritis,C0029408,NA,Approved,NA,NA,salicylic acid
Salicylic acid,DB00936,Hyperkeratosis,C0870082,NA,Approved,NA,NA,salicylic acid
Salicylic acid,DB00936,Fever,C0015967,NA,Approved,NA,NA,salicylic acid
Salicylic acid,DB00936,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,salicylic acid
Salicylic acid,DB00936,Scurfiness of scalp,C0423775,NA,Approved,NA,NA,salicylic acid
Salicylic acid,DB00936,Common Cold,C0009443,NA,Approved,NA,NA,salicylic acid
Salicylic acid,DB00936,Plantar wart,C0042548,NA,Approved,NA,NA,salicylic acid
Salicylic acid,DB00936,Acne Vulgaris,C0001144,NA,Approved,NA,NA,salicylic acid
Salicylic acid,DB00936,Tinea Pedis,C0040259,NA,Approved,NA,NA,salicylic acid
Salicylic acid,DB00936,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,salicylic acid
Salicylic acid,DB00936,Pain,C0030193,NA,Approved,NA,NA,salicylic acid
Salicylic acid,DB00936,Tinea corporis (disorder),C0040252,NA,Approved,NA,NA,salicylic acid
Salicylic acid,DB00936,Greasy skin,C0234925,NA,Approved,NA,NA,salicylic acid
Salicylic acid,DB00936,Synovitis,C0039103,NA,Approved,NA,NA,salicylic acid
Salicylic acid,DB00936,Disorder of keratinization,C0475811,NA,Approved,NA,NA,salicylic acid
Salicylic acid,DB00936,Corns and callus,C0157726,NA,Approved,NA,NA,salicylic acid
Salicylic acid,DB00936,Influenza-like symptoms,C0392171,NA,Approved,NA,NA,salicylic acid
Salicylic acid,DB00936,Migraine Disorders,C0149931,NA,Approved,NA,NA,salicylic acid
Salicylic acid,DB00936,Back Pain,C0004604,NA,Approved,NA,NA,salicylic acid
Salicylic acid,DB00936,Headache Disorders,C0393735,NA,Approved,NA,NA,salicylic acid
Salicylic acid,DB00936,Sinus headache,C0037195,NA,Approved,NA,NA,salicylic acid
Salicylic acid,DB00936,Toothache,C0040460,NA,Approved,NA,NA,salicylic acid
Salicylic acid,DB00936,Myocardial Infarction,C0027051,NA,Approved,NA,NA,salicylic acid
Salicylic acid,DB00936,Arthralgia,C0003862,NA,Approved,NA,NA,salicylic acid
Salicylic acid,DB00936,Arthritic pains,C0857177,NA,Approved,NA,NA,salicylic acid
Diethylpropion,DB00937,Obesity,C0028754,NA,Approved,NA,NA,diethylpropion
Salmeterol,DB00938,Intrinsic asthma,C0155880,NA,Approved,NA,NA,salmeterol
Salmeterol,DB00938,Pulmonary Emphysema,C0034067,NA,Approved,NA,NA,salmeterol
Salmeterol,DB00938,Allergic asthma,C0155877,NA,Approved,NA,NA,salmeterol
Meclofenamic acid,DB00939,Degenerative polyarthritis,C0029408,NA,Approved,NA,NA,meclofenamic acid
Meclofenamic acid,DB00939,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,meclofenamic acid
Meclofenamic acid,DB00939,Menorrhagia,C0025323,NA,Approved,NA,NA,meclofenamic acid
Meclofenamic acid,DB00939,Dysmenorrhea,C0013390,NA,Approved,NA,NA,meclofenamic acid
Meclofenamic acid,DB00939,Pain,C0030193,NA,Approved,NA,NA,meclofenamic acid
Methantheline,DB00940,Peptic Ulcer,C0030920,NA,Approved,NA,NA,methantheline
Methantheline,DB00940,Gastric ulcer,C0038358,NA,Approved,NA,NA,methantheline
Methantheline,DB00940,Urinary Incontinence,C0042024,NA,Approved,NA,NA,methantheline
Cycrimine,DB00942,Parkinson Disease,C0030567,NA,Approved,NA,NA,cycrimine
Zalcitabine,DB00943,HIV Infections,C0019693,NA,Approved,NA,NA,zalcitabine
Acetylsalicylic acid,DB00945,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,acetylsalicylic acid
Acetylsalicylic acid,DB00945,Influenza-like symptoms,C0392171,NA,Approved,NA,NA,acetylsalicylic acid
Acetylsalicylic acid,DB00945,Migraine Disorders,C0149931,NA,Approved,NA,NA,acetylsalicylic acid
Acetylsalicylic acid,DB00945,Back Pain,C0004604,NA,Approved,NA,NA,acetylsalicylic acid
Acetylsalicylic acid,DB00945,Degenerative polyarthritis,C0029408,NA,Approved,NA,NA,acetylsalicylic acid
Acetylsalicylic acid,DB00945,Headache Disorders,C0393735,NA,Approved,NA,NA,acetylsalicylic acid
Acetylsalicylic acid,DB00945,Common Cold,C0009443,NA,Approved,NA,NA,acetylsalicylic acid
Acetylsalicylic acid,DB00945,Pain,C0030193,NA,Approved,NA,NA,acetylsalicylic acid
Acetylsalicylic acid,DB00945,Sinus headache,C0037195,NA,Approved,NA,NA,acetylsalicylic acid
Acetylsalicylic acid,DB00945,Toothache,C0040460,NA,Approved,NA,NA,acetylsalicylic acid
Acetylsalicylic acid,DB00945,Myocardial Infarction,C0027051,NA,Approved,NA,NA,acetylsalicylic acid
Acetylsalicylic acid,DB00945,Arthralgia,C0003862,NA,Approved,NA,NA,acetylsalicylic acid
Acetylsalicylic acid,DB00945,Arthritic pains,C0857177,NA,Approved,NA,NA,acetylsalicylic acid
Phenprocoumon,DB00946,Thrombosis,C0040053,NA,Approved,NA,NA,phenprocoumon
Phenprocoumon,DB00946,Myocardial Infarction,C0027051,NA,Approved,NA,NA,phenprocoumon
Phenprocoumon,DB00946,Thromboembolism,C0040038,NA,Approved,NA,NA,phenprocoumon
Mezlocillin,DB00948,Bacterial sepsis,C0684256,NA,Approved,NA,NA,mezlocillin
Mezlocillin,DB00948,Urinary tract infection,C0042029,NA,Approved,NA,NA,mezlocillin
Mezlocillin,DB00948,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,mezlocillin
Mezlocillin,DB00948,Pneumonia due to Pseudomonas,C0155860,NA,Approved,NA,NA,mezlocillin
Mezlocillin,DB00948,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,mezlocillin
Mezlocillin,DB00948,Enterobacter pneumonia,C1096258,NA,Approved,NA,NA,mezlocillin
Mezlocillin,DB00948,Genitourinary tract infection,C1279247,NA,Approved,NA,NA,mezlocillin
Mezlocillin,DB00948,Serratia Infections,C0085394,NA,Approved,NA,NA,mezlocillin
Mezlocillin,DB00948,Aspiration Pneumonia,C0032290,NA,Approved,NA,NA,mezlocillin
Mezlocillin,DB00948,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,mezlocillin
Mezlocillin,DB00948,Pneumonia due to Escherichia coli,C0276089,NA,Approved,NA,NA,mezlocillin
Mezlocillin,DB00948,Acute gonococcal endometritis,C0153196,NA,Approved,NA,NA,mezlocillin
Mezlocillin,DB00948,Gonorrhea,C0018081,NA,Approved,NA,NA,mezlocillin
Mezlocillin,DB00948,Acute gonococcal cervicitis,C0153195,NA,Approved,NA,NA,mezlocillin
Mezlocillin,DB00948,Acute gonococcal urethritis,C0275652,NA,Approved,NA,NA,mezlocillin
Mezlocillin,DB00948,Bacterial infection due to Klebsiella pneumoniae,C0343402,NA,Approved,NA,NA,mezlocillin
Felbamate,DB00949,Simple Partial Seizures,C0234974,NA,Approved,NA,NA,felbamate
Felbamate,DB00949,Lennox-Gastaut syndrome,C0238111,NA,Approved,NA,NA,felbamate
Felbamate,DB00949,Epilepsy,C0014544,NA,Approved,NA,NA,felbamate
Fexofenadine,DB00950,Chronic idiopathic urticaria,C0578870,NA,Approved,NA,NA,fexofenadine
Fexofenadine,DB00950,Hay fever,C0018621,NA,Approved,NA,NA,fexofenadine
Fexofenadine,DB00950,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,fexofenadine
Fexofenadine,DB00950,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,fexofenadine
Fexofenadine,DB00950,Sneezing,C0037383,NA,Approved,NA,NA,fexofenadine
Isoniazid,DB00951,Acute tuberculosis,C0275959,NA,Approved,NA,NA,isoniazid
Isoniazid,DB00951,"Tuberculosis, Pulmonary",C0041327,NA,Approved,NA,NA,isoniazid
Naratriptan,DB00952,Migraine Disorders,C0149931,NA,Approved,NA,NA,naratriptan
Rizatriptan,DB00953,Migraine Disorders,C0149931,NA,Approved,NA,NA,rizatriptan
Dirithromycin,DB00954,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,dirithromycin
Dirithromycin,DB00954,Pharyngitis,C0031350,NA,Approved,NA,NA,dirithromycin
Dirithromycin,DB00954,Acute Moraxella catarrhalis bronchitis,C0339932,NA,Approved,NA,NA,dirithromycin
Dirithromycin,DB00954,Legionella pneumophila pneumonia,C0857846,NA,Approved,NA,NA,dirithromycin
Dirithromycin,DB00954,Streptococcal tonsillitis,C0275804,NA,Approved,NA,NA,dirithromycin
Dirithromycin,DB00954,Bronchitis,C0006277,NA,Approved,NA,NA,dirithromycin
Dirithromycin,DB00954,Tonsillitis,C0040425,NA,Approved,NA,NA,dirithromycin
Dirithromycin,DB00954,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,dirithromycin
Dirithromycin,DB00954,Pneumonia,C0032285,NA,Approved,NA,NA,dirithromycin
Dirithromycin,DB00954,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,dirithromycin
Dirithromycin,DB00954,Mycoplasma pneumonia,C0032302,NA,Approved,NA,NA,dirithromycin
Hydrocodone,DB00956,Rhinorrhea,C1260880,NA,Approved,NA,NA,hydrocodone
Hydrocodone,DB00956,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,hydrocodone
Hydrocodone,DB00956,Coughing,C0010200,NA,Approved,NA,NA,hydrocodone
Hydrocodone,DB00956,Rhinitis,C0035455,NA,Approved,NA,NA,hydrocodone
Hydrocodone,DB00956,Pain,C0030193,NA,Approved,NA,NA,hydrocodone
Hydrocodone,DB00956,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,hydrocodone
Hydrocodone,DB00956,Common Cold,C0009443,NA,Approved,NA,NA,hydrocodone
Norgestimate,DB00957,Acne Vulgaris,C0001144,NA,Approved,NA,NA,norgestimate
Norgestimate,DB00957,Atrophic Vaginitis,C0221392,NA,Approved,NA,NA,norgestimate
Norgestimate,DB00957,Atrophy of vulva,C0156393,NA,Approved,NA,NA,norgestimate
Norgestimate,DB00957,Hot flushes,C0600142,NA,Approved,NA,NA,norgestimate
Carboplatin,DB00958,Malignant neoplasm of ovary,C1140680,NA,Approved,NA,NA,carboplatin
Methylprednisolone,DB00959,Mycosis Fungoides,C0026948,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Asthma,C0004096,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Rheumatic Heart Disease,C0035439,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Pruritus Ani,C0033775,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Laryngeal Edema,C0023052,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Congenital adrenal hyperplasia,C0001627,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Dermatologic disorders,C0037274,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,"Arthritis, Psoriatic",C0003872,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Addison Disease,C0001403,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Exacerbation of asthma,C0349790,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Epicondylitis,C0014488,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Exfoliative dermatitis,C0011606,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Multiple Sclerosis,C0026769,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Lichen Simplex Chronicus,C0149922,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,"Arthritis, Gouty",C0003868,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Thyroiditis,C0040147,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Autoimmune hemolytic anemia,C0002880,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,"Lymphoma, T-Cell, Cutaneous",C0079773,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Hodgkin Disease,C0019829,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Dermatitis Herpetiformis,C0011608,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Cerebral Edema,C0006114,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,"Lymphoma, Follicular",C0024301,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Berylliosis,C0005138,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,"Lymphoma, Non-Hodgkin",C0024305,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Erythema Multiforme,C0014742,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Exanthema,C0015230,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Granuloma Annulare,C0085074,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Pruritus of genital organs,C0033777,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Acute lymphocytic leukemia,C0023449,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Synovitis,C0039103,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Tendinitis,C0039503,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Adrenogenital disorder,C0701163,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Angioedema,C0002994,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Serum Sickness,C0036830,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Post traumatic osteoarthritis,C2894027,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Scalp psoriasis,C0406326,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Humoral hypercalcemia of malignancy (disorder),C0149911,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,"Lupus Erythematosus, Discoid",C0024138,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Transplanted organ rejection,C0345468,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Acquired thrombocytopenia,C0154301,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,"Lupus Erythematosus, Systemic",C0024141,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Tenosynovitis,C0039520,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Musculoskeletal Diseases,C0026857,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Pemphigus,C0030807,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Sarcoidosis,C0036202,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Status Asthmaticus,C0038218,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Simple Pulmonary Eosinophilia,C0242459,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Contact Dermatitis,C0011616,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Trichinellosis,C0040896,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,"Anemia, Diamond-Blackfan",C1260899,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Adrenal cortical hypofunction,C0405580,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Nephrotic Syndrome,C0027726,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Ankylosing spondylitis,C0038013,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Bursitis,C0006444,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Crohn Disease,C0010346,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Autoimmune Diseases,C0004364,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Psoriasis,C0033860,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,"Tuberculosis, Miliary",C0041321,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Addisonian crisis,C0151467,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Disorder of eye,C0015397,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Inflammatory Bowel Diseases,C0021390,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Cooley's anemia,C0002875,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Aspiration pneumonitis,C1761609,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,"Dermatitis, Atopic",C0011615,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,Hay fever,C0018621,NA,Approved,NA,NA,methylprednisolone
Methylprednisolone,DB00959,"Rhinitis, Allergic, Perennial",C0035457,NA,Approved,NA,NA,methylprednisolone
Pindolol,DB00960,Hypertensive disease,C0020538,NA,Approved,NA,NA,pindolol
Zaleplon,DB00962,Initial insomnia,C0393760,NA,Approved,NA,NA,zaleplon
Zaleplon,DB00962,Sleep Initiation and Maintenance Disorders,C0021603,NA,Approved,NA,NA,zaleplon
Bromfenac,DB00963,Pain,C0030193,NA,Approved,NA,NA,bromfenac
Apraclonidine,DB00964,Cerebrovascular Occlusion,C0596298,NA,Approved,NA,NA,apraclonidine
Apraclonidine,DB00964,"Glaucoma, Open-Angle",C0017612,NA,Approved,NA,NA,apraclonidine
Telmisartan,DB00966,Hypertensive disease,C0020538,NA,Approved,NA,NA,telmisartan
Telmisartan,DB00966,Cerebrovascular accident,C0038454,NA,Approved,NA,NA,telmisartan
Desloratadine,DB00967,Chronic idiopathic urticaria,C0578870,NA,Approved,NA,NA,desloratadine
Desloratadine,DB00967,"Rhinitis, Vasomotor",C0035460,NA,Approved,NA,NA,desloratadine
Desloratadine,DB00967,Hay fever,C0018621,NA,Approved,NA,NA,desloratadine
Desloratadine,DB00967,Sneezing,C0037383,NA,Approved,NA,NA,desloratadine
Desloratadine,DB00967,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,desloratadine
Desloratadine,DB00967,Common Cold,C0009443,NA,Approved,NA,NA,desloratadine
Desloratadine,DB00967,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,desloratadine
Desloratadine,DB00967,Rhinorrhea,C1260880,NA,Approved,NA,NA,desloratadine
Desloratadine,DB00967,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,desloratadine
Desloratadine,DB00967,Allergic urticaria,C0149526,NA,Approved,NA,NA,desloratadine
Methyldopa,DB00968,Hypertensive disease,C0020538,NA,Approved,NA,NA,methyldopa
Alosetron,DB00969,Irritable bowel syndrome with diarrhea,C0348898,NA,Approved,NA,NA,alosetron
Alosetron,DB00969,Diarrhoea predominant irritable bowel syndrome,C1262211,NA,Approved,NA,NA,alosetron
Dactinomycin,DB00970,Gestational Trophoblastic Neoplasms,C1135868,NA,Approved,NA,NA,dactinomycin
Dactinomycin,DB00970,Nephroblastoma,C0027708,NA,Approved,NA,NA,dactinomycin
Dactinomycin,DB00970,Rhabdomyosarcoma,C0035412,NA,Approved,NA,NA,dactinomycin
Dactinomycin,DB00970,Ewings sarcoma,C0553580,NA,Approved,NA,NA,dactinomycin
Selenium Sulfide,DB00971,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,selenium sulfide
Selenium Sulfide,DB00971,Scurfiness of scalp,C0423775,NA,Approved,NA,NA,selenium sulfide
Selenium Sulfide,DB00971,Tinea Versicolor,C0040262,NA,Approved,NA,NA,selenium sulfide
Azelastine,DB00972,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,azelastine
Azelastine,DB00972,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,azelastine
Azelastine,DB00972,"Rhinitis, Vasomotor",C0035460,NA,Approved,NA,NA,azelastine
Azelastine,DB00972,Hay fever,C0018621,NA,Approved,NA,NA,azelastine
Ezetimibe,DB00973,"Hyperlipidemia, Familial Combined",C0020474,NA,Approved,NA,NA,ezetimibe
Ezetimibe,DB00973,Familial hypercholesterolemia - homozygous,C0342881,NA,Approved,NA,NA,ezetimibe
Ezetimibe,DB00973,Hypercholesterolemia,C0020443,NA,Approved,NA,NA,ezetimibe
Ezetimibe,DB00973,Familial hypercholesterolemia - heterozygous,C0342882,NA,Approved,NA,NA,ezetimibe
Ezetimibe,DB00973,Hyperlipidemia,C0020473,NA,Approved,NA,NA,ezetimibe
Ezetimibe,DB00973,Sitosterolemia,C0342907,NA,Approved,NA,NA,ezetimibe
Edetic Acid,DB00974,Accidental poisoning by lead and its compounds and fumes,C0261486,NA,Approved,NA,NA,edetic acid
Edetic Acid,DB00974,Hypercalcemia,C0020437,NA,Approved,NA,NA,edetic acid
Dipyridamole,DB00975,Chronic heart failure,C0264716,NA,Approved,NA,NA,dipyridamole
Dipyridamole,DB00975,Atrial Fibrillation,C0004238,NA,Approved,NA,NA,dipyridamole
Dipyridamole,DB00975,Platelet aggregation inhibition,C0919737,NA,Approved,NA,NA,dipyridamole
Telithromycin,DB00976,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,telithromycin
Telithromycin,DB00976,Moraxella catarrhalis pneumonia,C0857831,NA,Approved,NA,NA,telithromycin
Telithromycin,DB00976,Mycoplasma pneumonia,C0032302,NA,Approved,NA,NA,telithromycin
Telithromycin,DB00976,Chlamydial pneumonia,C0339959,NA,Approved,NA,NA,telithromycin
Telithromycin,DB00976,Streptococcal pneumonia,C0155862,NA,Approved,NA,NA,telithromycin
Ethinyl Estradiol,DB00977,Premenstrual Dysphoric Disorder,C0520676,NA,Approved,NA,NA,ethinyl estradiol
Ethinyl Estradiol,DB00977,Atrophy of vulva,C0156393,NA,Approved,NA,NA,ethinyl estradiol
Ethinyl Estradiol,DB00977,Hot flushes,C0600142,NA,Approved,NA,NA,ethinyl estradiol
Ethinyl Estradiol,DB00977,Acne Vulgaris,C0001144,NA,Approved,NA,NA,ethinyl estradiol
Ethinyl Estradiol,DB00977,Atrophic Vaginitis,C0221392,NA,Approved,NA,NA,ethinyl estradiol
Lomefloxacin,DB00978,Acute exacerbation of chronic bronchitis,C0856695,NA,Approved,NA,NA,lomefloxacin
Lomefloxacin,DB00978,Cystitis escherichia,C0853852,NA,Approved,NA,NA,lomefloxacin
Lomefloxacin,DB00978,Urinary tract infection,C0042029,NA,Approved,NA,NA,lomefloxacin
Lomefloxacin,DB00978,Bronchitis,C0006277,NA,Approved,NA,NA,lomefloxacin
Lomefloxacin,DB00978,Lower respiratory tract infection,C0149725,NA,Approved,NA,NA,lomefloxacin
Cyclopentolate,DB00979,Cycloplegia,C0235238,NA,Approved,NA,NA,cyclopentolate
Cyclopentolate,DB00979,Mydriasis,C0026961,NA,Approved,NA,NA,cyclopentolate
Ramelteon,DB00980,Initial insomnia,C0393760,NA,Approved,NA,NA,ramelteon
Physostigmine,DB00981,anticholinergic toxicity,C0237996,NA,Approved,NA,NA,physostigmine
Physostigmine,DB00981,"Glaucoma, Open-Angle",C0017612,NA,Approved,NA,NA,physostigmine
Isotretinoin,DB00982,Hypertensive disease,C0020538,NA,Approved,NA,NA,isotretinoin
Formoterol,DB00983,Intrinsic asthma,C0155880,NA,Approved,NA,NA,formoterol
Formoterol,DB00983,Pulmonary Emphysema,C0034067,NA,Approved,NA,NA,formoterol
Formoterol,DB00983,Allergic asthma,C0155877,NA,Approved,NA,NA,formoterol
Dimenhydrinate,DB00985,Vomiting,C0042963,NA,Approved,NA,NA,dimenhydrinate
Dimenhydrinate,DB00985,Motion Sickness,C0026603,NA,Approved,NA,NA,dimenhydrinate
Dimenhydrinate,DB00985,Nausea,C0027497,NA,Approved,NA,NA,dimenhydrinate
Dimenhydrinate,DB00985,Vertigo,C0042571,NA,Approved,NA,NA,dimenhydrinate
Dimenhydrinate,DB00985,Nausea and vomiting,C0027498,NA,Approved,NA,NA,dimenhydrinate
Glycopyrronium,DB00986,Peptic Ulcer,C0030920,NA,Approved,NA,NA,glycopyrronium
Glycopyrronium,DB00986,Sialorrhea,C0037036,NA,Approved,NA,NA,glycopyrronium
Glycopyrronium,DB00986,Chronic Obstructive Airway Disease,C0024117,NA,Approved,NA,NA,glycopyrronium
Cytarabine,DB00987,Meningeal Leukemia,C0948840,NA,Approved,NA,NA,cytarabine
Cytarabine,DB00987,Metastatic Malignant Neoplasm to the Leptomeninges,C1704231,NA,Approved,NA,NA,cytarabine
Cytarabine,DB00987,Acute Promyelocytic Leukemia,C0023487,NA,Approved,NA,NA,cytarabine
Cytarabine,DB00987,"Leukemia, Myelocytic, Acute",C0023467,NA,Approved,NA,NA,cytarabine
Cytarabine,DB00987,Acute lymphocytic leukemia,C0023449,NA,Approved,NA,NA,cytarabine
Dopamine,DB00988,Low Cardiac Output Syndrome,C0600177,NA,Approved,NA,NA,dopamine
Dopamine,DB00988,Hypotension,C0020649,NA,Approved,NA,NA,dopamine
Dopamine,DB00988,Decompensated cardiac failure,C0581377,NA,Approved,NA,NA,dopamine
Dopamine,DB00988,"Parkinson Disease, Postencephalitic",C0030568,NA,Approved,NA,NA,dopamine
Dopamine,DB00988,Parkinsonian Disorders,C0242422,NA,Approved,NA,NA,dopamine
Dopamine,DB00988,Parkinson Disease,C0030567,NA,Approved,NA,NA,dopamine
Rivastigmine,DB00989,Alzheimer's Disease,C0002395,NA,Approved,NA,NA,rivastigmine
Rivastigmine,DB00989,Dementia associated with Parkinson's Disease,C1828079,NA,Approved,NA,NA,rivastigmine
Oxaprozin,DB00991,Degenerative polyarthritis,C0029408,NA,Approved,NA,NA,oxaprozin
Oxaprozin,DB00991,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,oxaprozin
Azathioprine,DB00993,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,azathioprine
Neomycin,DB00994,Urinary tract infection,C0042029,NA,Approved,NA,NA,neomycin
Neomycin,DB00994,Otitis Externa,C0029878,NA,Approved,NA,NA,neomycin
Neomycin,DB00994,Blepharoconjunctivitis,C0005743,NA,Approved,NA,NA,neomycin
Neomycin,DB00994,Hepatic Encephalopathy,C0019151,NA,Approved,NA,NA,neomycin
Neomycin,DB00994,Hepatic Coma,C0019147,NA,Approved,NA,NA,neomycin
Neomycin,DB00994,Keratitis,C0022568,NA,Approved,NA,NA,neomycin
Neomycin,DB00994,Uveitis,C0042164,NA,Approved,NA,NA,neomycin
Neomycin,DB00994,Infective blepharitis,C0729587,NA,Approved,NA,NA,neomycin
Neomycin,DB00994,Corneal abrasion,C0010032,NA,Approved,NA,NA,neomycin
Neomycin,DB00994,Bacterial keratitis,C0854211,NA,Approved,NA,NA,neomycin
Auranofin,DB00995,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,auranofin
Gabapentin,DB00996,Postherpetic neuralgia,C0032768,NA,Approved,NA,NA,gabapentin
Gabapentin,DB00996,Restless Legs Syndrome,C0035258,NA,Approved,NA,NA,gabapentin
Doxorubicin,DB00997,Hodgkin Disease,C0019829,NA,Approved,NA,NA,doxorubicin
Doxorubicin,DB00997,Carcinoma breast stage IV,C0278488,NA,Approved,NA,NA,doxorubicin
Doxorubicin,DB00997,Malignant epithelial neoplasm of female breast,C3163805,NA,Approved,NA,NA,doxorubicin
Doxorubicin,DB00997,Multiple Myeloma,C0026764,NA,Approved,NA,NA,doxorubicin
Doxorubicin,DB00997,Osteosarcoma of bone,C0585442,NA,Approved,NA,NA,doxorubicin
Doxorubicin,DB00997,AIDS with Kaposi's sarcoma,C0276535,NA,Approved,NA,NA,doxorubicin
Doxorubicin,DB00997,Diffuse Large B-Cell Lymphoma,C0079744,NA,Approved,NA,NA,doxorubicin
Doxorubicin,DB00997,"Lymphoma, Follicular",C0024301,NA,Approved,NA,NA,doxorubicin
Doxorubicin,DB00997,"Leukemia, Myelocytic, Acute",C0023467,NA,Approved,NA,NA,doxorubicin
Doxorubicin,DB00997,Nephroblastoma,C0027708,NA,Approved,NA,NA,doxorubicin
Doxorubicin,DB00997,"Lymphoma, Non-Hodgkin",C0024305,NA,Approved,NA,NA,doxorubicin
Doxorubicin,DB00997,Breast Carcinoma,C0678222,NA,Approved,NA,NA,doxorubicin
Doxorubicin,DB00997,Malignant neoplasm of lung,C0242379,NA,Approved,NA,NA,doxorubicin
Doxorubicin,DB00997,Small cell carcinoma of lung,C0149925,NA,Approved,NA,NA,doxorubicin
Doxorubicin,DB00997,Acute lymphocytic leukemia,C0023449,NA,Approved,NA,NA,doxorubicin
Doxorubicin,DB00997,Burkitt Lymphoma,C0006413,NA,Approved,NA,NA,doxorubicin
Doxorubicin,DB00997,Malignant neoplasm of stomach stage IV,C0278498,NA,Approved,NA,NA,doxorubicin
Doxorubicin,DB00997,Malignant neoplasm of thyroid,C0007115,NA,Approved,NA,NA,doxorubicin
Doxorubicin,DB00997,Kaposi Sarcoma,C0036220,NA,Approved,NA,NA,doxorubicin
Doxorubicin,DB00997,Neuroblastoma,C0027819,NA,Approved,NA,NA,doxorubicin
Doxorubicin,DB00997,Malignant neoplasm of ovary,C1140680,NA,Approved,NA,NA,doxorubicin
Frovatriptan,DB00998,Migraine Disorders,C0149931,NA,Approved,NA,NA,frovatriptan
Hydrochlorothiazide,DB00999,Hypertensive urgency,C0745138,NA,Approved,NA,NA,hydrochlorothiazide
Hydrochlorothiazide,DB00999,Hypertensive disease,C0020538,NA,Approved,NA,NA,hydrochlorothiazide
Hydrochlorothiazide,DB00999,Edema,C0013604,NA,Approved,NA,NA,hydrochlorothiazide
Hydrochlorothiazide,DB00999,Chronic heart failure,C0264716,NA,Approved,NA,NA,hydrochlorothiazide
Cyclacillin,DB01000,Pharyngitis,C0031350,NA,Approved,NA,NA,cyclacillin
Cyclacillin,DB01000,Urinary tract infection,C0042029,NA,Approved,NA,NA,cyclacillin
Cyclacillin,DB01000,Bronchitis,C0006277,NA,Approved,NA,NA,cyclacillin
Cyclacillin,DB01000,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,cyclacillin
Cyclacillin,DB01000,Infective otitis media,C0729586,NA,Approved,NA,NA,cyclacillin
Salbutamol,DB01001,Bronchial Spasm,C0006266,NA,Approved,NA,NA,salbutamol
Salbutamol,DB01001,Asthma attack,C0347950,NA,Approved,NA,NA,salbutamol
Cromoglicic acid,DB01003,Asthma,C0004096,NA,Approved,NA,NA,cromoglicic acid
Cromoglicic acid,DB01003,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,cromoglicic acid
Cromoglicic acid,DB01003,"Conjunctivitis, Giant Papillary",C0009769,NA,Approved,NA,NA,cromoglicic acid
Cromoglicic acid,DB01003,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,cromoglicic acid
Cromoglicic acid,DB01003,"Conjunctivitis, Vernal",C0009773,NA,Approved,NA,NA,cromoglicic acid
Cromoglicic acid,DB01003,Allergic keratoconjunctivitis,C1112631,NA,Approved,NA,NA,cromoglicic acid
Cromoglicic acid,DB01003,"Keratoconjunctivitis, Vernal",C0022577,NA,Approved,NA,NA,cromoglicic acid
Cromoglicic acid,DB01003,"Mastocytosis, Systemic",C0221013,NA,Approved,NA,NA,cromoglicic acid
Ganciclovir,DB01004,"Keratitis, Dendritic",C0022570,NA,Approved,NA,NA,ganciclovir
Ganciclovir,DB01004,Paroxysmal supraventricular tachycardia,C0030590,NA,Approved,NA,NA,ganciclovir
Ganciclovir,DB01004,Cytomegalovirus Retinitis,C0206178,NA,Approved,NA,NA,ganciclovir
Hydroxyurea,DB01005,Cancer of Head and Neck,C0278996,NA,Approved,NA,NA,hydroxyurea
Hydroxyurea,DB01005,Hemoglobin SS disease with crisis,C0238425,NA,Approved,NA,NA,hydroxyurea
Hydroxyurea,DB01005,"Myeloid Leukemia, Chronic",C0023473,NA,Approved,NA,NA,hydroxyurea
Hydroxyurea,DB01005,Malignant neoplasm of ovary,C1140680,NA,Approved,NA,NA,hydroxyurea
Hydroxyurea,DB01005,"Anemia, Sickle Cell",C0002895,NA,Approved,NA,NA,hydroxyurea
Hydroxyurea,DB01005,melanoma,C0025202,NA,Approved,NA,NA,hydroxyurea
Tioconazole,DB01007,"Candidiasis, Vulvovaginal",C0700345,NA,Approved,NA,NA,tioconazole
Busulfan,DB01008,Philadelphia chromosome positive chronic myelogenous leukemia,C0279543,NA,Approved,NA,NA,busulfan
Ketoprofen,DB01009,Degenerative polyarthritis,C0029408,NA,Approved,NA,NA,ketoprofen
Ketoprofen,DB01009,Pain,C0030193,NA,Approved,NA,NA,ketoprofen
Ketoprofen,DB01009,Dysmenorrhea,C0013390,NA,Approved,NA,NA,ketoprofen
Ketoprofen,DB01009,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,ketoprofen
Clobetasol propionate,DB01013,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,clobetasol propionate
Clobetasol propionate,DB01013,Contact Dermatitis,C0011616,NA,Approved,NA,NA,clobetasol propionate
Clobetasol propionate,DB01013,Scalp psoriasis,C0406326,NA,Approved,NA,NA,clobetasol propionate
Clobetasol propionate,DB01013,Inflammatory dermatosis,C3875321,NA,Approved,NA,NA,clobetasol propionate
Clobetasol propionate,DB01013,Scalp Dermatoses,C0036271,NA,Approved,NA,NA,clobetasol propionate
Clobetasol propionate,DB01013,Nummular eczema,C0085656,NA,Approved,NA,NA,clobetasol propionate
Clobetasol propionate,DB01013,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,clobetasol propionate
Balsalazide,DB01014,Ulcerative Colitis,C0009324,NA,Approved,NA,NA,balsalazide
Sulfamethoxazole,DB01015,Shigella Infections,C0013371,NA,Approved,NA,NA,sulfamethoxazole
Sulfamethoxazole,DB01015,Infective otitis media,C0729586,NA,Approved,NA,NA,sulfamethoxazole
Sulfamethoxazole,DB01015,Toxoplasmosis,C0040558,NA,Approved,NA,NA,sulfamethoxazole
Sulfamethoxazole,DB01015,Klebsiella cystitis,C0520775,NA,Approved,NA,NA,sulfamethoxazole
Sulfamethoxazole,DB01015,Proteus urinary tract infection,C0577709,NA,Approved,NA,NA,sulfamethoxazole
Sulfamethoxazole,DB01015,Nocardia Infections,C0028242,NA,Approved,NA,NA,sulfamethoxazole
Sulfamethoxazole,DB01015,Bacterial urinary infection,C0729524,NA,Approved,NA,NA,sulfamethoxazole
Sulfamethoxazole,DB01015,Acute exacerbation of chronic bronchitis,C0856695,NA,Approved,NA,NA,sulfamethoxazole
Sulfamethoxazole,DB01015,Acute otitis media,C0271429,NA,Approved,NA,NA,sulfamethoxazole
Sulfamethoxazole,DB01015,Inclusion conjunctivitis,C0009770,NA,Approved,NA,NA,sulfamethoxazole
Sulfamethoxazole,DB01015,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,sulfamethoxazole
Glyburide,DB01016,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,glyburide
Minocycline,DB01017,Bronchitis,C0006277,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Infection by Campylobacter fetus,C0275979,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,TYPHUS,C0041471,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Listeriosis,C0023860,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Plague,C0032064,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Cholera,C0008354,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Acute gonococcal endometritis,C0153196,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Gonorrhea of pharynx,C0149966,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Relapsing Fever,C0035021,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Meningococcus carrier,C0421162,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Psittacosis,C0029291,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Acne Vulgaris,C0001144,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Actinomycosis,C0001261,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Syphilis,C0039128,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Infective otitis media,C0729586,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Brucellosis,C0006309,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Lymphogranuloma Venereum,C0024286,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Periodontitis,C0031099,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Granuloma Inguinale,C0018190,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Sinusitis,C0037199,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Chlamydia trachomatis infection of genital structure,C1997322,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Gonorrhea of rectum,C0275665,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Acute gonococcal urethritis,C0275652,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Gonorrhea,C0018081,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Fusospirochetal pharyngitis,C1318559,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Rocky Mountain Spotted Fever,C0035793,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Chancroids,C0007947,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Trachoma,C0040592,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Tularemia,C0041351,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Pharyngitis,C0031350,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Gingivostomatitis,C0149704,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Q Fever,C0034362,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Acute gonococcal cervicitis,C0153195,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Urinary tract infection,C0042029,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Bartonella Infections,C0004771,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Yaws,C0043388,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Rickettsialpox,C0035597,NA,Approved,NA,NA,minocycline
Minocycline,DB01017,Pneumonia,C0032285,NA,Approved,NA,NA,minocycline
Guanfacine,DB01018,Hypertensive disease,C0020538,NA,Approved,NA,NA,guanfacine
Guanfacine,DB01018,Attention deficit hyperactivity disorder,C1263846,NA,Approved,NA,NA,guanfacine
Bethanechol,DB01019,Urinary Retention,C0080274,NA,Approved,NA,NA,bethanechol
Isosorbide Mononitrate,DB01020,Angina Pectoris,C0002962,NA,Approved,NA,NA,isosorbide mononitrate
Trichlormethiazide,DB01021,Hypertensive disease,C0020538,NA,Approved,NA,NA,trichlormethiazide
Phylloquinone,DB01022,Hypocalcemia,C0020598,NA,Approved,NA,NA,phylloquinone
Phylloquinone,DB01022,Osteoporosis,C0029456,NA,Approved,NA,NA,phylloquinone
Phylloquinone,DB01022,Factor II deficiency,C3203356,NA,Approved,NA,NA,phylloquinone
Felodipine,DB01023,Hypertensive disease,C0020538,NA,Approved,NA,NA,felodipine
Amlexanox,DB01025,Aphthous Stomatitis,C0038363,NA,Approved,NA,NA,amlexanox
Ketoconazole,DB01026,Oral candidiasis,C0006849,NA,Approved,NA,NA,ketoconazole
Ketoconazole,DB01026,Scurfiness of scalp,C0423775,NA,Approved,NA,NA,ketoconazole
Ketoconazole,DB01026,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,ketoconazole
Ketoconazole,DB01026,Coccidioidomycosis,C0009186,NA,Approved,NA,NA,ketoconazole
Ketoconazole,DB01026,Chromoblastomycosis,C0008582,NA,Approved,NA,NA,ketoconazole
Ketoconazole,DB01026,Histoplasmosis,C0019655,NA,Approved,NA,NA,ketoconazole
Ketoconazole,DB01026,Tinea Versicolor,C0040262,NA,Approved,NA,NA,ketoconazole
Ketoconazole,DB01026,Paracoccidioidomycosis,C0030409,NA,Approved,NA,NA,ketoconazole
Ketoconazole,DB01026,Systemic candidiasis,C0153252,NA,Approved,NA,NA,ketoconazole
Ketoconazole,DB01026,Tinea cruris,C1384589,NA,Approved,NA,NA,ketoconazole
Ketoconazole,DB01026,Cutaneous Candidiasis,C0006846,NA,Approved,NA,NA,ketoconazole
Ketoconazole,DB01026,Tinea corporis (disorder),C0040252,NA,Approved,NA,NA,ketoconazole
Ketoconazole,DB01026,Blastomycosis,C0005716,NA,Approved,NA,NA,ketoconazole
Ketoconazole,DB01026,Tinea Pedis,C0040259,NA,Approved,NA,NA,ketoconazole
Ketoconazole,DB01026,Adrenal Gland Hyperfunction,C0001622,NA,Approved,NA,NA,ketoconazole
Irbesartan,DB01029,Hypertensive disease,C0020538,NA,Approved,NA,NA,irbesartan
Irbesartan,DB01029,Diabetic Nephropathy,C0011881,NA,Approved,NA,NA,irbesartan
Topotecan,DB01030,Malignant neoplasm of ovary,C1140680,NA,Approved,NA,NA,topotecan
Topotecan,DB01030,Small cell carcinoma of lung,C0149925,NA,Approved,NA,NA,topotecan
Topotecan,DB01030,Malignant tumor of cervix,C0007847,NA,Approved,NA,NA,topotecan
Ethinamate,DB01031,Sleeplessness,C0917801,NA,Approved,NA,NA,ethinamate
Probenecid,DB01032,Acute gonococcal endometritis,C0153196,NA,Approved,NA,NA,probenecid
Probenecid,DB01032,"Arthritis, Gouty",C0003868,NA,Approved,NA,NA,probenecid
Probenecid,DB01032,Acute gonococcal urethritis,C0275652,NA,Approved,NA,NA,probenecid
Probenecid,DB01032,Acute gonococcal cervicitis,C0153195,NA,Approved,NA,NA,probenecid
Probenecid,DB01032,Gonorrhea,C0018081,NA,Approved,NA,NA,probenecid
Probenecid,DB01032,Chronic gouty arthritis,C0268108,NA,Approved,NA,NA,probenecid
Probenecid,DB01032,Hyperuricemia,C0740394,NA,Approved,NA,NA,probenecid
Probenecid,DB01032,Gonorrhea of rectum,C0275665,NA,Approved,NA,NA,probenecid
Mercaptopurine,DB01033,Acute Promyelocytic Leukemia,C0023487,NA,Approved,NA,NA,mercaptopurine
Mercaptopurine,DB01033,Acute lymphocytic leukemia,C0023449,NA,Approved,NA,NA,mercaptopurine
Tolterodine,DB01036,Increased frequency of micturition,C0042023,NA,Approved,NA,NA,tolterodine
Tolterodine,DB01036,Urge Incontinence,C0150045,NA,Approved,NA,NA,tolterodine
Tolterodine,DB01036,Urgency of micturition,C0085606,NA,Approved,NA,NA,tolterodine
Tolterodine,DB01036,Bladder muscle dysfunction - overactive,C0403643,NA,Approved,NA,NA,tolterodine
Selegiline,DB01037,Major Depressive Disorder,C1269683,NA,Approved,NA,NA,selegiline
Selegiline,DB01037,Parkinson Disease,C0030567,NA,Approved,NA,NA,selegiline
Fenofibrate,DB01039,Hypercholesterolemia,C0020443,NA,Approved,NA,NA,fenofibrate
Fenofibrate,DB01039,Hyperlipidemia,C0020473,NA,Approved,NA,NA,fenofibrate
Fenofibrate,DB01039,Hypertriglyceridemia,C0020557,NA,Approved,NA,NA,fenofibrate
Fenofibrate,DB01039,"Hyperlipidemia, Familial Combined",C0020474,NA,Approved,NA,NA,fenofibrate
Fenofibrate,DB01039,Hypoalphalipoproteinemias,C0473527,NA,Approved,NA,NA,fenofibrate
Fenofibrate,DB01039,Familial hypercholesterolemia - heterozygous,C0342882,NA,Approved,NA,NA,fenofibrate
Thalidomide,DB01041,Multiple Myeloma,C0026764,NA,Approved,NA,NA,thalidomide
Thalidomide,DB01041,Erythema nodosum leprosum,C0343467,NA,Approved,NA,NA,thalidomide
Melphalan,DB01042,Malignant neoplasm of ovary,C1140680,NA,Approved,NA,NA,melphalan
Melphalan,DB01042,Multiple Myeloma,C0026764,NA,Approved,NA,NA,melphalan
Gatifloxacin,DB01044,Acute exacerbation of chronic bronchitis,C0856695,NA,Approved,NA,NA,gatifloxacin
Gatifloxacin,DB01044,Moraxella catarrhalis pneumonia,C0857831,NA,Approved,NA,NA,gatifloxacin
Gatifloxacin,DB01044,Bacterial conjunctivitis,C0009768,NA,Approved,NA,NA,gatifloxacin
Gatifloxacin,DB01044,Legionella pneumophila pneumonia,C0857846,NA,Approved,NA,NA,gatifloxacin
Gatifloxacin,DB01044,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,gatifloxacin
Gatifloxacin,DB01044,Streptococcal pneumonia,C0155862,NA,Approved,NA,NA,gatifloxacin
Gatifloxacin,DB01044,Chlamydial pneumonia,C0339959,NA,Approved,NA,NA,gatifloxacin
Gatifloxacin,DB01044,Acute gonococcal urethritis,C0275652,NA,Approved,NA,NA,gatifloxacin
Gatifloxacin,DB01044,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,gatifloxacin
Gatifloxacin,DB01044,Staphylococcal Pneumonia,C0032308,NA,Approved,NA,NA,gatifloxacin
Gatifloxacin,DB01044,Gonorrhea of rectum,C0275665,NA,Approved,NA,NA,gatifloxacin
Gatifloxacin,DB01044,PYELONEPHRITIS E COLI,C0748196,NA,Approved,NA,NA,gatifloxacin
Gatifloxacin,DB01044,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,gatifloxacin
Gatifloxacin,DB01044,Acute gonococcal cervicitis,C0153195,NA,Approved,NA,NA,gatifloxacin
Gatifloxacin,DB01044,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,gatifloxacin
Gatifloxacin,DB01044,Mycoplasma pneumonia,C0032302,NA,Approved,NA,NA,gatifloxacin
Gatifloxacin,DB01044,Klebsiella cystitis,C0520775,NA,Approved,NA,NA,gatifloxacin
Gatifloxacin,DB01044,Haemophilus parainfluenzae pneumonia,C0877633,NA,Approved,NA,NA,gatifloxacin
Gatifloxacin,DB01044,Proteus urinary tract infection,C0577709,NA,Approved,NA,NA,gatifloxacin
Rifampicin,DB01045,Acute tuberculosis,C0275959,NA,Approved,NA,NA,rifampicin
Rifampicin,DB01045,Meningococcus carrier,C0421162,NA,Approved,NA,NA,rifampicin
Rifampicin,DB01045,"Tuberculosis, Pulmonary",C0041327,NA,Approved,NA,NA,rifampicin
Lubiprostone,DB01046,Chronic idiopathic constipation,C0267509,NA,Approved,NA,NA,lubiprostone
Lubiprostone,DB01046,Irritable bowel syndrome characterized by constipation,C1868889,NA,Approved,NA,NA,lubiprostone
Fluocinonide,DB01047,Lichen Simplex Chronicus,C0149922,NA,Approved,NA,NA,fluocinonide
Fluocinonide,DB01047,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,fluocinonide
Fluocinonide,DB01047,Scalp psoriasis,C0406326,NA,Approved,NA,NA,fluocinonide
Fluocinonide,DB01047,Contact Dermatitis,C0011616,NA,Approved,NA,NA,fluocinonide
Fluocinonide,DB01047,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,fluocinonide
Fluocinonide,DB01047,Pruritus of genital organs,C0033777,NA,Approved,NA,NA,fluocinonide
Fluocinonide,DB01047,Inflammatory dermatosis,C3875321,NA,Approved,NA,NA,fluocinonide
Fluocinonide,DB01047,Granuloma Annulare,C0085074,NA,Approved,NA,NA,fluocinonide
Fluocinonide,DB01047,Exanthema,C0015230,NA,Approved,NA,NA,fluocinonide
Fluocinonide,DB01047,Pruritus Ani,C0033775,NA,Approved,NA,NA,fluocinonide
Fluocinonide,DB01047,"Lupus Erythematosus, Discoid",C0024138,NA,Approved,NA,NA,fluocinonide
Fluocinonide,DB01047,"Lymphoma, T-Cell, Cutaneous",C0079773,NA,Approved,NA,NA,fluocinonide
Abacavir,DB01048,HIV Infections,C0019693,NA,Approved,NA,NA,abacavir
Ergoloid mesylate,DB01049,Dementia,C0497327,NA,Approved,NA,NA,ergoloid mesylate
Ibuprofen,DB01050,Influenza-like symptoms,C0392171,NA,Approved,NA,NA,ibuprofen
Ibuprofen,DB01050,Severe pain,C0278140,NA,Approved,NA,NA,ibuprofen
Ibuprofen,DB01050,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,ibuprofen
Ibuprofen,DB01050,Acute postoperative pain,C2215257,NA,Approved,NA,NA,ibuprofen
Ibuprofen,DB01050,Pain,C0030193,NA,Approved,NA,NA,ibuprofen
Ibuprofen,DB01050,Fever,C0015967,NA,Approved,NA,NA,ibuprofen
Ibuprofen,DB01050,Headache Disorders,C0393735,NA,Approved,NA,NA,ibuprofen
Ibuprofen,DB01050,Dysmenorrhea,C0013390,NA,Approved,NA,NA,ibuprofen
Ibuprofen,DB01050,Degenerative polyarthritis,C0029408,NA,Approved,NA,NA,ibuprofen
Ibuprofen,DB01050,Sinus headache,C0037195,NA,Approved,NA,NA,ibuprofen
Benzylpenicillin,DB01053,Septicemia due to enterococcus,C0588233,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Streptococcal toxic shock syndrome,C0343532,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Botulism,C0006057,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Gonococcal joint infection,C0153216,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,"Syphilis, Congenital",C0039131,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Neurosyphilis,C0027927,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Neonatal meningitis,C0456107,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,"Syphilis, secondary",C0149985,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Pasteurella Infections,C0030636,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Yaws,C0043388,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Infection by Pasteurella multocida,C1260911,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Gingivostomatitis,C0149704,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Abdominal actinomycosis,C0001263,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Latent yaws,C0153240,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Tetanus,C0039614,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Infection due to Erysipelothrix rhusiopathiae (disorder),C1276801,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Acute otitis media,C0271429,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Cutaneous anthrax,C0003177,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Late latent syphilis,C1260915,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Meningococcal meningitis,C0025294,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Listerial endocarditis,C0348868,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Rat-Bite Fever,C0034686,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Streptococcal meningitis,C0154639,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,"Syphilis, Latent",C0039133,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Granulomatosis infantiseptica,C1535478,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Pulmonary actinomycosis,C0275566,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Upper Respiratory Infections,C0041912,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,"Meningitis, Pneumococcal",C0025295,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Anthrax sepsis,C0152946,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Pinta,C0031946,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Streptococcal Infections,C0038395,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Streptococcal pneumonia,C0155862,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Bejel,C0004945,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,"Pneumonia, Necrotizing",C0264515,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Cervicofacial actinomycosis,C0001264,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Lung Abscess,C0024110,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Syphilis,C0039128,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Infective otitis media,C0729586,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,"Syphilis, tertiary",C0153188,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Streptococcal tonsillitis,C0275804,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Erysipelas,C0014733,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Primary genital syphilis,C0017418,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,GONOCOCCAL INFECTION DISSEMINATED,C0744451,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Anthrax disease,C0003175,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Sepsis of the newborn,C0456103,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,"Early latent syphilis, positive serology, negative cerebrospinal fluid, less than 2 years after infection",C0275842,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Fusospirochetal pharyngitis,C1318559,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Bacterial Endocarditis,C0014121,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Gas gangrene caused by clostridium perfringens,C0343500,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Scarlet Fever,C0036285,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Neonatal pneumonia,C0339968,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,"Meningitis, Listeria",C0025293,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Gastrointestinal anthrax,C0152945,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Streptococcal endocarditis,C3665800,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Tertiary lesion of yaws,C0343833,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Inhalational anthrax,C0155866,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Pharyngitis,C0031350,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Actinomycosis,C0001261,NA,Approved,NA,NA,benzylpenicillin
Benzylpenicillin,DB01053,Meningococcemia,C0025306,NA,Approved,NA,NA,benzylpenicillin
Tocainide,DB01056,Ventricular arrhythmia,C0085612,NA,Approved,NA,NA,tocainide
Echothiophate,DB01057,Glaucoma,C0017601,NA,Approved,NA,NA,echothiophate
Echothiophate,DB01057,"Glaucoma, Open-Angle",C0017612,NA,Approved,NA,NA,echothiophate
Echothiophate,DB01057,Esotropia,C0014877,NA,Approved,NA,NA,echothiophate
Echothiophate,DB01057,Stargardt's disease,C0271093,NA,Approved,NA,NA,echothiophate
Praziquantel,DB01058,Opisthorchiasis,C0029106,NA,Approved,NA,NA,praziquantel
Praziquantel,DB01058,Schistosomiasis,C0036323,NA,Approved,NA,NA,praziquantel
Norfloxacin,DB01059,Pneumonia due to Pseudomonas,C0155860,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Pneumonia due to Klebsiella pneumoniae,C0519030,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Enterobacter pneumonia,C1096258,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Streptococcal pneumonia,C0155862,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Acute Moraxella catarrhalis bronchitis,C0339932,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Female pelvic cellulitis,C0349734,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Bacterial infection due to Klebsiella pneumoniae,C0343402,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Miscarriage with sepsis,C0269398,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,URINARY TRACT INFECTION ENTEROCOCCUS,C0749958,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Shigella Infections,C0013371,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,prostatitis,C0033581,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Pneumonia due to Escherichia coli,C0276089,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Legionella pneumophila pneumonia,C0857846,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Cystitis escherichia,C0853852,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Lower respiratory tract infection,C0149725,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Escherichia coli septicemia,C0276088,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Staphylococcal Pneumonia,C0032308,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Moraxella catarrhalis pneumonia,C0857831,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Postnatal infection,C1278797,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Proteus pneumonia,C1260917,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Acute gonococcal endometritis,C0153196,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Acute osteomyelitis,C0158371,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Malignant otitis externa due to Pseudomonas aeruginosa,C0395818,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Peritonitis,C0031154,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Acute maxillary sinusitis,C0155804,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Proteus urinary tract infection,C0577709,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Otitis Externa,C0029878,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Urinary tract infection,C0042029,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Rhinoscleroma,C0035468,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Chlamydial pelvic inflammatory disease,C0520777,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Anthrax disease,C0003175,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Arthropathy associated with infection,C0157749,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Bacterial urinary infection,C0729524,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Traveler's diarrhea,C0277528,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Bronchitis,C0006277,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Bacterial conjunctivitis,C0009768,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Female genital tract infection,C1263758,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,PYELONEPHRITIS E COLI,C0748196,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Chancroids,C0007947,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Chlamydial cervicitis,C0341834,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Acute bacterial bronchitis,C0339933,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Chlamydial pneumonia,C0339959,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Acute exacerbation of chronic bronchitis,C0856695,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Pyelonephritis,C0034186,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Endomyometritis,C0269050,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Typhoid Fever,C0041466,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Infective otitis externa,C0021355,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Gonorrhea of rectum,C0275665,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Haemophilus parainfluenzae pneumonia,C0877633,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Mycoplasma pneumonia,C0032302,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Chronic Bacterial Prostatitis,C1720797,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Enterobacteriaceae Infections,C0014347,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Chlamydial urethritis,C1278807,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Acute gonococcal cervicitis,C0153195,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,non-gonococcal urethritis (NGU),C1112709,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Pneumonia,C0032285,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Klebsiella cystitis,C0520775,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Infection of bone,C2242472,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,URINARY TRACT INFECTION CITROBACTER,C0749955,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Abdominal Abscess,C0243001,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Cystitis,C0010692,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Postoperative infection,C0392618,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Acute gonococcal urethritis,C0275652,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Gonorrhea,C0018081,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Escherichia coli Infections,C0014836,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Enteric campylobacteriosis,C0275982,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Infective cystitis,C0600041,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Acute bacterial sinusitis,C0275556,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Nosocomial pneumonia,C0949083,NA,Approved,NA,NA,norfloxacin
Norfloxacin,DB01059,Chronic tubotympanic suppurative otitis media,C0155440,NA,Approved,NA,NA,norfloxacin
Amoxicillin,DB01060,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,amoxicillin
Amoxicillin,DB01060,Acute otitis media,C0271429,NA,Approved,NA,NA,amoxicillin
Amoxicillin,DB01060,pharyngitis due to Haemophilus influenzae,C2062475,NA,Approved,NA,NA,amoxicillin
Amoxicillin,DB01060,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,amoxicillin
Amoxicillin,DB01060,Lower respiratory tract infection,C0149725,NA,Approved,NA,NA,amoxicillin
Amoxicillin,DB01060,Genitourinary tract infection,C1279247,NA,Approved,NA,NA,amoxicillin
Amoxicillin,DB01060,Pneumonia due to Staphylococcus aureus,C2349530,NA,Approved,NA,NA,amoxicillin
Amoxicillin,DB01060,Haemophilus parainfluenzae pneumonia,C0877633,NA,Approved,NA,NA,amoxicillin
Amoxicillin,DB01060,Acute exacerbation of chronic bronchitis,C0856695,NA,Approved,NA,NA,amoxicillin
Amoxicillin,DB01060,Bacterial urinary infection,C0729524,NA,Approved,NA,NA,amoxicillin
Amoxicillin,DB01060,Pharyngitis,C0031350,NA,Approved,NA,NA,amoxicillin
Amoxicillin,DB01060,Rhinoscleroma,C0035468,NA,Approved,NA,NA,amoxicillin
Amoxicillin,DB01060,Moraxella catarrhalis pneumonia,C0857831,NA,Approved,NA,NA,amoxicillin
Amoxicillin,DB01060,Streptococcal pneumonia,C0155862,NA,Approved,NA,NA,amoxicillin
Amoxicillin,DB01060,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,amoxicillin
Amoxicillin,DB01060,Pneumonia due to Klebsiella pneumoniae,C0519030,NA,Approved,NA,NA,amoxicillin
Amoxicillin,DB01060,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,amoxicillin
Amoxicillin,DB01060,Staphylococcal pharyngitis,C0275794,NA,Approved,NA,NA,amoxicillin
Amoxicillin,DB01060,Streptococcal tonsillitis,C0275804,NA,Approved,NA,NA,amoxicillin
Amoxicillin,DB01060,Helicobacter-associated gastritis,C0343378,NA,Approved,NA,NA,amoxicillin
Amoxicillin,DB01060,Staphylococcal tonsillitis,C0275793,NA,Approved,NA,NA,amoxicillin
Amoxicillin,DB01060,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,amoxicillin
Amoxicillin,DB01060,Escherichia coli Infections,C0014836,NA,Approved,NA,NA,amoxicillin
Amoxicillin,DB01060,Klebsiella cystitis,C0520775,NA,Approved,NA,NA,amoxicillin
Amoxicillin,DB01060,Acute bacterial sinusitis,C0275556,NA,Approved,NA,NA,amoxicillin
Amoxicillin,DB01060,Urinary tract infection,C0042029,NA,Approved,NA,NA,amoxicillin
Amoxicillin,DB01060,Infective otitis media,C0729586,NA,Approved,NA,NA,amoxicillin
Azlocillin,DB01061,Aspiration Pneumonia,C0032290,NA,Approved,NA,NA,azlocillin
Azlocillin,DB01061,Enterobacter pneumonia,C1096258,NA,Approved,NA,NA,azlocillin
Azlocillin,DB01061,Serratia Infections,C0085394,NA,Approved,NA,NA,azlocillin
Azlocillin,DB01061,Pneumonia due to Pseudomonas,C0155860,NA,Approved,NA,NA,azlocillin
Azlocillin,DB01061,Pneumonia due to Escherichia coli,C0276089,NA,Approved,NA,NA,azlocillin
Azlocillin,DB01061,Urinary tract infection,C0042029,NA,Approved,NA,NA,azlocillin
Azlocillin,DB01061,Bacterial sepsis,C0684256,NA,Approved,NA,NA,azlocillin
Azlocillin,DB01061,Infection of bone,C2242472,NA,Approved,NA,NA,azlocillin
Azlocillin,DB01061,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,azlocillin
Azlocillin,DB01061,Arthropathy associated with infection,C0157749,NA,Approved,NA,NA,azlocillin
Azlocillin,DB01061,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,azlocillin
Azlocillin,DB01061,Bacterial infection due to Klebsiella pneumoniae,C0343402,NA,Approved,NA,NA,azlocillin
Oxybutynin,DB01062,Increased frequency of micturition,C0042023,NA,Approved,NA,NA,oxybutynin
Oxybutynin,DB01062,Urgency of micturition,C0085606,NA,Approved,NA,NA,oxybutynin
Oxybutynin,DB01062,Urge Incontinence,C0150045,NA,Approved,NA,NA,oxybutynin
Oxybutynin,DB01062,Bladder muscle dysfunction - overactive,C0403643,NA,Approved,NA,NA,oxybutynin
Oxybutynin,DB01062,Neurogenic Urinary Bladder,C0005697,NA,Approved,NA,NA,oxybutynin
Acetophenazine,DB01063,Psychotic Disorders,C0033975,NA,Approved,NA,NA,acetophenazine
Isoprenaline,DB01064,Common Cold,C0009443,NA,Approved,NA,NA,isoprenaline
Isoprenaline,DB01064,Low Cardiac Output Syndrome,C0600177,NA,Approved,NA,NA,isoprenaline
Isoprenaline,DB01064,Atrioventricular Block,C0004245,NA,Approved,NA,NA,isoprenaline
Isoprenaline,DB01064,Hypovolemic Shock,C0020683,NA,Approved,NA,NA,isoprenaline
Isoprenaline,DB01064,Cardiac Arrest,C0018790,NA,Approved,NA,NA,isoprenaline
Melatonin,DB01065,Sleep Initiation and Maintenance Disorders,C0021603,NA,Approved,NA,NA,melatonin
Cefditoren,DB01066,Streptococcal tonsillitis,C0275804,NA,Approved,NA,NA,cefditoren
Cefditoren,DB01066,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,cefditoren
Cefditoren,DB01066,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,cefditoren
Cefditoren,DB01066,Acute exacerbation of chronic bronchitis,C0856695,NA,Approved,NA,NA,cefditoren
Cefditoren,DB01066,Streptococcal pneumonia,C0155862,NA,Approved,NA,NA,cefditoren
Cefditoren,DB01066,Haemophilus parainfluenzae pneumonia,C0877633,NA,Approved,NA,NA,cefditoren
Cefditoren,DB01066,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,cefditoren
Cefditoren,DB01066,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,cefditoren
Cefditoren,DB01066,Moraxella catarrhalis pneumonia,C0857831,NA,Approved,NA,NA,cefditoren
Glipizide,DB01067,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,glipizide
Clonazepam,DB01068,Epileptic drop attack,C0270846,NA,Approved,NA,NA,clonazepam
Clonazepam,DB01068,Panic Disorder,C0030319,NA,Approved,NA,NA,clonazepam
Clonazepam,DB01068,Absence Epilepsy,C0014553,NA,Approved,NA,NA,clonazepam
Clonazepam,DB01068,Lennox-Gastaut syndrome,C0238111,NA,Approved,NA,NA,clonazepam
Clonazepam,DB01068,"Epilepsies, Myoclonic",C0014550,NA,Approved,NA,NA,clonazepam
Promethazine,DB01069,Hay fever,C0018621,NA,Approved,NA,NA,promethazine
Promethazine,DB01069,Nausea and vomiting,C0027498,NA,Approved,NA,NA,promethazine
Promethazine,DB01069,"Rhinitis, Vasomotor",C0035460,NA,Approved,NA,NA,promethazine
Promethazine,DB01069,Urticaria,C0042109,NA,Approved,NA,NA,promethazine
Promethazine,DB01069,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,promethazine
Dihydrotachysterol,DB01070,Hypocalcemia,C0020598,NA,Approved,NA,NA,dihydrotachysterol
Dihydrotachysterol,DB01070,Tetany,C0039621,NA,Approved,NA,NA,dihydrotachysterol
Dihydrotachysterol,DB01070,Hypoparathyroidism,C0020626,NA,Approved,NA,NA,dihydrotachysterol
Dihydrotachysterol,DB01070,Rickets,C0035579,NA,Approved,NA,NA,dihydrotachysterol
Dihydrotachysterol,DB01070,Hypophosphatemia,C0085682,NA,Approved,NA,NA,dihydrotachysterol
Atazanavir,DB01072,HIV Infections,C0019693,NA,Approved,NA,NA,atazanavir
Diphenhydramine,DB01075,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,diphenhydramine
Diphenhydramine,DB01075,"Rhinitis, Vasomotor",C0035460,NA,Approved,NA,NA,diphenhydramine
Diphenhydramine,DB01075,Hay fever,C0018621,NA,Approved,NA,NA,diphenhydramine
Diphenhydramine,DB01075,Sleeplessness,C0917801,NA,Approved,NA,NA,diphenhydramine
Atorvastatin,DB01076,Angina Pectoris,C0002962,NA,Approved,NA,NA,atorvastatin
Atorvastatin,DB01076,Hypercholesterolemia,C0020443,NA,Approved,NA,NA,atorvastatin
Atorvastatin,DB01076,Hypertensive disease,C0020538,NA,Approved,NA,NA,atorvastatin
Atorvastatin,DB01076,Cerebrovascular accident,C0038454,NA,Approved,NA,NA,atorvastatin
Atorvastatin,DB01076,Familial hypercholesterolemia - heterozygous,C0342882,NA,Approved,NA,NA,atorvastatin
Atorvastatin,DB01076,"Hyperlipidemia, Familial Combined",C0020474,NA,Approved,NA,NA,atorvastatin
Atorvastatin,DB01076,Arteriosclerosis,C0003850,NA,Approved,NA,NA,atorvastatin
Atorvastatin,DB01076,Hyperlipoproteinemia Type III,C0020479,NA,Approved,NA,NA,atorvastatin
Atorvastatin,DB01076,Familial hypercholesterolemia - homozygous,C0342881,NA,Approved,NA,NA,atorvastatin
Atorvastatin,DB01076,"Angina Pectoris, Variant",C0002963,NA,Approved,NA,NA,atorvastatin
Atorvastatin,DB01076,Hypertriglyceridemia,C0020557,NA,Approved,NA,NA,atorvastatin
Etidronic acid,DB01077,Osteitis Deformans,C0029401,NA,Approved,NA,NA,etidronic acid
Etidronic acid,DB01077,Humoral hypercalcemia of malignancy (disorder),C0149911,NA,Approved,NA,NA,etidronic acid
Etidronic acid,DB01077,Heterotopic Ossification,C0029396,NA,Approved,NA,NA,etidronic acid
Vigabatrin,DB01080,Epilepsy characterized by intractable complex partial seizures,C2711653,NA,Approved,NA,NA,vigabatrin
Vigabatrin,DB01080,West Syndrome,C0037769,NA,Approved,NA,NA,vigabatrin
Diphenoxylate,DB01081,Diarrhea,C0011991,NA,Approved,NA,NA,diphenoxylate
Streptomycin,DB01082,Plague,C0032064,NA,Approved,NA,NA,streptomycin
Streptomycin,DB01082,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,streptomycin
Streptomycin,DB01082,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,streptomycin
Streptomycin,DB01082,Proteus urinary tract infection,C0577709,NA,Approved,NA,NA,streptomycin
Streptomycin,DB01082,Chancroids,C0007947,NA,Approved,NA,NA,streptomycin
Streptomycin,DB01082,Endocarditis haemophilus,C0854528,NA,Approved,NA,NA,streptomycin
Streptomycin,DB01082,URINARY TRACT INFECTION ENTEROCOCCUS,C0749958,NA,Approved,NA,NA,streptomycin
Streptomycin,DB01082,Klebsiella cystitis,C0520775,NA,Approved,NA,NA,streptomycin
Streptomycin,DB01082,Brucellosis,C0006309,NA,Approved,NA,NA,streptomycin
Streptomycin,DB01082,Acute tuberculosis,C0275959,NA,Approved,NA,NA,streptomycin
Streptomycin,DB01082,Granuloma Inguinale,C0018190,NA,Approved,NA,NA,streptomycin
Streptomycin,DB01082,Bacterial urinary infection,C0729524,NA,Approved,NA,NA,streptomycin
Streptomycin,DB01082,Tularemia,C0041351,NA,Approved,NA,NA,streptomycin
Streptomycin,DB01082,"Tuberculosis, Pulmonary",C0041327,NA,Approved,NA,NA,streptomycin
Orlistat,DB01083,Obesity,C0028754,NA,Approved,NA,NA,orlistat
Emedastine,DB01084,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,emedastine
Emedastine,DB01084,Urticaria,C0042109,NA,Approved,NA,NA,emedastine
Emedastine,DB01084,Pruritus,C0033774,NA,Approved,NA,NA,emedastine
Pilocarpine,DB01085,Xerostomia,C0043352,NA,Approved,NA,NA,pilocarpine
Pilocarpine,DB01085,"Glaucoma, Open-Angle",C0017612,NA,Approved,NA,NA,pilocarpine
Pilocarpine,DB01085,Ocular Hypertension,C0028840,NA,Approved,NA,NA,pilocarpine
Benzocaine,DB01086,Skin irritation,C0152030,NA,Approved,NA,NA,benzocaine
Benzocaine,DB01086,Coughing,C0010200,NA,Approved,NA,NA,benzocaine
Benzocaine,DB01086,Sore Throat,C0242429,NA,Approved,NA,NA,benzocaine
Benzocaine,DB01086,Pruritus,C0033774,NA,Approved,NA,NA,benzocaine
Benzocaine,DB01086,Mouth irritation,C0235339,NA,Approved,NA,NA,benzocaine
Benzocaine,DB01086,Tinea,C0040247,NA,Approved,NA,NA,benzocaine
Benzocaine,DB01086,Tinea corporis (disorder),C0040252,NA,Approved,NA,NA,benzocaine
Benzocaine,DB01086,Tinea Pedis,C0040259,NA,Approved,NA,NA,benzocaine
Primaquine,DB01087,"Malaria, Vivax",C0024537,NA,Approved,NA,NA,primaquine
Iloprost,DB01088,Pulmonary arterial hypertension,C2973725,NA,Approved,NA,NA,iloprost
Butenafine,DB01091,Tinea corporis (disorder),C0040252,NA,Approved,NA,NA,butenafine
Butenafine,DB01091,Tinea Versicolor,C0040262,NA,Approved,NA,NA,butenafine
Butenafine,DB01091,Tinea Pedis,C0040259,NA,Approved,NA,NA,butenafine
Butenafine,DB01091,Tinea cruris,C1384589,NA,Approved,NA,NA,butenafine
Dimethyl sulfoxide,DB01093,Interstitial Cystitis,C0282488,NA,Approved,NA,NA,dimethyl sulfoxide
Fluvastatin,DB01095,"Hyperlipidemia, Familial Combined",C0020474,NA,Approved,NA,NA,fluvastatin
Fluvastatin,DB01095,Familial hypercholesterolemia - heterozygous,C0342882,NA,Approved,NA,NA,fluvastatin
Fluvastatin,DB01095,Hypercholesterolemia,C0020443,NA,Approved,NA,NA,fluvastatin
Fluvastatin,DB01095,Arteriosclerosis,C0003850,NA,Approved,NA,NA,fluvastatin
Oxamniquine,DB01096,Schistosomiasis,C0036323,NA,Approved,NA,NA,oxamniquine
Leflunomide,DB01097,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,leflunomide
Leflunomide,DB01097,"Arthritis, Psoriatic",C0003872,NA,Approved,NA,NA,leflunomide
Rosuvastatin,DB01098,Familial hypercholesterolemia - heterozygous,C0342882,NA,Approved,NA,NA,rosuvastatin
Rosuvastatin,DB01098,Cerebrovascular accident,C0038454,NA,Approved,NA,NA,rosuvastatin
Rosuvastatin,DB01098,"Hyperlipidemia, Familial Combined",C0020474,NA,Approved,NA,NA,rosuvastatin
Rosuvastatin,DB01098,Familial hypercholesterolemia - homozygous,C0342881,NA,Approved,NA,NA,rosuvastatin
Rosuvastatin,DB01098,Arteriosclerosis,C0003850,NA,Approved,NA,NA,rosuvastatin
Rosuvastatin,DB01098,Hypercholesterolemia,C0020443,NA,Approved,NA,NA,rosuvastatin
Rosuvastatin,DB01098,Hypertriglyceridemia,C0020557,NA,Approved,NA,NA,rosuvastatin
Rosuvastatin,DB01098,Hyperlipoproteinemia Type III,C0020479,NA,Approved,NA,NA,rosuvastatin
Pimozide,DB01100,Gilles de la Tourette syndrome,C0040517,NA,Approved,NA,NA,pimozide
Capecitabine,DB01101,Metastasis from malignant tumor of colon,C1282500,NA,Approved,NA,NA,capecitabine
Capecitabine,DB01101,Malignant neoplasm of stomach,C0024623,NA,Approved,NA,NA,capecitabine
Capecitabine,DB01101,Carcinoma breast stage IV,C0278488,NA,Approved,NA,NA,capecitabine
Quinacrine,DB01103,Giardiasis,C0017536,NA,Approved,NA,NA,quinacrine
Sertraline,DB01104,Premenstrual Dysphoric Disorder,C0520676,NA,Approved,NA,NA,sertraline
Sertraline,DB01104,Depressive disorder,C0011581,NA,Approved,NA,NA,sertraline
Sertraline,DB01104,"Phobia, Social",C0031572,NA,Approved,NA,NA,sertraline
Sertraline,DB01104,Obsessive-Compulsive Disorder,C0028768,NA,Approved,NA,NA,sertraline
Sertraline,DB01104,Panic Disorder,C0030319,NA,Approved,NA,NA,sertraline
Sertraline,DB01104,Post-Traumatic Stress Disorder,C0038436,NA,Approved,NA,NA,sertraline
Sibutramine,DB01105,Obesity,C0028754,NA,Approved,NA,NA,sibutramine
Levocabastine,DB01106,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,levocabastine
Methyprylon,DB01107,Sleeplessness,C0917801,NA,Approved,NA,NA,methyprylon
Trilostane,DB01108,Adrenal Gland Hyperfunction,C0001622,NA,Approved,NA,NA,trilostane
Heparin,DB01109,Deep Vein Thrombosis,C0149871,NA,Approved,NA,NA,heparin
Heparin,DB01109,Non-Q wave myocardial infarction,C0542269,NA,Approved,NA,NA,heparin
Heparin,DB01109,Disseminated Intravascular Coagulation,C0012739,NA,Approved,NA,NA,heparin
Heparin,DB01109,Peripheral arterial embolism,C0564750,NA,Approved,NA,NA,heparin
Miconazole,DB01110,Diaper Rash,C0011974,NA,Approved,NA,NA,miconazole
Miconazole,DB01110,Tinea Pedis,C0040259,NA,Approved,NA,NA,miconazole
Miconazole,DB01110,"Candidiasis, Vulvovaginal",C0700345,NA,Approved,NA,NA,miconazole
Miconazole,DB01110,Tinea Versicolor,C0040262,NA,Approved,NA,NA,miconazole
Miconazole,DB01110,Tinea corporis (disorder),C0040252,NA,Approved,NA,NA,miconazole
Miconazole,DB01110,Tinea cruris,C1384589,NA,Approved,NA,NA,miconazole
Miconazole,DB01110,Cutaneous Candidiasis,C0006846,NA,Approved,NA,NA,miconazole
Miconazole,DB01110,Oropharyngeal candidiasis,C0919659,NA,Approved,NA,NA,miconazole
Miconazole,DB01110,Onychomycosis,C0040261,NA,Approved,NA,NA,miconazole
Colistimethate,DB01111,Infection caused by Enterobacter,C0948205,NA,Approved,NA,NA,colistimethate
Colistimethate,DB01111,Pseudomonas aeruginosa infection,C0854135,NA,Approved,NA,NA,colistimethate
Colistimethate,DB01111,Klebsiella Infections,C0022729,NA,Approved,NA,NA,colistimethate
Cefuroxime,DB01112,Klebsiella cystitis,C0520775,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Acute maxillary sinusitis,C0155804,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Staphylococcal bacteraemia,C0152965,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Haemophilus sepsis,C0854324,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,GONOCOCCAL INFECTION DISSEMINATED,C0744451,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Gonorrhea of rectum,C0275665,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Escherichia coli Infections,C0014836,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Bacterial sepsis,C0684256,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Acute otitis media,C0271429,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Streptococcal tonsillitis,C0275804,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Lower respiratory tract infection,C0149725,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Impetigo,C0021099,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Escherichia coli septicemia,C0276088,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Infective otitis media,C0729586,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Osteomyelitis due to Staphylococcus aureus,C1997728,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Infection of bone,C2242472,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Gonorrhea,C0018081,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Bacterial infection due to Klebsiella pneumoniae,C0343402,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Lyme Disease,C0024198,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Staphylococcal Pneumonia,C0032308,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Enterobacteriaceae Infections,C0014347,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Acute gonococcal endometritis,C0153196,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Acute gonococcal cervicitis,C0153195,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,"Meningitis, Bacterial",C0085437,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Gonorrhea of pharynx,C0149966,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Rhinoscleroma,C0035468,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Pneumonia due to Escherichia coli,C0276089,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Acute gonococcal urethritis,C0275652,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Streptococcal sepsis,C0152964,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Arthropathy associated with infection,C0157749,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Staphylococcal meningitis,C0154640,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Streptococcal meningitis,C0154639,NA,Approved,NA,NA,cefuroxime
Cefuroxime,DB01112,Acute exacerbation of chronic bronchitis,C0856695,NA,Approved,NA,NA,cefuroxime
Papaverine,DB01113,Peripheral Vascular Diseases,C0085096,NA,Approved,NA,NA,papaverine
Papaverine,DB01113,Cerebral Ischemia,C0917798,NA,Approved,NA,NA,papaverine
Chlorphenamine,DB01114,Urticaria,C0042109,NA,Approved,NA,NA,chlorphenamine
Chlorphenamine,DB01114,Symptomatic dermographism,C0343065,NA,Approved,NA,NA,chlorphenamine
Chlorphenamine,DB01114,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,chlorphenamine
Chlorphenamine,DB01114,"Rhinitis, Vasomotor",C0035460,NA,Approved,NA,NA,chlorphenamine
Chlorphenamine,DB01114,Influenza-like symptoms,C0392171,NA,Approved,NA,NA,chlorphenamine
Chlorphenamine,DB01114,Rhinorrhea,C1260880,NA,Approved,NA,NA,chlorphenamine
Chlorphenamine,DB01114,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,chlorphenamine
Chlorphenamine,DB01114,Sneezing,C0037383,NA,Approved,NA,NA,chlorphenamine
Chlorphenamine,DB01114,Hay fever,C0018621,NA,Approved,NA,NA,chlorphenamine
Chlorphenamine,DB01114,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,chlorphenamine
Chlorphenamine,DB01114,Common Cold,C0009443,NA,Approved,NA,NA,chlorphenamine
Chlorphenamine,DB01114,Pruritus,C0033774,NA,Approved,NA,NA,chlorphenamine
Nifedipine,DB01115,"Angina Pectoris, Variant",C0002963,NA,Approved,NA,NA,nifedipine
Nifedipine,DB01115,Hypertensive disease,C0020538,NA,Approved,NA,NA,nifedipine
Nifedipine,DB01115,Angina Pectoris,C0002962,NA,Approved,NA,NA,nifedipine
Trimethaphan,DB01116,Hypertensive emergency,C0745136,NA,Approved,NA,NA,trimethaphan
Trimethaphan,DB01116,Pulmonary Edema,C0034063,NA,Approved,NA,NA,trimethaphan
Atovaquone,DB01117,"Malaria, Falciparum",C0024535,NA,Approved,NA,NA,atovaquone
Amiodarone,DB01118,Ventricular Fibrillation,C0042510,NA,Approved,NA,NA,amiodarone
Diazoxide,DB01119,Hyperinsulinism,C0020459,NA,Approved,NA,NA,diazoxide
Diazoxide,DB01119,insulinoma,C0021670,NA,Approved,NA,NA,diazoxide
Diazoxide,DB01119,Nesidioblastosis,C0027773,NA,Approved,NA,NA,diazoxide
Diazoxide,DB01119,Hypertensive urgency,C0745138,NA,Approved,NA,NA,diazoxide
Diazoxide,DB01119,Hypertensive emergency,C0745136,NA,Approved,NA,NA,diazoxide
Gliclazide,DB01120,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,gliclazide
Phenacemide,DB01121,Epilepsy,C0014544,NA,Approved,NA,NA,phenacemide
Phenacemide,DB01121,Epilepsy characterized by intractable complex partial seizures,C2711653,NA,Approved,NA,NA,phenacemide
Ambenonium,DB01122,Myasthenia Gravis,C0026896,NA,Approved,NA,NA,ambenonium
Tolbutamide,DB01124,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,tolbutamide
Dutasteride,DB01126,Prostatic Hypertrophy,C1739363,NA,Approved,NA,NA,dutasteride
Econazole,DB01127,Cutaneous Candidiasis,C0006846,NA,Approved,NA,NA,econazole
Econazole,DB01127,Tinea Pedis,C0040259,NA,Approved,NA,NA,econazole
Econazole,DB01127,Tinea Versicolor,C0040262,NA,Approved,NA,NA,econazole
Econazole,DB01127,Tinea cruris,C1384589,NA,Approved,NA,NA,econazole
Econazole,DB01127,Tinea corporis (disorder),C0040252,NA,Approved,NA,NA,econazole
Bicalutamide,DB01128,Metastatic Prostate Carcinoma,C0936223,NA,Approved,NA,NA,bicalutamide
Rabeprazole,DB01129,Multiple Endocrine Neoplasia,C0027662,NA,Approved,NA,NA,rabeprazole
Rabeprazole,DB01129,Zollinger-Ellison syndrome,C0043515,NA,Approved,NA,NA,rabeprazole
Rabeprazole,DB01129,"Mastocytosis, Systemic",C0221013,NA,Approved,NA,NA,rabeprazole
Rabeprazole,DB01129,Gastroesophageal reflux disease,C0017168,NA,Approved,NA,NA,rabeprazole
Rabeprazole,DB01129,Duodenal Ulcer,C0013295,NA,Approved,NA,NA,rabeprazole
Rabeprazole,DB01129,Peptic Ulcer,C0030920,NA,Approved,NA,NA,rabeprazole
Prednicarbate,DB01130,"Dermatitis, Atopic",C0011615,NA,Approved,NA,NA,prednicarbate
Prednicarbate,DB01130,Pruritus of genital organs,C0033777,NA,Approved,NA,NA,prednicarbate
Prednicarbate,DB01130,Pruritus Ani,C0033775,NA,Approved,NA,NA,prednicarbate
Prednicarbate,DB01130,"Lupus Erythematosus, Discoid",C0024138,NA,Approved,NA,NA,prednicarbate
Prednicarbate,DB01130,Lichen Simplex Chronicus,C0149922,NA,Approved,NA,NA,prednicarbate
Prednicarbate,DB01130,"Lymphoma, T-Cell, Cutaneous",C0079773,NA,Approved,NA,NA,prednicarbate
Prednicarbate,DB01130,Contact Dermatitis,C0011616,NA,Approved,NA,NA,prednicarbate
Prednicarbate,DB01130,Granuloma Annulare,C0085074,NA,Approved,NA,NA,prednicarbate
Prednicarbate,DB01130,Exanthema,C0015230,NA,Approved,NA,NA,prednicarbate
Prednicarbate,DB01130,Scalp psoriasis,C0406326,NA,Approved,NA,NA,prednicarbate
Prednicarbate,DB01130,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,prednicarbate
Prednicarbate,DB01130,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,prednicarbate
Proguanil,DB01131,"Malaria, Falciparum",C0024535,NA,Approved,NA,NA,proguanil
Pioglitazone,DB01132,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,pioglitazone
Tiludronate,DB01133,Osteitis Deformans,C0029401,NA,Approved,NA,NA,tiludronate
Carvedilol,DB01136,Chronic heart failure,C0264716,NA,Approved,NA,NA,carvedilol
Carvedilol,DB01136,Hypertensive disease,C0020538,NA,Approved,NA,NA,carvedilol
Levofloxacin,DB01137,Acute Moraxella catarrhalis bronchitis,C0339932,NA,Approved,NA,NA,levofloxacin
Levofloxacin,DB01137,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,levofloxacin
Levofloxacin,DB01137,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,levofloxacin
Levofloxacin,DB01137,Bacterial infection due to Klebsiella pneumoniae,C0343402,NA,Approved,NA,NA,levofloxacin
Levofloxacin,DB01137,Haemophilus parainfluenzae pneumonia,C0877633,NA,Approved,NA,NA,levofloxacin
Levofloxacin,DB01137,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,levofloxacin
Levofloxacin,DB01137,Acute maxillary sinusitis,C0155804,NA,Approved,NA,NA,levofloxacin
Levofloxacin,DB01137,Chlamydial pneumonia,C0339959,NA,Approved,NA,NA,levofloxacin
Levofloxacin,DB01137,URINARY TRACT INFECTION ENTEROCOCCUS,C0749958,NA,Approved,NA,NA,levofloxacin
Levofloxacin,DB01137,Streptococcal pneumonia,C0155862,NA,Approved,NA,NA,levofloxacin
Levofloxacin,DB01137,Klebsiella cystitis,C0520775,NA,Approved,NA,NA,levofloxacin
Levofloxacin,DB01137,Legionella pneumophila pneumonia,C0857846,NA,Approved,NA,NA,levofloxacin
Levofloxacin,DB01137,PYELONEPHRITIS E COLI,C0748196,NA,Approved,NA,NA,levofloxacin
Levofloxacin,DB01137,Anthrax disease,C0003175,NA,Approved,NA,NA,levofloxacin
Levofloxacin,DB01137,Acute exacerbation of chronic bronchitis,C0856695,NA,Approved,NA,NA,levofloxacin
Levofloxacin,DB01137,Pyelonephritis,C0034186,NA,Approved,NA,NA,levofloxacin
Levofloxacin,DB01137,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,levofloxacin
Levofloxacin,DB01137,Bacterial conjunctivitis,C0009768,NA,Approved,NA,NA,levofloxacin
Levofloxacin,DB01137,Mycoplasma pneumonia,C0032302,NA,Approved,NA,NA,levofloxacin
Levofloxacin,DB01137,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,levofloxacin
Levofloxacin,DB01137,Bacterial urinary infection,C0729524,NA,Approved,NA,NA,levofloxacin
Levofloxacin,DB01137,Staphylococcal Pneumonia,C0032308,NA,Approved,NA,NA,levofloxacin
Levofloxacin,DB01137,Proteus urinary tract infection,C0577709,NA,Approved,NA,NA,levofloxacin
Levofloxacin,DB01137,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,levofloxacin
Levofloxacin,DB01137,Moraxella catarrhalis pneumonia,C0857831,NA,Approved,NA,NA,levofloxacin
Sulfinpyrazone,DB01138,Hyperuricemia,C0740394,NA,Approved,NA,NA,sulfinpyrazone
Sulfinpyrazone,DB01138,Chronic gouty arthritis,C0268108,NA,Approved,NA,NA,sulfinpyrazone
Cefapirin,DB01139,Staphylococcal endocarditis,C0520767,NA,Approved,NA,NA,cefapirin
Cefapirin,DB01139,Staphylococcal bacteraemia,C0152965,NA,Approved,NA,NA,cefapirin
Cefapirin,DB01139,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,cefapirin
Cefapirin,DB01139,Streptococcal endocarditis,C3665800,NA,Approved,NA,NA,cefapirin
Cefapirin,DB01139,Pneumonia,C0032285,NA,Approved,NA,NA,cefapirin
Cefapirin,DB01139,Staphylococcal Pneumonia,C0032308,NA,Approved,NA,NA,cefapirin
Cefapirin,DB01139,Proteus urinary tract infection,C0577709,NA,Approved,NA,NA,cefapirin
Cefapirin,DB01139,Urinary tract infection,C0042029,NA,Approved,NA,NA,cefapirin
Cefapirin,DB01139,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,cefapirin
Cefapirin,DB01139,Bacterial sepsis,C0684256,NA,Approved,NA,NA,cefapirin
Cefapirin,DB01139,Escherichia coli Infections,C0014836,NA,Approved,NA,NA,cefapirin
Cefapirin,DB01139,Escherichia coli septicemia,C0276088,NA,Approved,NA,NA,cefapirin
Cefapirin,DB01139,Arthropathy associated with infection,C0157749,NA,Approved,NA,NA,cefapirin
Cefapirin,DB01139,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,cefapirin
Cefapirin,DB01139,Bacterial infection due to Klebsiella pneumoniae,C0343402,NA,Approved,NA,NA,cefapirin
Cefapirin,DB01139,Streptococcal sepsis,C0152964,NA,Approved,NA,NA,cefapirin
Cefapirin,DB01139,Klebsiella cystitis,C0520775,NA,Approved,NA,NA,cefapirin
Cefapirin,DB01139,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,cefapirin
Cefapirin,DB01139,Rhinoscleroma,C0035468,NA,Approved,NA,NA,cefapirin
Cefapirin,DB01139,Infection of bone,C2242472,NA,Approved,NA,NA,cefapirin
Cefapirin,DB01139,Osteomyelitis due to Staphylococcus aureus,C1997728,NA,Approved,NA,NA,cefapirin
Cefapirin,DB01139,Lower respiratory tract infection,C0149725,NA,Approved,NA,NA,cefapirin
Cefapirin,DB01139,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,cefapirin
Cefadroxil,DB01140,Urinary tract infection,C0042029,NA,Approved,NA,NA,cefadroxil
Cefadroxil,DB01140,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,cefadroxil
Cefadroxil,DB01140,Proteus urinary tract infection,C0577709,NA,Approved,NA,NA,cefadroxil
Cefadroxil,DB01140,Klebsiella cystitis,C0520775,NA,Approved,NA,NA,cefadroxil
Cefadroxil,DB01140,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,cefadroxil
Cefadroxil,DB01140,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,cefadroxil
Cefadroxil,DB01140,Tonsillitis,C0040425,NA,Approved,NA,NA,cefadroxil
Cefadroxil,DB01140,Streptococcal tonsillitis,C0275804,NA,Approved,NA,NA,cefadroxil
Cefadroxil,DB01140,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,cefadroxil
Micafungin,DB01141,Candidemia,C0877445,NA,Approved,NA,NA,micafungin
Micafungin,DB01141,Systemic candidiasis,C0153252,NA,Approved,NA,NA,micafungin
Micafungin,DB01141,Septicemia candida,C0349009,NA,Approved,NA,NA,micafungin
Micafungin,DB01141,Candidiasis of the esophagus,C0239295,NA,Approved,NA,NA,micafungin
Micafungin,DB01141,candidal peritonitis,C2062982,NA,Approved,NA,NA,micafungin
Doxepin,DB01142,"Depression, Bipolar",C0005587,NA,Approved,NA,NA,doxepin
Doxepin,DB01142,Severe major depression with psychotic features,C0270458,NA,Approved,NA,NA,doxepin
Doxepin,DB01142,Anxiety,C0003467,NA,Approved,NA,NA,doxepin
Doxepin,DB01142,Depressive disorder,C0011581,NA,Approved,NA,NA,doxepin
Doxepin,DB01142,Sleeplessness,C0917801,NA,Approved,NA,NA,doxepin
Doxepin,DB01142,Pruritus,C0033774,NA,Approved,NA,NA,doxepin
Doxepin,DB01142,Lichen Simplex Chronicus,C0149922,NA,Approved,NA,NA,doxepin
Diclofenamide,DB01144,"Glaucoma, Open-Angle",C0017612,NA,Approved,NA,NA,diclofenamide
Diclofenamide,DB01144,Angle Closure Glaucoma,C0017605,NA,Approved,NA,NA,diclofenamide
Diclofenamide,DB01144,Secondary glaucoma,C0149893,NA,Approved,NA,NA,diclofenamide
Diphenylpyraline,DB01146,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,diphenylpyraline
Diphenylpyraline,DB01146,"Rhinitis, Vasomotor",C0035460,NA,Approved,NA,NA,diphenylpyraline
Diphenylpyraline,DB01146,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,diphenylpyraline
Diphenylpyraline,DB01146,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,diphenylpyraline
Diphenylpyraline,DB01146,Urticaria,C0042109,NA,Approved,NA,NA,diphenylpyraline
Diphenylpyraline,DB01146,Pruritus,C0033774,NA,Approved,NA,NA,diphenylpyraline
Diphenylpyraline,DB01146,Symptomatic dermographism,C0343065,NA,Approved,NA,NA,diphenylpyraline
Diphenylpyraline,DB01146,Sneezing,C0037383,NA,Approved,NA,NA,diphenylpyraline
Diphenylpyraline,DB01146,Rhinorrhea,C1260880,NA,Approved,NA,NA,diphenylpyraline
Cloxacillin,DB01147,Staphylococcal meningitis,C0154640,NA,Approved,NA,NA,cloxacillin
Cloxacillin,DB01147,Staphylococcal Pneumonia,C0032308,NA,Approved,NA,NA,cloxacillin
Cloxacillin,DB01147,Pharyngitis,C0031350,NA,Approved,NA,NA,cloxacillin
Cloxacillin,DB01147,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,cloxacillin
Cloxacillin,DB01147,Staphylococcal bacteraemia,C0152965,NA,Approved,NA,NA,cloxacillin
Cloxacillin,DB01147,Lower respiratory tract infection,C0149725,NA,Approved,NA,NA,cloxacillin
Cloxacillin,DB01147,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,cloxacillin
Cloxacillin,DB01147,Sinusitis,C0037199,NA,Approved,NA,NA,cloxacillin
Flavoxate,DB01148,Urgency of micturition,C0085606,NA,Approved,NA,NA,flavoxate
Flavoxate,DB01148,Nocturia,C0028734,NA,Approved,NA,NA,flavoxate
Flavoxate,DB01148,Urinary Incontinence,C0042024,NA,Approved,NA,NA,flavoxate
Flavoxate,DB01148,Suprapubic pain,C0241310,NA,Approved,NA,NA,flavoxate
Flavoxate,DB01148,Increased frequency of micturition,C0042023,NA,Approved,NA,NA,flavoxate
Flavoxate,DB01148,Dysuria,C0013428,NA,Approved,NA,NA,flavoxate
Nefazodone,DB01149,Major Depressive Disorder,C1269683,NA,Approved,NA,NA,nefazodone
Cefprozil,DB01150,Acute otitis media,C0271429,NA,Approved,NA,NA,cefprozil
Cefprozil,DB01150,Upper Respiratory Infections,C0041912,NA,Approved,NA,NA,cefprozil
Cefprozil,DB01150,Acute bacterial sinusitis,C0275556,NA,Approved,NA,NA,cefprozil
Cefprozil,DB01150,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,cefprozil
Cefprozil,DB01150,Acute exacerbation of chronic bronchitis,C0856695,NA,Approved,NA,NA,cefprozil
Cefprozil,DB01150,Streptococcal tonsillitis,C0275804,NA,Approved,NA,NA,cefprozil
Cefprozil,DB01150,Infective otitis media,C0729586,NA,Approved,NA,NA,cefprozil
Cefprozil,DB01150,Acute Moraxella catarrhalis bronchitis,C0339932,NA,Approved,NA,NA,cefprozil
Cefprozil,DB01150,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,cefprozil
Cefprozil,DB01150,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,cefprozil
Cefprozil,DB01150,Tonsillitis,C0040425,NA,Approved,NA,NA,cefprozil
Cefprozil,DB01150,Bronchitis,C0006277,NA,Approved,NA,NA,cefprozil
Desipramine,DB01151,Depressive disorder,C0011581,NA,Approved,NA,NA,desipramine
Sertaconazole,DB01153,Tinea Pedis,C0040259,NA,Approved,NA,NA,sertaconazole
Gemifloxacin,DB01155,Pneumonia due to Klebsiella pneumoniae,C0519030,NA,Approved,NA,NA,gemifloxacin
Gemifloxacin,DB01155,Acute bacterial bronchitis,C0339933,NA,Approved,NA,NA,gemifloxacin
Gemifloxacin,DB01155,Mycoplasma pneumonia,C0032302,NA,Approved,NA,NA,gemifloxacin
Gemifloxacin,DB01155,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,gemifloxacin
Gemifloxacin,DB01155,Moraxella catarrhalis pneumonia,C0857831,NA,Approved,NA,NA,gemifloxacin
Gemifloxacin,DB01155,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,gemifloxacin
Gemifloxacin,DB01155,Chlamydial pneumonia,C0339959,NA,Approved,NA,NA,gemifloxacin
Gemifloxacin,DB01155,Acute exacerbation of chronic bronchitis,C0856695,NA,Approved,NA,NA,gemifloxacin
Gemifloxacin,DB01155,Streptococcal pneumonia,C0155862,NA,Approved,NA,NA,gemifloxacin
Bupropion,DB01156,Nicotine Dependence,C0028043,NA,Approved,NA,NA,bupropion
Bupropion,DB01156,Depressive disorder,C0011581,NA,Approved,NA,NA,bupropion
Bupropion,DB01156,Major Depressive Disorder,C1269683,NA,Approved,NA,NA,bupropion
Bupropion,DB01156,Seasonal Affective Disorder,C0085159,NA,Approved,NA,NA,bupropion
Bupropion,DB01156,Obesity,C0028754,NA,Approved,NA,NA,bupropion
Bretylium,DB01158,Ventricular Fibrillation,C0042510,NA,Approved,NA,NA,bretylium
Bretylium,DB01158,Ventricular arrhythmia,C0085612,NA,Approved,NA,NA,bretylium
Dinoprost Tromethamine,DB01160,Unspecified Abortion,C0156543,NA,Approved,NA,NA,dinoprost tromethamine
Dinoprost Tromethamine,DB01160,"Hydatidiform mole, benign",C0549315,NA,Approved,NA,NA,dinoprost tromethamine
Dinoprost Tromethamine,DB01160,Incomplete spontaneous abortion,C0000810,NA,Approved,NA,NA,dinoprost tromethamine
Terazosin,DB01162,Prostatic Hypertrophy,C1739363,NA,Approved,NA,NA,terazosin
Terazosin,DB01162,Hypertensive disease,C0020538,NA,Approved,NA,NA,terazosin
Calcium Chloride,DB01164,Hypokalemia,C0020621,NA,Approved,NA,NA,calcium chloride
Calcium Chloride,DB01164,Hypermagnesemia,C0151714,NA,Approved,NA,NA,calcium chloride
Calcium Chloride,DB01164,Disorder of electrolytes,C1704431,NA,Approved,NA,NA,calcium chloride
Calcium Chloride,DB01164,Cardiac Arrest,C0018790,NA,Approved,NA,NA,calcium chloride
Calcium Chloride,DB01164,Hypocalcemic tetany,C0151940,NA,Approved,NA,NA,calcium chloride
Calcium Chloride,DB01164,Hypocalcemia,C0020598,NA,Approved,NA,NA,calcium chloride
Calcium Chloride,DB01164,Hyperkalemia,C0020461,NA,Approved,NA,NA,calcium chloride
Ofloxacin,DB01165,Pyelonephritis,C0034186,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,URINARY TRACT INFECTION CITROBACTER,C0749955,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Anthrax disease,C0003175,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Typhoid Fever,C0041466,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Proteus pneumonia,C1260917,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Infective otitis externa,C0021355,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Escherichia coli septicemia,C0276088,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Shigella Infections,C0013371,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Chronic tubotympanic suppurative otitis media,C0155440,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Gonorrhea,C0018081,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Infective cystitis,C0600041,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,URINARY TRACT INFECTION ENTEROCOCCUS,C0749958,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Proteus urinary tract infection,C0577709,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Staphylococcal Pneumonia,C0032308,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Pneumonia due to Pseudomonas,C0155860,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Bacterial urinary infection,C0729524,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,non-gonococcal urethritis (NGU),C1112709,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Escherichia coli Infections,C0014836,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Arthropathy associated with infection,C0157749,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Chlamydial pneumonia,C0339959,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Klebsiella cystitis,C0520775,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Chancroids,C0007947,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Enterobacter pneumonia,C1096258,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Infection of bone,C2242472,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Chlamydial cervicitis,C0341834,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Acute maxillary sinusitis,C0155804,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Pneumonia due to Escherichia coli,C0276089,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Gonorrhea of rectum,C0275665,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Female genital tract infection,C1263758,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Acute gonococcal urethritis,C0275652,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Enteric campylobacteriosis,C0275982,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Acute gonococcal cervicitis,C0153195,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Otitis Externa,C0029878,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Haemophilus parainfluenzae pneumonia,C0877633,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Acute exacerbation of chronic bronchitis,C0856695,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Rhinoscleroma,C0035468,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Acute gonococcal endometritis,C0153196,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Bacterial infection due to Klebsiella pneumoniae,C0343402,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Chronic Bacterial Prostatitis,C1720797,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Enterobacteriaceae Infections,C0014347,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Chlamydial pelvic inflammatory disease,C0520777,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Cystitis,C0010692,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Postoperative infection,C0392618,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Malignant otitis externa due to Pseudomonas aeruginosa,C0395818,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Urinary tract infection,C0042029,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Pneumonia,C0032285,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,prostatitis,C0033581,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Acute Moraxella catarrhalis bronchitis,C0339932,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Streptococcal pneumonia,C0155862,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Lower respiratory tract infection,C0149725,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Bronchitis,C0006277,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Traveler's diarrhea,C0277528,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Mycoplasma pneumonia,C0032302,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Legionella pneumophila pneumonia,C0857846,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Acute bacterial sinusitis,C0275556,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Moraxella catarrhalis pneumonia,C0857831,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Chlamydial urethritis,C1278807,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Acute osteomyelitis,C0158371,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,PYELONEPHRITIS E COLI,C0748196,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Nosocomial pneumonia,C0949083,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Cystitis escherichia,C0853852,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Bacterial conjunctivitis,C0009768,NA,Approved,NA,NA,ofloxacin
Ofloxacin,DB01165,Abdominal Abscess,C0243001,NA,Approved,NA,NA,ofloxacin
Cilostazol,DB01166,Intermittent Claudication,C0021775,NA,Approved,NA,NA,cilostazol
Itraconazole,DB01167,Candidemia,C0877445,NA,Approved,NA,NA,itraconazole
Itraconazole,DB01167,Onychomycosis of fingernails,C1274469,NA,Approved,NA,NA,itraconazole
Itraconazole,DB01167,Systemic candidiasis,C0153252,NA,Approved,NA,NA,itraconazole
Itraconazole,DB01167,Candidiasis of the esophagus,C0239295,NA,Approved,NA,NA,itraconazole
Itraconazole,DB01167,Onychomycosis of toenails,C1274470,NA,Approved,NA,NA,itraconazole
Itraconazole,DB01167,Fusariosis,C0276758,NA,Approved,NA,NA,itraconazole
Itraconazole,DB01167,Aspergillosis,C0004030,NA,Approved,NA,NA,itraconazole
Itraconazole,DB01167,Oropharyngeal candidiasis,C0919659,NA,Approved,NA,NA,itraconazole
Itraconazole,DB01167,Invasive Pulmonary Aspergillosis,C0276653,NA,Approved,NA,NA,itraconazole
Itraconazole,DB01167,Blastomycosis,C0005716,NA,Approved,NA,NA,itraconazole
Itraconazole,DB01167,Histoplasmosis,C0019655,NA,Approved,NA,NA,itraconazole
Procarbazine,DB01168,Hodgkin Disease,C0019829,NA,Approved,NA,NA,procarbazine
Arsenic trioxide,DB01169,Acute myelomonocytic leukemia,C0023479,NA,Approved,NA,NA,arsenic trioxide
Arsenic trioxide,DB01169,Acute Promyelocytic Leukemia,C0023487,NA,Approved,NA,NA,arsenic trioxide
Guanethidine,DB01170,Hypertensive disease,C0020538,NA,Approved,NA,NA,guanethidine
Moclobemide,DB01171,Depressive disorder,C0011581,NA,Approved,NA,NA,moclobemide
Kanamycin,DB01172,Infection of bone,C2242472,NA,Approved,NA,NA,kanamycin
Kanamycin,DB01172,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,kanamycin
Kanamycin,DB01172,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,kanamycin
Kanamycin,DB01172,Meningitis,C0025289,NA,Approved,NA,NA,kanamycin
Kanamycin,DB01172,Urinary tract infection,C0042029,NA,Approved,NA,NA,kanamycin
Kanamycin,DB01172,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,kanamycin
Kanamycin,DB01172,Arthropathy associated with infection,C0157749,NA,Approved,NA,NA,kanamycin
Kanamycin,DB01172,Bacterial sepsis,C0684256,NA,Approved,NA,NA,kanamycin
Kanamycin,DB01172,Cholangitis,C0008311,NA,Approved,NA,NA,kanamycin
Orphenadrine,DB01173,Muscle Spasticity,C0026838,NA,Approved,NA,NA,orphenadrine
Orphenadrine,DB01173,Parkinsonian Disorders,C0242422,NA,Approved,NA,NA,orphenadrine
Phenobarbital,DB01174,Simple Partial Seizures,C0234974,NA,Approved,NA,NA,phenobarbital
Phenobarbital,DB01174,Bipolar disorder in remission,C0270425,NA,Approved,NA,NA,phenobarbital
Phenobarbital,DB01174,Vascular Headaches,C0042376,NA,Approved,NA,NA,phenobarbital
Phenobarbital,DB01174,Lennox-Gastaut syndrome,C0238111,NA,Approved,NA,NA,phenobarbital
Phenobarbital,DB01174,Epilepsy,C0014544,NA,Approved,NA,NA,phenobarbital
Phenobarbital,DB01174,Tonic - clonic seizures,C0494475,NA,Approved,NA,NA,phenobarbital
Phenobarbital,DB01174,Cluster Headache,C0009088,NA,Approved,NA,NA,phenobarbital
Phenobarbital,DB01174,Migraine Disorders,C0149931,NA,Approved,NA,NA,phenobarbital
Phenobarbital,DB01174,Tonic-Clonic Epilepsy,C0014549,NA,Approved,NA,NA,phenobarbital
Phenobarbital,DB01174,Epilepsy characterized by intractable complex partial seizures,C2711653,NA,Approved,NA,NA,phenobarbital
Escitalopram,DB01175,Major Depressive Disorder,C1269683,NA,Approved,NA,NA,escitalopram
Escitalopram,DB01175,Generalized Anxiety Disorder,C0270549,NA,Approved,NA,NA,escitalopram
Cyclizine,DB01176,Coughing,C0010200,NA,Approved,NA,NA,cyclizine
Cyclizine,DB01176,Hay fever,C0018621,NA,Approved,NA,NA,cyclizine
Cyclizine,DB01176,Motion Sickness,C0026603,NA,Approved,NA,NA,cyclizine
Cyclizine,DB01176,Rhinorrhea,C1260880,NA,Approved,NA,NA,cyclizine
Cyclizine,DB01176,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,cyclizine
Cyclizine,DB01176,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,cyclizine
Cyclizine,DB01176,"Rhinitis, Vasomotor",C0035460,NA,Approved,NA,NA,cyclizine
Cyclizine,DB01176,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,cyclizine
Cyclizine,DB01176,Common Cold,C0009443,NA,Approved,NA,NA,cyclizine
Cyclizine,DB01176,Sneezing,C0037383,NA,Approved,NA,NA,cyclizine
Idarubicin,DB01177,"Leukemia, Myelocytic, Acute",C0023467,NA,Approved,NA,NA,idarubicin
Idarubicin,DB01177,Acute Promyelocytic Leukemia,C0023487,NA,Approved,NA,NA,idarubicin
Chlormezanone,DB01178,Anxiety,C0003467,NA,Approved,NA,NA,chlormezanone
Podofilox,DB01179,Condylomata Acuminata,C0009663,NA,Approved,NA,NA,podofilox
Ifosfamide,DB01181,Testicular Germ Cell Tumor,C1336708,NA,Approved,NA,NA,ifosfamide
Propafenone,DB01182,Paroxysmal atrial fibrillation,C0235480,NA,Approved,NA,NA,propafenone
Propafenone,DB01182,Paroxysmal atrial flutter,C0741292,NA,Approved,NA,NA,propafenone
Propafenone,DB01182,Paroxysmal supraventricular tachycardia,C0030590,NA,Approved,NA,NA,propafenone
Naloxone,DB01183,Poisoning by opiate analgesic drug,C0412850,NA,Approved,NA,NA,naloxone
Naloxone,DB01183,Opiate Addiction,C0524662,NA,Approved,NA,NA,naloxone
Naloxone,DB01183,Pain,C0030193,NA,Approved,NA,NA,naloxone
Naloxone,DB01183,Drug-induced constipation,C0267511,NA,Approved,NA,NA,naloxone
Domperidone,DB01184,Nausea and vomiting,C0027498,NA,Approved,NA,NA,domperidone
Fluoxymesterone,DB01185,Noonan Syndrome,C0028326,NA,Approved,NA,NA,fluoxymesterone
Fluoxymesterone,DB01185,Hormone receptor positive malignant neoplasm of breast,C1562029,NA,Approved,NA,NA,fluoxymesterone
Fluoxymesterone,DB01185,Testicular hypogonadism,C0151721,NA,Approved,NA,NA,fluoxymesterone
Fluoxymesterone,DB01185,Cryptorchidism,C0010417,NA,Approved,NA,NA,fluoxymesterone
Fluoxymesterone,DB01185,Klinefelter Syndrome,C0022735,NA,Approved,NA,NA,fluoxymesterone
Fluoxymesterone,DB01185,Deficiency of testosterone biosynthesis,C0342527,NA,Approved,NA,NA,fluoxymesterone
Fluoxymesterone,DB01185,Delayed Puberty,C0034012,NA,Approved,NA,NA,fluoxymesterone
Fluoxymesterone,DB01185,Generalized Myotonia of Thomsen,C2936781,NA,Approved,NA,NA,fluoxymesterone
Pergolide,DB01186,Parkinsonian Disorders,C0242422,NA,Approved,NA,NA,pergolide
Ciclopirox,DB01188,Scurfiness of scalp,C0423775,NA,Approved,NA,NA,ciclopirox
Ciclopirox,DB01188,Tinea corporis (disorder),C0040252,NA,Approved,NA,NA,ciclopirox
Ciclopirox,DB01188,Onychomycosis,C0040261,NA,Approved,NA,NA,ciclopirox
Ciclopirox,DB01188,Tinea cruris,C1384589,NA,Approved,NA,NA,ciclopirox
Ciclopirox,DB01188,Tinea Versicolor,C0040262,NA,Approved,NA,NA,ciclopirox
Ciclopirox,DB01188,Tinea Pedis,C0040259,NA,Approved,NA,NA,ciclopirox
Ciclopirox,DB01188,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,ciclopirox
Ciclopirox,DB01188,Cutaneous Candidiasis,C0006846,NA,Approved,NA,NA,ciclopirox
Clindamycin,DB01190,Streptococcal pneumonia,C0155862,NA,Approved,NA,NA,clindamycin
Clindamycin,DB01190,Streptococcal sepsis,C0152964,NA,Approved,NA,NA,clindamycin
Clindamycin,DB01190,Bacterial sepsis,C0684256,NA,Approved,NA,NA,clindamycin
Clindamycin,DB01190,Osteomyelitis due to Staphylococcus aureus,C1997728,NA,Approved,NA,NA,clindamycin
Clindamycin,DB01190,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,clindamycin
Clindamycin,DB01190,Staphylococcal bacteraemia,C0152965,NA,Approved,NA,NA,clindamycin
Clindamycin,DB01190,Gas gangrene caused by clostridium perfringens,C0343500,NA,Approved,NA,NA,clindamycin
Clindamycin,DB01190,Arthropathy associated with infection,C0157749,NA,Approved,NA,NA,clindamycin
Clindamycin,DB01190,Aspiration Pneumonia,C0032290,NA,Approved,NA,NA,clindamycin
Clindamycin,DB01190,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,clindamycin
Clindamycin,DB01190,Staphylococcal Pneumonia,C0032308,NA,Approved,NA,NA,clindamycin
Clindamycin,DB01190,Pelvic Inflammatory Disease,C0242172,NA,Approved,NA,NA,clindamycin
Clindamycin,DB01190,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,clindamycin
Clindamycin,DB01190,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,clindamycin
Clindamycin,DB01190,Septicemia due to anaerobes,C0152967,NA,Approved,NA,NA,clindamycin
Clindamycin,DB01190,Infection of bone,C2242472,NA,Approved,NA,NA,clindamycin
Clindamycin,DB01190,"Empyema, Pleural",C0014013,NA,Approved,NA,NA,clindamycin
Clindamycin,DB01190,Acne Vulgaris,C0001144,NA,Approved,NA,NA,clindamycin
Clindamycin,DB01190,Bacterial Vaginosis,C0085166,NA,Approved,NA,NA,clindamycin
Dexfenfluramine,DB01191,Obesity,C0028754,NA,Approved,NA,NA,dexfenfluramine
Oxymorphone,DB01192,Pain,C0030193,NA,Approved,NA,NA,oxymorphone
Oxymorphone,DB01192,Chronic pain,C0150055,NA,Approved,NA,NA,oxymorphone
Oxymorphone,DB01192,Severe pain,C0278140,NA,Approved,NA,NA,oxymorphone
Oxymorphone,DB01192,Labor Pain,C0474368,NA,Approved,NA,NA,oxymorphone
Acebutolol,DB01193,Hypertensive disease,C0020538,NA,Approved,NA,NA,acebutolol
Acebutolol,DB01193,Premature ventricular contractions,C0151636,NA,Approved,NA,NA,acebutolol
Brinzolamide,DB01194,Ocular Hypertension,C0028840,NA,Approved,NA,NA,brinzolamide
Brinzolamide,DB01194,"Glaucoma, Open-Angle",C0017612,NA,Approved,NA,NA,brinzolamide
Flecainide,DB01195,Paroxysmal atrial flutter,C0741292,NA,Approved,NA,NA,flecainide
Flecainide,DB01195,Paroxysmal atrial fibrillation,C0235480,NA,Approved,NA,NA,flecainide
Estramustine,DB01196,Prostatic Neoplasms,C0033578,NA,Approved,NA,NA,estramustine
Captopril,DB01197,Chronic heart failure,C0264716,NA,Approved,NA,NA,captopril
Captopril,DB01197,Hypertensive disease,C0020538,NA,Approved,NA,NA,captopril
Captopril,DB01197,Diabetic Nephropathy,C0011881,NA,Approved,NA,NA,captopril
Zopiclone,DB01198,Sleeplessness,C0917801,NA,Approved,NA,NA,zopiclone
Bromocriptine,DB01200,"Parkinson Disease, Postencephalitic",C0030568,NA,Approved,NA,NA,bromocriptine
Bromocriptine,DB01200,Acromegaly,C0001206,NA,Approved,NA,NA,bromocriptine
Bromocriptine,DB01200,Parkinson Disease,C0030567,NA,Approved,NA,NA,bromocriptine
Bromocriptine,DB01200,Hyperprolactinemia,C0020514,NA,Approved,NA,NA,bromocriptine
Rifapentine,DB01201,"Tuberculosis, Pulmonary",C0041327,NA,Approved,NA,NA,rifapentine
Levetiracetam,DB01202,Simple Partial Seizures,C0234974,NA,Approved,NA,NA,levetiracetam
Levetiracetam,DB01202,Epilepsy characterized by intractable complex partial seizures,C2711653,NA,Approved,NA,NA,levetiracetam
Nadolol,DB01203,Angina Pectoris,C0002962,NA,Approved,NA,NA,nadolol
Nadolol,DB01203,Hypertensive disease,C0020538,NA,Approved,NA,NA,nadolol
Mitoxantrone,DB01204,"Leukemia, Myelocytic, Acute",C0023467,NA,Approved,NA,NA,mitoxantrone
Mitoxantrone,DB01204,Metastatic Prostate Carcinoma,C0936223,NA,Approved,NA,NA,mitoxantrone
Mitoxantrone,DB01204,"Multiple Sclerosis, Relapsing-Remitting",C0751967,NA,Approved,NA,NA,mitoxantrone
Lomustine,DB01206,Hodgkin Disease,C0019829,NA,Approved,NA,NA,lomustine
Lomustine,DB01206,Brain Neoplasms,C0006118,NA,Approved,NA,NA,lomustine
Sparfloxacin,DB01208,Mycoplasma pneumonia,C0032302,NA,Approved,NA,NA,sparfloxacin
Sparfloxacin,DB01208,Haemophilus parainfluenzae pneumonia,C0877633,NA,Approved,NA,NA,sparfloxacin
Sparfloxacin,DB01208,Moraxella catarrhalis pneumonia,C0857831,NA,Approved,NA,NA,sparfloxacin
Sparfloxacin,DB01208,Pneumonia,C0032285,NA,Approved,NA,NA,sparfloxacin
Sparfloxacin,DB01208,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,sparfloxacin
Sparfloxacin,DB01208,Acute Moraxella catarrhalis bronchitis,C0339932,NA,Approved,NA,NA,sparfloxacin
Sparfloxacin,DB01208,Chlamydial pneumonia,C0339959,NA,Approved,NA,NA,sparfloxacin
Dezocine,DB01209,Pain,C0030193,NA,Approved,NA,NA,dezocine
Levobunolol,DB01210,Ocular Hypertension,C0028840,NA,Approved,NA,NA,levobunolol
Levobunolol,DB01210,"Glaucoma, Open-Angle",C0017612,NA,Approved,NA,NA,levobunolol
Clarithromycin,DB01211,Acute maxillary sinusitis,C0155804,NA,Approved,NA,NA,clarithromycin
Clarithromycin,DB01211,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,clarithromycin
Clarithromycin,DB01211,Acute bacterial sinusitis,C0275556,NA,Approved,NA,NA,clarithromycin
Clarithromycin,DB01211,Infective otitis media,C0729586,NA,Approved,NA,NA,clarithromycin
Clarithromycin,DB01211,Pulmonary Mycobacterium avium complex infection,C2733595,NA,Approved,NA,NA,clarithromycin
Clarithromycin,DB01211,Helicobacter-associated gastritis,C0343378,NA,Approved,NA,NA,clarithromycin
Clarithromycin,DB01211,Chlamydial pneumonia,C0339959,NA,Approved,NA,NA,clarithromycin
Clarithromycin,DB01211,Acute otitis media,C0271429,NA,Approved,NA,NA,clarithromycin
Clarithromycin,DB01211,Mycoplasma pneumonia,C0032302,NA,Approved,NA,NA,clarithromycin
Clarithromycin,DB01211,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,clarithromycin
Clarithromycin,DB01211,Acute exacerbation of chronic bronchitis,C0856695,NA,Approved,NA,NA,clarithromycin
Clarithromycin,DB01211,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,clarithromycin
Clarithromycin,DB01211,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,clarithromycin
Clarithromycin,DB01211,Moraxella catarrhalis pneumonia,C0857831,NA,Approved,NA,NA,clarithromycin
Clarithromycin,DB01211,Acute Moraxella catarrhalis bronchitis,C0339932,NA,Approved,NA,NA,clarithromycin
Clarithromycin,DB01211,Acute bacterial bronchitis,C0339933,NA,Approved,NA,NA,clarithromycin
Clarithromycin,DB01211,Streptococcal pneumonia,C0155862,NA,Approved,NA,NA,clarithromycin
Clarithromycin,DB01211,Streptococcal tonsillitis,C0275804,NA,Approved,NA,NA,clarithromycin
Clarithromycin,DB01211,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,clarithromycin
Clarithromycin,DB01211,Haemophilus parainfluenzae pneumonia,C0877633,NA,Approved,NA,NA,clarithromycin
Ceftriaxone,DB01212,Serratia Infections,C0085394,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Proteus pneumonia,C1260917,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Pneumonia due to Escherichia coli,C0276089,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,GONOCOCCAL INFECTION DISSEMINATED,C0744451,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Staphylococcal meningitis,C0154640,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Chancroids,C0007947,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Acute gonococcal cervicitis,C0153195,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Gonococcal endocarditis,C0153227,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Septic arthritis haemophilus,C0860048,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Enterobacter pneumonia,C1096258,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Arthropathy associated with infection,C0157749,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Staphylococcal bacteraemia,C0152965,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Meningitis due to Klebsiella mobilis,C1719906,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Gonococcal meningitis,C0153225,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Rhinoscleroma,C0035468,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Escherichia coli septicemia,C0276088,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Klebsiella cystitis,C0520775,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Streptococcal meningitis,C0154639,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Meningococcal meningitis,C0025294,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Endometritis,C0014179,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,"Arthritis, Bacterial",C1692886,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Gonococcal joint infection,C0153216,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Lower respiratory tract infection,C0149725,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Salmonella sepsis,C0152486,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Bacterial sepsis,C0684256,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,"Meningitis, Escherichia coli",C0338395,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Staphylococcal Pneumonia,C0032308,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Pelvic Inflammatory Disease,C0242172,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Gonorrhea of pharynx,C0149966,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Haemophilus parainfluenzae pneumonia,C0877633,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Gonorrhea,C0018081,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Female genital tract infection,C1263758,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Escherichia coli Infections,C0014836,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Acute gonococcal urethritis,C0275652,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Infection of bone,C2242472,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Gonorrhea of rectum,C0275665,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Streptococcal sepsis,C0152964,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Acute gonococcal endometritis,C0153196,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Haemophilus influenzae type b infection,C2028293,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,"Meningitis, Pneumococcal",C0025295,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Proteus urinary tract infection,C0577709,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Haemophilus sepsis,C0854324,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,"Meningitis, Bacterial",C0085437,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Enterobacteriaceae Infections,C0014347,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Bacterial infection due to Klebsiella pneumoniae,C0343402,NA,Approved,NA,NA,ceftriaxone
Ceftriaxone,DB01212,Infective otitis media,C0729586,NA,Approved,NA,NA,ceftriaxone
Fomepizole,DB01213,Accidental poisoning by methyl alcohol,C0261439,NA,Approved,NA,NA,fomepizole
Fomepizole,DB01213,Ethylene glycol poisoning (disorder),C0413194,NA,Approved,NA,NA,fomepizole
Metipranolol,DB01214,"Glaucoma, Open-Angle",C0017612,NA,Approved,NA,NA,metipranolol
Metipranolol,DB01214,Ocular Hypertension,C0028840,NA,Approved,NA,NA,metipranolol
Finasteride,DB01216,Prostatic Hypertrophy,C1739363,NA,Approved,NA,NA,finasteride
Finasteride,DB01216,"Alopecia, Male Pattern",C4083212,NA,Approved,NA,NA,finasteride
Anastrozole,DB01217,Hormone receptor positive malignant neoplasm of breast,C1562029,NA,Approved,NA,NA,anastrozole
Halofantrine,DB01218,"Malaria, Falciparum",C0024535,NA,Approved,NA,NA,halofantrine
Dantrolene,DB01219,Malignant hyperpyrexia due to anesthesia,C0024591,NA,Approved,NA,NA,dantrolene
Dantrolene,DB01219,Muscle Spasticity,C0026838,NA,Approved,NA,NA,dantrolene
Dantrolene,DB01219,Muscle spasticity of spinal origin,C1562430,NA,Approved,NA,NA,dantrolene
Rifaximin,DB01220,Hepatic Encephalopathy,C0019151,NA,Approved,NA,NA,rifaximin
Rifaximin,DB01220,Irritable bowel syndrome with diarrhea,C0348898,NA,Approved,NA,NA,rifaximin
Rifaximin,DB01220,Diarrhoea predominant irritable bowel syndrome,C1262211,NA,Approved,NA,NA,rifaximin
Budesonide,DB01222,Crohn Disease,C0010346,NA,Approved,NA,NA,budesonide
Budesonide,DB01222,Asthma,C0004096,NA,Approved,NA,NA,budesonide
Budesonide,DB01222,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,budesonide
Budesonide,DB01222,Crohn's disease in remission,C1960764,NA,Approved,NA,NA,budesonide
Aminophylline,DB01223,Lung diseases,C0024115,NA,Approved,NA,NA,aminophylline
Aminophylline,DB01223,Status Asthmaticus,C0038218,NA,Approved,NA,NA,aminophylline
Aminophylline,DB01223,Asthma night-time symptoms,C1273489,NA,Approved,NA,NA,aminophylline
Aminophylline,DB01223,Asthma,C0004096,NA,Approved,NA,NA,aminophylline
Aminophylline,DB01223,Bronchitis,C0006277,NA,Approved,NA,NA,aminophylline
Aminophylline,DB01223,Pulmonary Emphysema,C0034067,NA,Approved,NA,NA,aminophylline
Aminophylline,DB01223,Asthma-chronic obstructive pulmonary disease overlap syndrome,C4038730,NA,Approved,NA,NA,aminophylline
Aminophylline,DB01223,Bronchial Spasm,C0006266,NA,Approved,NA,NA,aminophylline
Aminophylline,DB01223,Asthma attack,C0347950,NA,Approved,NA,NA,aminophylline
Quetiapine,DB01224,Schizophrenia,C0036341,NA,Approved,NA,NA,quetiapine
Quetiapine,DB01224,"Depression, Bipolar",C0005587,NA,Approved,NA,NA,quetiapine
Quetiapine,DB01224,Bipolar Disorder,C0005586,NA,Approved,NA,NA,quetiapine
Quetiapine,DB01224,"Bipolar affective disorder, current episode manic",C0338873,NA,Approved,NA,NA,quetiapine
Quetiapine,DB01224,Bipolar disorder in remission,C0270425,NA,Approved,NA,NA,quetiapine
Enoxaparin,DB01225,Deep Vein Thrombosis,C0149871,NA,Approved,NA,NA,enoxaparin
Levomethadyl Acetate,DB01227,Opiate Addiction,C0524662,NA,Approved,NA,NA,levomethadyl acetate
Encainide,DB01228,Premature ventricular contractions,C0151636,NA,Approved,NA,NA,encainide
Paclitaxel,DB01229,Kaposi Sarcoma,C0036220,NA,Approved,NA,NA,paclitaxel
Paclitaxel,DB01229,"Glaucoma, Open-Angle",C0017612,NA,Approved,NA,NA,paclitaxel
Paclitaxel,DB01229,Carcinoma breast stage IV,C0278488,NA,Approved,NA,NA,paclitaxel
Paclitaxel,DB01229,Malignant neoplasm of ovary,C1140680,NA,Approved,NA,NA,paclitaxel
Paclitaxel,DB01229,Ocular Hypertension,C0028840,NA,Approved,NA,NA,paclitaxel
Paclitaxel,DB01229,Non-Small Cell Lung Carcinoma,C0007131,NA,Approved,NA,NA,paclitaxel
Paclitaxel,DB01229,Hypertensive disease,C0020538,NA,Approved,NA,NA,paclitaxel
Paclitaxel,DB01229,Breast Carcinoma,C0678222,NA,Approved,NA,NA,paclitaxel
Paclitaxel,DB01229,Secondary malignant neoplasm of pancreas,C0346976,NA,Approved,NA,NA,paclitaxel
Diphenidol,DB01231,Vertigo,C0042571,NA,Approved,NA,NA,diphenidol
Saquinavir,DB01232,HIV Infections,C0019693,NA,Approved,NA,NA,saquinavir
Metoclopramide,DB01233,Gastroesophageal reflux disease,C0017168,NA,Approved,NA,NA,metoclopramide
Metoclopramide,DB01233,Chemotherapy-induced nausea and vomiting,C0401160,NA,Approved,NA,NA,metoclopramide
Metoclopramide,DB01233,Gastroparesis due to diabetes mellitus,C0267176,NA,Approved,NA,NA,metoclopramide
Dexamethasone,DB01234,Keloid,C0022548,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Branch retinal vein occlusion with macular edema,C0339507,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Dermatitis Herpetiformis,C0011608,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Blepharoconjunctivitis,C0005743,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Corneal abrasion,C0010032,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Exanthema,C0015230,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Exacerbation of asthma,C0349790,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Humoral hypercalcemia of malignancy (disorder),C0149911,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Scalp psoriasis,C0406326,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Asthma,C0004096,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Autoimmune hemolytic anemia,C0002880,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Transplanted organ rejection,C0345468,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Angioedema,C0002994,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Pruritus Ani,C0033775,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Mycosis Fungoides,C0026948,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Epicondylitis,C0014488,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Punctate keratitis,C0259799,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Tenosynovitis,C0039520,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Rheumatic Heart Disease,C0035439,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Addisonian crisis,C0151467,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Inflammatory Bowel Diseases,C0021390,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Disorder of eye,C0015397,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Iridocyclitis,C0022073,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Bacterial keratitis,C0854211,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Ankylosing spondylitis,C0038013,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,"Lupus Erythematosus, Discoid",C0024138,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Acquired thrombocytopenia,C0154301,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Lichen Simplex Chronicus,C0149922,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Herpes zoster keratitis,C1275687,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Crohn Disease,C0010346,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Trichinellosis,C0040896,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Cyclitis,C0010543,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Addison Disease,C0001403,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Erythema Multiforme,C0014742,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Adrenogenital disorder,C0701163,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,"Dermatitis, Atopic",C0011615,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Corneal Ulcer,C0010043,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Hodgkin Disease,C0019829,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,"Tuberculosis, Miliary",C0041321,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Serum Sickness,C0036830,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Exfoliative dermatitis,C0011606,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Psoriasis,C0033860,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Cerebral Edema,C0006114,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Granuloma Annulare,C0085074,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Pruritus of genital organs,C0033777,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Berylliosis,C0005138,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Sarcoidosis,C0036202,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Thyroiditis,C0040147,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Multiple Myeloma,C0026764,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,"Lymphoma, Follicular",C0024301,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Contact Dermatitis,C0011616,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Infective blepharitis,C0729587,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Dermatologic disorders,C0037274,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,"Lymphoma, Non-Hodgkin",C0024305,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Pemphigus,C0030807,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Iritis,C0022081,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Simple Pulmonary Eosinophilia,C0242459,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Acute lymphocytic leukemia,C0023449,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Cooley's anemia,C0002875,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Allergic otitis externa,C1320547,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Keratitis,C0022568,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,"Lymphoma, T-Cell, Cutaneous",C0079773,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Multiple Sclerosis,C0026769,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Bursitis,C0006444,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Otitis Externa,C0029878,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Rosacea,C0035854,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,"Lupus Erythematosus, Systemic",C0024141,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,"Anemia, Diamond-Blackfan",C1260899,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Musculoskeletal Diseases,C0026857,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,"Arthritis, Gouty",C0003868,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Nephrotic Syndrome,C0027726,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Punctate keratopathy,C0423234,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Laryngeal Edema,C0023052,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,"Arthritis, Psoriatic",C0003872,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Uveitis,C0042164,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Diffuse Large B-Cell Lymphoma,C0079744,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Anterior uveitis,C0042165,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Malignant otitis externa due to Pseudomonas aeruginosa,C0395818,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Burkitt Lymphoma,C0006413,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Adrenal cortical hypofunction,C0405580,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Corneal Perforation,C0339293,NA,Approved,NA,NA,dexamethasone
Dexamethasone,DB01234,Central retinal vein occlusion with macular edema,C0339498,NA,Approved,NA,NA,dexamethasone
Levodopa,DB01235,"Parkinson Disease, Postencephalitic",C0030568,NA,Approved,NA,NA,levodopa
Levodopa,DB01235,Parkinsonian Disorders,C0242422,NA,Approved,NA,NA,levodopa
Levodopa,DB01235,Parkinson Disease,C0030567,NA,Approved,NA,NA,levodopa
Bromodiphenhydramine,DB01237,Rhinorrhea,C1260880,NA,Approved,NA,NA,bromodiphenhydramine
Bromodiphenhydramine,DB01237,Coughing,C0010200,NA,Approved,NA,NA,bromodiphenhydramine
Bromodiphenhydramine,DB01237,Common Cold,C0009443,NA,Approved,NA,NA,bromodiphenhydramine
Bromodiphenhydramine,DB01237,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,bromodiphenhydramine
Aripiprazole,DB01238,Bipolar disorder in remission,C0270425,NA,Approved,NA,NA,aripiprazole
Aripiprazole,DB01238,Autistic Disorder,C0004352,NA,Approved,NA,NA,aripiprazole
Aripiprazole,DB01238,Mixed bipolar I disorder,C0236780,NA,Approved,NA,NA,aripiprazole
Aripiprazole,DB01238,Schizophrenia,C0036341,NA,Approved,NA,NA,aripiprazole
Aripiprazole,DB01238,"Bipolar affective disorder, current episode manic",C0338873,NA,Approved,NA,NA,aripiprazole
Chlorprothixene,DB01239,Schizophrenia,C0036341,NA,Approved,NA,NA,chlorprothixene
Epoprostenol,DB01240,Pulmonary arterial hypertension,C2973725,NA,Approved,NA,NA,epoprostenol
Epoprostenol,DB01240,Pulmonary Hypertension,C0020542,NA,Approved,NA,NA,epoprostenol
Epoprostenol,DB01240,Rhinorrhea,C1260880,NA,Approved,NA,NA,epoprostenol
Epoprostenol,DB01240,Coughing,C0010200,NA,Approved,NA,NA,epoprostenol
Epoprostenol,DB01240,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,epoprostenol
Epoprostenol,DB01240,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,epoprostenol
Epoprostenol,DB01240,Rhinitis,C0035455,NA,Approved,NA,NA,epoprostenol
Epoprostenol,DB01240,Common Cold,C0009443,NA,Approved,NA,NA,epoprostenol
Gemfibrozil,DB01241,Hypertriglyceridemia,C0020557,NA,Approved,NA,NA,gemfibrozil
Clomipramine,DB01242,Obsessive-Compulsive Disorder,C0028768,NA,Approved,NA,NA,clomipramine
Chloroxine,DB01243,Scurfiness of scalp,C0423775,NA,Approved,NA,NA,chloroxine
Chloroxine,DB01243,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,chloroxine
Bepridil,DB01244,Angina Pectoris,C0002962,NA,Approved,NA,NA,bepridil
Alimemazine,DB01246,Sneezing,C0037383,NA,Approved,NA,NA,alimemazine
Alimemazine,DB01246,Rhinorrhea,C1260880,NA,Approved,NA,NA,alimemazine
Alimemazine,DB01246,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,alimemazine
Alimemazine,DB01246,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,alimemazine
Alimemazine,DB01246,Angioedema,C0002994,NA,Approved,NA,NA,alimemazine
Alimemazine,DB01246,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,alimemazine
Alimemazine,DB01246,Symptomatic dermographism,C0343065,NA,Approved,NA,NA,alimemazine
Alimemazine,DB01246,Urticaria,C0042109,NA,Approved,NA,NA,alimemazine
Alimemazine,DB01246,Pruritus,C0033774,NA,Approved,NA,NA,alimemazine
Isocarboxazid,DB01247,Major Depressive Disorder,C1269683,NA,Approved,NA,NA,isocarboxazid
Docetaxel,DB01248,Cancer of Head and Neck,C0278996,NA,Approved,NA,NA,docetaxel
Docetaxel,DB01248,Breast Carcinoma,C0678222,NA,Approved,NA,NA,docetaxel
Docetaxel,DB01248,Non-Small Cell Lung Carcinoma,C0007131,NA,Approved,NA,NA,docetaxel
Docetaxel,DB01248,Carcinoma breast stage IV,C0278488,NA,Approved,NA,NA,docetaxel
Docetaxel,DB01248,Malignant neoplasm of stomach,C0024623,NA,Approved,NA,NA,docetaxel
Docetaxel,DB01248,Malignant neoplasm of prostate,C0376358,NA,Approved,NA,NA,docetaxel
Olsalazine,DB01250,Ulcerative colitis in remission,C3697010,NA,Approved,NA,NA,olsalazine
Gliquidone,DB01251,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,gliquidone
Mitiglinide,DB01252,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,mitiglinide
Ergonovine,DB01253,Postpartum Hemorrhage,C0032797,NA,Approved,NA,NA,ergonovine
Dasatinib,DB01254,Philadelphia chromosome positive chronic myelogenous leukemia,C0279543,NA,Approved,NA,NA,dasatinib
Dasatinib,DB01254,Philadelphia chromosome-positive acute lymphoblastic leukemia,C1960397,NA,Approved,NA,NA,dasatinib
Dasatinib,DB01254,Blast Phase,C0005699,NA,Approved,NA,NA,dasatinib
Dasatinib,DB01254,"Leukemia, Myeloid, Chronic-Phase",C0023474,NA,Approved,NA,NA,dasatinib
Dasatinib,DB01254,"Leukemia, Myeloid, Accelerated Phase",C0023472,NA,Approved,NA,NA,dasatinib
Lisdexamfetamine,DB01255,Attention deficit hyperactivity disorder,C1263846,NA,Approved,NA,NA,lisdexamfetamine
Lisdexamfetamine,DB01255,Binge eating disorder,C0596170,NA,Approved,NA,NA,lisdexamfetamine
Retapamulin,DB01256,Impetigo,C0021099,NA,Approved,NA,NA,retapamulin
Retapamulin,DB01256,Superficial bacterial infection of skin,C0342985,NA,Approved,NA,NA,retapamulin
Eculizumab,DB01257,Paroxysmal nocturnal hemoglobinuria,C0024790,NA,Approved,NA,NA,eculizumab
Eculizumab,DB01257,Congenital hemolytic uremic syndrome,C2919522,NA,Approved,NA,NA,eculizumab
Desonide,DB01260,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,desonide
Desonide,DB01260,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,desonide
Desonide,DB01260,Crohn Disease,C0010346,NA,Approved,NA,NA,desonide
Desonide,DB01260,Otitis Externa,C0029878,NA,Approved,NA,NA,desonide
Desonide,DB01260,Granuloma Annulare,C0085074,NA,Approved,NA,NA,desonide
Desonide,DB01260,"Lymphoma, T-Cell, Cutaneous",C0079773,NA,Approved,NA,NA,desonide
Desonide,DB01260,Pruritus of genital organs,C0033777,NA,Approved,NA,NA,desonide
Desonide,DB01260,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,desonide
Desonide,DB01260,Crohn's disease in remission,C1960764,NA,Approved,NA,NA,desonide
Desonide,DB01260,Exanthema,C0015230,NA,Approved,NA,NA,desonide
Desonide,DB01260,Pruritus Ani,C0033775,NA,Approved,NA,NA,desonide
Desonide,DB01260,"Lupus Erythematosus, Discoid",C0024138,NA,Approved,NA,NA,desonide
Desonide,DB01260,Lichen Simplex Chronicus,C0149922,NA,Approved,NA,NA,desonide
Desonide,DB01260,Scalp psoriasis,C0406326,NA,Approved,NA,NA,desonide
Desonide,DB01260,Contact Dermatitis,C0011616,NA,Approved,NA,NA,desonide
Desonide,DB01260,Asthma,C0004096,NA,Approved,NA,NA,desonide
Sitagliptin,DB01261,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,sitagliptin
Decitabine,DB01262,"Leukemia, Myelocytic, Acute",C0023467,NA,Approved,NA,NA,decitabine
Posaconazole,DB01263,Aspergillosis,C0004030,NA,Approved,NA,NA,posaconazole
Posaconazole,DB01263,Fusariosis,C0276758,NA,Approved,NA,NA,posaconazole
Posaconazole,DB01263,Chromoblastomycosis,C0008582,NA,Approved,NA,NA,posaconazole
Posaconazole,DB01263,Mycetoma,C0024449,NA,Approved,NA,NA,posaconazole
Posaconazole,DB01263,Coccidioidomycosis,C0009186,NA,Approved,NA,NA,posaconazole
Posaconazole,DB01263,Candidiasis,C0006840,NA,Approved,NA,NA,posaconazole
Darunavir,DB01264,HIV Infections,C0019693,NA,Approved,NA,NA,darunavir
Telbivudine,DB01265,"Hepatitis B, Chronic",C0524909,NA,Approved,NA,NA,telbivudine
Sinecatechins,DB01266,Condylomata Acuminata,C0009663,NA,Approved,NA,NA,sinecatechins
Sinecatechins,DB01266,Perianal warts,C0343730,NA,Approved,NA,NA,sinecatechins
Paliperidone,DB01267,Schizoaffective Disorder,C0036337,NA,Approved,NA,NA,paliperidone
Paliperidone,DB01267,Schizophrenia,C0036341,NA,Approved,NA,NA,paliperidone
Paliperidone,DB01267,Psychotic Disorders,C0033975,NA,Approved,NA,NA,paliperidone
Sunitinib,DB01268,Gastrointestinal Stromal Tumors,C0238198,NA,Approved,NA,NA,sunitinib
Sunitinib,DB01268,Renal Cell Carcinoma,C0007134,NA,Approved,NA,NA,sunitinib
Panitumumab,DB01269,Secondary malignant neoplasm of colon,C0346974,NA,Approved,NA,NA,panitumumab
Ranibizumab,DB01270,Exudative age-related macular degeneration,C0271084,NA,Approved,NA,NA,ranibizumab
Ranibizumab,DB01270,Central retinal vein occlusion with macular edema,C0339498,NA,Approved,NA,NA,ranibizumab
Ranibizumab,DB01270,Branch retinal vein occlusion with macular edema,C0339507,NA,Approved,NA,NA,ranibizumab
Ranibizumab,DB01270,Diabetic macular edema,C0730285,NA,Approved,NA,NA,ranibizumab
Ranibizumab,DB01270,Diabetic Retinopathy,C0011884,NA,Approved,NA,NA,ranibizumab
Idursulfase,DB01271,Mucopolysaccharidosis II,C0026705,NA,Approved,NA,NA,idursulfase
Alglucosidase alfa,DB01272,Generalized glycogen storage disease of infants,C0342751,NA,Approved,NA,NA,alglucosidase alfa
Arformoterol,DB01274,Chronic Obstructive Airway Disease,C0024117,NA,Approved,NA,NA,arformoterol
Arformoterol,DB01274,"Bronchitis, Chronic",C0008677,NA,Approved,NA,NA,arformoterol
Arformoterol,DB01274,Pulmonary Emphysema,C0034067,NA,Approved,NA,NA,arformoterol
Hydralazine,DB01275,Chronic heart failure,C0264716,NA,Approved,NA,NA,hydralazine
Hydralazine,DB01275,Hypertensive disease,C0020538,NA,Approved,NA,NA,hydralazine
Mecasermin,DB01277,Laron Syndrome,C0271568,NA,Approved,NA,NA,mecasermin
Galsulfase,DB01279,Mucopolysaccharidosis VI,C0026709,NA,Approved,NA,NA,galsulfase
Nelarabine,DB01280,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,C1961099,NA,Approved,NA,NA,nelarabine
Nelarabine,DB01280,Precursor T-cell lymphoblastic lymphoma,C1292758,NA,Approved,NA,NA,nelarabine
Abatacept,DB01281,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,abatacept
Abatacept,DB01281,Juvenile arthritis,C3495559,NA,Approved,NA,NA,abatacept
Carbetocin,DB01282,Prader-Willi Syndrome,C0032897,NA,Approved,NA,NA,carbetocin
Carbetocin,DB01282,Uterine Inertia,C0042135,NA,Approved,NA,NA,carbetocin
Lumiracoxib,DB01283,Degenerative polyarthritis,C0029408,NA,Approved,NA,NA,lumiracoxib
Corticotropin,DB01285,West Syndrome,C0037769,NA,Approved,NA,NA,corticotropin
Corticotropin,DB01285,Exacerbation of multiple sclerosis,C0581392,NA,Approved,NA,NA,corticotropin
Corticotropin,DB01285,Stevens-Johnson Syndrome,C0038325,NA,Approved,NA,NA,corticotropin
Glisoxepide,DB01289,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,glisoxepide
Pirbuterol,DB01291,Lung diseases,C0024115,NA,Approved,NA,NA,pirbuterol
Pirbuterol,DB01291,Bronchiectasis,C0006267,NA,Approved,NA,NA,pirbuterol
Pirbuterol,DB01291,Pulmonary Emphysema,C0034067,NA,Approved,NA,NA,pirbuterol
Pirbuterol,DB01291,Asthma,C0004096,NA,Approved,NA,NA,pirbuterol
Pirbuterol,DB01291,Bronchitis,C0006277,NA,Approved,NA,NA,pirbuterol
Pirbuterol,DB01291,Asthma attack,C0347950,NA,Approved,NA,NA,pirbuterol
Bismuth Subsalicylate,DB01294,Dyspepsia,C0013395,NA,Approved,NA,NA,bismuth subsalicylate
Bismuth Subsalicylate,DB01294,Diarrhea,C0011991,NA,Approved,NA,NA,bismuth subsalicylate
Insulin Aspart,DB01306,Diabetes Mellitus,C0011849,NA,Approved,NA,NA,insulin aspart
Insulin Detemir,DB01307,Diabetes Mellitus,C0011849,NA,Approved,NA,NA,insulin detemir
Insulin Glulisine,DB01309,Diabetes Mellitus,C0011849,NA,Approved,NA,NA,insulin glulisine
Fosamprenavir,DB01319,HIV Infections,C0019693,NA,Approved,NA,NA,fosamprenavir
Fosphenytoin,DB01320,Status Epilepticus,C0038220,NA,Approved,NA,NA,fosphenytoin
Fosphenytoin,DB01320,Epilepsy characterized by intractable complex partial seizures,C2711653,NA,Approved,NA,NA,fosphenytoin
Fosphenytoin,DB01320,Epilepsy,C0014544,NA,Approved,NA,NA,fosphenytoin
Polythiazide,DB01324,Hypertensive disease,C0020538,NA,Approved,NA,NA,polythiazide
Cefamandole,DB01326,Bacterial peritonitis,C0341503,NA,Approved,NA,NA,cefamandole
Cefamandole,DB01326,Proteus pneumonia,C1260917,NA,Approved,NA,NA,cefamandole
Cefamandole,DB01326,Urinary tract infection,C0042029,NA,Approved,NA,NA,cefamandole
Cefamandole,DB01326,Escherichia coli septicemia,C0276088,NA,Approved,NA,NA,cefamandole
Cefamandole,DB01326,Arthropathy associated with infection,C0157749,NA,Approved,NA,NA,cefamandole
Cefamandole,DB01326,Haemophilus sepsis,C0854324,NA,Approved,NA,NA,cefamandole
Cefamandole,DB01326,Bacterial sepsis,C0684256,NA,Approved,NA,NA,cefamandole
Cefamandole,DB01326,Pneumonia,C0032285,NA,Approved,NA,NA,cefamandole
Cefamandole,DB01326,Infection of bone,C2242472,NA,Approved,NA,NA,cefamandole
Cefamandole,DB01326,Staphylococcal Pneumonia,C0032308,NA,Approved,NA,NA,cefamandole
Cefamandole,DB01326,Peritonitis,C0031154,NA,Approved,NA,NA,cefamandole
Cefamandole,DB01326,Escherichia coli Infections,C0014836,NA,Approved,NA,NA,cefamandole
Cefamandole,DB01326,Bacterial urinary infection,C0729524,NA,Approved,NA,NA,cefamandole
Cefamandole,DB01326,Lower respiratory tract infection,C0149725,NA,Approved,NA,NA,cefamandole
Cefamandole,DB01326,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,cefamandole
Cefamandole,DB01326,Pneumonia due to Escherichia coli,C0276089,NA,Approved,NA,NA,cefamandole
Cefamandole,DB01326,Osteomyelitis due to Staphylococcus aureus,C1997728,NA,Approved,NA,NA,cefamandole
Cefamandole,DB01326,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,cefamandole
Cefamandole,DB01326,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,cefamandole
Cefamandole,DB01326,Bacterial infection due to Klebsiella pneumoniae,C0343402,NA,Approved,NA,NA,cefamandole
Cefamandole,DB01326,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,cefamandole
Cefamandole,DB01326,URINARY TRACT INFECTION ENTEROCOCCUS,C0749958,NA,Approved,NA,NA,cefamandole
Cefamandole,DB01326,Enterobacteriaceae Infections,C0014347,NA,Approved,NA,NA,cefamandole
Cefamandole,DB01326,Klebsiella cystitis,C0520775,NA,Approved,NA,NA,cefamandole
Cefamandole,DB01326,Proteus urinary tract infection,C0577709,NA,Approved,NA,NA,cefamandole
Cefamandole,DB01326,Staphylococcal bacteraemia,C0152965,NA,Approved,NA,NA,cefamandole
Cefamandole,DB01326,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,cefamandole
Cefamandole,DB01326,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,cefamandole
Cefamandole,DB01326,Streptococcal sepsis,C0152964,NA,Approved,NA,NA,cefamandole
Cefazolin,DB01327,Arthropathy associated with infection,C0157749,NA,Approved,NA,NA,cefazolin
Cefazolin,DB01327,Lower respiratory tract infection,C0149725,NA,Approved,NA,NA,cefazolin
Cefazolin,DB01327,Staphylococcal Pneumonia,C0032308,NA,Approved,NA,NA,cefazolin
Cefazolin,DB01327,Genitourinary tract infection,C1279247,NA,Approved,NA,NA,cefazolin
Cefazolin,DB01327,Infection of bone,C2242472,NA,Approved,NA,NA,cefazolin
Cefazolin,DB01327,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,cefazolin
Cefazolin,DB01327,Bacterial sepsis,C0684256,NA,Approved,NA,NA,cefazolin
Cefazolin,DB01327,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,cefazolin
Cefazolin,DB01327,Cholangitis,C0008311,NA,Approved,NA,NA,cefazolin
Cefonicid,DB01328,Klebsiella cystitis,C0520775,NA,Approved,NA,NA,cefonicid
Cefonicid,DB01328,Urinary tract infection,C0042029,NA,Approved,NA,NA,cefonicid
Cefonicid,DB01328,Escherichia coli septicemia,C0276088,NA,Approved,NA,NA,cefonicid
Cefonicid,DB01328,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,cefonicid
Cefonicid,DB01328,Bacterial infection due to Klebsiella pneumoniae,C0343402,NA,Approved,NA,NA,cefonicid
Cefonicid,DB01328,Lower respiratory tract infection,C0149725,NA,Approved,NA,NA,cefonicid
Cefonicid,DB01328,Proteus urinary tract infection,C0577709,NA,Approved,NA,NA,cefonicid
Cefonicid,DB01328,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,cefonicid
Cefonicid,DB01328,Osteomyelitis due to Staphylococcus aureus,C1997728,NA,Approved,NA,NA,cefonicid
Cefonicid,DB01328,Pneumonia due to Escherichia coli,C0276089,NA,Approved,NA,NA,cefonicid
Cefonicid,DB01328,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,cefonicid
Cefonicid,DB01328,Streptococcal sepsis,C0152964,NA,Approved,NA,NA,cefonicid
Cefonicid,DB01328,Bacterial sepsis,C0684256,NA,Approved,NA,NA,cefonicid
Cefonicid,DB01328,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,cefonicid
Cefonicid,DB01328,Arthropathy associated with infection,C0157749,NA,Approved,NA,NA,cefonicid
Cefonicid,DB01328,Infection of bone,C2242472,NA,Approved,NA,NA,cefonicid
Cefonicid,DB01328,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,cefonicid
Cefonicid,DB01328,Pneumonia,C0032285,NA,Approved,NA,NA,cefonicid
Cefotetan,DB01330,Proteus urinary tract infection,C0577709,NA,Approved,NA,NA,cefotetan
Cefotetan,DB01330,Female genital tract infection,C1263758,NA,Approved,NA,NA,cefotetan
Cefotetan,DB01330,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,cefotetan
Cefotetan,DB01330,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,cefotetan
Cefotetan,DB01330,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,cefotetan
Cefotetan,DB01330,Pneumonia due to Escherichia coli,C0276089,NA,Approved,NA,NA,cefotetan
Cefotetan,DB01330,Bacterial infection due to Klebsiella pneumoniae,C0343402,NA,Approved,NA,NA,cefotetan
Cefotetan,DB01330,Staphylococcal Pneumonia,C0032308,NA,Approved,NA,NA,cefotetan
Cefotetan,DB01330,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,cefotetan
Cefotetan,DB01330,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,cefotetan
Cefotetan,DB01330,Bacterial sepsis,C0684256,NA,Approved,NA,NA,cefotetan
Cefotetan,DB01330,Escherichia coli Infections,C0014836,NA,Approved,NA,NA,cefotetan
Cefotetan,DB01330,Endometritis,C0014179,NA,Approved,NA,NA,cefotetan
Cefotetan,DB01330,Lower respiratory tract infection,C0149725,NA,Approved,NA,NA,cefotetan
Cefotetan,DB01330,Klebsiella cystitis,C0520775,NA,Approved,NA,NA,cefotetan
Cefotetan,DB01330,Pelvic Inflammatory Disease,C0242172,NA,Approved,NA,NA,cefotetan
Cefotetan,DB01330,Proteus pneumonia,C1260917,NA,Approved,NA,NA,cefotetan
Cefotetan,DB01330,Osteomyelitis due to Staphylococcus aureus,C1997728,NA,Approved,NA,NA,cefotetan
Cefotetan,DB01330,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,cefotetan
Cefotetan,DB01330,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,cefotetan
Cefotetan,DB01330,Acute gonococcal endometritis,C0153196,NA,Approved,NA,NA,cefotetan
Cefoxitin,DB01331,Bacterial sepsis,C0684256,NA,Approved,NA,NA,cefoxitin
Cefoxitin,DB01331,Sepsis due to Staphylococcus aureus,C2887088,NA,Approved,NA,NA,cefoxitin
Cefoxitin,DB01331,Abdominal Abscess,C0243001,NA,Approved,NA,NA,cefoxitin
Cefoxitin,DB01331,Postoperative infection,C0392618,NA,Approved,NA,NA,cefoxitin
Cefoxitin,DB01331,Staphylococcal Pneumonia,C0032308,NA,Approved,NA,NA,cefoxitin
Cefoxitin,DB01331,Endometritis,C0014179,NA,Approved,NA,NA,cefoxitin
Cefoxitin,DB01331,Female genital tract infection,C1263758,NA,Approved,NA,NA,cefoxitin
Cefoxitin,DB01331,Rhinoscleroma,C0035468,NA,Approved,NA,NA,cefoxitin
Cefoxitin,DB01331,Acute gonococcal endometritis,C0153196,NA,Approved,NA,NA,cefoxitin
Cefoxitin,DB01331,Klebsiella cystitis,C0520775,NA,Approved,NA,NA,cefoxitin
Cefoxitin,DB01331,Peritonitis,C0031154,NA,Approved,NA,NA,cefoxitin
Cefoxitin,DB01331,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,cefoxitin
Cefoxitin,DB01331,Pelvic Inflammatory Disease,C0242172,NA,Approved,NA,NA,cefoxitin
Cefoxitin,DB01331,Arthropathy associated with infection,C0157749,NA,Approved,NA,NA,cefoxitin
Cefoxitin,DB01331,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,cefoxitin
Cefoxitin,DB01331,Escherichia coli septicemia,C0276088,NA,Approved,NA,NA,cefoxitin
Cefoxitin,DB01331,Pneumonia due to Escherichia coli,C0276089,NA,Approved,NA,NA,cefoxitin
Cefoxitin,DB01331,Bacterial infection due to Klebsiella pneumoniae,C0343402,NA,Approved,NA,NA,cefoxitin
Cefoxitin,DB01331,Proteus urinary tract infection,C0577709,NA,Approved,NA,NA,cefoxitin
Cefoxitin,DB01331,Osteomyelitis due to Staphylococcus aureus,C1997728,NA,Approved,NA,NA,cefoxitin
Cefoxitin,DB01331,Female pelvic cellulitis,C0349734,NA,Approved,NA,NA,cefoxitin
Cefoxitin,DB01331,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,cefoxitin
Cefoxitin,DB01331,Lung Abscess,C0024110,NA,Approved,NA,NA,cefoxitin
Cefoxitin,DB01331,Septicemia due to Bacteroides,C0276064,NA,Approved,NA,NA,cefoxitin
Cefoxitin,DB01331,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,cefoxitin
Cefoxitin,DB01331,Escherichia coli Infections,C0014836,NA,Approved,NA,NA,cefoxitin
Cefoxitin,DB01331,Streptococcal sepsis,C0152964,NA,Approved,NA,NA,cefoxitin
Cefoxitin,DB01331,Gonorrhea,C0018081,NA,Approved,NA,NA,cefoxitin
Cefoxitin,DB01331,Infection of bone,C2242472,NA,Approved,NA,NA,cefoxitin
Cefoxitin,DB01331,Acute gonococcal cervicitis,C0153195,NA,Approved,NA,NA,cefoxitin
Cefoxitin,DB01331,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,cefoxitin
Cefoxitin,DB01331,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,cefoxitin
Cefoxitin,DB01331,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,cefoxitin
Ceftizoxime,DB01332,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Proteus urinary tract infection,C0577709,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Gonorrhea of rectum,C0275665,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Rhinoscleroma,C0035468,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Streptococcal sepsis,C0152964,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Pneumonia due to Escherichia coli,C0276089,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Escherichia coli Infections,C0014836,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Serratia Infections,C0085394,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Urinary tract infection,C0042029,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Pneumonia,C0032285,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Meningitis,C0025289,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Serratia sepsis,C0152973,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Arthropathy associated with infection,C0157749,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Enterobacter pneumonia,C1096258,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Acute gonococcal cervicitis,C0153195,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Bacterial sepsis,C0684256,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Infection of bone,C2242472,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Acute gonococcal urethritis,C0275652,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Klebsiella cystitis,C0520775,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Staphylococcal Pneumonia,C0032308,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Osteomyelitis due to Staphylococcus aureus,C1997728,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Proteus pneumonia,C1260917,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Acute gonococcal endometritis,C0153196,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Bacterial infection due to Klebsiella pneumoniae,C0343402,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Lower respiratory tract infection,C0149725,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Bacterial urinary infection,C0729524,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Sepsis due to Staphylococcus aureus,C2887088,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Enterobacteriaceae Infections,C0014347,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Streptococcal meningitis,C0154639,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Gonorrhea,C0018081,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Bacterial peritonitis,C0341503,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Septicemia due to Bacteroides,C0276064,NA,Approved,NA,NA,ceftizoxime
Ceftizoxime,DB01332,Escherichia coli septicemia,C0276088,NA,Approved,NA,NA,ceftizoxime
Cefradine,DB01333,Infection of bone,C2242472,NA,Approved,NA,NA,cefradine
Cefradine,DB01333,Urinary tract infection,C0042029,NA,Approved,NA,NA,cefradine
Cefradine,DB01333,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,cefradine
Cefradine,DB01333,Upper Respiratory Infections,C0041912,NA,Approved,NA,NA,cefradine
Cefradine,DB01333,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,cefradine
Cefradine,DB01333,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,cefradine
Cefradine,DB01333,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,cefradine
Cefradine,DB01333,Bacterial infection due to Klebsiella pneumoniae,C0343402,NA,Approved,NA,NA,cefradine
Cefradine,DB01333,Streptococcal tonsillitis,C0275804,NA,Approved,NA,NA,cefradine
Cefradine,DB01333,prostatitis,C0033581,NA,Approved,NA,NA,cefradine
Cefradine,DB01333,Arthropathy associated with infection,C0157749,NA,Approved,NA,NA,cefradine
Cefradine,DB01333,Tonsillitis,C0040425,NA,Approved,NA,NA,cefradine
Cefradine,DB01333,Staphylococcal Pneumonia,C0032308,NA,Approved,NA,NA,cefradine
Cefradine,DB01333,Pharyngitis,C0031350,NA,Approved,NA,NA,cefradine
Cefradine,DB01333,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,cefradine
Cefradine,DB01333,Infective otitis media,C0729586,NA,Approved,NA,NA,cefradine
Cefradine,DB01333,Pneumonia,C0032285,NA,Approved,NA,NA,cefradine
Cefradine,DB01333,URINARY TRACT INFECTION ENTEROCOCCUS,C0749958,NA,Approved,NA,NA,cefradine
Cefradine,DB01333,Proteus urinary tract infection,C0577709,NA,Approved,NA,NA,cefradine
Cefradine,DB01333,Lower respiratory tract infection,C0149725,NA,Approved,NA,NA,cefradine
Cefradine,DB01333,Klebsiella cystitis,C0520775,NA,Approved,NA,NA,cefradine
Cefradine,DB01333,Acute otitis media,C0271429,NA,Approved,NA,NA,cefradine
Cilazapril,DB01340,Hypertensive disease,C0020538,NA,Approved,NA,NA,cilazapril
Polystyrene sulfonate,DB01344,Hyperkalemia,C0020461,NA,Approved,NA,NA,polystyrene sulfonate
Spirapril,DB01348,Hypertensive disease,C0020538,NA,Approved,NA,NA,spirapril
Tasosartan,DB01349,Hypertensive disease,C0020538,NA,Approved,NA,NA,tasosartan
Amobarbital,DB01351,Epilepsy,C0014544,NA,Approved,NA,NA,amobarbital
Amobarbital,DB01351,Sleeplessness,C0917801,NA,Approved,NA,NA,amobarbital
Amobarbital,DB01351,Status Epilepticus,C0038220,NA,Approved,NA,NA,amobarbital
Amobarbital,DB01351,Severe anxiety (panic),C0231403,NA,Approved,NA,NA,amobarbital
Aprobarbital,DB01352,Severe anxiety (panic),C0231403,NA,Approved,NA,NA,aprobarbital
Aprobarbital,DB01352,Sleeplessness,C0917801,NA,Approved,NA,NA,aprobarbital
Butethal,DB01353,Sleeplessness,C0917801,NA,Approved,NA,NA,butethal
Butethal,DB01353,Severe anxiety (panic),C0231403,NA,Approved,NA,NA,butethal
Lithium,DB01356,Bipolar Disorder,C0005586,NA,Approved,NA,NA,lithium
Lithium,DB01356,"Bipolar affective disorder, current episode manic",C0338873,NA,Approved,NA,NA,lithium
Lithium,DB01356,Bipolar disorder in remission,C0270425,NA,Approved,NA,NA,lithium
Lithium,DB01356,Headache Disorders,C0393735,NA,Approved,NA,NA,lithium
Lithium,DB01356,Pain,C0030193,NA,Approved,NA,NA,lithium
Lithium,DB01356,Fever,C0015967,NA,Approved,NA,NA,lithium
Lithium,DB01356,Degenerative polyarthritis,C0029408,NA,Approved,NA,NA,lithium
Lithium,DB01356,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,lithium
Lithium,DB01356,Dysmenorrhea,C0013390,NA,Approved,NA,NA,lithium
Mestranol,DB01357,Menorrhagia,C0025323,NA,Approved,NA,NA,mestranol
Mestranol,DB01357,Endometriosis,C0014175,NA,Approved,NA,NA,mestranol
Mestranol,DB01357,Female hypogonadism syndrome,C0271578,NA,Approved,NA,NA,mestranol
Penbutolol,DB01359,Hypertensive disease,C0020538,NA,Approved,NA,NA,penbutolol
Troleandomycin,DB01361,Streptococcal pneumonia,C0155862,NA,Approved,NA,NA,troleandomycin
Ephedrine,DB01364,Sinus headache,C0037195,NA,Approved,NA,NA,ephedrine
Ephedrine,DB01364,Bronchitis,C0006277,NA,Approved,NA,NA,ephedrine
Ephedrine,DB01364,Headache Disorders,C0393735,NA,Approved,NA,NA,ephedrine
Ephedrine,DB01364,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,ephedrine
Ephedrine,DB01364,Rhinorrhea,C1260880,NA,Approved,NA,NA,ephedrine
Ephedrine,DB01364,Influenza-like symptoms,C0392171,NA,Approved,NA,NA,ephedrine
Ephedrine,DB01364,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,ephedrine
Ephedrine,DB01364,Hay fever,C0018621,NA,Approved,NA,NA,ephedrine
Ephedrine,DB01364,Bronchial Spasm,C0006266,NA,Approved,NA,NA,ephedrine
Ephedrine,DB01364,"Rhinitis, Vasomotor",C0035460,NA,Approved,NA,NA,ephedrine
Ephedrine,DB01364,Hypotension,C0020649,NA,Approved,NA,NA,ephedrine
Ephedrine,DB01364,Rhinitis,C0035455,NA,Approved,NA,NA,ephedrine
Ephedrine,DB01364,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,ephedrine
Ephedrine,DB01364,Sneezing,C0037383,NA,Approved,NA,NA,ephedrine
Ephedrine,DB01364,Common Cold,C0009443,NA,Approved,NA,NA,ephedrine
Mephentermine,DB01365,Hypotension,C0020649,NA,Approved,NA,NA,mephentermine
Rasagiline,DB01367,Parkinson Disease,C0030567,NA,Approved,NA,NA,rasagiline
Quinupristin,DB01369,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,quinupristin
Magnesium oxide,DB01377,Incomplete passage of stool,C0426639,NA,Approved,NA,NA,magnesium oxide
Magnesium oxide,DB01377,Hypocalcemia,C0020598,NA,Approved,NA,NA,magnesium oxide
Magnesium oxide,DB01377,Constipation,C0009806,NA,Approved,NA,NA,magnesium oxide
Magnesium oxide,DB01377,Osteoporosis,C0029456,NA,Approved,NA,NA,magnesium oxide
Magnesium oxide,DB01377,Dyspepsia,C0013395,NA,Approved,NA,NA,magnesium oxide
Magnesium oxide,DB01377,Hypomagnesemia,C0151723,NA,Approved,NA,NA,magnesium oxide
Cortisone acetate,DB01380,Punctate keratopathy,C0423234,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Herpes zoster keratitis,C1275687,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Granuloma Annulare,C0085074,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Addisonian crisis,C0151467,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Pemphigus,C0030807,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Asthma,C0004096,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,"Anemia, Diamond-Blackfan",C1260899,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Bursitis,C0006444,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Sarcoidosis,C0036202,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,"Lupus Erythematosus, Systemic",C0024141,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Recurrent herpes simplex labialis,C1274321,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Rosacea,C0035854,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Exanthema,C0015230,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Autoimmune hemolytic anemia,C0002880,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,"Lymphoma, T-Cell, Cutaneous",C0079773,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Tinea Pedis,C0040259,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,"Lymphoma, Follicular",C0024301,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Serum Sickness,C0036830,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Otitis Externa,C0029878,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Mycosis Fungoides,C0026948,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Inflammatory Bowel Diseases,C0021390,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Congenital adrenal hyperplasia,C0001627,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Post traumatic osteoarthritis,C2894027,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Tendinitis,C0039503,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Malignant otitis externa due to Pseudomonas aeruginosa,C0395818,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Proctitis,C0033246,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Pruritus Ani,C0033775,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Pruritus of genital organs,C0033777,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Dermatitis Herpetiformis,C0011608,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Scalp psoriasis,C0406326,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Uveitis,C0042164,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,"Arthritis, Gouty",C0003868,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Synovitis,C0039103,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Hemorrhoids,C0019112,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Addison Disease,C0001403,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Cerebral Edema,C0006114,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Erythema Multiforme,C0014742,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Corneal abrasion,C0010032,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Humoral hypercalcemia of malignancy (disorder),C0149911,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Dermatologic disorders,C0037274,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Corneal Ulcer,C0010043,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Gingival Diseases,C0017563,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Disorder of eye,C0015397,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Musculoskeletal Diseases,C0026857,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Exfoliative dermatitis,C0011606,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Keratitis,C0022568,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Epicondylitis,C0014488,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Nephrotic Syndrome,C0027726,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Bacterial keratitis,C0854211,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Iridocyclitis,C0022073,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Lichen Simplex Chronicus,C0149922,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Cooley's anemia,C0002875,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Hodgkin Disease,C0019829,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Thyroiditis,C0040147,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Laryngeal Edema,C0023052,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Transplanted organ rejection,C0345468,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Tenosynovitis,C0039520,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Acute lymphocytic leukemia,C0023449,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Berylliosis,C0005138,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Infective blepharitis,C0729587,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Adrenogenital disorder,C0701163,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Ankylosing spondylitis,C0038013,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Tinea corporis (disorder),C0040252,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Blepharoconjunctivitis,C0005743,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,"Lupus Erythematosus, Discoid",C0024138,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Simple Pulmonary Eosinophilia,C0242459,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Acquired thrombocytopenia,C0154301,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Psoriasis,C0033860,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Adrenal cortical hypofunction,C0405580,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Trichinellosis,C0040896,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Chronic ulcerative proctitis,C2937222,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Contact Dermatitis,C0011616,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Tinea cruris,C1384589,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Itching of ear,C0849907,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,"Tuberculosis, Miliary",C0041321,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,"Lymphoma, Non-Hodgkin",C0024305,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Acne Vulgaris,C0001144,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Multiple Sclerosis,C0026769,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Iritis,C0022081,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Ulcerative Colitis,C0009324,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Autoimmune Diseases,C0004364,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Inflammatory dermatosis,C3875321,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Rheumatic Heart Disease,C0035439,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Crohn Disease,C0010346,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,"Arthritis, Psoriatic",C0003872,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Status Asthmaticus,C0038218,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Cyclitis,C0010543,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Aphthous Stomatitis,C0038363,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Angioedema,C0002994,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Aspiration pneumonitis,C1761609,NA,Approved,NA,NA,cortisone acetate
Cortisone acetate,DB01380,Infective otitis externa,C0021355,NA,Approved,NA,NA,cortisone acetate
Glycodiazine,DB01382,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,glycodiazine
Bezafibrate,DB01393,Hyperlipidemia,C0020473,NA,Approved,NA,NA,bezafibrate
Bezafibrate,DB01393,Hypercholesterolemia,C0020443,NA,Approved,NA,NA,bezafibrate
Colchicine,DB01394,Familial Mediterranean Fever,C0031069,NA,Approved,NA,NA,colchicine
Colchicine,DB01394,Gout,C0018099,NA,Approved,NA,NA,colchicine
Colchicine,DB01394,Chronic gouty arthritis,C0268108,NA,Approved,NA,NA,colchicine
Drospirenone,DB01395,Atrophic Vaginitis,C0221392,NA,Approved,NA,NA,drospirenone
Drospirenone,DB01395,Hot flushes,C0600142,NA,Approved,NA,NA,drospirenone
Drospirenone,DB01395,Premenstrual Dysphoric Disorder,C0520676,NA,Approved,NA,NA,drospirenone
Drospirenone,DB01395,Acne Vulgaris,C0001144,NA,Approved,NA,NA,drospirenone
Drospirenone,DB01395,Atrophy of vulva,C0156393,NA,Approved,NA,NA,drospirenone
Magnesium salicylate,DB01397,Back Pain,C0004604,NA,Approved,NA,NA,magnesium salicylate
Magnesium salicylate,DB01397,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,magnesium salicylate
Magnesium salicylate,DB01397,Fever,C0015967,NA,Approved,NA,NA,magnesium salicylate
Magnesium salicylate,DB01397,Shoulder tendinitis,C0262633,NA,Approved,NA,NA,magnesium salicylate
Magnesium salicylate,DB01397,Pain,C0030193,NA,Approved,NA,NA,magnesium salicylate
Magnesium salicylate,DB01397,Degenerative polyarthritis,C0029408,NA,Approved,NA,NA,magnesium salicylate
Magnesium salicylate,DB01397,Dysmenorrhea,C0013390,NA,Approved,NA,NA,magnesium salicylate
Magnesium salicylate,DB01397,Synovitis,C0039103,NA,Approved,NA,NA,magnesium salicylate
Magnesium salicylate,DB01397,Arthralgia,C0003862,NA,Approved,NA,NA,magnesium salicylate
Magnesium salicylate,DB01397,Bursitis,C0006444,NA,Approved,NA,NA,magnesium salicylate
Magnesium salicylate,DB01397,Headache Disorders,C0393735,NA,Approved,NA,NA,magnesium salicylate
Salsalate,DB01399,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,salsalate
Salsalate,DB01399,Degenerative polyarthritis,C0029408,NA,Approved,NA,NA,salsalate
Neostigmine,DB01400,Myasthenia Gravis,C0026896,NA,Approved,NA,NA,neostigmine
Neostigmine,DB01400,Urinary Retention,C0080274,NA,Approved,NA,NA,neostigmine
Danazol,DB01406,Endometriosis,C0014175,NA,Approved,NA,NA,danazol
Danazol,DB01406,Breast Fibrocystic Disease,C0016034,NA,Approved,NA,NA,danazol
Tiotropium,DB01409,"Bronchitis, Chronic",C0008677,NA,Approved,NA,NA,tiotropium
Tiotropium,DB01409,Pulmonary Emphysema,C0034067,NA,Approved,NA,NA,tiotropium
Tiotropium,DB01409,Asthma,C0004096,NA,Approved,NA,NA,tiotropium
Ciclesonide,DB01410,Asthma,C0004096,NA,Approved,NA,NA,ciclesonide
Ciclesonide,DB01410,Hay fever,C0018621,NA,Approved,NA,NA,ciclesonide
Ciclesonide,DB01410,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,ciclesonide
Pranlukast,DB01411,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,pranlukast
Pranlukast,DB01411,Asthma,C0004096,NA,Approved,NA,NA,pranlukast
Cefepime,DB01413,PYELONEPHRITIS E COLI,C0748196,NA,Approved,NA,NA,cefepime
Cefepime,DB01413,Klebsiella cystitis,C0520775,NA,Approved,NA,NA,cefepime
Cefepime,DB01413,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,cefepime
Cefepime,DB01413,Pneumonia due to Pseudomonas,C0155860,NA,Approved,NA,NA,cefepime
Cefepime,DB01413,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,cefepime
Cefepime,DB01413,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,cefepime
Cefepime,DB01413,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,cefepime
Cefepime,DB01413,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,cefepime
Cefepime,DB01413,Bacterial infection due to Klebsiella pneumoniae,C0343402,NA,Approved,NA,NA,cefepime
Cefepime,DB01413,Proteus urinary tract infection,C0577709,NA,Approved,NA,NA,cefepime
Cefepime,DB01413,Enterobacter pneumonia,C1096258,NA,Approved,NA,NA,cefepime
Cefepime,DB01413,Streptococcal pneumonia,C0155862,NA,Approved,NA,NA,cefepime
Ceftibuten,DB01415,Tonsillitis,C0040425,NA,Approved,NA,NA,ceftibuten
Ceftibuten,DB01415,Acute otitis media,C0271429,NA,Approved,NA,NA,ceftibuten
Ceftibuten,DB01415,Infective otitis media,C0729586,NA,Approved,NA,NA,ceftibuten
Ceftibuten,DB01415,Streptococcal tonsillitis,C0275804,NA,Approved,NA,NA,ceftibuten
Cefpodoxime,DB01416,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,cefpodoxime
Cefpodoxime,DB01416,Infective otitis media,C0729586,NA,Approved,NA,NA,cefpodoxime
Cefpodoxime,DB01416,Acute gonococcal cervicitis,C0153195,NA,Approved,NA,NA,cefpodoxime
Cefpodoxime,DB01416,Streptococcal tonsillitis,C0275804,NA,Approved,NA,NA,cefpodoxime
Cefpodoxime,DB01416,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,cefpodoxime
Cefpodoxime,DB01416,Streptococcal pneumonia,C0155862,NA,Approved,NA,NA,cefpodoxime
Cefpodoxime,DB01416,Acute maxillary sinusitis,C0155804,NA,Approved,NA,NA,cefpodoxime
Cefpodoxime,DB01416,Acute Moraxella catarrhalis bronchitis,C0339932,NA,Approved,NA,NA,cefpodoxime
Cefpodoxime,DB01416,Klebsiella cystitis,C0520775,NA,Approved,NA,NA,cefpodoxime
Cefpodoxime,DB01416,Gonorrhea of rectum,C0275665,NA,Approved,NA,NA,cefpodoxime
Cefpodoxime,DB01416,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,cefpodoxime
Cefpodoxime,DB01416,Tonsillitis,C0040425,NA,Approved,NA,NA,cefpodoxime
Cefpodoxime,DB01416,Proteus urinary tract infection,C0577709,NA,Approved,NA,NA,cefpodoxime
Cefpodoxime,DB01416,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,cefpodoxime
Cefpodoxime,DB01416,Gonorrhea,C0018081,NA,Approved,NA,NA,cefpodoxime
Cefpodoxime,DB01416,Acute exacerbation of chronic bronchitis,C0856695,NA,Approved,NA,NA,cefpodoxime
Cefpodoxime,DB01416,Acute otitis media,C0271429,NA,Approved,NA,NA,cefpodoxime
Cefpodoxime,DB01416,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,cefpodoxime
Cefpodoxime,DB01416,Pharyngitis,C0031350,NA,Approved,NA,NA,cefpodoxime
Cefpodoxime,DB01416,Acute gonococcal urethritis,C0275652,NA,Approved,NA,NA,cefpodoxime
Cefpodoxime,DB01416,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,cefpodoxime
Testosterone Propionate,DB01420,Cryptorchidism,C0010417,NA,Approved,NA,NA,testosterone propionate
Testosterone Propionate,DB01420,Klinefelter Syndrome,C0022735,NA,Approved,NA,NA,testosterone propionate
Testosterone Propionate,DB01420,Delayed Puberty,C0034012,NA,Approved,NA,NA,testosterone propionate
Testosterone Propionate,DB01420,Testicular hypogonadism,C0151721,NA,Approved,NA,NA,testosterone propionate
Testosterone Propionate,DB01420,Deficiency of testosterone biosynthesis,C0342527,NA,Approved,NA,NA,testosterone propionate
Testosterone Propionate,DB01420,Hormone receptor positive malignant neoplasm of breast,C1562029,NA,Approved,NA,NA,testosterone propionate
Paromomycin,DB01421,Chronic intestinal amebiasis,C0002440,NA,Approved,NA,NA,paromomycin
Paromomycin,DB01421,Hepatic Coma,C0019147,NA,Approved,NA,NA,paromomycin
Amrinone,DB01427,Decompensated cardiac failure,C0581377,NA,Approved,NA,NA,amrinone
Aprindine,DB01429,Supraventricular arrhythmia,C0428974,NA,Approved,NA,NA,aprindine
Aprindine,DB01429,Ventricular arrhythmia,C0085612,NA,Approved,NA,NA,aprindine
Almitrine,DB01430,Chronic Obstructive Airway Disease,C0024117,NA,Approved,NA,NA,almitrine
Cholestyramine,DB01432,Hyperlipidemia,C0020473,NA,Approved,NA,NA,cholestyramine
Cholestyramine,DB01432,Hypercholesterolemia,C0020443,NA,Approved,NA,NA,cholestyramine
Methadyl Acetate,DB01433,Opiate Addiction,C0524662,NA,Approved,NA,NA,methadyl acetate
Antipyrine,DB01435,Infective otitis media,C0729586,NA,Approved,NA,NA,antipyrine
Alfacalcidol,DB01436,Renal Osteodystrophy,C0035086,NA,Approved,NA,NA,alfacalcidol
Alfacalcidol,DB01436,Hyperparathyroidism,C0020502,NA,Approved,NA,NA,alfacalcidol
Alfacalcidol,DB01436,Hypoparathyroidism,C0020626,NA,Approved,NA,NA,alfacalcidol
Alfacalcidol,DB01436,Neonatal hypocalcemia,C0342634,NA,Approved,NA,NA,alfacalcidol
Glutethimide,DB01437,Sleeplessness,C0917801,NA,Approved,NA,NA,glutethimide
Phenazopyridine,DB01438,Dysuria,C0013428,NA,Approved,NA,NA,phenazopyridine
Gamma Hydroxybutyric Acid,DB01440,Narcolepsy-Cataplexy Syndrome,C0751362,NA,Approved,NA,NA,gamma hydroxybutyric acid
Gamma Hydroxybutyric Acid,DB01440,Narcolepsy,C0027404,NA,Approved,NA,NA,gamma hydroxybutyric acid
Heroin,DB01452,Severe pain,C0278140,NA,Approved,NA,NA,heroin
Difenoxin,DB01501,Diarrhea,C0011991,NA,Approved,NA,NA,difenoxin
Ethyl loflazepate,DB01545,Anxiety,C0003467,NA,Approved,NA,NA,ethyl loflazepate
Ethyl loflazepate,DB01545,Depressive disorder,C0011581,NA,Approved,NA,NA,ethyl loflazepate
Fenproporex,DB01550,Obesity,C0028754,NA,Approved,NA,NA,fenproporex
Dihydrocodeine,DB01551,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,dihydrocodeine
Dihydrocodeine,DB01551,Rhinitis,C0035455,NA,Approved,NA,NA,dihydrocodeine
Dihydrocodeine,DB01551,Common Cold,C0009443,NA,Approved,NA,NA,dihydrocodeine
Dihydrocodeine,DB01551,Rhinorrhea,C1260880,NA,Approved,NA,NA,dihydrocodeine
Dihydrocodeine,DB01551,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,dihydrocodeine
Dihydrocodeine,DB01551,Pain,C0030193,NA,Approved,NA,NA,dihydrocodeine
Dihydrocodeine,DB01551,Coughing,C0010200,NA,Approved,NA,NA,dihydrocodeine
Chloral hydrate,DB01563,Sleeplessness,C0917801,NA,Approved,NA,NA,chloral hydrate
Dextroamphetamine,DB01576,Narcolepsy,C0027404,NA,Approved,NA,NA,dextroamphetamine
Dextroamphetamine,DB01576,Attention deficit hyperactivity disorder,C1263846,NA,Approved,NA,NA,dextroamphetamine
Methamphetamine,DB01577,Attention deficit hyperactivity disorder,C1263846,NA,Approved,NA,NA,methamphetamine
Methamphetamine,DB01577,Obesity,C0028754,NA,Approved,NA,NA,methamphetamine
Phendimetrazine,DB01579,Obesity,C0028754,NA,Approved,NA,NA,phendimetrazine
Oxprenolol,DB01580,Hypertensive disease,C0020538,NA,Approved,NA,NA,oxprenolol
Oxprenolol,DB01580,Ventricular arrhythmia,C0085612,NA,Approved,NA,NA,oxprenolol
Oxprenolol,DB01580,Anxiety,C0003467,NA,Approved,NA,NA,oxprenolol
Ursodeoxycholic acid,DB01586,Cholelithiasis,C0008350,NA,Approved,NA,NA,ursodeoxycholic acid
Ursodeoxycholic acid,DB01586,Primary biliary cirrhosis,C0008312,NA,Approved,NA,NA,ursodeoxycholic acid
Prazepam,DB01588,Anxiety,C0003467,NA,Approved,NA,NA,prazepam
Prazepam,DB01588,Sleeplessness,C0917801,NA,Approved,NA,NA,prazepam
Quazepam,DB01589,Sleeplessness,C0917801,NA,Approved,NA,NA,quazepam
Everolimus,DB01590,Renal Cell Carcinoma,C0007134,NA,Approved,NA,NA,everolimus
Everolimus,DB01590,Breast Carcinoma,C0678222,NA,Approved,NA,NA,everolimus
Everolimus,DB01590,Hormone receptor positive malignant neoplasm of breast,C1562029,NA,Approved,NA,NA,everolimus
Everolimus,DB01590,Angiomyolipoma of kidney,C0241961,NA,Approved,NA,NA,everolimus
Everolimus,DB01590,Tuberous Sclerosis,C0041341,NA,Approved,NA,NA,everolimus
Solifenacin,DB01591,Bladder muscle dysfunction - overactive,C0403643,NA,Approved,NA,NA,solifenacin
Solifenacin,DB01591,Urgency of micturition,C0085606,NA,Approved,NA,NA,solifenacin
Solifenacin,DB01591,Increased frequency of micturition,C0042023,NA,Approved,NA,NA,solifenacin
Solifenacin,DB01591,Urge Incontinence,C0150045,NA,Approved,NA,NA,solifenacin
Iron,DB01592,Iron deficiency anemia,C0162316,NA,Approved,NA,NA,iron
Iron,DB01592,Anemia of prematurity,C0158996,NA,Approved,NA,NA,iron
Iron,DB01592,Megaloblastic anemia due to folate deficiency,C0151482,NA,Approved,NA,NA,iron
Nitrazepam,DB01595,Sleeplessness,C0917801,NA,Approved,NA,NA,nitrazepam
Nitrazepam,DB01595,"Epilepsies, Myoclonic",C0014550,NA,Approved,NA,NA,nitrazepam
Cilastatin,DB01597,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,cilastatin
Cilastatin,DB01597,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,cilastatin
Cilastatin,DB01597,Peritonitis,C0031154,NA,Approved,NA,NA,cilastatin
Cilastatin,DB01597,Pneumonia due to Escherichia coli,C0276089,NA,Approved,NA,NA,cilastatin
Cilastatin,DB01597,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,cilastatin
Cilastatin,DB01597,Female genital tract infection,C1263758,NA,Approved,NA,NA,cilastatin
Cilastatin,DB01597,Abdominal Abscess,C0243001,NA,Approved,NA,NA,cilastatin
Cilastatin,DB01597,Enterobacter pneumonia,C1096258,NA,Approved,NA,NA,cilastatin
Cilastatin,DB01597,Acute exacerbation of chronic bronchitis,C0856695,NA,Approved,NA,NA,cilastatin
Cilastatin,DB01597,Bacterial sepsis,C0684256,NA,Approved,NA,NA,cilastatin
Cilastatin,DB01597,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,cilastatin
Cilastatin,DB01597,Bacterial infection due to Klebsiella pneumoniae,C0343402,NA,Approved,NA,NA,cilastatin
Cilastatin,DB01597,Lower respiratory tract infection,C0149725,NA,Approved,NA,NA,cilastatin
Cilastatin,DB01597,Infection of bone,C2242472,NA,Approved,NA,NA,cilastatin
Cilastatin,DB01597,Pelvic Inflammatory Disease,C0242172,NA,Approved,NA,NA,cilastatin
Cilastatin,DB01597,Endometritis,C0014179,NA,Approved,NA,NA,cilastatin
Cilastatin,DB01597,Arthropathy associated with infection,C0157749,NA,Approved,NA,NA,cilastatin
Cilastatin,DB01597,Diabetic foot infection,C0744130,NA,Approved,NA,NA,cilastatin
Imipenem,DB01598,Pneumonia due to Escherichia coli,C0276089,NA,Approved,NA,NA,imipenem
Imipenem,DB01598,Endometritis,C0014179,NA,Approved,NA,NA,imipenem
Imipenem,DB01598,Diabetic foot infection,C0744130,NA,Approved,NA,NA,imipenem
Imipenem,DB01598,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,imipenem
Imipenem,DB01598,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,imipenem
Imipenem,DB01598,Bacterial infection due to Klebsiella pneumoniae,C0343402,NA,Approved,NA,NA,imipenem
Imipenem,DB01598,Arthropathy associated with infection,C0157749,NA,Approved,NA,NA,imipenem
Imipenem,DB01598,Abdominal Abscess,C0243001,NA,Approved,NA,NA,imipenem
Imipenem,DB01598,Lower respiratory tract infection,C0149725,NA,Approved,NA,NA,imipenem
Imipenem,DB01598,Enterobacter pneumonia,C1096258,NA,Approved,NA,NA,imipenem
Imipenem,DB01598,Female genital tract infection,C1263758,NA,Approved,NA,NA,imipenem
Imipenem,DB01598,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,imipenem
Imipenem,DB01598,Bacterial sepsis,C0684256,NA,Approved,NA,NA,imipenem
Imipenem,DB01598,Infection of bone,C2242472,NA,Approved,NA,NA,imipenem
Imipenem,DB01598,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,imipenem
Imipenem,DB01598,Peritonitis,C0031154,NA,Approved,NA,NA,imipenem
Imipenem,DB01598,Pelvic Inflammatory Disease,C0242172,NA,Approved,NA,NA,imipenem
Imipenem,DB01598,Acute exacerbation of chronic bronchitis,C0856695,NA,Approved,NA,NA,imipenem
Probucol,DB01599,Hypercholesterolemia,C0020443,NA,Approved,NA,NA,probucol
Probucol,DB01599,Hyperlipidemia,C0020473,NA,Approved,NA,NA,probucol
Tiaprofenic acid,DB01600,Degenerative polyarthritis,C0029408,NA,Approved,NA,NA,tiaprofenic acid
Tiaprofenic acid,DB01600,Pain,C0030193,NA,Approved,NA,NA,tiaprofenic acid
Tiaprofenic acid,DB01600,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,tiaprofenic acid
Lopinavir,DB01601,HIV Infections,C0019693,NA,Approved,NA,NA,lopinavir
Bacampicillin,DB01602,Gonorrhea,C0018081,NA,Approved,NA,NA,bacampicillin
Bacampicillin,DB01602,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,bacampicillin
Bacampicillin,DB01602,Urinary tract infection,C0042029,NA,Approved,NA,NA,bacampicillin
Bacampicillin,DB01602,Pharyngitis,C0031350,NA,Approved,NA,NA,bacampicillin
Bacampicillin,DB01602,Sinusitis,C0037199,NA,Approved,NA,NA,bacampicillin
Bacampicillin,DB01602,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,bacampicillin
Bacampicillin,DB01602,Infective otitis media,C0729586,NA,Approved,NA,NA,bacampicillin
Meticillin,DB01603,Bacterial sepsis,C0684256,NA,Approved,NA,NA,meticillin
Meticillin,DB01603,Staphylococcal Pneumonia,C0032308,NA,Approved,NA,NA,meticillin
Meticillin,DB01603,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,meticillin
Meticillin,DB01603,Sinusitis,C0037199,NA,Approved,NA,NA,meticillin
Tazobactam,DB01606,Pelvic Inflammatory Disease,C0242172,NA,Approved,NA,NA,tazobactam
Tazobactam,DB01606,Diabetic foot infection,C0744130,NA,Approved,NA,NA,tazobactam
Tazobactam,DB01606,Appendicitis,C0003615,NA,Approved,NA,NA,tazobactam
Tazobactam,DB01606,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,tazobactam
Tazobactam,DB01606,Nosocomial pneumonia,C0949083,NA,Approved,NA,NA,tazobactam
Tazobactam,DB01606,Peritonitis,C0031154,NA,Approved,NA,NA,tazobactam
Tazobactam,DB01606,Abdominal Abscess,C0243001,NA,Approved,NA,NA,tazobactam
Tazobactam,DB01606,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,tazobactam
Tazobactam,DB01606,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,tazobactam
Tazobactam,DB01606,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,tazobactam
Ticarcillin,DB01607,Enterobacter pneumonia,C1096258,NA,Approved,NA,NA,ticarcillin
Ticarcillin,DB01607,Pneumonia due to Escherichia coli,C0276089,NA,Approved,NA,NA,ticarcillin
Ticarcillin,DB01607,Lung Abscess,C0024110,NA,Approved,NA,NA,ticarcillin
Ticarcillin,DB01607,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,ticarcillin
Ticarcillin,DB01607,Salpingitis,C0036130,NA,Approved,NA,NA,ticarcillin
Ticarcillin,DB01607,Klebsiella cystitis,C0520775,NA,Approved,NA,NA,ticarcillin
Ticarcillin,DB01607,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,ticarcillin
Ticarcillin,DB01607,Pneumonia due to Pseudomonas,C0155860,NA,Approved,NA,NA,ticarcillin
Ticarcillin,DB01607,Serratia Infections,C0085394,NA,Approved,NA,NA,ticarcillin
Ticarcillin,DB01607,Enterobacteriaceae Infections,C0014347,NA,Approved,NA,NA,ticarcillin
Ticarcillin,DB01607,Sepsis due to Pseudomonas,C2887096,NA,Approved,NA,NA,ticarcillin
Ticarcillin,DB01607,"Empyema, Pleural",C0014013,NA,Approved,NA,NA,ticarcillin
Ticarcillin,DB01607,Rhinoscleroma,C0035468,NA,Approved,NA,NA,ticarcillin
Ticarcillin,DB01607,Proteus pneumonia,C1260917,NA,Approved,NA,NA,ticarcillin
Ticarcillin,DB01607,Urinary tract infection,C0042029,NA,Approved,NA,NA,ticarcillin
Ticarcillin,DB01607,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,ticarcillin
Ticarcillin,DB01607,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,ticarcillin
Ticarcillin,DB01607,Osteomyelitis due to Staphylococcus aureus,C1997728,NA,Approved,NA,NA,ticarcillin
Ticarcillin,DB01607,Bacterial sepsis,C0684256,NA,Approved,NA,NA,ticarcillin
Ticarcillin,DB01607,Sepsis due to Gram negative bacteria,C3163829,NA,Approved,NA,NA,ticarcillin
Ticarcillin,DB01607,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,ticarcillin
Ticarcillin,DB01607,Escherichia coli Infections,C0014836,NA,Approved,NA,NA,ticarcillin
Ticarcillin,DB01607,Pelvic Inflammatory Disease,C0242172,NA,Approved,NA,NA,ticarcillin
Ticarcillin,DB01607,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,ticarcillin
Ticarcillin,DB01607,Escherichia coli septicemia,C0276088,NA,Approved,NA,NA,ticarcillin
Ticarcillin,DB01607,Bacterial infection due to Klebsiella pneumoniae,C0343402,NA,Approved,NA,NA,ticarcillin
Ticarcillin,DB01607,Pelvic abscess,C0030785,NA,Approved,NA,NA,ticarcillin
Ticarcillin,DB01607,Bacterial urinary infection,C0729524,NA,Approved,NA,NA,ticarcillin
Ticarcillin,DB01607,Genitourinary tract infection,C1279247,NA,Approved,NA,NA,ticarcillin
Ticarcillin,DB01607,URINARY TRACT INFECTION CITROBACTER,C0749955,NA,Approved,NA,NA,ticarcillin
Ticarcillin,DB01607,Staphylococcal Pneumonia,C0032308,NA,Approved,NA,NA,ticarcillin
Ticarcillin,DB01607,Aspiration Pneumonia,C0032290,NA,Approved,NA,NA,ticarcillin
Ticarcillin,DB01607,Proteus septicemia,C0577690,NA,Approved,NA,NA,ticarcillin
Ticarcillin,DB01607,Sepsis due to Staphylococcus aureus,C2887088,NA,Approved,NA,NA,ticarcillin
Deferasirox,DB01609,Chronic iron overload,C1739382,NA,Approved,NA,NA,deferasirox
Deferasirox,DB01609,beta Thalassemia,C0005283,NA,Approved,NA,NA,deferasirox
Hydroxychloroquine,DB01611,"Malaria, Vivax",C0024537,NA,Approved,NA,NA,hydroxychloroquine
Hydroxychloroquine,DB01611,"Lupus Erythematosus, Systemic",C0024141,NA,Approved,NA,NA,hydroxychloroquine
Hydroxychloroquine,DB01611,Ovale malaria,C0152072,NA,Approved,NA,NA,hydroxychloroquine
Hydroxychloroquine,DB01611,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,hydroxychloroquine
Hydroxychloroquine,DB01611,"Lupus Erythematosus, Discoid",C0024138,NA,Approved,NA,NA,hydroxychloroquine
Hydroxychloroquine,DB01611,Quartan malaria,C0024536,NA,Approved,NA,NA,hydroxychloroquine
Hydroxychloroquine,DB01611,"Malaria, Falciparum",C0024535,NA,Approved,NA,NA,hydroxychloroquine
Amyl Nitrite,DB01612,Toxic effect of cyanide,C0238080,NA,Approved,NA,NA,amyl nitrite
Aceprometazine,DB01615,Sleeplessness,C0917801,NA,Approved,NA,NA,aceprometazine
Molindone,DB01618,Schizophrenia,C0036341,NA,Approved,NA,NA,molindone
Phenindamine,DB01619,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,phenindamine
Phenindamine,DB01619,Pruritus,C0033774,NA,Approved,NA,NA,phenindamine
Phenindamine,DB01619,Rhinorrhea,C1260880,NA,Approved,NA,NA,phenindamine
Phenindamine,DB01619,Symptomatic dermographism,C0343065,NA,Approved,NA,NA,phenindamine
Phenindamine,DB01619,"Rhinitis, Vasomotor",C0035460,NA,Approved,NA,NA,phenindamine
Phenindamine,DB01619,Urticaria,C0042109,NA,Approved,NA,NA,phenindamine
Phenindamine,DB01619,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,phenindamine
Phenindamine,DB01619,Sneezing,C0037383,NA,Approved,NA,NA,phenindamine
Phenindamine,DB01619,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,phenindamine
Pheniramine,DB01620,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,pheniramine
Pheniramine,DB01620,Symptomatic dermographism,C0343065,NA,Approved,NA,NA,pheniramine
Pheniramine,DB01620,Redness of eye,C0235267,NA,Approved,NA,NA,pheniramine
Pheniramine,DB01620,Fever,C0015967,NA,Approved,NA,NA,pheniramine
Pheniramine,DB01620,Hay fever,C0018621,NA,Approved,NA,NA,pheniramine
Pheniramine,DB01620,Itching of eye,C0022281,NA,Approved,NA,NA,pheniramine
Pheniramine,DB01620,Rhinorrhea,C1260880,NA,Approved,NA,NA,pheniramine
Pheniramine,DB01620,Urticaria,C0042109,NA,Approved,NA,NA,pheniramine
Pheniramine,DB01620,Influenza-like symptoms,C0392171,NA,Approved,NA,NA,pheniramine
Pheniramine,DB01620,Sore Throat,C0242429,NA,Approved,NA,NA,pheniramine
Pheniramine,DB01620,Sneezing,C0037383,NA,Approved,NA,NA,pheniramine
Pheniramine,DB01620,Sinus headache,C0037195,NA,Approved,NA,NA,pheniramine
Pheniramine,DB01620,Headache Disorders,C0393735,NA,Approved,NA,NA,pheniramine
Pheniramine,DB01620,Common Cold,C0009443,NA,Approved,NA,NA,pheniramine
Pheniramine,DB01620,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,pheniramine
Pheniramine,DB01620,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,pheniramine
Pheniramine,DB01620,Coughing,C0010200,NA,Approved,NA,NA,pheniramine
Pheniramine,DB01620,"Rhinitis, Vasomotor",C0035460,NA,Approved,NA,NA,pheniramine
Pheniramine,DB01620,Pruritus,C0033774,NA,Approved,NA,NA,pheniramine
Pipotiazine,DB01621,Schizophrenia,C0036341,NA,Approved,NA,NA,pipotiazine
Thiothixene,DB01623,Schizophrenia,C0036341,NA,Approved,NA,NA,thiothixene
Isopropamide,DB01625,Peptic Ulcer,C0030920,NA,Approved,NA,NA,isopropamide
Pargyline,DB01626,Hypertensive disease,C0020538,NA,Approved,NA,NA,pargyline
Lincomycin,DB01627,Pneumococcal Infections,C0032269,NA,Approved,NA,NA,lincomycin
Lincomycin,DB01627,Streptococcal Infections,C0038395,NA,Approved,NA,NA,lincomycin
Roflumilast,DB01656,Severe chronic obstructive pulmonary disease,C0730607,NA,Approved,NA,NA,roflumilast
Camphor,DB01744,Sprains and Strains,C0038048,NA,Approved,NA,NA,camphor
Camphor,DB01744,Back Pain,C0004604,NA,Approved,NA,NA,camphor
Camphor,DB01744,Arthritic pains,C0857177,NA,Approved,NA,NA,camphor
Dalfopristin,DB01764,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,dalfopristin
Calcipotriol,DB02300,Scalp psoriasis,C0406326,NA,Approved,NA,NA,calcipotriol
Calcipotriol,DB02300,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,calcipotriol
Vorinostat,DB02546,"Lymphoma, T-Cell, Cutaneous",C0079773,NA,Approved,NA,NA,vorinostat
Cholic Acid,DB02659,Biliary Tract Diseases,C0005424,NA,Approved,NA,NA,cholic acid
Cholic Acid,DB02659,Cholelithiasis,C0008350,NA,Approved,NA,NA,cholic acid
Cholic Acid,DB02659,Constipation,C0009806,NA,Approved,NA,NA,cholic acid
Cholic Acid,DB02659,Incomplete passage of stool,C0426639,NA,Approved,NA,NA,cholic acid
Cholic Acid,DB02659,3-Beta-hydroxy-delta-5-C27-steroid dehydrogenase deficiency,C0342826,NA,Approved,NA,NA,cholic acid
Cholic Acid,DB02659,Delta-4-3-oxosteroid-5-beta-reductase deficiency,C0342827,NA,Approved,NA,NA,cholic acid
Cholic Acid,DB02659,"Xanthomatosis, Cerebrotendinous",C0238052,NA,Approved,NA,NA,cholic acid
Nicotinamide,DB02701,Acne Vulgaris,C0001144,NA,Approved,NA,NA,nicotinamide
Nicotinamide,DB02701,Pellagra,C0030783,NA,Approved,NA,NA,nicotinamide
Fusidic Acid,DB02703,Pneumonia due to Escherichia coli,C0276089,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Furunculosis,C0016867,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Bacterial keratitis,C0854211,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Gingivostomatitis,C0149704,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Endemic Flea-Borne Typhus,C0041472,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Pharyngitis,C0031350,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Rosacea,C0035854,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Keratoconjunctivitis,C0022573,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Acute gonococcal endometritis,C0153196,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Herpes zoster keratitis,C1275687,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Escherichia coli septicemia,C0276088,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Anthrax disease,C0003175,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Peritonitis,C0031154,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Osteomyelitis due to Staphylococcus aureus,C1997728,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Tularemia,C0041351,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Infection of bone,C2242472,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Brucellosis,C0006309,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Staphylococcal Pneumonia,C0032308,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Acute gonococcal urethritis,C0275652,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,non-gonococcal urethritis (NGU),C1112709,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Sinusitis,C0037199,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Gonorrhea,C0018081,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Actinomycosis,C0001261,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Sepsis due to Pseudomonas,C2887096,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Pneumonia due to Pseudomonas,C0155860,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Granuloma Inguinale,C0018190,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Rickettsia Infections,C0035585,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Yaws,C0043388,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Boutonneuse Fever,C0006060,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Corneal Perforation,C0339293,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Serratia sepsis,C0152973,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Citrobacter sepsis,C1096254,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Q Fever,C0034362,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Bacterial sepsis,C0684256,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Q fever endocarditis,C0340354,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Pneumococcal Infections,C0032269,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,"Meningitis, Bacterial",C0085437,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Sepsis of the newborn,C0456103,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Mycoplasma pneumonia,C0032302,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Inhalational anthrax,C0155866,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Dacryocystitis,C0010930,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Rhinoscleroma,C0035468,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Bacterial infection due to Klebsiella pneumoniae,C0343402,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Urinary tract infection,C0042029,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Sepsis due to Gram negative bacteria,C3163829,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Gonorrhea of pharynx,C0149966,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Listeriosis,C0023860,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Cholangitis,C0008311,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Anterior uveitis,C0042165,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Relapsing Fever,C0035021,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Bacterial conjunctivitis,C0009768,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Acne Vulgaris,C0001144,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Cutaneous anthrax,C0003177,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Infective otitis media,C0729586,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Meibomianitis,C0549398,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Trachoma,C0040592,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Rocky Mountain Spotted Fever,C0035793,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Gonorrhea of rectum,C0275665,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Paronychia Inflammation,C0030578,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Folliculitis,C0016436,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Chancroids,C0007947,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Escherichia coli Infections,C0014836,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Brill-Zinsser Disease,C0006181,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Infection due to Pseudomonas aeruginosa,C0276075,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Neonatal meningitis,C0456107,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Cholera,C0008354,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Bacterial peritonitis,C0341503,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Neonatal pneumonia,C0339968,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,"Typhus, Epidemic Louse-Borne",C0041473,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Pseudomonas aeruginosa meningitis,C3665869,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Enterobacteriaceae Infections,C0014347,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Bronchitis,C0006277,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Acute gonococcal cervicitis,C0153195,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Acute gonococcal epididymo-orchitis,C0153193,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Klebsiella sepsis,C0745528,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Syphilis,C0039128,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Psittacosis,C0029291,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,TYPHUS,C0041471,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Blepharoconjunctivitis,C0005743,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Enterobacter pneumonia,C1096258,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Lymphogranuloma Venereum,C0024286,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Chlamydia Infections,C0008149,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Gastrointestinal anthrax,C0152945,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Proteus pneumonia,C1260917,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Arthropathy associated with infection,C0157749,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Chlamydia trachomatis infection of genital structure,C1997322,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Rickettsialpox,C0035597,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Infective blepharitis,C0729587,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Nosocomial pneumonia,C0949083,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Proteus septicemia,C0577690,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Punctate keratitis,C0259799,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Streptococcal Infections,C0038395,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Bartonella Infections,C0004771,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Pneumonia,C0032285,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Scrub Typhus,C0036472,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Serratia Infections,C0085394,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,Corneal abrasion,C0010032,NA,Approved,NA,NA,fusidic acid
Fusidic Acid,DB02703,GONOCOCCAL INFECTION DISSEMINATED,C0744451,NA,Approved,NA,NA,fusidic acid
Acetic acid,DB03166,Otitis Externa,C0029878,NA,Approved,NA,NA,acetic acid
Oteracil,DB03209,Malignant neoplasm of stomach,C0024623,NA,Approved,NA,NA,oteracil
Phenol,DB03255,Skin irritation,C0152030,NA,Approved,NA,NA,phenol
Phenol,DB03255,Mouth irritation,C0235339,NA,Approved,NA,NA,phenol
Phenol,DB03255,Pruritus,C0033774,NA,Approved,NA,NA,phenol
Hemin,DB03404,Acute intermittent porphyria,C0162565,NA,Approved,NA,NA,hemin
Deoxycholic Acid,DB03619,Excess subcutaneous fat,C0424620,NA,Approved,NA,NA,deoxycholic acid
Benzoic Acid,DB03793,Dermatomyositis,C0011633,NA,Approved,NA,NA,benzoic acid
Benzoic Acid,DB03793,Scleroderma,C0011644,NA,Approved,NA,NA,benzoic acid
Benzoic Acid,DB03793,Morphea,C1527383,NA,Approved,NA,NA,benzoic acid
Benzoic Acid,DB03793,Peyronie Disease,C0030848,NA,Approved,NA,NA,benzoic acid
Benzoic Acid,DB03793,Pemphigus,C0030807,NA,Approved,NA,NA,benzoic acid
Benzoic Acid,DB03793,Hyperammonemia,C0220994,NA,Approved,NA,NA,benzoic acid
Formaldehyde,DB03843,Influenza,C0021400,NA,Approved,NA,NA,formaldehyde
Urea,DB03904,Impacted cerumen,C0021092,NA,Approved,NA,NA,urea
Urea,DB03904,Exanthema,C0015230,NA,Approved,NA,NA,urea
Urea,DB03904,Contact Dermatitis,C0011616,NA,Approved,NA,NA,urea
Urea,DB03904,Scurfiness of scalp,C0423775,NA,Approved,NA,NA,urea
Urea,DB03904,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,urea
Urea,DB03904,Tinea Versicolor,C0040262,NA,Approved,NA,NA,urea
Lactic Acid,DB04398,Pruritus,C0033774,NA,Approved,NA,NA,lactic acid
Lactose,DB04465,Lactose Intolerance,C0022951,NA,Approved,NA,NA,lactose
Trioxsalen,DB04571,Photosensitivity of skin,C0349506,NA,Approved,NA,NA,trioxsalen
Trioxsalen,DB04571,Vitiligo,C0042900,NA,Approved,NA,NA,trioxsalen
Thiotepa,DB04572,Hodgkin Disease,C0019829,NA,Approved,NA,NA,thiotepa
Thiotepa,DB04572,"Pleural Effusion, Malignant",C0080032,NA,Approved,NA,NA,thiotepa
Thiotepa,DB04572,Malignant neoplasm of ovary,C1140680,NA,Approved,NA,NA,thiotepa
Thiotepa,DB04572,"Lymphoma, Non-Hodgkin",C0024305,NA,Approved,NA,NA,thiotepa
Thiotepa,DB04572,Malignant epithelial neoplasm of female breast,C3163805,NA,Approved,NA,NA,thiotepa
Thiotepa,DB04572,Malignant ascites,C0220656,NA,Approved,NA,NA,thiotepa
Thiotepa,DB04572,Malignant pericardial effusion,C0220655,NA,Approved,NA,NA,thiotepa
Thiotepa,DB04572,Malignant neoplasm of urinary bladder,C0005684,NA,Approved,NA,NA,thiotepa
Estrone sulfate,DB04574,Atrophic Vaginitis,C0221392,NA,Approved,NA,NA,estrone sulfate
Quinestrol,DB04575,Female hypogonadism syndrome,C0271578,NA,Approved,NA,NA,quinestrol
Quinestrol,DB04575,Hot flushes,C0600142,NA,Approved,NA,NA,quinestrol
Quinestrol,DB04575,Atrophic Vaginitis,C0221392,NA,Approved,NA,NA,quinestrol
Suramin,DB04786,African Trypanosomiasis,C0041228,NA,Approved,NA,NA,suramin
Clofedanol,DB04837,Coughing,C0010200,NA,Approved,NA,NA,clofedanol
Clofedanol,DB04837,Common Cold,C0009443,NA,Approved,NA,NA,clofedanol
Clofedanol,DB04837,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,clofedanol
Clofedanol,DB04837,"Rhinitis, Vasomotor",C0035460,NA,Approved,NA,NA,clofedanol
Clofedanol,DB04837,Rhinorrhea,C1260880,NA,Approved,NA,NA,clofedanol
Clofedanol,DB04837,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,clofedanol
Clofedanol,DB04837,Rhinitis,C0035455,NA,Approved,NA,NA,clofedanol
Fluspirilene,DB04842,Schizophrenia,C0036341,NA,Approved,NA,NA,fluspirilene
Mepenzolate,DB04843,Gastric ulcer,C0038358,NA,Approved,NA,NA,mepenzolate
Mepenzolate,DB04843,Peptic Ulcer,C0030920,NA,Approved,NA,NA,mepenzolate
Ixabepilone,DB04845,Breast Carcinoma,C0678222,NA,Approved,NA,NA,ixabepilone
Ixabepilone,DB04845,Carcinoma breast stage IV,C0278488,NA,Approved,NA,NA,ixabepilone
Celiprolol,DB04846,Hypertensive disease,C0020538,NA,Approved,NA,NA,celiprolol
Febuxostat,DB04854,Hyperuricemia,C0740394,NA,Approved,NA,NA,febuxostat
Dronedarone,DB04855,Paroxysmal atrial fibrillation,C0235480,NA,Approved,NA,NA,dronedarone
Nebivolol,DB04861,Hypertensive disease,C0020538,NA,Approved,NA,NA,nebivolol
Homoharringtonine,DB04865,"Myeloid Leukemia, Chronic",C0023473,NA,Approved,NA,NA,homoharringtonine
Nilotinib,DB04868,"Leukemia, Myeloid, Accelerated Phase",C0023472,NA,Approved,NA,NA,nilotinib
Nilotinib,DB04868,Philadelphia chromosome positive chronic myelogenous leukemia,C0279543,NA,Approved,NA,NA,nilotinib
Nilotinib,DB04868,"Leukemia, Myeloid, Chronic-Phase",C0023474,NA,Approved,NA,NA,nilotinib
Lorcaserin,DB04871,Obesity,C0028754,NA,Approved,NA,NA,lorcaserin
Vildagliptin,DB04876,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,vildagliptin
Voglibose,DB04878,Gaucher Disease,C0017205,NA,Approved,NA,NA,voglibose
Voglibose,DB04878,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,voglibose
Bepotastine,DB04890,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,bepotastine
Pegaptanib,DB04895,Exudative age-related macular degeneration,C0271084,NA,Approved,NA,NA,pegaptanib
Milnacipran,DB04896,Fibromyalgia,C0016053,NA,Approved,NA,NA,milnacipran
Lucinactant,DB04897,"Respiratory Distress Syndrome, Newborn",C0035220,NA,Approved,NA,NA,lucinactant
Nesiritide,DB04899,Decompensated chronic heart failure,C1827266,NA,Approved,NA,NA,nesiritide
Nesiritide,DB04899,Decompensated cardiac failure,C0581377,NA,Approved,NA,NA,nesiritide
Flibanserin,DB04908,Hypoactive Sexual Desire Disorder,C0020594,NA,Approved,NA,NA,flibanserin
Oritavancin,DB04911,"Skin Diseases, Bacterial",C0162627,NA,Approved,NA,NA,oritavancin
Oritavancin,DB04911,Staphylococcal Skin Infections,C0038166,NA,Approved,NA,NA,oritavancin
Oritavancin,DB04911,Streptococcal infection of skin,C1274355,NA,Approved,NA,NA,oritavancin
Clevidipine,DB04920,Hypertensive disease,C0020538,NA,Approved,NA,NA,clevidipine
Permethrin,DB04930,Scabies <infestation>,C0036262,NA,Approved,NA,NA,permethrin
Permethrin,DB04930,Pediculus capitis infestation,C0030757,NA,Approved,NA,NA,permethrin
Permethrin,DB04930,Infestation by Phthirus pubis,C0030759,NA,Approved,NA,NA,permethrin
Permethrin,DB04930,Body louse infestation,C0030758,NA,Approved,NA,NA,permethrin
Afamelanotide,DB04931,Erythropoietic Protoporphyria,C0162568,NA,Approved,NA,NA,afamelanotide
Defibrotide,DB04932,Hepatic Veno-Occlusive Disease,C0019156,NA,Approved,NA,NA,defibrotide
Ospemifene,DB04938,Dyspareunia,C1384606,NA,Approved,NA,NA,ospemifene
Crofelemer,DB04941,Non-infective diarrhea,C0267436,NA,Approved,NA,NA,crofelemer
Tamibarotene,DB04942,Acute Promyelocytic Leukemia,C0023487,NA,Approved,NA,NA,tamibarotene
Iloperidone,DB04946,Schizophrenia,C0036341,NA,Approved,NA,NA,iloperidone
Lofexidine,DB04948,Opioid withdrawal,C0029104,NA,Approved,NA,NA,lofexidine
Ingenol Mebutate,DB05013,Actinic keratosis,C0022602,NA,Approved,NA,NA,ingenol mebutate
Belinostat,DB05015,Peripheral T-Cell Lymphoma,C0079774,NA,Approved,NA,NA,belinostat
Ataluren,DB05016,"Muscular Dystrophy, Duchenne",C0013264,NA,Approved,NA,NA,ataluren
Trabectedin,DB05109,Malignant neoplasm of ovary,C1140680,NA,Approved,NA,NA,trabectedin
Trabectedin,DB05109,liposarcoma,C0023827,NA,Approved,NA,NA,trabectedin
Trabectedin,DB05109,leiomyosarcoma,C0023269,NA,Approved,NA,NA,trabectedin
Cobimetinib,DB05239,"Malignant melanoma, metastatic",C0860594,NA,Approved,NA,NA,cobimetinib
Silver sulfadiazine,DB05245,Skin Ulcer,C0037299,NA,Approved,NA,NA,silver sulfadiazine
Methsuximide,DB05246,Absence Epilepsy,C0014553,NA,Approved,NA,NA,methsuximide
Methsuximide,DB05246,Epilepsy,C0014544,NA,Approved,NA,NA,methsuximide
Glatiramer Acetate,DB05259,Multiple Sclerosis,C0026769,NA,Approved,NA,NA,glatiramer acetate
Ecabet,DB05265,Peptic Ulcer,C0030920,NA,Approved,NA,NA,ecabet
Ibudilast,DB05266,Asthma,C0004096,NA,Approved,NA,NA,ibudilast
Rotigotine,DB05271,Restless Legs Syndrome,C0035258,NA,Approved,NA,NA,rotigotine
Rotigotine,DB05271,Parkinson Disease,C0030567,NA,Approved,NA,NA,rotigotine
Vandetanib,DB05294,Malignant epithelial neoplasm of thyroid,C3163939,NA,Approved,NA,NA,vandetanib
Ecallantide,DB05311,"Angioedemas, Hereditary",C0019243,NA,Approved,NA,NA,ecallantide
Romiplostim,DB05332,Chronic idiopathic thrombocytopenic purpura,C0272293,NA,Approved,NA,NA,romiplostim
Obiltoxaximab,DB05336,Inhalational anthrax,C0155866,NA,Approved,NA,NA,obiltoxaximab
Telaprevir,DB05521,"Hepatitis C, Chronic",C0524910,NA,Approved,NA,NA,telaprevir
Mipomersen,DB05528,Familial hypercholesterolemia - homozygous,C0342881,NA,Approved,NA,NA,mipomersen
Ramucirumab,DB05578,Gastric Adenocarcinoma,C0278701,NA,Approved,NA,NA,ramucirumab
Ramucirumab,DB05578,Non-Small Cell Lung Carcinoma,C0007131,NA,Approved,NA,NA,ramucirumab
Sodium stibogluconate,DB05630,Leishmaniasis,C0023281,NA,Approved,NA,NA,sodium stibogluconate
Apremilast,DB05676,"Arthritis, Psoriatic",C0003872,NA,Approved,NA,NA,apremilast
Apremilast,DB05676,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,apremilast
Ustekinumab,DB05679,Psoriasis,C0033860,NA,Approved,NA,NA,ustekinumab
Ustekinumab,DB05679,"Arthritis, Psoriatic",C0003872,NA,Approved,NA,NA,ustekinumab
Trastuzumab emtansine,DB05773,HER2-positive carcinoma of breast,C1960398,NA,Approved,NA,NA,trastuzumab emtansine
Abiraterone,DB05812,Malignant neoplasm of prostate,C0376358,NA,Approved,NA,NA,abiraterone
Parathyroid hormone,DB05829,Hypoparathyroidism,C0020626,NA,Approved,NA,NA,parathyroid hormone
Cariprazine,DB06016,Schizophrenia,C0036341,NA,Approved,NA,NA,cariprazine
Cariprazine,DB06016,Mixed bipolar I disorder,C0236780,NA,Approved,NA,NA,cariprazine
Cariprazine,DB06016,"Bipolar affective disorder, current episode manic",C0338873,NA,Approved,NA,NA,cariprazine
Sertindole,DB06144,Schizophrenia,C0036341,NA,Approved,NA,NA,sertindole
Sulfathiazole,DB06147,Vulvovaginitis,C0042998,NA,Approved,NA,NA,sulfathiazole
Mianserin,DB06148,Major Depressive Disorder,C1269683,NA,Approved,NA,NA,mianserin
Acetylcysteine,DB06151,Poisoning by acetaminophen,C0237963,NA,Approved,NA,NA,acetylcysteine
Acetylcysteine,DB06151,Bronchiectasis,C0006267,NA,Approved,NA,NA,acetylcysteine
Acetylcysteine,DB06151,Bronchitis,C0006277,NA,Approved,NA,NA,acetylcysteine
Acetylcysteine,DB06151,Amyloidosis,C0002726,NA,Approved,NA,NA,acetylcysteine
Acetylcysteine,DB06151,Pulmonary Cystic Fibrosis,C0392164,NA,Approved,NA,NA,acetylcysteine
Rimonabant,DB06155,Obesity,C0028754,NA,Approved,NA,NA,rimonabant
Canakinumab,DB06168,Cryopyrin-Associated Periodic Syndromes,C2316212,NA,Approved,NA,NA,canakinumab
Canakinumab,DB06168,Systemic onset juvenile chronic arthritis,C1384600,NA,Approved,NA,NA,canakinumab
Canakinumab,DB06168,"Arthritis, Gouty",C0003868,NA,Approved,NA,NA,canakinumab
Canakinumab,DB06168,Deficiency of mevalonate kinase,C0342731,NA,Approved,NA,NA,canakinumab
Canakinumab,DB06168,Familial Mediterranean Fever,C0031069,NA,Approved,NA,NA,canakinumab
Canakinumab,DB06168,TNF receptor-associated periodic fever syndrome (TRAPS),C1275126,NA,Approved,NA,NA,canakinumab
Romidepsin,DB06176,Peripheral T-Cell Lymphoma,C0079774,NA,Approved,NA,NA,romidepsin
Romidepsin,DB06176,"Lymphoma, T-Cell, Cutaneous",C0079773,NA,Approved,NA,NA,romidepsin
Ipilimumab,DB06186,"Malignant melanoma, metastatic",C0860594,NA,Approved,NA,NA,ipilimumab
Icatibant,DB06196,"Angioedemas, Hereditary",C0019243,NA,Approved,NA,NA,icatibant
Rufinamide,DB06201,Lennox-Gastaut syndrome,C0238111,NA,Approved,NA,NA,rufinamide
Alogliptin,DB06203,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,alogliptin
Tapentadol,DB06204,Pain,C0030193,NA,Approved,NA,NA,tapentadol
Silodosin,DB06207,Prostatic Hypertrophy,C1739363,NA,Approved,NA,NA,silodosin
Prasugrel,DB06209,Acute Coronary Syndrome,C0948089,NA,Approved,NA,NA,prasugrel
Eltrombopag,DB06210,Chronic idiopathic thrombocytopenic purpura,C0272293,NA,Approved,NA,NA,eltrombopag
Doripenem,DB06211,Pyelonephritis,C0034186,NA,Approved,NA,NA,doripenem
Doripenem,DB06211,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,doripenem
Doripenem,DB06211,Complicated appendicitis,C1632842,NA,Approved,NA,NA,doripenem
Doripenem,DB06211,Cholecystitis,C0008325,NA,Approved,NA,NA,doripenem
Doripenem,DB06211,Abdominal Abscess,C0243001,NA,Approved,NA,NA,doripenem
Tolvaptan,DB06212,Inappropriate ADH Syndrome,C0021141,NA,Approved,NA,NA,tolvaptan
Tolvaptan,DB06212,Hyponatremia,C0020625,NA,Approved,NA,NA,tolvaptan
Tolvaptan,DB06212,"Polycystic Kidney, Autosomal Dominant",C0085413,NA,Approved,NA,NA,tolvaptan
Asenapine,DB06216,Schizophrenia,C0036341,NA,Approved,NA,NA,asenapine
Asenapine,DB06216,Mixed bipolar I disorder,C0236780,NA,Approved,NA,NA,asenapine
Asenapine,DB06216,"Bipolar affective disorder, current episode manic",C0338873,NA,Approved,NA,NA,asenapine
Dalbavancin,DB06219,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,dalbavancin
Dalbavancin,DB06219,Staphylococcal Skin Infections,C0038166,NA,Approved,NA,NA,dalbavancin
Dalbavancin,DB06219,"Skin Diseases, Bacterial",C0162627,NA,Approved,NA,NA,dalbavancin
Avanafil,DB06237,Erectile dysfunction,C0242350,NA,Approved,NA,NA,avanafil
Eflornithine,DB06243,African Trypanosomiasis,C0041228,NA,Approved,NA,NA,eflornithine
Incadronic acid,DB06255,Osteoporosis,C0029456,NA,Approved,NA,NA,incadronic acid
Droxidopa,DB06262,Parkinson Disease,C0030567,NA,Approved,NA,NA,droxidopa
Udenafil,DB06267,Erectile dysfunction,C0242350,NA,Approved,NA,NA,udenafil
Sitaxentan,DB06268,Pulmonary arterial hypertension,C2973725,NA,Approved,NA,NA,sitaxentan
Tocilizumab,DB06273,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,tocilizumab
Tocilizumab,DB06273,Angiolymphoid hyperplasia,C0017531,NA,Approved,NA,NA,tocilizumab
Alvimopan,DB06274,Postoperative ileus,C0400877,NA,Approved,NA,NA,alvimopan
Levocetirizine,DB06282,Hay fever,C0018621,NA,Approved,NA,NA,levocetirizine
Levocetirizine,DB06282,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,levocetirizine
Levocetirizine,DB06282,Chronic idiopathic urticaria,C0578870,NA,Approved,NA,NA,levocetirizine
Ziconotide,DB06283,Chronic pain,C0150055,NA,Approved,NA,NA,ziconotide
Ziconotide,DB06283,Severe pain,C0278140,NA,Approved,NA,NA,ziconotide
Ziconotide,DB06283,Pain in spine,C0423673,NA,Approved,NA,NA,ziconotide
Teriparatide,DB06285,"Osteoporosis, Postmenopausal",C0029458,NA,Approved,NA,NA,teriparatide
Temsirolimus,DB06287,Renal Cell Carcinoma,C0007134,NA,Approved,NA,NA,temsirolimus
Temsirolimus,DB06287,"Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse",C0334634,NA,Approved,NA,NA,temsirolimus
Amisulpride,DB06288,Chronic schizophrenia,C0221765,NA,Approved,NA,NA,amisulpride
Simeprevir,DB06290,"Hepatitis C, Chronic",C0524910,NA,Approved,NA,NA,simeprevir
Dapagliflozin,DB06292,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,dapagliflozin
Elotuzumab,DB06317,Multiple Myeloma,C0026764,NA,Approved,NA,NA,elotuzumab
Saxagliptin,DB06335,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,saxagliptin
Pertuzumab,DB06366,HER2-positive carcinoma of breast,C1960398,NA,Approved,NA,NA,pertuzumab
Rilonacept,DB06372,Cryopyrin-Associated Periodic Syndromes,C2316212,NA,Approved,NA,NA,rilonacept
Bazedoxifene,DB06401,"Osteoporosis, Postmenopausal",C0029458,NA,Approved,NA,NA,bazedoxifene
Bazedoxifene,DB06401,Hot flushes,C0600142,NA,Approved,NA,NA,bazedoxifene
Telavancin,DB06402,Pneumonia due to Staphylococcus aureus,C2349530,NA,Approved,NA,NA,telavancin
Telavancin,DB06402,"Pneumonia, Bacterial",C0004626,NA,Approved,NA,NA,telavancin
Ambrisentan,DB06403,Pulmonary arterial hypertension,C2973725,NA,Approved,NA,NA,ambrisentan
Oxymetholone,DB06412,Aplastic Anemia,C0002874,NA,Approved,NA,NA,oxymetholone
Oxymetholone,DB06412,Hypoplastic anemia,C0178416,NA,Approved,NA,NA,oxymetholone
Oxymetholone,DB06412,"Anemia, Diamond-Blackfan",C1260899,NA,Approved,NA,NA,oxymetholone
Armodafinil,DB06413,Narcolepsy,C0027404,NA,Approved,NA,NA,armodafinil
Etravirine,DB06414,HIV Infections,C0019693,NA,Approved,NA,NA,etravirine
Calfactant,DB06415,"Respiratory Distress Syndrome, Newborn",C0035220,NA,Approved,NA,NA,calfactant
Tyloxapol,DB06439,"Respiratory Distress Syndrome, Newborn",C0035220,NA,Approved,NA,NA,tyloxapol
Prucalopride,DB06480,Constipation,C0009806,NA,Approved,NA,NA,prucalopride
Pazopanib,DB06589,Renal Cell Carcinoma,C0007134,NA,Approved,NA,NA,pazopanib
Pazopanib,DB06589,Sarcoma,C1261473,NA,Approved,NA,NA,pazopanib
Ceftaroline fosamil,DB06590,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,ceftaroline fosamil
Ceftaroline fosamil,DB06590,Bacterial infection due to Klebsiella pneumoniae,C0343402,NA,Approved,NA,NA,ceftaroline fosamil
Ceftaroline fosamil,DB06590,Escherichia coli Infections,C0014836,NA,Approved,NA,NA,ceftaroline fosamil
Ceftaroline fosamil,DB06590,Pneumonia due to Staphylococcus aureus,C2349530,NA,Approved,NA,NA,ceftaroline fosamil
Ceftaroline fosamil,DB06590,Rhinoscleroma,C0035468,NA,Approved,NA,NA,ceftaroline fosamil
Ceftaroline fosamil,DB06590,Haemophilus influenzae pneumonia,C0276026,NA,Approved,NA,NA,ceftaroline fosamil
Ceftaroline fosamil,DB06590,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,ceftaroline fosamil
Ceftaroline fosamil,DB06590,Streptococcal pneumonia,C0155862,NA,Approved,NA,NA,ceftaroline fosamil
Ceftaroline fosamil,DB06590,Pneumonia due to Escherichia coli,C0276089,NA,Approved,NA,NA,ceftaroline fosamil
Agomelatine,DB06594,Major Depressive Disorder,C1269683,NA,Approved,NA,NA,agomelatine
Panobinostat,DB06603,"Lymphoma, T-Cell, Cutaneous",C0079773,NA,Approved,NA,NA,panobinostat
Panobinostat,DB06603,Multiple Myeloma,C0026764,NA,Approved,NA,NA,panobinostat
Apixaban,DB06605,Arterial embolus and thrombosis,C0155749,NA,Approved,NA,NA,apixaban
Mepolizumab,DB06612,Eosinophilic Pneumonia,C1527407,NA,Approved,NA,NA,mepolizumab
Peramivir,DB06614,Influenza,C0021400,NA,Approved,NA,NA,peramivir
Bosutinib,DB06616,"Leukemia, Myeloid, Accelerated Phase",C0023472,NA,Approved,NA,NA,bosutinib
Bosutinib,DB06616,Blast Phase,C0005699,NA,Approved,NA,NA,bosutinib
Axitinib,DB06626,Renal Cell Carcinoma,C0007134,NA,Approved,NA,NA,axitinib
Isavuconazonium,DB06636,Mucormycosis,C0026718,NA,Approved,NA,NA,isavuconazonium
Isavuconazonium,DB06636,Aspergillosis,C0004030,NA,Approved,NA,NA,isavuconazonium
Dalfampridine,DB06637,Multiple Sclerosis,C0026769,NA,Approved,NA,NA,dalfampridine
Denosumab,DB06643,"Osteoporosis, Postmenopausal",C0029458,NA,Approved,NA,NA,denosumab
Denosumab,DB06643,Osteoporosis,C0029456,NA,Approved,NA,NA,denosumab
Denosumab,DB06643,Drug-induced osteoporosis,C0264115,NA,Approved,NA,NA,denosumab
Ofatumumab,DB06650,Chronic Lymphocytic Leukemia,C0023434,NA,Approved,NA,NA,ofatumumab
Liraglutide,DB06655,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,liraglutide
Pasireotide,DB06663,Adrenal Gland Hyperfunction,C0001622,NA,Approved,NA,NA,pasireotide
golimumab,DB06674,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,golimumab
golimumab,DB06674,"Arthritis, Psoriatic",C0003872,NA,Approved,NA,NA,golimumab
golimumab,DB06674,Ankylosing spondylitis,C0038013,NA,Approved,NA,NA,golimumab
golimumab,DB06674,Ulcerative Colitis,C0009324,NA,Approved,NA,NA,golimumab
Belatacept,DB06681,Renal transplant rejection,C0238217,NA,Approved,NA,NA,belatacept
Vilazodone,DB06684,Major Depressive Disorder,C1269683,NA,Approved,NA,NA,vilazodone
Mepyramine,DB06691,Sneezing,C0037383,NA,Approved,NA,NA,mepyramine
Mepyramine,DB06691,Pruritus,C0033774,NA,Approved,NA,NA,mepyramine
Mepyramine,DB06691,Common Cold,C0009443,NA,Approved,NA,NA,mepyramine
Mepyramine,DB06691,Influenza-like symptoms,C0392171,NA,Approved,NA,NA,mepyramine
Mepyramine,DB06691,Rhinorrhea,C1260880,NA,Approved,NA,NA,mepyramine
Mepyramine,DB06691,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,mepyramine
Mepyramine,DB06691,Hay fever,C0018621,NA,Approved,NA,NA,mepyramine
Mepyramine,DB06691,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,mepyramine
Mepyramine,DB06691,"Rhinitis, Vasomotor",C0035460,NA,Approved,NA,NA,mepyramine
Mepyramine,DB06691,Urticaria,C0042109,NA,Approved,NA,NA,mepyramine
Mepyramine,DB06691,Symptomatic dermographism,C0343065,NA,Approved,NA,NA,mepyramine
Mepyramine,DB06691,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,mepyramine
Mepyramine,DB06691,Sinus headache,C0037195,NA,Approved,NA,NA,mepyramine
Mepyramine,DB06691,Dysmenorrhea,C0013390,NA,Approved,NA,NA,mepyramine
Aprotinin,DB06692,Hemorrhage,C0019080,NA,Approved,NA,NA,aprotinin
Xylometazoline,DB06694,Rhinorrhea,C1260880,NA,Approved,NA,NA,xylometazoline
Xylometazoline,DB06694,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,xylometazoline
Betahistine,DB06698,Meniere Disease,C0025281,NA,Approved,NA,NA,betahistine
Desvenlafaxine,DB06700,Major Depressive Disorder,C1269683,NA,Approved,NA,NA,desvenlafaxine
Dexmethylphenidate,DB06701,Attention deficit hyperactivity disorder,C1263846,NA,Approved,NA,NA,dexmethylphenidate
Fesoterodine,DB06702,Increased frequency of micturition,C0042023,NA,Approved,NA,NA,fesoterodine
Fesoterodine,DB06702,Bladder muscle dysfunction - overactive,C0403643,NA,Approved,NA,NA,fesoterodine
Fesoterodine,DB06702,Urge Incontinence,C0150045,NA,Approved,NA,NA,fesoterodine
Fesoterodine,DB06702,Urgency of micturition,C0085606,NA,Approved,NA,NA,fesoterodine
Lumefantrine,DB06708,"Malaria, Falciparum",C0024535,NA,Approved,NA,NA,lumefantrine
Methyltestosterone,DB06710,Testicular hypogonadism,C0151721,NA,Approved,NA,NA,methyltestosterone
Methyltestosterone,DB06710,Deficiency of testosterone biosynthesis,C0342527,NA,Approved,NA,NA,methyltestosterone
Methyltestosterone,DB06710,Hormone receptor positive malignant neoplasm of breast,C1562029,NA,Approved,NA,NA,methyltestosterone
Methyltestosterone,DB06710,Hot flushes,C0600142,NA,Approved,NA,NA,methyltestosterone
Methyltestosterone,DB06710,Delayed Puberty,C0034012,NA,Approved,NA,NA,methyltestosterone
Naphazoline,DB06711,Itching of eye,C0022281,NA,Approved,NA,NA,naphazoline
Naphazoline,DB06711,Redness of eye,C0235267,NA,Approved,NA,NA,naphazoline
Potassium Iodide,DB06715,Coughing,C0010200,NA,Approved,NA,NA,potassium iodide
Potassium Iodide,DB06715,Common Cold,C0009443,NA,Approved,NA,NA,potassium iodide
Potassium Iodide,DB06715,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,potassium iodide
Potassium Iodide,DB06715,Rhinorrhea,C1260880,NA,Approved,NA,NA,potassium iodide
Potassium Iodide,DB06715,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,potassium iodide
Fosaprepitant,DB06717,Chemotherapy-induced nausea and vomiting,C0401160,NA,Approved,NA,NA,fosaprepitant
Stanozolol,DB06718,"Angioedemas, Hereditary",C0019243,NA,Approved,NA,NA,stanozolol
Velaglucerase alfa,DB06720,Gaucher Disease,C0017205,NA,Approved,NA,NA,velaglucerase alfa
Velaglucerase alfa,DB06720,"Gaucher Disease, Type 1",C1961835,NA,Approved,NA,NA,velaglucerase alfa
Aluminum hydroxide,DB06723,Gastric ulcer,C0038358,NA,Approved,NA,NA,aluminum hydroxide
Aluminum hydroxide,DB06723,Heartburn,C0018834,NA,Approved,NA,NA,aluminum hydroxide
Aluminum hydroxide,DB06723,Peptic Ulcer,C0030920,NA,Approved,NA,NA,aluminum hydroxide
Aluminum hydroxide,DB06723,Dyspepsia,C0013395,NA,Approved,NA,NA,aluminum hydroxide
Aluminum hydroxide,DB06723,Duodenal Ulcer,C0013295,NA,Approved,NA,NA,aluminum hydroxide
Aluminum hydroxide,DB06723,Gastroesophageal reflux disease,C0017168,NA,Approved,NA,NA,aluminum hydroxide
Calcium carbonate,DB06724,Hypocalcemia,C0020598,NA,Approved,NA,NA,calcium carbonate
Calcium carbonate,DB06724,Dyspepsia,C0013395,NA,Approved,NA,NA,calcium carbonate
Lornoxicam,DB06725,Pain,C0030193,NA,Approved,NA,NA,lornoxicam
Ambroxol,DB06742,Sore Throat,C0242429,NA,Approved,NA,NA,ambroxol
Glycine betaine,DB06756,Homocystinuria,C0019880,NA,Approved,NA,NA,glycine betaine
Glycine betaine,DB06756,Klebsiella cystitis,C0520775,NA,Approved,NA,NA,glycine betaine
Glycine betaine,DB06756,Escherichia coli urinary tract infection,C0577708,NA,Approved,NA,NA,glycine betaine
Glycine betaine,DB06756,Infective cystitis,C0600041,NA,Approved,NA,NA,glycine betaine
Glycine betaine,DB06756,Cystitis,C0010692,NA,Approved,NA,NA,glycine betaine
Glycine betaine,DB06756,PYELONEPHRITIS E COLI,C0748196,NA,Approved,NA,NA,glycine betaine
Sacrosidase,DB06760,"Sucrase-isomaltase deficiency, congenital",C1283620,NA,Approved,NA,NA,sacrosidase
Beractant,DB06761,"Respiratory Distress Syndrome, Newborn",C0035220,NA,Approved,NA,NA,beractant
Tetryzoline,DB06764,Rhinorrhea,C1260880,NA,Approved,NA,NA,tetryzoline
Tetryzoline,DB06764,Redness of eye,C0235267,NA,Approved,NA,NA,tetryzoline
Tetryzoline,DB06764,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,tetryzoline
Alcaftadine,DB06766,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,alcaftadine
Ammonium chloride,DB06767,Coughing,C0010200,NA,Approved,NA,NA,ammonium chloride
Ammonium chloride,DB06767,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,ammonium chloride
Ammonium chloride,DB06767,Common Cold,C0009443,NA,Approved,NA,NA,ammonium chloride
Ammonium chloride,DB06767,Rhinorrhea,C1260880,NA,Approved,NA,NA,ammonium chloride
Ammonium lactate,DB06768,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,ammonium lactate
Ammonium lactate,DB06768,Exanthema,C0015230,NA,Approved,NA,NA,ammonium lactate
Ammonium lactate,DB06768,Dry skin,C0151908,NA,Approved,NA,NA,ammonium lactate
Ammonium lactate,DB06768,Pruritus Ani,C0033775,NA,Approved,NA,NA,ammonium lactate
Ammonium lactate,DB06768,Contact Dermatitis,C0011616,NA,Approved,NA,NA,ammonium lactate
Ammonium lactate,DB06768,Pruritus,C0033774,NA,Approved,NA,NA,ammonium lactate
Ammonium lactate,DB06768,Pruritus of genital organs,C0033777,NA,Approved,NA,NA,ammonium lactate
Ammonium lactate,DB06768,"Dermatitis, Atopic",C0011615,NA,Approved,NA,NA,ammonium lactate
Ammonium lactate,DB06768,Granuloma Annulare,C0085074,NA,Approved,NA,NA,ammonium lactate
Bendamustine,DB06769,"Lymphoma, Follicular",C0024301,NA,Approved,NA,NA,bendamustine
Bendamustine,DB06769,Chronic Lymphocytic Leukemia,C0023434,NA,Approved,NA,NA,bendamustine
Benzyl alcohol,DB06770,Skin irritation,C0152030,NA,Approved,NA,NA,benzyl alcohol
Benzyl alcohol,DB06770,Pruritus,C0033774,NA,Approved,NA,NA,benzyl alcohol
Besifloxacin,DB06771,Bacterial conjunctivitis,C0009768,NA,Approved,NA,NA,besifloxacin
Cabazitaxel,DB06772,Metastatic Prostate Carcinoma,C0936223,NA,Approved,NA,NA,cabazitaxel
Capsaicin,DB06774,Postherpetic neuralgia,C0032768,NA,Approved,NA,NA,capsaicin
Capsaicin,DB06774,Arthritic pains,C0857177,NA,Approved,NA,NA,capsaicin
Capsaicin,DB06774,Sprains and Strains,C0038048,NA,Approved,NA,NA,capsaicin
Capsaicin,DB06774,Neuralgia,C0027796,NA,Approved,NA,NA,capsaicin
Capsaicin,DB06774,Back Pain,C0004604,NA,Approved,NA,NA,capsaicin
Chenodeoxycholic acid,DB06777,Cholelithiasis,C0008350,NA,Approved,NA,NA,chenodeoxycholic acid
Dimercaprol,DB06782,Arsenic Poisoning,C0311375,NA,Approved,NA,NA,dimercaprol
Dimercaprol,DB06782,Accidental poisoning by lead and its compounds and fumes,C0261486,NA,Approved,NA,NA,dimercaprol
Prussian blue,DB06783,Thallium poisoning,C0238452,NA,Approved,NA,NA,prussian blue
Halcinonide,DB06786,"Lymphoma, T-Cell, Cutaneous",C0079773,NA,Approved,NA,NA,halcinonide
Halcinonide,DB06786,"Lupus Erythematosus, Discoid",C0024138,NA,Approved,NA,NA,halcinonide
Halcinonide,DB06786,Lichen Simplex Chronicus,C0149922,NA,Approved,NA,NA,halcinonide
Halcinonide,DB06786,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,halcinonide
Halcinonide,DB06786,Exanthema,C0015230,NA,Approved,NA,NA,halcinonide
Halcinonide,DB06786,Contact Dermatitis,C0011616,NA,Approved,NA,NA,halcinonide
Halcinonide,DB06786,Pruritus Ani,C0033775,NA,Approved,NA,NA,halcinonide
Halcinonide,DB06786,Pruritus of genital organs,C0033777,NA,Approved,NA,NA,halcinonide
Halcinonide,DB06786,"Dermatitis, Atopic",C0011615,NA,Approved,NA,NA,halcinonide
Halcinonide,DB06786,Granuloma Annulare,C0085074,NA,Approved,NA,NA,halcinonide
Halcinonide,DB06786,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,halcinonide
Halcinonide,DB06786,Scalp psoriasis,C0406326,NA,Approved,NA,NA,halcinonide
Histrelin,DB06788,Precocious Puberty,C0034013,NA,Approved,NA,NA,histrelin
Lanreotide,DB06791,Acromegaly,C0001206,NA,Approved,NA,NA,lanreotide
Lanreotide,DB06791,Hypersomatotropic gigantism,C0001207,NA,Approved,NA,NA,lanreotide
Lodoxamide,DB06794,"Conjunctivitis, Vernal",C0009773,NA,Approved,NA,NA,lodoxamide
Lodoxamide,DB06794,"Keratoconjunctivitis, Vernal",C0022577,NA,Approved,NA,NA,lodoxamide
Hexamethylenetetramine,DB06799,Urinary tract infection,C0042029,NA,Approved,NA,NA,hexamethylenetetramine
Methylnaltrexone,DB06800,Drug-induced constipation,C0267511,NA,Approved,NA,NA,methylnaltrexone
Niclosamide,DB06803,Teniasis,C0039254,NA,Approved,NA,NA,niclosamide
Niclosamide,DB06803,Diphyllobothriasis,C0012561,NA,Approved,NA,NA,niclosamide
Plerixafor,DB06809,Multiple Myeloma,C0026764,NA,Approved,NA,NA,plerixafor
Polidocanol,DB06811,Varicosity,C0042345,NA,Approved,NA,NA,polidocanol
Pralatrexate,DB06813,Peripheral T-Cell Lymphoma,C0079774,NA,Approved,NA,NA,pralatrexate
Raltegravir,DB06817,HIV Infections,C0019693,NA,Approved,NA,NA,raltegravir
Sodium phenylbutyrate,DB06819,Carbamoyl-Phosphate Synthase I Deficiency Disease,C0751753,NA,Approved,NA,NA,sodium phenylbutyrate
Sodium phenylbutyrate,DB06819,Citrullinemia,C0175683,NA,Approved,NA,NA,sodium phenylbutyrate
Sodium phenylbutyrate,DB06819,"Urea Cycle Disorders, Inborn",C0154246,NA,Approved,NA,NA,sodium phenylbutyrate
Sulconazole,DB06820,Tinea corporis (disorder),C0040252,NA,Approved,NA,NA,sulconazole
Sulconazole,DB06820,Tinea Versicolor,C0040262,NA,Approved,NA,NA,sulconazole
Sulconazole,DB06820,Tinea Pedis,C0040259,NA,Approved,NA,NA,sulconazole
Sulconazole,DB06820,Tinea cruris,C1384589,NA,Approved,NA,NA,sulconazole
Tiopronin,DB06823,Cystinuria,C0010691,NA,Approved,NA,NA,tiopronin
Triethylenetetramine,DB06824,Renal Cell Carcinoma,C0007134,NA,Approved,NA,NA,triethylenetetramine
Triethylenetetramine,DB06824,Hepatolenticular Degeneration,C0019202,NA,Approved,NA,NA,triethylenetetramine
Triethylenetetramine,DB06824,Scalp psoriasis,C0406326,NA,Approved,NA,NA,triethylenetetramine
Triethylenetetramine,DB06824,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,triethylenetetramine
Unoprostone,DB06826,Ocular Hypertension,C0028840,NA,Approved,NA,NA,unoprostone
Unoprostone,DB06826,"Glaucoma, Open-Angle",C0017612,NA,Approved,NA,NA,unoprostone
Tranilast,DB07615,Asthma,C0004096,NA,Approved,NA,NA,tranilast
Tranilast,DB07615,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,tranilast
Tranilast,DB07615,Keloid,C0022548,NA,Approved,NA,NA,tranilast
Tranilast,DB07615,"Cicatrix, Hypertrophic",C0162810,NA,Approved,NA,NA,tranilast
Parecoxib,DB08439,Acute postoperative pain,C2215257,NA,Approved,NA,NA,parecoxib
Diloxanide,DB08792,Amebiasis,C0002438,NA,Approved,NA,NA,diloxanide
Azidocillin,DB08795,Respiratory Tract Infections,C0035243,NA,Approved,NA,NA,azidocillin
Salicylamide,DB08797,Back Pain,C0004604,NA,Approved,NA,NA,salicylamide
Salicylamide,DB08797,Headache Disorders,C0393735,NA,Approved,NA,NA,salicylamide
Salicylamide,DB08797,Arthralgia,C0003862,NA,Approved,NA,NA,salicylamide
Salicylamide,DB08797,Fever,C0015967,NA,Approved,NA,NA,salicylamide
Salicylamide,DB08797,Pain,C0030193,NA,Approved,NA,NA,salicylamide
Antazoline,DB08799,"Rhinitis, Vasomotor",C0035460,NA,Approved,NA,NA,antazoline
Antazoline,DB08799,Symptomatic dermographism,C0343065,NA,Approved,NA,NA,antazoline
Antazoline,DB08799,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,antazoline
Antazoline,DB08799,Pruritus,C0033774,NA,Approved,NA,NA,antazoline
Antazoline,DB08799,Itching of eye,C0022281,NA,Approved,NA,NA,antazoline
Antazoline,DB08799,Sneezing,C0037383,NA,Approved,NA,NA,antazoline
Antazoline,DB08799,Rhinorrhea,C1260880,NA,Approved,NA,NA,antazoline
Antazoline,DB08799,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,antazoline
Antazoline,DB08799,Redness of eye,C0235267,NA,Approved,NA,NA,antazoline
Antazoline,DB08799,Urticaria,C0042109,NA,Approved,NA,NA,antazoline
Antazoline,DB08799,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,antazoline
Nandrolone decanoate,DB08804,Anemia in chronic kidney disease,C1561828,NA,Approved,NA,NA,nandrolone decanoate
Roxatidine acetate,DB08806,Gastric ulcer,C0038358,NA,Approved,NA,NA,roxatidine acetate
Roxatidine acetate,DB08806,Gastroesophageal reflux disease,C0017168,NA,Approved,NA,NA,roxatidine acetate
Roxatidine acetate,DB08806,Zollinger-Ellison syndrome,C0043515,NA,Approved,NA,NA,roxatidine acetate
Bupranolol,DB08808,Glaucoma,C0017601,NA,Approved,NA,NA,bupranolol
Bupranolol,DB08808,Hypertensive disease,C0020538,NA,Approved,NA,NA,bupranolol
Lurasidone,DB08815,Schizophrenia,C0036341,NA,Approved,NA,NA,lurasidone
Lurasidone,DB08815,"Depression, Bipolar",C0005587,NA,Approved,NA,NA,lurasidone
Ticagrelor,DB08816,Acute Coronary Syndrome,C0948089,NA,Approved,NA,NA,ticagrelor
Ticagrelor,DB08816,Peripheral Vascular Diseases,C0085096,NA,Approved,NA,NA,ticagrelor
Tafluprost,DB08819,Ocular Hypertension,C0028840,NA,Approved,NA,NA,tafluprost
Tafluprost,DB08819,"Glaucoma, Open-Angle",C0017612,NA,Approved,NA,NA,tafluprost
Ivacaftor,DB08820,Pulmonary Cystic Fibrosis,C0392164,NA,Approved,NA,NA,ivacaftor
Azilsartan medoxomil,DB08822,Hypertensive disease,C0020538,NA,Approved,NA,NA,azilsartan medoxomil
Spinosad,DB08823,Pediculus capitis infestation,C0030757,NA,Approved,NA,NA,spinosad
Deferiprone,DB08826,beta Thalassemia,C0005283,NA,Approved,NA,NA,deferiprone
Deferiprone,DB08826,Iron Overload,C0282193,NA,Approved,NA,NA,deferiprone
Lomitapide,DB08827,Familial hypercholesterolemia - homozygous,C0342881,NA,Approved,NA,NA,lomitapide
Vismodegib,DB08828,Basal cell carcinoma,C0007117,NA,Approved,NA,NA,vismodegib
Pitavastatin,DB08860,"Hyperlipidemia, Familial Combined",C0020474,NA,Approved,NA,NA,pitavastatin
Pitavastatin,DB08860,Hypercholesterolemia,C0020443,NA,Approved,NA,NA,pitavastatin
Rilpivirine,DB08864,HIV Infections,C0019693,NA,Approved,NA,NA,rilpivirine
Ulipristal,DB08867,Uterine Fibroids,C0042133,NA,Approved,NA,NA,ulipristal
Fingolimod,DB08868,"Multiple Sclerosis, Relapsing-Remitting",C0751967,NA,Approved,NA,NA,fingolimod
Tesamorelin,DB08869,Lipodystrophy due to Human immunodeficiency virus infection and antiretroviral therapy,C3854116,NA,Approved,NA,NA,tesamorelin
Brentuximab vedotin,DB08870,Hodgkin Disease,C0019829,NA,Approved,NA,NA,brentuximab vedotin
Brentuximab vedotin,DB08870,Anaplastic large T-cell systemic malignant lymphoma,C1275317,NA,Approved,NA,NA,brentuximab vedotin
Eribulin,DB08871,Carcinoma breast stage IV,C0278488,NA,Approved,NA,NA,eribulin
Eribulin,DB08871,liposarcoma,C0023827,NA,Approved,NA,NA,eribulin
gabapentin enacarbil,DB08872,Postherpetic neuralgia,C0032768,NA,Approved,NA,NA,gabapentin enacarbil
gabapentin enacarbil,DB08872,Restless Legs Syndrome,C0035258,NA,Approved,NA,NA,gabapentin enacarbil
Boceprevir,DB08873,"Hepatitis C, Chronic",C0524910,NA,Approved,NA,NA,boceprevir
Fidaxomicin,DB08874,"Enterocolitis, Pseudomembranous",C0014358,NA,Approved,NA,NA,fidaxomicin
Fidaxomicin,DB08874,Clostridium difficile infection,C0343386,NA,Approved,NA,NA,fidaxomicin
Fidaxomicin,DB08874,Clostridium Infections,C0009062,NA,Approved,NA,NA,fidaxomicin
Cabozantinib,DB08875,Medullary carcinoma of thyroid,C0238462,NA,Approved,NA,NA,cabozantinib
Cabozantinib,DB08875,Renal Cell Carcinoma,C0007134,NA,Approved,NA,NA,cabozantinib
Ruxolitinib,DB08877,Myeloproliferative disease,C0027022,NA,Approved,NA,NA,ruxolitinib
Ruxolitinib,DB08877,Myelofibrosis,C0026987,NA,Approved,NA,NA,ruxolitinib
Belimumab,DB08879,"Lupus Erythematosus, Systemic",C0024141,NA,Approved,NA,NA,belimumab
Teriflunomide,DB08880,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,teriflunomide
Teriflunomide,DB08880,"Arthritis, Psoriatic",C0003872,NA,Approved,NA,NA,teriflunomide
Teriflunomide,DB08880,Multiple Sclerosis,C0026769,NA,Approved,NA,NA,teriflunomide
Linagliptin,DB08882,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,linagliptin
Aflibercept,DB08885,Exudative age-related macular degeneration,C0271084,NA,Approved,NA,NA,aflibercept
Aflibercept,DB08885,Central retinal vein occlusion with macular edema,C0339498,NA,Approved,NA,NA,aflibercept
Aflibercept,DB08885,Branch retinal vein occlusion with macular edema,C0339507,NA,Approved,NA,NA,aflibercept
Aflibercept,DB08885,Diabetic macular edema,C0730285,NA,Approved,NA,NA,aflibercept
Aflibercept,DB08885,Metastasis from malignant tumor of colon,C1282500,NA,Approved,NA,NA,aflibercept
Icosapent ethyl,DB08887,Hypertriglyceridemia,C0020557,NA,Approved,NA,NA,icosapent ethyl
Ocriplasmin,DB08888,Vitreomacular traction syndrome,C0730274,NA,Approved,NA,NA,ocriplasmin
Carfilzomib,DB08889,Multiple Myeloma,C0026764,NA,Approved,NA,NA,carfilzomib
Linaclotide,DB08890,Irritable bowel syndrome characterized by constipation,C1868889,NA,Approved,NA,NA,linaclotide
Linaclotide,DB08890,Chronic idiopathic constipation,C0267509,NA,Approved,NA,NA,linaclotide
Linaclotide,DB08890,Irritable Bowel Syndrome,C0022104,NA,Approved,NA,NA,linaclotide
Mirabegron,DB08893,Bladder muscle dysfunction - overactive,C0403643,NA,Approved,NA,NA,mirabegron
Peginesatide,DB08894,Anemia in chronic kidney disease,C1561828,NA,Approved,NA,NA,peginesatide
Tofacitinib,DB08895,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,tofacitinib
Regorafenib,DB08896,Metastasis from malignant tumor of colon,C1282500,NA,Approved,NA,NA,regorafenib
Regorafenib,DB08896,Gastrointestinal Stromal Tumors,C0238198,NA,Approved,NA,NA,regorafenib
Aclidinium,DB08897,Chronic Obstructive Airway Disease,C0024117,NA,Approved,NA,NA,aclidinium
Enzalutamide,DB08899,Malignant neoplasm of prostate,C0376358,NA,Approved,NA,NA,enzalutamide
Teduglutide,DB08900,Short Bowel Syndrome,C0036992,NA,Approved,NA,NA,teduglutide
Ponatinib,DB08901,"Myeloid Leukemia, Chronic",C0023473,NA,Approved,NA,NA,ponatinib
Ponatinib,DB08901,Philadelphia chromosome-positive acute lymphoblastic leukemia,C1960397,NA,Approved,NA,NA,ponatinib
Raxibacumab,DB08902,Inhalational anthrax,C0155866,NA,Approved,NA,NA,raxibacumab
Bedaquiline,DB08903,"Tuberculosis, Pulmonary",C0041327,NA,Approved,NA,NA,bedaquiline
Bedaquiline,DB08903,"Tuberculosis, Drug-Resistant",C0206525,NA,Approved,NA,NA,bedaquiline
Certolizumab pegol,DB08904,Crohn Disease,C0010346,NA,Approved,NA,NA,certolizumab pegol
Certolizumab pegol,DB08904,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,certolizumab pegol
Certolizumab pegol,DB08904,"Arthritis, Psoriatic",C0003872,NA,Approved,NA,NA,certolizumab pegol
Certolizumab pegol,DB08904,Ankylosing spondylitis,C0038013,NA,Approved,NA,NA,certolizumab pegol
Formestane,DB08905,Malignant epithelial neoplasm of female breast,C3163805,NA,Approved,NA,NA,formestane
Fluticasone furoate,DB08906,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,fluticasone furoate
Fluticasone furoate,DB08906,Asthma,C0004096,NA,Approved,NA,NA,fluticasone furoate
Canagliflozin,DB08907,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,canagliflozin
Dimethyl fumarate,DB08908,"Multiple Sclerosis, Relapsing-Remitting",C0751967,NA,Approved,NA,NA,dimethyl fumarate
Glycerol Phenylbutyrate,DB08909,"Urea Cycle Disorders, Inborn",C0154246,NA,Approved,NA,NA,glycerol phenylbutyrate
Pomalidomide,DB08910,Multiple Myeloma,C0026764,NA,Approved,NA,NA,pomalidomide
Trametinib,DB08911,"Malignant melanoma, metastatic",C0860594,NA,Approved,NA,NA,trametinib
Dabrafenib,DB08912,"Malignant melanoma, metastatic",C0860594,NA,Approved,NA,NA,dabrafenib
Radium Ra 223 Dichloride,DB08913,Malignant neoplasm of prostate,C0376358,NA,Approved,NA,NA,radium ra 223 dichloride
Afatinib,DB08916,Epidermal growth factor receptor positive non-small cell lung cancer,C1960925,NA,Approved,NA,NA,afatinib
Ferric Carboxymaltose,DB08917,Iron deficiency anemia,C0162316,NA,Approved,NA,NA,ferric carboxymaltose
Levomilnacipran,DB08918,Major Depressive Disorder,C1269683,NA,Approved,NA,NA,levomilnacipran
Perospirone,DB08922,Schizophrenia,C0036341,NA,Approved,NA,NA,perospirone
Epoetin Zeta,DB08923,Anemia in chronic kidney disease,C1561828,NA,Approved,NA,NA,epoetin zeta
Dolutegravir,DB08930,HIV Infections,C0019693,NA,Approved,NA,NA,dolutegravir
Riociguat,DB08931,Chronic thromboembolic pulmonary hypertension,C2363973,NA,Approved,NA,NA,riociguat
Riociguat,DB08931,Pulmonary arterial hypertension,C2973725,NA,Approved,NA,NA,riociguat
Macitentan,DB08932,Pulmonary arterial hypertension,C2973725,NA,Approved,NA,NA,macitentan
Luliconazole,DB08933,Tinea Pedis,C0040259,NA,Approved,NA,NA,luliconazole
Luliconazole,DB08933,Tinea cruris,C1384589,NA,Approved,NA,NA,luliconazole
Luliconazole,DB08933,Tinea corporis (disorder),C0040252,NA,Approved,NA,NA,luliconazole
Sofosbuvir,DB08934,"Hepatitis C, Chronic",C0524910,NA,Approved,NA,NA,sofosbuvir
Obinutuzumab,DB08935,Chronic Lymphocytic Leukemia,C0023434,NA,Approved,NA,NA,obinutuzumab
Chlorcyclizine,DB08936,Common Cold,C0009443,NA,Approved,NA,NA,chlorcyclizine
Chlorcyclizine,DB08936,Hay fever,C0018621,NA,Approved,NA,NA,chlorcyclizine
Chlorcyclizine,DB08936,Rhinorrhea,C1260880,NA,Approved,NA,NA,chlorcyclizine
Chlorcyclizine,DB08936,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,chlorcyclizine
Chlorcyclizine,DB08936,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,chlorcyclizine
Chlorcyclizine,DB08936,Sneezing,C0037383,NA,Approved,NA,NA,chlorcyclizine
Chlorcyclizine,DB08936,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,chlorcyclizine
Chlorcyclizine,DB08936,Coughing,C0010200,NA,Approved,NA,NA,chlorcyclizine
Chlorcyclizine,DB08936,"Rhinitis, Vasomotor",C0035460,NA,Approved,NA,NA,chlorcyclizine
Isoxsuprine,DB08941,Vascular Diseases,C0042373,NA,Approved,NA,NA,isoxsuprine
Isoxsuprine,DB08941,Cerebrovascular Disorders,C0007820,NA,Approved,NA,NA,isoxsuprine
Isoxsuprine,DB08941,Raynaud Disease,C0034734,NA,Approved,NA,NA,isoxsuprine
Floctafenine,DB08976,Acute onset pain,C0184567,NA,Approved,NA,NA,floctafenine
Etofenamate,DB08984,Degenerative polyarthritis,C0029408,NA,Approved,NA,NA,etofenamate
Enviomycin,DB08993,"Tuberculosis, Pulmonary",C0041327,NA,Approved,NA,NA,enviomycin
Demexiptiline,DB08998,Depressive disorder,C0011581,NA,Approved,NA,NA,demexiptiline
Captodiame,DB09014,Anxiety Disorders,C0003469,NA,Approved,NA,NA,captodiame
Butriptyline,DB09016,Depressive disorder,C0011581,NA,Approved,NA,NA,butriptyline
Bisacodyl,DB09020,Incomplete passage of stool,C0426639,NA,Approved,NA,NA,bisacodyl
Bisacodyl,DB09020,Constipation,C0009806,NA,Approved,NA,NA,bisacodyl
Aliskiren,DB09026,Hypertensive disease,C0020538,NA,Approved,NA,NA,aliskiren
Ledipasvir,DB09027,"Hepatitis C, Chronic",C0524910,NA,Approved,NA,NA,ledipasvir
Secukinumab,DB09029,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,secukinumab
Vorapaxar,DB09030,Cerebrovascular accident,C0038454,NA,Approved,NA,NA,vorapaxar
Miltefosine,DB09031,"Leishmaniasis, Visceral",C0023290,NA,Approved,NA,NA,miltefosine
Miltefosine,DB09031,"Leishmaniasis, Cutaneous",C0023283,NA,Approved,NA,NA,miltefosine
Miltefosine,DB09031,Mucocutaneous leishmaniasis,C1328252,NA,Approved,NA,NA,miltefosine
Vedolizumab,DB09033,Ulcerative Colitis,C0009324,NA,Approved,NA,NA,vedolizumab
Vedolizumab,DB09033,Crohn Disease,C0010346,NA,Approved,NA,NA,vedolizumab
Suvorexant,DB09034,Sleeplessness,C0917801,NA,Approved,NA,NA,suvorexant
Nivolumab,DB09035,"Malignant melanoma, metastatic",C0860594,NA,Approved,NA,NA,nivolumab
Nivolumab,DB09035,Squamous cell carcinoma of lung,C0149782,NA,Approved,NA,NA,nivolumab
Nivolumab,DB09035,Non-Small Cell Lung Carcinoma,C0007131,NA,Approved,NA,NA,nivolumab
Nivolumab,DB09035,Metastatic Renal Cell Cancer,C0278678,NA,Approved,NA,NA,nivolumab
Siltuximab,DB09036,Angiolymphoid hyperplasia,C0017531,NA,Approved,NA,NA,siltuximab
Pembrolizumab,DB09037,"Malignant melanoma, metastatic",C0860594,NA,Approved,NA,NA,pembrolizumab
Pembrolizumab,DB09037,Non-Small Cell Lung Carcinoma,C0007131,NA,Approved,NA,NA,pembrolizumab
Empagliflozin,DB09038,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,empagliflozin
Eliglustat,DB09039,Gaucher Disease,C0017205,NA,Approved,NA,NA,eliglustat
Efinaconazole,DB09040,Onychomycosis of toenails,C1274470,NA,Approved,NA,NA,efinaconazole
Efinaconazole,DB09040,Onychomycosis due to Trichophyton mentagrophytes,C0276755,NA,Approved,NA,NA,efinaconazole
Efinaconazole,DB09040,Onychomycosis,C0040261,NA,Approved,NA,NA,efinaconazole
Tavaborole,DB09041,Onychomycosis of toenails,C1274470,NA,Approved,NA,NA,tavaborole
Tavaborole,DB09041,Onychomycosis due to Trichophyton mentagrophytes,C0276755,NA,Approved,NA,NA,tavaborole
Tavaborole,DB09041,Onychomycosis due to Trichophyton rubrum,C0276754,NA,Approved,NA,NA,tavaborole
Tedizolid Phosphate,DB09042,Staphylococcal Skin Infections,C0038166,NA,Approved,NA,NA,tedizolid phosphate
Tedizolid Phosphate,DB09042,"Skin Diseases, Bacterial",C0162627,NA,Approved,NA,NA,tedizolid phosphate
Tedizolid Phosphate,DB09042,Streptococcal infection of skin,C1274355,NA,Approved,NA,NA,tedizolid phosphate
Albiglutide,DB09043,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,albiglutide
Dulaglutide,DB09045,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,dulaglutide
Metreleptin,DB09046,Familial generalized lipodystrophy,C0221032,NA,Approved,NA,NA,metreleptin
Metreleptin,DB09046,Acquired generalized lipodystrophy,C0271693,NA,Approved,NA,NA,metreleptin
Metreleptin,DB09046,Acquired partial lipodystrophy,C0220989,NA,Approved,NA,NA,metreleptin
Finafloxacin,DB09047,Acute otitis externa,C0149948,NA,Approved,NA,NA,finafloxacin
Netupitant,DB09048,Chemotherapy-induced nausea and vomiting,C0401160,NA,Approved,NA,NA,netupitant
Naloxegol,DB09049,Drug-induced constipation,C0267511,NA,Approved,NA,NA,naloxegol
Ceftolozane,DB09050,Urinary tract infection,C0042029,NA,Approved,NA,NA,ceftolozane
Ceftolozane,DB09050,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,ceftolozane
Elosulfase alfa,DB09051,"Mucopolysaccharidosis, MPS-IV-A",C0086651,NA,Approved,NA,NA,elosulfase alfa
Blinatumomab,DB09052,Pre B-cell acute lymphoblastic leukemia,C0349636,NA,Approved,NA,NA,blinatumomab
Ibrutinib,DB09053,"Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse",C0334634,NA,Approved,NA,NA,ibrutinib
Ibrutinib,DB09053,Chronic Lymphocytic Leukemia,C0023434,NA,Approved,NA,NA,ibrutinib
Ibrutinib,DB09053,Waldenstrom Macroglobulinemia,C0024419,NA,Approved,NA,NA,ibrutinib
Idelalisib,DB09054,Chronic Lymphocytic Leukemia,C0023434,NA,Approved,NA,NA,idelalisib
Idelalisib,DB09054,"Lymphoma, Follicular",C0024301,NA,Approved,NA,NA,idelalisib
Idelalisib,DB09054,Small Lymphocytic Lymphoma,C0855095,NA,Approved,NA,NA,idelalisib
Avibactam,DB09060,Pyelonephritis,C0034186,NA,Approved,NA,NA,avibactam
Avibactam,DB09060,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,avibactam
Cobicistat,DB09065,HIV Infections,C0019693,NA,Approved,NA,NA,cobicistat
Vortioxetine,DB09068,Major Depressive Disorder,C1269683,NA,Approved,NA,NA,vortioxetine
Tasimelteon,DB09071,Non-24 hour sleep-wake cycle,C0393772,NA,Approved,NA,NA,tasimelteon
Sodium oxybate,DB09072,Narcolepsy-Cataplexy Syndrome,C0751362,NA,Approved,NA,NA,sodium oxybate
Sodium oxybate,DB09072,Narcolepsy,C0027404,NA,Approved,NA,NA,sodium oxybate
Palbociclib,DB09073,Human epidermal growth factor 2 negative carcinoma of breast,C2316304,NA,Approved,NA,NA,palbociclib
Olaparib,DB09074,Malignant tumor of peritoneum,C0153467,NA,Approved,NA,NA,olaparib
Olaparib,DB09074,Malignant neoplasm of ovary,C1140680,NA,Approved,NA,NA,olaparib
Olaparib,DB09074,Epithelial tumor of ovary,C0341823,NA,Approved,NA,NA,olaparib
Edoxaban,DB09075,Pulmonary Embolism,C0034065,NA,Approved,NA,NA,edoxaban
Edoxaban,DB09075,Embolism,C0013922,NA,Approved,NA,NA,edoxaban
Umeclidinium,DB09076,Chronic Obstructive Airway Disease,C0024117,NA,Approved,NA,NA,umeclidinium
Dinutuximab,DB09077,Neuroblastoma,C0027819,NA,Approved,NA,NA,dinutuximab
Lenvatinib,DB09078,Follicular thyroid carcinoma,C0206682,NA,Approved,NA,NA,lenvatinib
Lenvatinib,DB09078,Papillary thyroid carcinoma,C0238463,NA,Approved,NA,NA,lenvatinib
Nintedanib,DB09079,Hamman-Rich syndrome,C0085786,NA,Approved,NA,NA,nintedanib
Nintedanib,DB09079,Non-Small Cell Lung Carcinoma,C0007131,NA,Approved,NA,NA,nintedanib
Olodaterol,DB09080,Chronic Obstructive Airway Disease,C0024117,NA,Approved,NA,NA,olodaterol
Idebenone,DB09081,"Optic Atrophy, Hereditary, Leber",C0917796,NA,Approved,NA,NA,idebenone
Vilanterol,DB09082,"Bronchitis, Chronic",C0008677,NA,Approved,NA,NA,vilanterol
Vilanterol,DB09082,Pulmonary Emphysema,C0034067,NA,Approved,NA,NA,vilanterol
Vilanterol,DB09082,Chronic Obstructive Airway Disease,C0024117,NA,Approved,NA,NA,vilanterol
Vilanterol,DB09082,Asthma,C0004096,NA,Approved,NA,NA,vilanterol
Ivabradine,DB09083,Chronic heart failure,C0264716,NA,Approved,NA,NA,ivabradine
Benzydamine,DB09084,Pain,C0030193,NA,Approved,NA,NA,benzydamine
Tetracaine,DB09085,Pruritus,C0033774,NA,Approved,NA,NA,tetracaine
Tetracaine,DB09085,Skin irritation,C0152030,NA,Approved,NA,NA,tetracaine
Potassium alum,DB09087,Heartburn,C0018834,NA,Approved,NA,NA,potassium alum
Potassium alum,DB09087,Dyspepsia,C0013395,NA,Approved,NA,NA,potassium alum
Potassium alum,DB09087,Peptic Ulcer,C0030920,NA,Approved,NA,NA,potassium alum
Potassium alum,DB09087,Gastroesophageal reflux disease,C0017168,NA,Approved,NA,NA,potassium alum
Chlortetracycline,DB09093,Ophthalmia Neonatorum,C0029076,NA,Approved,NA,NA,chlortetracycline
Chlortetracycline,DB09093,Trachoma,C0040592,NA,Approved,NA,NA,chlortetracycline
Benzoyl peroxide,DB09096,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,benzoyl peroxide
Benzoyl peroxide,DB09096,Acne Vulgaris,C0001144,NA,Approved,NA,NA,benzoyl peroxide
Benzoyl peroxide,DB09096,Exanthema,C0015230,NA,Approved,NA,NA,benzoyl peroxide
Benzoyl peroxide,DB09096,Granuloma Annulare,C0085074,NA,Approved,NA,NA,benzoyl peroxide
Benzoyl peroxide,DB09096,Pruritus of genital organs,C0033777,NA,Approved,NA,NA,benzoyl peroxide
Benzoyl peroxide,DB09096,Contact Dermatitis,C0011616,NA,Approved,NA,NA,benzoyl peroxide
Benzoyl peroxide,DB09096,Pruritus Ani,C0033775,NA,Approved,NA,NA,benzoyl peroxide
Elvitegravir,DB09101,HIV Infections,C0019693,NA,Approved,NA,NA,elvitegravir
Daclatasvir,DB09102,"Hepatitis C, Chronic",C0524910,NA,Approved,NA,NA,daclatasvir
Magnesium hydroxide,DB09104,Constipation,C0009806,NA,Approved,NA,NA,magnesium hydroxide
Magnesium hydroxide,DB09104,Incomplete passage of stool,C0426639,NA,Approved,NA,NA,magnesium hydroxide
Magnesium hydroxide,DB09104,Peptic Ulcer,C0030920,NA,Approved,NA,NA,magnesium hydroxide
Magnesium hydroxide,DB09104,Dyspepsia,C0013395,NA,Approved,NA,NA,magnesium hydroxide
Magnesium hydroxide,DB09104,Gastroesophageal reflux disease,C0017168,NA,Approved,NA,NA,magnesium hydroxide
Magnesium hydroxide,DB09104,Heartburn,C0018834,NA,Approved,NA,NA,magnesium hydroxide
Asfotase Alfa,DB09105,Hypophosphatasia,C0020630,NA,Approved,NA,NA,asfotase alfa
Methoxy polyethylene glycol-epoetin beta,DB09107,Anemia in chronic kidney disease,C1561828,NA,Approved,NA,NA,methoxy polyethylene glycol-epoetin beta
Turoctocog alfa,DB09109,Hemophilia A,C0019069,NA,Approved,NA,NA,turoctocog alfa
Mesna,DB09110,Testicular Germ Cell Tumor,C1336708,NA,Approved,NA,NA,mesna
Sodium Nitrite,DB09112,Toxic effect of cyanide,C0238080,NA,Approved,NA,NA,sodium nitrite
Poractant alfa,DB09113,"Respiratory Distress Syndrome, Newborn",C0035220,NA,Approved,NA,NA,poractant alfa
Colfosceril palmitate,DB09114,"Respiratory Distress Syndrome, Newborn",C0035220,NA,Approved,NA,NA,colfosceril palmitate
Diiodohydroxyquinoline,DB09115,Amebiasis,C0002438,NA,Approved,NA,NA,diiodohydroxyquinoline
Stiripentol,DB09118,"Epilepsies, Myoclonic",C0014550,NA,Approved,NA,NA,stiripentol
Stiripentol,DB09118,Infantile Severe Myoclonic Epilepsy,C0751122,NA,Approved,NA,NA,stiripentol
Peginterferon beta-1a,DB09122,"Multiple Sclerosis, Relapsing-Remitting",C0751967,NA,Approved,NA,NA,peginterferon beta-1a
Potassium Citrate,DB09125,Hypokalemia,C0020621,NA,Approved,NA,NA,potassium citrate
Potassium Citrate,DB09125,Calcium renal calculus,C1959799,NA,Approved,NA,NA,potassium citrate
Potassium Citrate,DB09125,Renal tubular acidosis,C0001126,NA,Approved,NA,NA,potassium citrate
Potassium Citrate,DB09125,RENAL CALCULUS CALCIUM OXALATE,C0748267,NA,Approved,NA,NA,potassium citrate
Potassium Citrate,DB09125,Uric acid renal calculus,C0558595,NA,Approved,NA,NA,potassium citrate
Disodium phosphate,DB09127,Constipation,C0009806,NA,Approved,NA,NA,disodium phosphate
Brexpiprazole,DB09128,Schizophrenia,C0036341,NA,Approved,NA,NA,brexpiprazole
Brexpiprazole,DB09128,Major Depressive Disorder,C1269683,NA,Approved,NA,NA,brexpiprazole
Protamine sulfate,DB09141,Heparin overdose,C0573789,NA,Approved,NA,NA,protamine sulfate
Sonidegib,DB09143,Basal cell carcinoma,C0007117,NA,Approved,NA,NA,sonidegib
Uridine triacetate,DB09144,Hereditary orotic aciduria,C0220987,NA,Approved,NA,NA,uridine triacetate
Uridine triacetate,DB09144,Antimetabolite overdose,C0572583,NA,Approved,NA,NA,uridine triacetate
Sucroferric Oxyhydroxide,DB09146,Hyperphosphatemia (disorder),C0085681,NA,Approved,NA,NA,sucroferric oxyhydroxide
Nitrogen,DB09152,Persistent Fetal Circulation Syndrome,C0031190,NA,Approved,NA,NA,nitrogen
Sodium Citrate,DB09154,Common Cold,C0009443,NA,Approved,NA,NA,sodium citrate
Sodium Citrate,DB09154,Peptic Ulcer,C0030920,NA,Approved,NA,NA,sodium citrate
Sodium Citrate,DB09154,Gastroesophageal reflux disease,C0017168,NA,Approved,NA,NA,sodium citrate
Sodium Citrate,DB09154,Dyspepsia,C0013395,NA,Approved,NA,NA,sodium citrate
Sodium Citrate,DB09154,Coughing,C0010200,NA,Approved,NA,NA,sodium citrate
Sodium Citrate,DB09154,Rhinitis,C0035455,NA,Approved,NA,NA,sodium citrate
Sodium Citrate,DB09154,Heartburn,C0018834,NA,Approved,NA,NA,sodium citrate
Sodium Citrate,DB09154,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,sodium citrate
Sodium Citrate,DB09154,Rhinorrhea,C1260880,NA,Approved,NA,NA,sodium citrate
Ferric Citrate,DB09162,Hyperphosphatemia (disorder),C0085681,NA,Approved,NA,NA,ferric citrate
Etizolam,DB09166,Anxiety,C0003467,NA,Approved,NA,NA,etizolam
Dosulepin,DB09167,Major Depressive Disorder,C1269683,NA,Approved,NA,NA,dosulepin
Dasabuvir,DB09183,"Hepatitis C, Chronic",C0524910,NA,Approved,NA,NA,dasabuvir
Viloxazine,DB09185,Narcolepsy-Cataplexy Syndrome,C0751362,NA,Approved,NA,NA,viloxazine
Lobeglitazone,DB09198,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,lobeglitazone
Moxisylyte,DB09205,Erectile dysfunction,C0242350,NA,Approved,NA,NA,moxisylyte
Moxisylyte,DB09205,Raynaud Disease,C0034734,NA,Approved,NA,NA,moxisylyte
Loxoprofen,DB09212,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,loxoprofen
Dexibuprofen,DB09213,Headache Disorders,C0393735,NA,Approved,NA,NA,dexibuprofen
Dexibuprofen,DB09213,Pain,C0030193,NA,Approved,NA,NA,dexibuprofen
Dexibuprofen,DB09213,Fever,C0015967,NA,Approved,NA,NA,dexibuprofen
Dexibuprofen,DB09213,Degenerative polyarthritis,C0029408,NA,Approved,NA,NA,dexibuprofen
Dexibuprofen,DB09213,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,dexibuprofen
Dexibuprofen,DB09213,Dysmenorrhea,C0013390,NA,Approved,NA,NA,dexibuprofen
Polaprezinc,DB09221,Peptic Ulcer,C0030920,NA,Approved,NA,NA,polaprezinc
Blonanserin,DB09223,Schizophrenia,C0036341,NA,Approved,NA,NA,blonanserin
Conestat alfa,DB09228,Hereditary C1 esterase inhibitor deficiency - deficient factor,C0398775,NA,Approved,NA,NA,conestat alfa
Aranidipine,DB09229,Hypertensive disease,C0020538,NA,Approved,NA,NA,aranidipine
Azelnidipine,DB09230,Hypertensive disease,C0020538,NA,Approved,NA,NA,azelnidipine
Efonidipine,DB09235,Hypertensive disease,C0020538,NA,Approved,NA,NA,efonidipine
Pirlindole,DB09244,Depressive disorder,C0011581,NA,Approved,NA,NA,pirlindole
Toloxatone,DB09245,Depressive disorder,C0011581,NA,Approved,NA,NA,toloxatone
Tegafur,DB09256,Malignant neoplasm of stomach,C0024623,NA,Approved,NA,NA,tegafur
Gimeracil,DB09257,Malignant neoplasm of stomach,C0024623,NA,Approved,NA,NA,gimeracil
Bemiparin,DB09258,Pulmonary Embolism,C0034065,NA,Approved,NA,NA,bemiparin
Bemiparin,DB09258,Deep Vein Thrombosis,C0149871,NA,Approved,NA,NA,bemiparin
Imidafenacin,DB09262,Bladder muscle dysfunction - overactive,C0403643,NA,Approved,NA,NA,imidafenacin
Patiromer,DB09263,Hyperkalemia,C0020461,NA,Approved,NA,NA,patiromer
Idarucizumab,DB09264,Drug-induced coagulation inhibitor disorder,C0272373,NA,Approved,NA,NA,idarucizumab
Lixisenatide,DB09265,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NA,Approved,NA,NA,lixisenatide
Strontium ranelate,DB09267,"Osteoporosis, Postmenopausal",C0029458,NA,Approved,NA,NA,strontium ranelate
Phenylacetic acid,DB09269,Hyperammonemia,C0220994,NA,Approved,NA,NA,phenylacetic acid
Eluxadoline,DB09272,Irritable bowel syndrome with diarrhea,C0348898,NA,Approved,NA,NA,eluxadoline
Eluxadoline,DB09272,Diarrhoea predominant irritable bowel syndrome,C1262211,NA,Approved,NA,NA,eluxadoline
Artesunate,DB09274,"Malaria, Falciparum",C0024535,NA,Approved,NA,NA,artesunate
Sodium aurothiomalate,DB09276,Rheumatoid Arthritis,C0003873,NA,Approved,NA,NA,sodium aurothiomalate
Fimasartan,DB09279,Hypertensive disease,C0020538,NA,Approved,NA,NA,fimasartan
Magnesium Trisilicate,DB09281,Dyspepsia,C0013395,NA,Approved,NA,NA,magnesium trisilicate
Magnesium Trisilicate,DB09281,Peptic Ulcer,C0030920,NA,Approved,NA,NA,magnesium trisilicate
Magnesium Trisilicate,DB09281,Gastroesophageal reflux disease,C0017168,NA,Approved,NA,NA,magnesium trisilicate
Magnesium Trisilicate,DB09281,Heartburn,C0018834,NA,Approved,NA,NA,magnesium trisilicate
Polyethylene glycol,DB09287,Incomplete passage of stool,C0426639,NA,Approved,NA,NA,polyethylene glycol
Polyethylene glycol,DB09287,Dry Eye Syndromes,C0013238,NA,Approved,NA,NA,polyethylene glycol
Polyethylene glycol,DB09287,Redness of eye,C0235267,NA,Approved,NA,NA,polyethylene glycol
Polyethylene glycol,DB09287,Constipation,C0009806,NA,Approved,NA,NA,polyethylene glycol
Ramosetron,DB09290,Irritable bowel syndrome with diarrhea,C0348898,NA,Approved,NA,NA,ramosetron
Ramosetron,DB09290,Diarrhoea predominant irritable bowel syndrome,C1262211,NA,Approved,NA,NA,ramosetron
Rolapitant,DB09291,Chemotherapy-induced nausea and vomiting,C0401160,NA,Approved,NA,NA,rolapitant
Sacubitril,DB09292,Chronic heart failure,C0264716,NA,Approved,NA,NA,sacubitril
Sodium Iodide I-131,DB09293,Hyperthyroidism,C0020550,NA,Approved,NA,NA,sodium iodide i-131
Ombitasvir,DB09296,"Hepatitis C, Chronic",C0524910,NA,Approved,NA,NA,ombitasvir
Paritaprevir,DB09297,"Hepatitis C, Chronic",C0524910,NA,Approved,NA,NA,paritaprevir
Tenofovir alafenamide,DB09299,HIV Infections,C0019693,NA,Approved,NA,NA,tenofovir alafenamide
Scopolamine butylbromide,DB09300,Gastric spasm (disorder),C0581358,NA,Approved,NA,NA,scopolamine butylbromide
Alirocumab,DB09302,Hypercholesterolemia,C0020443,NA,Approved,NA,NA,alirocumab
Alirocumab,DB09302,Complex dyslipidemia,C3875286,NA,Approved,NA,NA,alirocumab
Alirocumab,DB09302,Familial hypercholesterolemia - heterozygous,C0342882,NA,Approved,NA,NA,alirocumab
Alirocumab,DB09302,Atherosclerosis,C0004153,NA,Approved,NA,NA,alirocumab
Evolocumab,DB09303,Hypercholesterolemia,C0020443,NA,Approved,NA,NA,evolocumab
Evolocumab,DB09303,Complex dyslipidemia,C3875286,NA,Approved,NA,NA,evolocumab
Evolocumab,DB09303,Familial hypercholesterolemia - heterozygous,C0342882,NA,Approved,NA,NA,evolocumab
Evolocumab,DB09303,Familial hypercholesterolemia - homozygous,C0342881,NA,Approved,NA,NA,evolocumab
Coagulation Factor XIII A-Subunit (Recombinant),DB09310,Hereditary factor XIII A subunit deficiency,C2584877,NA,Approved,NA,NA,coagulation factor xiii a-subunit (recombinant)
Procaine benzylpenicillin,DB09320,Gingivostomatitis,C0149704,NA,Approved,NA,NA,procaine benzylpenicillin
Procaine benzylpenicillin,DB09320,Streptococcal tonsillitis,C0275804,NA,Approved,NA,NA,procaine benzylpenicillin
Procaine benzylpenicillin,DB09320,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,procaine benzylpenicillin
Procaine benzylpenicillin,DB09320,"Syphilis, tertiary",C0153188,NA,Approved,NA,NA,procaine benzylpenicillin
Procaine benzylpenicillin,DB09320,Pharyngitis,C0031350,NA,Approved,NA,NA,procaine benzylpenicillin
Procaine benzylpenicillin,DB09320,"Syphilis, secondary",C0149985,NA,Approved,NA,NA,procaine benzylpenicillin
Procaine benzylpenicillin,DB09320,Acute otitis media,C0271429,NA,Approved,NA,NA,procaine benzylpenicillin
Procaine benzylpenicillin,DB09320,Streptococcal Infections,C0038395,NA,Approved,NA,NA,procaine benzylpenicillin
Procaine benzylpenicillin,DB09320,Fusospirochetal pharyngitis,C1318559,NA,Approved,NA,NA,procaine benzylpenicillin
Procaine benzylpenicillin,DB09320,"Syphilis, Latent",C0039133,NA,Approved,NA,NA,procaine benzylpenicillin
Procaine benzylpenicillin,DB09320,Streptococcal endocarditis,C3665800,NA,Approved,NA,NA,procaine benzylpenicillin
Procaine benzylpenicillin,DB09320,Scarlet Fever,C0036285,NA,Approved,NA,NA,procaine benzylpenicillin
Procaine benzylpenicillin,DB09320,Neurosyphilis,C0027927,NA,Approved,NA,NA,procaine benzylpenicillin
Procaine benzylpenicillin,DB09320,Bejel,C0004945,NA,Approved,NA,NA,procaine benzylpenicillin
Procaine benzylpenicillin,DB09320,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,procaine benzylpenicillin
Procaine benzylpenicillin,DB09320,Streptococcal pneumonia,C0155862,NA,Approved,NA,NA,procaine benzylpenicillin
Procaine benzylpenicillin,DB09320,Primary genital syphilis,C0017418,NA,Approved,NA,NA,procaine benzylpenicillin
Procaine benzylpenicillin,DB09320,Rat-Bite Fever,C0034686,NA,Approved,NA,NA,procaine benzylpenicillin
Procaine benzylpenicillin,DB09320,Anthrax disease,C0003175,NA,Approved,NA,NA,procaine benzylpenicillin
Procaine benzylpenicillin,DB09320,"Syphilis, Congenital",C0039131,NA,Approved,NA,NA,procaine benzylpenicillin
Procaine benzylpenicillin,DB09320,Pinta,C0031946,NA,Approved,NA,NA,procaine benzylpenicillin
Procaine benzylpenicillin,DB09320,Yaws,C0043388,NA,Approved,NA,NA,procaine benzylpenicillin
Procaine benzylpenicillin,DB09320,Erysipelas,C0014733,NA,Approved,NA,NA,procaine benzylpenicillin
Procaine benzylpenicillin,DB09320,Syphilis,C0039128,NA,Approved,NA,NA,procaine benzylpenicillin
Procaine benzylpenicillin,DB09320,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,procaine benzylpenicillin
Zinc oxide,DB09321,Exanthema,C0015230,NA,Approved,NA,NA,zinc oxide
Zinc oxide,DB09321,Tinea Versicolor,C0040262,NA,Approved,NA,NA,zinc oxide
Zinc oxide,DB09321,Skin irritation,C0152030,NA,Approved,NA,NA,zinc oxide
Zinc oxide,DB09321,Arthropod bite wound,C1444173,NA,Approved,NA,NA,zinc oxide
Zinc oxide,DB09321,Tinea cruris,C1384589,NA,Approved,NA,NA,zinc oxide
Zinc oxide,DB09321,Tinea corporis (disorder),C0040252,NA,Approved,NA,NA,zinc oxide
Zinc oxide,DB09321,Cutaneous Candidiasis,C0006846,NA,Approved,NA,NA,zinc oxide
Zinc oxide,DB09321,Pruritus,C0033774,NA,Approved,NA,NA,zinc oxide
Zinc oxide,DB09321,Pruritus Ani,C0033775,NA,Approved,NA,NA,zinc oxide
Zinc oxide,DB09321,Burn injury,C0006434,NA,Approved,NA,NA,zinc oxide
Zinc oxide,DB09321,Hemorrhoids,C0019112,NA,Approved,NA,NA,zinc oxide
Zinc oxide,DB09321,Diaper Rash,C0011974,NA,Approved,NA,NA,zinc oxide
Zinc oxide,DB09321,Injury wounds,C0043250,NA,Approved,NA,NA,zinc oxide
Zinc oxide,DB09321,Proctitis,C0033246,NA,Approved,NA,NA,zinc oxide
Zinc oxide,DB09321,Rectal pain,C0034886,NA,Approved,NA,NA,zinc oxide
Zinc oxide,DB09321,Tinea Pedis,C0040259,NA,Approved,NA,NA,zinc oxide
Zinc sulfate,DB09322,Redness of eye,C0235267,NA,Approved,NA,NA,zinc sulfate
Zinc sulfate,DB09322,Zinc deficiency,C0235950,NA,Approved,NA,NA,zinc sulfate
Benzathine benzylpenicillin,DB09323,Erysipelas,C0014733,NA,Approved,NA,NA,benzathine benzylpenicillin
Benzathine benzylpenicillin,DB09323,Scarlet Fever,C0036285,NA,Approved,NA,NA,benzathine benzylpenicillin
Benzathine benzylpenicillin,DB09323,Streptococcal pneumonia,C0155862,NA,Approved,NA,NA,benzathine benzylpenicillin
Benzathine benzylpenicillin,DB09323,Streptococcus pyogenes infection,C0554628,NA,Approved,NA,NA,benzathine benzylpenicillin
Benzathine benzylpenicillin,DB09323,Streptococcal Infections,C0038395,NA,Approved,NA,NA,benzathine benzylpenicillin
Sulbactam,DB09324,Intraabdominal Infections,C1112209,NA,Approved,NA,NA,sulbactam
Sulbactam,DB09324,Rhinoscleroma,C0035468,NA,Approved,NA,NA,sulbactam
Sulbactam,DB09324,Infection of skin AND/OR subcutaneous tissue,C0178299,NA,Approved,NA,NA,sulbactam
Sulbactam,DB09324,Female genital tract infection,C1263758,NA,Approved,NA,NA,sulbactam
Sulbactam,DB09324,Staphylococcus aureus infection,C1318973,NA,Approved,NA,NA,sulbactam
Sulbactam,DB09324,Bacterial peritonitis,C0341503,NA,Approved,NA,NA,sulbactam
Sulbactam,DB09324,Cholangitis,C0008311,NA,Approved,NA,NA,sulbactam
Sulbactam,DB09324,Pelvic Inflammatory Disease,C0242172,NA,Approved,NA,NA,sulbactam
Sulbactam,DB09324,Enterobacteriaceae Infections,C0014347,NA,Approved,NA,NA,sulbactam
Sulbactam,DB09324,Escherichia coli Infections,C0014836,NA,Approved,NA,NA,sulbactam
Sodium fluoride,DB09325,Vitamin Deficiency,C1510471,NA,Approved,NA,NA,sodium fluoride
Osimertinib,DB09330,Epidermal growth factor receptor positive non-small cell lung cancer,C1960925,NA,Approved,NA,NA,osimertinib
Daratumumab,DB09331,Multiple Myeloma,C0026764,NA,Approved,NA,NA,daratumumab
Kappadione,DB09332,"Jaundice, Obstructive",C0022354,NA,Approved,NA,NA,kappadione
Tipiracil,DB09343,Malignant tumor of colon,C0007102,NA,Approved,NA,NA,tipiracil
Pramocaine,DB09345,Pruritus,C0033774,NA,Approved,NA,NA,pramocaine
Pramocaine,DB09345,Skin irritation,C0152030,NA,Approved,NA,NA,pramocaine
Pramocaine,DB09345,Tinea cruris,C1384589,NA,Approved,NA,NA,pramocaine
Pramocaine,DB09345,Proctitis,C0033246,NA,Approved,NA,NA,pramocaine
Pramocaine,DB09345,Injury wounds,C0043250,NA,Approved,NA,NA,pramocaine
Pramocaine,DB09345,Rectal pain,C0034886,NA,Approved,NA,NA,pramocaine
Pramocaine,DB09345,Arthropod bite wound,C1444173,NA,Approved,NA,NA,pramocaine
Pramocaine,DB09345,Otitis Externa,C0029878,NA,Approved,NA,NA,pramocaine
Pramocaine,DB09345,Tinea Pedis,C0040259,NA,Approved,NA,NA,pramocaine
Pramocaine,DB09345,Pruritus Ani,C0033775,NA,Approved,NA,NA,pramocaine
Pramocaine,DB09345,Exanthema,C0015230,NA,Approved,NA,NA,pramocaine
Pramocaine,DB09345,Dry skin,C0151908,NA,Approved,NA,NA,pramocaine
Pramocaine,DB09345,Tinea corporis (disorder),C0040252,NA,Approved,NA,NA,pramocaine
Pramocaine,DB09345,Burn injury,C0006434,NA,Approved,NA,NA,pramocaine
Pramocaine,DB09345,Hemorrhoids,C0019112,NA,Approved,NA,NA,pramocaine
Pramocaine,DB09345,Itching of ear,C0849907,NA,Approved,NA,NA,pramocaine
Pramocaine,DB09345,Inflammatory dermatosis,C3875321,NA,Approved,NA,NA,pramocaine
Pramocaine,DB09345,Allergic otitis externa,C1320547,NA,Approved,NA,NA,pramocaine
Piperonyl butoxide,DB09350,Pediculus capitis infestation,C0030757,NA,Approved,NA,NA,piperonyl butoxide
Piperonyl butoxide,DB09350,Infestation by Phthirus pubis,C0030759,NA,Approved,NA,NA,piperonyl butoxide
Piperonyl butoxide,DB09350,Body louse infestation,C0030758,NA,Approved,NA,NA,piperonyl butoxide
Levobetaxolol,DB09351,"Glaucoma, Open-Angle",C0017612,NA,Approved,NA,NA,levobetaxolol
Levobetaxolol,DB09351,Ocular Hypertension,C0028840,NA,Approved,NA,NA,levobetaxolol
Hydroxyamphetamine hydrobromide,DB09352,Mydriasis,C0026961,NA,Approved,NA,NA,hydroxyamphetamine hydrobromide
Sulfur,DB09353,Necrotizing Ulcerative Gingivitis,C0017575,NA,Approved,NA,NA,sulfur
Sulfur,DB09353,Acne Vulgaris,C0001144,NA,Approved,NA,NA,sulfur
Sulfur,DB09353,Acneiform Eruptions,C0175167,NA,Approved,NA,NA,sulfur
Sulfur,DB09353,Greasy skin,C0234925,NA,Approved,NA,NA,sulfur
Sulfur,DB09353,Aphthous Stomatitis,C0038363,NA,Approved,NA,NA,sulfur
Sulfur,DB09353,Seborrheic dermatitis,C0036508,NA,Approved,NA,NA,sulfur
Sulfur,DB09353,Scurfiness of scalp,C0423775,NA,Approved,NA,NA,sulfur
Dexpanthenol,DB09357,Dermatologic disorders,C0037274,NA,Approved,NA,NA,dexpanthenol
Dexpanthenol,DB09357,Diaper Rash,C0011974,NA,Approved,NA,NA,dexpanthenol
Dexpanthenol,DB09357,Gastroparesis,C0152020,NA,Approved,NA,NA,dexpanthenol
Dexpanthenol,DB09357,Paralytic Ileus,C0030446,NA,Approved,NA,NA,dexpanthenol
Dexpanthenol,DB09357,Contact dermatitis due to Rhus diversiloba,C0263283,NA,Approved,NA,NA,dexpanthenol
Dexpanthenol,DB09357,Eczema,C0013595,NA,Approved,NA,NA,dexpanthenol
Dexpanthenol,DB09357,Arthropod bite wound,C1444173,NA,Approved,NA,NA,dexpanthenol
Norgestrel,DB09389,Menorrhagia,C0025323,NA,Approved,NA,NA,norgestrel
Norgestrel,DB09389,Hot flushes,C0600142,NA,Approved,NA,NA,norgestrel
Propoxyphene napsylate,DB09396,Pain,C0030193,NA,Approved,NA,NA,propoxyphene napsylate
Magnesium chloride,DB09407,Hypomagnesemia,C0151723,NA,Approved,NA,NA,magnesium chloride
Sodium phosphate,DB09449,Constipation,C0009806,NA,Approved,NA,NA,sodium phosphate
Glycerin,DB09462,Constipation,C0009806,NA,Approved,NA,NA,glycerin
"Sodium phosphate, dibasic, heptahydrate",DB09468,Constipation,C0009806,NA,Approved,NA,NA,"sodium phosphate, dibasic, heptahydrate"
"Sodium phosphate, monobasic, anhydrous",DB09469,Constipation,C0009806,NA,Approved,NA,NA,"sodium phosphate, monobasic, anhydrous"
Sodium sulfate,DB09472,Incomplete passage of stool,C0426639,NA,Approved,NA,NA,sodium sulfate
Enalaprilat,DB09477,Asymptomatic left ventricular systolic dysfunction,C3698411,NA,Approved,NA,NA,enalaprilat
Enalaprilat,DB09477,Hypertensive disease,C0020538,NA,Approved,NA,NA,enalaprilat
Enalaprilat,DB09477,Congestive heart failure,C0018802,NA,Approved,NA,NA,enalaprilat
Magnesium carbonate,DB09481,Gastroesophageal reflux disease,C0017168,NA,Approved,NA,NA,magnesium carbonate
Magnesium carbonate,DB09481,Hypomagnesemia,C0151723,NA,Approved,NA,NA,magnesium carbonate
Magnesium carbonate,DB09481,Heartburn,C0018834,NA,Approved,NA,NA,magnesium carbonate
Magnesium carbonate,DB09481,Peptic Ulcer,C0030920,NA,Approved,NA,NA,magnesium carbonate
Magnesium carbonate,DB09481,Incomplete passage of stool,C0426639,NA,Approved,NA,NA,magnesium carbonate
Magnesium carbonate,DB09481,Dyspepsia,C0013395,NA,Approved,NA,NA,magnesium carbonate
Magnesium carbonate,DB09481,Constipation,C0009806,NA,Approved,NA,NA,magnesium carbonate
Cysteine hydrochloride,DB09485,Bronchitis,C0006277,NA,Approved,NA,NA,cysteine hydrochloride
Cysteine hydrochloride,DB09485,Poisoning by acetaminophen,C0237963,NA,Approved,NA,NA,cysteine hydrochloride
Cysteine hydrochloride,DB09485,Amyloidosis,C0002726,NA,Approved,NA,NA,cysteine hydrochloride
Cysteine hydrochloride,DB09485,Pulmonary Cystic Fibrosis,C0392164,NA,Approved,NA,NA,cysteine hydrochloride
Cysteine hydrochloride,DB09485,Bronchiectasis,C0006267,NA,Approved,NA,NA,cysteine hydrochloride
Acrivastine,DB09488,Hay fever,C0018621,NA,Approved,NA,NA,acrivastine
Acrivastine,DB09488,"Rhinitis, Vasomotor",C0035460,NA,Approved,NA,NA,acrivastine
Acrivastine,DB09488,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,acrivastine
Acrivastine,DB09488,Rhinorrhea,C1260880,NA,Approved,NA,NA,acrivastine
Acrivastine,DB09488,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,acrivastine
Acrivastine,DB09488,Sneezing,C0037383,NA,Approved,NA,NA,acrivastine
Acrivastine,DB09488,Common Cold,C0009443,NA,Approved,NA,NA,acrivastine
Acrivastine,DB09488,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,acrivastine
Octinoxate,DB09496,Chloasma,C0025218,NA,Approved,NA,NA,octinoxate
Octinoxate,DB09496,Discoloration of skin,C0151907,NA,Approved,NA,NA,octinoxate
Sodium thiosulfate,DB09499,Toxic effect of cyanide,C0238080,NA,Approved,NA,NA,sodium thiosulfate
Simethicone,DB09512,Diaper Rash,C0011974,NA,Approved,NA,NA,simethicone
Sodium ferric gluconate complex,DB09517,Iron deficiency anemia,C0162316,NA,Approved,NA,NA,sodium ferric gluconate complex
Sodium ferric gluconate complex,DB09517,Anemia of prematurity,C0158996,NA,Approved,NA,NA,sodium ferric gluconate complex
"Sodium phosphate, monobasic, monohydrate",DB09525,Urinary tract infection,C0042029,NA,Approved,NA,NA,"sodium phosphate, monobasic, monohydrate"
"Sodium phosphate, monobasic, monohydrate",DB09525,Calcium renal calculus,C1959799,NA,Approved,NA,NA,"sodium phosphate, monobasic, monohydrate"
"Sodium phosphate, monobasic, monohydrate",DB09525,Incomplete passage of stool,C0426639,NA,Approved,NA,NA,"sodium phosphate, monobasic, monohydrate"
"Sodium phosphate, monobasic, monohydrate",DB09525,Hypophosphatemia,C0085682,NA,Approved,NA,NA,"sodium phosphate, monobasic, monohydrate"
Hydroquinone,DB09526,Facial hyperpigmentation,C2677857,NA,Approved,NA,NA,hydroquinone
Hydroquinone,DB09526,Discoloration of skin,C0151907,NA,Approved,NA,NA,hydroquinone
Hydroquinone,DB09526,Chloasma,C0025218,NA,Approved,NA,NA,hydroquinone
Methyl salicylate,DB09543,Back Pain,C0004604,NA,Approved,NA,NA,methyl salicylate
Methyl salicylate,DB09543,Sprains and Strains,C0038048,NA,Approved,NA,NA,methyl salicylate
Methyl salicylate,DB09543,Arthritic pains,C0857177,NA,Approved,NA,NA,methyl salicylate
Thonzonium bromide,DB09552,Otitis Externa,C0029878,NA,Approved,NA,NA,thonzonium bromide
Dexchlorpheniramine maleate,DB09555,Symptomatic dermographism,C0343065,NA,Approved,NA,NA,dexchlorpheniramine maleate
Dexchlorpheniramine maleate,DB09555,Allergic Conjunctivitis,C0009766,NA,Approved,NA,NA,dexchlorpheniramine maleate
Dexchlorpheniramine maleate,DB09555,Urticaria,C0042109,NA,Approved,NA,NA,dexchlorpheniramine maleate
Dexchlorpheniramine maleate,DB09555,Pruritus,C0033774,NA,Approved,NA,NA,dexchlorpheniramine maleate
Dexchlorpheniramine maleate,DB09555,Hay fever,C0018621,NA,Approved,NA,NA,dexchlorpheniramine maleate
Dexchlorpheniramine maleate,DB09555,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,dexchlorpheniramine maleate
Dexchlorpheniramine maleate,DB09555,"Rhinitis, Vasomotor",C0035460,NA,Approved,NA,NA,dexchlorpheniramine maleate
Necitumumab,DB09559,Non-Small Cell Lung Carcinoma,C0007131,NA,Approved,NA,NA,necitumumab
Filgrastim-sndz,DB09560,Chemotherapy-induced neutropenia,C1827687,NA,Approved,NA,NA,filgrastim-sndz
Filgrastim-sndz,DB09560,Congenital neutropenia,C0340970,NA,Approved,NA,NA,filgrastim-sndz
Filgrastim-sndz,DB09560,Cyclic neutropenia,C0221023,NA,Approved,NA,NA,filgrastim-sndz
Filgrastim-sndz,DB09560,Chronic idiopathic neutropenia,C2267231,NA,Approved,NA,NA,filgrastim-sndz
Insulin Degludec,DB09564,Diabetes Mellitus,C0011849,NA,Approved,NA,NA,insulin degludec
Omega-3-carboxylic acids,DB09568,Hypertriglyceridemia,C0020557,NA,Approved,NA,NA,omega-3-carboxylic acids
Ixazomib,DB09570,Multiple Myeloma,C0026764,NA,Approved,NA,NA,ixazomib
Levomethamphetamine,DB09571,Nasal congestion (finding),C0027424,NA,Approved,NA,NA,levomethamphetamine
Histamine,DB11320,Degenerative polyarthritis,C0029408,NA,Approved,NA,NA,histamine
Selexipag,DB11362,Pulmonary arterial hypertension,C2973725,NA,Approved,NA,NA,selexipag
Alectinib,DB11363,Non-Small Cell Lung Carcinoma,C0007131,NA,Approved,NA,NA,alectinib
Senna glycoside,DB11365,Constipation,C0009806,NA,Approved,NA,NA,senna glycoside
Lesinurad,DB11560,Hyperuricemia,C0740394,NA,Approved,NA,NA,lesinurad
Sebelipase alfa,DB11563,Wolman Disease,C0043208,NA,Approved,NA,NA,sebelipase alfa
Ixekizumab,DB11569,Chronic small plaque psoriasis,C0406317,NA,Approved,NA,NA,ixekizumab
Elbasvir,DB11574,"Hepatitis C, Chronic",C0524910,NA,Approved,NA,NA,elbasvir
Grazoprevir,DB11575,"Hepatitis C, Chronic",C0524910,NA,Approved,NA,NA,grazoprevir
Venetoclax,DB11581,Chronic Lymphocytic Leukemia,C0023434,NA,Approved,NA,NA,venetoclax
Thiocolchicoside,DB11582,Muscle Spasticity,C0026838,NA,Approved,NA,NA,thiocolchicoside
Bilastine,DB11591,Urticaria,C0042109,NA,Approved,NA,NA,bilastine
Bilastine,DB11591,Allergic rhinitis (disorder),C2607914,NA,Approved,NA,NA,bilastine
Atezolizumab,DB11595,"Carcinoma, Transitional Cell",C0007138,NA,Approved,NA,NA,atezolizumab
Levoleucovorin,DB11596,Poisoning by sulfadiazine,C0274462,NA,Approved,NA,NA,levoleucovorin
Levoleucovorin,DB11596,Methotrexate poisoning,C0568062,NA,Approved,NA,NA,levoleucovorin
Levoleucovorin,DB11596,Poisoning by pyrimethamine,C0274478,NA,Approved,NA,NA,levoleucovorin
Levoleucovorin,DB11596,"Anemia, Megaloblastic",C0002888,NA,Approved,NA,NA,levoleucovorin
Levoleucovorin,DB11596,Folic Acid Deficiency,C0016412,NA,Approved,NA,NA,levoleucovorin
Susoctocog alfa,DB11606,"Factor 8 deficiency, acquired",C0272325,NA,Approved,NA,NA,susoctocog alfa
Eftrenonacog alfa,DB11608,Hemophilia B,C0008533,NA,Approved,NA,NA,eftrenonacog alfa
Buprenorphine,DB00921,Heroin Dependence,C0019337,NCT00000330,Terminated,Phase 2,,buprenorphine
Buprenorphine,DB00921,Opioid-Related Disorders,C0027412,NCT00000330,Terminated,Phase 2,,buprenorphine
Dextroamphetamine,DB01576,Cocaine-Related Disorders,C0236736,NCT00000305,Terminated,Phase 1,Original P.I. left the institution,dextroamphetamine
Buprenorphine,DB00921,Heroin Dependence,C0019337,NCT00000331,Terminated,Phase 2,,buprenorphine
Buprenorphine,DB00921,Opioid-Related Disorders,C0027412,NCT00000331,Terminated,Phase 2,,buprenorphine
Methotrexate,DB00563,Sensorineural Hearing Loss (disorder),C0018784,NCT00000361,Terminated,Phase 3,,methotrexate
Glycine,DB00145,Schizophrenia,C0036341,NCT00000372,Withdrawn,Phase 3,"Pairing D-Cycloserine with Clozapine was found to worsen negative side effects in patients    with Schizophrenia, so the study was suspended.",glycine
Cycloserine,DB00260,Schizophrenia,C0036341,NCT00000372,Withdrawn,Phase 3,"Pairing D-Cycloserine with Clozapine was found to worsen negative side effects in patients    with Schizophrenia, so the study was suspended.",cycloserine
Clozapine,DB00363,Schizophrenia,C0036341,NCT00000372,Withdrawn,Phase 3,"Pairing D-Cycloserine with Clozapine was found to worsen negative side effects in patients    with Schizophrenia, so the study was suspended.",clozapine
Alendronic acid,DB00630,Osteopenia,C0029453,NCT00000430,Terminated,Phase 3,,alendronic acid
Alendronic acid,DB00630,Osteoporosis,C0029456,NCT00000430,Terminated,Phase 3,,alendronic acid
Zidovudine,DB00495,Kidney Diseases,C0022658,NCT00000685,Withdrawn,Phase 1,,zidovudine
Foscarnet,DB00529,Cytomegalovirus Retinitis,C0206178,NCT00000697,Withdrawn,Phase 2,,foscarnet
Trimethoprim,DB00440,Pneumocystis jiroveci pneumonia,C1535939,NCT00000730,Terminated,Phase 3,,trimethoprim
Pentamidine,DB00738,Pneumocystis jiroveci pneumonia,C1535939,NCT00000730,Terminated,Phase 3,,pentamidine
Prednisolone,DB00860,Pneumocystis jiroveci pneumonia,C1535939,NCT00000730,Terminated,Phase 3,,prednisolone
Methylprednisolone,DB00959,Pneumocystis jiroveci pneumonia,C1535939,NCT00000730,Terminated,Phase 3,,methylprednisolone
Sulfamethoxazole,DB01015,Pneumocystis jiroveci pneumonia,C1535939,NCT00000730,Terminated,Phase 3,,sulfamethoxazole
Trimetrexate,DB01157,Pneumocystis jiroveci pneumonia,C1535939,NCT00000730,Terminated,Phase 3,,trimetrexate
Levoleucovorin,DB11596,Pneumocystis jiroveci pneumonia,C1535939,NCT00000730,Terminated,Phase 3,,levoleucovorin
Vitamin E,DB00163,Carotid Artery Diseases,C0007273,NCT00000600,Terminated,Phase 2,,vitamin e
Vitamin E,DB00163,Intracranial Arteriosclerosis,C0007771,NCT00000600,Terminated,Phase 2,,vitamin e
Vitamin E,DB00163,Heart Diseases,C0018799,NCT00000600,Terminated,Phase 2,,vitamin e
Vitamin E,DB00163,Atherosclerosis,C0004153,NCT00000600,Terminated,Phase 2,,vitamin e
Foscarnet,DB00529,Radiculitis,C0034544,NCT00000856,Withdrawn,Phase 1,,foscarnet
Ganciclovir,DB01004,Radiculitis,C0034544,NCT00000856,Withdrawn,Phase 1,,ganciclovir
Pseudoephedrine,DB00852,Sinusitis,C0037199,NCT00000752,Withdrawn,Phase 2,,pseudoephedrine
Cefuroxime,DB01112,Sinusitis,C0037199,NCT00000752,Withdrawn,Phase 2,,cefuroxime
Ephedrine,DB01364,Sinusitis,C0037199,NCT00000752,Withdrawn,Phase 2,,ephedrine
Prednisolone,DB00860,Pneumocystis jiroveci pneumonia,C1535939,NCT00000741,Withdrawn,Phase 3,,prednisolone
Methylprednisolone,DB00959,Pneumocystis jiroveci pneumonia,C1535939,NCT00000741,Withdrawn,Phase 3,,methylprednisolone
Cidofovir,DB00369,Cytomegalovirus Infections,C0010823,NCT00000881,Withdrawn,Phase 1,,cidofovir
Cidofovir,DB00369,Cytomegalovirus Retinitis,C0206178,NCT00000881,Withdrawn,Phase 1,,cidofovir
Calcitriol,DB00136,Rickets,C0035579,NCT00001151,Terminated,Phase 2,Terminated because of lack of drug supply,calcitriol
Daclizumab,DB00111,Aplastic Anemia,C0002874,NCT00001962,Terminated,Phase 2,DSMB recommended closing the study and publishing the results,daclizumab
Daclizumab,DB00111,Pure Red-Cell Aplasia,C0034902,NCT00001962,Terminated,Phase 2,DSMB recommended closing the study and publishing the results,daclizumab
Cyclosporine,DB00091,leukemia,C0023418,NCT00003056,Terminated,Phase 3,Interim analysis indicated study should be terminated,cyclosporine
Methotrexate,DB00563,leukemia,C0023418,NCT00003056,Terminated,Phase 3,Interim analysis indicated study should be terminated,methotrexate
Pegfilgrastim,DB00019,Mucosa-Associated Lymphoid Tissue Lymphoma,C0242647,NCT00012298,Terminated,Phase 1/Phase 2,Trial completed prematurely.,pegfilgrastim
Oprelvekin,DB00038,Mucosa-Associated Lymphoid Tissue Lymphoma,C0242647,NCT00012298,Terminated,Phase 1/Phase 2,Trial completed prematurely.,oprelvekin
Rituximab,DB00073,Mucosa-Associated Lymphoid Tissue Lymphoma,C0242647,NCT00012298,Terminated,Phase 1/Phase 2,Trial completed prematurely.,rituximab
Pegfilgrastim,DB00019,Monocytoid B-cell lymphoma,C0855139,NCT00012298,Terminated,Phase 1/Phase 2,Trial completed prematurely.,pegfilgrastim
Oprelvekin,DB00038,Monocytoid B-cell lymphoma,C0855139,NCT00012298,Terminated,Phase 1/Phase 2,Trial completed prematurely.,oprelvekin
Rituximab,DB00073,Monocytoid B-cell lymphoma,C0855139,NCT00012298,Terminated,Phase 1/Phase 2,Trial completed prematurely.,rituximab
Pegfilgrastim,DB00019,recurrent grade 1 follicular lymphoma,C0280182,NCT00012298,Terminated,Phase 1/Phase 2,Trial completed prematurely.,pegfilgrastim
Oprelvekin,DB00038,recurrent grade 1 follicular lymphoma,C0280182,NCT00012298,Terminated,Phase 1/Phase 2,Trial completed prematurely.,oprelvekin
Rituximab,DB00073,recurrent grade 1 follicular lymphoma,C0280182,NCT00012298,Terminated,Phase 1/Phase 2,Trial completed prematurely.,rituximab
Pegfilgrastim,DB00019,recurrent grade 2 follicular lymphoma,C0280183,NCT00012298,Terminated,Phase 1/Phase 2,Trial completed prematurely.,pegfilgrastim
Oprelvekin,DB00038,recurrent grade 2 follicular lymphoma,C0280183,NCT00012298,Terminated,Phase 1/Phase 2,Trial completed prematurely.,oprelvekin
Rituximab,DB00073,recurrent grade 2 follicular lymphoma,C0280183,NCT00012298,Terminated,Phase 1/Phase 2,Trial completed prematurely.,rituximab
Pegfilgrastim,DB00019,recurrent grade 3 follicular lymphoma,C0280185,NCT00012298,Terminated,Phase 1/Phase 2,Trial completed prematurely.,pegfilgrastim
Oprelvekin,DB00038,recurrent grade 3 follicular lymphoma,C0280185,NCT00012298,Terminated,Phase 1/Phase 2,Trial completed prematurely.,oprelvekin
Rituximab,DB00073,recurrent grade 3 follicular lymphoma,C0280185,NCT00012298,Terminated,Phase 1/Phase 2,Trial completed prematurely.,rituximab
Pegfilgrastim,DB00019,Marginal zone lymphoma recurrent,C1541273,NCT00012298,Terminated,Phase 1/Phase 2,Trial completed prematurely.,pegfilgrastim
Oprelvekin,DB00038,Marginal zone lymphoma recurrent,C1541273,NCT00012298,Terminated,Phase 1/Phase 2,Trial completed prematurely.,oprelvekin
Rituximab,DB00073,Marginal zone lymphoma recurrent,C1541273,NCT00012298,Terminated,Phase 1/Phase 2,Trial completed prematurely.,rituximab
Pegfilgrastim,DB00019,B-cell small lymphocytic lymphoma recurrent,C0855096,NCT00012298,Terminated,Phase 1/Phase 2,Trial completed prematurely.,pegfilgrastim
Oprelvekin,DB00038,B-cell small lymphocytic lymphoma recurrent,C0855096,NCT00012298,Terminated,Phase 1/Phase 2,Trial completed prematurely.,oprelvekin
Rituximab,DB00073,B-cell small lymphocytic lymphoma recurrent,C0855096,NCT00012298,Terminated,Phase 1/Phase 2,Trial completed prematurely.,rituximab
Pegfilgrastim,DB00019,Splenic Marginal Zone B-Cell Lymphoma,C0349632,NCT00012298,Terminated,Phase 1/Phase 2,Trial completed prematurely.,pegfilgrastim
Oprelvekin,DB00038,Splenic Marginal Zone B-Cell Lymphoma,C0349632,NCT00012298,Terminated,Phase 1/Phase 2,Trial completed prematurely.,oprelvekin
Rituximab,DB00073,Splenic Marginal Zone B-Cell Lymphoma,C0349632,NCT00012298,Terminated,Phase 1/Phase 2,Trial completed prematurely.,rituximab
Cisplatin,DB00515,Malignant neoplasm of lung,C0242379,NCT00014196,Terminated,Phase 2,This study was closed early due to poor accrual.,cisplatin
Docetaxel,DB01248,Malignant neoplasm of lung,C0242379,NCT00014196,Terminated,Phase 2,This study was closed early due to poor accrual.,docetaxel
Metronidazole,DB00916,"unspecified adult solid tumor, protocol specific",C0279004,NCT00009958,Terminated,Phase 1,,metronidazole
Cisplatin,DB00515,"unspecified adult solid tumor, protocol specific",C0279004,NCT00012194,Terminated,Phase 1,,cisplatin
Nitric Oxide,DB00435,Pneumonia,C0032285,NCT00016523,Terminated,Phase 3,Preliminary results showed increased intraventricular hemorrhage (IVH) in experimental arm,nitric oxide
Nitric Oxide,DB00435,"Infant, Small for Gestational Age",C0021296,NCT00016523,Terminated,Phase 3,Preliminary results showed increased intraventricular hemorrhage (IVH) in experimental arm,nitric oxide
Betamethasone,DB00443,Pregnancy Complications,C0032962,NCT00015002,Terminated,Phase 3,Concerns regarding neonatal data,betamethasone
Trastuzumab,DB00072,Cardiotoxicity,C0876994,NCT00016276,Terminated,Phase 3,Administratively complete.,trastuzumab
Dexrazoxane,DB00380,Cardiotoxicity,C0876994,NCT00016276,Terminated,Phase 3,Administratively complete.,dexrazoxane
Cyclophosphamide,DB00531,Cardiotoxicity,C0876994,NCT00016276,Terminated,Phase 3,Administratively complete.,cyclophosphamide
Tamoxifen,DB00675,Cardiotoxicity,C0876994,NCT00016276,Terminated,Phase 3,Administratively complete.,tamoxifen
Doxorubicin,DB00997,Cardiotoxicity,C0876994,NCT00016276,Terminated,Phase 3,Administratively complete.,doxorubicin
Paclitaxel,DB01229,Cardiotoxicity,C0876994,NCT00016276,Terminated,Phase 3,Administratively complete.,paclitaxel
Trastuzumab,DB00072,Inflammatory Breast Carcinoma,C0278601,NCT00016276,Terminated,Phase 3,Administratively complete.,trastuzumab
Dexrazoxane,DB00380,Inflammatory Breast Carcinoma,C0278601,NCT00016276,Terminated,Phase 3,Administratively complete.,dexrazoxane
Cyclophosphamide,DB00531,Inflammatory Breast Carcinoma,C0278601,NCT00016276,Terminated,Phase 3,Administratively complete.,cyclophosphamide
Tamoxifen,DB00675,Inflammatory Breast Carcinoma,C0278601,NCT00016276,Terminated,Phase 3,Administratively complete.,tamoxifen
Doxorubicin,DB00997,Inflammatory Breast Carcinoma,C0278601,NCT00016276,Terminated,Phase 3,Administratively complete.,doxorubicin
Paclitaxel,DB01229,Inflammatory Breast Carcinoma,C0278601,NCT00016276,Terminated,Phase 3,Administratively complete.,paclitaxel
Vincristine,DB00541,leukemia,C0023418,NCT00019409,Withdrawn,Phase 3,,vincristine
Daunorubicin,DB00694,leukemia,C0023418,NCT00019409,Withdrawn,Phase 3,,daunorubicin
Hydrocortisone,DB00741,leukemia,C0023418,NCT00019409,Withdrawn,Phase 3,,hydrocortisone
Cytarabine,DB00987,leukemia,C0023418,NCT00019409,Withdrawn,Phase 3,,cytarabine
Doxorubicin,DB00997,stage III adult soft tissue sarcoma,C0278663,NCT00017160,Withdrawn,Phase 2,,doxorubicin
Ifosfamide,DB01181,stage III adult soft tissue sarcoma,C0278663,NCT00017160,Withdrawn,Phase 2,,ifosfamide
Doxorubicin,DB00997,recurrent adult soft tissue sarcoma,C0278665,NCT00017160,Withdrawn,Phase 2,,doxorubicin
Ifosfamide,DB01181,recurrent adult soft tissue sarcoma,C0278665,NCT00017160,Withdrawn,Phase 2,,ifosfamide
Doxorubicin,DB00997,"soft tissue sarcoma, adult, stage IVA",C0279771,NCT00017160,Withdrawn,Phase 2,,doxorubicin
Ifosfamide,DB01181,"soft tissue sarcoma, adult, stage IVA",C0279771,NCT00017160,Withdrawn,Phase 2,,ifosfamide
Doxorubicin,DB00997,"soft tissue sarcoma, adult, stage IIB",C0796438,NCT00017160,Withdrawn,Phase 2,,doxorubicin
Ifosfamide,DB01181,"soft tissue sarcoma, adult, stage IIB",C0796438,NCT00017160,Withdrawn,Phase 2,,ifosfamide
Doxorubicin,DB00997,"soft tissue sarcoma, adult, stage IIC",C0796439,NCT00017160,Withdrawn,Phase 2,,doxorubicin
Ifosfamide,DB01181,"soft tissue sarcoma, adult, stage IIC",C0796439,NCT00017160,Withdrawn,Phase 2,,ifosfamide
Temozolomide,DB00853,Cutaneous Melanoma,C0151779,NCT00020839,Terminated,Phase 3,low accrual,temozolomide
Imatinib,DB00619,leukemia,C0023418,NCT00015847,Terminated,Phase 2,,imatinib
Thalidomide,DB01041,Malignant tumor of colon,C0007102,NCT00019747,Terminated,Phase 2,DSMB recommended closure of the protocol due to slow accrual.,thalidomide
Dexrazoxane,DB00380,Cardiotoxicity,C0876994,NCT00019864,Terminated,Phase 2,,dexrazoxane
Doxorubicin,DB00997,Cardiotoxicity,C0876994,NCT00019864,Terminated,Phase 2,,doxorubicin
Levoleucovorin,DB11596,Cardiotoxicity,C0876994,NCT00019864,Terminated,Phase 2,,levoleucovorin
Alendronic acid,DB00630,Secondary malignant neoplasm of bone,C0153690,NCT00019695,Terminated,Phase 2,,alendronic acid
Ketoconazole,DB01026,Secondary malignant neoplasm of bone,C0153690,NCT00019695,Terminated,Phase 2,,ketoconazole
Alendronic acid,DB00630,Adenocarcinoma of prostate,C0007112,NCT00019695,Terminated,Phase 2,,alendronic acid
Ketoconazole,DB01026,Adenocarcinoma of prostate,C0007112,NCT00019695,Terminated,Phase 2,,ketoconazole
Alendronic acid,DB00630,Prostate cancer recurrent,C0278838,NCT00019695,Terminated,Phase 2,,alendronic acid
Ketoconazole,DB01026,Prostate cancer recurrent,C0278838,NCT00019695,Terminated,Phase 2,,ketoconazole
Paclitaxel,DB01229,Neoplasm Metastasis,C0027627,NCT00023166,Terminated,Phase 1,,paclitaxel
Gemcitabine,DB00441,Renal Pelvis and Ureter Urothelial Carcinoma,C0220648,NCT00022633,Terminated,Phase 2,Permanently Closed Due to Poor Accrual,gemcitabine
Paclitaxel,DB01229,Renal Pelvis and Ureter Urothelial Carcinoma,C0220648,NCT00022633,Terminated,Phase 2,Permanently Closed Due to Poor Accrual,paclitaxel
Gemcitabine,DB00441,Urethral Carcinoma,C0700101,NCT00022633,Terminated,Phase 2,Permanently Closed Due to Poor Accrual,gemcitabine
Paclitaxel,DB01229,Urethral Carcinoma,C0700101,NCT00022633,Terminated,Phase 2,Permanently Closed Due to Poor Accrual,paclitaxel
Imatinib,DB00619,leukemia,C0023418,NCT00022490,Terminated,Phase 2,,imatinib
Cytarabine,DB00987,leukemia,C0023418,NCT00022490,Terminated,Phase 2,,cytarabine
Amifostine,DB01143,Oral Complication,C3898092,NCT00025298,Terminated,Phase 2,low accrual,amifostine
Amifostine,DB01143,Radiation Sickness,C1510432,NCT00025298,Terminated,Phase 2,low accrual,amifostine
Carboplatin,DB00958,"unspecified adult solid tumor, protocol specific",C0279004,NCT00028561,Terminated,Phase 1,Administratively complete.,carboplatin
Celecoxib,DB00482,Precancerous Conditions,C0032927,NCT00027976,Withdrawn,Phase 2/Phase 3,,celecoxib
Doxorubicin,DB00997,Primary Systemic Amyloidosis,C0281479,NCT00030381,Terminated,Phase 1,Administratively complete.,doxorubicin
Homoharringtonine,DB04865,leukemia,C0023418,NCT00030355,Withdrawn,Phase 1/Phase 2,,homoharringtonine
Metronidazole,DB00916,"unspecified adult solid tumor, protocol specific",C0279004,NCT00030693,Terminated,Phase 1,Administratively complete.,metronidazole
Pentostatin,DB00552,Acute GVH disease,C0856825,NCT00032773,Terminated,Phase 1/Phase 2,,pentostatin
Nicotine,DB00184,Malignant neoplasm of lung,C0242379,NCT00032084,Terminated,Phase 3,This study was closed early due to poor accrual,nicotine
Bupropion,DB01156,Malignant neoplasm of lung,C0242379,NCT00032084,Terminated,Phase 3,This study was closed early due to poor accrual,bupropion
Sertraline,DB01104,Epilepsy,C0014544,NCT00026637,Terminated,Phase 3,The PI left Columbia in 2008. No research related activity has taken place since then.,sertraline
Methylphenidate,DB00422,cognitive/functional effects,C0935657,NCT00031798,Terminated,Phase 3,low accrual; loss of funding,methylphenidate
Methylphenidate,DB00422,Depressive disorder,C0011581,NCT00031798,Terminated,Phase 3,low accrual; loss of funding,methylphenidate
Cisplatin,DB00515,Central Nervous System Neoplasms,C0085136,NCT00031590,Terminated,Phase 2,The study was terminated prematurely due to slow accrual.,cisplatin
Cyclophosphamide,DB00531,Central Nervous System Neoplasms,C0085136,NCT00031590,Terminated,Phase 2,The study was terminated prematurely due to slow accrual.,cyclophosphamide
Vincristine,DB00541,Central Nervous System Neoplasms,C0085136,NCT00031590,Terminated,Phase 2,The study was terminated prematurely due to slow accrual.,vincristine
Lomustine,DB01206,Central Nervous System Neoplasms,C0085136,NCT00031590,Terminated,Phase 2,The study was terminated prematurely due to slow accrual.,lomustine
Cisplatin,DB00515,Medulloblastoma,C0025149,NCT00031590,Terminated,Phase 2,The study was terminated prematurely due to slow accrual.,cisplatin
Cyclophosphamide,DB00531,Medulloblastoma,C0025149,NCT00031590,Terminated,Phase 2,The study was terminated prematurely due to slow accrual.,cyclophosphamide
Vincristine,DB00541,Medulloblastoma,C0025149,NCT00031590,Terminated,Phase 2,The study was terminated prematurely due to slow accrual.,vincristine
Lomustine,DB01206,Medulloblastoma,C0025149,NCT00031590,Terminated,Phase 2,The study was terminated prematurely due to slow accrual.,lomustine
Cisplatin,DB00515,"Neuroectodermal Tumor, Primitive",C0206663,NCT00031590,Terminated,Phase 2,The study was terminated prematurely due to slow accrual.,cisplatin
Cyclophosphamide,DB00531,"Neuroectodermal Tumor, Primitive",C0206663,NCT00031590,Terminated,Phase 2,The study was terminated prematurely due to slow accrual.,cyclophosphamide
Vincristine,DB00541,"Neuroectodermal Tumor, Primitive",C0206663,NCT00031590,Terminated,Phase 2,The study was terminated prematurely due to slow accrual.,vincristine
Lomustine,DB01206,"Neuroectodermal Tumor, Primitive",C0206663,NCT00031590,Terminated,Phase 2,The study was terminated prematurely due to slow accrual.,lomustine
Irinotecan,DB00762,Malignant tumor of colon,C0007102,NCT00033306,Terminated,Phase 2,,irinotecan
Gefitinib,DB00317,Squamous cell carcinoma of the hypopharynx stage III,C0280390,NCT00033449,Terminated,Phase 1,Administratively complete.,gefitinib
Cisplatin,DB00515,Squamous cell carcinoma of the hypopharynx stage III,C0280390,NCT00033449,Terminated,Phase 1,Administratively complete.,cisplatin
Gefitinib,DB00317,Laryngeal squamous cell carcinoma stage III,C0280397,NCT00033449,Terminated,Phase 1,Administratively complete.,gefitinib
Cisplatin,DB00515,Laryngeal squamous cell carcinoma stage III,C0280397,NCT00033449,Terminated,Phase 1,Administratively complete.,cisplatin
Gefitinib,DB00317,stage III squamous cell carcinoma of the lip and oral cavity,C0280353,NCT00033449,Terminated,Phase 1,Administratively complete.,gefitinib
Cisplatin,DB00515,stage III squamous cell carcinoma of the lip and oral cavity,C0280353,NCT00033449,Terminated,Phase 1,Administratively complete.,cisplatin
Gefitinib,DB00317,Oropharyngeal squamous cell carcinoma stage III,C0280372,NCT00033449,Terminated,Phase 1,Administratively complete.,gefitinib
Cisplatin,DB00515,Oropharyngeal squamous cell carcinoma stage III,C0280372,NCT00033449,Terminated,Phase 1,Administratively complete.,cisplatin
Gefitinib,DB00317,Squamous cell carcinoma of the hypopharynx stage IV,C0280391,NCT00033449,Terminated,Phase 1,Administratively complete.,gefitinib
Cisplatin,DB00515,Squamous cell carcinoma of the hypopharynx stage IV,C0280391,NCT00033449,Terminated,Phase 1,Administratively complete.,cisplatin
Gefitinib,DB00317,Laryngeal squamous cell carcinoma stage IV,C0280399,NCT00033449,Terminated,Phase 1,Administratively complete.,gefitinib
Cisplatin,DB00515,Laryngeal squamous cell carcinoma stage IV,C0280399,NCT00033449,Terminated,Phase 1,Administratively complete.,cisplatin
Gefitinib,DB00317,stage IV squamous cell carcinoma of the lip and oral cavity,C0280358,NCT00033449,Terminated,Phase 1,Administratively complete.,gefitinib
Cisplatin,DB00515,stage IV squamous cell carcinoma of the lip and oral cavity,C0280358,NCT00033449,Terminated,Phase 1,Administratively complete.,cisplatin
Gefitinib,DB00317,stage IV squamous cell carcinoma of the oropharynx,C0280374,NCT00033449,Terminated,Phase 1,Administratively complete.,gefitinib
Cisplatin,DB00515,stage IV squamous cell carcinoma of the oropharynx,C0280374,NCT00033449,Terminated,Phase 1,Administratively complete.,cisplatin
Celecoxib,DB00482,Malignant tumor of colon,C0007102,NCT00033371,Terminated,Phase 2,Slow recruitment.,celecoxib
Eflornithine,DB06243,Malignant tumor of colon,C0007102,NCT00033371,Terminated,Phase 2,Slow recruitment.,eflornithine
Celecoxib,DB00482,Adenomatous Polyposis Coli,C0032580,NCT00033371,Terminated,Phase 2,Slow recruitment.,celecoxib
Eflornithine,DB06243,Adenomatous Polyposis Coli,C0032580,NCT00033371,Terminated,Phase 2,Slow recruitment.,eflornithine
Dexrazoxane,DB00380,Ewings sarcoma,C0553580,NCT00038142,Terminated,Phase 2,Low Accrual,dexrazoxane
Cyclophosphamide,DB00531,Ewings sarcoma,C0553580,NCT00038142,Terminated,Phase 2,Low Accrual,cyclophosphamide
Vincristine,DB00541,Ewings sarcoma,C0553580,NCT00038142,Terminated,Phase 2,Low Accrual,vincristine
Doxorubicin,DB00997,Ewings sarcoma,C0553580,NCT00038142,Terminated,Phase 2,Low Accrual,doxorubicin
Celecoxib,DB00482,Neoplasm Metastasis,C0027627,NCT00037180,Terminated,Phase 2,,celecoxib
Celecoxib,DB00482,Colorectal Neoplasms,C0009404,NCT00037180,Terminated,Phase 2,,celecoxib
Abatacept,DB01281,Multiple Sclerosis,C0026769,NCT00035529,Terminated,Phase 2,,abatacept
Irinotecan,DB00762,Colorectal Neoplasms,C0009404,NCT00040391,Terminated,Phase 2,,irinotecan
Irinotecan,DB00762,Diarrhea,C0011991,NCT00040391,Terminated,Phase 2,,irinotecan
Pegfilgrastim,DB00019,Hemoglobinopathies,C0019045,NCT00040417,Terminated,Phase 2,,pegfilgrastim
Pegfilgrastim,DB00019,Thalassemia,C0039730,NCT00040417,Terminated,Phase 2,,pegfilgrastim
Trastuzumab,DB00072,Breast cancer recurrent,C0278493,NCT00039455,Terminated,Phase 1,Administratively complete.,trastuzumab
Oprelvekin,DB00038,Ulcerative Colitis,C0009324,NCT00038922,Terminated,Phase 1,,oprelvekin
Oprelvekin,DB00038,Inflammatory Bowel Diseases,C0021390,NCT00038922,Terminated,Phase 1,,oprelvekin
Isotretinoin,DB00982,T-Cell Lymphoma,C0079772,NCT00038376,Terminated,Phase 2,,isotretinoin
Isotretinoin,DB00982,Mycosis Fungoides,C0026948,NCT00038376,Terminated,Phase 2,,isotretinoin
Isotretinoin,DB00982,Hematologic Neoplasms,C0376545,NCT00038376,Terminated,Phase 2,,isotretinoin
Bevacizumab,DB00112,Malignant tumor of colon,C0007102,NCT00043004,Terminated,Phase 2,low accrual,bevacizumab
Levoleucovorin,DB11596,Malignant tumor of colon,C0007102,NCT00043004,Terminated,Phase 2,low accrual,levoleucovorin
Carboplatin,DB00958,Non-small cell lung cancer stage IIIB,C0278984,NCT00042302,Terminated,Phase 3,,carboplatin
Paclitaxel,DB01229,Non-small cell lung cancer stage IIIB,C0278984,NCT00042302,Terminated,Phase 3,,paclitaxel
Carboplatin,DB00958,Non-small cell lung cancer metastatic,C0278987,NCT00042302,Terminated,Phase 3,,carboplatin
Paclitaxel,DB01229,Non-small cell lung cancer metastatic,C0278987,NCT00042302,Terminated,Phase 3,,paclitaxel
Vinorelbine,DB00361,Non-small cell lung cancer stage IIIB,C0278984,NCT00042315,Terminated,Phase 3,,vinorelbine
Vinblastine,DB00570,Non-small cell lung cancer stage IIIB,C0278984,NCT00042315,Terminated,Phase 3,,vinblastine
Vinorelbine,DB00361,Non-small cell lung cancer metastatic,C0278987,NCT00042315,Terminated,Phase 3,,vinorelbine
Vinblastine,DB00570,Non-small cell lung cancer metastatic,C0278987,NCT00042315,Terminated,Phase 3,,vinblastine
Docetaxel,DB01248,thorax/respiratory cancer,C0279170,NCT00041171,Withdrawn,Phase 3,The study was not activated.,docetaxel
Docetaxel,DB01248,adult solid tumor,C0280099,NCT00041171,Withdrawn,Phase 3,The study was not activated.,docetaxel
Docetaxel,DB01248,kidney/urinary cancer,C0279521,NCT00041171,Withdrawn,Phase 3,The study was not activated.,docetaxel
Docetaxel,DB01248,male reproductive cancer,C0699888,NCT00041171,Withdrawn,Phase 3,The study was not activated.,docetaxel
Nitric Oxide,DB00435,Hypoxemia,C0700292,NCT00041548,Terminated,Phase 1/Phase 2,slow enrollment,nitric oxide
Nitric Oxide,DB00435,"Acidosis, Respiratory",C0001127,NCT00041548,Terminated,Phase 1/Phase 2,slow enrollment,nitric oxide
Cyclophosphamide,DB00531,Scleroderma,C0011644,NCT00040651,Terminated,Phase 1,,cyclophosphamide
Cyclophosphamide,DB00531,Systemic Scleroderma,C0036421,NCT00040651,Terminated,Phase 1,,cyclophosphamide
Nitric Oxide,DB00435,Anoxemia,C0003129,NCT00041561,Terminated,Phase 3,Study stopped due to poor enrollment,nitric oxide
Cisplatin,DB00515,Malignant neoplasm of lung,C0242379,NCT00045617,Terminated,Phase 2,Closed due to lack of drug availability.,cisplatin
Etoposide,DB00773,Malignant neoplasm of lung,C0242379,NCT00045617,Terminated,Phase 2,Closed due to lack of drug availability.,etoposide
Fluorouracil,DB00544,Solid tumour,C0280100,NCT00044785,Terminated,Phase 1,,fluorouracil
Bortezomib,DB00188,Non-small cell lung cancer metastatic,C0278987,NCT00040768,Terminated,Phase 2,Administratively complete.,bortezomib
Bortezomib,DB00188,Non-small cell lung cancer recurrent,C0278517,NCT00040768,Terminated,Phase 2,Administratively complete.,bortezomib
Micafungin,DB01141,Aspergillosis,C0004030,NCT00047827,Terminated,Phase 2,Inadequate enrollment,micafungin
Decitabine,DB01262,adult acute myeloid leukemia with 11q23 (MLL) abnormalities,C1541334,NCT00049582,Terminated,Phase 1,,decitabine
Decitabine,DB01262,adult acute myeloid leukemia with inv(16)(p13;q22),C1541333,NCT00049582,Terminated,Phase 1,,decitabine
Decitabine,DB01262,adult acute myeloid leukemia with t(15;17)(q22;q12),C1541335,NCT00049582,Terminated,Phase 1,,decitabine
Decitabine,DB01262,adult acute myeloid leukemia with t(16;16)(p13;q22),C1541332,NCT00049582,Terminated,Phase 1,,decitabine
Decitabine,DB01262,adult acute myeloid leukemia with t(8;21)(q22;q22),C1541331,NCT00049582,Terminated,Phase 1,,decitabine
Decitabine,DB01262,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative",C1292772,NCT00049582,Terminated,Phase 1,,decitabine
Decitabine,DB01262,de novo myelodysplastic syndromes,C0280451,NCT00049582,Terminated,Phase 1,,decitabine
Decitabine,DB01262,"Myelodysplastic/myeloproliferative neoplasm, unclassifiable",C1328061,NCT00049582,Terminated,Phase 1,,decitabine
Decitabine,DB01262,previously treated myelodysplastic syndromes,C0280744,NCT00049582,Terminated,Phase 1,,decitabine
Decitabine,DB01262,recurrent adult acute myeloid leukemia,C0278780,NCT00049582,Terminated,Phase 1,,decitabine
Decitabine,DB01262,secondary acute myeloid leukemia,C0280449,NCT00049582,Terminated,Phase 1,,decitabine
Decitabine,DB01262,secondary myelodysplastic syndromes,C0280745,NCT00049582,Terminated,Phase 1,,decitabine
Decitabine,DB01262,untreated adult acute myeloid leukemia,C0279089,NCT00049582,Terminated,Phase 1,,decitabine
Alemtuzumab,DB00087,Graft failure,C1262018,NCT00048399,Terminated,Phase 1/Phase 2,,alemtuzumab
Erlotinib,DB00530,adult primary hepatocellular carcinoma,C0279607,NCT00047333,Terminated,Phase 2,Administratively complete.,erlotinib
Erlotinib,DB00530,advanced adult primary liver cancer,C0278774,NCT00047333,Terminated,Phase 2,Administratively complete.,erlotinib
Erlotinib,DB00530,localized unresectable adult primary liver cancer,C0278773,NCT00047333,Terminated,Phase 2,Administratively complete.,erlotinib
Oxaliplatin,DB00526,Colorectal Neoplasms,C0009404,NCT00051688,Terminated,Phase 2,,oxaliplatin
Micafungin,DB01141,Invasive Fungal Infections,C1262313,NCT00048750,Terminated,Phase 3,Inadequate enrollment,micafungin
Verteporfin,DB00460,Basal Cell Nevus Syndrome,C0004779,NCT00049959,Terminated,Phase 3,,verteporfin
Bevacizumab,DB00112,"unspecified adult solid tumor, protocol specific",C0279004,NCT00049088,Terminated,Phase 1,Administratively complete.,bevacizumab
Docetaxel,DB01248,"unspecified adult solid tumor, protocol specific",C0279004,NCT00049088,Terminated,Phase 1,Administratively complete.,docetaxel
Aldesleukin,DB00041,childhood chronic myelogenous leukemia,C1327920,NCT00052598,Terminated,Phase 1/Phase 2,,aldesleukin
Aldesleukin,DB00041,Childhood myelodysplastic syndrome,C2347761,NCT00052598,Terminated,Phase 1/Phase 2,,aldesleukin
Aldesleukin,DB00041,recurrent adult acute myeloid leukemia,C0278780,NCT00052598,Terminated,Phase 1/Phase 2,,aldesleukin
Aldesleukin,DB00041,recurrent childhood acute myeloid leukemia,C0278776,NCT00052598,Terminated,Phase 1/Phase 2,,aldesleukin
Aldesleukin,DB00041,chronic myelogenous leukemia in relapse,C0278787,NCT00052598,Terminated,Phase 1/Phase 2,,aldesleukin
Aldesleukin,DB00041,secondary acute myeloid leukemia,C0280449,NCT00052598,Terminated,Phase 1/Phase 2,,aldesleukin
Aldesleukin,DB00041,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,C1332153,NCT00052598,Terminated,Phase 1/Phase 2,,aldesleukin
Aldesleukin,DB00041,adult acute myeloid leukemia with 11q23 (MLL) abnormalities,C1541334,NCT00052598,Terminated,Phase 1/Phase 2,,aldesleukin
Aldesleukin,DB00041,adult acute myeloid leukemia with inv(16)(p13;q22),C1541333,NCT00052598,Terminated,Phase 1/Phase 2,,aldesleukin
Aldesleukin,DB00041,adult acute myeloid leukemia with t(15;17)(q22;q12),C1541335,NCT00052598,Terminated,Phase 1/Phase 2,,aldesleukin
Aldesleukin,DB00041,adult acute myeloid leukemia with t(16;16)(p13;q22),C1541332,NCT00052598,Terminated,Phase 1/Phase 2,,aldesleukin
Aldesleukin,DB00041,adult acute myeloid leukemia with t(8;21)(q22;q22),C1541331,NCT00052598,Terminated,Phase 1/Phase 2,,aldesleukin
Gemcitabine,DB00441,Malignant tumor of colon,C0007102,NCT00049608,Terminated,Phase 1,Principal investigator [PI] has left institution.,gemcitabine
Gemcitabine,DB00441,Malignant neoplasm of lung,C0242379,NCT00049608,Terminated,Phase 1,Principal investigator [PI] has left institution.,gemcitabine
Gefitinib,DB00317,Adenocarcinoma of colon,C0338106,NCT00052585,Terminated,Phase 2,Administratively complete.,gefitinib
Fluorouracil,DB00544,Adenocarcinoma of colon,C0338106,NCT00052585,Terminated,Phase 2,Administratively complete.,fluorouracil
Irinotecan,DB00762,Adenocarcinoma of colon,C0338106,NCT00052585,Terminated,Phase 2,Administratively complete.,irinotecan
Levoleucovorin,DB11596,Adenocarcinoma of colon,C0338106,NCT00052585,Terminated,Phase 2,Administratively complete.,levoleucovorin
Gefitinib,DB00317,Adenocarcinoma of rectum,C0149978,NCT00052585,Terminated,Phase 2,Administratively complete.,gefitinib
Fluorouracil,DB00544,Adenocarcinoma of rectum,C0149978,NCT00052585,Terminated,Phase 2,Administratively complete.,fluorouracil
Irinotecan,DB00762,Adenocarcinoma of rectum,C0149978,NCT00052585,Terminated,Phase 2,Administratively complete.,irinotecan
Levoleucovorin,DB11596,Adenocarcinoma of rectum,C0149978,NCT00052585,Terminated,Phase 2,Administratively complete.,levoleucovorin
Gefitinib,DB00317,Mucinous adenocarcinoma of colon,C0279639,NCT00052585,Terminated,Phase 2,Administratively complete.,gefitinib
Fluorouracil,DB00544,Mucinous adenocarcinoma of colon,C0279639,NCT00052585,Terminated,Phase 2,Administratively complete.,fluorouracil
Irinotecan,DB00762,Mucinous adenocarcinoma of colon,C0279639,NCT00052585,Terminated,Phase 2,Administratively complete.,irinotecan
Levoleucovorin,DB11596,Mucinous adenocarcinoma of colon,C0279639,NCT00052585,Terminated,Phase 2,Administratively complete.,levoleucovorin
Gefitinib,DB00317,mucinous adenocarcinoma of rectum,C0279652,NCT00052585,Terminated,Phase 2,Administratively complete.,gefitinib
Fluorouracil,DB00544,mucinous adenocarcinoma of rectum,C0279652,NCT00052585,Terminated,Phase 2,Administratively complete.,fluorouracil
Irinotecan,DB00762,mucinous adenocarcinoma of rectum,C0279652,NCT00052585,Terminated,Phase 2,Administratively complete.,irinotecan
Levoleucovorin,DB11596,mucinous adenocarcinoma of rectum,C0279652,NCT00052585,Terminated,Phase 2,Administratively complete.,levoleucovorin
Gefitinib,DB00317,Colon cancer recurrent,C0278553,NCT00052585,Terminated,Phase 2,Administratively complete.,gefitinib
Fluorouracil,DB00544,Colon cancer recurrent,C0278553,NCT00052585,Terminated,Phase 2,Administratively complete.,fluorouracil
Irinotecan,DB00762,Colon cancer recurrent,C0278553,NCT00052585,Terminated,Phase 2,Administratively complete.,irinotecan
Levoleucovorin,DB11596,Colon cancer recurrent,C0278553,NCT00052585,Terminated,Phase 2,Administratively complete.,levoleucovorin
Gefitinib,DB00317,Recurrent Rectal Cancer,C0278554,NCT00052585,Terminated,Phase 2,Administratively complete.,gefitinib
Fluorouracil,DB00544,Recurrent Rectal Cancer,C0278554,NCT00052585,Terminated,Phase 2,Administratively complete.,fluorouracil
Irinotecan,DB00762,Recurrent Rectal Cancer,C0278554,NCT00052585,Terminated,Phase 2,Administratively complete.,irinotecan
Levoleucovorin,DB11596,Recurrent Rectal Cancer,C0278554,NCT00052585,Terminated,Phase 2,Administratively complete.,levoleucovorin
Gefitinib,DB00317,signet ring adenocarcinoma of the colon,C0279640,NCT00052585,Terminated,Phase 2,Administratively complete.,gefitinib
Fluorouracil,DB00544,signet ring adenocarcinoma of the colon,C0279640,NCT00052585,Terminated,Phase 2,Administratively complete.,fluorouracil
Irinotecan,DB00762,signet ring adenocarcinoma of the colon,C0279640,NCT00052585,Terminated,Phase 2,Administratively complete.,irinotecan
Levoleucovorin,DB11596,signet ring adenocarcinoma of the colon,C0279640,NCT00052585,Terminated,Phase 2,Administratively complete.,levoleucovorin
Gefitinib,DB00317,signet ring adenocarcinoma of the rectum,C0279654,NCT00052585,Terminated,Phase 2,Administratively complete.,gefitinib
Fluorouracil,DB00544,signet ring adenocarcinoma of the rectum,C0279654,NCT00052585,Terminated,Phase 2,Administratively complete.,fluorouracil
Irinotecan,DB00762,signet ring adenocarcinoma of the rectum,C0279654,NCT00052585,Terminated,Phase 2,Administratively complete.,irinotecan
Levoleucovorin,DB11596,signet ring adenocarcinoma of the rectum,C0279654,NCT00052585,Terminated,Phase 2,Administratively complete.,levoleucovorin
Aldesleukin,DB00041,Mycosis fungoides/Sezary syndrome recurrent,C0862200,NCT00052377,Terminated,Phase 1/Phase 2,Administratively complete.,aldesleukin
Aldesleukin,DB00041,Cutaneous T-cell lymphoma recurrent,C0278580,NCT00052377,Terminated,Phase 1/Phase 2,Administratively complete.,aldesleukin
Aldesleukin,DB00041,Cutaneous T-cell lymphoma stage I,C0278566,NCT00052377,Terminated,Phase 1/Phase 2,Administratively complete.,aldesleukin
Aldesleukin,DB00041,Mycosis fungoides/Sezary syndrome stage I,C0862211,NCT00052377,Terminated,Phase 1/Phase 2,Administratively complete.,aldesleukin
Aldesleukin,DB00041,Cutaneous T-cell lymphoma stage II,C0278568,NCT00052377,Terminated,Phase 1/Phase 2,Administratively complete.,aldesleukin
Aldesleukin,DB00041,Mycosis fungoides/Sezary syndrome stage II,C0862216,NCT00052377,Terminated,Phase 1/Phase 2,Administratively complete.,aldesleukin
Aldesleukin,DB00041,Cutaneous T-cell lymphoma stage III,C0278570,NCT00052377,Terminated,Phase 1/Phase 2,Administratively complete.,aldesleukin
Aldesleukin,DB00041,Mycosis fungoides/Sezary syndrome stage III,C0862221,NCT00052377,Terminated,Phase 1/Phase 2,Administratively complete.,aldesleukin
Aldesleukin,DB00041,Cutaneous T-cell lymphoma stage IV,C0278572,NCT00052377,Terminated,Phase 1/Phase 2,Administratively complete.,aldesleukin
Aldesleukin,DB00041,Mycosis fungoides/Sezary syndrome stage IV,C0862226,NCT00052377,Terminated,Phase 1/Phase 2,Administratively complete.,aldesleukin
Gemcitabine,DB00441,ovarian neoplasm,C0919267,NCT00051584,Terminated,Phase 2,,gemcitabine
Doxorubicin,DB00997,ovarian neoplasm,C0919267,NCT00051584,Terminated,Phase 2,,doxorubicin
Azathioprine,DB00993,Pulmonary Fibrosis,C0034069,NCT00052039,Terminated,Phase 3,Study design changes were needed based on GIPF-001 results,azathioprine
Cyclosporine,DB00091,leukemia,C0023418,NCT00053014,Terminated,Phase 2,Poor accrual,cyclosporine
Mycophenolate mofetil,DB00688,leukemia,C0023418,NCT00053014,Terminated,Phase 2,Poor accrual,mycophenolate mofetil
Mycophenolic acid,DB01024,leukemia,C0023418,NCT00053014,Terminated,Phase 2,Poor accrual,mycophenolic acid
Aldesleukin,DB00041,Neuroblastoma recurrent,C0278695,NCT00054405,Terminated,Phase 1,Administratively complete.,aldesleukin
Gemcitabine,DB00441,Malignant neoplasm of lung,C0242379,NCT00054392,Withdrawn,Phase 3,Not opened at Fox Chase Cancer Center,gemcitabine
Carboplatin,DB00958,Malignant neoplasm of lung,C0242379,NCT00054392,Withdrawn,Phase 3,Not opened at Fox Chase Cancer Center,carboplatin
Trastuzumab,DB00072,Breast cancer recurrent,C0278493,NCT00053339,Withdrawn,Phase 3,The study was not activated.,trastuzumab
Tamoxifen,DB00675,Breast cancer recurrent,C0278493,NCT00053339,Withdrawn,Phase 3,The study was not activated.,tamoxifen
Vinorelbine,DB00361,Malignant neoplasm of lung,C0242379,NCT00055887,Withdrawn,Phase 3,Study never started. No patients were enrolled.,vinorelbine
Gemcitabine,DB00441,Malignant neoplasm of lung,C0242379,NCT00055887,Withdrawn,Phase 3,Study never started. No patients were enrolled.,gemcitabine
Fondaparinux sodium,DB00569,Myocardial Infarction,C0027051,NCT00060554,Withdrawn,Phase 2,Drug sold to Sanofi-Aventis who sold it to GSK; OBS no longer owns study and does not have    data.,fondaparinux sodium
Gemcitabine,DB00441,stage IV adult Hodgkin's lymphoma,C0278473,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Gemcitabine,DB00441,stage IV adult immunoblastic large cell lymphoma,C0280177,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Gemcitabine,DB00441,stage IV adult lymphoblastic lymphoma,C0280178,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Gemcitabine,DB00441,Adult T-cell lymphoma/leukaemia stage IV,C0280426,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Gemcitabine,DB00441,Cutaneous T-cell lymphoma stage IV,C0278572,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Gemcitabine,DB00441,stage IV adult diffuse small cleaved cell lymphoma,C0280173,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Gemcitabine,DB00441,recurrent grade 3 follicular lymphoma,C0280185,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Gemcitabine,DB00441,recurrent grade 1 follicular lymphoma,C0280182,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Gemcitabine,DB00441,recurrent grade 2 follicular lymphoma,C0280183,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Gemcitabine,DB00441,Mantle cell lymphoma recurrent,C0677725,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Gemcitabine,DB00441,Marginal zone lymphoma recurrent,C1541273,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Gemcitabine,DB00441,B-cell small lymphocytic lymphoma recurrent,C0855096,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Gemcitabine,DB00441,Splenic Marginal Zone B-Cell Lymphoma,C0349632,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Gemcitabine,DB00441,stage IV adult Burkitt's lymphoma,C0280179,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Gemcitabine,DB00441,stage IV adult diffuse large cell lymphoma,C0280175,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Gemcitabine,DB00441,stage IV adult diffuse mixed cell lymphoma,C0280174,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Gemcitabine,DB00441,stage IV grade 1 follicular lymphoma,C0280169,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Gemcitabine,DB00441,stage IV grade 2 follicular lymphoma,C0280170,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Gemcitabine,DB00441,stage IV grade 3 follicular lymphoma,C0280172,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Gemcitabine,DB00441,Mantle cell lymphoma stage IV,C0677721,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Gemcitabine,DB00441,Marginal zone lymphoma stage IV,C1541270,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Gemcitabine,DB00441,B-cell small lymphocytic lymphoma stage IV,C0855101,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Gemcitabine,DB00441,"unspecified adult solid tumor, protocol specific",C0279004,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Gemcitabine,DB00441,Mucosa-Associated Lymphoid Tissue Lymphoma,C0242647,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Gemcitabine,DB00441,Monocytoid B-cell lymphoma,C0855139,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Gemcitabine,DB00441,recurrent adult Burkitt's lymphoma,C0280192,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Gemcitabine,DB00441,recurrent adult diffuse large cell lymphoma,C0280188,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Gemcitabine,DB00441,recurrent adult diffuse mixed cell lymphoma,C0280187,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Gemcitabine,DB00441,recurrent adult diffuse small cleaved cell lymphoma,C0280186,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Gemcitabine,DB00441,recurrent adult Hodgkin's lymphoma,C0278530,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Gemcitabine,DB00441,recurrent adult immunoblastic large cell lymphoma,C0280190,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Gemcitabine,DB00441,recurrent adult lymphoblastic lymphoma,C0280191,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Gemcitabine,DB00441,Adult T-cell lymphoma/leukaemia recurrent,C0280427,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Gemcitabine,DB00441,Cutaneous T-cell lymphoma recurrent,C0278580,NCT00060112,Terminated,Phase 1,Administratively complete.,gemcitabine
Rituximab,DB00073,"Lymphoma, Mixed-Cell, Follicular",C0079758,NCT00060671,Terminated,Phase 3,,rituximab
Arsenic trioxide,DB01169,Adenocarcinoma Of Esophagus,C0279628,NCT00061958,Terminated,Phase 2,Administratively complete.,arsenic trioxide
Arsenic trioxide,DB01169,Esophageal neoplasm metastatic,C0278562,NCT00061958,Terminated,Phase 2,Administratively complete.,arsenic trioxide
Nitric Oxide,DB00435,Reperfusion Injury,C0035126,NCT00060450,Terminated,Phase 3,Slow Enrollment,nitric oxide
Treprostinil,DB00374,Critical limb ischemia,C1142264,NCT00060996,Terminated,Phase 3,,treprostinil
Treprostinil,DB00374,Peripheral Vascular Diseases,C0085096,NCT00060996,Terminated,Phase 3,,treprostinil
Treprostinil,DB00374,Foot Ulcer,C0085119,NCT00060996,Terminated,Phase 3,,treprostinil
Sulindac,DB00605,Malignant tumor of colon,C0007102,NCT00062023,Terminated,Phase 2,Study closed by the NCI.,sulindac
Salicylic acid,DB00936,Malignant tumor of colon,C0007102,NCT00062023,Terminated,Phase 2,Study closed by the NCI.,salicylic acid
Acetylsalicylic acid,DB00945,Malignant tumor of colon,C0007102,NCT00062023,Terminated,Phase 2,Study closed by the NCI.,acetylsalicylic acid
Ursodeoxycholic acid,DB01586,Malignant tumor of colon,C0007102,NCT00062023,Terminated,Phase 2,Study closed by the NCI.,ursodeoxycholic acid
Alfuzosin,DB00346,Benign Prostatic Hyperplasia,C1704272,NCT00064649,Terminated,Phase 3,Inability to recruit required sample size.,alfuzosin
Finasteride,DB01216,Benign Prostatic Hyperplasia,C1704272,NCT00064649,Terminated,Phase 3,Inability to recruit required sample size.,finasteride
Cisplatin,DB00515,Adenocarcinoma Of Esophagus,C0279628,NCT00064259,Terminated,Phase 1/Phase 2,Discontinued development of G3139 (oblimersen),cisplatin
Fluorouracil,DB00544,Adenocarcinoma Of Esophagus,C0279628,NCT00064259,Terminated,Phase 1/Phase 2,Discontinued development of G3139 (oblimersen),fluorouracil
Cisplatin,DB00515,Adenocarcinoma of the gastroesophageal junction,C1332166,NCT00064259,Terminated,Phase 1/Phase 2,Discontinued development of G3139 (oblimersen),cisplatin
Fluorouracil,DB00544,Adenocarcinoma of the gastroesophageal junction,C1332166,NCT00064259,Terminated,Phase 1/Phase 2,Discontinued development of G3139 (oblimersen),fluorouracil
Cisplatin,DB00515,diffuse adenocarcinoma of the stomach,C0279635,NCT00064259,Terminated,Phase 1/Phase 2,Discontinued development of G3139 (oblimersen),cisplatin
Fluorouracil,DB00544,diffuse adenocarcinoma of the stomach,C0279635,NCT00064259,Terminated,Phase 1/Phase 2,Discontinued development of G3139 (oblimersen),fluorouracil
Cisplatin,DB00515,intestinal adenocarcinoma of the stomach,C0279633,NCT00064259,Terminated,Phase 1/Phase 2,Discontinued development of G3139 (oblimersen),cisplatin
Fluorouracil,DB00544,intestinal adenocarcinoma of the stomach,C0279633,NCT00064259,Terminated,Phase 1/Phase 2,Discontinued development of G3139 (oblimersen),fluorouracil
Cisplatin,DB00515,mixed adenocarcinoma of the stomach,C0279638,NCT00064259,Terminated,Phase 1/Phase 2,Discontinued development of G3139 (oblimersen),cisplatin
Fluorouracil,DB00544,mixed adenocarcinoma of the stomach,C0279638,NCT00064259,Terminated,Phase 1/Phase 2,Discontinued development of G3139 (oblimersen),fluorouracil
Cisplatin,DB00515,Oesophageal carcinoma recurrent,C0854761,NCT00064259,Terminated,Phase 1/Phase 2,Discontinued development of G3139 (oblimersen),cisplatin
Fluorouracil,DB00544,Oesophageal carcinoma recurrent,C0854761,NCT00064259,Terminated,Phase 1/Phase 2,Discontinued development of G3139 (oblimersen),fluorouracil
Cisplatin,DB00515,recurrent gastric cancer,C0278502,NCT00064259,Terminated,Phase 1/Phase 2,Discontinued development of G3139 (oblimersen),cisplatin
Fluorouracil,DB00544,recurrent gastric cancer,C0278502,NCT00064259,Terminated,Phase 1/Phase 2,Discontinued development of G3139 (oblimersen),fluorouracil
Cisplatin,DB00515,Squamous cell carcinoma of esophagus,C0279626,NCT00064259,Terminated,Phase 1/Phase 2,Discontinued development of G3139 (oblimersen),cisplatin
Fluorouracil,DB00544,Squamous cell carcinoma of esophagus,C0279626,NCT00064259,Terminated,Phase 1/Phase 2,Discontinued development of G3139 (oblimersen),fluorouracil
Cisplatin,DB00515,Stage IIIC Gastric Cancer,C2981365,NCT00064259,Terminated,Phase 1/Phase 2,Discontinued development of G3139 (oblimersen),cisplatin
Fluorouracil,DB00544,Stage IIIC Gastric Cancer,C2981365,NCT00064259,Terminated,Phase 1/Phase 2,Discontinued development of G3139 (oblimersen),fluorouracil
Cisplatin,DB00515,Esophageal neoplasm metastatic,C0278562,NCT00064259,Terminated,Phase 1/Phase 2,Discontinued development of G3139 (oblimersen),cisplatin
Fluorouracil,DB00544,Esophageal neoplasm metastatic,C0278562,NCT00064259,Terminated,Phase 1/Phase 2,Discontinued development of G3139 (oblimersen),fluorouracil
Erlotinib,DB00530,Malignant neoplasm of lung,C0242379,NCT00063258,Terminated,Phase 2,Low accrual rate,erlotinib
Carboplatin,DB00958,Malignant neoplasm of lung,C0242379,NCT00063258,Terminated,Phase 2,Low accrual rate,carboplatin
Paclitaxel,DB01229,Malignant neoplasm of lung,C0242379,NCT00063258,Terminated,Phase 2,Low accrual rate,paclitaxel
Lamotrigine,DB00555,Bipolar Disorder,C0005586,NCT00063362,Terminated,Phase 3,Funding Expiration,lamotrigine
Prednisolone,DB00860,Chronic myeloproliferative disorder,C1292778,NCT00066417,Terminated,Phase 2,Trial was withdrawn for drug availability issues.,prednisolone
Methylprednisolone,DB00959,Chronic myeloproliferative disorder,C1292778,NCT00066417,Terminated,Phase 2,Trial was withdrawn for drug availability issues.,methylprednisolone
Fludarabine,DB01073,Chronic myeloproliferative disorder,C1292778,NCT00066417,Terminated,Phase 2,Trial was withdrawn for drug availability issues.,fludarabine
Prednisolone,DB00860,leukemia,C0023418,NCT00066417,Terminated,Phase 2,Trial was withdrawn for drug availability issues.,prednisolone
Methylprednisolone,DB00959,leukemia,C0023418,NCT00066417,Terminated,Phase 2,Trial was withdrawn for drug availability issues.,methylprednisolone
Fludarabine,DB01073,leukemia,C0023418,NCT00066417,Terminated,Phase 2,Trial was withdrawn for drug availability issues.,fludarabine
Bortezomib,DB00188,"unspecified adult solid tumor, protocol specific",C0279004,NCT00066625,Terminated,Phase 1,Administratively complete.,bortezomib
Oxaliplatin,DB00526,"unspecified adult solid tumor, protocol specific",C0279004,NCT00066625,Terminated,Phase 1,Administratively complete.,oxaliplatin
Oxaliplatin,DB00526,Colorectal Neoplasms,C0009404,NCT00065117,Terminated,Phase 2,,oxaliplatin
Fluorouracil,DB00544,Colorectal Neoplasms,C0009404,NCT00065117,Terminated,Phase 2,,fluorouracil
Modafinil,DB00745,Postpoliomyelitis Syndrome,C0080040,NCT00067496,Terminated,Phase 3,,modafinil
Armodafinil,DB06413,Postpoliomyelitis Syndrome,C0080040,NCT00067496,Terminated,Phase 3,,armodafinil
Treprostinil,DB00374,Peripheral Vascular Diseases,C0085096,NCT00067041,Terminated,Phase 2/Phase 3,,treprostinil
Oxaliplatin,DB00526,Recurrent Rectal Cancer,C0278554,NCT00068692,Terminated,Phase 3,Administratively complete.,oxaliplatin
Fluorouracil,DB00544,Recurrent Rectal Cancer,C0278554,NCT00068692,Terminated,Phase 3,Administratively complete.,fluorouracil
Leucovorin,DB00650,Recurrent Rectal Cancer,C0278554,NCT00068692,Terminated,Phase 3,Administratively complete.,leucovorin
Irinotecan,DB00762,Recurrent Rectal Cancer,C0278554,NCT00068692,Terminated,Phase 3,Administratively complete.,irinotecan
Levoleucovorin,DB11596,Recurrent Rectal Cancer,C0278554,NCT00068692,Terminated,Phase 3,Administratively complete.,levoleucovorin
Oxaliplatin,DB00526,signet ring adenocarcinoma of the rectum,C0279654,NCT00068692,Terminated,Phase 3,Administratively complete.,oxaliplatin
Fluorouracil,DB00544,signet ring adenocarcinoma of the rectum,C0279654,NCT00068692,Terminated,Phase 3,Administratively complete.,fluorouracil
Leucovorin,DB00650,signet ring adenocarcinoma of the rectum,C0279654,NCT00068692,Terminated,Phase 3,Administratively complete.,leucovorin
Irinotecan,DB00762,signet ring adenocarcinoma of the rectum,C0279654,NCT00068692,Terminated,Phase 3,Administratively complete.,irinotecan
Levoleucovorin,DB11596,signet ring adenocarcinoma of the rectum,C0279654,NCT00068692,Terminated,Phase 3,Administratively complete.,levoleucovorin
Oxaliplatin,DB00526,Stage IIA Rectal Cancer,C3897537,NCT00068692,Terminated,Phase 3,Administratively complete.,oxaliplatin
Fluorouracil,DB00544,Stage IIA Rectal Cancer,C3897537,NCT00068692,Terminated,Phase 3,Administratively complete.,fluorouracil
Leucovorin,DB00650,Stage IIA Rectal Cancer,C3897537,NCT00068692,Terminated,Phase 3,Administratively complete.,leucovorin
Irinotecan,DB00762,Stage IIA Rectal Cancer,C3897537,NCT00068692,Terminated,Phase 3,Administratively complete.,irinotecan
Levoleucovorin,DB11596,Stage IIA Rectal Cancer,C3897537,NCT00068692,Terminated,Phase 3,Administratively complete.,levoleucovorin
Oxaliplatin,DB00526,Stage IIB Rectal Cancer,C3897536,NCT00068692,Terminated,Phase 3,Administratively complete.,oxaliplatin
Fluorouracil,DB00544,Stage IIB Rectal Cancer,C3897536,NCT00068692,Terminated,Phase 3,Administratively complete.,fluorouracil
Leucovorin,DB00650,Stage IIB Rectal Cancer,C3897536,NCT00068692,Terminated,Phase 3,Administratively complete.,leucovorin
Irinotecan,DB00762,Stage IIB Rectal Cancer,C3897536,NCT00068692,Terminated,Phase 3,Administratively complete.,irinotecan
Levoleucovorin,DB11596,Stage IIB Rectal Cancer,C3897536,NCT00068692,Terminated,Phase 3,Administratively complete.,levoleucovorin
Oxaliplatin,DB00526,Stage IIC Rectal Cancer,C3897535,NCT00068692,Terminated,Phase 3,Administratively complete.,oxaliplatin
Fluorouracil,DB00544,Stage IIC Rectal Cancer,C3897535,NCT00068692,Terminated,Phase 3,Administratively complete.,fluorouracil
Leucovorin,DB00650,Stage IIC Rectal Cancer,C3897535,NCT00068692,Terminated,Phase 3,Administratively complete.,leucovorin
Irinotecan,DB00762,Stage IIC Rectal Cancer,C3897535,NCT00068692,Terminated,Phase 3,Administratively complete.,irinotecan
Levoleucovorin,DB11596,Stage IIC Rectal Cancer,C3897535,NCT00068692,Terminated,Phase 3,Administratively complete.,levoleucovorin
Oxaliplatin,DB00526,Stage IIIA Rectal Cancer,C3897531,NCT00068692,Terminated,Phase 3,Administratively complete.,oxaliplatin
Fluorouracil,DB00544,Stage IIIA Rectal Cancer,C3897531,NCT00068692,Terminated,Phase 3,Administratively complete.,fluorouracil
Leucovorin,DB00650,Stage IIIA Rectal Cancer,C3897531,NCT00068692,Terminated,Phase 3,Administratively complete.,leucovorin
Irinotecan,DB00762,Stage IIIA Rectal Cancer,C3897531,NCT00068692,Terminated,Phase 3,Administratively complete.,irinotecan
Levoleucovorin,DB11596,Stage IIIA Rectal Cancer,C3897531,NCT00068692,Terminated,Phase 3,Administratively complete.,levoleucovorin
Oxaliplatin,DB00526,Stage IIIB Rectal Cancer,C3897528,NCT00068692,Terminated,Phase 3,Administratively complete.,oxaliplatin
Fluorouracil,DB00544,Stage IIIB Rectal Cancer,C3897528,NCT00068692,Terminated,Phase 3,Administratively complete.,fluorouracil
Leucovorin,DB00650,Stage IIIB Rectal Cancer,C3897528,NCT00068692,Terminated,Phase 3,Administratively complete.,leucovorin
Irinotecan,DB00762,Stage IIIB Rectal Cancer,C3897528,NCT00068692,Terminated,Phase 3,Administratively complete.,irinotecan
Levoleucovorin,DB11596,Stage IIIB Rectal Cancer,C3897528,NCT00068692,Terminated,Phase 3,Administratively complete.,levoleucovorin
Oxaliplatin,DB00526,Stage IIIC Rectal Cancer,C3897525,NCT00068692,Terminated,Phase 3,Administratively complete.,oxaliplatin
Fluorouracil,DB00544,Stage IIIC Rectal Cancer,C3897525,NCT00068692,Terminated,Phase 3,Administratively complete.,fluorouracil
Leucovorin,DB00650,Stage IIIC Rectal Cancer,C3897525,NCT00068692,Terminated,Phase 3,Administratively complete.,leucovorin
Irinotecan,DB00762,Stage IIIC Rectal Cancer,C3897525,NCT00068692,Terminated,Phase 3,Administratively complete.,irinotecan
Levoleucovorin,DB11596,Stage IIIC Rectal Cancer,C3897525,NCT00068692,Terminated,Phase 3,Administratively complete.,levoleucovorin
Oxaliplatin,DB00526,Stage IVA Rectal Cancer,C3897520,NCT00068692,Terminated,Phase 3,Administratively complete.,oxaliplatin
Fluorouracil,DB00544,Stage IVA Rectal Cancer,C3897520,NCT00068692,Terminated,Phase 3,Administratively complete.,fluorouracil
Leucovorin,DB00650,Stage IVA Rectal Cancer,C3897520,NCT00068692,Terminated,Phase 3,Administratively complete.,leucovorin
Irinotecan,DB00762,Stage IVA Rectal Cancer,C3897520,NCT00068692,Terminated,Phase 3,Administratively complete.,irinotecan
Levoleucovorin,DB11596,Stage IVA Rectal Cancer,C3897520,NCT00068692,Terminated,Phase 3,Administratively complete.,levoleucovorin
Oxaliplatin,DB00526,Stage IVB Rectal Cancer,C3897513,NCT00068692,Terminated,Phase 3,Administratively complete.,oxaliplatin
Fluorouracil,DB00544,Stage IVB Rectal Cancer,C3897513,NCT00068692,Terminated,Phase 3,Administratively complete.,fluorouracil
Leucovorin,DB00650,Stage IVB Rectal Cancer,C3897513,NCT00068692,Terminated,Phase 3,Administratively complete.,leucovorin
Irinotecan,DB00762,Stage IVB Rectal Cancer,C3897513,NCT00068692,Terminated,Phase 3,Administratively complete.,irinotecan
Levoleucovorin,DB11596,Stage IVB Rectal Cancer,C3897513,NCT00068692,Terminated,Phase 3,Administratively complete.,levoleucovorin
Oxaliplatin,DB00526,mucinous adenocarcinoma of rectum,C0279652,NCT00068692,Terminated,Phase 3,Administratively complete.,oxaliplatin
Fluorouracil,DB00544,mucinous adenocarcinoma of rectum,C0279652,NCT00068692,Terminated,Phase 3,Administratively complete.,fluorouracil
Leucovorin,DB00650,mucinous adenocarcinoma of rectum,C0279652,NCT00068692,Terminated,Phase 3,Administratively complete.,leucovorin
Irinotecan,DB00762,mucinous adenocarcinoma of rectum,C0279652,NCT00068692,Terminated,Phase 3,Administratively complete.,irinotecan
Levoleucovorin,DB11596,mucinous adenocarcinoma of rectum,C0279652,NCT00068692,Terminated,Phase 3,Administratively complete.,levoleucovorin
Metronidazole,DB00916,Breast cancer recurrent,C0278493,NCT00071942,Terminated,Phase 1,,metronidazole
Chlorhexidine,DB00878,Dental caries,C0011334,NCT00067340,Terminated,Phase 3,Unable to recruit sufficient number of subjects,chlorhexidine
Sirolimus,DB00877,leukemia,C0023418,NCT00068302,Terminated,Phase 1,Recruiting/enrolling participants halted prematurely but potentially will resume,sirolimus
Everolimus,DB01590,leukemia,C0023418,NCT00068302,Terminated,Phase 1,Recruiting/enrolling participants halted prematurely but potentially will resume,everolimus
Gefitinib,DB00317,Malignant tumor of colon,C0007102,NCT00087334,Terminated,Phase 1/Phase 2,Withdrawn due to poor/low accrual,gefitinib
Oxaliplatin,DB00526,Malignant tumor of colon,C0007102,NCT00087334,Terminated,Phase 1/Phase 2,Withdrawn due to poor/low accrual,oxaliplatin
Capecitabine,DB01101,Malignant tumor of colon,C0007102,NCT00087334,Terminated,Phase 1/Phase 2,Withdrawn due to poor/low accrual,capecitabine
Amphetamine,DB00182,Depressive disorder,C0011581,NCT00069927,Terminated,Phase 2,Only 12 subjects enrolled. DSMB recommended closing due to lack of feasibility,amphetamine
Methylphenidate,DB00422,Depressive disorder,C0011581,NCT00069927,Terminated,Phase 2,Only 12 subjects enrolled. DSMB recommended closing due to lack of feasibility,methylphenidate
Amphetamine,DB00182,Neurotoxicity Syndromes,C0235032,NCT00069927,Terminated,Phase 2,Only 12 subjects enrolled. DSMB recommended closing due to lack of feasibility,amphetamine
Methylphenidate,DB00422,Neurotoxicity Syndromes,C0235032,NCT00069927,Terminated,Phase 2,Only 12 subjects enrolled. DSMB recommended closing due to lack of feasibility,methylphenidate
Amphetamine,DB00182,"unspecified childhood solid tumor, protocol specific",C0279002,NCT00069927,Terminated,Phase 2,Only 12 subjects enrolled. DSMB recommended closing due to lack of feasibility,amphetamine
Methylphenidate,DB00422,"unspecified childhood solid tumor, protocol specific",C0279002,NCT00069927,Terminated,Phase 2,Only 12 subjects enrolled. DSMB recommended closing due to lack of feasibility,methylphenidate
Alemtuzumab,DB00087,Chronic myeloproliferative disorder,C1292778,NCT00069992,Terminated,Phase 2,Closed due to competing protocols,alemtuzumab
Fludarabine,DB01073,Chronic myeloproliferative disorder,C1292778,NCT00069992,Terminated,Phase 2,Closed due to competing protocols,fludarabine
Alemtuzumab,DB00087,leukemia,C0023418,NCT00069992,Terminated,Phase 2,Closed due to competing protocols,alemtuzumab
Fludarabine,DB01073,leukemia,C0023418,NCT00069992,Terminated,Phase 2,Closed due to competing protocols,fludarabine
Romidepsin,DB06176,Renal Pelvis and Ureter Urothelial Carcinoma,C0220648,NCT00087295,Terminated,Phase 2,Permanently Closed Due to Poor Accrual,romidepsin
Romidepsin,DB06176,Urethral Carcinoma,C0700101,NCT00087295,Terminated,Phase 2,Permanently Closed Due to Poor Accrual,romidepsin
Erlotinib,DB00530,Stage IA Non-Small Cell Lung Carcinoma,C1336119,NCT00087269,Terminated,Phase 2,,erlotinib
Erlotinib,DB00530,Stage IB Non-Small Cell Lung Carcinoma,C1336139,NCT00087269,Terminated,Phase 2,,erlotinib
Erlotinib,DB00530,Stage IIA Non-Small Cell Lung Carcinoma,C1336167,NCT00087269,Terminated,Phase 2,,erlotinib
Erlotinib,DB00530,Stage IIB Non-Small Cell Lung Carcinoma,C1336190,NCT00087269,Terminated,Phase 2,,erlotinib
Erlotinib,DB00530,Non-small cell lung cancer stage IIIA,C0278983,NCT00087269,Terminated,Phase 2,,erlotinib
Bevacizumab,DB00112,Adenocarcinoma of colon,C0338106,NCT00070122,Terminated,Phase 3,Administratively complete.,bevacizumab
Oxaliplatin,DB00526,Adenocarcinoma of colon,C0338106,NCT00070122,Terminated,Phase 3,Administratively complete.,oxaliplatin
Fluorouracil,DB00544,Adenocarcinoma of colon,C0338106,NCT00070122,Terminated,Phase 3,Administratively complete.,fluorouracil
Leucovorin,DB00650,Adenocarcinoma of colon,C0338106,NCT00070122,Terminated,Phase 3,Administratively complete.,leucovorin
Capecitabine,DB01101,Adenocarcinoma of colon,C0338106,NCT00070122,Terminated,Phase 3,Administratively complete.,capecitabine
Levoleucovorin,DB11596,Adenocarcinoma of colon,C0338106,NCT00070122,Terminated,Phase 3,Administratively complete.,levoleucovorin
Bevacizumab,DB00112,Adenocarcinoma of rectum,C0149978,NCT00070122,Terminated,Phase 3,Administratively complete.,bevacizumab
Oxaliplatin,DB00526,Adenocarcinoma of rectum,C0149978,NCT00070122,Terminated,Phase 3,Administratively complete.,oxaliplatin
Fluorouracil,DB00544,Adenocarcinoma of rectum,C0149978,NCT00070122,Terminated,Phase 3,Administratively complete.,fluorouracil
Leucovorin,DB00650,Adenocarcinoma of rectum,C0149978,NCT00070122,Terminated,Phase 3,Administratively complete.,leucovorin
Capecitabine,DB01101,Adenocarcinoma of rectum,C0149978,NCT00070122,Terminated,Phase 3,Administratively complete.,capecitabine
Levoleucovorin,DB11596,Adenocarcinoma of rectum,C0149978,NCT00070122,Terminated,Phase 3,Administratively complete.,levoleucovorin
Bevacizumab,DB00112,Colon cancer recurrent,C0278553,NCT00070122,Terminated,Phase 3,Administratively complete.,bevacizumab
Oxaliplatin,DB00526,Colon cancer recurrent,C0278553,NCT00070122,Terminated,Phase 3,Administratively complete.,oxaliplatin
Fluorouracil,DB00544,Colon cancer recurrent,C0278553,NCT00070122,Terminated,Phase 3,Administratively complete.,fluorouracil
Leucovorin,DB00650,Colon cancer recurrent,C0278553,NCT00070122,Terminated,Phase 3,Administratively complete.,leucovorin
Capecitabine,DB01101,Colon cancer recurrent,C0278553,NCT00070122,Terminated,Phase 3,Administratively complete.,capecitabine
Levoleucovorin,DB11596,Colon cancer recurrent,C0278553,NCT00070122,Terminated,Phase 3,Administratively complete.,levoleucovorin
Bevacizumab,DB00112,Recurrent Rectal Cancer,C0278554,NCT00070122,Terminated,Phase 3,Administratively complete.,bevacizumab
Oxaliplatin,DB00526,Recurrent Rectal Cancer,C0278554,NCT00070122,Terminated,Phase 3,Administratively complete.,oxaliplatin
Fluorouracil,DB00544,Recurrent Rectal Cancer,C0278554,NCT00070122,Terminated,Phase 3,Administratively complete.,fluorouracil
Leucovorin,DB00650,Recurrent Rectal Cancer,C0278554,NCT00070122,Terminated,Phase 3,Administratively complete.,leucovorin
Capecitabine,DB01101,Recurrent Rectal Cancer,C0278554,NCT00070122,Terminated,Phase 3,Administratively complete.,capecitabine
Levoleucovorin,DB11596,Recurrent Rectal Cancer,C0278554,NCT00070122,Terminated,Phase 3,Administratively complete.,levoleucovorin
Oxaliplatin,DB00526,Secondary malignant neoplasm of liver,C0494165,NCT00070265,Terminated,Phase 2,Administratively complete.,oxaliplatin
Fluorouracil,DB00544,Secondary malignant neoplasm of liver,C0494165,NCT00070265,Terminated,Phase 2,Administratively complete.,fluorouracil
Capecitabine,DB01101,Secondary malignant neoplasm of liver,C0494165,NCT00070265,Terminated,Phase 2,Administratively complete.,capecitabine
Oxaliplatin,DB00526,Colon cancer recurrent,C0278553,NCT00070265,Terminated,Phase 2,Administratively complete.,oxaliplatin
Fluorouracil,DB00544,Colon cancer recurrent,C0278553,NCT00070265,Terminated,Phase 2,Administratively complete.,fluorouracil
Capecitabine,DB01101,Colon cancer recurrent,C0278553,NCT00070265,Terminated,Phase 2,Administratively complete.,capecitabine
Oxaliplatin,DB00526,Recurrent Rectal Cancer,C0278554,NCT00070265,Terminated,Phase 2,Administratively complete.,oxaliplatin
Fluorouracil,DB00544,Recurrent Rectal Cancer,C0278554,NCT00070265,Terminated,Phase 2,Administratively complete.,fluorouracil
Capecitabine,DB01101,Recurrent Rectal Cancer,C0278554,NCT00070265,Terminated,Phase 2,Administratively complete.,capecitabine
Oxaliplatin,DB00526,Malignant tumor of colon,C0007102,NCT00070434,Withdrawn,Phase 2,poor accrual,oxaliplatin
Irinotecan,DB00762,Malignant tumor of colon,C0007102,NCT00070434,Withdrawn,Phase 2,poor accrual,irinotecan
Levoleucovorin,DB11596,Malignant tumor of colon,C0007102,NCT00070434,Withdrawn,Phase 2,poor accrual,levoleucovorin
Gefitinib,DB00317,Malignant neoplasm of lung,C0242379,NCT00091156,Terminated,Phase 3,low accrual,gefitinib
Triptorelin,DB06825,Drug toxicity,C0013221,NCT00090844,Terminated,Phase 2,Early closure due to low accrual,triptorelin
Fluorouracil,DB00544,Biliary Tract Cancer,C0750952,NCT00090025,Terminated,Phase 3,Futility reasons after Independent Data Monitoring Committee interim analysis,fluorouracil
Celecoxib,DB00482,Malignant tumor of colon,C0007102,NCT00087256,Terminated,Phase 3,"For scientific, logistic, and administrative reasons.",celecoxib
Capsaicin,DB06774,Peripheral Neuropathy,C0031117,NCT00085761,Terminated,Phase 3,Terminated in view of the C107 findings demonstrating efficacy at doses of 90 and 30 minutes,capsaicin
Capsaicin,DB06774,Pain,C0030193,NCT00085761,Terminated,Phase 3,Terminated in view of the C107 findings demonstrating efficacy at doses of 90 and 30 minutes,capsaicin
Gefitinib,DB00317,Recurrent Head and Neck Carcinoma,C1335703,NCT00088907,Terminated,Phase 3,It was unlikely that the primary endpoint would be reached based on the fifth interim analysis    results.,gefitinib
Docetaxel,DB01248,Recurrent Head and Neck Carcinoma,C1335703,NCT00088907,Terminated,Phase 3,It was unlikely that the primary endpoint would be reached based on the fifth interim analysis    results.,docetaxel
Gefitinib,DB00317,Head and neck cancer metastatic,C0744619,NCT00088907,Terminated,Phase 3,It was unlikely that the primary endpoint would be reached based on the fifth interim analysis    results.,gefitinib
Docetaxel,DB01248,Head and neck cancer metastatic,C0744619,NCT00088907,Terminated,Phase 3,It was unlikely that the primary endpoint would be reached based on the fifth interim analysis    results.,docetaxel
Metronidazole,DB00916,Small cell lung cancer extensive stage,C0278726,NCT00088933,Terminated,Phase 1,,metronidazole
Docetaxel,DB01248,Small cell lung cancer extensive stage,C0278726,NCT00088933,Terminated,Phase 1,,docetaxel
Metronidazole,DB00916,Colon cancer recurrent,C0278553,NCT00088933,Terminated,Phase 1,,metronidazole
Docetaxel,DB01248,Colon cancer recurrent,C0278553,NCT00088933,Terminated,Phase 1,,docetaxel
Metronidazole,DB00916,Non-small cell lung cancer recurrent,C0278517,NCT00088933,Terminated,Phase 1,,metronidazole
Docetaxel,DB01248,Non-small cell lung cancer recurrent,C0278517,NCT00088933,Terminated,Phase 1,,docetaxel
Metronidazole,DB00916,Recurrent Rectal Cancer,C0278554,NCT00088933,Terminated,Phase 1,,metronidazole
Docetaxel,DB01248,Recurrent Rectal Cancer,C0278554,NCT00088933,Terminated,Phase 1,,docetaxel
Metronidazole,DB00916,Small cell lung cancer recurrent,C0278727,NCT00088933,Terminated,Phase 1,,metronidazole
Docetaxel,DB01248,Small cell lung cancer recurrent,C0278727,NCT00088933,Terminated,Phase 1,,docetaxel
Metronidazole,DB00916,Non-small cell lung cancer metastatic,C0278987,NCT00088933,Terminated,Phase 1,,metronidazole
Docetaxel,DB01248,Non-small cell lung cancer metastatic,C0278987,NCT00088933,Terminated,Phase 1,,docetaxel
Romidepsin,DB06176,Ovarian epithelial cancer recurrent,C0278689,NCT00091195,Terminated,Phase 2,Administratively complete.,romidepsin
Romidepsin,DB06176,Gastrinoma,C0017150,NCT00084461,Terminated,Phase 2,,romidepsin
Romidepsin,DB06176,Glucagonoma,C0017689,NCT00084461,Terminated,Phase 2,,romidepsin
Romidepsin,DB06176,insulinoma,C0021670,NCT00084461,Terminated,Phase 2,,romidepsin
Romidepsin,DB06176,pancreatic polypeptide tumor,C1882278,NCT00084461,Terminated,Phase 2,,romidepsin
Romidepsin,DB06176,Carcinoid tumor of lung,C0280089,NCT00084461,Terminated,Phase 2,,romidepsin
Romidepsin,DB06176,recurrent gastrointestinal carcinoid tumor,C0278750,NCT00084461,Terminated,Phase 2,,romidepsin
Romidepsin,DB06176,recurrent islet cell carcinoma,C0278843,NCT00084461,Terminated,Phase 2,,romidepsin
Romidepsin,DB06176,regional gastrointestinal carcinoid tumor,C0278748,NCT00084461,Terminated,Phase 2,,romidepsin
Valsartan,DB00177,Kidney Diseases,C0022658,NCT00089518,Withdrawn,Phase 3,,valsartan
Capsaicin,DB06774,Diabetic Neuropathies,C0011882,NCT00089557,Terminated,Phase 2,,capsaicin
Capsaicin,DB06774,Diabetes Mellitus,C0011849,NCT00089557,Terminated,Phase 2,,capsaicin
Capsaicin,DB06774,Polyneuropathy,C0152025,NCT00089557,Terminated,Phase 2,,capsaicin
Capsaicin,DB06774,Herpes zoster disease,C0019360,NCT00089557,Terminated,Phase 2,,capsaicin
Capsaicin,DB06774,Pain,C0030193,NCT00089557,Terminated,Phase 2,,capsaicin
Capsaicin,DB06774,Peripheral Neuropathy,C0031117,NCT00089557,Terminated,Phase 2,,capsaicin
Metronidazole,DB00916,Melanoma recurrent,C0278884,NCT00087373,Terminated,Phase 2,,metronidazole
Doxorubicin,DB00997,recurrent adult soft tissue sarcoma,C0278665,NCT00089544,Terminated,Phase 2,,doxorubicin
Thalidomide,DB01041,recurrent adult soft tissue sarcoma,C0278665,NCT00089544,Terminated,Phase 2,,thalidomide
Ifosfamide,DB01181,recurrent adult soft tissue sarcoma,C0278665,NCT00089544,Terminated,Phase 2,,ifosfamide
Doxorubicin,DB00997,stage I adult soft tissue sarcoma,C0278661,NCT00089544,Terminated,Phase 2,,doxorubicin
Thalidomide,DB01041,stage I adult soft tissue sarcoma,C0278661,NCT00089544,Terminated,Phase 2,,thalidomide
Ifosfamide,DB01181,stage I adult soft tissue sarcoma,C0278661,NCT00089544,Terminated,Phase 2,,ifosfamide
Doxorubicin,DB00997,stage II adult soft tissue sarcoma,C0278662,NCT00089544,Terminated,Phase 2,,doxorubicin
Thalidomide,DB01041,stage II adult soft tissue sarcoma,C0278662,NCT00089544,Terminated,Phase 2,,thalidomide
Ifosfamide,DB01181,stage II adult soft tissue sarcoma,C0278662,NCT00089544,Terminated,Phase 2,,ifosfamide
Doxorubicin,DB00997,stage III adult soft tissue sarcoma,C0278663,NCT00089544,Terminated,Phase 2,,doxorubicin
Thalidomide,DB01041,stage III adult soft tissue sarcoma,C0278663,NCT00089544,Terminated,Phase 2,,thalidomide
Ifosfamide,DB01181,stage III adult soft tissue sarcoma,C0278663,NCT00089544,Terminated,Phase 2,,ifosfamide
Rituximab,DB00073,contiguous stage II adult diffuse large cell lymphoma,C0677695,NCT00088881,Terminated,Phase 2,,rituximab
Cyclophosphamide,DB00531,contiguous stage II adult diffuse large cell lymphoma,C0677695,NCT00088881,Terminated,Phase 2,,cyclophosphamide
Vincristine,DB00541,contiguous stage II adult diffuse large cell lymphoma,C0677695,NCT00088881,Terminated,Phase 2,,vincristine
Doxorubicin,DB00997,contiguous stage II adult diffuse large cell lymphoma,C0677695,NCT00088881,Terminated,Phase 2,,doxorubicin
Rituximab,DB00073,Mucosa-Associated Lymphoid Tissue Lymphoma,C0242647,NCT00088881,Terminated,Phase 2,,rituximab
Cyclophosphamide,DB00531,Mucosa-Associated Lymphoid Tissue Lymphoma,C0242647,NCT00088881,Terminated,Phase 2,,cyclophosphamide
Vincristine,DB00541,Mucosa-Associated Lymphoid Tissue Lymphoma,C0242647,NCT00088881,Terminated,Phase 2,,vincristine
Doxorubicin,DB00997,Mucosa-Associated Lymphoid Tissue Lymphoma,C0242647,NCT00088881,Terminated,Phase 2,,doxorubicin
Rituximab,DB00073,Monocytoid B-cell lymphoma,C0855139,NCT00088881,Terminated,Phase 2,,rituximab
Cyclophosphamide,DB00531,Monocytoid B-cell lymphoma,C0855139,NCT00088881,Terminated,Phase 2,,cyclophosphamide
Vincristine,DB00541,Monocytoid B-cell lymphoma,C0855139,NCT00088881,Terminated,Phase 2,,vincristine
Doxorubicin,DB00997,Monocytoid B-cell lymphoma,C0855139,NCT00088881,Terminated,Phase 2,,doxorubicin
Rituximab,DB00073,noncontiguous stage II adult diffuse large cell lymphoma,C0677709,NCT00088881,Terminated,Phase 2,,rituximab
Cyclophosphamide,DB00531,noncontiguous stage II adult diffuse large cell lymphoma,C0677709,NCT00088881,Terminated,Phase 2,,cyclophosphamide
Vincristine,DB00541,noncontiguous stage II adult diffuse large cell lymphoma,C0677709,NCT00088881,Terminated,Phase 2,,vincristine
Doxorubicin,DB00997,noncontiguous stage II adult diffuse large cell lymphoma,C0677709,NCT00088881,Terminated,Phase 2,,doxorubicin
Rituximab,DB00073,Splenic Marginal Zone B-Cell Lymphoma,C0349632,NCT00088881,Terminated,Phase 2,,rituximab
Cyclophosphamide,DB00531,Splenic Marginal Zone B-Cell Lymphoma,C0349632,NCT00088881,Terminated,Phase 2,,cyclophosphamide
Vincristine,DB00541,Splenic Marginal Zone B-Cell Lymphoma,C0349632,NCT00088881,Terminated,Phase 2,,vincristine
Doxorubicin,DB00997,Splenic Marginal Zone B-Cell Lymphoma,C0349632,NCT00088881,Terminated,Phase 2,,doxorubicin
Rituximab,DB00073,stage I adult diffuse large cell lymphoma,C0279960,NCT00088881,Terminated,Phase 2,,rituximab
Cyclophosphamide,DB00531,stage I adult diffuse large cell lymphoma,C0279960,NCT00088881,Terminated,Phase 2,,cyclophosphamide
Vincristine,DB00541,stage I adult diffuse large cell lymphoma,C0279960,NCT00088881,Terminated,Phase 2,,vincristine
Doxorubicin,DB00997,stage I adult diffuse large cell lymphoma,C0279960,NCT00088881,Terminated,Phase 2,,doxorubicin
Rituximab,DB00073,Malignant lymphoma of testis,C0349644,NCT00088881,Terminated,Phase 2,,rituximab
Cyclophosphamide,DB00531,Malignant lymphoma of testis,C0349644,NCT00088881,Terminated,Phase 2,,cyclophosphamide
Vincristine,DB00541,Malignant lymphoma of testis,C0349644,NCT00088881,Terminated,Phase 2,,vincristine
Doxorubicin,DB00997,Malignant lymphoma of testis,C0349644,NCT00088881,Terminated,Phase 2,,doxorubicin
Ifosfamide,DB01181,"unspecified adult solid tumor, protocol specific",C0279004,NCT00086970,Terminated,Phase 1,Administratively complete.,ifosfamide
Vitamin C,DB00126,refractory plasma cell neoplasm,C0278620,NCT00085345,Withdrawn,Phase 2,,vitamin c
Melphalan,DB01042,refractory plasma cell neoplasm,C0278620,NCT00085345,Withdrawn,Phase 2,,melphalan
Arsenic trioxide,DB01169,refractory plasma cell neoplasm,C0278620,NCT00085345,Withdrawn,Phase 2,,arsenic trioxide
Oxaliplatin,DB00526,"unspecified adult solid tumor, protocol specific",C0279004,NCT00086983,Terminated,Phase 1,,oxaliplatin
Rituximab,DB00073,leukemia,C0023418,NCT00087009,Terminated,Phase 1,Lack of Accrual,rituximab
Rituximab,DB00073,Lymphoproliferative Disorders,C0024314,NCT00087009,Terminated,Phase 1,Lack of Accrual,rituximab
Topotecan,DB01030,Malignant neoplasm of lung,C0242379,NCT00087048,Terminated,Phase 2,Slow accrual,topotecan
Sirolimus,DB00877,Rheumatoid Arthritis,C0003873,NCT00076206,Terminated,Phase 2,,sirolimus
Everolimus,DB01590,Rheumatoid Arthritis,C0003873,NCT00076206,Terminated,Phase 2,,everolimus
Pegfilgrastim,DB00019,Central Nervous System Neoplasms,C0085136,NCT00107471,Terminated,Phase 1/Phase 2,The unpromising experience of the French group with topotecan given at a dosage of 0.4    mg/m2/day over 30 mins w/in 1 hr of radiation (Cancer 2005; 104: 2792).,pegfilgrastim
Topotecan,DB01030,Central Nervous System Neoplasms,C0085136,NCT00107471,Terminated,Phase 1/Phase 2,The unpromising experience of the French group with topotecan given at a dosage of 0.4    mg/m2/day over 30 mins w/in 1 hr of radiation (Cancer 2005; 104: 2792).,topotecan
Vancomycin,DB00512,Bacteremia,C0004610,NCT00108433,Terminated,Phase 3,See Detailed Description,vancomycin
Linezolid,DB00601,Bacteremia,C0004610,NCT00108433,Terminated,Phase 3,See Detailed Description,linezolid
Cefazolin,DB01327,Bacteremia,C0004610,NCT00108433,Terminated,Phase 3,See Detailed Description,cefazolin
Vancomycin,DB00512,Gram-Positive Bacterial Infections,C0085426,NCT00108433,Terminated,Phase 3,See Detailed Description,vancomycin
Linezolid,DB00601,Gram-Positive Bacterial Infections,C0085426,NCT00108433,Terminated,Phase 3,See Detailed Description,linezolid
Cefazolin,DB01327,Gram-Positive Bacterial Infections,C0085426,NCT00108433,Terminated,Phase 3,See Detailed Description,cefazolin
Niacin,DB00627,"Kidney Failure, Chronic",C0022661,NCT00108485,Terminated,Phase 3,Unable to recruit sufficient study subjects,niacin
Sorafenib,DB00398,Conventional (Clear Cell) Renal Cell Carcinoma,C0279702,NCT00098618,Terminated,Phase 2,,sorafenib
Nicotinamide,DB02701,Conventional (Clear Cell) Renal Cell Carcinoma,C0279702,NCT00098618,Terminated,Phase 2,,nicotinamide
Rituximab,DB00073,recurrent grade 1 follicular lymphoma,C0280182,NCT00079443,Terminated,Phase 2,,rituximab
Fludarabine,DB01073,recurrent grade 1 follicular lymphoma,C0280182,NCT00079443,Terminated,Phase 2,,fludarabine
Romidepsin,DB06176,recurrent grade 1 follicular lymphoma,C0280182,NCT00079443,Terminated,Phase 2,,romidepsin
Rituximab,DB00073,recurrent grade 2 follicular lymphoma,C0280183,NCT00079443,Terminated,Phase 2,,rituximab
Fludarabine,DB01073,recurrent grade 2 follicular lymphoma,C0280183,NCT00079443,Terminated,Phase 2,,fludarabine
Romidepsin,DB06176,recurrent grade 2 follicular lymphoma,C0280183,NCT00079443,Terminated,Phase 2,,romidepsin
Rituximab,DB00073,B-cell small lymphocytic lymphoma recurrent,C0855096,NCT00079443,Terminated,Phase 2,,rituximab
Fludarabine,DB01073,B-cell small lymphocytic lymphoma recurrent,C0855096,NCT00079443,Terminated,Phase 2,,fludarabine
Romidepsin,DB06176,B-cell small lymphocytic lymphoma recurrent,C0855096,NCT00079443,Terminated,Phase 2,,romidepsin
Infliximab,DB00065,Berylliosis,C0005138,NCT00111917,Terminated,Phase 1/Phase 2,Not enough patients meeting criteria to enroll in the time period,infliximab
Vorinostat,DB02546,Multiple Myeloma,C0026764,NCT00109109,Terminated,Phase 1,,vorinostat
Trimethoprim,DB00440,HIV Infections,C0019693,NCT00080119,Terminated,Phase 2/Phase 3,Data Safety Monitoring Board (DSMB) recommended stopping study due to futility,trimethoprim
Isoniazid,DB00951,HIV Infections,C0019693,NCT00080119,Terminated,Phase 2/Phase 3,Data Safety Monitoring Board (DSMB) recommended stopping study due to futility,isoniazid
Sulfamethoxazole,DB01015,HIV Infections,C0019693,NCT00080119,Terminated,Phase 2/Phase 3,Data Safety Monitoring Board (DSMB) recommended stopping study due to futility,sulfamethoxazole
Trimethoprim,DB00440,Tuberculosis,C0041296,NCT00080119,Terminated,Phase 2/Phase 3,Data Safety Monitoring Board (DSMB) recommended stopping study due to futility,trimethoprim
Isoniazid,DB00951,Tuberculosis,C0041296,NCT00080119,Terminated,Phase 2/Phase 3,Data Safety Monitoring Board (DSMB) recommended stopping study due to futility,isoniazid
Sulfamethoxazole,DB01015,Tuberculosis,C0041296,NCT00080119,Terminated,Phase 2/Phase 3,Data Safety Monitoring Board (DSMB) recommended stopping study due to futility,sulfamethoxazole
Exemestane,DB00990,Breast cancer stage II,C0278486,NCT00080613,Withdrawn,Phase 2,,exemestane
Lenalidomide,DB00480,Reflex Sympathetic Dystrophy,C0034931,NCT00109772,Terminated,Phase 2,Interim analysis showed the primary outcome was not reached,lenalidomide
Thalidomide,DB01041,Reflex Sympathetic Dystrophy,C0034931,NCT00109772,Terminated,Phase 2,Interim analysis showed the primary outcome was not reached,thalidomide
Alemtuzumab,DB00087,"Lymphoma, Non-Hodgkin",C0024305,NCT00077961,Terminated,Phase 1/Phase 2,,alemtuzumab
Trastuzumab,DB00072,Breast cancer recurrent,C0278493,NCT00079326,Terminated,Phase 2,Slow accrual.,trastuzumab
Imatinib,DB00619,chronic myelogenous leukemia in relapse,C0278787,NCT00101088,Terminated,Phase 1,,imatinib
Sirolimus,DB00877,chronic myelogenous leukemia in relapse,C0278787,NCT00101088,Terminated,Phase 1,,sirolimus
Everolimus,DB01590,chronic myelogenous leukemia in relapse,C0278787,NCT00101088,Terminated,Phase 1,,everolimus
Lopinavir,DB01601,Human immunodeficiency virus I infection,C0276500,NCT00102778,Terminated,Phase 2,,lopinavir
Rituximab,DB00073,contiguous stage II adult diffuse large cell lymphoma,C0677695,NCT00080847,Terminated,Phase 2,,rituximab
Cyclophosphamide,DB00531,contiguous stage II adult diffuse large cell lymphoma,C0677695,NCT00080847,Terminated,Phase 2,,cyclophosphamide
Vincristine,DB00541,contiguous stage II adult diffuse large cell lymphoma,C0677695,NCT00080847,Terminated,Phase 2,,vincristine
Prednisone,DB00635,contiguous stage II adult diffuse large cell lymphoma,C0677695,NCT00080847,Terminated,Phase 2,,prednisone
Doxorubicin,DB00997,contiguous stage II adult diffuse large cell lymphoma,C0677695,NCT00080847,Terminated,Phase 2,,doxorubicin
Rituximab,DB00073,noncontiguous stage II adult diffuse large cell lymphoma,C0677709,NCT00080847,Terminated,Phase 2,,rituximab
Cyclophosphamide,DB00531,noncontiguous stage II adult diffuse large cell lymphoma,C0677709,NCT00080847,Terminated,Phase 2,,cyclophosphamide
Vincristine,DB00541,noncontiguous stage II adult diffuse large cell lymphoma,C0677709,NCT00080847,Terminated,Phase 2,,vincristine
Prednisone,DB00635,noncontiguous stage II adult diffuse large cell lymphoma,C0677709,NCT00080847,Terminated,Phase 2,,prednisone
Doxorubicin,DB00997,noncontiguous stage II adult diffuse large cell lymphoma,C0677709,NCT00080847,Terminated,Phase 2,,doxorubicin
Rituximab,DB00073,stage III adult diffuse large cell lymphoma,C0280162,NCT00080847,Terminated,Phase 2,,rituximab
Cyclophosphamide,DB00531,stage III adult diffuse large cell lymphoma,C0280162,NCT00080847,Terminated,Phase 2,,cyclophosphamide
Vincristine,DB00541,stage III adult diffuse large cell lymphoma,C0280162,NCT00080847,Terminated,Phase 2,,vincristine
Prednisone,DB00635,stage III adult diffuse large cell lymphoma,C0280162,NCT00080847,Terminated,Phase 2,,prednisone
Doxorubicin,DB00997,stage III adult diffuse large cell lymphoma,C0280162,NCT00080847,Terminated,Phase 2,,doxorubicin
Rituximab,DB00073,stage IV adult diffuse large cell lymphoma,C0280175,NCT00080847,Terminated,Phase 2,,rituximab
Cyclophosphamide,DB00531,stage IV adult diffuse large cell lymphoma,C0280175,NCT00080847,Terminated,Phase 2,,cyclophosphamide
Vincristine,DB00541,stage IV adult diffuse large cell lymphoma,C0280175,NCT00080847,Terminated,Phase 2,,vincristine
Prednisone,DB00635,stage IV adult diffuse large cell lymphoma,C0280175,NCT00080847,Terminated,Phase 2,,prednisone
Doxorubicin,DB00997,stage IV adult diffuse large cell lymphoma,C0280175,NCT00080847,Terminated,Phase 2,,doxorubicin
Bevacizumab,DB00112,Colorectal Neoplasms,C0009404,NCT00106054,Terminated,Phase 2,After 1 year only 2 subjects enrolled and treated thus no meaningful efficacy analyses could    be performed.,bevacizumab
Irinotecan,DB00762,Colorectal Neoplasms,C0009404,NCT00106054,Terminated,Phase 2,After 1 year only 2 subjects enrolled and treated thus no meaningful efficacy analyses could    be performed.,irinotecan
Bevacizumab,DB00112,Liver neoplasms,C0023903,NCT00106054,Terminated,Phase 2,After 1 year only 2 subjects enrolled and treated thus no meaningful efficacy analyses could    be performed.,bevacizumab
Irinotecan,DB00762,Liver neoplasms,C0023903,NCT00106054,Terminated,Phase 2,After 1 year only 2 subjects enrolled and treated thus no meaningful efficacy analyses could    be performed.,irinotecan
Ezetimibe,DB00973,"Lipid Metabolism, Inborn Errors",C0023772,NCT00092833,Terminated,Phase 3,,ezetimibe
Clofarabine,DB00631,leukemia,C0023418,NCT00081887,Terminated,Phase 1,low accrual,clofarabine
Sirolimus,DB00877,Multiple Sclerosis,C0026769,NCT00095329,Terminated,Phase 1/Phase 2,,sirolimus
Everolimus,DB01590,Multiple Sclerosis,C0026769,NCT00095329,Terminated,Phase 1/Phase 2,,everolimus
Erlotinib,DB00530,Metastatic malignant neoplasm to brain,C0220650,NCT00096265,Terminated,Phase 3,,erlotinib
Temozolomide,DB00853,Metastatic malignant neoplasm to brain,C0220650,NCT00096265,Terminated,Phase 3,,temozolomide
Erlotinib,DB00530,Non-small cell lung cancer recurrent,C0278517,NCT00096265,Terminated,Phase 3,,erlotinib
Temozolomide,DB00853,Non-small cell lung cancer recurrent,C0278517,NCT00096265,Terminated,Phase 3,,temozolomide
Erlotinib,DB00530,Non-small cell lung cancer metastatic,C0278987,NCT00096265,Terminated,Phase 3,,erlotinib
Temozolomide,DB00853,Non-small cell lung cancer metastatic,C0278987,NCT00096265,Terminated,Phase 3,,temozolomide
Bortezomib,DB00188,adult grade III lymphomatoid granulomatosis,C1541468,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,Ki-1+ Anaplastic Large Cell Lymphoma,C0206180,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,Angioimmunoblastic Lymphadenopathy,C0020981,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,Mucosa-Associated Lymphoid Tissue Lymphoma,C0242647,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,Monocytoid B-cell lymphoma,C0855139,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,recurrent adult Burkitt's lymphoma,C0280192,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,recurrent adult diffuse large cell lymphoma,C0280188,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,Cutaneous T-cell lymphoma recurrent,C0278580,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,recurrent grade 1 follicular lymphoma,C0280182,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,recurrent grade 2 follicular lymphoma,C0280183,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,recurrent grade 3 follicular lymphoma,C0280185,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,Mantle cell lymphoma recurrent,C0677725,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,Marginal zone lymphoma recurrent,C1541273,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,Mycosis fungoides/Sezary syndrome recurrent,C0862200,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,B-cell small lymphocytic lymphoma recurrent,C0855096,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,stage III adult Burkitt's lymphoma,C0280166,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,stage III adult diffuse large cell lymphoma,C0280162,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,stage III adult diffuse mixed cell lymphoma,C0280161,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,stage III adult diffuse small cleaved cell lymphoma,C0280160,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,stage III adult Hodgkin's lymphoma,C0278472,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,stage III adult immunoblastic large cell lymphoma,C0280164,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,stage III adult lymphoblastic lymphoma,C0280165,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,Adult T-cell lymphoma/leukaemia stage III,C0280425,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,Cutaneous T-cell lymphoma stage III,C0278570,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,stage III grade 1 follicular lymphoma,C0280156,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,stage III grade 2 follicular lymphoma,C0280157,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,stage III grade 3 follicular lymphoma,C0280159,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,Mantle cell lymphoma stage III,C0677714,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,Marginal zone lymphoma stage III,C1541269,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,Mycosis fungoides/Sezary syndrome stage III,C0862221,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,B-cell small lymphocytic lymphoma stage III,C0855100,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,stage IV adult Burkitt's lymphoma,C0280179,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,stage IV adult diffuse large cell lymphoma,C0280175,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,stage IV adult diffuse mixed cell lymphoma,C0280174,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,stage IV adult diffuse small cleaved cell lymphoma,C0280173,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,stage IV adult Hodgkin's lymphoma,C0278473,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,stage IV adult immunoblastic large cell lymphoma,C0280177,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,stage IV adult lymphoblastic lymphoma,C0280178,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,Adult T-cell lymphoma/leukaemia stage IV,C0280426,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,Cutaneous T-cell lymphoma stage IV,C0278572,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,AIDS-related peripheral/systemic lymphoma,C0281240,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,stage IV grade 1 follicular lymphoma,C0280169,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,stage IV grade 2 follicular lymphoma,C0280170,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,stage IV grade 3 follicular lymphoma,C0280172,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,Mantle cell lymphoma stage IV,C0677721,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,Marginal zone lymphoma stage IV,C1541270,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,Mycosis fungoides/Sezary syndrome stage IV,C0862226,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,B-cell small lymphocytic lymphoma stage IV,C0855101,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,"unspecified adult solid tumor, protocol specific",C0279004,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,recurrent adult diffuse mixed cell lymphoma,C0280187,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,recurrent adult diffuse small cleaved cell lymphoma,C0280186,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,recurrent adult grade III lymphomatoid granulomatosis,C1541469,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,recurrent adult Hodgkin's lymphoma,C0278530,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,recurrent adult immunoblastic large cell lymphoma,C0280190,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,recurrent adult lymphoblastic lymphoma,C0280191,NCT00096005,Terminated,Phase 1,,bortezomib
Bortezomib,DB00188,Adult T-cell lymphoma/leukaemia recurrent,C0280427,NCT00096005,Terminated,Phase 1,,bortezomib
Sorafenib,DB00398,Anaplastic thyroid carcinoma,C0238461,NCT00095693,Terminated,Phase 2,,sorafenib
Nicotinamide,DB02701,Anaplastic thyroid carcinoma,C0238461,NCT00095693,Terminated,Phase 2,,nicotinamide
Sorafenib,DB00398,insular thyroid cancer,C1134506,NCT00095693,Terminated,Phase 2,,sorafenib
Nicotinamide,DB02701,insular thyroid cancer,C1134506,NCT00095693,Terminated,Phase 2,,nicotinamide
Sorafenib,DB00398,Recurrent Thyroid Carcinoma,C0278861,NCT00095693,Terminated,Phase 2,,sorafenib
Nicotinamide,DB02701,Recurrent Thyroid Carcinoma,C0278861,NCT00095693,Terminated,Phase 2,,nicotinamide
Sorafenib,DB00398,stage III follicular thyroid cancer,C0279178,NCT00095693,Terminated,Phase 2,,sorafenib
Nicotinamide,DB02701,stage III follicular thyroid cancer,C0279178,NCT00095693,Terminated,Phase 2,,nicotinamide
Sorafenib,DB00398,stage III papillary thyroid cancer,C0279179,NCT00095693,Terminated,Phase 2,,sorafenib
Nicotinamide,DB02701,stage III papillary thyroid cancer,C0279179,NCT00095693,Terminated,Phase 2,,nicotinamide
Sorafenib,DB00398,stage IV follicular thyroid cancer,C0278854,NCT00095693,Terminated,Phase 2,,sorafenib
Nicotinamide,DB02701,stage IV follicular thyroid cancer,C0278854,NCT00095693,Terminated,Phase 2,,nicotinamide
Sorafenib,DB00398,Metastatic papillary thyroid carcinoma,C0278851,NCT00095693,Terminated,Phase 2,,sorafenib
Nicotinamide,DB02701,Metastatic papillary thyroid carcinoma,C0278851,NCT00095693,Terminated,Phase 2,,nicotinamide
Sirolimus,DB00877,recurrent adult diffuse large cell lymphoma,C0280188,NCT00086840,Terminated,Phase 2,Administratively complete.,sirolimus
Everolimus,DB01590,recurrent adult diffuse large cell lymphoma,C0280188,NCT00086840,Terminated,Phase 2,Administratively complete.,everolimus
Sirolimus,DB00877,recurrent adult Hodgkin's lymphoma,C0278530,NCT00086840,Terminated,Phase 2,Administratively complete.,sirolimus
Everolimus,DB01590,recurrent adult Hodgkin's lymphoma,C0278530,NCT00086840,Terminated,Phase 2,Administratively complete.,everolimus
Sirolimus,DB00877,Chronic lymphocytic leukaemia refractory,C0278791,NCT00086840,Terminated,Phase 2,Administratively complete.,sirolimus
Everolimus,DB01590,Chronic lymphocytic leukaemia refractory,C0278791,NCT00086840,Terminated,Phase 2,Administratively complete.,everolimus
Romidepsin,DB06176,melanoma,C0025202,NCT00104884,Terminated,Phase 2,"The study was terminated on May 17, 2006 due to slow accrual.",romidepsin
Ciprofloxacin,DB00537,Fever,C0015967,NCT00107081,Terminated,Phase 3,Accrual goal for interventional part not achievable,ciprofloxacin
Bortezomib,DB00188,Malignant neoplasm of stomach,C0024623,NCT00103103,Terminated,Phase 2,,bortezomib
Levoleucovorin,DB11596,Malignant neoplasm of stomach,C0024623,NCT00103103,Terminated,Phase 2,,levoleucovorin
Venlafaxine,DB00285,Anxiety Disorders,C0003469,NCT00083980,Terminated,Phase 2,European reports of liver toxicity from kava meant that the study had to stop,venlafaxine
Metronidazole,DB00916,Bladder Adenocarcinoma,C0279682,NCT00072137,Terminated,Phase 1,,metronidazole
Metronidazole,DB00916,Bladder Squamous Cell Carcinoma,C0279681,NCT00072137,Terminated,Phase 1,,metronidazole
Metronidazole,DB00916,Transitional cell carcinoma of bladder,C0279680,NCT00072137,Terminated,Phase 1,,metronidazole
Metronidazole,DB00916,Bladder cancer recurrent,C0278827,NCT00072137,Terminated,Phase 1,,metronidazole
Metronidazole,DB00916,Bladder cancer stage II,C0278823,NCT00072137,Terminated,Phase 1,,metronidazole
Metronidazole,DB00916,Bladder cancer stage III,C0278824,NCT00072137,Terminated,Phase 1,,metronidazole
Infliximab,DB00065,Giant Cell Arteritis,C0039483,NCT00076726,Terminated,Phase 2,"Interim analysis, infliximab did not reduce number of first relapses in GCA or cumulative    glucocorticosteroid dosage",infliximab
Sirolimus,DB00877,Neoplasm Metastasis,C0027627,NCT00083993,Terminated,Phase 3,,sirolimus
Letrozole,DB01006,Neoplasm Metastasis,C0027627,NCT00083993,Terminated,Phase 3,,letrozole
Everolimus,DB01590,Neoplasm Metastasis,C0027627,NCT00083993,Terminated,Phase 3,,everolimus
Gemcitabine,DB00441,Meningitis,C0025289,NCT00074607,Terminated,Phase 1,,gemcitabine
Abciximab,DB00054,Brain Ischemia,C0007786,NCT00073372,Terminated,Phase 3,"Based on the data and observed benefit-risk profile, the trial's independent oversight    committee recommended that enrollment not resume.",abciximab
Abciximab,DB00054,Acute Disease,C0001314,NCT00073372,Terminated,Phase 3,"Based on the data and observed benefit-risk profile, the trial's independent oversight    committee recommended that enrollment not resume.",abciximab
Cisplatin,DB00515,extragonadal germ cell tumor,C0262963,NCT00072215,Terminated,Phase 3,poor accrual,cisplatin
Vinblastine,DB00570,extragonadal germ cell tumor,C0262963,NCT00072215,Terminated,Phase 3,poor accrual,vinblastine
Ifosfamide,DB01181,extragonadal germ cell tumor,C0262963,NCT00072215,Terminated,Phase 3,poor accrual,ifosfamide
Paclitaxel,DB01229,extragonadal germ cell tumor,C0262963,NCT00072215,Terminated,Phase 3,poor accrual,paclitaxel
Vinblastine,DB00570,Testicular Germ Cell Tumor,C1336708,NCT00072215,Terminated,Phase 3,poor accrual,vinblastine
Paclitaxel,DB01229,Testicular Germ Cell Tumor,C1336708,NCT00072215,Terminated,Phase 3,poor accrual,paclitaxel
Celecoxib,DB00482,High-Grade Squamous Intraepithelial Lesions,C0333875,NCT00072540,Withdrawn,Phase 2,drug issues,celecoxib
Gemcitabine,DB00441,"unspecified adult solid tumor, protocol specific",C0279004,NCT00072228,Withdrawn,Phase 1,,gemcitabine
Thalidomide,DB01041,Stomatitis,C0038362,NCT00075023,Terminated,Phase 2,unable to enroll adequate subjects,thalidomide
Sorafenib,DB00398,Anaplastic thyroid carcinoma,C0238461,NCT00126568,Terminated,Phase 2,,sorafenib
Nicotinamide,DB02701,Anaplastic thyroid carcinoma,C0238461,NCT00126568,Terminated,Phase 2,,nicotinamide
Sorafenib,DB00398,Recurrent Thyroid Carcinoma,C0278861,NCT00126568,Terminated,Phase 2,,sorafenib
Nicotinamide,DB02701,Recurrent Thyroid Carcinoma,C0278861,NCT00126568,Terminated,Phase 2,,nicotinamide
Cyclophosphamide,DB00531,"Leukemia, Myelocytic, Acute",C0023467,NCT00125606,Terminated,Phase 3,insufficient patient recruitement,cyclophosphamide
Fludarabine,DB01073,"Leukemia, Myelocytic, Acute",C0023467,NCT00125606,Terminated,Phase 3,insufficient patient recruitement,fludarabine
Bortezomib,DB00188,Bronchioloalveolar Adenocarcinoma,C0007120,NCT00117351,Terminated,Phase 2,insufficient efficacy,bortezomib
Rituximab,DB00073,Atypical Burkitt's lymphoma,C1629504,NCT00126191,Terminated,Phase 2,closed due to slow accrual,rituximab
Cyclophosphamide,DB00531,Atypical Burkitt's lymphoma,C1629504,NCT00126191,Terminated,Phase 2,closed due to slow accrual,cyclophosphamide
Vincristine,DB00541,Atypical Burkitt's lymphoma,C1629504,NCT00126191,Terminated,Phase 2,closed due to slow accrual,vincristine
Methotrexate,DB00563,Atypical Burkitt's lymphoma,C1629504,NCT00126191,Terminated,Phase 2,closed due to slow accrual,methotrexate
Etoposide,DB00773,Atypical Burkitt's lymphoma,C1629504,NCT00126191,Terminated,Phase 2,closed due to slow accrual,etoposide
Cytarabine,DB00987,Atypical Burkitt's lymphoma,C1629504,NCT00126191,Terminated,Phase 2,closed due to slow accrual,cytarabine
Doxorubicin,DB00997,Atypical Burkitt's lymphoma,C1629504,NCT00126191,Terminated,Phase 2,closed due to slow accrual,doxorubicin
Ifosfamide,DB01181,Atypical Burkitt's lymphoma,C1629504,NCT00126191,Terminated,Phase 2,closed due to slow accrual,ifosfamide
Tacrolimus,DB00864,Graft-vs-Host Disease,C0018133,NCT00117702,Terminated,Phase 2/Phase 3,safety reasons,tacrolimus
Sirolimus,DB00877,Graft-vs-Host Disease,C0018133,NCT00117702,Terminated,Phase 2/Phase 3,safety reasons,sirolimus
Everolimus,DB01590,Graft-vs-Host Disease,C0018133,NCT00117702,Terminated,Phase 2/Phase 3,safety reasons,everolimus
Sorafenib,DB00398,Conventional (Clear Cell) Renal Cell Carcinoma,C0279702,NCT00126659,Terminated,Phase 2,,sorafenib
Nicotinamide,DB02701,Conventional (Clear Cell) Renal Cell Carcinoma,C0279702,NCT00126659,Terminated,Phase 2,,nicotinamide
Bevacizumab,DB00112,Adenocarcinoma,C0001418,NCT00127036,Terminated,Phase 2,drug now on market,bevacizumab
Oxaliplatin,DB00526,Adenocarcinoma,C0001418,NCT00127036,Terminated,Phase 2,drug now on market,oxaliplatin
Fluorouracil,DB00544,Adenocarcinoma,C0001418,NCT00127036,Terminated,Phase 2,drug now on market,fluorouracil
Irinotecan,DB00762,Adenocarcinoma,C0001418,NCT00127036,Terminated,Phase 2,drug now on market,irinotecan
Capecitabine,DB01101,Adenocarcinoma,C0001418,NCT00127036,Terminated,Phase 2,drug now on market,capecitabine
Bevacizumab,DB00112,adult acute basophilic leukemia,C0279631,NCT00096148,Terminated,Phase 2,Administratively complete.,bevacizumab
Cytarabine,DB00987,adult acute basophilic leukemia,C0279631,NCT00096148,Terminated,Phase 2,Administratively complete.,cytarabine
Idarubicin,DB01177,adult acute basophilic leukemia,C0279631,NCT00096148,Terminated,Phase 2,Administratively complete.,idarubicin
Bevacizumab,DB00112,adult acute eosinophilic leukemia,C0279630,NCT00096148,Terminated,Phase 2,Administratively complete.,bevacizumab
Cytarabine,DB00987,adult acute eosinophilic leukemia,C0279630,NCT00096148,Terminated,Phase 2,Administratively complete.,cytarabine
Idarubicin,DB01177,adult acute eosinophilic leukemia,C0279630,NCT00096148,Terminated,Phase 2,Administratively complete.,idarubicin
Bevacizumab,DB00112,adult acute megakaryoblastic leukemia (M7),C0279632,NCT00096148,Terminated,Phase 2,Administratively complete.,bevacizumab
Cytarabine,DB00987,adult acute megakaryoblastic leukemia (M7),C0279632,NCT00096148,Terminated,Phase 2,Administratively complete.,cytarabine
Idarubicin,DB01177,adult acute megakaryoblastic leukemia (M7),C0279632,NCT00096148,Terminated,Phase 2,Administratively complete.,idarubicin
Bevacizumab,DB00112,adult acute minimally differentiated myeloid leukemia (M0),C0281641,NCT00096148,Terminated,Phase 2,Administratively complete.,bevacizumab
Cytarabine,DB00987,adult acute minimally differentiated myeloid leukemia (M0),C0281641,NCT00096148,Terminated,Phase 2,Administratively complete.,cytarabine
Idarubicin,DB01177,adult acute minimally differentiated myeloid leukemia (M0),C0281641,NCT00096148,Terminated,Phase 2,Administratively complete.,idarubicin
Bevacizumab,DB00112,adult acute monoblastic leukemia (M5a),C0279629,NCT00096148,Terminated,Phase 2,Administratively complete.,bevacizumab
Cytarabine,DB00987,adult acute monoblastic leukemia (M5a),C0279629,NCT00096148,Terminated,Phase 2,Administratively complete.,cytarabine
Idarubicin,DB01177,adult acute monoblastic leukemia (M5a),C0279629,NCT00096148,Terminated,Phase 2,Administratively complete.,idarubicin
Bevacizumab,DB00112,adult acute monocytic leukemia (M5b),C0280634,NCT00096148,Terminated,Phase 2,Administratively complete.,bevacizumab
Cytarabine,DB00987,adult acute monocytic leukemia (M5b),C0280634,NCT00096148,Terminated,Phase 2,Administratively complete.,cytarabine
Idarubicin,DB01177,adult acute monocytic leukemia (M5b),C0280634,NCT00096148,Terminated,Phase 2,Administratively complete.,idarubicin
Bevacizumab,DB00112,adult acute myeloblastic leukemia with maturation (M2),C0279624,NCT00096148,Terminated,Phase 2,Administratively complete.,bevacizumab
Cytarabine,DB00987,adult acute myeloblastic leukemia with maturation (M2),C0279624,NCT00096148,Terminated,Phase 2,Administratively complete.,cytarabine
Idarubicin,DB01177,adult acute myeloblastic leukemia with maturation (M2),C0279624,NCT00096148,Terminated,Phase 2,Administratively complete.,idarubicin
Bevacizumab,DB00112,Adult Acute Myeloid Leukemia without Maturation,C0279623,NCT00096148,Terminated,Phase 2,Administratively complete.,bevacizumab
Cytarabine,DB00987,Adult Acute Myeloid Leukemia without Maturation,C0279623,NCT00096148,Terminated,Phase 2,Administratively complete.,cytarabine
Idarubicin,DB01177,Adult Acute Myeloid Leukemia without Maturation,C0279623,NCT00096148,Terminated,Phase 2,Administratively complete.,idarubicin
Bevacizumab,DB00112,adult acute myeloid leukemia with 11q23 (MLL) abnormalities,C1541334,NCT00096148,Terminated,Phase 2,Administratively complete.,bevacizumab
Cytarabine,DB00987,adult acute myeloid leukemia with 11q23 (MLL) abnormalities,C1541334,NCT00096148,Terminated,Phase 2,Administratively complete.,cytarabine
Idarubicin,DB01177,adult acute myeloid leukemia with 11q23 (MLL) abnormalities,C1541334,NCT00096148,Terminated,Phase 2,Administratively complete.,idarubicin
Bevacizumab,DB00112,adult acute myelomonocytic leukemia (M4),C0279627,NCT00096148,Terminated,Phase 2,Administratively complete.,bevacizumab
Cytarabine,DB00987,adult acute myelomonocytic leukemia (M4),C0279627,NCT00096148,Terminated,Phase 2,Administratively complete.,cytarabine
Idarubicin,DB01177,adult acute myelomonocytic leukemia (M4),C0279627,NCT00096148,Terminated,Phase 2,Administratively complete.,idarubicin
Bevacizumab,DB00112,adult erythroleukemia (M6a),C1541339,NCT00096148,Terminated,Phase 2,Administratively complete.,bevacizumab
Cytarabine,DB00987,adult erythroleukemia (M6a),C1541339,NCT00096148,Terminated,Phase 2,Administratively complete.,cytarabine
Idarubicin,DB01177,adult erythroleukemia (M6a),C1541339,NCT00096148,Terminated,Phase 2,Administratively complete.,idarubicin
Bevacizumab,DB00112,adult pure erythroid leukemia (M6b),C1541340,NCT00096148,Terminated,Phase 2,Administratively complete.,bevacizumab
Cytarabine,DB00987,adult pure erythroid leukemia (M6b),C1541340,NCT00096148,Terminated,Phase 2,Administratively complete.,cytarabine
Idarubicin,DB01177,adult pure erythroid leukemia (M6b),C1541340,NCT00096148,Terminated,Phase 2,Administratively complete.,idarubicin
Bevacizumab,DB00112,childhood acute basophilic leukemia,C0279649,NCT00096148,Terminated,Phase 2,Administratively complete.,bevacizumab
Cytarabine,DB00987,childhood acute basophilic leukemia,C0279649,NCT00096148,Terminated,Phase 2,Administratively complete.,cytarabine
Idarubicin,DB01177,childhood acute basophilic leukemia,C0279649,NCT00096148,Terminated,Phase 2,Administratively complete.,idarubicin
Bevacizumab,DB00112,childhood acute eosinophilic leukemia,C0279648,NCT00096148,Terminated,Phase 2,Administratively complete.,bevacizumab
Cytarabine,DB00987,childhood acute eosinophilic leukemia,C0279648,NCT00096148,Terminated,Phase 2,Administratively complete.,cytarabine
Idarubicin,DB01177,childhood acute eosinophilic leukemia,C0279648,NCT00096148,Terminated,Phase 2,Administratively complete.,idarubicin
Bevacizumab,DB00112,childhood acute erythroleukemia (M6),C0279647,NCT00096148,Terminated,Phase 2,Administratively complete.,bevacizumab
Cytarabine,DB00987,childhood acute erythroleukemia (M6),C0279647,NCT00096148,Terminated,Phase 2,Administratively complete.,cytarabine
Idarubicin,DB01177,childhood acute erythroleukemia (M6),C0279647,NCT00096148,Terminated,Phase 2,Administratively complete.,idarubicin
Bevacizumab,DB00112,childhood acute megakaryocytic leukemia (M7),C0279650,NCT00096148,Terminated,Phase 2,Administratively complete.,bevacizumab
Cytarabine,DB00987,childhood acute megakaryocytic leukemia (M7),C0279650,NCT00096148,Terminated,Phase 2,Administratively complete.,cytarabine
Idarubicin,DB01177,childhood acute megakaryocytic leukemia (M7),C0279650,NCT00096148,Terminated,Phase 2,Administratively complete.,idarubicin
Bevacizumab,DB00112,childhood acute myeloblastic leukemia with maturation (M2),C0279636,NCT00096148,Terminated,Phase 2,Administratively complete.,bevacizumab
Cytarabine,DB00987,childhood acute myeloblastic leukemia with maturation (M2),C0279636,NCT00096148,Terminated,Phase 2,Administratively complete.,cytarabine
Idarubicin,DB01177,childhood acute myeloblastic leukemia with maturation (M2),C0279636,NCT00096148,Terminated,Phase 2,Administratively complete.,idarubicin
Bevacizumab,DB00112,childhood acute myeloblastic leukemia without maturation (M1),C0279634,NCT00096148,Terminated,Phase 2,Administratively complete.,bevacizumab
Cytarabine,DB00987,childhood acute myeloblastic leukemia without maturation (M1),C0279634,NCT00096148,Terminated,Phase 2,Administratively complete.,cytarabine
Idarubicin,DB01177,childhood acute myeloblastic leukemia without maturation (M1),C0279634,NCT00096148,Terminated,Phase 2,Administratively complete.,idarubicin
Bevacizumab,DB00112,childhood acute myelomonocytic leukemia (M4),C0279644,NCT00096148,Terminated,Phase 2,Administratively complete.,bevacizumab
Cytarabine,DB00987,childhood acute myelomonocytic leukemia (M4),C0279644,NCT00096148,Terminated,Phase 2,Administratively complete.,cytarabine
Idarubicin,DB01177,childhood acute myelomonocytic leukemia (M4),C0279644,NCT00096148,Terminated,Phase 2,Administratively complete.,idarubicin
Bevacizumab,DB00112,secondary acute myeloid leukemia,C0280449,NCT00096148,Terminated,Phase 2,Administratively complete.,bevacizumab
Cytarabine,DB00987,secondary acute myeloid leukemia,C0280449,NCT00096148,Terminated,Phase 2,Administratively complete.,cytarabine
Idarubicin,DB01177,secondary acute myeloid leukemia,C0280449,NCT00096148,Terminated,Phase 2,Administratively complete.,idarubicin
Bevacizumab,DB00112,untreated adult acute myeloid leukemia,C0279089,NCT00096148,Terminated,Phase 2,Administratively complete.,bevacizumab
Cytarabine,DB00987,untreated adult acute myeloid leukemia,C0279089,NCT00096148,Terminated,Phase 2,Administratively complete.,cytarabine
Idarubicin,DB01177,untreated adult acute myeloid leukemia,C0279089,NCT00096148,Terminated,Phase 2,Administratively complete.,idarubicin
Bevacizumab,DB00112,untreated childhood acute myeloid leukemia and other myeloid malignancies,C0279090,NCT00096148,Terminated,Phase 2,Administratively complete.,bevacizumab
Cytarabine,DB00987,untreated childhood acute myeloid leukemia and other myeloid malignancies,C0279090,NCT00096148,Terminated,Phase 2,Administratively complete.,cytarabine
Idarubicin,DB01177,untreated childhood acute myeloid leukemia and other myeloid malignancies,C0279090,NCT00096148,Terminated,Phase 2,Administratively complete.,idarubicin
Cidofovir,DB00369,BK virus nephropathy,C1697878,NCT00138424,Terminated,Phase 1/Phase 2,,cidofovir
Sildenafil,DB00203,Pre-Eclampsia,C0032914,NCT00141310,Terminated,Phase 2,Study prematurely discont’d 20-Apr-2006 after interim analysis suggested sample size could be    reduced without losing power. No safety concerns led to decision.,sildenafil
Alefacept,DB00092,Lichen Planus,C0023646,NCT00135733,Terminated,Phase 2,Pharmaceutical sponsor withdrew financial support.,alefacept
Rituximab,DB00073,Waldenstrom Macroglobulinemia,C0024419,NCT00142168,Terminated,Phase 2,Toxicity,rituximab
Lenalidomide,DB00480,Waldenstrom Macroglobulinemia,C0024419,NCT00142168,Terminated,Phase 2,Toxicity,lenalidomide
Thalidomide,DB01041,Waldenstrom Macroglobulinemia,C0024419,NCT00142168,Terminated,Phase 2,Toxicity,thalidomide
Amlodipine,DB00381,Chronic heart failure,C0264716,NCT00151619,Suspended,Phase 2,,amlodipine
Memantine,DB01043,Schizophrenia,C0036341,NCT00148590,Terminated,Phase 3,,memantine
Pioglitazone,DB01132,HIV-Associated Lipodystrophy Syndrome,C1136321,NCT00148850,Terminated,Phase 3,,pioglitazone
Memantine,DB01043,Chronic schizophrenia,C0221765,NCT00148616,Terminated,Phase 3,,memantine
Mycophenolate mofetil,DB00688,Evidence of liver transplantation,C0940823,NCT00151632,Terminated,Phase 3,insufficient enrollment,mycophenolate mofetil
Tacrolimus,DB00864,Evidence of liver transplantation,C0940823,NCT00151632,Terminated,Phase 3,insufficient enrollment,tacrolimus
Mycophenolic acid,DB01024,Evidence of liver transplantation,C0940823,NCT00151632,Terminated,Phase 3,insufficient enrollment,mycophenolic acid
Cyclophosphamide,DB00531,"Leukemia, Myelocytic, Acute",C0023467,NCT00150878,Terminated,Phase 3,Insurance coverage reached,cyclophosphamide
Clonidine,DB00575,Treatment related secondary malignancy,C0877578,NCT00166686,Withdrawn,Phase 1/Phase 2,Study was never initiated,clonidine
Octreotide,DB00104,Proliferative diabetic retinopathy,C0154830,NCT00170742,Terminated,Phase 3,"trial stopped on Sept 24, 2007",octreotide
Oxaliplatin,DB00526,Colonic Neoplasms,C0009375,NCT00180960,Terminated,Phase 2,,oxaliplatin
Irinotecan,DB00762,Colonic Neoplasms,C0009375,NCT00180960,Terminated,Phase 2,,irinotecan
Oxaliplatin,DB00526,Rectal Neoplasms,C0034885,NCT00180960,Terminated,Phase 2,,oxaliplatin
Irinotecan,DB00762,Rectal Neoplasms,C0034885,NCT00180960,Terminated,Phase 2,,irinotecan
Oxaliplatin,DB00526,Appendiceal Neoplasms,C0003614,NCT00180960,Terminated,Phase 2,,oxaliplatin
Irinotecan,DB00762,Appendiceal Neoplasms,C0003614,NCT00180960,Terminated,Phase 2,,irinotecan
Oxaliplatin,DB00526,Peritoneal Neoplasms,C0031149,NCT00180960,Terminated,Phase 2,,oxaliplatin
Irinotecan,DB00762,Peritoneal Neoplasms,C0031149,NCT00180960,Terminated,Phase 2,,irinotecan
Oxaliplatin,DB00526,Endocrine Gland Neoplasms,C0014132,NCT00180960,Terminated,Phase 2,,oxaliplatin
Irinotecan,DB00762,Endocrine Gland Neoplasms,C0014132,NCT00180960,Terminated,Phase 2,,irinotecan
Estradiol,DB00783,Malignant epithelial neoplasm of female breast,C3163805,NCT00183963,Terminated,Phase 2,Insufficient accrual,estradiol
Fulvestrant,DB00947,Malignant epithelial neoplasm of female breast,C3163805,NCT00183963,Terminated,Phase 2,Insufficient accrual,fulvestrant
Rituximab,DB00073,Primary Effusion Lymphoma,C1292753,NCT00183976,Terminated,Phase 2,Insufficient Accrual,rituximab
Doxorubicin,DB00997,Primary Effusion Lymphoma,C1292753,NCT00183976,Terminated,Phase 2,Insufficient Accrual,doxorubicin
Rituximab,DB00073,"Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse",C0334634,NCT00183989,Terminated,Phase 2,Insufficient accrual,rituximab
Fludarabine,DB01073,"Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse",C0334634,NCT00183989,Terminated,Phase 2,Insufficient accrual,fludarabine
Mitoxantrone,DB01204,"Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse",C0334634,NCT00183989,Terminated,Phase 2,Insufficient accrual,mitoxantrone
Gemcitabine,DB00441,Carcinoma of unknown primary,C0220647,NCT00148135,Terminated,Phase 2,recruitment goals met,gemcitabine
Fluorouracil,DB00544,Carcinoma of unknown primary,C0220647,NCT00148135,Terminated,Phase 2,recruitment goals met,fluorouracil
Carboplatin,DB00958,Carcinoma of unknown primary,C0220647,NCT00148135,Terminated,Phase 2,recruitment goals met,carboplatin
Capecitabine,DB01101,Carcinoma of unknown primary,C0220647,NCT00148135,Terminated,Phase 2,recruitment goals met,capecitabine
Cisplatin,DB00515,Esophageal Neoplasms,C0014859,NCT00190554,Terminated,Phase 3,,cisplatin
Methotrexate,DB00563,Urticaria,C0042109,NCT00189878,Terminated,Phase 2,unable to recruit,methotrexate
Donepezil,DB00843,Schizophrenia,C0036341,NCT00206947,Terminated,Phase 2,No more funding,donepezil
Alemtuzumab,DB00087,"Leukemia, Myelocytic, Acute",C0023467,NCT00226512,Withdrawn,Phase 3,the PI is no longer work at Hadassah,alemtuzumab
Simvastatin,DB00641,Depressive disorder,C0011581,NCT00208117,Terminated,Phase 1,Unable to enroll subjects,simvastatin
Simvastatin,DB00641,Coronary Artery Disease,C1956346,NCT00208117,Terminated,Phase 1,Unable to enroll subjects,simvastatin
Sertraline,DB01104,Coronary Artery Disease,C1956346,NCT00208117,Terminated,Phase 1,Unable to enroll subjects,sertraline
Omeprazole,DB00338,Nausea,C0027497,NCT00206440,Terminated,Phase 3,Accrual was not optimized,omeprazole
Esomeprazole,DB00736,Nausea,C0027497,NCT00206440,Terminated,Phase 3,Accrual was not optimized,esomeprazole
Erythropoietin,DB00016,Malignant neoplasm of gastrointestinal tract,C0685938,NCT00254436,Terminated,Phase 3,,erythropoietin
Pentoxifylline,DB00806,"Hepatitis, Alcoholic",C0019187,NCT00205049,Terminated,Phase 1,lack of funding,pentoxifylline
Dexamethasone,DB01234,Malignant neoplasm of lung,C0242379,NCT00215748,Terminated,Phase 2,slow accrual,dexamethasone
Salicylic acid,DB00936,Adenomatous polyp of colon,C0850572,NCT00224679,Terminated,Phase 3,,salicylic acid
Acetylsalicylic acid,DB00945,Adenomatous polyp of colon,C0850572,NCT00224679,Terminated,Phase 3,,acetylsalicylic acid
Testosterone,DB00624,Hypogonadism,C0020619,NCT00254553,Terminated,Phase 2,Recruitment issues,testosterone
Methyltestosterone,DB06710,Hypogonadism,C0020619,NCT00254553,Terminated,Phase 2,Recruitment issues,methyltestosterone
Ciprofloxacin,DB00537,Crohn Disease,C0010346,NCT00257699,Terminated,Phase 2,Inadequate recruitment to meet completion date,ciprofloxacin
Metronidazole,DB00916,Crohn Disease,C0010346,NCT00257699,Terminated,Phase 2,Inadequate recruitment to meet completion date,metronidazole
Bevacizumab,DB00112,Pancreatic carcinoma recurrent,C0854777,NCT00253526,Withdrawn,Phase 2,,bevacizumab
Gemcitabine,DB00441,Pancreatic carcinoma recurrent,C0854777,NCT00253526,Withdrawn,Phase 2,,gemcitabine
Bevacizumab,DB00112,Pancreatic carcinoma stage I,C1167720,NCT00253526,Withdrawn,Phase 2,,bevacizumab
Gemcitabine,DB00441,Pancreatic carcinoma stage I,C1167720,NCT00253526,Withdrawn,Phase 2,,gemcitabine
Bevacizumab,DB00112,Pancreatic carcinoma stage II,C1167721,NCT00253526,Withdrawn,Phase 2,,bevacizumab
Gemcitabine,DB00441,Pancreatic carcinoma stage II,C1167721,NCT00253526,Withdrawn,Phase 2,,gemcitabine
Bevacizumab,DB00112,Pancreatic carcinoma stage III,C1167722,NCT00253526,Withdrawn,Phase 2,,bevacizumab
Gemcitabine,DB00441,Pancreatic carcinoma stage III,C1167722,NCT00253526,Withdrawn,Phase 2,,gemcitabine
Trioxsalen,DB04571,cholangiocarcinoma of the extrahepatic bile duct,C0280533,NCT00253617,Withdrawn,Phase 3,,trioxsalen
Trioxsalen,DB04571,cholangiocarcinoma of the gallbladder,C0280532,NCT00253617,Withdrawn,Phase 3,,trioxsalen
Trioxsalen,DB04571,unresectable extrahepatic bile duct cancer,C0278811,NCT00253617,Withdrawn,Phase 3,,trioxsalen
Trioxsalen,DB04571,unresectable gallbladder cancer,C0278807,NCT00253617,Withdrawn,Phase 3,,trioxsalen
Trioxsalen,DB04571,recurrent extrahepatic bile duct cancer,C0278812,NCT00253617,Withdrawn,Phase 3,,trioxsalen
Octreotide,DB00104,Diabetic Retinopathy,C0011884,NCT00248131,Terminated,Phase 3,,octreotide
Imiquimod,DB00724,Morphea,C1527383,NCT00230373,Withdrawn,Phase 3,Study never started.,imiquimod
Rituximab,DB00073,"Purpura, Thrombotic Thrombocytopenic",C0034155,NCT00251277,Withdrawn,Phase 1/Phase 2,,rituximab
Atorvastatin,DB01076,Inflammation,C0021368,NCT00252967,Terminated,Phase 3,Insufficient power to show therapy difference at interim analysis.,atorvastatin
Levofloxacin,DB01137,"Lymphoma, Non-Hodgkin",C0024305,NCT00250718,Terminated,Phase 2,Low rate of accrual,levofloxacin
Ofloxacin,DB01165,"Lymphoma, Non-Hodgkin",C0024305,NCT00250718,Terminated,Phase 2,Low rate of accrual,ofloxacin
Capecitabine,DB01101,Malignant tumor of colon,C0007102,NCT00251186,Terminated,Phase 2,Funding unavailable,capecitabine
Tenecteplase,DB00031,Pulmonary Embolism,C0034065,NCT00222651,Terminated,Phase 2,competitor study about to start,tenecteplase
Nandrolone phenpropionate,DB00984,Malnutrition,C0162429,NCT00242463,Terminated,Phase 2,drug no longer available in canada,nandrolone phenpropionate
Nandrolone decanoate,DB08804,Malnutrition,C0162429,NCT00242463,Terminated,Phase 2,drug no longer available in canada,nandrolone decanoate
Nandrolone phenpropionate,DB00984,Critical Illness,C0010340,NCT00242463,Terminated,Phase 2,drug no longer available in canada,nandrolone phenpropionate
Nandrolone decanoate,DB08804,Critical Illness,C0010340,NCT00242463,Terminated,Phase 2,drug no longer available in canada,nandrolone decanoate
Azacitidine,DB00928,leukemia,C0023418,NCT00234000,Terminated,Phase 1,The study was closed due to poor enrollment,azacitidine
Arsenic trioxide,DB01169,leukemia,C0023418,NCT00234000,Terminated,Phase 1,The study was closed due to poor enrollment,arsenic trioxide
Topiramate,DB00273,Obesity,C0028754,NCT00231634,Terminated,Phase 3,Program discontinued,topiramate
Topiramate,DB00273,Obesity,C0028754,NCT00231621,Terminated,Phase 3,The study was terminated prior to completion to focus on the development of a controlled    release formulation.,topiramate
Topiramate,DB00273,Hyperlipidemia,C0020473,NCT00231621,Terminated,Phase 3,The study was terminated prior to completion to focus on the development of a controlled    release formulation.,topiramate
Topiramate,DB00273,Hypertriglyceridemia,C0020557,NCT00231621,Terminated,Phase 3,The study was terminated prior to completion to focus on the development of a controlled    release formulation.,topiramate
Belinostat,DB05015,"Lymphoma, T-Cell, Cutaneous",C0079773,NCT00274651,Terminated,Phase 2,"Enrollment stopped prior to reaching expected number of patients, study had accumulated    sufficient data to allow a registration study in PTCL (PXD101-CLN-19)",belinostat
Belinostat,DB05015,"Lymphoma, Non-Hodgkin",C0024305,NCT00274651,Terminated,Phase 2,"Enrollment stopped prior to reaching expected number of patients, study had accumulated    sufficient data to allow a registration study in PTCL (PXD101-CLN-19)",belinostat
Rituximab,DB00073,Immune thrombocytopenic purpura,C0398650,NCT00225875,Terminated,Phase 2,,rituximab
Methylphenidate,DB00422,Asthenia,C0004093,NCT00273741,Terminated,Phase 3,difficulty of recrutement,methylphenidate
Arsenic trioxide,DB01169,MYELODYSPLASTIC SYNDROME,C3463824,NCT00225992,Terminated,Phase 2,terminated due to lack of accrual.,arsenic trioxide
Pemetrexed,DB00642,Malignant neoplasm of lung,C0242379,NCT00265785,Terminated,Phase 2,Closed due to poor accrual,pemetrexed
Simvastatin,DB00641,Dyslipidemias,C0242339,NCT00267280,Terminated,Phase 3,,simvastatin
Atorvastatin,DB01076,Dyslipidemias,C0242339,NCT00267280,Terminated,Phase 3,,atorvastatin
Simvastatin,DB00641,Hyperlipidemia,C0020473,NCT00267280,Terminated,Phase 3,,simvastatin
Atorvastatin,DB01076,Hyperlipidemia,C0020473,NCT00267280,Terminated,Phase 3,,atorvastatin
Simvastatin,DB00641,Hyperlipidemia,C0020473,NCT00267267,Terminated,Phase 3,,simvastatin
Atorvastatin,DB01076,Hyperlipidemia,C0020473,NCT00267267,Terminated,Phase 3,,atorvastatin
Simvastatin,DB00641,Dyslipidemias,C0242339,NCT00267267,Terminated,Phase 3,,simvastatin
Ezetimibe,DB00973,Dyslipidemias,C0242339,NCT00267267,Terminated,Phase 3,,ezetimibe
Atorvastatin,DB01076,Dyslipidemias,C0242339,NCT00267267,Terminated,Phase 3,,atorvastatin
Erythropoietin,DB00016,Chemotherapy-induced peripheral neuropathy,C3873567,NCT00267007,Terminated,Phase 2,Slow enrollment,erythropoietin
Diclofenac,DB00586,Non-cyclical mastalgia,C0405473,NCT00276419,Terminated,Phase 2/Phase 3,"Lack of funds; FDA approved a topical form of diclofenac during study, no need to continue    study of pharmacy-compounded drug.",diclofenac
Octreotide,DB00104,Diabetic Retinopathy,C0011884,NCT00248157,Terminated,Phase 3,Inconsistent treatment benefit,octreotide
Bupropion,DB01156,Tobacco Dependence,C0040332,NCT00248118,Terminated,Phase 2/Phase 3,PI left NIH,bupropion
Imatinib,DB00619,Chronic myeloproliferative disorder,C1292778,NCT00245128,Terminated,Phase 2,"Per PI, results from another similar study were published prior to study analysis. Negative    study results were published therefore analysis was not completed",imatinib
Floxuridine,DB00322,Malignant tumor of colon,C0007102,NCT00268463,Terminated,Phase 3,The study was terminated due to low accrual.,floxuridine
Oxaliplatin,DB00526,Malignant tumor of colon,C0007102,NCT00268463,Terminated,Phase 3,The study was terminated due to low accrual.,oxaliplatin
Capecitabine,DB01101,Malignant tumor of colon,C0007102,NCT00268463,Terminated,Phase 3,The study was terminated due to low accrual.,capecitabine
Aldesleukin,DB00041,"Lymphoma, Non-Hodgkin",C0024305,NCT00250861,Terminated,Phase 2,Study terminated due to lack of enrollment.,aldesleukin
Mitomycin,DB00305,Malignant tumor of colon,C0007102,NCT00271011,Terminated,Phase 2,The study was discontinued due to the death of a co-investigator and a second co-investigator    leaving the institution.,mitomycin
Irinotecan,DB00762,Malignant tumor of colon,C0007102,NCT00271011,Terminated,Phase 2,The study was discontinued due to the death of a co-investigator and a second co-investigator    leaving the institution.,irinotecan
Ganciclovir,DB01004,Cytomegalovirus Infections,C0010823,NCT00241345,Terminated,Phase 3,Due to low accrual,ganciclovir
Valganciclovir,DB01610,Cytomegalovirus Infections,C0010823,NCT00241345,Terminated,Phase 3,Due to low accrual,valganciclovir
Toremifene,DB00539,"Neoplasms, Hormone-Dependent",C0027661,NCT00267553,Terminated,Phase 3,This was a follow-on study to Biomed 777-CLP-029 which did not meet superiority endpoint,toremifene
Letrozole,DB01006,"Neoplasms, Hormone-Dependent",C0027661,NCT00267553,Terminated,Phase 3,This was a follow-on study to Biomed 777-CLP-029 which did not meet superiority endpoint,letrozole
Clofarabine,DB00631,Multiple Myeloma,C0026764,NCT00241371,Terminated,Phase 2,No response seen in patients,clofarabine
Rituximab,DB00073,leukemia,C0023418,NCT00265915,Terminated,Phase 2,,rituximab
Ritonavir,DB00503,HIV-1 infection,C2363741,NCT00242879,Terminated,Phase 2,,ritonavir
Pemetrexed,DB00642,Lung Neoplasms,C0024121,NCT00290017,Terminated,Phase 3,FDA Hold May 2007,pemetrexed
Pemetrexed,DB00642,Malignant neoplasm of lung,C0242379,NCT00290017,Terminated,Phase 3,FDA Hold May 2007,pemetrexed
Etodolac,DB00749,Multiple Myeloma,C0026764,NCT00293111,Terminated,Phase 2,,etodolac
Labetalol,DB00598,Pregnancy associated hypertension,C0852036,NCT00293735,Suspended,Phase 2/Phase 3,Lack of funding,labetalol
Magnesium Sulfate,DB00653,Pregnancy associated hypertension,C0852036,NCT00293735,Suspended,Phase 2/Phase 3,Lack of funding,magnesium sulfate
Labetalol,DB00598,hypertension chronic,C0745114,NCT00293735,Suspended,Phase 2/Phase 3,Lack of funding,labetalol
Magnesium Sulfate,DB00653,hypertension chronic,C0745114,NCT00293735,Suspended,Phase 2/Phase 3,Lack of funding,magnesium sulfate
Topiramate,DB00273,Metabolic Syndrome X,C0524620,NCT00243984,Suspended,Phase 3,Study was discontinued because of high drop out rate.,topiramate
Cisplatin,DB00515,Non-Small Cell Lung Carcinoma,C0007131,NCT00291850,Terminated,Phase 2,no patient recruitment,cisplatin
Hydroxocobalamin,DB00200,Cerebral Edema,C0006114,NCT00243022,Terminated,Phase 2,Slow accrual,hydroxocobalamin
Bevacizumab,DB00112,Malignant neoplasm of lung,C0242379,NCT00293332,Terminated,Phase 2,Terminated due to low subject accrual,bevacizumab
Carboplatin,DB00958,Malignant neoplasm of lung,C0242379,NCT00293332,Terminated,Phase 2,Terminated due to low subject accrual,carboplatin
Docetaxel,DB01248,Malignant neoplasm of lung,C0242379,NCT00293332,Terminated,Phase 2,Terminated due to low subject accrual,docetaxel
Methamphetamine,DB01577,Depressive disorder,C0011581,NCT00252434,Terminated,Phase 1,Slow enrollment,methamphetamine
Methamphetamine,DB01577,Sexually Transmitted Diseases,C0036916,NCT00252434,Terminated,Phase 1,Slow enrollment,methamphetamine
Topotecan,DB01030,Malignant neoplasm of lung,C0242379,NCT00253461,Terminated,Phase 0,Drugs unavailable:unable to make radioactive topotecan,topotecan
Topotecan,DB01030,"unspecified adult solid tumor, protocol specific",C0279004,NCT00253461,Terminated,Phase 0,Drugs unavailable:unable to make radioactive topotecan,topotecan
Carboplatin,DB00958,Malignant neoplasm of lung,C0242379,NCT00290537,Terminated,Phase 2,Accrual was suboptimal and increasing the number of patients was not feasible.,carboplatin
Paclitaxel,DB01229,Malignant neoplasm of lung,C0242379,NCT00290537,Terminated,Phase 2,Accrual was suboptimal and increasing the number of patients was not feasible.,paclitaxel
Modafinil,DB00745,Pain,C0030193,NCT00267332,Terminated,Phase 3,Low accrual,modafinil
Armodafinil,DB06413,Pain,C0030193,NCT00267332,Terminated,Phase 3,Low accrual,armodafinil
Gemcitabine,DB00441,leukemia,C0023418,NCT00268242,Terminated,Phase 2,"If </= 5 of the initial 18 patients had a CR, the study would be stopped. Only 5 patients    (21%) of 24 enrolled patients had a CR so the study was terminated.",gemcitabine
Mitoxantrone,DB01204,leukemia,C0023418,NCT00268242,Terminated,Phase 2,"If </= 5 of the initial 18 patients had a CR, the study would be stopped. Only 5 patients    (21%) of 24 enrolled patients had a CR so the study was terminated.",mitoxantrone
Leuprolide,DB00007,Multiple Myeloma,C0026764,NCT00275262,Terminated,Phase 2,,leuprolide
Leuprolide,DB00007,"Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse",C0334634,NCT00275262,Terminated,Phase 2,,leuprolide
Lidocaine,DB00281,Carpal Tunnel Syndrome,C0007286,NCT00266214,Terminated,Phase 3,Sponsor decision,lidocaine
Cyclosporine,DB00091,"Leukemia, Large Granular Lymphocytic",C1522378,NCT00363779,Terminated,Phase 2,Study terminated due to low accrual and the investigator left the NIH.,cyclosporine
Darbepoetin alfa,DB00012,Chronic Kidney Diseases,C1561643,NCT00364845,Terminated,Phase 3,The reason for the discontinuation of the study is difficulty with recruitment and timely    enrolment and is not related to safety concerns,darbepoetin alfa
Dacarbazine,DB00851,Glioblastoma,C0017636,NCT00365222,Terminated,Phase 2,IRB Study Closure,dacarbazine
Temozolomide,DB00853,Glioblastoma,C0017636,NCT00365222,Terminated,Phase 2,IRB Study Closure,temozolomide
Dacarbazine,DB00851,gliosarcoma,C0206726,NCT00365222,Terminated,Phase 2,IRB Study Closure,dacarbazine
Temozolomide,DB00853,gliosarcoma,C0206726,NCT00365222,Terminated,Phase 2,IRB Study Closure,temozolomide
Micafungin,DB01141,Invasive aspergillosis,C0238013,NCT00376337,Terminated,Phase 2,Study was stopped due to difficulties in recruitment and changes in standard care for invasive    aspergillosis,micafungin
Pregabalin,DB00230,Epilepsy,C0014544,NCT00372528,Terminated,Phase 3,"This study was terminated on April 8, 2011 as Pfizer Canada could no longer supply study drug.    No efficacy or safety concerns factored into this decision.",pregabalin
Fenofibrate,DB01039,Obesity,C0028754,NCT00376285,Withdrawn,Phase 1,,fenofibrate
Cyclosporine,DB00091,"Hepatitis C, Chronic",C0524910,NCT00375895,Terminated,Phase 3,Insufficient enrollment,cyclosporine
Cyclosporine,DB00091,Evidence of liver transplantation,C0940823,NCT00375895,Terminated,Phase 3,Insufficient enrollment,cyclosporine
Erlotinib,DB00530,Malignant neoplasm of lung,C0242379,NCT00385398,Withdrawn,Phase 2,lack of funding and drug supply,erlotinib
Temozolomide,DB00853,Malignant neoplasm of lung,C0242379,NCT00385398,Withdrawn,Phase 2,lack of funding and drug supply,temozolomide
Clopidogrel,DB00758,Atherosclerosis,C0004153,NCT00385138,Terminated,Phase 3,Insufficient evidence of the clinical effectiveness of cangrelor,clopidogrel
Cangrelor,DB06441,Atherosclerosis,C0004153,NCT00385138,Terminated,Phase 3,Insufficient evidence of the clinical effectiveness of cangrelor,cangrelor
Cyclophosphamide,DB00531,Myelofibrosis due to another disorder,C0242006,NCT00376519,Terminated,Phase 1,Slow accrual,cyclophosphamide
Mycophenolate mofetil,DB00688,Myelofibrosis due to another disorder,C0242006,NCT00376519,Terminated,Phase 1,Slow accrual,mycophenolate mofetil
Mycophenolic acid,DB01024,Myelofibrosis due to another disorder,C0242006,NCT00376519,Terminated,Phase 1,Slow accrual,mycophenolic acid
Fludarabine,DB01073,Myelofibrosis due to another disorder,C0242006,NCT00376519,Terminated,Phase 1,Slow accrual,fludarabine
Cyclophosphamide,DB00531,leukemia,C0023418,NCT00376519,Terminated,Phase 1,Slow accrual,cyclophosphamide
Mycophenolate mofetil,DB00688,leukemia,C0023418,NCT00376519,Terminated,Phase 1,Slow accrual,mycophenolate mofetil
Mycophenolic acid,DB01024,leukemia,C0023418,NCT00376519,Terminated,Phase 1,Slow accrual,mycophenolic acid
Fludarabine,DB01073,leukemia,C0023418,NCT00376519,Terminated,Phase 1,Slow accrual,fludarabine
Infliximab,DB00065,Toxic Epidermal Necrolysis,C0014518,NCT00372723,Withdrawn,Phase 2,slow enrollment,infliximab
Trastuzumab,DB00072,Neoplasm Metastasis,C0027627,NCT00377780,Terminated,Phase 2,wothdrawal of sponsor,trastuzumab
Doxorubicin,DB00997,Neoplasm Metastasis,C0027627,NCT00377780,Terminated,Phase 2,wothdrawal of sponsor,doxorubicin
Docetaxel,DB01248,Neoplasm Metastasis,C0027627,NCT00377780,Terminated,Phase 2,wothdrawal of sponsor,docetaxel
Peginterferon alfa-2b,DB00022,Liver Cirrhosis,C0023890,NCT00381017,Withdrawn,Phase 3,Non-protocol feasibility,peginterferon alfa-2b
Cyclosporine,DB00091,Psoriasis,C0033860,NCT00377325,Withdrawn,Phase 2,Study terminated by the DSMB due to low recruitment,cyclosporine
Salmon Calcitonin,DB00017,Degenerative polyarthritis,C0029408,NCT00376311,Terminated,Phase 2,,salmon calcitonin
Methadone,DB00333,Pain,C0030193,NCT00351637,Terminated,Phase 2,Study suspended due to low accrual,methadone
Imatinib,DB00619,leukemia,C0023418,NCT00362466,Terminated,Phase 3,Insufficient Enrollment,imatinib
Dasatinib,DB01254,leukemia,C0023418,NCT00362466,Terminated,Phase 3,Insufficient Enrollment,dasatinib
Pentoxifylline,DB00806,Glomerulonephritis,C0017658,NCT00354198,Terminated,Phase 3,short of participants,pentoxifylline
Prednisolone,DB00860,Glomerulonephritis,C0017658,NCT00354198,Terminated,Phase 3,short of participants,prednisolone
Methylprednisolone,DB00959,Glomerulonephritis,C0017658,NCT00354198,Terminated,Phase 3,short of participants,methylprednisolone
Doxorubicin,DB00997,ovarian neoplasm,C0919267,NCT00350948,Terminated,Phase 3,Business reasons,doxorubicin
Methadone,DB00333,Pain,C0030193,NCT00351715,Terminated,Phase 2,Study stopped due to low accrual,methadone
Reboxetine,DB00234,Pain,C0030193,NCT00353808,Terminated,Phase 2,This study has been terminated early as the esreboxetine development program is being    discontinued. There are no safety or efficacy concerns.,reboxetine
Irinotecan,DB00762,Astrocytoma,C0004114,NCT00360828,Terminated,Phase 2,Principal Investigator left Moffitt and study had low accrual.,irinotecan
Sirolimus,DB00877,Non-Small Cell Lung Carcinoma,C0007131,NCT00352950,Withdrawn,Phase 1,,sirolimus
Donepezil,DB00843,Advanced cancer,C0877373,NCT00352664,Terminated,Phase 3,Low patient accrual,donepezil
Pregabalin,DB00230,Herpes zoster disease,C0019360,NCT00352651,Terminated,Phase 2,"This study should be terminated as the study has been closed for years and the investigator    has since retired. No records are available.    Thank you, Marlene",pregabalin
Pemetrexed,DB00642,Esophageal Neoplasms,C0014859,NCT00383266,Terminated,Phase 2,Low accrual,pemetrexed
Carboplatin,DB00958,Esophageal Neoplasms,C0014859,NCT00383266,Terminated,Phase 2,Low accrual,carboplatin
Romidepsin,DB06176,recurrent adult diffuse large cell lymphoma,C0280188,NCT00383565,Terminated,Phase 2,,romidepsin
Romidepsin,DB06176,Mantle cell lymphoma recurrent,C0677725,NCT00383565,Terminated,Phase 2,,romidepsin
Infliximab,DB00065,Lupus Nephritis,C0024143,NCT00368264,Terminated,Phase 2/Phase 3,Failure to recruit patients with membranous lupus nephritis not previously treated with    azathioprine .,infliximab
Azathioprine,DB00993,Lupus Nephritis,C0024143,NCT00368264,Terminated,Phase 2/Phase 3,Failure to recruit patients with membranous lupus nephritis not previously treated with    azathioprine .,azathioprine
Bevacizumab,DB00112,Colorectal Neoplasms,C0009404,NCT00385021,Terminated,Phase 2,,bevacizumab
Azacitidine,DB00928,Chronic myeloproliferative disorder,C1292778,NCT00381693,Terminated,Phase 2,Due to lack of accrual and trial has demonstrated too little clinical benefit,azacitidine
Azacitidine,DB00928,Myelofibrosis due to another disorder,C0242006,NCT00381693,Terminated,Phase 2,Due to lack of accrual and trial has demonstrated too little clinical benefit,azacitidine
Nitazoxanide,DB00507,Clostridium difficile infection,C0343386,NCT00384527,Terminated,Phase 3,Study was terminated early due to slow recruitment.,nitazoxanide
Vancomycin,DB00512,Clostridium difficile infection,C0343386,NCT00384527,Terminated,Phase 3,Study was terminated early due to slow recruitment.,vancomycin
Nitazoxanide,DB00507,Clostridium Infections,C0009062,NCT00384527,Terminated,Phase 3,Study was terminated early due to slow recruitment.,nitazoxanide
Vancomycin,DB00512,Clostridium Infections,C0009062,NCT00384527,Terminated,Phase 3,Study was terminated early due to slow recruitment.,vancomycin
Hydroxyurea,DB01005,Pulmonary Hypertension,C0020542,NCT00350844,Terminated,Phase 1/Phase 2,Low subject accrual,hydroxyurea
Mitomycin,DB00305,Urinary Bladder Diseases,C0005686,NCT00384891,Terminated,Phase 3,slow accrual,mitomycin
Mitomycin,DB00305,Bladder Neoplasm,C0005695,NCT00384891,Terminated,Phase 3,slow accrual,mitomycin
Mitomycin,DB00305,Malignant neoplasm of urinary bladder,C0005684,NCT00384891,Terminated,Phase 3,slow accrual,mitomycin
Mitomycin,DB00305,Urologic Diseases,C0042075,NCT00384891,Terminated,Phase 3,slow accrual,mitomycin
Mitomycin,DB00305,Urologic Neoplasms,C0042076,NCT00384891,Terminated,Phase 3,slow accrual,mitomycin
Everolimus,DB01590,Malignant tumor of colon,C0007102,NCT00390364,Terminated,Phase 2,Withdrawn due to low accrual,everolimus
Teriparatide,DB06285,Myelofibrosis,C0026987,NCT00393380,Terminated,Phase 2,Study stopped because of toxicity concerns.,teriparatide
Cisplatin,DB00515,untreated childhood medulloblastoma,C0338341,NCT00392327,Suspended,Phase 3,Temporarily stopped for assessment,cisplatin
Cyclophosphamide,DB00531,untreated childhood medulloblastoma,C0338341,NCT00392327,Suspended,Phase 3,Temporarily stopped for assessment,cyclophosphamide
Vincristine,DB00541,untreated childhood medulloblastoma,C0338341,NCT00392327,Suspended,Phase 3,Temporarily stopped for assessment,vincristine
Carboplatin,DB00958,untreated childhood medulloblastoma,C0338341,NCT00392327,Suspended,Phase 3,Temporarily stopped for assessment,carboplatin
Isotretinoin,DB00982,untreated childhood medulloblastoma,C0338341,NCT00392327,Suspended,Phase 3,Temporarily stopped for assessment,isotretinoin
Cisplatin,DB00515,untreated childhood supratentorial primitive neuroectodermal tumors,C0338333,NCT00392327,Suspended,Phase 3,Temporarily stopped for assessment,cisplatin
Cyclophosphamide,DB00531,untreated childhood supratentorial primitive neuroectodermal tumors,C0338333,NCT00392327,Suspended,Phase 3,Temporarily stopped for assessment,cyclophosphamide
Vincristine,DB00541,untreated childhood supratentorial primitive neuroectodermal tumors,C0338333,NCT00392327,Suspended,Phase 3,Temporarily stopped for assessment,vincristine
Carboplatin,DB00958,untreated childhood supratentorial primitive neuroectodermal tumors,C0338333,NCT00392327,Suspended,Phase 3,Temporarily stopped for assessment,carboplatin
Isotretinoin,DB00982,untreated childhood supratentorial primitive neuroectodermal tumors,C0338333,NCT00392327,Suspended,Phase 3,Temporarily stopped for assessment,isotretinoin
Cisplatin,DB00515,Malignant neoplasm of lung,C0242379,NCT00389688,Terminated,Phase 2,low accrual,cisplatin
Pemetrexed,DB00642,Malignant neoplasm of lung,C0242379,NCT00389688,Terminated,Phase 2,low accrual,pemetrexed
Bevacizumab,DB00112,Malignant tumor of colon,C0007102,NCT00394992,Terminated,Phase 3,Data from the C08 study and Avant study,bevacizumab
Oxaliplatin,DB00526,Malignant tumor of colon,C0007102,NCT00394992,Terminated,Phase 3,Data from the C08 study and Avant study,oxaliplatin
Capecitabine,DB01101,Malignant tumor of colon,C0007102,NCT00394992,Terminated,Phase 3,Data from the C08 study and Avant study,capecitabine
Bevacizumab,DB00112,Secondary malignant neoplasm of liver,C0494165,NCT00394992,Terminated,Phase 3,Data from the C08 study and Avant study,bevacizumab
Oxaliplatin,DB00526,Secondary malignant neoplasm of liver,C0494165,NCT00394992,Terminated,Phase 3,Data from the C08 study and Avant study,oxaliplatin
Fluorouracil,DB00544,Secondary malignant neoplasm of liver,C0494165,NCT00394992,Terminated,Phase 3,Data from the C08 study and Avant study,fluorouracil
Capecitabine,DB01101,Secondary malignant neoplasm of liver,C0494165,NCT00394992,Terminated,Phase 3,Data from the C08 study and Avant study,capecitabine
Simvastatin,DB00641,Diabetes Mellitus,C0011849,NCT00395603,Terminated,Phase 3,This study was terminated early due to poor recruitment.,simvastatin
Ezetimibe,DB00973,Diabetes Mellitus,C0011849,NCT00395603,Terminated,Phase 3,This study was terminated early due to poor recruitment.,ezetimibe
Atorvastatin,DB01076,Diabetes Mellitus,C0011849,NCT00395603,Terminated,Phase 3,This study was terminated early due to poor recruitment.,atorvastatin
Trastuzumab,DB00072,cognitive/functional effects,C0935657,NCT00397501,Withdrawn,Phase 1/Phase 2,"after original approval, IRB closed enrollment; major revisions required to re-open.",trastuzumab
Methotrexate,DB00563,cognitive/functional effects,C0935657,NCT00397501,Withdrawn,Phase 1/Phase 2,"after original approval, IRB closed enrollment; major revisions required to re-open.",methotrexate
Carboplatin,DB00958,cognitive/functional effects,C0935657,NCT00397501,Withdrawn,Phase 1/Phase 2,"after original approval, IRB closed enrollment; major revisions required to re-open.",carboplatin
Sodium thiosulfate,DB09499,cognitive/functional effects,C0935657,NCT00397501,Withdrawn,Phase 1/Phase 2,"after original approval, IRB closed enrollment; major revisions required to re-open.",sodium thiosulfate
Valproic Acid,DB00313,Locally advanced breast cancer,C3495949,NCT00395655,Terminated,Phase 2,,valproic acid
Hydralazine,DB01275,Locally advanced breast cancer,C3495949,NCT00395655,Terminated,Phase 2,,hydralazine
Heparin,DB01109,Diabetic Angiopathies,C0011875,NCT00399425,Terminated,Phase 2/Phase 3,,heparin
Pegfilgrastim,DB00019,Multiple Myeloma,C0026764,NCT00395967,Terminated,Phase 2,Enrollment terminated in 2005 to focus on Phase 3 study enrollment.,pegfilgrastim
Cocaine,DB00907,Cocaine Dependence,C0600427,NCT00373581,Terminated,Phase 2,Funding ran out,cocaine
Vigabatrin,DB01080,Cocaine Dependence,C0600427,NCT00373581,Terminated,Phase 2,Funding ran out,vigabatrin
Cetuximab,DB00002,Multiple Myeloma,C0026764,NCT00368121,Terminated,Phase 2,Lack of recruitable patients,cetuximab
Scopolamine,DB00747,Unipolar Depression,C0041696,NCT00369915,Terminated,Phase 2,,scopolamine
Fluorouracil,DB00544,Esophageal Neoplasms,C0014859,NCT00368329,Terminated,Phase 1,low accrual,fluorouracil
Carboplatin,DB00958,Esophageal Neoplasms,C0014859,NCT00368329,Terminated,Phase 1,low accrual,carboplatin
Capecitabine,DB01101,Esophageal Neoplasms,C0014859,NCT00368329,Terminated,Phase 1,low accrual,capecitabine
Fluorouracil,DB00544,Adenocarcinoma,C0001418,NCT00368329,Terminated,Phase 1,low accrual,fluorouracil
Carboplatin,DB00958,Adenocarcinoma,C0001418,NCT00368329,Terminated,Phase 1,low accrual,carboplatin
Capecitabine,DB01101,Adenocarcinoma,C0001418,NCT00368329,Terminated,Phase 1,low accrual,capecitabine
Bevacizumab,DB00112,Adenocarcinoma of lung (disorder),C0152013,NCT00369551,Terminated,Phase 1,,bevacizumab
Carboplatin,DB00958,Adenocarcinoma of lung (disorder),C0152013,NCT00369551,Terminated,Phase 1,,carboplatin
Paclitaxel,DB01229,Adenocarcinoma of lung (disorder),C0152013,NCT00369551,Terminated,Phase 1,,paclitaxel
Bevacizumab,DB00112,Large cell carcinoma of lung,C0345958,NCT00369551,Terminated,Phase 1,,bevacizumab
Carboplatin,DB00958,Large cell carcinoma of lung,C0345958,NCT00369551,Terminated,Phase 1,,carboplatin
Paclitaxel,DB01229,Large cell carcinoma of lung,C0345958,NCT00369551,Terminated,Phase 1,,paclitaxel
Bevacizumab,DB00112,Non-small cell lung cancer stage II,C0278505,NCT00369551,Terminated,Phase 1,,bevacizumab
Carboplatin,DB00958,Non-small cell lung cancer stage II,C0278505,NCT00369551,Terminated,Phase 1,,carboplatin
Paclitaxel,DB01229,Non-small cell lung cancer stage II,C0278505,NCT00369551,Terminated,Phase 1,,paclitaxel
Bevacizumab,DB00112,Non-small cell lung cancer stage IIIA,C0278983,NCT00369551,Terminated,Phase 1,,bevacizumab
Carboplatin,DB00958,Non-small cell lung cancer stage IIIA,C0278983,NCT00369551,Terminated,Phase 1,,carboplatin
Paclitaxel,DB01229,Non-small cell lung cancer stage IIIA,C0278983,NCT00369551,Terminated,Phase 1,,paclitaxel
Imatinib,DB00619,Choroidal retinal neovascularization,C0271066,NCT00403156,Withdrawn,Phase 1,Lack of recruitment,imatinib
Imatinib,DB00619,Choroidal Neovascularization,C0600518,NCT00403156,Withdrawn,Phase 1,Lack of recruitment,imatinib
Bevacizumab,DB00112,Malignant neoplasm of lung,C0242379,NCT00402883,Terminated,Phase 2,Terminated due to bevacizumab and chemoradiotherapy toxicity,bevacizumab
Folic Acid,DB00158,Malignant neoplasm of lung,C0242379,NCT00402883,Terminated,Phase 2,Terminated due to bevacizumab and chemoradiotherapy toxicity,folic acid
Hydroxocobalamin,DB00200,Malignant neoplasm of lung,C0242379,NCT00402883,Terminated,Phase 2,Terminated due to bevacizumab and chemoradiotherapy toxicity,hydroxocobalamin
Pemetrexed,DB00642,Malignant neoplasm of lung,C0242379,NCT00402883,Terminated,Phase 2,Terminated due to bevacizumab and chemoradiotherapy toxicity,pemetrexed
Carboplatin,DB00958,Malignant neoplasm of lung,C0242379,NCT00402883,Terminated,Phase 2,Terminated due to bevacizumab and chemoradiotherapy toxicity,carboplatin
Cisplatin,DB00515,Squamous cell carcinoma,C0007137,NCT00400205,Terminated,Phase 2,Safety reasons,cisplatin
Fluorouracil,DB00544,Squamous cell carcinoma,C0007137,NCT00400205,Terminated,Phase 2,Safety reasons,fluorouracil
Docetaxel,DB01248,Squamous cell carcinoma,C0007137,NCT00400205,Terminated,Phase 2,Safety reasons,docetaxel
Imatinib,DB00619,Metastatic melanoma,C0278883,NCT00402662,Terminated,Phase 2,unexpected level of toxicity,imatinib
Sirolimus,DB00877,Metastatic melanoma,C0278883,NCT00402662,Terminated,Phase 2,unexpected level of toxicity,sirolimus
Everolimus,DB01590,Metastatic melanoma,C0278883,NCT00402662,Terminated,Phase 2,unexpected level of toxicity,everolimus
Metoprolol,DB00264,Cardiac Arrest,C0018790,NCT00401882,Terminated,Phase 2,Difficult accrual,metoprolol
Metoprolol,DB00264,Sudden Cardiac Death,C0085298,NCT00401882,Terminated,Phase 2,Difficult accrual,metoprolol
Metoprolol,DB00264,Ventricular Fibrillation,C0042510,NCT00401882,Terminated,Phase 2,Difficult accrual,metoprolol
Cetuximab,DB00002,Colorectal Neoplasms,C0009404,NCT00403052,Terminated,Phase 1,Administrative reasons,cetuximab
Irinotecan,DB00762,Colorectal Neoplasms,C0009404,NCT00403052,Terminated,Phase 1,Administrative reasons,irinotecan
Minocycline,DB01017,Carotid Stenosis,C0007282,NCT00401921,Terminated,Phase 2,PI moved to a new facility,minocycline
Lithium,DB01356,Major Depressive Disorder,C1269683,NCT00400088,Terminated,Phase 3,Recruitment difficulties,lithium
Azacitidine,DB00928,Multiple Myeloma,C0026764,NCT00412919,Terminated,Phase 2,Lack of efficacy,azacitidine
Salbutamol,DB01001,Status Asthmaticus,C0038218,NCT00410150,Terminated,Phase 2,Study was stopped after interim analysis and slow enrollment.,salbutamol
Aminosalicylic Acid,DB00233,Crohn Disease,C0010346,NCT00417690,Terminated,Phase 2,Efforts at recruitment have halted as recruitment was poor.,aminosalicylic acid
Alemtuzumab,DB00087,leukemia,C0023418,NCT00416884,Terminated,Phase 2,Low enrollment,alemtuzumab
Fludarabine,DB01073,leukemia,C0023418,NCT00416884,Terminated,Phase 2,Low enrollment,fludarabine
Bevacizumab,DB00112,Malignant neoplasm of lung,C0242379,NCT00411593,Withdrawn,Phase 1/Phase 2,Lack of Patient Accrual,bevacizumab
Bortezomib,DB00188,Malignant neoplasm of lung,C0242379,NCT00411593,Withdrawn,Phase 1/Phase 2,Lack of Patient Accrual,bortezomib
Rituximab,DB00073,B-Cell Lymphomas,C0079731,NCT00413959,Terminated,Phase 2,,rituximab
Bortezomib,DB00188,B-Cell Lymphomas,C0079731,NCT00413959,Terminated,Phase 2,,bortezomib
Cyclophosphamide,DB00531,B-Cell Lymphomas,C0079731,NCT00413959,Terminated,Phase 2,,cyclophosphamide
Dexamethasone,DB01234,B-Cell Lymphomas,C0079731,NCT00413959,Terminated,Phase 2,,dexamethasone
Cytarabine,DB00987,leukemia,C0023418,NCT00411281,Withdrawn,Phase 3,Per Group Chair: This study will not move forward.,cytarabine
Prednisone,DB00635,Multiple Myeloma,C0026764,NCT00406978,Terminated,Phase 1/Phase 2,difficulties in enrolling patients,prednisone
Defibrotide,DB04932,Multiple Myeloma,C0026764,NCT00406978,Terminated,Phase 1/Phase 2,difficulties in enrolling patients,defibrotide
Peginterferon alfa-2b,DB00022,leukemia,C0023418,NCT00415857,Terminated,Phase 2,Vaccine sponsor ceased operations.,peginterferon alfa-2b
Imatinib,DB00619,leukemia,C0023418,NCT00415857,Terminated,Phase 2,Vaccine sponsor ceased operations.,imatinib
Azacitidine,DB00928,leukemia,C0023418,NCT00413478,Terminated,Phase 2,Slow accrual.,azacitidine
Sorafenib,DB00398,Non-Small Cell Lung Carcinoma,C0007131,NCT00417248,Terminated,Phase 1/Phase 2,Negative sorafenib results from ESCAPE trial and safety concerns of regimen,sorafenib
Cisplatin,DB00515,Non-Small Cell Lung Carcinoma,C0007131,NCT00417248,Terminated,Phase 1/Phase 2,Negative sorafenib results from ESCAPE trial and safety concerns of regimen,cisplatin
Etoposide,DB00773,Non-Small Cell Lung Carcinoma,C0007131,NCT00417248,Terminated,Phase 1/Phase 2,Negative sorafenib results from ESCAPE trial and safety concerns of regimen,etoposide
Gabapentin,DB00996,Chronic intractable pain,C0476481,NCT00414466,Terminated,Phase 2,Study closed and subject follow-up completed following analysis of blinded study data.,gabapentin
Abatacept,DB01281,Crohn Disease,C0010346,NCT00406653,Terminated,Phase 3,Sponsor Decision,abatacept
Sirolimus,DB00877,Malignant neoplasm of lung,C0242379,NCT00406276,Terminated,Phase 1/Phase 2,data analysis showed insufficient drug efficacy,sirolimus
Docetaxel,DB01248,Malignant neoplasm of lung,C0242379,NCT00406276,Terminated,Phase 1/Phase 2,data analysis showed insufficient drug efficacy,docetaxel
Everolimus,DB01590,Malignant neoplasm of lung,C0242379,NCT00406276,Terminated,Phase 1/Phase 2,data analysis showed insufficient drug efficacy,everolimus
Rituximab,DB00073,Lupus Nephritis,C0024143,NCT00404157,Withdrawn,Phase 3,,rituximab
Bevacizumab,DB00112,Non-Small Cell Lung Carcinoma,C0007131,NCT00404703,Terminated,Phase 2,Primary (safety) endpoint reached,bevacizumab
Erlotinib,DB00530,adult brain tumor,C0220624,NCT00387894,Terminated,Phase 2,Insufficient accrual of population likely to benefit; progression in 6 patients,erlotinib
Topotecan,DB01030,Neuroblastoma,C0027819,NCT00389766,Withdrawn,Phase 2,Withdrawn because protocol has been discontinued. It was never opened.,topotecan
Fentanyl,DB00813,Chronic pain,C0150055,NCT00387010,Terminated,Phase 3,The sponsor felt enough information was available for the exploratory assessment of the effect    of treatment with FBT on pain anxiety,fentanyl
Fentanyl,DB00813,Breakthrough Pain,C1135120,NCT00387010,Terminated,Phase 3,The sponsor felt enough information was available for the exploratory assessment of the effect    of treatment with FBT on pain anxiety,fentanyl
Citalopram,DB00215,Malignant tumor of colon,C0007102,NCT00387348,Terminated,Phase 3,DSMB stopped study because placebo arm had more adverse events,citalopram
Citalopram,DB00215,Malignant neoplasm of stomach,C0024623,NCT00387348,Terminated,Phase 3,DSMB stopped study because placebo arm had more adverse events,citalopram
Citalopram,DB00215,Malignant neoplasm of lung,C0242379,NCT00387348,Terminated,Phase 3,DSMB stopped study because placebo arm had more adverse events,citalopram
Dacarbazine,DB00851,Astrocytoma,C0004114,NCT00389090,Terminated,Phase 2,AOI Pharma terminated the license agreement. IND Transferred to NCI,dacarbazine
Temozolomide,DB00853,Astrocytoma,C0004114,NCT00389090,Terminated,Phase 2,AOI Pharma terminated the license agreement. IND Transferred to NCI,temozolomide
Dacarbazine,DB00851,Mixed Oligodendroglioma-Astrocytoma,C0280793,NCT00389090,Terminated,Phase 2,AOI Pharma terminated the license agreement. IND Transferred to NCI,dacarbazine
Temozolomide,DB00853,Mixed Oligodendroglioma-Astrocytoma,C0280793,NCT00389090,Terminated,Phase 2,AOI Pharma terminated the license agreement. IND Transferred to NCI,temozolomide
Sunitinib,DB01268,Acute Undifferentiated Leukemia,C0280141,NCT00387426,Terminated,Phase 2,,sunitinib
Sunitinib,DB01268,adult acute lymphoblastic leukemia in remission,C0279095,NCT00387426,Terminated,Phase 2,,sunitinib
Sunitinib,DB01268,adult acute myeloid leukemia in remission,C0279094,NCT00387426,Terminated,Phase 2,,sunitinib
Sunitinib,DB01268,adult acute myeloid leukemia with 11q23 (MLL) abnormalities,C1541334,NCT00387426,Terminated,Phase 2,,sunitinib
Sunitinib,DB01268,adult acute myeloid leukemia with inv(16)(p13;q22),C1541333,NCT00387426,Terminated,Phase 2,,sunitinib
Sunitinib,DB01268,adult acute myeloid leukemia with t(15;17)(q22;q12),C1541335,NCT00387426,Terminated,Phase 2,,sunitinib
Sunitinib,DB01268,adult acute myeloid leukemia with t(16;16)(p13;q22),C1541332,NCT00387426,Terminated,Phase 2,,sunitinib
Sunitinib,DB01268,adult acute myeloid leukemia with t(8;21)(q22;q22),C1541331,NCT00387426,Terminated,Phase 2,,sunitinib
Sunitinib,DB01268,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative",C1292772,NCT00387426,Terminated,Phase 2,,sunitinib
Sunitinib,DB01268,"Leukemia, Myelomonocytic, Chronic",C0023480,NCT00387426,Terminated,Phase 2,,sunitinib
Sunitinib,DB01268,"Leukemia, Mast-Cell",C0023461,NCT00387426,Terminated,Phase 2,,sunitinib
Sunitinib,DB01268,meningeal chronic myelogenous leukemia,C0279083,NCT00387426,Terminated,Phase 2,,sunitinib
Sunitinib,DB01268,Primary Myelofibrosis,C0001815,NCT00387426,Terminated,Phase 2,,sunitinib
Sunitinib,DB01268,"progressive hairy cell leukemia, initial treatment",C0279779,NCT00387426,Terminated,Phase 2,,sunitinib
Sunitinib,DB01268,Prolymphocytic Leukemia,C0023486,NCT00387426,Terminated,Phase 2,,sunitinib
Sunitinib,DB01268,recurrent adult acute lymphoblastic leukemia,C0278785,NCT00387426,Terminated,Phase 2,,sunitinib
Sunitinib,DB01268,recurrent adult acute myeloid leukemia,C0278780,NCT00387426,Terminated,Phase 2,,sunitinib
Sunitinib,DB01268,Chronic lymphocytic leukaemia refractory,C0278791,NCT00387426,Terminated,Phase 2,,sunitinib
Sunitinib,DB01268,Hairy cell leukaemia recurrent,C0279780,NCT00387426,Terminated,Phase 2,,sunitinib
Sunitinib,DB01268,chronic myelogenous leukemia in relapse,C0278787,NCT00387426,Terminated,Phase 2,,sunitinib
Sunitinib,DB01268,secondary acute myeloid leukemia,C0280449,NCT00387426,Terminated,Phase 2,,sunitinib
Sunitinib,DB01268,Chronic lymphocytic leukaemia stage 1,C0278767,NCT00387426,Terminated,Phase 2,,sunitinib
Sunitinib,DB01268,Chronic lymphocytic leukaemia stage 2,C0854803,NCT00387426,Terminated,Phase 2,,sunitinib
Sunitinib,DB01268,Chronic lymphocytic leukaemia stage 3,C0278769,NCT00387426,Terminated,Phase 2,,sunitinib
Sunitinib,DB01268,Chronic lymphocytic leukaemia stage 4,C0854804,NCT00387426,Terminated,Phase 2,,sunitinib
Sunitinib,DB01268,T-Cell Large Granular Lymphocyte Leukemia,C1955861,NCT00387426,Terminated,Phase 2,,sunitinib
Sunitinib,DB01268,untreated adult acute lymphoblastic leukemia,C0279088,NCT00387426,Terminated,Phase 2,,sunitinib
Sunitinib,DB01268,untreated adult acute myeloid leukemia,C0279089,NCT00387426,Terminated,Phase 2,,sunitinib
Sunitinib,DB01268,untreated hairy cell leukemia,C0279778,NCT00387426,Terminated,Phase 2,,sunitinib
Phenylephrine,DB00388,Fecal Incontinence,C0015732,NCT00420797,Withdrawn,Phase 3,"Terminated, new protocol to be developed",phenylephrine
Oxymetazoline,DB00935,Fecal Incontinence,C0015732,NCT00420797,Withdrawn,Phase 3,"Terminated, new protocol to be developed",oxymetazoline
Losartan,DB00678,Prehypertension,C1696708,NCT00388388,Terminated,Phase 2,"Few subjects recruited, sponsor withdrew support.",losartan
Hydrochlorothiazide,DB00999,Prehypertension,C1696708,NCT00388388,Terminated,Phase 2,"Few subjects recruited, sponsor withdrew support.",hydrochlorothiazide
Losartan,DB00678,Prediabetes syndrome,C0362046,NCT00388388,Terminated,Phase 2,"Few subjects recruited, sponsor withdrew support.",losartan
Hydrochlorothiazide,DB00999,Prediabetes syndrome,C0362046,NCT00388388,Terminated,Phase 2,"Few subjects recruited, sponsor withdrew support.",hydrochlorothiazide
Gemcitabine,DB00441,cervical cancer,C4048328,NCT00421096,Terminated,Phase 2,Problems of recruitment,gemcitabine
Lidocaine,DB00281,Overactive Bladder,C0878773,NCT00427648,Terminated,Phase 3,Data collection complete; analysis to take place,lidocaine
Bevacizumab,DB00112,Non-Small Cell Lung Carcinoma,C0007131,NCT00434226,Terminated,Phase 2,"Based on data collected, the combination appeared to be poorly tolearated.",bevacizumab
Carboplatin,DB00958,Non-Small Cell Lung Carcinoma,C0007131,NCT00434226,Terminated,Phase 2,"Based on data collected, the combination appeared to be poorly tolearated.",carboplatin
Sunitinib,DB01268,Non-Small Cell Lung Carcinoma,C0007131,NCT00434226,Terminated,Phase 2,"Based on data collected, the combination appeared to be poorly tolearated.",sunitinib
Ketoprofen,DB01009,Tendinitis,C0039503,NCT00426985,Terminated,Phase 3,Sufficient number of subjects accrued to conduct analysis,ketoprofen
Ketoprofen,DB01009,Bursitis,C0006444,NCT00426985,Terminated,Phase 3,Sufficient number of subjects accrued to conduct analysis,ketoprofen
Flucloxacillin,DB00301,Chronic Kidney Diseases,C1561643,NCT00433342,Suspended,Phase 1,,flucloxacillin
Salbutamol,DB01001,"Respiratory Distress Syndrome, Adult",C0035222,NCT00434993,Terminated,Phase 2/Phase 3,Stopped for futility by DSMB,salbutamol
Sunitinib,DB01268,Pancreatic Endocrine Carcinoma,C1328479,NCT00428597,Terminated,Phase 3,Refer to Detailed Description.,sunitinib
Sunitinib,DB01268,Pancreatic carcinoma,C0235974,NCT00428597,Terminated,Phase 3,Refer to Detailed Description.,sunitinib
Dutasteride,DB01126,Benign Prostatic Hyperplasia,C1704272,NCT00431626,Terminated,Phase 3,Low enrollment,dutasteride
Imatinib,DB00619,Malignant Peripheral Nerve Sheath Tumor,C0751690,NCT00427583,Terminated,Phase 2/Phase 3,stopped due to slow recruitment and no effect,imatinib
Lorazepam,DB00186,Nausea,C0027497,NCT00429702,Terminated,Phase 2,Closed due to poor accrual and lack of feasibility to finish study per DSMB,lorazepam
Ondansetron,DB00904,Nausea,C0027497,NCT00429702,Terminated,Phase 2,Closed due to poor accrual and lack of feasibility to finish study per DSMB,ondansetron
Promethazine,DB01069,Nausea,C0027497,NCT00429702,Terminated,Phase 2,Closed due to poor accrual and lack of feasibility to finish study per DSMB,promethazine
Diphenhydramine,DB01075,Nausea,C0027497,NCT00429702,Terminated,Phase 2,Closed due to poor accrual and lack of feasibility to finish study per DSMB,diphenhydramine
Dexamethasone,DB01234,Nausea,C0027497,NCT00429702,Terminated,Phase 2,Closed due to poor accrual and lack of feasibility to finish study per DSMB,dexamethasone
Lorazepam,DB00186,Vomiting,C0042963,NCT00429702,Terminated,Phase 2,Closed due to poor accrual and lack of feasibility to finish study per DSMB,lorazepam
Ondansetron,DB00904,Vomiting,C0042963,NCT00429702,Terminated,Phase 2,Closed due to poor accrual and lack of feasibility to finish study per DSMB,ondansetron
Promethazine,DB01069,Vomiting,C0042963,NCT00429702,Terminated,Phase 2,Closed due to poor accrual and lack of feasibility to finish study per DSMB,promethazine
Diphenhydramine,DB01075,Vomiting,C0042963,NCT00429702,Terminated,Phase 2,Closed due to poor accrual and lack of feasibility to finish study per DSMB,diphenhydramine
Dexamethasone,DB01234,Vomiting,C0042963,NCT00429702,Terminated,Phase 2,Closed due to poor accrual and lack of feasibility to finish study per DSMB,dexamethasone
Lorazepam,DB00186,"unspecified childhood solid tumor, protocol specific",C0279002,NCT00429702,Terminated,Phase 2,Closed due to poor accrual and lack of feasibility to finish study per DSMB,lorazepam
Ondansetron,DB00904,"unspecified childhood solid tumor, protocol specific",C0279002,NCT00429702,Terminated,Phase 2,Closed due to poor accrual and lack of feasibility to finish study per DSMB,ondansetron
Promethazine,DB01069,"unspecified childhood solid tumor, protocol specific",C0279002,NCT00429702,Terminated,Phase 2,Closed due to poor accrual and lack of feasibility to finish study per DSMB,promethazine
Diphenhydramine,DB01075,"unspecified childhood solid tumor, protocol specific",C0279002,NCT00429702,Terminated,Phase 2,Closed due to poor accrual and lack of feasibility to finish study per DSMB,diphenhydramine
Dexamethasone,DB01234,"unspecified childhood solid tumor, protocol specific",C0279002,NCT00429702,Terminated,Phase 2,Closed due to poor accrual and lack of feasibility to finish study per DSMB,dexamethasone
Benzylpenicillin,DB01053,Psoriasis,C0033860,NCT00427609,Terminated,Phase 2,Not enough enrollees to obtain a valid conclusion,benzylpenicillin
Procaine benzylpenicillin,DB09320,Psoriasis,C0033860,NCT00427609,Terminated,Phase 2,Not enough enrollees to obtain a valid conclusion,procaine benzylpenicillin
Benzathine benzylpenicillin,DB09323,Psoriasis,C0033860,NCT00427609,Terminated,Phase 2,Not enough enrollees to obtain a valid conclusion,benzathine benzylpenicillin
Cyclophosphamide,DB00531,Lupus Nephritis,C0024143,NCT00425438,Terminated,Phase 3,Study was terminated early for administrative reasons.,cyclophosphamide
Mycophenolate mofetil,DB00688,Lupus Nephritis,C0024143,NCT00425438,Terminated,Phase 3,Study was terminated early for administrative reasons.,mycophenolate mofetil
Prednisolone,DB00860,Lupus Nephritis,C0024143,NCT00425438,Terminated,Phase 3,Study was terminated early for administrative reasons.,prednisolone
Azathioprine,DB00993,Lupus Nephritis,C0024143,NCT00425438,Terminated,Phase 3,Study was terminated early for administrative reasons.,azathioprine
Mycophenolic acid,DB01024,Lupus Nephritis,C0024143,NCT00425438,Terminated,Phase 3,Study was terminated early for administrative reasons.,mycophenolic acid
Cisplatin,DB00515,Squamous cell carcinoma,C0007137,NCT00427102,Terminated,Phase 1,No subjects enrolled and PI went to another facility,cisplatin
Bevacizumab,DB00112,Cholangiocarcinoma,C0206698,NCT00426829,Terminated,Phase 1,Low Accural,bevacizumab
Mometasone,DB00764,Sinusitis,C0037199,NCT00423176,Terminated,Phase 3,Based on business priorities. Not related to any safety or efficacy issue & took place before    data were unblinded or analyzed,mometasone
Clavulanate,DB00766,Sinusitis,C0037199,NCT00423176,Terminated,Phase 3,Based on business priorities. Not related to any safety or efficacy issue & took place before    data were unblinded or analyzed,clavulanate
Amoxicillin,DB01060,Sinusitis,C0037199,NCT00423176,Terminated,Phase 3,Based on business priorities. Not related to any safety or efficacy issue & took place before    data were unblinded or analyzed,amoxicillin
Rituximab,DB00073,Churg-Strauss Syndrome,C0008728,NCT00424749,Terminated,Phase 2,Company providing study drug terminated study due to lack of funds,rituximab
Carboplatin,DB00958,Fallopian Tube Neoplasms,C0015558,NCT00407407,Terminated,Phase 1,MTD not determined,carboplatin
Paclitaxel,DB01229,Fallopian Tube Neoplasms,C0015558,NCT00407407,Terminated,Phase 1,MTD not determined,paclitaxel
Carboplatin,DB00958,ovarian neoplasm,C0919267,NCT00407407,Terminated,Phase 1,MTD not determined,carboplatin
Paclitaxel,DB01229,ovarian neoplasm,C0919267,NCT00407407,Terminated,Phase 1,MTD not determined,paclitaxel
Sunitinib,DB01268,Recurrent disease,C0277556,NCT00408252,Terminated,Phase 2,Too frequent grade 3-4 toxicities,sunitinib
Folic Acid,DB00158,Infertility,C0021359,NCT00406874,Terminated,Phase 2,reports indicating that increased folic acid intake may increase colin cancer,folic acid
Anastrozole,DB01217,Obesity,C0028754,NCT00440180,Terminated,Phase 3,Not able meet target enrollment.,anastrozole
Sorafenib,DB00398,"unspecified adult solid tumor, protocol specific",C0279004,NCT00436579,Terminated,Phase 1,,sorafenib
Nicotinamide,DB02701,"unspecified adult solid tumor, protocol specific",C0279004,NCT00436579,Terminated,Phase 1,,nicotinamide
Sodium phenylbutyrate,DB06819,"Muscular Atrophy, Spinal, Type II",C0393538,NCT00439569,Terminated,Phase 1/Phase 2,Due to poor compliance with study drug administration.,sodium phenylbutyrate
Sodium phenylbutyrate,DB06819,Juvenile Spinal Muscular Atrophy,C0152109,NCT00439569,Terminated,Phase 1/Phase 2,Due to poor compliance with study drug administration.,sodium phenylbutyrate
Asparaginase,DB00023,recurrent childhood acute lymphoblastic leukemia,C0278519,NCT00439296,Terminated,Phase 1,The study was stopped due to poor accrual and lack of funding.,asparaginase
Pegaspargase,DB00059,recurrent childhood acute lymphoblastic leukemia,C0278519,NCT00439296,Terminated,Phase 1,The study was stopped due to poor accrual and lack of funding.,pegaspargase
Doxorubicin,DB00997,recurrent childhood acute lymphoblastic leukemia,C0278519,NCT00439296,Terminated,Phase 1,The study was stopped due to poor accrual and lack of funding.,doxorubicin
Dexamethasone,DB01234,recurrent childhood acute lymphoblastic leukemia,C0278519,NCT00439296,Terminated,Phase 1,The study was stopped due to poor accrual and lack of funding.,dexamethasone
Carboplatin,DB00958,Non-Small Cell Lung Carcinoma,C0007131,NCT00437749,Terminated,Phase 3,slow accrual rate; interim accrual objective met,carboplatin
Olanzapine,DB00334,Schizoaffective Disorder,C0036337,NCT00440843,Withdrawn,Phase 3,,olanzapine
Daptomycin,DB00080,"Skin Diseases, Infectious",C0037278,NCT00430937,Terminated,Phase 3,,daptomycin
Vancomycin,DB00512,"Skin Diseases, Infectious",C0037278,NCT00430937,Terminated,Phase 3,,vancomycin
Teicoplanin,DB06149,"Skin Diseases, Infectious",C0037278,NCT00430937,Terminated,Phase 3,,teicoplanin
Daptomycin,DB00080,Soft Tissue Infections,C0149778,NCT00430937,Terminated,Phase 3,,daptomycin
Vancomycin,DB00512,Soft Tissue Infections,C0149778,NCT00430937,Terminated,Phase 3,,vancomycin
Teicoplanin,DB06149,Soft Tissue Infections,C0149778,NCT00430937,Terminated,Phase 3,,teicoplanin
Atorvastatin,DB01076,Venous Thromboembolism,C1861172,NCT00437892,Terminated,Phase 2,Competitive trials and slow recruitment rate,atorvastatin
Ropivacaine,DB00296,Phantom Limb Syndrome,C0031315,NCT00427947,Terminated,Phase 3,lack of patients,ropivacaine
Darbepoetin alfa,DB00012,Chronic Kidney Diseases,C1561643,NCT00436748,Terminated,Phase 3,Study Terminated; Commitment met per Regulatory Authorities.,darbepoetin alfa
Darbepoetin alfa,DB00012,Kidney Diseases,C0022658,NCT00436748,Terminated,Phase 3,Study Terminated; Commitment met per Regulatory Authorities.,darbepoetin alfa
Mycophenolate mofetil,DB00688,Interstitial Cystitis,C0282488,NCT00451867,Terminated,Phase 3,The major and primary reason for the study termination is the observed reduced efficacy of    CellCept compared to placebo.,mycophenolate mofetil
Mycophenolic acid,DB01024,Interstitial Cystitis,C0282488,NCT00451867,Terminated,Phase 3,The major and primary reason for the study termination is the observed reduced efficacy of    CellCept compared to placebo.,mycophenolic acid
Mycophenolate mofetil,DB00688,Painful Bladder Syndrome,C1720830,NCT00451867,Terminated,Phase 3,The major and primary reason for the study termination is the observed reduced efficacy of    CellCept compared to placebo.,mycophenolate mofetil
Mycophenolic acid,DB01024,Painful Bladder Syndrome,C1720830,NCT00451867,Terminated,Phase 3,The major and primary reason for the study termination is the observed reduced efficacy of    CellCept compared to placebo.,mycophenolic acid
Dapsone,DB00250,Pemphigus Vulgaris,C0030809,NCT00429533,Terminated,Phase 2,,dapsone
Mycophenolate mofetil,DB00688,"Lupus Erythematosus, Systemic",C0024141,NCT00430677,Terminated,Phase 2/Phase 3,Terminated due to failure to meet the primary efficacy endpoint in the Short-term Period,mycophenolate mofetil
Mycophenolic acid,DB01024,"Lupus Erythematosus, Systemic",C0024141,NCT00430677,Terminated,Phase 2/Phase 3,Terminated due to failure to meet the primary efficacy endpoint in the Short-term Period,mycophenolic acid
Abatacept,DB01281,"Lupus Erythematosus, Systemic",C0024141,NCT00430677,Terminated,Phase 2/Phase 3,Terminated due to failure to meet the primary efficacy endpoint in the Short-term Period,abatacept
Ciprofloxacin,DB00537,Inflammation,C0021368,NCT00431028,Terminated,Phase 1/Phase 2,Terminated,ciprofloxacin
Triamcinolone,DB00620,Inflammation,C0021368,NCT00431028,Terminated,Phase 1/Phase 2,Terminated,triamcinolone
Ciprofloxacin,DB00537,Bacterial Infections,C0004623,NCT00431028,Terminated,Phase 1/Phase 2,Terminated,ciprofloxacin
Triamcinolone,DB00620,Bacterial Infections,C0004623,NCT00431028,Terminated,Phase 1/Phase 2,Terminated,triamcinolone
Belinostat,DB05015,Multiple Myeloma,C0026764,NCT00431340,Terminated,Phase 2,Terminated due to dose limiting toxicity,belinostat
Hydroxyprogesterone caproate,DB06789,Premature Birth,C0151526,NCT00439374,Terminated,Phase 3,Halted by NICHD after recommendation by DSMC to stop for futility,hydroxyprogesterone caproate
Hydroxyprogesterone caproate,DB06789,transvaginal ultrasound: length of cervix,C2145605,NCT00439374,Terminated,Phase 3,Halted by NICHD after recommendation by DSMC to stop for futility,hydroxyprogesterone caproate
Lidocaine,DB00281,Vulvar Vestibulitis,C0269084,NCT00450242,Terminated,Phase 2,lack of funding,lidocaine
Chloroquine,DB00608,Malaria,C0024530,NCT00442403,Suspended,Phase 3,"At the end of the year 2002, Cameroon switched from chloroquine to amodiaquine as first-line    therapy for of uncomplicated malaria.",chloroquine
Erythropoietin,DB00016,Kidney Failure,C0035078,NCT00450333,Terminated,Phase 3,The termination of the study is not linked to a product recall or result of any safety signal.    Rather it was sponsor's commercial decision to withdraw the MA,erythropoietin
Alemtuzumab,DB00087,leukemia,C0023418,NCT00453193,Terminated,Phase 2,Slow accrual.,alemtuzumab
Pentostatin,DB00552,leukemia,C0023418,NCT00453193,Terminated,Phase 2,Slow accrual.,pentostatin
Rosiglitazone,DB00412,Chronic Kidney Diseases,C1561643,NCT00452166,Terminated,Phase 3,it was not possible to recruit new patients anymore,rosiglitazone
Alfuzosin,DB00346,Urinary Retention,C0080274,NCT00453908,Terminated,Phase 3,The study was early terminated due to slow and difficult recruitment,alfuzosin
Omeprazole,DB00338,Solid tumour,C0280100,NCT00442741,Withdrawn,Phase 1,pts. will be captured in core,omeprazole
Midazolam,DB00683,Solid tumour,C0280100,NCT00442741,Withdrawn,Phase 1,pts. will be captured in core,midazolam
Bevacizumab,DB00112,Esophageal Neoplasms,C0014859,NCT00442507,Terminated,Phase 2,Slow accrual,bevacizumab
Erlotinib,DB00530,Esophageal Neoplasms,C0014859,NCT00442507,Terminated,Phase 2,Slow accrual,erlotinib
Bevacizumab,DB00112,Esophageal Diseases,C0014852,NCT00442507,Terminated,Phase 2,Slow accrual,bevacizumab
Erlotinib,DB00530,Esophageal Diseases,C0014852,NCT00442507,Terminated,Phase 2,Slow accrual,erlotinib
Flibanserin,DB04908,Psychosexual Disorders,C0033953,NCT00441558,Terminated,Phase 3,terminated for administrative reasons,flibanserin
Vincristine,DB00541,Multiple Myeloma,C0026764,NCT00441168,Terminated,Phase 2,TRIAL STOPPED due to a change in standard of care and the required patient numbers could no    longer be achieved,vincristine
Methamphetamine,DB01577,Anxiety,C0003467,NCT00442923,Withdrawn,Phase 2,This study was withdrawn for lack of progress. No subjects were recruited.,methamphetamine
Methamphetamine,DB01577,Substance Dependence,C0038580,NCT00442923,Withdrawn,Phase 2,This study was withdrawn for lack of progress. No subjects were recruited.,methamphetamine
Sildenafil,DB00203,Coronary Artery Vasospasm,C0010073,NCT00454714,Suspended,Phase 3,Patient study insurance expired,sildenafil
Tolterodine,DB01036,Overactive Bladder,C0878773,NCT00439192,Terminated,Phase 2,side effect profile did not match expectations,tolterodine
Tolterodine,DB01036,Urinary Incontinence,C0042024,NCT00439192,Terminated,Phase 2,side effect profile did not match expectations,tolterodine
Sodium phenylbutyrate,DB06819,HMN (Hereditary Motor Neuropathy) Proximal Type I,C0043116,NCT00439218,Terminated,Phase 1/Phase 2,Extremely slow enrollment,sodium phenylbutyrate
Rituximab,DB00073,B-Cell Lymphomas,C0079731,NCT00455897,Terminated,Phase 2,Accrual was too slow. Trial terminated,rituximab
Rituximab,DB00073,"Lymphoma, Diffuse",C3714542,NCT00455897,Terminated,Phase 2,Accrual was too slow. Trial terminated,rituximab
Rimonabant,DB06155,Microalbuminuria,C0730345,NCT00458081,Terminated,Phase 3,Company decision has been taken in light of recent demands by certain national health    authorities,rimonabant
Rimonabant,DB06155,Dyslipidemias,C0242339,NCT00458081,Terminated,Phase 3,Company decision has been taken in light of recent demands by certain national health    authorities,rimonabant
Gemcitabine,DB00441,Unknown Primary Tumors,C0087135,NCT00458315,Withdrawn,Phase 2,never been started,gemcitabine
Cisplatin,DB00515,Unknown Primary Tumors,C0087135,NCT00458315,Withdrawn,Phase 2,never been started,cisplatin
Paclitaxel,DB01229,Unknown Primary Tumors,C0087135,NCT00458315,Withdrawn,Phase 2,never been started,paclitaxel
Cyclosporine,DB00091,Corneal Diseases,C0010034,NCT00447187,Terminated,Phase 3,The primary efficacy endpoint was not met,cyclosporine
Carboplatin,DB00958,Non-Small Cell Lung Carcinoma,C0007131,NCT00460317,Terminated,Phase 3,Amgen discontinued the development of AMG706 because 20050201 did not meet its primary    objective.,carboplatin
Mycophenolate mofetil,DB00688,Lupus Nephritis,C0024143,NCT00447265,Terminated,Phase 2,The perceived risk-benefit ratio for individuals with early active RA,mycophenolate mofetil
Mycophenolic acid,DB01024,Lupus Nephritis,C0024143,NCT00447265,Terminated,Phase 2,The perceived risk-benefit ratio for individuals with early active RA,mycophenolic acid
Oxaliplatin,DB00526,Malignant neoplasm of stomach,C0024623,NCT00568529,Suspended,Phase 2,There are not enough patients enrolled.,oxaliplatin
Tretinoin,DB00755,Neuroblastoma,C0027819,NCT00533169,Terminated,Phase 1,Lack of enrollment.,tretinoin
Isotretinoin,DB00982,Neuroblastoma,C0027819,NCT00533169,Terminated,Phase 1,Lack of enrollment.,isotretinoin
Piracetam,DB09210,"Epilepsy, Post-Traumatic",C0014557,NCT00566046,Terminated,Phase 3,Sponsor decision because of to small enrollment,piracetam
Levonorgestrel,DB00367,Hereditary Nonpolyposis Colorectal Cancer,C1333990,NCT00566644,Terminated,Phase 3,Withdrawn due to poor accrual,levonorgestrel
Norgestrel,DB09389,Hereditary Nonpolyposis Colorectal Cancer,C1333990,NCT00566644,Terminated,Phase 3,Withdrawn due to poor accrual,norgestrel
Quetiapine,DB01224,Methamphetamine dependence,C1533217,NCT00567866,Terminated,Phase 0,Study was terminated due to insufficient funds,quetiapine
Methamphetamine,DB01577,Methamphetamine dependence,C1533217,NCT00567866,Terminated,Phase 0,Study was terminated due to insufficient funds,methamphetamine
Ticlopidine,DB00208,Acute Coronary Syndrome,C0948089,NCT00557921,Terminated,Phase 3,Terminated by Sponsor,ticlopidine
Salicylic acid,DB00936,Acute Coronary Syndrome,C0948089,NCT00557921,Terminated,Phase 3,Terminated by Sponsor,salicylic acid
Acetylsalicylic acid,DB00945,Acute Coronary Syndrome,C0948089,NCT00557921,Terminated,Phase 3,Terminated by Sponsor,acetylsalicylic acid
Ticlopidine,DB00208,Myocardial Infarction,C0027051,NCT00557921,Terminated,Phase 3,Terminated by Sponsor,ticlopidine
Clopidogrel,DB00758,Myocardial Infarction,C0027051,NCT00557921,Terminated,Phase 3,Terminated by Sponsor,clopidogrel
Gemcitabine,DB00441,Carcinoma,C0007097,NCT00557596,Terminated,Phase 1/Phase 2,,gemcitabine
Bexarotene,DB00307,Schizophrenia,C0036341,NCT00534898,Withdrawn,Phase 3,The study withdrawn due to lack financial support,bexarotene
Bexarotene,DB00307,Schizoaffective Disorder,C0036337,NCT00534898,Withdrawn,Phase 3,The study withdrawn due to lack financial support,bexarotene
Methadone,DB00333,Pain,C0030193,NCT00558870,Terminated,Phase 2,Low Accrual.,methadone
Cyclosporine,DB00091,Myeloid Leukemia,C0023470,NCT00568633,Terminated,Phase 3,Poor accrual,cyclosporine
Mycophenolate mofetil,DB00688,Myeloid Leukemia,C0023470,NCT00568633,Terminated,Phase 3,Poor accrual,mycophenolate mofetil
Mycophenolic acid,DB01024,Myeloid Leukemia,C0023470,NCT00568633,Terminated,Phase 3,Poor accrual,mycophenolic acid
Cyclosporine,DB00091,leukemia,C0023418,NCT00568633,Terminated,Phase 3,Poor accrual,cyclosporine
Mycophenolate mofetil,DB00688,leukemia,C0023418,NCT00568633,Terminated,Phase 3,Poor accrual,mycophenolate mofetil
Mycophenolic acid,DB01024,leukemia,C0023418,NCT00568633,Terminated,Phase 3,Poor accrual,mycophenolic acid
Omeprazole,DB00338,Laryngeal Diseases,C0023051,NCT00567658,Withdrawn,Phase 3,The decision of terminate the study was reached due to difficulties surrounding recruitment    and enrollment of subjects since the inception of the study.,omeprazole
Esomeprazole,DB00736,Laryngeal Diseases,C0023051,NCT00567658,Withdrawn,Phase 3,The decision of terminate the study was reached due to difficulties surrounding recruitment    and enrollment of subjects since the inception of the study.,esomeprazole
Finasteride,DB01216,Benign Prostatic Hyperplasia,C1704272,NCT00564460,Withdrawn,Phase 3,Change of practice pattern. Green light laser,finasteride
Cisplatin,DB00515,Malignant neoplasm of stomach,C0024623,NCT00568971,Terminated,Phase 2,The study has finished.,cisplatin
Alemtuzumab,DB00087,leukemia,C0023418,NCT00555048,Terminated,Phase 1/Phase 2,Low accrual,alemtuzumab
Cyclophosphamide,DB00531,leukemia,C0023418,NCT00555048,Terminated,Phase 1/Phase 2,Low accrual,cyclophosphamide
Busulfan,DB01008,leukemia,C0023418,NCT00555048,Terminated,Phase 1/Phase 2,Low accrual,busulfan
Bevacizumab,DB00112,Renal Cell Carcinoma,C0007134,NCT00556205,Withdrawn,Phase 2,Toxicity of combination from other trials,bevacizumab
Temozolomide,DB00853,Cutaneous Melanoma,C0151779,NCT00568451,Terminated,Phase 2,Slow accrual.,temozolomide
Carboplatin,DB00958,Cutaneous Melanoma,C0151779,NCT00568451,Terminated,Phase 2,Slow accrual.,carboplatin
Paclitaxel,DB01229,Cutaneous Melanoma,C0151779,NCT00568451,Terminated,Phase 2,Slow accrual.,paclitaxel
Ketamine,DB01221,Traumatic Brain Injury,C0876926,NCT00556387,Withdrawn,Phase 2,This study has been withdraw from the IRB. The PI has transferred to another university. The    IND was transferred.,ketamine
Rituximab,DB00073,Chronic rejection of renal transplant,C0403592,NCT00568477,Terminated,Phase 2,lacking recruitment,rituximab
Celecoxib,DB00482,Malignant neoplasm of lung,C0242379,NCT00520845,Terminated,Phase 2,slow accrual,celecoxib
Pemetrexed,DB00642,Malignant neoplasm of lung,C0242379,NCT00520845,Terminated,Phase 2,slow accrual,pemetrexed
Docetaxel,DB01248,Malignant neoplasm of lung,C0242379,NCT00520845,Terminated,Phase 2,slow accrual,docetaxel
Sunitinib,DB01268,Kaposi's sarcoma classical type,C0279084,NCT00521092,Withdrawn,Phase 2,No participants enrolled.,sunitinib
Ethanol,DB00898,Pancreatic Cyst,C0030283,NCT00550108,Terminated,Phase 3,Inability to enroll subjects.,ethanol
Bevacizumab,DB00112,Malignant tumor of colon,C0007102,NCT00537823,Terminated,Phase 2,Poor accrual.,bevacizumab
Oxaliplatin,DB00526,Malignant tumor of colon,C0007102,NCT00537823,Terminated,Phase 2,Poor accrual.,oxaliplatin
Trastuzumab,DB00072,Advanced breast cancer,C3495917,NCT00522457,Terminated,Phase 2,"change in development plan, not due to safety concerns.",trastuzumab
Etoposide,DB00773,Neuroblastoma,C0027819,NCT00539500,Terminated,Phase 2/Phase 3,Slow Accrual.,etoposide
Carboplatin,DB00958,Neuroblastoma,C0027819,NCT00539500,Terminated,Phase 2/Phase 3,Slow Accrual.,carboplatin
Melphalan,DB01042,Neuroblastoma,C0027819,NCT00539500,Terminated,Phase 2/Phase 3,Slow Accrual.,melphalan
Prednisolone,DB00860,Lupus Nephritis,C0024143,NCT00539799,Withdrawn,Phase 3,Local pharmacy unwilling to comply with study protocol,prednisolone
Methylprednisolone,DB00959,Lupus Nephritis,C0024143,NCT00539799,Withdrawn,Phase 3,Local pharmacy unwilling to comply with study protocol,methylprednisolone
Nicotine,DB00184,Postoperative Nausea and Vomiting,C0520909,NCT00553709,Terminated,Phase 2,Unexpected difficult recruitment. Study drug expired,nicotine
Sirolimus,DB00877,Hepatitis C recurrent,C2938989,NCT00582738,Terminated,Phase 2,,sirolimus
Everolimus,DB01590,Hepatitis C recurrent,C2938989,NCT00582738,Terminated,Phase 2,,everolimus
Penicillamine,DB00859,Lead Poisoning,C0023176,NCT00552630,Withdrawn,Phase 2/Phase 3,,penicillamine
Imatinib,DB00619,Pulmonary Hypertension,C0020542,NCT00583115,Terminated,Phase 2,Unable to enroll subjects,imatinib
Topiramate,DB00273,Epilepsy,C0014544,NCT00563459,Terminated,Phase 3,Carisbamate partial onset seizures studies lacked consistent efficacy data so trials in this    indication were terminated.,topiramate
Piracetam,DB09210,Epilepsy,C0014544,NCT00563459,Terminated,Phase 3,Carisbamate partial onset seizures studies lacked consistent efficacy data so trials in this    indication were terminated.,piracetam
Erlotinib,DB00530,Malignant neoplasm of lung,C0242379,NCT00554775,Terminated,Phase 2,IDMC made a recommendation to stop the trial as the target for continuing to the 2nd phase was    not met.,erlotinib
Methadone,DB00333,Pain,C0030193,NCT00573937,Terminated,Phase 2,Slow accrual.,methadone
Cisplatin,DB00515,Primary peritoneal carcinoma,C1514428,NCT00582205,Terminated,Phase 2,Study completed per investigator.,cisplatin
Paclitaxel,DB01229,Primary peritoneal carcinoma,C1514428,NCT00582205,Terminated,Phase 2,Study completed per investigator.,paclitaxel
Quetiapine,DB01224,Anorexia Nervosa,C0003125,NCT00584688,Terminated,Phase 2,Lack of Enrollment,quetiapine
Gemcitabine,DB00441,Pancreatic Neoplasm,C0030297,NCT00574275,Terminated,Phase 3,Data Monitoring Committee concluded after a planned interim analysis that aflibercept added to    gemcitabine would be unable to demonstrate improved survival,gemcitabine
Belimumab,DB08879,Rheumatoid Arthritis,C0003873,NCT00583557,Terminated,Phase 2,Sponsor decision - not related to safety,belimumab
Clofarabine,DB00631,leukemia,C0023418,NCT00577694,Terminated,Phase 1,funding unavailable,clofarabine
Bevacizumab,DB00112,Malignant tumor of colon,C0007102,NCT00577109,Terminated,Phase 2,,bevacizumab
Vidarabine,DB00194,"Lymphoma, Non-Hodgkin",C0024305,NCT00577161,Terminated,Phase 3,closed to enrollment,vidarabine
Fludarabine,DB01073,"Lymphoma, Non-Hodgkin",C0024305,NCT00577161,Terminated,Phase 3,closed to enrollment,fludarabine
Peginterferon alfa-2b,DB00022,Solid tumour,C0280100,NCT00585221,Terminated,Phase 2,PI terminated at the recommendation of DSMC & IRB,peginterferon alfa-2b
Imatinib,DB00619,Solid tumour,C0280100,NCT00585221,Terminated,Phase 2,PI terminated at the recommendation of DSMC & IRB,imatinib
Docetaxel,DB01248,Malignant neoplasm of lung,C0242379,NCT00539968,Terminated,Phase 1/Phase 2,,docetaxel
Paclitaxel,DB01229,"Mammary Carcinoma, Human",C1257930,NCT00558545,Terminated,Phase 1/Phase 2,Avastin approved for first-in-line treatment.,paclitaxel
Capecitabine,DB01101,Malignant tumor of colon,C0007102,NCT00538291,Terminated,Phase 2,Study was terminated early due to lack of efficacy.,capecitabine
Vancomycin,DB00512,"Pneumonia, Ventilator-Associated",C1701940,NCT00543608,Terminated,Phase 2,Trial terminated due to financial resource limitations,vancomycin
Milrinone,DB00235,Congenital Heart Defects,C0018798,NCT00543309,Terminated,Phase 2,DSMB recommended termination based on interim outcomes analysis,milrinone
Sorafenib,DB00398,Malignant neoplasm of lung,C0242379,NCT00543335,Terminated,Phase 1,Lack of Accrual.,sorafenib
Nitric Oxide,DB00435,Varicose Ulcer,C0042344,NCT00545298,Terminated,Phase 2,Strategic direction of the sponsor changed,nitric oxide
Carboplatin,DB00958,Malignant neoplasm of lung,C0242379,NCT00544648,Terminated,Phase 1/Phase 2,Ph I completed. Funding became unavailable causing Ph II to cease after two patients were    enrolled.,carboplatin
Paclitaxel,DB01229,Malignant neoplasm of lung,C0242379,NCT00544648,Terminated,Phase 1/Phase 2,Ph I completed. Funding became unavailable causing Ph II to cease after two patients were    enrolled.,paclitaxel
Cisplatin,DB00515,Esophageal Neoplasms,C0014859,NCT00559351,Terminated,Phase 3,difficulty in recruitment,cisplatin
Fluorouracil,DB00544,Esophageal Neoplasms,C0014859,NCT00559351,Terminated,Phase 3,difficulty in recruitment,fluorouracil
Progesterone,DB00396,Premature Birth,C0151526,NCT00536003,Terminated,Phase 3,,progesterone
Tadalafil,DB00820,Priapism,C0033117,NCT00538564,Terminated,Phase 2,,tadalafil
Cisplatin,DB00515,Adenocarcinoma Of Esophagus,C0279628,NCT00573131,Terminated,Phase 2,OncoGel did not show any impact on overall tumor response,cisplatin
Cisplatin,DB00515,Squamous cell carcinoma,C0007137,NCT00573131,Terminated,Phase 2,OncoGel did not show any impact on overall tumor response,cisplatin
Dasatinib,DB01254,Multiple Myeloma,C0026764,NCT00560352,Terminated,Phase 1,,dasatinib
Mycophenolate mofetil,DB00688,Lupus Nephritis,C0024143,NCT00573157,Terminated,Phase 2/Phase 3,The study was terminated due to unanticipated safety issues,mycophenolate mofetil
Mycophenolic acid,DB01024,Lupus Nephritis,C0024143,NCT00573157,Terminated,Phase 2/Phase 3,The study was terminated due to unanticipated safety issues,mycophenolic acid
Aminolevulinic acid,DB00855,"Leukoplakia, Oral",C0023532,NCT00571558,Terminated,Phase 1,,aminolevulinic acid
Dacarbazine,DB00851,Adenocarcinoma,C0001418,NCT00632203,Terminated,Phase 2,,dacarbazine
Temozolomide,DB00853,Adenocarcinoma,C0001418,NCT00632203,Terminated,Phase 2,,temozolomide
Dacarbazine,DB00851,"Carcinoma, Large Cell",C0206704,NCT00632203,Terminated,Phase 2,,dacarbazine
Temozolomide,DB00853,"Carcinoma, Large Cell",C0206704,NCT00632203,Terminated,Phase 2,,temozolomide
Alprostadil,DB00770,Pulmonary Hypertension,C0020542,NCT00598429,Withdrawn,Phase 2,Withdrawn due to lack of recruitment,alprostadil
Erythropoietin,DB00016,Brain Injuries,C0270611,NCT00589953,Terminated,Phase 2,,erythropoietin
Erythropoietin,DB00016,Ventricular hemorrhage,C0240059,NCT00589953,Terminated,Phase 2,,erythropoietin
Erythropoietin,DB00016,"Leukomalacia, Periventricular",C0023529,NCT00589953,Terminated,Phase 2,,erythropoietin
Prednisone,DB00635,Adenocarcinoma of prostate,C0007112,NCT00598858,Withdrawn,Phase 2,Halted due to zero accrual and lack of funding,prednisone
Docetaxel,DB01248,Adenocarcinoma of prostate,C0007112,NCT00598858,Withdrawn,Phase 2,Halted due to zero accrual and lack of funding,docetaxel
Phenylacetic acid,DB09269,Hepatic Encephalopathy,C0019151,NCT00597909,Terminated,Phase 2,Study was terminated due to lack of enrollment and business decisions.,phenylacetic acid
Fluticasone Propionate,DB00588,Bronchiolitis,C0006271,NCT00656916,Terminated,Phase 2,Terminated due to slow accrual.,fluticasone propionate
Teriparatide,DB06285,Osteopenia,C0029453,NCT00624481,Withdrawn,Phase 2,,teriparatide
Teriparatide,DB06285,Osteoporosis,C0029456,NCT00624481,Withdrawn,Phase 2,,teriparatide
Fondaparinux sodium,DB00569,Malignant neoplasm of ovary,C1140680,NCT00659399,Withdrawn,Phase 1,Low accrual,fondaparinux sodium
Busulfan,DB01008,Retinoblastoma,C0035335,NCT00623077,Terminated,Phase 1,Replaced by another study,busulfan
Ifosfamide,DB01181,Retinoblastoma,C0035335,NCT00623077,Terminated,Phase 1,Replaced by another study,ifosfamide
Lithium,DB01356,Canavan Disease,C0206307,NCT00657748,Withdrawn,Phase 2,,lithium
Parecoxib,DB08439,Pain,C0030193,NCT00651300,Terminated,Phase 3,See Detailed Description field.,parecoxib
Etoposide,DB00773,"Leukemia, Myelocytic, Acute",C0023467,NCT00660036,Terminated,Phase 1,due to new safety information,etoposide
Nelfinavir,DB00220,Diarrhea,C0011991,NCT00650637,Terminated,Phase 3,"The study was prematurely discontinued due to administrative reasons on August 18, 2003. There    were no safety concerns that led to the decision to terminate.",nelfinavir
Zidovudine,DB00495,Diarrhea,C0011991,NCT00650637,Terminated,Phase 3,"The study was prematurely discontinued due to administrative reasons on August 18, 2003. There    were no safety concerns that led to the decision to terminate.",zidovudine
Lamivudine,DB00709,Diarrhea,C0011991,NCT00650637,Terminated,Phase 3,"The study was prematurely discontinued due to administrative reasons on August 18, 2003. There    were no safety concerns that led to the decision to terminate.",lamivudine
Calcium carbonate,DB06724,Diarrhea,C0011991,NCT00650637,Terminated,Phase 3,"The study was prematurely discontinued due to administrative reasons on August 18, 2003. There    were no safety concerns that led to the decision to terminate.",calcium carbonate
Simvastatin,DB00641,Atherosclerosis,C0004153,NCT00651391,Terminated,Phase 3,Slow enrollment,simvastatin
Ezetimibe,DB00973,Atherosclerosis,C0004153,NCT00651391,Terminated,Phase 3,Slow enrollment,ezetimibe
Doxorubicin,DB00997,ovarian neoplasm,C0919267,NCT00653952,Terminated,Phase 3,Poor accrual,doxorubicin
Paclitaxel,DB01229,ovarian neoplasm,C0919267,NCT00653952,Terminated,Phase 3,Poor accrual,paclitaxel
Vorinostat,DB02546,adult acute megakaryoblastic leukemia (M7),C0279632,NCT00673153,Terminated,Phase 2,,vorinostat
Vorinostat,DB02546,adult acute minimally differentiated myeloid leukemia (M0),C0281641,NCT00673153,Terminated,Phase 2,,vorinostat
Vorinostat,DB02546,adult acute monoblastic leukemia (M5a),C0279629,NCT00673153,Terminated,Phase 2,,vorinostat
Vorinostat,DB02546,adult acute monocytic leukemia (M5b),C0280634,NCT00673153,Terminated,Phase 2,,vorinostat
Vorinostat,DB02546,adult acute myeloblastic leukemia with maturation (M2),C0279624,NCT00673153,Terminated,Phase 2,,vorinostat
Vorinostat,DB02546,Adult Acute Myeloid Leukemia without Maturation,C0279623,NCT00673153,Terminated,Phase 2,,vorinostat
Vorinostat,DB02546,adult acute myeloid leukemia with 11q23 (MLL) abnormalities,C1541334,NCT00673153,Terminated,Phase 2,,vorinostat
Vorinostat,DB02546,adult acute myeloid leukemia with inv(16)(p13;q22),C1541333,NCT00673153,Terminated,Phase 2,,vorinostat
Vorinostat,DB02546,adult acute myeloid leukemia with t(16;16)(p13;q22),C1541332,NCT00673153,Terminated,Phase 2,,vorinostat
Vorinostat,DB02546,adult acute myeloid leukemia with t(8;21)(q22;q22),C1541331,NCT00673153,Terminated,Phase 2,,vorinostat
Vorinostat,DB02546,adult acute myelomonocytic leukemia (M4),C0279627,NCT00673153,Terminated,Phase 2,,vorinostat
Vorinostat,DB02546,adult erythroleukemia (M6a),C1541339,NCT00673153,Terminated,Phase 2,,vorinostat
Vorinostat,DB02546,adult pure erythroid leukemia (M6b),C1541340,NCT00673153,Terminated,Phase 2,,vorinostat
Vorinostat,DB02546,untreated adult acute myeloid leukemia,C0279089,NCT00673153,Terminated,Phase 2,,vorinostat
Morphine,DB00295,Advanced cancer,C0877373,NCT00634010,Terminated,Phase 3,Slow Accrual,morphine
Methadone,DB00333,Advanced cancer,C0877373,NCT00634010,Terminated,Phase 3,Slow Accrual,methadone
Morphine,DB00295,Solid tumour,C0280100,NCT00634010,Terminated,Phase 3,Slow Accrual,morphine
Methadone,DB00333,Solid tumour,C0280100,NCT00634010,Terminated,Phase 3,Slow Accrual,methadone
Aldesleukin,DB00041,leukemia,C0023418,NCT00625729,Terminated,Phase 1/Phase 2,No patients exhibited natural killer cell expansion (primary endpoint).,aldesleukin
Rituximab,DB00073,leukemia,C0023418,NCT00625729,Terminated,Phase 1/Phase 2,No patients exhibited natural killer cell expansion (primary endpoint).,rituximab
Fludarabine,DB01073,leukemia,C0023418,NCT00625729,Terminated,Phase 1/Phase 2,No patients exhibited natural killer cell expansion (primary endpoint).,fludarabine
Teriparatide,DB06285,Hypocalcemia,C0020598,NCT00623974,Terminated,Phase 2,Terminated due to slow accrual.,teriparatide
Cyclophosphamide,DB00531,leukemia,C0023418,NCT00626626,Terminated,Phase 1/Phase 2,Investigator decision,cyclophosphamide
Clofarabine,DB00631,leukemia,C0023418,NCT00626626,Terminated,Phase 1/Phase 2,Investigator decision,clofarabine
Cyclophosphamide,DB00531,Hodgkin Disease,C0019829,NCT00626626,Terminated,Phase 1/Phase 2,Investigator decision,cyclophosphamide
Clofarabine,DB00631,Hodgkin Disease,C0019829,NCT00626626,Terminated,Phase 1/Phase 2,Investigator decision,clofarabine
Clofarabine,DB00631,Multiple Myeloma,C0026764,NCT00626626,Terminated,Phase 1/Phase 2,Investigator decision,clofarabine
Reboxetine,DB00234,Diabetic Neuropathies,C0011882,NCT00625833,Terminated,Phase 2,Study was terminated for futility following the planned interim analysis.,reboxetine
Irinotecan,DB00762,Malignant tumor of colon,C0007102,NCT00677924,Terminated,Phase 1/Phase 2,Due to changes in portfolio review,irinotecan
Oxaliplatin,DB00526,Malignant tumor of colon,C0007102,NCT00625183,Terminated,Phase 2,Withdrawn due to poor/low accrual,oxaliplatin
Capecitabine,DB01101,Malignant tumor of colon,C0007102,NCT00625183,Terminated,Phase 2,Withdrawn due to poor/low accrual,capecitabine
Iloprost,DB01088,Systemic Scleroderma,C0036421,NCT00622687,Terminated,Phase 2,sufficient number to reach the primary endpoint and as planned,iloprost
Cetuximab,DB00002,Esophageal carcinoma,C0152018,NCT00636298,Withdrawn,Phase 2,lack of funding,cetuximab
Bevacizumab,DB00112,Esophageal carcinoma,C0152018,NCT00636298,Withdrawn,Phase 2,lack of funding,bevacizumab
Bevacizumab,DB00112,Renal Cell Carcinoma,C0007134,NCT00684996,Terminated,Phase 1/Phase 2,,bevacizumab
Zonisamide,DB00909,Epilepsy,C0014544,NCT00693017,Terminated,Phase 3,Sponsor's decision,zonisamide
Mesalazine,DB00244,Diverticulitis,C0012813,NCT00695643,Terminated,Phase 3,,mesalazine
Lenalidomide,DB00480,Advanced cancer,C0877373,NCT00684242,Terminated,Phase 2,Low accrual.,lenalidomide
Thalidomide,DB01041,Advanced cancer,C0877373,NCT00684242,Terminated,Phase 2,Low accrual.,thalidomide
Lenalidomide,DB00480,Pain,C0030193,NCT00684242,Terminated,Phase 2,Low accrual.,lenalidomide
Thalidomide,DB01041,Pain,C0030193,NCT00684242,Terminated,Phase 2,Low accrual.,thalidomide
Alemtuzumab,DB00087,"Lupus Erythematosus, Systemic",C0024141,NCT00684255,Terminated,Phase 1,inactive,alemtuzumab
Busulfan,DB01008,"Lupus Erythematosus, Systemic",C0024141,NCT00684255,Terminated,Phase 1,inactive,busulfan
Fludarabine,DB01073,"Lupus Erythematosus, Systemic",C0024141,NCT00684255,Terminated,Phase 1,inactive,fludarabine
Alemtuzumab,DB00087,Systemic Scleroderma,C0036421,NCT00684255,Terminated,Phase 1,inactive,alemtuzumab
Busulfan,DB01008,Systemic Scleroderma,C0036421,NCT00684255,Terminated,Phase 1,inactive,busulfan
Fludarabine,DB01073,Systemic Scleroderma,C0036421,NCT00684255,Terminated,Phase 1,inactive,fludarabine
Adalimumab,DB00051,Sarcoidosis,C0036202,NCT00690911,Withdrawn,Phase 2,Dr. Jorizzo has decided to withdraw from this study due to the time it is taking to get the    study started.,adalimumab
Propranolol,DB00571,Cocaine Dependence,C0600427,NCT00688805,Terminated,Phase 1,,propranolol
Lovastatin,DB00227,Severe persistent asthma,C1960048,NCT00689806,Withdrawn,Phase 1/Phase 2,Study never opened,lovastatin
Pramipexole,DB00413,Fibromyalgia,C0016053,NCT00689052,Terminated,Phase 2,,pramipexole
Nitroprusside,DB00325,Sarcopenia,C0872084,NCT00690534,Terminated,Phase 1,,nitroprusside
Adalimumab,DB00051,Pyoderma Gangrenosum,C0085652,NCT00690846,Withdrawn,Phase 2,Dr. Jorizzo has decided to withdraw from this study due to the time it is taking to get the    study started.,adalimumab
Alfuzosin,DB00346,Multiple Sclerosis,C0026769,NCT00688948,Terminated,Phase 2/Phase 3,Lack of funding,alfuzosin
Alfuzosin,DB00346,Bladder dysfunction,C0232841,NCT00688948,Terminated,Phase 2/Phase 3,Lack of funding,alfuzosin
Pioglitazone,DB01132,Amyotrophic Lateral Sclerosis,C0002736,NCT00690118,Terminated,Phase 2,The interim analysis showed no tendency in favour of the verum group. Therefore it was decided    to stop the study prematurely.,pioglitazone
Zonisamide,DB00909,Epilepsy,C0014544,NCT00692003,Terminated,Phase 3,Sponsor's decision,zonisamide
Ziprasidone,DB00246,Schizoaffective Disorder,C0036337,NCT00645229,Terminated,Phase 3,Please see Detailed Description for termination reason.,ziprasidone
Citalopram,DB00215,Sleeplessness,C0917801,NCT00642694,Terminated,Phase 3,Enrollment discontinued based on mutually agreed upon decision by PI and funding sponsor,citalopram
Bevacizumab,DB00112,Malignant tumor of colon,C0007102,NCT00642603,Terminated,Phase 2,,bevacizumab
Oxaliplatin,DB00526,Malignant tumor of colon,C0007102,NCT00642603,Terminated,Phase 2,,oxaliplatin
Irinotecan,DB00762,Malignant tumor of colon,C0007102,NCT00642603,Terminated,Phase 2,,irinotecan
Capecitabine,DB01101,Malignant tumor of colon,C0007102,NCT00642603,Terminated,Phase 2,,capecitabine
Pyrimethamine,DB00205,"Malaria, antepartum",C0747820,NCT00711906,Terminated,Phase 3,"Malaria prev. fell in the study area, so we cannot evaluate the primary endpoint",pyrimethamine
Sulfadoxine,DB01299,"Malaria, antepartum",C0747820,NCT00711906,Terminated,Phase 3,"Malaria prev. fell in the study area, so we cannot evaluate the primary endpoint",sulfadoxine
Treprostinil,DB00374,Hamman-Rich syndrome,C0085786,NCT00703339,Terminated,Phase 2,Lack of enrollment to the trial. Very difficult population to recruit.,treprostinil
Treprostinil,DB00374,Pulmonary Hypertension,C0020542,NCT00703339,Terminated,Phase 2,Lack of enrollment to the trial. Very difficult population to recruit.,treprostinil
Pemetrexed,DB00642,Primary central nervous system lymphoma,C0280803,NCT00712062,Withdrawn,Phase 2,Lack of accrual,pemetrexed
Lenalidomide,DB00480,Adult T-Cell Lymphoma/Leukemia,C0023493,NCT00704691,Terminated,Phase 0,Closed due to futility with only 1 patient accrued,lenalidomide
Thalidomide,DB01041,Adult T-Cell Lymphoma/Leukemia,C0023493,NCT00704691,Terminated,Phase 0,Closed due to futility with only 1 patient accrued,thalidomide
Lenalidomide,DB00480,Angioimmunoblastic Lymphadenopathy,C0020981,NCT00704691,Terminated,Phase 0,Closed due to futility with only 1 patient accrued,lenalidomide
Thalidomide,DB01041,Angioimmunoblastic Lymphadenopathy,C0020981,NCT00704691,Terminated,Phase 0,Closed due to futility with only 1 patient accrued,thalidomide
Lenalidomide,DB00480,Ki-1+ Anaplastic Large Cell Lymphoma,C0206180,NCT00704691,Terminated,Phase 0,Closed due to futility with only 1 patient accrued,lenalidomide
Thalidomide,DB01041,Ki-1+ Anaplastic Large Cell Lymphoma,C0206180,NCT00704691,Terminated,Phase 0,Closed due to futility with only 1 patient accrued,thalidomide
Salmon Calcitonin,DB00017,Degenerative polyarthritis,C0029408,NCT00704847,Terminated,Phase 3,Male subjects were terminated due to an imbalance in prostate cancer events,salmon calcitonin
Testosterone,DB00624,Hypogonadism,C0020619,NCT00705796,Withdrawn,Phase 1,financial constraints,testosterone
Methyltestosterone,DB06710,Hypogonadism,C0020619,NCT00705796,Withdrawn,Phase 1,financial constraints,methyltestosterone
Aldesleukin,DB00041,Cutaneous Melanoma,C0151779,NCT00704938,Terminated,Phase 2,Terminated due to withdrawal of support from our collaborator.,aldesleukin
Fludarabine,DB01073,Cutaneous Melanoma,C0151779,NCT00704938,Terminated,Phase 2,Terminated due to withdrawal of support from our collaborator.,fludarabine
Aldesleukin,DB00041,"unspecified adult solid tumor, protocol specific",C0279004,NCT00704938,Terminated,Phase 2,Terminated due to withdrawal of support from our collaborator.,aldesleukin
Fludarabine,DB01073,"unspecified adult solid tumor, protocol specific",C0279004,NCT00704938,Terminated,Phase 2,Terminated due to withdrawal of support from our collaborator.,fludarabine
Temozolomide,DB00853,Glioblastoma,C0017636,NCT00703859,Withdrawn,Phase 1,,temozolomide
Aminolevulinic acid,DB00855,Cervical Intraepithelial Neoplasia,C0206708,NCT00708942,Terminated,Phase 2,"Slow recruitment, study stopped with only 13 of 70 patients included in second part of the    study",aminolevulinic acid
Riboflavin,DB00140,progressive keratoconus,C2114756,NCT00679666,Withdrawn,Phase 2/Phase 3,Investigator no longer at university,riboflavin
Riboflavin,DB00140,Corneal ectasia,C0155135,NCT00679666,Withdrawn,Phase 2/Phase 3,Investigator no longer at university,riboflavin
Peginterferon alfa-2b,DB00022,"unspecified adult solid tumor, protocol specific",C0279004,NCT00701298,Terminated,Phase 1,,peginterferon alfa-2b
Decitabine,DB01262,"unspecified adult solid tumor, protocol specific",C0279004,NCT00701298,Terminated,Phase 1,,decitabine
Heparin,DB01109,Burn injury,C0006434,NCT00701623,Withdrawn,Phase 2/Phase 3,,heparin
Bisoprolol,DB00612,Chronic Obstructive Airway Disease,C0024117,NCT00702156,Terminated,Phase 2,Inadequate patient recruitment,bisoprolol
Calfactant,DB06415,"Respiratory Distress Syndrome, Adult",C0035222,NCT00682500,Terminated,Phase 3,Expected mortality rates in placebo and treatment groups lower than predicted,calfactant
Exenatide,DB01276,Diabetes Mellitus,C0011849,NCT00701935,Terminated,Phase 2,"Enrollment was much slower than anticipated, leading to a decision to terminate the study    early for enrollment futility.",exenatide
Gemcitabine,DB00441,Cholangiocarcinoma,C0206698,NCT00713687,Withdrawn,Phase 2,recruiting failed,gemcitabine
Oxaliplatin,DB00526,Cholangiocarcinoma,C0206698,NCT00713687,Withdrawn,Phase 2,recruiting failed,oxaliplatin
Bevacizumab,DB00112,Colorectal Carcinoma,C0009402,NCT00735241,Withdrawn,Phase 2/Phase 3,Withdrawn by the study sponsor.,bevacizumab
Folic Acid,DB00158,Colorectal Carcinoma,C0009402,NCT00735241,Withdrawn,Phase 2/Phase 3,Withdrawn by the study sponsor.,folic acid
Levoleucovorin,DB11596,Colorectal Carcinoma,C0009402,NCT00735241,Withdrawn,Phase 2/Phase 3,Withdrawn by the study sponsor.,levoleucovorin
Bevacizumab,DB00112,Secondary malignant neoplasm of liver,C0494165,NCT00735241,Withdrawn,Phase 2/Phase 3,Withdrawn by the study sponsor.,bevacizumab
Folic Acid,DB00158,Secondary malignant neoplasm of liver,C0494165,NCT00735241,Withdrawn,Phase 2/Phase 3,Withdrawn by the study sponsor.,folic acid
Levoleucovorin,DB11596,Secondary malignant neoplasm of liver,C0494165,NCT00735241,Withdrawn,Phase 2/Phase 3,Withdrawn by the study sponsor.,levoleucovorin
Ethanol,DB00898,Pregnancy in Adolescence,C0032968,NCT00747630,Terminated,Phase 0,This project was not a clinical trial requiring registration,ethanol
Mefloquine,DB00358,"Leukoencephalopathy, Progressive Multifocal",C0023524,NCT00746941,Terminated,Phase 1/Phase 2,Primary endpoint not achieved,mefloquine
Exemestane,DB00990,Advanced breast cancer,C3495917,NCT00793546,Terminated,Phase 2,See termination reason in detailed description.,exemestane
Tenofovir,DB00300,Hepatitis B,C0019163,NCT00823342,Terminated,Phase 3,,tenofovir
Nitric Oxide,DB00435,MRSA - Methicillin resistant Staphylococcus aureus infection,C0343401,NCT00790608,Terminated,Phase 2,Limited recruitment,nitric oxide
Alemtuzumab,DB00087,leukemia,C0023418,NCT00801931,Terminated,Phase 1/Phase 2,Poor accrual,alemtuzumab
Vidarabine,DB00194,leukemia,C0023418,NCT00801931,Terminated,Phase 1/Phase 2,Poor accrual,vidarabine
Cyclophosphamide,DB00531,leukemia,C0023418,NCT00801931,Terminated,Phase 1/Phase 2,Poor accrual,cyclophosphamide
Busulfan,DB01008,leukemia,C0023418,NCT00801931,Terminated,Phase 1/Phase 2,Poor accrual,busulfan
Fludarabine,DB01073,leukemia,C0023418,NCT00801931,Terminated,Phase 1/Phase 2,Poor accrual,fludarabine
Thiotepa,DB04572,leukemia,C0023418,NCT00801931,Terminated,Phase 1/Phase 2,Poor accrual,thiotepa
Alemtuzumab,DB00087,Neuroblastoma,C0027819,NCT00801931,Terminated,Phase 1/Phase 2,Poor accrual,alemtuzumab
Vidarabine,DB00194,Neuroblastoma,C0027819,NCT00801931,Terminated,Phase 1/Phase 2,Poor accrual,vidarabine
Busulfan,DB01008,Neuroblastoma,C0027819,NCT00801931,Terminated,Phase 1/Phase 2,Poor accrual,busulfan
Fludarabine,DB01073,Neuroblastoma,C0027819,NCT00801931,Terminated,Phase 1/Phase 2,Poor accrual,fludarabine
Thiotepa,DB04572,Neuroblastoma,C0027819,NCT00801931,Terminated,Phase 1/Phase 2,Poor accrual,thiotepa
Alemtuzumab,DB00087,Immunologic Deficiency Syndromes,C0021051,NCT00801931,Terminated,Phase 1/Phase 2,Poor accrual,alemtuzumab
Vidarabine,DB00194,Immunologic Deficiency Syndromes,C0021051,NCT00801931,Terminated,Phase 1/Phase 2,Poor accrual,vidarabine
Cyclophosphamide,DB00531,Immunologic Deficiency Syndromes,C0021051,NCT00801931,Terminated,Phase 1/Phase 2,Poor accrual,cyclophosphamide
Busulfan,DB01008,Immunologic Deficiency Syndromes,C0021051,NCT00801931,Terminated,Phase 1/Phase 2,Poor accrual,busulfan
Fludarabine,DB01073,Immunologic Deficiency Syndromes,C0021051,NCT00801931,Terminated,Phase 1/Phase 2,Poor accrual,fludarabine
Thiotepa,DB04572,Immunologic Deficiency Syndromes,C0021051,NCT00801931,Terminated,Phase 1/Phase 2,Poor accrual,thiotepa
Erlotinib,DB00530,Malignant neoplasm of lung,C0242379,NCT00826449,Terminated,Phase 1/Phase 2,Closed early due to determination of futility/efficacy.,erlotinib
Dasatinib,DB01254,Malignant neoplasm of lung,C0242379,NCT00826449,Terminated,Phase 1/Phase 2,Closed early due to determination of futility/efficacy.,dasatinib
Dasatinib,DB01254,Non-Small Cell Lung Carcinoma,C0007131,NCT00826449,Terminated,Phase 1/Phase 2,Closed early due to determination of futility/efficacy.,dasatinib
Nitric Oxide,DB00435,Chronic ulcer of lower extremity,C0263560,NCT00823095,Terminated,Phase 2,Subject recuitment halted and won't resume; subjects are no longer being treated.,nitric oxide
Budesonide,DB01222,Inflammatory Bowel Diseases,C0021390,NCT00805285,Terminated,Phase 2,Study terminated due to insufficient enrollment,budesonide
Budesonide,DB01222,Ulcerative Colitis,C0009324,NCT00805285,Terminated,Phase 2,Study terminated due to insufficient enrollment,budesonide
Anidulafungin,DB00362,Fungemia,C0085082,NCT00806351,Terminated,Phase 3,"The study was prematurely terminated on May 18, 2012 due to slow enrollment. The study was not    terminate due to any safety issues or concerns.",anidulafungin
Caspofungin,DB00520,Fungemia,C0085082,NCT00806351,Terminated,Phase 3,"The study was prematurely terminated on May 18, 2012 due to slow enrollment. The study was not    terminate due to any safety issues or concerns.",caspofungin
Anidulafungin,DB00362,Candidiasis,C0006840,NCT00806351,Terminated,Phase 3,"The study was prematurely terminated on May 18, 2012 due to slow enrollment. The study was not    terminate due to any safety issues or concerns.",anidulafungin
Caspofungin,DB00520,Candidiasis,C0006840,NCT00806351,Terminated,Phase 3,"The study was prematurely terminated on May 18, 2012 due to slow enrollment. The study was not    terminate due to any safety issues or concerns.",caspofungin
Vidarabine,DB00194,Myeloproliferative disease,C0027022,NCT00827099,Terminated,Phase 2,Unacceptable morbidity & mortality,vidarabine
Mycophenolate mofetil,DB00688,Myeloproliferative disease,C0027022,NCT00827099,Terminated,Phase 2,Unacceptable morbidity & mortality,mycophenolate mofetil
Tacrolimus,DB00864,Myeloproliferative disease,C0027022,NCT00827099,Terminated,Phase 2,Unacceptable morbidity & mortality,tacrolimus
Mycophenolic acid,DB01024,Myeloproliferative disease,C0027022,NCT00827099,Terminated,Phase 2,Unacceptable morbidity & mortality,mycophenolic acid
Melphalan,DB01042,Myeloproliferative disease,C0027022,NCT00827099,Terminated,Phase 2,Unacceptable morbidity & mortality,melphalan
Fludarabine,DB01073,Myeloproliferative disease,C0027022,NCT00827099,Terminated,Phase 2,Unacceptable morbidity & mortality,fludarabine
Vidarabine,DB00194,leukemia,C0023418,NCT00827099,Terminated,Phase 2,Unacceptable morbidity & mortality,vidarabine
Mycophenolate mofetil,DB00688,leukemia,C0023418,NCT00827099,Terminated,Phase 2,Unacceptable morbidity & mortality,mycophenolate mofetil
Tacrolimus,DB00864,leukemia,C0023418,NCT00827099,Terminated,Phase 2,Unacceptable morbidity & mortality,tacrolimus
Mycophenolic acid,DB01024,leukemia,C0023418,NCT00827099,Terminated,Phase 2,Unacceptable morbidity & mortality,mycophenolic acid
Melphalan,DB01042,leukemia,C0023418,NCT00827099,Terminated,Phase 2,Unacceptable morbidity & mortality,melphalan
Fludarabine,DB01073,leukemia,C0023418,NCT00827099,Terminated,Phase 2,Unacceptable morbidity & mortality,fludarabine
Budesonide,DB01222,Radiation proctitis,C0400827,NCT00828230,Terminated,Phase 2,Study was prematurely stopped due to slow recruitment after 17 of 32 anticipated patients were    recruited.,budesonide
Colchicine,DB01394,"Hepatitis C, Chronic",C0524910,NCT00840489,Terminated,Phase 2,Preliminary analysis,colchicine
Pegfilgrastim,DB00019,Non-Small Cell Lung Carcinoma,C0007131,NCT00862134,Terminated,Phase 2,Interim analysis indicated low probability of clinically significant result,pegfilgrastim
Erlotinib,DB00530,Meningeal Carcinomatosis,C0220654,NCT00830245,Terminated,Phase 2,low accrual rate,erlotinib
Cycloserine,DB00260,Smoker,C0337664,NCT00827281,Withdrawn,Phase 2,Study was not funded and pilot work proved impractical.,cycloserine
Clofarabine,DB00631,adult acute myeloid leukemia in remission,C0279094,NCT00863434,Terminated,Phase 2,,clofarabine
Cytarabine,DB00987,adult acute myeloid leukemia in remission,C0279094,NCT00863434,Terminated,Phase 2,,cytarabine
Clofarabine,DB00631,adult acute myeloid leukemia with 11q23 (MLL) abnormalities,C1541334,NCT00863434,Terminated,Phase 2,,clofarabine
Cytarabine,DB00987,adult acute myeloid leukemia with 11q23 (MLL) abnormalities,C1541334,NCT00863434,Terminated,Phase 2,,cytarabine
Clofarabine,DB00631,adult acute myeloid leukemia with inv(16)(p13;q22),C1541333,NCT00863434,Terminated,Phase 2,,clofarabine
Cytarabine,DB00987,adult acute myeloid leukemia with inv(16)(p13;q22),C1541333,NCT00863434,Terminated,Phase 2,,cytarabine
Clofarabine,DB00631,adult acute myeloid leukemia with t(15;17)(q22;q12),C1541335,NCT00863434,Terminated,Phase 2,,clofarabine
Cytarabine,DB00987,adult acute myeloid leukemia with t(15;17)(q22;q12),C1541335,NCT00863434,Terminated,Phase 2,,cytarabine
Clofarabine,DB00631,adult acute myeloid leukemia with t(16;16)(p13;q22),C1541332,NCT00863434,Terminated,Phase 2,,clofarabine
Cytarabine,DB00987,adult acute myeloid leukemia with t(16;16)(p13;q22),C1541332,NCT00863434,Terminated,Phase 2,,cytarabine
Clofarabine,DB00631,adult acute myeloid leukemia with t(8;21)(q22;q22),C1541331,NCT00863434,Terminated,Phase 2,,clofarabine
Cytarabine,DB00987,adult acute myeloid leukemia with t(8;21)(q22;q22),C1541331,NCT00863434,Terminated,Phase 2,,cytarabine
Clofarabine,DB00631,recurrent adult acute myeloid leukemia,C0278780,NCT00863434,Terminated,Phase 2,,clofarabine
Cytarabine,DB00987,recurrent adult acute myeloid leukemia,C0278780,NCT00863434,Terminated,Phase 2,,cytarabine
Topiramate,DB00273,"Alcoholic Intoxication, Chronic",C0001973,NCT00862563,Terminated,Phase 2,Recruitment goals could not be met before ending of funding for this project.,topiramate
Zonisamide,DB00909,"Alcoholic Intoxication, Chronic",C0001973,NCT00862563,Terminated,Phase 2,Recruitment goals could not be met before ending of funding for this project.,zonisamide
Piracetam,DB09210,"Alcoholic Intoxication, Chronic",C0001973,NCT00862563,Terminated,Phase 2,Recruitment goals could not be met before ending of funding for this project.,piracetam
Voriconazole,DB00582,Invasive aspergillosis,C0238013,NCT00836875,Terminated,Phase 3,"This protocol terminated prematurely on July 8, 2013 due to slow enrollment, not because of    any safety issues or concerns.",voriconazole
Sevelamer,DB00658,Chronic Kidney Diseases,C1561643,NCT00833768,Terminated,Phase 3,"After an extensive review,the ASPIRE in CKD study was terminated because it was not possible    to complete the study in an appropriate time frame.",sevelamer
Sevelamer,DB00658,Hyperphosphatemia (disorder),C0085681,NCT00833768,Terminated,Phase 3,"After an extensive review,the ASPIRE in CKD study was terminated because it was not possible    to complete the study in an appropriate time frame.",sevelamer
Busulfan,DB01008,Refractory Brain Neoplasm,C2347923,NCT00836628,Withdrawn,Phase 1,slow accrual,busulfan
Rituximab,DB00073,leukemia,C0023418,NCT00833534,Withdrawn,Phase 2,No patient enrolled on study. Did not get patients in timely fashion. All referrals for study    when assessed were not eligible.,rituximab
Lenalidomide,DB00480,leukemia,C0023418,NCT00833534,Withdrawn,Phase 2,No patient enrolled on study. Did not get patients in timely fashion. All referrals for study    when assessed were not eligible.,lenalidomide
Paroxetine,DB00715,Anxiety Disorders,C0003469,NCT00836069,Terminated,Phase 3,Pfizer has terminated the execution of this protocol,paroxetine
Floxuridine,DB00322,Malignant neoplasm of stomach,C0024623,NCT00848783,Terminated,Phase 2,Due to slow accrual,floxuridine
Cisplatin,DB00515,Malignant neoplasm of stomach,C0024623,NCT00848783,Terminated,Phase 2,Due to slow accrual,cisplatin
Irinotecan,DB00762,Malignant neoplasm of stomach,C0024623,NCT00848783,Terminated,Phase 2,Due to slow accrual,irinotecan
Amphotericin B,DB00681,"Meningitis, Cryptococcal",C0085436,NCT00847678,Terminated,Phase 2,,amphotericin b
Flucytosine,DB01099,"Meningitis, Cryptococcal",C0085436,NCT00847678,Terminated,Phase 2,,flucytosine
Glycine betaine,DB06756,"Hepatitis C, Chronic",C0524910,NCT00882193,Terminated,Phase 0,"new medications with improved response released, nonaccrual",glycine betaine
Ampicillin,DB00415,Chorioamnionitis,C0008495,NCT00879190,Suspended,Phase 2/Phase 3,We are currently performing and interim analysis for possible neonatal organism resistance to    antibiotic regimens.,ampicillin
Sulbactam,DB09324,Chorioamnionitis,C0008495,NCT00879190,Suspended,Phase 2/Phase 3,We are currently performing and interim analysis for possible neonatal organism resistance to    antibiotic regimens.,sulbactam
Valsartan,DB00177,Oxidative Stress,C0242606,NCT00878969,Terminated,Phase 3,insufficient enrollment and retention,valsartan
Ramipril,DB00178,Oxidative Stress,C0242606,NCT00878969,Terminated,Phase 3,insufficient enrollment and retention,ramipril
Valsartan,DB00177,Endothelial dysfunction,C0856169,NCT00878969,Terminated,Phase 3,insufficient enrollment and retention,valsartan
Ramipril,DB00178,Endothelial dysfunction,C0856169,NCT00878969,Terminated,Phase 3,insufficient enrollment and retention,ramipril
Bevacizumab,DB00112,Biliary Tract Cancer,C0750952,NCT00881504,Terminated,Phase 2,It was not possible to get insurance companies to cover bevacizumab.,bevacizumab
Pregabalin,DB00230,Spinal Cord Injuries,C0037929,NCT00879021,Terminated,Phase 3,lack of funding and patients,pregabalin
Pregabalin,DB00230,Pain,C0030193,NCT00879021,Terminated,Phase 3,lack of funding and patients,pregabalin
Prednisone,DB00635,Adenocarcinoma of prostate,C0007112,NCT00879619,Terminated,Phase 1/Phase 2,Terminated due to slow accrual.,prednisone
Sunitinib,DB01268,Adenocarcinoma of prostate,C0007112,NCT00879619,Terminated,Phase 1/Phase 2,Terminated due to slow accrual.,sunitinib
Prednisone,DB00635,Prostate cancer recurrent,C0278838,NCT00879619,Terminated,Phase 1/Phase 2,Terminated due to slow accrual.,prednisone
Sunitinib,DB01268,Prostate cancer recurrent,C0278838,NCT00879619,Terminated,Phase 1/Phase 2,Terminated due to slow accrual.,sunitinib
Pregabalin,DB00230,Orofacial Pain,C0178782,NCT00852436,Terminated,Phase 2,difficulty to recruit patients,pregabalin
Thiamine,DB00152,Hyperemesis Gravidarum,C0020450,NCT00861523,Terminated,Phase 3,Difficulties in recruiting patients,thiamine
Promethazine,DB01069,Hyperemesis Gravidarum,C0020450,NCT00861523,Terminated,Phase 3,Difficulties in recruiting patients,promethazine
Diphenhydramine,DB01075,Hyperemesis Gravidarum,C0020450,NCT00861523,Terminated,Phase 3,Difficulties in recruiting patients,diphenhydramine
Modafinil,DB00745,Methamphetamine dependence,C1533217,NCT00859573,Terminated,Phase 2,Terminated due to lack of funding.,modafinil
Methamphetamine,DB01577,Methamphetamine dependence,C1533217,NCT00859573,Terminated,Phase 2,Terminated due to lack of funding.,methamphetamine
Armodafinil,DB06413,Methamphetamine dependence,C1533217,NCT00859573,Terminated,Phase 2,Terminated due to lack of funding.,armodafinil
Dasatinib,DB01254,Malignant neoplasm of lung,C0242379,NCT00858403,Terminated,Phase 2,Slow Accrual,dasatinib
Risperidone,DB00734,Schizoaffective Disorder,C0036337,NCT00857818,Terminated,Phase 3,Slow Accrual,risperidone
Quetiapine,DB01224,Schizoaffective Disorder,C0036337,NCT00857818,Terminated,Phase 3,Slow Accrual,quetiapine
Aripiprazole,DB01238,Schizoaffective Disorder,C0036337,NCT00857818,Terminated,Phase 3,Slow Accrual,aripiprazole
Risperidone,DB00734,Bipolar I disorder,C0853193,NCT00857818,Terminated,Phase 3,Slow Accrual,risperidone
Quetiapine,DB01224,Bipolar I disorder,C0853193,NCT00857818,Terminated,Phase 3,Slow Accrual,quetiapine
Aripiprazole,DB01238,Bipolar I disorder,C0853193,NCT00857818,Terminated,Phase 3,Slow Accrual,aripiprazole
Pregabalin,DB00230,Vulvodynia,C0406670,NCT00853229,Terminated,Phase 2,Not feasible due to low accrual,pregabalin
Pregabalin,DB00230,Vulvar Vestibulitis,C0269084,NCT00853229,Terminated,Phase 2,Not feasible due to low accrual,pregabalin
Prednisone,DB00635,Multiple Myeloma,C0026764,NCT00857324,Terminated,Phase 1/Phase 2,"The Phase I of the study was completed, but Phase 2 has not been activated",prednisone
Vorinostat,DB02546,Multiple Myeloma,C0026764,NCT00857324,Terminated,Phase 1/Phase 2,"The Phase I of the study was completed, but Phase 2 has not been activated",vorinostat
Zoledronic acid,DB00399,Adenocarcinoma,C0001418,NCT00892242,Terminated,Phase 1,Principal Investigator decided to close the study early.,zoledronic acid
Linezolid,DB00601,"Skin Diseases, Infectious",C0037278,NCT00865280,Terminated,Phase 3,Terminated,linezolid
Quetiapine,DB01224,Major Depressive Disorder,C1269683,NCT00868374,Terminated,Phase 3,Study terminated due to low enrollment,quetiapine
Quetiapine,DB01224,Generalized Anxiety Disorder,C0270549,NCT00868374,Terminated,Phase 3,Study terminated due to low enrollment,quetiapine
Cisplatin,DB00515,Epithelial ovarian cancer,C0677886,NCT00889733,Terminated,Phase 1/Phase 2,Poor recruitment,cisplatin
Temozolomide,DB00853,Mixed Oligodendroglioma-Astrocytoma,C0280793,NCT00897377,Terminated,Phase 3,Difficulty in recruiting patients,temozolomide
Mifepristone,DB00834,"Affective Disorders, Psychotic",C0001723,NCT00867360,Terminated,Phase 3,,mifepristone
Rituximab,DB00073,Lymphoproliferative Disorders,C0024314,NCT00869323,Terminated,Phase 2,Funding unavailable,rituximab
Bortezomib,DB00188,Lymphoproliferative Disorders,C0024314,NCT00869323,Terminated,Phase 2,Funding unavailable,bortezomib
Dacarbazine,DB00851,Glioblastoma,C0017636,NCT00895960,Terminated,Phase 1,Sponsor withdrew support; Study did not progress to Phase II.,dacarbazine
Temozolomide,DB00853,Glioblastoma,C0017636,NCT00895960,Terminated,Phase 1,Sponsor withdrew support; Study did not progress to Phase II.,temozolomide
Dasatinib,DB01254,Glioblastoma,C0017636,NCT00895960,Terminated,Phase 1,Sponsor withdrew support; Study did not progress to Phase II.,dasatinib
Dacarbazine,DB00851,CNS disorder,C0007682,NCT00895960,Terminated,Phase 1,Sponsor withdrew support; Study did not progress to Phase II.,dacarbazine
Temozolomide,DB00853,CNS disorder,C0007682,NCT00895960,Terminated,Phase 1,Sponsor withdrew support; Study did not progress to Phase II.,temozolomide
Dasatinib,DB01254,CNS disorder,C0007682,NCT00895960,Terminated,Phase 1,Sponsor withdrew support; Study did not progress to Phase II.,dasatinib
Dacarbazine,DB00851,Brain Diseases,C0006111,NCT00895960,Terminated,Phase 1,Sponsor withdrew support; Study did not progress to Phase II.,dacarbazine
Temozolomide,DB00853,Brain Diseases,C0006111,NCT00895960,Terminated,Phase 1,Sponsor withdrew support; Study did not progress to Phase II.,temozolomide
Dasatinib,DB01254,Brain Diseases,C0006111,NCT00895960,Terminated,Phase 1,Sponsor withdrew support; Study did not progress to Phase II.,dasatinib
Cetuximab,DB00002,metastatic squamous neck cancer with occult primary squamous cell carcinoma,C0279696,NCT00906360,Terminated,Phase 1,,cetuximab
Sunitinib,DB01268,metastatic squamous neck cancer with occult primary squamous cell carcinoma,C0279696,NCT00906360,Terminated,Phase 1,,sunitinib
Cetuximab,DB00002,recurrent metastatic squamous neck cancer with occult primary,C0279100,NCT00906360,Terminated,Phase 1,,cetuximab
Sunitinib,DB01268,recurrent metastatic squamous neck cancer with occult primary,C0279100,NCT00906360,Terminated,Phase 1,,sunitinib
Cetuximab,DB00002,Recurrent Salivary Gland Cancer,C0278993,NCT00906360,Terminated,Phase 1,,cetuximab
Sunitinib,DB01268,Recurrent Salivary Gland Cancer,C0278993,NCT00906360,Terminated,Phase 1,,sunitinib
Cetuximab,DB00002,Squamous cell carcinoma of the hypopharynx recurrent,C0280392,NCT00906360,Terminated,Phase 1,,cetuximab
Sunitinib,DB01268,Squamous cell carcinoma of the hypopharynx recurrent,C0280392,NCT00906360,Terminated,Phase 1,,sunitinib
Cetuximab,DB00002,Laryngeal squamous cell carcinoma recurrent,C0280401,NCT00906360,Terminated,Phase 1,,cetuximab
Sunitinib,DB01268,Laryngeal squamous cell carcinoma recurrent,C0280401,NCT00906360,Terminated,Phase 1,,sunitinib
Cetuximab,DB00002,recurrent squamous cell carcinoma of the lip and oral cavity,C0280363,NCT00906360,Terminated,Phase 1,,cetuximab
Sunitinib,DB01268,recurrent squamous cell carcinoma of the lip and oral cavity,C0280363,NCT00906360,Terminated,Phase 1,,sunitinib
Cetuximab,DB00002,Nasopharyngeal squamous cell carcinoma recurrent,C0280386,NCT00906360,Terminated,Phase 1,,cetuximab
Sunitinib,DB01268,Nasopharyngeal squamous cell carcinoma recurrent,C0280386,NCT00906360,Terminated,Phase 1,,sunitinib
Cetuximab,DB00002,Oropharyngeal squamous cell carcinoma recurrent,C0280376,NCT00906360,Terminated,Phase 1,,cetuximab
Sunitinib,DB01268,Oropharyngeal squamous cell carcinoma recurrent,C0280376,NCT00906360,Terminated,Phase 1,,sunitinib
Cetuximab,DB00002,recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity,C0280419,NCT00906360,Terminated,Phase 1,,cetuximab
Sunitinib,DB01268,recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity,C0280419,NCT00906360,Terminated,Phase 1,,sunitinib
Cetuximab,DB00002,Laryngeal verrucous carcinoma recurrent,C0280402,NCT00906360,Terminated,Phase 1,,cetuximab
Sunitinib,DB01268,Laryngeal verrucous carcinoma recurrent,C0280402,NCT00906360,Terminated,Phase 1,,sunitinib
Cetuximab,DB00002,Verrucous carcinoma of the oral cavity recurrent,C0280365,NCT00906360,Terminated,Phase 1,,cetuximab
Sunitinib,DB01268,Verrucous carcinoma of the oral cavity recurrent,C0280365,NCT00906360,Terminated,Phase 1,,sunitinib
Cetuximab,DB00002,squamous cell carcinoma of salivary gland,C0279697,NCT00906360,Terminated,Phase 1,,cetuximab
Sunitinib,DB01268,squamous cell carcinoma of salivary gland,C0279697,NCT00906360,Terminated,Phase 1,,sunitinib
Cetuximab,DB00002,Salivary gland cancer stage III,C0278991,NCT00906360,Terminated,Phase 1,,cetuximab
Sunitinib,DB01268,Salivary gland cancer stage III,C0278991,NCT00906360,Terminated,Phase 1,,sunitinib
Cetuximab,DB00002,Squamous cell carcinoma of the hypopharynx stage III,C0280390,NCT00906360,Terminated,Phase 1,,cetuximab
Sunitinib,DB01268,Squamous cell carcinoma of the hypopharynx stage III,C0280390,NCT00906360,Terminated,Phase 1,,sunitinib
Cetuximab,DB00002,Laryngeal squamous cell carcinoma stage III,C0280397,NCT00906360,Terminated,Phase 1,,cetuximab
Sunitinib,DB01268,Laryngeal squamous cell carcinoma stage III,C0280397,NCT00906360,Terminated,Phase 1,,sunitinib
Cetuximab,DB00002,stage III squamous cell carcinoma of the lip and oral cavity,C0280353,NCT00906360,Terminated,Phase 1,,cetuximab
Sunitinib,DB01268,stage III squamous cell carcinoma of the lip and oral cavity,C0280353,NCT00906360,Terminated,Phase 1,,sunitinib
Cetuximab,DB00002,Nasopharyngeal squamous cell carcinoma stage III,C0280382,NCT00906360,Terminated,Phase 1,,cetuximab
Sunitinib,DB01268,Nasopharyngeal squamous cell carcinoma stage III,C0280382,NCT00906360,Terminated,Phase 1,,sunitinib
Cetuximab,DB00002,Oropharyngeal squamous cell carcinoma stage III,C0280372,NCT00906360,Terminated,Phase 1,,cetuximab
Sunitinib,DB01268,Oropharyngeal squamous cell carcinoma stage III,C0280372,NCT00906360,Terminated,Phase 1,,sunitinib
Cetuximab,DB00002,stage III squamous cell carcinoma of the paranasal sinus and nasal cavity,C0280411,NCT00906360,Terminated,Phase 1,,cetuximab
Sunitinib,DB01268,stage III squamous cell carcinoma of the paranasal sinus and nasal cavity,C0280411,NCT00906360,Terminated,Phase 1,,sunitinib
Cetuximab,DB00002,Laryngeal verrucous carcinoma stage III,C0280398,NCT00906360,Terminated,Phase 1,,cetuximab
Sunitinib,DB01268,Laryngeal verrucous carcinoma stage III,C0280398,NCT00906360,Terminated,Phase 1,,sunitinib
Cetuximab,DB00002,Verrucous carcinoma of the oral cavity stage III,C0280355,NCT00906360,Terminated,Phase 1,,cetuximab
Sunitinib,DB01268,Verrucous carcinoma of the oral cavity stage III,C0280355,NCT00906360,Terminated,Phase 1,,sunitinib
Cetuximab,DB00002,Salivary gland cancer stage IV,C0278992,NCT00906360,Terminated,Phase 1,,cetuximab
Sunitinib,DB01268,Salivary gland cancer stage IV,C0278992,NCT00906360,Terminated,Phase 1,,sunitinib
Cetuximab,DB00002,Squamous cell carcinoma of the hypopharynx stage IV,C0280391,NCT00906360,Terminated,Phase 1,,cetuximab
Sunitinib,DB01268,Squamous cell carcinoma of the hypopharynx stage IV,C0280391,NCT00906360,Terminated,Phase 1,,sunitinib
Cetuximab,DB00002,Laryngeal squamous cell carcinoma stage IV,C0280399,NCT00906360,Terminated,Phase 1,,cetuximab
Sunitinib,DB01268,Laryngeal squamous cell carcinoma stage IV,C0280399,NCT00906360,Terminated,Phase 1,,sunitinib
Cetuximab,DB00002,stage IV squamous cell carcinoma of the lip and oral cavity,C0280358,NCT00906360,Terminated,Phase 1,,cetuximab
Sunitinib,DB01268,stage IV squamous cell carcinoma of the lip and oral cavity,C0280358,NCT00906360,Terminated,Phase 1,,sunitinib
Cetuximab,DB00002,Nasopharyngeal squamous cell carcinoma stage IV,C0280384,NCT00906360,Terminated,Phase 1,,cetuximab
Sunitinib,DB01268,Nasopharyngeal squamous cell carcinoma stage IV,C0280384,NCT00906360,Terminated,Phase 1,,sunitinib
Cetuximab,DB00002,stage IV squamous cell carcinoma of the oropharynx,C0280374,NCT00906360,Terminated,Phase 1,,cetuximab
Sunitinib,DB01268,stage IV squamous cell carcinoma of the oropharynx,C0280374,NCT00906360,Terminated,Phase 1,,sunitinib
Cetuximab,DB00002,stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity,C0280415,NCT00906360,Terminated,Phase 1,,cetuximab
Sunitinib,DB01268,stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity,C0280415,NCT00906360,Terminated,Phase 1,,sunitinib
Cetuximab,DB00002,Laryngeal verrucous carcinoma stage IV,C0280400,NCT00906360,Terminated,Phase 1,,cetuximab
Sunitinib,DB01268,Laryngeal verrucous carcinoma stage IV,C0280400,NCT00906360,Terminated,Phase 1,,sunitinib
Cetuximab,DB00002,Verrucous carcinoma of the oral cavity stage IV,C0280360,NCT00906360,Terminated,Phase 1,,cetuximab
Sunitinib,DB01268,Verrucous carcinoma of the oral cavity stage IV,C0280360,NCT00906360,Terminated,Phase 1,,sunitinib
Cetuximab,DB00002,untreated metastatic squamous neck cancer with occult primary,C0279099,NCT00906360,Terminated,Phase 1,,cetuximab
Sunitinib,DB01268,untreated metastatic squamous neck cancer with occult primary,C0279099,NCT00906360,Terminated,Phase 1,,sunitinib
Sorafenib,DB00398,Colorectal Neoplasms,C0009404,NCT00889343,Terminated,Phase 2,,sorafenib
Oxaliplatin,DB00526,Colorectal Neoplasms,C0009404,NCT00889343,Terminated,Phase 2,,oxaliplatin
Irinotecan,DB00762,Colorectal Neoplasms,C0009404,NCT00889343,Terminated,Phase 2,,irinotecan
Oxytocin,DB00107,"Fetal Membranes, Premature Rupture",C0015944,NCT00890630,Terminated,Phase 2,Inadequate Patient Recruitment.,oxytocin
Lamotrigine,DB00555,Bipolar Disorder,C0005586,NCT00907985,Terminated,Phase 1,Slow recruitment; trial unlikely to reach completion,lamotrigine
Zoledronic acid,DB00399,Giant Cell Tumor of Bone,C0206638,NCT00889590,Terminated,Phase 2,low recruitment with registration denosumab,zoledronic acid
Panobinostat,DB06603,Non-Small Cell Lung Carcinoma,C0007131,NCT00907179,Terminated,Phase 1,Widespread use firstline Pemetrexed; slow recruitment; funding withdrawn..,panobinostat
Cetuximab,DB00002,Neoplasm Metastasis,C0027627,NCT00908024,Terminated,Phase 1/Phase 2,,cetuximab
Sunitinib,DB01268,cognitive/functional effects,C0935657,NCT00910039,Terminated,Phase 2,Slow Accrual,sunitinib
Sunitinib,DB01268,"unspecified adult solid tumor, protocol specific",C0279004,NCT00910039,Terminated,Phase 2,Slow Accrual,sunitinib
Cisplatin,DB00515,Nausea and vomiting,C0027498,NCT00891761,Withdrawn,Phase 3,This study has been cancelled prior to enrollment.,cisplatin
Ondansetron,DB00904,Nausea and vomiting,C0027498,NCT00891761,Withdrawn,Phase 3,This study has been cancelled prior to enrollment.,ondansetron
Dexamethasone,DB01234,Nausea and vomiting,C0027498,NCT00891761,Withdrawn,Phase 3,This study has been cancelled prior to enrollment.,dexamethasone
Vincristine,DB00541,Adult Kidney Wilms Tumor,C1332219,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,vincristine
Etoposide,DB00773,Adult Kidney Wilms Tumor,C1332219,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,etoposide
Dactinomycin,DB00970,Adult Kidney Wilms Tumor,C1332219,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,dactinomycin
Doxorubicin,DB00997,Adult Kidney Wilms Tumor,C1332219,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,doxorubicin
Vincristine,DB00541,Beckwith-Wiedemann Syndrome,C0004903,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,vincristine
Etoposide,DB00773,Beckwith-Wiedemann Syndrome,C0004903,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,etoposide
Dactinomycin,DB00970,Beckwith-Wiedemann Syndrome,C0004903,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,dactinomycin
Doxorubicin,DB00997,Beckwith-Wiedemann Syndrome,C0004903,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,doxorubicin
Vincristine,DB00541,Childhood Kidney Wilms Tumor,C1333015,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,vincristine
Etoposide,DB00773,Childhood Kidney Wilms Tumor,C1333015,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,etoposide
Dactinomycin,DB00970,Childhood Kidney Wilms Tumor,C1333015,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,dactinomycin
Doxorubicin,DB00997,Childhood Kidney Wilms Tumor,C1333015,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,doxorubicin
Vincristine,DB00541,Diffuse Hyperplastic Perilobar Nephroblastomatosis,C1880323,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,vincristine
Etoposide,DB00773,Diffuse Hyperplastic Perilobar Nephroblastomatosis,C1880323,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,etoposide
Dactinomycin,DB00970,Diffuse Hyperplastic Perilobar Nephroblastomatosis,C1880323,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,dactinomycin
Doxorubicin,DB00997,Diffuse Hyperplastic Perilobar Nephroblastomatosis,C1880323,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,doxorubicin
Vincristine,DB00541,Congenital hemihypertrophy,C0332890,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,vincristine
Etoposide,DB00773,Congenital hemihypertrophy,C0332890,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,etoposide
Dactinomycin,DB00970,Congenital hemihypertrophy,C0332890,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,dactinomycin
Doxorubicin,DB00997,Congenital hemihypertrophy,C0332890,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,doxorubicin
Vincristine,DB00541,stage I Wilms' tumor,C0278711,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,vincristine
Etoposide,DB00773,stage I Wilms' tumor,C0278711,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,etoposide
Dactinomycin,DB00970,stage I Wilms' tumor,C0278711,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,dactinomycin
Doxorubicin,DB00997,stage I Wilms' tumor,C0278711,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,doxorubicin
Vincristine,DB00541,stage II Wilms' tumor,C0278712,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,vincristine
Etoposide,DB00773,stage II Wilms' tumor,C0278712,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,etoposide
Dactinomycin,DB00970,stage II Wilms' tumor,C0278712,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,dactinomycin
Doxorubicin,DB00997,stage II Wilms' tumor,C0278712,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,doxorubicin
Vincristine,DB00541,stage III Wilms' tumor,C0278713,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,vincristine
Etoposide,DB00773,stage III Wilms' tumor,C0278713,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,etoposide
Dactinomycin,DB00970,stage III Wilms' tumor,C0278713,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,dactinomycin
Doxorubicin,DB00997,stage III Wilms' tumor,C0278713,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,doxorubicin
Vincristine,DB00541,stage IV Wilms' tumor,C0278714,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,vincristine
Etoposide,DB00773,stage IV Wilms' tumor,C0278714,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,etoposide
Dactinomycin,DB00970,stage IV Wilms' tumor,C0278714,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,dactinomycin
Doxorubicin,DB00997,stage IV Wilms' tumor,C0278714,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,doxorubicin
Vincristine,DB00541,stage V Wilms' tumor,C0278715,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,vincristine
Etoposide,DB00773,stage V Wilms' tumor,C0278715,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,etoposide
Dactinomycin,DB00970,stage V Wilms' tumor,C0278715,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,dactinomycin
Doxorubicin,DB00997,stage V Wilms' tumor,C0278715,NCT00945009,Suspended,Phase 3,Temporarily stopped for assessment,doxorubicin
Gemcitabine,DB00441,Malignant neoplasm of lung,C0242379,NCT00951444,Withdrawn,Phase 2,The study was not activated.,gemcitabine
Carboplatin,DB00958,Malignant neoplasm of lung,C0242379,NCT00951444,Withdrawn,Phase 2,The study was not activated.,carboplatin
Dexamethasone,DB01234,Acute fungal otitis externa,C0728738,NCT00945646,Terminated,Phase 3,,dexamethasone
Haloperidol,DB00502,Delirium,C0011206,NCT00954603,Terminated,Phase 3,few delirious patients were enrolled.,haloperidol
Quetiapine,DB01224,Delirium,C0011206,NCT00954603,Terminated,Phase 3,few delirious patients were enrolled.,quetiapine
Cetuximab,DB00002,Colorectal cancer metastatic,C0948380,NCT00954876,Withdrawn,Phase 2,Study has been terminated due to lack of accrual.,cetuximab
Fluorouracil,DB00544,Colorectal cancer metastatic,C0948380,NCT00954876,Withdrawn,Phase 2,Study has been terminated due to lack of accrual.,fluorouracil
Capecitabine,DB01101,Colorectal cancer metastatic,C0948380,NCT00954876,Withdrawn,Phase 2,Study has been terminated due to lack of accrual.,capecitabine
Denileukin diftitox,DB00004,Melanoma recurrent,C0278884,NCT00945269,Terminated,Phase 1/Phase 2,"ONTAK has been pulled off the market for further testing. Subsequently, EISAI will no longer    be supporting clinical trials that utilize this drug.",denileukin diftitox
Aldesleukin,DB00041,Melanoma recurrent,C0278884,NCT00945269,Terminated,Phase 1/Phase 2,"ONTAK has been pulled off the market for further testing. Subsequently, EISAI will no longer    be supporting clinical trials that utilize this drug.",aldesleukin
Denileukin diftitox,DB00004,malignant melanoma of skin stage III,C0278882,NCT00945269,Terminated,Phase 1/Phase 2,"ONTAK has been pulled off the market for further testing. Subsequently, EISAI will no longer    be supporting clinical trials that utilize this drug.",denileukin diftitox
Aldesleukin,DB00041,malignant melanoma of skin stage III,C0278882,NCT00945269,Terminated,Phase 1/Phase 2,"ONTAK has been pulled off the market for further testing. Subsequently, EISAI will no longer    be supporting clinical trials that utilize this drug.",aldesleukin
Sunitinib,DB01268,Malignant neoplasm of lung,C0242379,NCT00953459,Terminated,Phase 2,poorly recruiting,sunitinib
Oxaliplatin,DB00526,Colorectal Neoplasms,C0009404,NCT00950820,Terminated,Phase 2,Recruitment rate to low; changed environment made protocol in its current state obsolete,oxaliplatin
Fluorouracil,DB00544,Colorectal Neoplasms,C0009404,NCT00950820,Terminated,Phase 2,Recruitment rate to low; changed environment made protocol in its current state obsolete,fluorouracil
Capecitabine,DB01101,Colorectal Neoplasms,C0009404,NCT00950820,Terminated,Phase 2,Recruitment rate to low; changed environment made protocol in its current state obsolete,capecitabine
Midazolam,DB00683,Pain,C0030193,NCT00942539,Terminated,Phase 2,,midazolam
Carboplatin,DB00958,ovarian neoplasm,C0919267,NCT00919984,Terminated,Phase 2,This study stopped due to slow accrual.,carboplatin
Paclitaxel,DB01229,ovarian neoplasm,C0919267,NCT00919984,Terminated,Phase 2,This study stopped due to slow accrual.,paclitaxel
Alemtuzumab,DB00087,B-cell small lymphocytic lymphoma recurrent,C0855096,NCT00947388,Terminated,Phase 1,No more eligible patients,alemtuzumab
Bendamustine,DB06769,B-cell small lymphocytic lymphoma recurrent,C0855096,NCT00947388,Terminated,Phase 1,No more eligible patients,bendamustine
Alemtuzumab,DB00087,Chronic lymphocytic leukaemia refractory,C0278791,NCT00947388,Terminated,Phase 1,No more eligible patients,alemtuzumab
Bendamustine,DB06769,Chronic lymphocytic leukaemia refractory,C0278791,NCT00947388,Terminated,Phase 1,No more eligible patients,bendamustine
Alemtuzumab,DB00087,Chronic lymphocytic leukaemia stage 3,C0278769,NCT00947388,Terminated,Phase 1,No more eligible patients,alemtuzumab
Bendamustine,DB06769,Chronic lymphocytic leukaemia stage 3,C0278769,NCT00947388,Terminated,Phase 1,No more eligible patients,bendamustine
Alemtuzumab,DB00087,B-cell small lymphocytic lymphoma stage III,C0855100,NCT00947388,Terminated,Phase 1,No more eligible patients,alemtuzumab
Bendamustine,DB06769,B-cell small lymphocytic lymphoma stage III,C0855100,NCT00947388,Terminated,Phase 1,No more eligible patients,bendamustine
Alemtuzumab,DB00087,Chronic lymphocytic leukaemia stage 4,C0854804,NCT00947388,Terminated,Phase 1,No more eligible patients,alemtuzumab
Bendamustine,DB06769,Chronic lymphocytic leukaemia stage 4,C0854804,NCT00947388,Terminated,Phase 1,No more eligible patients,bendamustine
Alemtuzumab,DB00087,B-cell small lymphocytic lymphoma stage IV,C0855101,NCT00947388,Terminated,Phase 1,No more eligible patients,alemtuzumab
Bendamustine,DB06769,B-cell small lymphocytic lymphoma stage IV,C0855101,NCT00947388,Terminated,Phase 1,No more eligible patients,bendamustine
Cyproheptadine,DB00434,leukemia,C0023418,NCT00949117,Terminated,Phase 2,study not feasible with low accrual. DSMB recommended closure,cyproheptadine
Cyproheptadine,DB00434,Malnutrition,C0162429,NCT00949117,Terminated,Phase 2,study not feasible with low accrual. DSMB recommended closure,cyproheptadine
Cyproheptadine,DB00434,"unspecified childhood solid tumor, protocol specific",C0279002,NCT00949117,Terminated,Phase 2,study not feasible with low accrual. DSMB recommended closure,cyproheptadine
Cyproheptadine,DB00434,Body Weight Changes,C0005911,NCT00949117,Terminated,Phase 2,study not feasible with low accrual. DSMB recommended closure,cyproheptadine
Erlotinib,DB00530,Neuroendocrine Tumors,C0206754,NCT00947167,Terminated,Phase 2,Extreme toxicity of Pertuzumab and Erlotinib combination,erlotinib
Pertuzumab,DB06366,Neuroendocrine Tumors,C0206754,NCT00947167,Terminated,Phase 2,Extreme toxicity of Pertuzumab and Erlotinib combination,pertuzumab
Erlotinib,DB00530,Adrenal Gland Neoplasms,C0001624,NCT00947167,Terminated,Phase 2,Extreme toxicity of Pertuzumab and Erlotinib combination,erlotinib
Pertuzumab,DB06366,Adrenal Gland Neoplasms,C0001624,NCT00947167,Terminated,Phase 2,Extreme toxicity of Pertuzumab and Erlotinib combination,pertuzumab
Erlotinib,DB00530,Neuroblastoma,C0027819,NCT00947167,Terminated,Phase 2,Extreme toxicity of Pertuzumab and Erlotinib combination,erlotinib
Pertuzumab,DB06366,Neuroblastoma,C0027819,NCT00947167,Terminated,Phase 2,Extreme toxicity of Pertuzumab and Erlotinib combination,pertuzumab
Erlotinib,DB00530,Multiple Endocrine Neoplasia,C0027662,NCT00947167,Terminated,Phase 2,Extreme toxicity of Pertuzumab and Erlotinib combination,erlotinib
Pertuzumab,DB06366,Multiple Endocrine Neoplasia,C0027662,NCT00947167,Terminated,Phase 2,Extreme toxicity of Pertuzumab and Erlotinib combination,pertuzumab
Bevacizumab,DB00112,Intracranial Meningioma,C0349604,NCT00972335,Terminated,Phase 2,Study terminated early due to slow accrual,bevacizumab
Sirolimus,DB00877,Intracranial Meningioma,C0349604,NCT00972335,Terminated,Phase 2,Study terminated early due to slow accrual,sirolimus
Everolimus,DB01590,Intracranial Meningioma,C0349604,NCT00972335,Terminated,Phase 2,Study terminated early due to slow accrual,everolimus
Lovastatin,DB00227,melanoma,C0025202,NCT00963664,Withdrawn,Phase 2,Modifications will be necessary before full IRB approval will be secured.,lovastatin
Darbepoetin alfa,DB00012,Chronic Kidney Diseases,C1561643,NCT00968617,Terminated,Phase 2,,darbepoetin alfa
Lenalidomide,DB00480,Renal Cell Carcinoma,C0007134,NCT00975806,Terminated,Phase 1/Phase 2,MTD determined sub-optimal as efficacious treatment for renal cell carcinoma.,lenalidomide
Thalidomide,DB01041,Renal Cell Carcinoma,C0007134,NCT00975806,Terminated,Phase 1/Phase 2,MTD determined sub-optimal as efficacious treatment for renal cell carcinoma.,thalidomide
Palonosetron,DB00377,Nausea,C0027497,NCT00982995,Terminated,Phase 2,site terminated due to lack of enrollment,palonosetron
Palonosetron,DB00377,Vomiting,C0042963,NCT00982995,Terminated,Phase 2,site terminated due to lack of enrollment,palonosetron
Oxycodone,DB00497,Degenerative polyarthritis,C0029408,NCT00985621,Terminated,Phase 3,See termination reason in detailed description.,oxycodone
Norepinephrine,DB00368,"orthostatic; hypotension, neurogenic",C1400301,NCT00977171,Terminated,Phase 2,Enrollment issues.,norepinephrine
Droxidopa,DB06262,"orthostatic; hypotension, neurogenic",C1400301,NCT00977171,Terminated,Phase 2,Enrollment issues.,droxidopa
Norepinephrine,DB00368,Chronic Fatigue Syndrome,C0015674,NCT00977171,Terminated,Phase 2,Enrollment issues.,norepinephrine
Droxidopa,DB06262,Chronic Fatigue Syndrome,C0015674,NCT00977171,Terminated,Phase 2,Enrollment issues.,droxidopa
Tramadol,DB00193,Premature Ejaculation,C0033038,NCT00983151,Terminated,Phase 3,,tramadol
Modafinil,DB00745,Traumatic Brain Injury,C0876926,NCT00983437,Terminated,Phase 3,Study has been stopped by sponsor decision,modafinil
Armodafinil,DB06413,Traumatic Brain Injury,C0876926,NCT00983437,Terminated,Phase 3,Study has been stopped by sponsor decision,armodafinil
Tramadol,DB00193,Premature Ejaculation,C0033038,NCT00983736,Terminated,Phase 3,This study was terminated because of recruitment difficulties.,tramadol
Cyclophosphamide,DB00531,Solid tumour,C0280100,NCT00960063,Terminated,Phase 1,Study was terminated for business reasons.,cyclophosphamide
Vincristine,DB00541,Solid tumour,C0280100,NCT00960063,Terminated,Phase 1,Study was terminated for business reasons.,vincristine
Irinotecan,DB00762,Solid tumour,C0280100,NCT00960063,Terminated,Phase 1,Study was terminated for business reasons.,irinotecan
Etoposide,DB00773,Solid tumour,C0280100,NCT00960063,Terminated,Phase 1,Study was terminated for business reasons.,etoposide
Temozolomide,DB00853,Solid tumour,C0280100,NCT00960063,Terminated,Phase 1,Study was terminated for business reasons.,temozolomide
Doxorubicin,DB00997,Solid tumour,C0280100,NCT00960063,Terminated,Phase 1,Study was terminated for business reasons.,doxorubicin
Ifosfamide,DB01181,Solid tumour,C0280100,NCT00960063,Terminated,Phase 1,Study was terminated for business reasons.,ifosfamide
Cyclophosphamide,DB00531,Kidney Neoplasm,C0022665,NCT00960063,Terminated,Phase 1,Study was terminated for business reasons.,cyclophosphamide
Vincristine,DB00541,Kidney Neoplasm,C0022665,NCT00960063,Terminated,Phase 1,Study was terminated for business reasons.,vincristine
Irinotecan,DB00762,Kidney Neoplasm,C0022665,NCT00960063,Terminated,Phase 1,Study was terminated for business reasons.,irinotecan
Etoposide,DB00773,Kidney Neoplasm,C0022665,NCT00960063,Terminated,Phase 1,Study was terminated for business reasons.,etoposide
Temozolomide,DB00853,Kidney Neoplasm,C0022665,NCT00960063,Terminated,Phase 1,Study was terminated for business reasons.,temozolomide
Doxorubicin,DB00997,Kidney Neoplasm,C0022665,NCT00960063,Terminated,Phase 1,Study was terminated for business reasons.,doxorubicin
Ifosfamide,DB01181,Kidney Neoplasm,C0022665,NCT00960063,Terminated,Phase 1,Study was terminated for business reasons.,ifosfamide
Irinotecan,DB00762,Neuroblastoma,C0027819,NCT00960063,Terminated,Phase 1,Study was terminated for business reasons.,irinotecan
Etoposide,DB00773,Neuroblastoma,C0027819,NCT00960063,Terminated,Phase 1,Study was terminated for business reasons.,etoposide
Temozolomide,DB00853,Neuroblastoma,C0027819,NCT00960063,Terminated,Phase 1,Study was terminated for business reasons.,temozolomide
Ifosfamide,DB01181,Neuroblastoma,C0027819,NCT00960063,Terminated,Phase 1,Study was terminated for business reasons.,ifosfamide
Clindamycin,DB01190,Malaria,C0024530,NCT01002183,Withdrawn,Phase 2,Drug combination is no longer pursued,clindamycin
Vardenafil,DB00862,Cystic Fibrosis,C0010674,NCT01002534,Suspended,Phase 2,not yet started,vardenafil
Erlotinib,DB00530,Psoriasis,C0033860,NCT01006096,Withdrawn,Phase 2,IND not obtained,erlotinib
Bevacizumab,DB00112,Non-Small Cell Lung Carcinoma,C0007131,NCT00998166,Terminated,Phase 2,Poor enrollment,bevacizumab
Cisplatin,DB00515,Non-Small Cell Lung Carcinoma,C0007131,NCT00998166,Terminated,Phase 2,Poor enrollment,cisplatin
Triptorelin,DB06825,Infertility,C0021359,NCT01007851,Terminated,Phase 3,Lower than anticipated recruitment,triptorelin
Sorafenib,DB00398,Liver cell carcinoma non-resectable,C1112459,NCT01009593,Terminated,Phase 3,See termination reason in detailed description,sorafenib
Sorafenib,DB00398,Hepatoma recurrent,C0861876,NCT01009593,Terminated,Phase 3,See termination reason in detailed description,sorafenib
Sorafenib,DB00398,Neoplasms by Histologic Type,C0027652,NCT01009593,Terminated,Phase 3,See termination reason in detailed description,sorafenib
Sorafenib,DB00398,Carcinoma,C0007097,NCT01009593,Terminated,Phase 3,See termination reason in detailed description,sorafenib
Sorafenib,DB00398,Liver neoplasms,C0023903,NCT01009593,Terminated,Phase 3,See termination reason in detailed description,sorafenib
Sorafenib,DB00398,Adenocarcinoma,C0001418,NCT01009593,Terminated,Phase 3,See termination reason in detailed description,sorafenib
Sorafenib,DB00398,"Neoplasms, Glandular and Epithelial",C0027660,NCT01009593,Terminated,Phase 3,See termination reason in detailed description,sorafenib
Cetuximab,DB00002,Colorectal cancer metastatic,C0948380,NCT01008475,Terminated,Phase 1/Phase 2,The study is terminated prematurely as the sponsor decided to discontinue program with EMD    525797 in oncology.,cetuximab
Irinotecan,DB00762,Colorectal cancer metastatic,C0948380,NCT01008475,Terminated,Phase 1/Phase 2,The study is terminated prematurely as the sponsor decided to discontinue program with EMD    525797 in oncology.,irinotecan
Carboplatin,DB00958,Epithelial ovarian cancer,C0677886,NCT01000896,Withdrawn,Phase 1,AstraZeneca has discontinued the development of AZD0530. No new AstraZeneca-sponsored clinical    studies will be initiated..,carboplatin
Paclitaxel,DB01229,Epithelial ovarian cancer,C0677886,NCT01000896,Withdrawn,Phase 1,AstraZeneca has discontinued the development of AZD0530. No new AstraZeneca-sponsored clinical    studies will be initiated..,paclitaxel
Azacitidine,DB00928,leukemia,C0023418,NCT00997243,Terminated,Phase 2,Drug no longer being supplied by sponsor,azacitidine
Danazol,DB01406,Dyskeratosis Congenita,C0265965,NCT01001598,Terminated,Phase 1/Phase 2,Study was terminated due to under enrollment,danazol
Indomethacin,DB00328,Gout acute,C2062908,NCT00997581,Withdrawn,Phase 2,Colaborator withdrew support.,indomethacin
Apremilast,DB05676,Gout acute,C2062908,NCT00997581,Withdrawn,Phase 2,Colaborator withdrew support.,apremilast
Cetuximab,DB00002,Malignant neoplasm of lung,C0242379,NCT00998101,Withdrawn,Phase 2,Study was withdrawn due issuses related to the science,cetuximab
Carboplatin,DB00958,Malignant neoplasm of lung,C0242379,NCT00998101,Withdrawn,Phase 2,Study was withdrawn due issuses related to the science,carboplatin
Ramipril,DB00178,Low density lipoprotein increased,C0549399,NCT01004705,Terminated,Phase 2,,ramipril
Simvastatin,DB00641,Low density lipoprotein increased,C0549399,NCT01004705,Terminated,Phase 2,,simvastatin
Salicylic acid,DB00936,Low density lipoprotein increased,C0549399,NCT01004705,Terminated,Phase 2,,salicylic acid
Acetylsalicylic acid,DB00945,Low density lipoprotein increased,C0549399,NCT01004705,Terminated,Phase 2,,acetylsalicylic acid
Simvastatin,DB00641,Hypertensive disease,C0020538,NCT01005290,Terminated,Phase 2,,simvastatin
Salicylic acid,DB00936,Hypertensive disease,C0020538,NCT01005290,Terminated,Phase 2,,salicylic acid
Acetylsalicylic acid,DB00945,Hypertensive disease,C0020538,NCT01005290,Terminated,Phase 2,,acetylsalicylic acid
Magnesium Sulfate,DB00653,Neuropathy,C0442874,NCT00998738,Terminated,Phase 3,lack of accrual,magnesium sulfate
Magnesium Sulfate,DB00653,Pain,C0030193,NCT00998738,Terminated,Phase 3,lack of accrual,magnesium sulfate
Aminosalicylic Acid,DB00233,Ulcerative Colitis,C0009324,NCT01004185,Terminated,Phase 3,Pediatric enrollment very slow.,aminosalicylic acid
Prednisone,DB00635,"Myasthenia Gravis, Ocular",C0751340,NCT00995722,Terminated,Phase 3,Slow recruitment rate,prednisone
Bevacizumab,DB00112,Non-small cell lung cancer recurrent,C0278517,NCT00976677,Terminated,Phase 2,,bevacizumab
Erlotinib,DB00530,Non-small cell lung cancer recurrent,C0278517,NCT00976677,Terminated,Phase 2,,erlotinib
Carboplatin,DB00958,Non-small cell lung cancer recurrent,C0278517,NCT00976677,Terminated,Phase 2,,carboplatin
Paclitaxel,DB01229,Non-small cell lung cancer recurrent,C0278517,NCT00976677,Terminated,Phase 2,,paclitaxel
Bevacizumab,DB00112,Non-small cell lung cancer metastatic,C0278987,NCT00976677,Terminated,Phase 2,,bevacizumab
Erlotinib,DB00530,Non-small cell lung cancer metastatic,C0278987,NCT00976677,Terminated,Phase 2,,erlotinib
Carboplatin,DB00958,Non-small cell lung cancer metastatic,C0278987,NCT00976677,Terminated,Phase 2,,carboplatin
Paclitaxel,DB01229,Non-small cell lung cancer metastatic,C0278987,NCT00976677,Terminated,Phase 2,,paclitaxel
Carboplatin,DB00958,ovarian neoplasm,C0919267,NCT00976183,Terminated,Phase 1/Phase 2,toxicities,carboplatin
Vorinostat,DB02546,ovarian neoplasm,C0919267,NCT00976183,Terminated,Phase 1/Phase 2,toxicities,vorinostat
Hydroxyurea,DB01005,"Fibromatosis, Aggressive",C0079218,NCT00978146,Withdrawn,Phase 2,Study was administratively withdrawn by the IRB; no subjects were enrolled,hydroxyurea
Hydroxyurea,DB01005,Fibromatosis,C0016048,NCT00978146,Withdrawn,Phase 2,Study was administratively withdrawn by the IRB; no subjects were enrolled,hydroxyurea
Cisplatin,DB00515,Small cell carcinoma of lung,C0149925,NCT00977561,Terminated,Phase 2,See termination reason in detailed description.,cisplatin
Carboplatin,DB00958,Small cell carcinoma of lung,C0149925,NCT00977561,Terminated,Phase 2,See termination reason in detailed description.,carboplatin
Irinotecan,DB00762,Malignant tumor of colon,C0007102,NCT01004159,Terminated,Phase 2,former PI left institute,irinotecan
Asparaginase,DB00023,leukemia,C0023418,NCT01005914,Terminated,Phase 2,Increased rate of bacterial infections,asparaginase
Pegaspargase,DB00059,leukemia,C0023418,NCT01005914,Terminated,Phase 2,Increased rate of bacterial infections,pegaspargase
Cyclophosphamide,DB00531,leukemia,C0023418,NCT01005914,Terminated,Phase 2,Increased rate of bacterial infections,cyclophosphamide
Vincristine,DB00541,leukemia,C0023418,NCT01005914,Terminated,Phase 2,Increased rate of bacterial infections,vincristine
Methotrexate,DB00563,leukemia,C0023418,NCT01005914,Terminated,Phase 2,Increased rate of bacterial infections,methotrexate
Imatinib,DB00619,leukemia,C0023418,NCT01005914,Terminated,Phase 2,Increased rate of bacterial infections,imatinib
Prednisolone,DB00860,leukemia,C0023418,NCT01005914,Terminated,Phase 2,Increased rate of bacterial infections,prednisolone
Methylprednisolone,DB00959,leukemia,C0023418,NCT01005914,Terminated,Phase 2,Increased rate of bacterial infections,methylprednisolone
Doxorubicin,DB00997,leukemia,C0023418,NCT01005914,Terminated,Phase 2,Increased rate of bacterial infections,doxorubicin
Dexamethasone,DB01234,leukemia,C0023418,NCT01005914,Terminated,Phase 2,Increased rate of bacterial infections,dexamethasone
Metoprolol,DB00264,Obesity,C0028754,NCT00993421,Terminated,Phase 2,Clinical trial terminated due to results from recent nonclinical studies,metoprolol
Pregabalin,DB00230,Chronic pain,C0150055,NCT00998816,Withdrawn,Phase 3,No funding,pregabalin
Artesunate,DB09274,Plasmodium falciparum infection,C0858318,NCT00988507,Terminated,Phase 2,Company decision to modify the ferroquine development strategy; discontinuation not due to    safety or activity unexpected findings,artesunate
Darbepoetin alfa,DB00012,Cancer anemia,C1536115,NCT00989092,Terminated,Phase 2,slow enrollment and change in product development strategy,darbepoetin alfa
Darbepoetin alfa,DB00012,Carcinoma,C0007097,NCT00989092,Terminated,Phase 2,slow enrollment and change in product development strategy,darbepoetin alfa
Erlotinib,DB00530,Squamous cell carcinoma,C0007137,NCT01009203,Terminated,Phase 2,High patient withdrawal rate,erlotinib
Sirolimus,DB00877,Squamous cell carcinoma,C0007137,NCT01009203,Terminated,Phase 2,High patient withdrawal rate,sirolimus
Everolimus,DB01590,Squamous cell carcinoma,C0007137,NCT01009203,Terminated,Phase 2,High patient withdrawal rate,everolimus
Sitagliptin,DB01261,Renal Insufficiency,C1565489,NCT00958269,Terminated,Phase 3,Technical/operational issues,sitagliptin
Bevacizumab,DB00112,Malignant tumor of colon,C0007102,NCT01006369,Suspended,Phase 2,Interim analysis,bevacizumab
Hydroxychloroquine,DB01611,Malignant tumor of colon,C0007102,NCT01006369,Suspended,Phase 2,Interim analysis,hydroxychloroquine
Warfarin,DB00682,Hamman-Rich syndrome,C0085786,NCT00957242,Terminated,Phase 3,Excess of mortality in the treatment group created safety concerns.,warfarin
Riluzole,DB00740,"unspecified adult solid tumor, protocol specific",C0279004,NCT01018836,Terminated,Phase 1,Slow accrual,riluzole
Bevacizumab,DB00112,Hemangioblastoma,C0206734,NCT01015300,Terminated,Phase 0,Study terminated due to low accrual.,bevacizumab
Bevacizumab,DB00112,Von Hippel-Lindau Syndrome,C0019562,NCT01015300,Terminated,Phase 0,Study terminated due to low accrual.,bevacizumab
Dopamine,DB00988,Malignant Carcinoid Syndrome,C0024586,NCT01018953,Terminated,Phase 2,Preliminary data from study NCT00994214 do not support expected inhibition of GH and IGF-1,dopamine
Somatostatin,DB09099,Malignant Carcinoid Syndrome,C0024586,NCT01018953,Terminated,Phase 2,Preliminary data from study NCT00994214 do not support expected inhibition of GH and IGF-1,somatostatin
Cytarabine,DB00987,leukemia,C0023418,NCT01018069,Terminated,Phase 2,Failed to reach endpoints,cytarabine
Idarubicin,DB01177,leukemia,C0023418,NCT01018069,Terminated,Phase 2,Failed to reach endpoints,idarubicin
Cyclophosphamide,DB00531,Lupus Nephritis,C0024143,NCT01015456,Terminated,Phase 3,Data Safety Monitoring Board concerning of the participants' safety,cyclophosphamide
Mycophenolate mofetil,DB00688,Lupus Nephritis,C0024143,NCT01015456,Terminated,Phase 3,Data Safety Monitoring Board concerning of the participants' safety,mycophenolate mofetil
Mycophenolic acid,DB01024,Lupus Nephritis,C0024143,NCT01015456,Terminated,Phase 3,Data Safety Monitoring Board concerning of the participants' safety,mycophenolic acid
Irinotecan,DB00762,Malignant tumor of colon,C0007102,NCT01016860,Terminated,Phase 1,This study was discontinued due to a shown lack of efficacy in the investigational agent,irinotecan
Gemcitabine,DB00441,Ovarian Diseases,C0029928,NCT01016054,Terminated,Phase 1,Trial was terminated to allow sponsors to evaluate the future development of the drug program,gemcitabine
Carboplatin,DB00958,Ovarian Diseases,C0029928,NCT01016054,Terminated,Phase 1,Trial was terminated to allow sponsors to evaluate the future development of the drug program,carboplatin
Doxorubicin,DB00997,Ovarian Diseases,C0029928,NCT01016054,Terminated,Phase 1,Trial was terminated to allow sponsors to evaluate the future development of the drug program,doxorubicin
Gemcitabine,DB00441,ovarian neoplasm,C0919267,NCT01016054,Terminated,Phase 1,Trial was terminated to allow sponsors to evaluate the future development of the drug program,gemcitabine
Carboplatin,DB00958,ovarian neoplasm,C0919267,NCT01016054,Terminated,Phase 1,Trial was terminated to allow sponsors to evaluate the future development of the drug program,carboplatin
Doxorubicin,DB00997,ovarian neoplasm,C0919267,NCT01016054,Terminated,Phase 1,Trial was terminated to allow sponsors to evaluate the future development of the drug program,doxorubicin
Gemcitabine,DB00441,Carcinoma,C0007097,NCT01016054,Terminated,Phase 1,Trial was terminated to allow sponsors to evaluate the future development of the drug program,gemcitabine
Carboplatin,DB00958,Carcinoma,C0007097,NCT01016054,Terminated,Phase 1,Trial was terminated to allow sponsors to evaluate the future development of the drug program,carboplatin
Doxorubicin,DB00997,Carcinoma,C0007097,NCT01016054,Terminated,Phase 1,Trial was terminated to allow sponsors to evaluate the future development of the drug program,doxorubicin
Valproic Acid,DB00313,High Grade Sarcoma,C1334008,NCT01010958,Terminated,Phase 1,Slow accrual,valproic acid
Sirolimus,DB00877,Hormone refractory prostate cancer,C1328504,NCT01020305,Terminated,Phase 1/Phase 2,Decision by funding sponsor due to poor accrual,sirolimus
Bicalutamide,DB01128,Hormone refractory prostate cancer,C1328504,NCT01020305,Terminated,Phase 1/Phase 2,Decision by funding sponsor due to poor accrual,bicalutamide
Everolimus,DB01590,Hormone refractory prostate cancer,C1328504,NCT01020305,Terminated,Phase 1/Phase 2,Decision by funding sponsor due to poor accrual,everolimus
Cisplatin,DB00515,Cervical carcinoma stage IB,C0278582,NCT01019278,Withdrawn,Phase 2,,cisplatin
Cisplatin,DB00515,Cervix carcinoma stage III,C0278577,NCT01019278,Withdrawn,Phase 2,,cisplatin
Atomoxetine,DB00289,Methamphetamine dependence,C1533217,NCT01019707,Terminated,Phase 1,End in funding,atomoxetine
Methamphetamine,DB01577,Methamphetamine dependence,C1533217,NCT01019707,Terminated,Phase 1,End in funding,methamphetamine
Atomoxetine,DB00289,Methamphetamine abuse,C1456624,NCT01019707,Terminated,Phase 1,End in funding,atomoxetine
Methamphetamine,DB01577,Methamphetamine abuse,C1456624,NCT01019707,Terminated,Phase 1,End in funding,methamphetamine
Hydrocortisone,DB00741,"Pneumonia, Viral",C0032310,NCT01014364,Terminated,Phase 3,"the H1N1 pandemic is now over, and fewer cases than expected were observed",hydrocortisone
Choline,DB00122,leukemia,C0023418,NCT01009931,Terminated,Phase 2,Study was terminated early due to lack of experimental medication (supply issues),choline
Dexamethasone,DB01234,leukemia,C0023418,NCT01009931,Terminated,Phase 2,Study was terminated early due to lack of experimental medication (supply issues),dexamethasone
Sirolimus,DB00877,Polycystic Kidney Diseases,C0022680,NCT01009957,Terminated,Phase 2/Phase 3,"After primary completition date, experimental drug was no longer available",sirolimus
Everolimus,DB01590,Polycystic Kidney Diseases,C0022680,NCT01009957,Terminated,Phase 2/Phase 3,"After primary completition date, experimental drug was no longer available",everolimus
Carboplatin,DB00958,Breast cancer recurrent,C0278493,NCT01009983,Terminated,Phase 2,Slow accrual,carboplatin
Paclitaxel,DB01229,Breast cancer recurrent,C0278493,NCT01009983,Terminated,Phase 2,Slow accrual,paclitaxel
Thalidomide,DB01041,"Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse",C0334634,NCT01021423,Terminated,Phase 3,Terminated by sponsor due to new unpublished data that rendered the current design of the    study no longer clinically relevant. There were no safety concerns.,thalidomide
Lenalidomide,DB00480,"Lymphoma, Non-Hodgkin",C0024305,NCT01021423,Terminated,Phase 3,Terminated by sponsor due to new unpublished data that rendered the current design of the    study no longer clinically relevant. There were no safety concerns.,lenalidomide
Thalidomide,DB01041,"Lymphoma, Non-Hodgkin",C0024305,NCT01021423,Terminated,Phase 3,Terminated by sponsor due to new unpublished data that rendered the current design of the    study no longer clinically relevant. There were no safety concerns.,thalidomide
Rosuvastatin,DB01098,Malignant tumor of colon,C0007102,NCT01011478,Terminated,Phase 3,,rosuvastatin
Rosuvastatin,DB01098,Precancerous Conditions,C0032927,NCT01011478,Terminated,Phase 3,,rosuvastatin
Dopamine,DB00988,Acromegaly,C0001206,NCT00994214,Terminated,Phase 2,Preliminary data from this study does not support expected inhibition of GH and IGF-1,dopamine
Somatostatin,DB09099,Acromegaly,C0001206,NCT00994214,Terminated,Phase 2,Preliminary data from this study does not support expected inhibition of GH and IGF-1,somatostatin
Topotecan,DB01030,Recurrent Primary Peritoneal Carcinoma,C3897731,NCT01012817,Suspended,Phase 1/Phase 2,Completion of dose escalation phase,topotecan
Irinotecan,DB00762,Malignant glioma of brain,C0349541,NCT01017653,Terminated,Phase 2,study did not reach benchmark efficacy rule at 16 subjects,irinotecan
Pegfilgrastim,DB00019,Lymphoma,C0024299,NCT01016795,Terminated,Phase 2,"Study closed Nov 2000 by Amgen, who stopped drug delivery",pegfilgrastim
Cyclophosphamide,DB00531,Non-Small Cell Lung Carcinoma,C0007131,NCT01015443,Terminated,Phase 3,The study is terminated prematurely as the sponsor decided to discontinue program with    Tecemotide in NSCLC.,cyclophosphamide
Oxycodone,DB00497,Constipation,C0009806,NCT01014559,Terminated,Phase 3,Lack of recruitment,oxycodone
Naloxone,DB01183,Constipation,C0009806,NCT01014559,Terminated,Phase 3,Lack of recruitment,naloxone
Oxycodone,DB00497,Pain,C0030193,NCT01014559,Terminated,Phase 3,Lack of recruitment,oxycodone
Dexmedetomidine,DB00633,Traumatic Brain Injury,C0876926,NCT01007773,Withdrawn,Phase 2,Study will not be intiated,dexmedetomidine
Fentanyl,DB00813,Traumatic Brain Injury,C0876926,NCT01007773,Withdrawn,Phase 2,Study will not be intiated,fentanyl
Propofol,DB00818,Traumatic Brain Injury,C0876926,NCT01007773,Withdrawn,Phase 2,Study will not be intiated,propofol
Acetaminophen,DB00316,Cardiac Arrhythmia,C0003811,NCT01026961,Withdrawn,Phase 1/Phase 2,Study is no longer required by Brazil health authority.,acetaminophen
Phenylephrine,DB00388,Cardiac Arrhythmia,C0003811,NCT01026961,Withdrawn,Phase 1/Phase 2,Study is no longer required by Brazil health authority.,phenylephrine
Oxymetazoline,DB00935,Cardiac Arrhythmia,C0003811,NCT01026961,Withdrawn,Phase 1/Phase 2,Study is no longer required by Brazil health authority.,oxymetazoline
Dimetindene,DB08801,Cardiac Arrhythmia,C0003811,NCT01026961,Withdrawn,Phase 1/Phase 2,Study is no longer required by Brazil health authority.,dimetindene
Acetylcysteine,DB06151,Bulimia Nervosa,C2267227,NCT01033149,Terminated,Phase 3,,acetylcysteine
Warfarin,DB00682,Pulmonary Hypertension,C0020542,NCT01036802,Terminated,Phase 2,Difficulty in accruing subjects,warfarin
Norepinephrine,DB00368,Psychosexual Disorders,C0033953,NCT01040208,Terminated,Phase 3,Study terminated by Sponsor for administrative reasons prior to completion of all study visits,norepinephrine
Flibanserin,DB04908,Psychosexual Disorders,C0033953,NCT01040208,Terminated,Phase 3,Study terminated by Sponsor for administrative reasons prior to completion of all study visits,flibanserin
Norepinephrine,DB00368,Depressive disorder,C0011581,NCT01040208,Terminated,Phase 3,Study terminated by Sponsor for administrative reasons prior to completion of all study visits,norepinephrine
Flibanserin,DB04908,Depressive disorder,C0011581,NCT01040208,Terminated,Phase 3,Study terminated by Sponsor for administrative reasons prior to completion of all study visits,flibanserin
Prednisolone,DB00860,Clinically isolated syndrome,C2921627,NCT01039103,Suspended,Phase 2,,prednisolone
Methylprednisolone,DB00959,Clinically isolated syndrome,C2921627,NCT01039103,Suspended,Phase 2,,methylprednisolone
Lenalidomide,DB00480,Malignant tumor of colon,C0007102,NCT01032291,Terminated,Phase 2,A business decision not to continue with Phase 2b based on non-safety observations during    proof of concept phase.,lenalidomide
Thalidomide,DB01041,Malignant tumor of colon,C0007102,NCT01032291,Terminated,Phase 2,A business decision not to continue with Phase 2b based on non-safety observations during    proof of concept phase.,thalidomide
Mesalazine,DB00244,Diverticulitis,C0012813,NCT01038739,Terminated,Phase 3,Stopped due to futility.,mesalazine
Rituximab,DB00073,Metastatic melanoma,C0278883,NCT01032122,Terminated,Phase 1,"the only reason is that recruitment was not sufficient to meet the planned patient numbers,    because complete remissions are still infrequent.",rituximab
Prednisolone,DB00860,Chronic graft-versus-host disease,C0867389,NCT01028313,Withdrawn,Phase 2,A decision was made to not move forward with the study. No participants were enrolled or    treated.,prednisolone
Methylprednisolone,DB00959,Chronic graft-versus-host disease,C0867389,NCT01028313,Withdrawn,Phase 2,A decision was made to not move forward with the study. No participants were enrolled or    treated.,methylprednisolone
Panobinostat,DB06603,Chronic graft-versus-host disease,C0867389,NCT01028313,Withdrawn,Phase 2,A decision was made to not move forward with the study. No participants were enrolled or    treated.,panobinostat
Propranolol,DB00571,Recurrent respiratory papillomatosis,C1168198,NCT01058317,Withdrawn,Phase 2/Phase 3,No participants enrolled,propranolol
Simvastatin,DB00641,Pneumonia,C0032285,NCT01057758,Terminated,Phase 3,stopped for futility,simvastatin
Cefixime,DB00671,Uterine Cervicitis,C0007860,NCT01072136,Terminated,Phase 3,,cefixime
Clofarabine,DB00631,"Leukemia, Myelocytic, Acute",C0023467,NCT01065545,Withdrawn,Phase 1,Due to funding issues.,clofarabine
Tretinoin,DB00755,"Leukemia, Myelocytic, Acute",C0023467,NCT01067274,Withdrawn,Phase 3,Study abandoned,tretinoin
Azacitidine,DB00928,"Leukemia, Myelocytic, Acute",C0023467,NCT01067274,Withdrawn,Phase 3,Study abandoned,azacitidine
Paclitaxel,DB01229,Pain,C0030193,NCT01096407,Terminated,Phase 1,slow accrual,paclitaxel
Paclitaxel,DB01229,"unspecified adult solid tumor, protocol specific",C0279004,NCT01096407,Terminated,Phase 1,slow accrual,paclitaxel
Dexmedetomidine,DB00633,Respiratory Failure,C1145670,NCT01076816,Terminated,Phase 3,Poor inclusion rate.,dexmedetomidine
Rituximab,DB00073,Chronic lymphocytic leukaemia stage 4,C0854804,NCT01076556,Terminated,Phase 1,,rituximab
Cyclophosphamide,DB00531,Chronic lymphocytic leukaemia stage 4,C0854804,NCT01076556,Terminated,Phase 1,,cyclophosphamide
Rituximab,DB00073,B-cell small lymphocytic lymphoma stage IV,C0855101,NCT01076556,Terminated,Phase 1,,rituximab
Cyclophosphamide,DB00531,B-cell small lymphocytic lymphoma stage IV,C0855101,NCT01076556,Terminated,Phase 1,,cyclophosphamide
Rituximab,DB00073,Prolymphocytic Leukemia,C0023486,NCT01076556,Terminated,Phase 1,,rituximab
Cyclophosphamide,DB00531,Prolymphocytic Leukemia,C0023486,NCT01076556,Terminated,Phase 1,,cyclophosphamide
Rituximab,DB00073,B-cell small lymphocytic lymphoma recurrent,C0855096,NCT01076556,Terminated,Phase 1,,rituximab
Cyclophosphamide,DB00531,B-cell small lymphocytic lymphoma recurrent,C0855096,NCT01076556,Terminated,Phase 1,,cyclophosphamide
Rituximab,DB00073,Chronic lymphocytic leukaemia refractory,C0278791,NCT01076556,Terminated,Phase 1,,rituximab
Cyclophosphamide,DB00531,Chronic lymphocytic leukaemia refractory,C0278791,NCT01076556,Terminated,Phase 1,,cyclophosphamide
Rituximab,DB00073,Chronic lymphocytic leukaemia stage 1,C0278767,NCT01076556,Terminated,Phase 1,,rituximab
Cyclophosphamide,DB00531,Chronic lymphocytic leukaemia stage 1,C0278767,NCT01076556,Terminated,Phase 1,,cyclophosphamide
Rituximab,DB00073,B-cell small lymphocytic lymphoma stage I,C0855098,NCT01076556,Terminated,Phase 1,,rituximab
Cyclophosphamide,DB00531,B-cell small lymphocytic lymphoma stage I,C0855098,NCT01076556,Terminated,Phase 1,,cyclophosphamide
Rituximab,DB00073,Chronic lymphocytic leukaemia stage 2,C0854803,NCT01076556,Terminated,Phase 1,,rituximab
Cyclophosphamide,DB00531,Chronic lymphocytic leukaemia stage 2,C0854803,NCT01076556,Terminated,Phase 1,,cyclophosphamide
Rituximab,DB00073,B-cell small lymphocytic lymphoma stage II,C0855099,NCT01076556,Terminated,Phase 1,,rituximab
Cyclophosphamide,DB00531,B-cell small lymphocytic lymphoma stage II,C0855099,NCT01076556,Terminated,Phase 1,,cyclophosphamide
Rituximab,DB00073,Chronic lymphocytic leukaemia stage 3,C0278769,NCT01076556,Terminated,Phase 1,,rituximab
Cyclophosphamide,DB00531,Chronic lymphocytic leukaemia stage 3,C0278769,NCT01076556,Terminated,Phase 1,,cyclophosphamide
Rituximab,DB00073,B-cell small lymphocytic lymphoma stage III,C0855100,NCT01076556,Terminated,Phase 1,,rituximab
Cyclophosphamide,DB00531,B-cell small lymphocytic lymphoma stage III,C0855100,NCT01076556,Terminated,Phase 1,,cyclophosphamide
Fenofibrate,DB01039,Coronary Arteriosclerosis,C0010054,NCT01030328,Terminated,Phase 3,Lack of patient population,fenofibrate
Atorvastatin,DB01076,Coronary Arteriosclerosis,C0010054,NCT01030328,Terminated,Phase 3,Lack of patient population,atorvastatin
Rifampicin,DB01045,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NCT01068756,Terminated,Phase 1,,rifampicin
Sildenafil,DB00203,Persistent Fetal Circulation Syndrome,C0031190,NCT01069861,Terminated,Phase 2,See termination reason in detailed description.,sildenafil
Sildenafil,DB00203,Hypoxic respiratory failure,C3805211,NCT01069861,Terminated,Phase 2,See termination reason in detailed description.,sildenafil
Ibuprofen,DB01050,Patent ductus arteriosus,C0013274,NCT01070745,Withdrawn,Phase 2,Changes in approach to PDA therapy,ibuprofen
Simvastatin,DB00641,Cystic Fibrosis,C0010674,NCT01092572,Withdrawn,Phase 1/Phase 2,Lack of funding,simvastatin
Voriconazole,DB00582,Candidiasis,C0006840,NCT01092832,Terminated,Phase 3,"This protocol terminated prematurely on July 8, 2013 due to slow enrollment, not because of    any safety issues or concerns.",voriconazole
Venlafaxine,DB00285,Depressive disorder,C0011581,NCT01114698,Terminated,Phase 2,Study was terminated due to sponsor portfolio decision.,venlafaxine
Cisplatin,DB00515,Carcinomatosis of peritoneal cavity,C0346990,NCT01116791,Terminated,Phase 2,Insufficient enrollment in Pancreatic & Biliary arm,cisplatin
Cisplatin,DB00515,Malignant neoplasm of gastrointestinal tract,C0685938,NCT01116791,Terminated,Phase 2,Insufficient enrollment in Pancreatic & Biliary arm,cisplatin
Cisplatin,DB00515,Mesothelioma malignant advanced,C0278752,NCT01105390,Withdrawn,Phase 2,withdrawn,cisplatin
Pemetrexed,DB00642,Mesothelioma malignant advanced,C0278752,NCT01105390,Withdrawn,Phase 2,withdrawn,pemetrexed
Cisplatin,DB00515,"Epithelioid mesothelioma, malignant",C0862312,NCT01105390,Withdrawn,Phase 2,withdrawn,cisplatin
Pemetrexed,DB00642,"Epithelioid mesothelioma, malignant",C0862312,NCT01105390,Withdrawn,Phase 2,withdrawn,pemetrexed
Cisplatin,DB00515,Mesothelioma malignant recurrent,C0278753,NCT01105390,Withdrawn,Phase 2,withdrawn,cisplatin
Pemetrexed,DB00642,Mesothelioma malignant recurrent,C0278753,NCT01105390,Withdrawn,Phase 2,withdrawn,pemetrexed
Cisplatin,DB00515,Sarcomatoid Mesothelioma,C0334513,NCT01105390,Withdrawn,Phase 2,withdrawn,cisplatin
Pemetrexed,DB00642,Sarcomatoid Mesothelioma,C0334513,NCT01105390,Withdrawn,Phase 2,withdrawn,pemetrexed
Ziprasidone,DB00246,Bipolar Disorder,C0005586,NCT01113541,Terminated,Phase 3,See termination reason in detailed description.,ziprasidone
Lovastatin,DB00227,Smith-Lemli-Opitz Syndrome,C0175694,NCT01110642,Withdrawn,Phase 2,Study was withdrawn due to lack of eligible population for study,lovastatin
Lovastatin,DB00227,"Chondrodysplasia punctata, X-linked dominant type",C0282102,NCT01110642,Withdrawn,Phase 2,Study was withdrawn due to lack of eligible population for study,lovastatin
Omeprazole,DB00338,Infection caused by Helicobacter pylori,C0850666,NCT01109381,Terminated,Phase 1/Phase 2,Poor efficacy (2 of 31 completing participants with H.pylori eradication),omeprazole
Gemcitabine,DB00441,Colorectal cancer metastatic,C0948380,NCT01109615,Terminated,Phase 2,Lacking effect of treatment,gemcitabine
Pemetrexed,DB00642,Colorectal cancer metastatic,C0948380,NCT01109615,Terminated,Phase 2,Lacking effect of treatment,pemetrexed
Erythromycin,DB00199,Gastroparesis,C0152020,NCT01117376,Terminated,Phase 2,The study was prematurely terminated because of unavailibility of Methylnaltrexone in the    region,erythromycin
Naltrexone,DB00704,Gastroparesis,C0152020,NCT01117376,Terminated,Phase 2,The study was prematurely terminated because of unavailibility of Methylnaltrexone in the    region,naltrexone
Methylnaltrexone,DB06800,Gastroparesis,C0152020,NCT01117376,Terminated,Phase 2,The study was prematurely terminated because of unavailibility of Methylnaltrexone in the    region,methylnaltrexone
Bevacizumab,DB00112,Colorectal Carcinoma,C0009402,NCT01126866,Terminated,Phase 2,recruiting inadequate,bevacizumab
Edetic Acid,DB00974,Acetaminophen overdose,C0572025,NCT01118663,Terminated,Phase 3,,edetic acid
Acetylcysteine,DB06151,Acetaminophen overdose,C0572025,NCT01118663,Terminated,Phase 3,,acetylcysteine
Lapatinib,DB01259,Neoplasm Metastasis,C0027627,NCT01118975,Terminated,Phase 1/Phase 2,Lost sponsorship for study drug,lapatinib
Vorinostat,DB02546,Neoplasm Metastasis,C0027627,NCT01118975,Terminated,Phase 1/Phase 2,Lost sponsorship for study drug,vorinostat
Goserelin,DB00014,HER2/Neu Negative,C2348908,NCT01149356,Terminated,Phase 1,Manufacturer discontinued drug development.,goserelin
Exemestane,DB00990,HER2/Neu Negative,C2348908,NCT01149356,Terminated,Phase 1,Manufacturer discontinued drug development.,exemestane
Goserelin,DB00014,Carcinoma of Male Breast,C0238033,NCT01149356,Terminated,Phase 1,Manufacturer discontinued drug development.,goserelin
Exemestane,DB00990,Carcinoma of Male Breast,C0238033,NCT01149356,Terminated,Phase 1,Manufacturer discontinued drug development.,exemestane
Dextroamphetamine,DB01576,Depressive disorder,C0011581,NCT01131559,Terminated,Phase 3,Sponsor halted study.,dextroamphetamine
Carboplatin,DB00958,Cholangiocarcinoma,C0206698,NCT01151761,Terminated,Phase 2,"Poor accrual, lack of enthusiasm from referring physicians, unusual outcomes regarding 2    patients",carboplatin
Carboplatin,DB00958,Hepatobiliary neoplasm,C0854196,NCT01151761,Terminated,Phase 2,"Poor accrual, lack of enthusiasm from referring physicians, unusual outcomes regarding 2    patients",carboplatin
Amitriptyline,DB00321,Transformed migraine,C1960870,NCT01151787,Terminated,Phase 3,Study was never initiated under new location/provider group. Contract to continue was never    signed between TEVA and Kennedy Headache Center,amitriptyline
Cyclobenzaprine,DB00924,Transformed migraine,C1960870,NCT01151787,Terminated,Phase 3,Study was never initiated under new location/provider group. Contract to continue was never    signed between TEVA and Kennedy Headache Center,cyclobenzaprine
Aminolevulinic acid,DB00855,adult anaplastic astrocytoma,C0280483,NCT01148966,Terminated,Phase 1/Phase 2,,aminolevulinic acid
Aminolevulinic acid,DB00855,adult anaplastic oligodendroglioma,C0280790,NCT01148966,Terminated,Phase 1/Phase 2,,aminolevulinic acid
Aminolevulinic acid,DB00855,adult giant cell glioblastoma,C1541316,NCT01148966,Terminated,Phase 1/Phase 2,,aminolevulinic acid
Aminolevulinic acid,DB00855,adult glioblastoma,C0278878,NCT01148966,Terminated,Phase 1/Phase 2,,aminolevulinic acid
Aminolevulinic acid,DB00855,adult gliosarcoma,C1541317,NCT01148966,Terminated,Phase 1/Phase 2,,aminolevulinic acid
Aminolevulinic acid,DB00855,Adult Mixed Glioma,C3900099,NCT01148966,Terminated,Phase 1/Phase 2,,aminolevulinic acid
Aminolevulinic acid,DB00855,recurrent adult brain tumor,C0278786,NCT01148966,Terminated,Phase 1/Phase 2,,aminolevulinic acid
Vitamin C,DB00126,Adenocarcinoma,C0001418,NCT01125449,Suspended,Phase 2,Awaiting response from FDA as to status of parenteral ascorbic acid manufactured by Bioniche    (Ireland).,vitamin c
Vitamin C,DB00126,Carcinoma,C0007097,NCT01125449,Suspended,Phase 2,Awaiting response from FDA as to status of parenteral ascorbic acid manufactured by Bioniche    (Ireland).,vitamin c
Vitamin C,DB00126,Multiple Myeloma,C0026764,NCT01125449,Suspended,Phase 2,Awaiting response from FDA as to status of parenteral ascorbic acid manufactured by Bioniche    (Ireland).,vitamin c
Vitamin C,DB00126,Desmoplastic Small Round Cell Tumor,C0281508,NCT01125449,Suspended,Phase 2,Awaiting response from FDA as to status of parenteral ascorbic acid manufactured by Bioniche    (Ireland).,vitamin c
Atorvastatin,DB01076,Acute Coronary Syndrome,C0948089,NCT01187992,Terminated,Phase 3,Interim analysis showed significant effect in favour of full-dose atorvastatin.,atorvastatin
Tolbutamide,DB01124,Advanced cancer,C0877373,NCT01185548,Terminated,Phase 1,Terminated based on safety results from another trial,tolbutamide
Lidocaine,DB00281,Pain,C0030193,NCT01155986,Terminated,Phase 2,Trial was stopped due to difficult enrolment,lidocaine
Lidocaine,DB00281,Chronic pain,C0150055,NCT01155986,Terminated,Phase 2,Trial was stopped due to difficult enrolment,lidocaine
Peginterferon alfa-2a,DB00008,Hepatitis C,C0019196,NCT01153919,Suspended,Phase 2,Interim analysis,peginterferon alfa-2a
Ribavirin,DB00811,Hepatitis C,C0019196,NCT01153919,Suspended,Phase 2,Interim analysis,ribavirin
Docetaxel,DB01248,Urologic Neoplasms,C0042076,NCT01155791,Terminated,Phase 1,,docetaxel
Anidulafungin,DB00362,Aspergillosis,C0004030,NCT01188759,Withdrawn,Phase 3,,anidulafungin
Voriconazole,DB00582,Aspergillosis,C0004030,NCT01188759,Withdrawn,Phase 3,,voriconazole
Anidulafungin,DB00362,Invasive Pulmonary Aspergillosis,C0276653,NCT01188759,Withdrawn,Phase 3,,anidulafungin
Anidulafungin,DB00362,Neuroaspergillosis,C0752342,NCT01188759,Withdrawn,Phase 3,,anidulafungin
Voriconazole,DB00582,Neuroaspergillosis,C0752342,NCT01188759,Withdrawn,Phase 3,,voriconazole
Cisplatin,DB00515,Small cell carcinoma of lung,C0149925,NCT01187615,Terminated,Phase 1,,cisplatin
Pemetrexed,DB00642,Small cell carcinoma of lung,C0149925,NCT01187615,Terminated,Phase 1,,pemetrexed
Rasagiline,DB01367,Progressive supranuclear palsy,C0038868,NCT01187888,Terminated,Phase 3,IMP used off label by phys. in pat. with PSP. Thus no more eligible patients were available    for the study(pre-treatm.with Rasagiline=exclusion criterion,rasagiline
Nicardipine,DB00622,Cerebral Hemorrhage,C2937358,NCT01176565,Suspended,Phase 3,Pre-planned interim analysis.,nicardipine
Celecoxib,DB00482,Malignant neoplasm of ovary,C1140680,NCT01175772,Terminated,Phase 2,Due to change in the national policy of medications,celecoxib
Methotrexate,DB00563,Malignant neoplasm of ovary,C1140680,NCT01175772,Terminated,Phase 2,Due to change in the national policy of medications,methotrexate
Methotrexate,DB00563,"Neoplasm, Residual",C0242596,NCT01158885,Terminated,Phase 2,Study terminated for lack of accrual.,methotrexate
Clofarabine,DB00631,"Neoplasm, Residual",C0242596,NCT01158885,Terminated,Phase 2,Study terminated for lack of accrual.,clofarabine
Cytarabine,DB00987,"Neoplasm, Residual",C0242596,NCT01158885,Terminated,Phase 2,Study terminated for lack of accrual.,cytarabine
Cisplatin,DB00515,Squamous cell carcinoma,C0007137,NCT01161498,Terminated,Phase 3,The changing aetiology of squamous cell carcinoma of the head and neck (SCCHN).,cisplatin
Cisplatin,DB00515,Malignant neoplasm of lung,C0242379,NCT01160731,Withdrawn,Phase 1,,cisplatin
Etoposide,DB00773,Malignant neoplasm of lung,C0242379,NCT01160731,Withdrawn,Phase 1,,etoposide
Panobinostat,DB06603,Malignant neoplasm of lung,C0242379,NCT01160731,Withdrawn,Phase 1,,panobinostat
Aldesleukin,DB00041,Metastatic melanoma,C0278883,NCT01160445,Terminated,Phase 2,The study was terminated because we were not able to obtain the study drug.,aldesleukin
Aldesleukin,DB00041,Renal cancer metastatic,C0919976,NCT01160445,Terminated,Phase 2,The study was terminated because we were not able to obtain the study drug.,aldesleukin
Pioglitazone,DB01132,Endometriosis,C0014175,NCT01184144,Withdrawn,Phase 2/Phase 3,,pioglitazone
Pegaspargase,DB00059,"Leukemia, Lymphocytic, Acute, L1",C0023452,NCT01186328,Terminated,Phase 1,The company (Enzon Pharmaceuticals)providing the drug EZN-3042 decided to end its development    of EZN-3042.,pegaspargase
Vincristine,DB00541,"Leukemia, Lymphocytic, Acute, L1",C0023452,NCT01186328,Terminated,Phase 1,The company (Enzon Pharmaceuticals)providing the drug EZN-3042 decided to end its development    of EZN-3042.,vincristine
Methotrexate,DB00563,"Leukemia, Lymphocytic, Acute, L1",C0023452,NCT01186328,Terminated,Phase 1,The company (Enzon Pharmaceuticals)providing the drug EZN-3042 decided to end its development    of EZN-3042.,methotrexate
Prednisone,DB00635,"Leukemia, Lymphocytic, Acute, L1",C0023452,NCT01186328,Terminated,Phase 1,The company (Enzon Pharmaceuticals)providing the drug EZN-3042 decided to end its development    of EZN-3042.,prednisone
Alefacept,DB00092,"transplant; failure, kidney",C1404117,NCT01163799,Terminated,Phase 1,"Noted increased risks, greater than expected for standard of care therapy.",alefacept
Sirolimus,DB00877,Mucosal Melanoma,C3898222,NCT01166126,Terminated,Phase 2,,sirolimus
Everolimus,DB01590,Mucosal Melanoma,C3898222,NCT01166126,Terminated,Phase 2,,everolimus
Sirolimus,DB00877,Melanoma recurrent,C0278884,NCT01166126,Terminated,Phase 2,,sirolimus
Everolimus,DB01590,Melanoma recurrent,C0278884,NCT01166126,Terminated,Phase 2,,everolimus
Zoledronic acid,DB00399,Multiple Sclerosis,C0026769,NCT01166178,Terminated,Phase 3,,zoledronic acid
Oxaliplatin,DB00526,Colorectal Carcinoma,C0009402,NCT01157039,Withdrawn,Phase 2,abandoned,oxaliplatin
Oxaliplatin,DB00526,Malignant tumor of colon,C0007102,NCT01157039,Withdrawn,Phase 2,abandoned,oxaliplatin
Clomifene,DB00882,Hypogonadotropic hypogonadism,C0271623,NCT01155518,Terminated,Phase 2,lack of funding,clomifene
Methyltestosterone,DB06710,Hypogonadotropic hypogonadism,C0271623,NCT01155518,Terminated,Phase 2,lack of funding,methyltestosterone
Pramlintide,DB01278,Diabetes Mellitus,C0011849,NCT01165944,Withdrawn,Phase 1/Phase 2,,pramlintide
Bortezomib,DB00188,leukemia,C0023418,NCT01162031,Withdrawn,Phase 2,Low accrual,bortezomib
Teriparatide,DB06285,Post-surgical hypoparathyroidism,C0342341,NCT01171690,Terminated,Phase 2,Funding problems,teriparatide
Valproic Acid,DB00313,"unspecified childhood solid tumor, protocol specific",C0279002,NCT01204450,Terminated,Phase 1,Funding has become unavailable,valproic acid
Sirolimus,DB00877,"unspecified childhood solid tumor, protocol specific",C0279002,NCT01204450,Terminated,Phase 1,Funding has become unavailable,sirolimus
Everolimus,DB01590,"unspecified childhood solid tumor, protocol specific",C0279002,NCT01204450,Terminated,Phase 1,Funding has become unavailable,everolimus
Valproic Acid,DB00313,Neuroblastoma,C0027819,NCT01204450,Terminated,Phase 1,Funding has become unavailable,valproic acid
Sirolimus,DB00877,Neuroblastoma,C0027819,NCT01204450,Terminated,Phase 1,Funding has become unavailable,sirolimus
Everolimus,DB01590,Neuroblastoma,C0027819,NCT01204450,Terminated,Phase 1,Funding has become unavailable,everolimus
Miltefosine,DB09031,Chronic urticaria,C0263338,NCT01170949,Terminated,Phase 2,Study medication expired,miltefosine
Gemcitabine,DB00441,Biliary Tract Cancer,C0750952,NCT01171755,Terminated,Phase 2,The objective response rate by more than two people are confirmed.,gemcitabine
Arsenic trioxide,DB01169,Endometrial Carcinoma,C0476089,NCT01184053,Terminated,Phase 2,Accrual was very low. No subject had been enrolled in a year.,arsenic trioxide
Carboplatin,DB00958,Non-Small Cell Lung Carcinoma,C0007131,NCT01184287,Withdrawn,Phase 2,Program discontinued,carboplatin
Latanoprost,DB00654,"Glaucoma, Primary Open Angle",C0339573,NCT01180062,Terminated,Phase 1,"Study terminated early due to manufacturer not replenishing study site supply of inserts,    despite repeated requests for more inserts.",latanoprost
Mesalazine,DB00244,Proctitis,C0033246,NCT01172444,Terminated,Phase 3,Enrollment difficulties,mesalazine
Sirolimus,DB00877,Brain Stem Neoplasms,C0677866,NCT01182883,Withdrawn,Phase 1,,sirolimus
Everolimus,DB01590,Brain Stem Neoplasms,C0677866,NCT01182883,Withdrawn,Phase 1,,everolimus
Cyclophosphamide,DB00531,secondary acute myeloid leukemia,C0280449,NCT01203228,Terminated,Phase 3,,cyclophosphamide
Busulfan,DB01008,secondary acute myeloid leukemia,C0280449,NCT01203228,Terminated,Phase 3,,busulfan
Bevacizumab,DB00112,adult anaplastic astrocytoma,C0280483,NCT01189240,Terminated,Phase 1/Phase 2,Company decided to stop development of drug - 7/31/12,bevacizumab
Bevacizumab,DB00112,adult anaplastic oligodendroglioma,C0280790,NCT01189240,Terminated,Phase 1/Phase 2,Company decided to stop development of drug - 7/31/12,bevacizumab
Bevacizumab,DB00112,adult giant cell glioblastoma,C1541316,NCT01189240,Terminated,Phase 1/Phase 2,Company decided to stop development of drug - 7/31/12,bevacizumab
Bevacizumab,DB00112,adult glioblastoma,C0278878,NCT01189240,Terminated,Phase 1/Phase 2,Company decided to stop development of drug - 7/31/12,bevacizumab
Bevacizumab,DB00112,adult gliosarcoma,C1541317,NCT01189240,Terminated,Phase 1/Phase 2,Company decided to stop development of drug - 7/31/12,bevacizumab
Bevacizumab,DB00112,recurrent adult brain tumor,C0278786,NCT01189240,Terminated,Phase 1/Phase 2,Company decided to stop development of drug - 7/31/12,bevacizumab
Sunitinib,DB01268,Neuroendocrine Tumors,C0206754,NCT01215578,Terminated,Phase 2,lack of recruitement,sunitinib
Sunitinib,DB01268,advanced disease,C0679246,NCT01215578,Terminated,Phase 2,lack of recruitement,sunitinib
Cisplatin,DB00515,Malignant neoplasm of lung,C0242379,NCT01222572,Terminated,Phase 1/Phase 2,Slow accrual due to restrictive eligibility criteria,cisplatin
Etoposide,DB00773,Malignant neoplasm of lung,C0242379,NCT01222572,Terminated,Phase 1/Phase 2,Slow accrual due to restrictive eligibility criteria,etoposide
Aldesleukin,DB00041,Malignant tumor of colon,C0007102,NCT01212887,Terminated,Phase 1,due to safety concerns and lack of efficacy,aldesleukin
Vidarabine,DB00194,Malignant tumor of colon,C0007102,NCT01212887,Terminated,Phase 1,due to safety concerns and lack of efficacy,vidarabine
Cyclophosphamide,DB00531,Malignant tumor of colon,C0007102,NCT01212887,Terminated,Phase 1,due to safety concerns and lack of efficacy,cyclophosphamide
Fludarabine,DB01073,Malignant tumor of colon,C0007102,NCT01212887,Terminated,Phase 1,due to safety concerns and lack of efficacy,fludarabine
Aldesleukin,DB00041,Malignant neoplasm of stomach,C0024623,NCT01212887,Terminated,Phase 1,due to safety concerns and lack of efficacy,aldesleukin
Vidarabine,DB00194,Malignant neoplasm of stomach,C0024623,NCT01212887,Terminated,Phase 1,due to safety concerns and lack of efficacy,vidarabine
Cyclophosphamide,DB00531,Malignant neoplasm of stomach,C0024623,NCT01212887,Terminated,Phase 1,due to safety concerns and lack of efficacy,cyclophosphamide
Fludarabine,DB01073,Malignant neoplasm of stomach,C0024623,NCT01212887,Terminated,Phase 1,due to safety concerns and lack of efficacy,fludarabine
Aldesleukin,DB00041,Malignant neoplasm of lung,C0242379,NCT01212887,Terminated,Phase 1,due to safety concerns and lack of efficacy,aldesleukin
Vidarabine,DB00194,Malignant neoplasm of lung,C0242379,NCT01212887,Terminated,Phase 1,due to safety concerns and lack of efficacy,vidarabine
Cyclophosphamide,DB00531,Malignant neoplasm of lung,C0242379,NCT01212887,Terminated,Phase 1,due to safety concerns and lack of efficacy,cyclophosphamide
Fludarabine,DB01073,Malignant neoplasm of lung,C0242379,NCT01212887,Terminated,Phase 1,due to safety concerns and lack of efficacy,fludarabine
Aldesleukin,DB00041,"unspecified adult solid tumor, protocol specific",C0279004,NCT01212887,Terminated,Phase 1,due to safety concerns and lack of efficacy,aldesleukin
Vidarabine,DB00194,"unspecified adult solid tumor, protocol specific",C0279004,NCT01212887,Terminated,Phase 1,due to safety concerns and lack of efficacy,vidarabine
Cyclophosphamide,DB00531,"unspecified adult solid tumor, protocol specific",C0279004,NCT01212887,Terminated,Phase 1,due to safety concerns and lack of efficacy,cyclophosphamide
Fludarabine,DB01073,"unspecified adult solid tumor, protocol specific",C0279004,NCT01212887,Terminated,Phase 1,due to safety concerns and lack of efficacy,fludarabine
Duloxetine,DB00476,Traumatic Brain Injury,C0876926,NCT01223001,Terminated,Phase 2,Most potential subjects had already been prescribed Cymbalta.,duloxetine
Duloxetine,DB00476,Depressive disorder,C0011581,NCT01223001,Terminated,Phase 2,Most potential subjects had already been prescribed Cymbalta.,duloxetine
Doxorubicin,DB00997,Hormone-Resistant Prostate Cancer,C3898877,NCT01240629,Suspended,Phase 1/Phase 2,Drug shortage,doxorubicin
Doxorubicin,DB00997,Prostate cancer recurrent,C0278838,NCT01240629,Suspended,Phase 1/Phase 2,Drug shortage,doxorubicin
Cisplatin,DB00515,Secondary malignant neoplasm of lung,C0153676,NCT01258634,Terminated,Phase 1,PI no longer affiliated with institution; only 2 subjects enrolled,cisplatin
Etoposide,DB00773,Secondary malignant neoplasm of lung,C0153676,NCT01258634,Terminated,Phase 1,PI no longer affiliated with institution; only 2 subjects enrolled,etoposide
Doxorubicin,DB00997,Secondary malignant neoplasm of lung,C0153676,NCT01258634,Terminated,Phase 1,PI no longer affiliated with institution; only 2 subjects enrolled,doxorubicin
Ifosfamide,DB01181,Secondary malignant neoplasm of lung,C0153676,NCT01258634,Terminated,Phase 1,PI no longer affiliated with institution; only 2 subjects enrolled,ifosfamide
Amlodipine,DB00381,Cardiovascular event,C1320716,NCT01259297,Terminated,Phase 3,Terminated early in agreement with Health Authorities for feasibility reasons,amlodipine
Hydrochlorothiazide,DB00999,Cardiovascular event,C1320716,NCT01259297,Terminated,Phase 3,Terminated early in agreement with Health Authorities for feasibility reasons,hydrochlorothiazide
Aprepitant,DB00673,Nausea,C0027497,NCT01249001,Suspended,Phase 2,lack of personnel resource and protocol amendment needed,aprepitant
Fosaprepitant,DB06717,Nausea,C0027497,NCT01249001,Suspended,Phase 2,lack of personnel resource and protocol amendment needed,fosaprepitant
Aprepitant,DB00673,Vomiting,C0042963,NCT01249001,Suspended,Phase 2,lack of personnel resource and protocol amendment needed,aprepitant
Fosaprepitant,DB06717,Vomiting,C0042963,NCT01249001,Suspended,Phase 2,lack of personnel resource and protocol amendment needed,fosaprepitant
Erlotinib,DB00530,Ependymoma,C0014474,NCT01247922,Terminated,Phase 2,"In a pre-planned interim analysis, OSI-774-205 met futility for efficacy with no safety    concerns. As a result, the companion trial, OSI-774-206 has been stopped",erlotinib
Sitagliptin,DB01261,Cystic Fibrosis,C0010674,NCT01257464,Terminated,Phase 2,Lack of recruitment,sitagliptin
Etomidate,DB00292,Hypertensive disease,C0020538,NCT01248234,Withdrawn,Phase 3,Did not begin,etomidate
Propofol,DB00818,Hypertensive disease,C0020538,NCT01248234,Withdrawn,Phase 3,Did not begin,propofol
Memantine,DB01043,Glioblastoma,C0017636,NCT01260467,Terminated,Phase 2,,memantine
Etoposide,DB00773,adult acute basophilic leukemia,C0279631,NCT01260714,Terminated,Phase 1,Inadequate accrual rate,etoposide
Azacitidine,DB00928,adult acute basophilic leukemia,C0279631,NCT01260714,Terminated,Phase 1,Inadequate accrual rate,azacitidine
Mitoxantrone,DB01204,adult acute basophilic leukemia,C0279631,NCT01260714,Terminated,Phase 1,Inadequate accrual rate,mitoxantrone
Etoposide,DB00773,adult acute eosinophilic leukemia,C0279630,NCT01260714,Terminated,Phase 1,Inadequate accrual rate,etoposide
Azacitidine,DB00928,adult acute eosinophilic leukemia,C0279630,NCT01260714,Terminated,Phase 1,Inadequate accrual rate,azacitidine
Mitoxantrone,DB01204,adult acute eosinophilic leukemia,C0279630,NCT01260714,Terminated,Phase 1,Inadequate accrual rate,mitoxantrone
Etoposide,DB00773,adult acute myeloid leukemia in remission,C0279094,NCT01260714,Terminated,Phase 1,Inadequate accrual rate,etoposide
Azacitidine,DB00928,adult acute myeloid leukemia in remission,C0279094,NCT01260714,Terminated,Phase 1,Inadequate accrual rate,azacitidine
Mitoxantrone,DB01204,adult acute myeloid leukemia in remission,C0279094,NCT01260714,Terminated,Phase 1,Inadequate accrual rate,mitoxantrone
Etoposide,DB00773,Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11,C2825114,NCT01260714,Terminated,Phase 1,Inadequate accrual rate,etoposide
Azacitidine,DB00928,Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11,C2825114,NCT01260714,Terminated,Phase 1,Inadequate accrual rate,azacitidine
Mitoxantrone,DB01204,Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11,C2825114,NCT01260714,Terminated,Phase 1,Inadequate accrual rate,mitoxantrone
Etoposide,DB00773,Adult Acute Myeloid Leukemia with t(8;21)(q22;q22); RUNX1-RUNX1T1,C2347540,NCT01260714,Terminated,Phase 1,Inadequate accrual rate,etoposide
Azacitidine,DB00928,Adult Acute Myeloid Leukemia with t(8;21)(q22;q22); RUNX1-RUNX1T1,C2347540,NCT01260714,Terminated,Phase 1,Inadequate accrual rate,azacitidine
Mitoxantrone,DB01204,Adult Acute Myeloid Leukemia with t(8;21)(q22;q22); RUNX1-RUNX1T1,C2347540,NCT01260714,Terminated,Phase 1,Inadequate accrual rate,mitoxantrone
Etoposide,DB00773,untreated adult acute myeloid leukemia,C0279089,NCT01260714,Terminated,Phase 1,Inadequate accrual rate,etoposide
Azacitidine,DB00928,untreated adult acute myeloid leukemia,C0279089,NCT01260714,Terminated,Phase 1,Inadequate accrual rate,azacitidine
Mitoxantrone,DB01204,untreated adult acute myeloid leukemia,C0279089,NCT01260714,Terminated,Phase 1,Inadequate accrual rate,mitoxantrone
Etoposide,DB00773,Adult Erythroleukemia,C2347748,NCT01260714,Terminated,Phase 1,Inadequate accrual rate,etoposide
Azacitidine,DB00928,Adult Erythroleukemia,C2347748,NCT01260714,Terminated,Phase 1,Inadequate accrual rate,azacitidine
Mitoxantrone,DB01204,Adult Erythroleukemia,C2347748,NCT01260714,Terminated,Phase 1,Inadequate accrual rate,mitoxantrone
Etoposide,DB00773,Adult Pure Erythroid Leukemia,C2347753,NCT01260714,Terminated,Phase 1,Inadequate accrual rate,etoposide
Azacitidine,DB00928,Adult Pure Erythroid Leukemia,C2347753,NCT01260714,Terminated,Phase 1,Inadequate accrual rate,azacitidine
Mitoxantrone,DB01204,Adult Pure Erythroid Leukemia,C2347753,NCT01260714,Terminated,Phase 1,Inadequate accrual rate,mitoxantrone
Etoposide,DB00773,Alkylating Agent-Related Acute Myeloid Leukemia,C1332233,NCT01260714,Terminated,Phase 1,Inadequate accrual rate,etoposide
Azacitidine,DB00928,Alkylating Agent-Related Acute Myeloid Leukemia,C1332233,NCT01260714,Terminated,Phase 1,Inadequate accrual rate,azacitidine
Mitoxantrone,DB01204,Alkylating Agent-Related Acute Myeloid Leukemia,C1332233,NCT01260714,Terminated,Phase 1,Inadequate accrual rate,mitoxantrone
Etoposide,DB00773,recurrent adult acute myeloid leukemia,C0278780,NCT01260714,Terminated,Phase 1,Inadequate accrual rate,etoposide
Azacitidine,DB00928,recurrent adult acute myeloid leukemia,C0278780,NCT01260714,Terminated,Phase 1,Inadequate accrual rate,azacitidine
Mitoxantrone,DB01204,recurrent adult acute myeloid leukemia,C0278780,NCT01260714,Terminated,Phase 1,Inadequate accrual rate,mitoxantrone
Etoposide,DB00773,secondary acute myeloid leukemia,C0280449,NCT01260714,Terminated,Phase 1,Inadequate accrual rate,etoposide
Azacitidine,DB00928,secondary acute myeloid leukemia,C0280449,NCT01260714,Terminated,Phase 1,Inadequate accrual rate,azacitidine
Mitoxantrone,DB01204,secondary acute myeloid leukemia,C0280449,NCT01260714,Terminated,Phase 1,Inadequate accrual rate,mitoxantrone
Amphotericin B,DB00681,Lung transplant recipient,C2063401,NCT01254708,Suspended,Phase 2,Study has been placed on hold due to unavailability of funding.,amphotericin b
Ramipril,DB00178,"unspecified adult solid tumor, protocol specific",C0279004,NCT01234922,Terminated,Phase 2,slow accrual,ramipril
Benazepril,DB00542,"unspecified adult solid tumor, protocol specific",C0279004,NCT01234922,Terminated,Phase 2,slow accrual,benazepril
Losartan,DB00678,"unspecified adult solid tumor, protocol specific",C0279004,NCT01234922,Terminated,Phase 2,slow accrual,losartan
Lisinopril,DB00722,"unspecified adult solid tumor, protocol specific",C0279004,NCT01234922,Terminated,Phase 2,slow accrual,lisinopril
Sirolimus,DB00877,Multiple Myeloma,C0026764,NCT01234974,Withdrawn,Phase 2,Study never undertaken,sirolimus
Everolimus,DB01590,Multiple Myeloma,C0026764,NCT01234974,Withdrawn,Phase 2,Study never undertaken,everolimus
Cyclophosphamide,DB00531,"Polyradiculoneuropathy, Chronic Inflammatory Demyelinating",C0393819,NCT01236456,Withdrawn,Phase 2,I am relocating to Johns Hopkins Medical Center,cyclophosphamide
Denileukin diftitox,DB00004,Multiple Myeloma,C0026764,NCT01251952,Terminated,Phase 1,Drug unavailable,denileukin diftitox
Cyclophosphamide,DB00531,Malignant neoplasm of skin,C0007114,NCT01236573,Terminated,Phase 1/Phase 2,"Unexpected toxicities, likely due to TIL/IL-12 & low % of durable responses.",cyclophosphamide
Fludarabine,DB01073,Malignant neoplasm of skin,C0007114,NCT01236573,Terminated,Phase 1/Phase 2,"Unexpected toxicities, likely due to TIL/IL-12 & low % of durable responses.",fludarabine
Cyclophosphamide,DB00531,Metastatic melanoma,C0278883,NCT01236573,Terminated,Phase 1/Phase 2,"Unexpected toxicities, likely due to TIL/IL-12 & low % of durable responses.",cyclophosphamide
Fludarabine,DB01073,Metastatic melanoma,C0278883,NCT01236573,Terminated,Phase 1/Phase 2,"Unexpected toxicities, likely due to TIL/IL-12 & low % of durable responses.",fludarabine
Infliximab,DB00065,Stevens-Johnson Syndrome,C0038325,NCT01256489,Withdrawn,Phase 1/Phase 2,Steven Johnson's Syndrome (SJS) and Toxic Epidermal Necrolysis Syndrome (TENS) are rare (~3 in    1 million). No eligible subjects have been identified.,infliximab
Norepinephrine,DB00368,Septic Shock,C0036983,NCT01271114,Terminated,Phase 3,Low recruitment rate,norepinephrine
Terlipressin,DB02638,Septic Shock,C0036983,NCT01271114,Terminated,Phase 3,Low recruitment rate,terlipressin
Norepinephrine,DB00368,Radiodermatitis,C0034561,NCT01263366,Terminated,Phase 1,Enrollment issues,norepinephrine
Irinotecan,DB00762,Secondary malignant neoplasm of liver,C0494165,NCT01285102,Terminated,Phase 2,This study was closed early by the DSMB due to increased toxicity.,irinotecan
Irinotecan,DB00762,Mucinous adenocarcinoma of colon,C0279639,NCT01285102,Terminated,Phase 2,This study was closed early by the DSMB due to increased toxicity.,irinotecan
Irinotecan,DB00762,mucinous adenocarcinoma of rectum,C0279652,NCT01285102,Terminated,Phase 2,This study was closed early by the DSMB due to increased toxicity.,irinotecan
Irinotecan,DB00762,Colon cancer recurrent,C0278553,NCT01285102,Terminated,Phase 2,This study was closed early by the DSMB due to increased toxicity.,irinotecan
Irinotecan,DB00762,Recurrent Rectal Cancer,C0278554,NCT01285102,Terminated,Phase 2,This study was closed early by the DSMB due to increased toxicity.,irinotecan
Irinotecan,DB00762,signet ring adenocarcinoma of the colon,C0279640,NCT01285102,Terminated,Phase 2,This study was closed early by the DSMB due to increased toxicity.,irinotecan
Irinotecan,DB00762,signet ring adenocarcinoma of the rectum,C0279654,NCT01285102,Terminated,Phase 2,This study was closed early by the DSMB due to increased toxicity.,irinotecan
Lapatinib,DB01259,melanoma,C0025202,NCT01264081,Terminated,Phase 2,Protocol would not be able to reach stated accrual.,lapatinib
Aldesleukin,DB00041,Stage IV Skin Melanoma,C1321872,NCT01271907,Terminated,Phase 2,Study was terminated due to poor accrual.,aldesleukin
Cyclophosphamide,DB00531,Stage IV Skin Melanoma,C1321872,NCT01271907,Terminated,Phase 2,Study was terminated due to poor accrual.,cyclophosphamide
Fludarabine,DB01073,Stage IV Skin Melanoma,C1321872,NCT01271907,Terminated,Phase 2,Study was terminated due to poor accrual.,fludarabine
Lenalidomide,DB00480,Chronic lymphocytic leukaemia stage 3,C0278769,NCT01271283,Withdrawn,Phase 2,,lenalidomide
Lenalidomide,DB00480,Chronic lymphocytic leukaemia stage 4,C0854804,NCT01271283,Withdrawn,Phase 2,,lenalidomide
Cholecalciferol,DB00169,Hyperlipidemia,C0020473,NCT01274104,Withdrawn,Phase 1,PI resigned.,cholecalciferol
Sirolimus,DB00877,Liver neoplasms,C0023903,NCT01281943,Withdrawn,Phase 2,Doxil Shortage,sirolimus
Doxorubicin,DB00997,Liver neoplasms,C0023903,NCT01281943,Withdrawn,Phase 2,Doxil Shortage,doxorubicin
Everolimus,DB01590,Liver neoplasms,C0023903,NCT01281943,Withdrawn,Phase 2,Doxil Shortage,everolimus
Varenicline,DB01273,Drug Dependence,C1510472,NCT01309685,Withdrawn,Phase 1,,varenicline
Niacin,DB00627,Primary hypercholesterolemia,C0342879,NCT01294683,Terminated,Phase 3,,niacin
Simvastatin,DB00641,Primary hypercholesterolemia,C0342879,NCT01294683,Terminated,Phase 3,,simvastatin
Nicotinamide,DB02701,Primary hypercholesterolemia,C0342879,NCT01294683,Terminated,Phase 3,,nicotinamide
Niacin,DB00627,Dyslipidemias,C0242339,NCT01294683,Terminated,Phase 3,,niacin
Simvastatin,DB00641,Dyslipidemias,C0242339,NCT01294683,Terminated,Phase 3,,simvastatin
Nicotinamide,DB02701,Dyslipidemias,C0242339,NCT01294683,Terminated,Phase 3,,nicotinamide
Bevacizumab,DB00112,Colorectal cancer metastatic,C0948380,NCT01293942,Withdrawn,Phase 2,,bevacizumab
Oxaliplatin,DB00526,Colorectal cancer metastatic,C0948380,NCT01293942,Withdrawn,Phase 2,,oxaliplatin
Fluorouracil,DB00544,Colorectal cancer metastatic,C0948380,NCT01293942,Withdrawn,Phase 2,,fluorouracil
Irinotecan,DB00762,Colorectal cancer metastatic,C0948380,NCT01293942,Withdrawn,Phase 2,,irinotecan
Capecitabine,DB01101,Colorectal cancer metastatic,C0948380,NCT01293942,Withdrawn,Phase 2,,capecitabine
Ropivacaine,DB00296,Other reconstructive surgery,C0418696,NCT01293149,Withdrawn,Phase 2,,ropivacaine
Clonidine,DB00575,Other reconstructive surgery,C0418696,NCT01293149,Withdrawn,Phase 2,,clonidine
Tacrolimus,DB00864,function of renal transplant,C2170323,NCT01292525,Terminated,Phase 3,Difficulties of recruitment,tacrolimus
Thalidomide,DB01041,Rheumatoid Arthritis,C0003873,NCT01285310,Terminated,Phase 2,Study is terminated due to lack of efficacy,thalidomide
Apremilast,DB05676,Rheumatoid Arthritis,C0003873,NCT01285310,Terminated,Phase 2,Study is terminated due to lack of efficacy,apremilast
Bupivacaine,DB00297,Fracture of lower leg,C1542178,NCT01308047,Withdrawn,Phase 3,The Sponsor has no interest in continuing the study.,bupivacaine
Levobupivacaine,DB01002,Fracture of lower leg,C1542178,NCT01308047,Withdrawn,Phase 3,The Sponsor has no interest in continuing the study.,levobupivacaine
Gemcitabine,DB00441,advanced adult primary liver cancer,C0278774,NCT01282333,Terminated,Phase 1,,gemcitabine
Cisplatin,DB00515,advanced adult primary liver cancer,C0278774,NCT01282333,Terminated,Phase 1,,cisplatin
Gemcitabine,DB00441,localized unresectable adult primary liver cancer,C0278773,NCT01282333,Terminated,Phase 1,,gemcitabine
Cisplatin,DB00515,localized unresectable adult primary liver cancer,C0278773,NCT01282333,Terminated,Phase 1,,cisplatin
Gemcitabine,DB00441,Transitional cell cancer of renal pelvis and ureter metastatic,C0279937,NCT01282333,Terminated,Phase 1,,gemcitabine
Cisplatin,DB00515,Transitional cell cancer of renal pelvis and ureter metastatic,C0279937,NCT01282333,Terminated,Phase 1,,cisplatin
Gemcitabine,DB00441,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,C0280281,NCT01282333,Terminated,Phase 1,,gemcitabine
Cisplatin,DB00515,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,C0280281,NCT01282333,Terminated,Phase 1,,cisplatin
Gemcitabine,DB00441,Bladder cancer stage III,C0278824,NCT01282333,Terminated,Phase 1,,gemcitabine
Cisplatin,DB00515,Bladder cancer stage III,C0278824,NCT01282333,Terminated,Phase 1,,cisplatin
Gemcitabine,DB00441,Pancreatic carcinoma stage III,C1167722,NCT01282333,Terminated,Phase 1,,gemcitabine
Cisplatin,DB00515,Pancreatic carcinoma stage III,C1167722,NCT01282333,Terminated,Phase 1,,cisplatin
Gemcitabine,DB00441,Non-small cell lung cancer stage IIIA,C0278983,NCT01282333,Terminated,Phase 1,,gemcitabine
Cisplatin,DB00515,Non-small cell lung cancer stage IIIA,C0278983,NCT01282333,Terminated,Phase 1,,cisplatin
Gemcitabine,DB00441,Non-small cell lung cancer metastatic,C0278987,NCT01282333,Terminated,Phase 1,,gemcitabine
Cisplatin,DB00515,Non-small cell lung cancer metastatic,C0278987,NCT01282333,Terminated,Phase 1,,cisplatin
Gemcitabine,DB00441,Stage IV Pancreatic Cancer,C1167725,NCT01282333,Terminated,Phase 1,,gemcitabine
Cisplatin,DB00515,Stage IV Pancreatic Cancer,C1167725,NCT01282333,Terminated,Phase 1,,cisplatin
Gemcitabine,DB00441,unresectable extrahepatic bile duct cancer,C0278811,NCT01282333,Terminated,Phase 1,,gemcitabine
Cisplatin,DB00515,unresectable extrahepatic bile duct cancer,C0278811,NCT01282333,Terminated,Phase 1,,cisplatin
Gemcitabine,DB00441,unresectable gallbladder cancer,C0278807,NCT01282333,Terminated,Phase 1,,gemcitabine
Cisplatin,DB00515,unresectable gallbladder cancer,C0278807,NCT01282333,Terminated,Phase 1,,cisplatin
Gemcitabine,DB00441,ovarian neoplasm,C0919267,NCT01279291,Terminated,Phase 1,The study was stopped due to the inability to determine an acceptable dose with the potential    for further study,gemcitabine
Carboplatin,DB00958,ovarian neoplasm,C0919267,NCT01279291,Terminated,Phase 1,The study was stopped due to the inability to determine an acceptable dose with the potential    for further study,carboplatin
Doxorubicin,DB00997,ovarian neoplasm,C0919267,NCT01279291,Terminated,Phase 1,The study was stopped due to the inability to determine an acceptable dose with the potential    for further study,doxorubicin
Paclitaxel,DB01229,ovarian neoplasm,C0919267,NCT01279291,Terminated,Phase 1,The study was stopped due to the inability to determine an acceptable dose with the potential    for further study,paclitaxel
Gemcitabine,DB00441,Fallopian Tube Neoplasms,C0015558,NCT01279291,Terminated,Phase 1,The study was stopped due to the inability to determine an acceptable dose with the potential    for further study,gemcitabine
Carboplatin,DB00958,Fallopian Tube Neoplasms,C0015558,NCT01279291,Terminated,Phase 1,The study was stopped due to the inability to determine an acceptable dose with the potential    for further study,carboplatin
Doxorubicin,DB00997,Fallopian Tube Neoplasms,C0015558,NCT01279291,Terminated,Phase 1,The study was stopped due to the inability to determine an acceptable dose with the potential    for further study,doxorubicin
Paclitaxel,DB01229,Fallopian Tube Neoplasms,C0015558,NCT01279291,Terminated,Phase 1,The study was stopped due to the inability to determine an acceptable dose with the potential    for further study,paclitaxel
Tacrolimus,DB00864,Lupus Nephritis,C0024143,NCT01288664,Withdrawn,Phase 3,sponsor withdraw from this study,tacrolimus
Temozolomide,DB00853,Melanoma recurrent,C0278884,NCT01328535,Suspended,Phase 2,,temozolomide
Carboplatin,DB00958,ovarian neoplasm,C0919267,NCT01329549,Terminated,Phase 1,,carboplatin
Doxorubicin,DB00997,ovarian neoplasm,C0919267,NCT01329549,Terminated,Phase 1,,doxorubicin
Nintedanib,DB09079,ovarian neoplasm,C0919267,NCT01329549,Terminated,Phase 1,,nintedanib
Bortezomib,DB00188,Relapse multiple myeloma,C2349261,NCT01329289,Withdrawn,Phase 2,Clinical trial being transferred to Columbia University with the Investigator.,bortezomib
Dexamethasone,DB01234,Relapse multiple myeloma,C2349261,NCT01329289,Withdrawn,Phase 2,Clinical trial being transferred to Columbia University with the Investigator.,dexamethasone
Milnacipran,DB04896,Primary fibromyalgia syndrome,C0521517,NCT01328002,Terminated,Phase 2,,milnacipran
Cholecalciferol,DB00169,"Hyperparathyroidism, Primary",C0221002,NCT01329666,Withdrawn,Phase 2/Phase 3,Poor enrollment,cholecalciferol
Cholecalciferol,DB00169,Hypercalcemia,C0020437,NCT01329666,Withdrawn,Phase 2/Phase 3,Poor enrollment,cholecalciferol
Cholecalciferol,DB00169,Osteopenia,C0029453,NCT01329666,Withdrawn,Phase 2/Phase 3,Poor enrollment,cholecalciferol
Cyclophosphamide,DB00531,Ewings sarcoma,C0553580,NCT01313884,Terminated,Phase 2,,cyclophosphamide
Vincristine,DB00541,Ewings sarcoma,C0553580,NCT01313884,Terminated,Phase 2,,vincristine
Irinotecan,DB00762,Ewings sarcoma,C0553580,NCT01313884,Terminated,Phase 2,,irinotecan
Temozolomide,DB00853,Ewings sarcoma,C0553580,NCT01313884,Terminated,Phase 2,,temozolomide
Doxorubicin,DB00997,Ewings sarcoma,C0553580,NCT01313884,Terminated,Phase 2,,doxorubicin
Cisplatin,DB00515,Adenocarcinoma,C0001418,NCT01301612,Withdrawn,Phase 2,Regulatory requirement. A phase III study is being designed.,cisplatin
Cisplatin,DB00515,Carcinoma,C0007097,NCT01301612,Withdrawn,Phase 2,Regulatory requirement. A phase III study is being designed.,cisplatin
Bortezomib,DB00188,"Lymphoma, Non-Hodgkin",C0024305,NCT01300793,Terminated,Phase 1,closed for low accrual and no data is available.,bortezomib
Etoposide,DB00773,"Lymphoma, Non-Hodgkin",C0024305,NCT01300793,Terminated,Phase 1,closed for low accrual and no data is available.,etoposide
Carboplatin,DB00958,"Lymphoma, Non-Hodgkin",C0024305,NCT01300793,Terminated,Phase 1,closed for low accrual and no data is available.,carboplatin
Ifosfamide,DB01181,"Lymphoma, Non-Hodgkin",C0024305,NCT01300793,Terminated,Phase 1,closed for low accrual and no data is available.,ifosfamide
Sirolimus,DB00877,Pemphigus,C0030807,NCT01313923,Terminated,Phase 0,Lack of funding,sirolimus
Everolimus,DB01590,Pemphigus,C0030807,NCT01313923,Terminated,Phase 0,Lack of funding,everolimus
Valrubicin,DB00385,Carcinoma in Situ,C0007099,NCT01310803,Terminated,Phase 3,,valrubicin
Dexamethasone,DB01234,Liver Cirrhosis,C0023890,NCT01311167,Terminated,Phase 3,Recruitment problems (not enough patients were found who met eligibility criteria),dexamethasone
Heparin,DB01109,Coronary Artery Disease,C1956346,NCT01312935,Terminated,Phase 2,PolyMedix decided to stop enrollment in both clinical trials due to observations of reductions    in blood pressure.,heparin
Gefitinib,DB00317,Glioblastoma,C0017636,NCT01310855,Terminated,Phase 2,closed to recruitment early due to AstraZeneca not developing cediranib further,gefitinib
Bevacizumab,DB00112,Secondary malignant neoplasm of liver,C0494165,NCT01320683,Terminated,Phase 2,This study will not be written up.,bevacizumab
Oxaliplatin,DB00526,Secondary malignant neoplasm of liver,C0494165,NCT01320683,Terminated,Phase 2,This study will not be written up.,oxaliplatin
Fluorouracil,DB00544,Secondary malignant neoplasm of liver,C0494165,NCT01320683,Terminated,Phase 2,This study will not be written up.,fluorouracil
Irinotecan,DB00762,Secondary malignant neoplasm of liver,C0494165,NCT01320683,Terminated,Phase 2,This study will not be written up.,irinotecan
Levoleucovorin,DB11596,Secondary malignant neoplasm of liver,C0494165,NCT01320683,Terminated,Phase 2,This study will not be written up.,levoleucovorin
Bevacizumab,DB00112,Colon cancer recurrent,C0278553,NCT01320683,Terminated,Phase 2,This study will not be written up.,bevacizumab
Oxaliplatin,DB00526,Colon cancer recurrent,C0278553,NCT01320683,Terminated,Phase 2,This study will not be written up.,oxaliplatin
Fluorouracil,DB00544,Colon cancer recurrent,C0278553,NCT01320683,Terminated,Phase 2,This study will not be written up.,fluorouracil
Irinotecan,DB00762,Colon cancer recurrent,C0278553,NCT01320683,Terminated,Phase 2,This study will not be written up.,irinotecan
Levoleucovorin,DB11596,Colon cancer recurrent,C0278553,NCT01320683,Terminated,Phase 2,This study will not be written up.,levoleucovorin
Bevacizumab,DB00112,Recurrent Rectal Cancer,C0278554,NCT01320683,Terminated,Phase 2,This study will not be written up.,bevacizumab
Oxaliplatin,DB00526,Recurrent Rectal Cancer,C0278554,NCT01320683,Terminated,Phase 2,This study will not be written up.,oxaliplatin
Fluorouracil,DB00544,Recurrent Rectal Cancer,C0278554,NCT01320683,Terminated,Phase 2,This study will not be written up.,fluorouracil
Irinotecan,DB00762,Recurrent Rectal Cancer,C0278554,NCT01320683,Terminated,Phase 2,This study will not be written up.,irinotecan
Levoleucovorin,DB11596,Recurrent Rectal Cancer,C0278554,NCT01320683,Terminated,Phase 2,This study will not be written up.,levoleucovorin
Bevacizumab,DB00112,Stage IVA Colon Cancer,C3897082,NCT01320683,Terminated,Phase 2,This study will not be written up.,bevacizumab
Oxaliplatin,DB00526,Stage IVA Colon Cancer,C3897082,NCT01320683,Terminated,Phase 2,This study will not be written up.,oxaliplatin
Fluorouracil,DB00544,Stage IVA Colon Cancer,C3897082,NCT01320683,Terminated,Phase 2,This study will not be written up.,fluorouracil
Irinotecan,DB00762,Stage IVA Colon Cancer,C3897082,NCT01320683,Terminated,Phase 2,This study will not be written up.,irinotecan
Levoleucovorin,DB11596,Stage IVA Colon Cancer,C3897082,NCT01320683,Terminated,Phase 2,This study will not be written up.,levoleucovorin
Bevacizumab,DB00112,Stage IVA Rectal Cancer,C3897520,NCT01320683,Terminated,Phase 2,This study will not be written up.,bevacizumab
Oxaliplatin,DB00526,Stage IVA Rectal Cancer,C3897520,NCT01320683,Terminated,Phase 2,This study will not be written up.,oxaliplatin
Fluorouracil,DB00544,Stage IVA Rectal Cancer,C3897520,NCT01320683,Terminated,Phase 2,This study will not be written up.,fluorouracil
Irinotecan,DB00762,Stage IVA Rectal Cancer,C3897520,NCT01320683,Terminated,Phase 2,This study will not be written up.,irinotecan
Levoleucovorin,DB11596,Stage IVA Rectal Cancer,C3897520,NCT01320683,Terminated,Phase 2,This study will not be written up.,levoleucovorin
Bevacizumab,DB00112,Stage IVB Colon Cancer,C3897517,NCT01320683,Terminated,Phase 2,This study will not be written up.,bevacizumab
Oxaliplatin,DB00526,Stage IVB Colon Cancer,C3897517,NCT01320683,Terminated,Phase 2,This study will not be written up.,oxaliplatin
Fluorouracil,DB00544,Stage IVB Colon Cancer,C3897517,NCT01320683,Terminated,Phase 2,This study will not be written up.,fluorouracil
Irinotecan,DB00762,Stage IVB Colon Cancer,C3897517,NCT01320683,Terminated,Phase 2,This study will not be written up.,irinotecan
Levoleucovorin,DB11596,Stage IVB Colon Cancer,C3897517,NCT01320683,Terminated,Phase 2,This study will not be written up.,levoleucovorin
Bevacizumab,DB00112,Stage IVB Rectal Cancer,C3897513,NCT01320683,Terminated,Phase 2,This study will not be written up.,bevacizumab
Oxaliplatin,DB00526,Stage IVB Rectal Cancer,C3897513,NCT01320683,Terminated,Phase 2,This study will not be written up.,oxaliplatin
Fluorouracil,DB00544,Stage IVB Rectal Cancer,C3897513,NCT01320683,Terminated,Phase 2,This study will not be written up.,fluorouracil
Irinotecan,DB00762,Stage IVB Rectal Cancer,C3897513,NCT01320683,Terminated,Phase 2,This study will not be written up.,irinotecan
Levoleucovorin,DB11596,Stage IVB Rectal Cancer,C3897513,NCT01320683,Terminated,Phase 2,This study will not be written up.,levoleucovorin
Propofol,DB00818,leukemia,C0023418,NCT01326078,Withdrawn,Phase 2/Phase 3,The Sponsor has no interest in continuing the study.,propofol
Erythromycin,DB00199,Gastroparesis,C0152020,NCT01323582,Terminated,Phase 2,"Original investigator left this institution, replacement investigator retired.",erythromycin
Buprenorphine,DB00921,Other acute postoperative pain,C1719392,NCT01324544,Withdrawn,Phase 3,Due to change in development plan.,buprenorphine
Buprenorphine,DB00921,INTUBATION ENDOTRACHEAL PROLONGED,C0745398,NCT01324544,Withdrawn,Phase 3,Due to change in development plan.,buprenorphine
Cyclosporine,DB00091,Lupus Nephritis,C0024143,NCT01299922,Withdrawn,Phase 3,IT was impossible to find patients,cyclosporine
Mycophenolate mofetil,DB00688,Lupus Nephritis,C0024143,NCT01299922,Withdrawn,Phase 3,IT was impossible to find patients,mycophenolate mofetil
Mycophenolic acid,DB01024,Lupus Nephritis,C0024143,NCT01299922,Withdrawn,Phase 3,IT was impossible to find patients,mycophenolic acid
Nicotine,DB00184,Tobacco Dependence,C0040332,NCT01296698,Terminated,Phase 3,Study terminated due to a technical issue (randomization error).,nicotine
Fluvoxamine,DB00176,Solid tumour,C0280100,NCT01299415,Terminated,Phase 1,,fluvoxamine
Methylphenidate,DB00422,"central nervous system tumor, pediatric",C1377665,NCT01348607,Terminated,Phase 2,Study only randomized 1 subject and was determined not feasible by DSMB,methylphenidate
Modafinil,DB00745,"central nervous system tumor, pediatric",C1377665,NCT01348607,Terminated,Phase 2,Study only randomized 1 subject and was determined not feasible by DSMB,modafinil
Armodafinil,DB06413,"central nervous system tumor, pediatric",C1377665,NCT01348607,Terminated,Phase 2,Study only randomized 1 subject and was determined not feasible by DSMB,armodafinil
Ethanol,DB00898,Alcohol problem,C0549393,NCT01348113,Terminated,Phase 3,,ethanol
Ethanol,DB00898,AOD misuse,C0678254,NCT01348113,Terminated,Phase 3,,ethanol
Gemcitabine,DB00441,Non-small cell lung cancer stage III,C0278506,NCT01336543,Withdrawn,Phase 2,"Low accrual, small patient population at center.",gemcitabine
Pemetrexed,DB00642,Non-small cell lung cancer stage III,C0278506,NCT01336543,Withdrawn,Phase 2,"Low accrual, small patient population at center.",pemetrexed
Etoposide,DB00773,Non-small cell lung cancer stage III,C0278506,NCT01336543,Withdrawn,Phase 2,"Low accrual, small patient population at center.",etoposide
Carboplatin,DB00958,Non-small cell lung cancer metastatic,C0278987,NCT01337154,Terminated,Phase 2,Interim analysis showed that the primary endpoint would not be met.,carboplatin
Irinotecan,DB00762,Advanced cancer,C0877373,NCT01347866,Terminated,Phase 1,Refer to Detailed Description for documentaion of Termination Statement.,irinotecan
Sirolimus,DB00877,Advanced cancer,C0877373,NCT01347866,Terminated,Phase 1,Refer to Detailed Description for documentaion of Termination Statement.,sirolimus
Everolimus,DB01590,Advanced cancer,C0877373,NCT01347866,Terminated,Phase 1,Refer to Detailed Description for documentaion of Termination Statement.,everolimus
Isotretinoin,DB00982,Neuroblastoma,C0027819,NCT01319838,Withdrawn,Phase 1,no patient enrollment,isotretinoin
Milnacipran,DB04896,"Fibromyalgia, Primary",C0751152,NCT01331109,Terminated,Phase 2,,milnacipran
Norepinephrine,DB00368,"Gait Disorders, Neurologic",C0751830,NCT01331122,Withdrawn,Phase 1/Phase 2,Never initiated. Withdrawn by sponsor.,norepinephrine
Droxidopa,DB06262,"Gait Disorders, Neurologic",C0751830,NCT01331122,Withdrawn,Phase 1/Phase 2,Never initiated. Withdrawn by sponsor.,droxidopa
Amikacin,DB00479,Cystic Fibrosis,C0010674,NCT01315691,Withdrawn,Phase 3,,amikacin
Nifedipine,DB01115,Threatened premature labor,C0473390,NCT01314859,Withdrawn,Phase 3,,nifedipine
Gemcitabine,DB00441,Bladder Neoplasm,C0005695,NCT01342172,Terminated,Phase 1/Phase 2,low accrual,gemcitabine
Lenalidomide,DB00480,Bladder Neoplasm,C0005695,NCT01342172,Terminated,Phase 1/Phase 2,low accrual,lenalidomide
Cisplatin,DB00515,Bladder Neoplasm,C0005695,NCT01342172,Terminated,Phase 1/Phase 2,low accrual,cisplatin
Thalidomide,DB01041,Bladder Neoplasm,C0005695,NCT01342172,Terminated,Phase 1/Phase 2,low accrual,thalidomide
Atomoxetine,DB00289,alcohol sensitivity,C0678306,NCT01343628,Terminated,Phase 1,Terminated due to lack of funding,atomoxetine
Heparin,DB01109,Malignant Childhood Neoplasm,C0278704,NCT01343680,Terminated,Phase 3,Poor patient accrual,heparin
Heparin,DB01109,Aplastic Anemia,C0002874,NCT01343680,Terminated,Phase 3,Poor patient accrual,heparin
Heparin,DB01109,Metabolic Diseases,C0025517,NCT01343680,Terminated,Phase 3,Poor patient accrual,heparin
Cisplatin,DB00515,Carcinoma,C0007097,NCT01345084,Withdrawn,Phase 3,change company strategy,cisplatin
Tacrolimus,DB00864,Lupus Nephritis,C0024143,NCT01342016,Terminated,Phase 3,Due to safety concern of active control drug,tacrolimus
Leflunomide,DB01097,Lupus Nephritis,C0024143,NCT01342016,Terminated,Phase 3,Due to safety concern of active control drug,leflunomide
Teriflunomide,DB08880,Lupus Nephritis,C0024143,NCT01342016,Terminated,Phase 3,Due to safety concern of active control drug,teriflunomide
Melatonin,DB01065,Depressive disorder,C0011581,NCT01355523,Terminated,Phase 2/Phase 3,Inclusion rate not as expected. Not financially possible to involve other centres.,melatonin
Prednisone,DB00635,Polymyalgia Rheumatica,C0032533,NCT01364389,Terminated,Phase 2,Data did not show that the two biologic treatments impacted PMR disease activity to the same    degree as steroid treatment within a 2-week treatment period.,prednisone
Prednisone,DB00635,Inflammatory disorder,C1290884,NCT01364389,Terminated,Phase 2,Data did not show that the two biologic treatments impacted PMR disease activity to the same    degree as steroid treatment within a 2-week treatment period.,prednisone
Bevacizumab,DB00112,Malignant tumor of colon,C0007102,NCT01338558,Withdrawn,Phase 3,,bevacizumab
Irinotecan,DB00762,Colorectal Neoplasms,C0009404,NCT01336985,Terminated,Phase 1,,irinotecan
Cyclosporine,DB00091,adult acute monocytic leukemia (M5b),C0280634,NCT01342887,Terminated,Phase 1/Phase 2,,cyclosporine
Pravastatin,DB00175,adult acute monocytic leukemia (M5b),C0280634,NCT01342887,Terminated,Phase 1/Phase 2,,pravastatin
Etoposide,DB00773,adult acute monocytic leukemia (M5b),C0280634,NCT01342887,Terminated,Phase 1/Phase 2,,etoposide
Mitoxantrone,DB01204,adult acute monocytic leukemia (M5b),C0280634,NCT01342887,Terminated,Phase 1/Phase 2,,mitoxantrone
Cyclosporine,DB00091,adult acute myeloblastic leukemia with maturation (M2),C0279624,NCT01342887,Terminated,Phase 1/Phase 2,,cyclosporine
Pravastatin,DB00175,adult acute myeloblastic leukemia with maturation (M2),C0279624,NCT01342887,Terminated,Phase 1/Phase 2,,pravastatin
Etoposide,DB00773,adult acute myeloblastic leukemia with maturation (M2),C0279624,NCT01342887,Terminated,Phase 1/Phase 2,,etoposide
Mitoxantrone,DB01204,adult acute myeloblastic leukemia with maturation (M2),C0279624,NCT01342887,Terminated,Phase 1/Phase 2,,mitoxantrone
Cyclosporine,DB00091,Adult Acute Myeloid Leukemia without Maturation,C0279623,NCT01342887,Terminated,Phase 1/Phase 2,,cyclosporine
Pravastatin,DB00175,Adult Acute Myeloid Leukemia without Maturation,C0279623,NCT01342887,Terminated,Phase 1/Phase 2,,pravastatin
Etoposide,DB00773,Adult Acute Myeloid Leukemia without Maturation,C0279623,NCT01342887,Terminated,Phase 1/Phase 2,,etoposide
Mitoxantrone,DB01204,Adult Acute Myeloid Leukemia without Maturation,C0279623,NCT01342887,Terminated,Phase 1/Phase 2,,mitoxantrone
Cyclosporine,DB00091,adult acute myeloid leukemia with 11q23 (MLL) abnormalities,C1541334,NCT01342887,Terminated,Phase 1/Phase 2,,cyclosporine
Pravastatin,DB00175,adult acute myeloid leukemia with 11q23 (MLL) abnormalities,C1541334,NCT01342887,Terminated,Phase 1/Phase 2,,pravastatin
Etoposide,DB00773,adult acute myeloid leukemia with 11q23 (MLL) abnormalities,C1541334,NCT01342887,Terminated,Phase 1/Phase 2,,etoposide
Mitoxantrone,DB01204,adult acute myeloid leukemia with 11q23 (MLL) abnormalities,C1541334,NCT01342887,Terminated,Phase 1/Phase 2,,mitoxantrone
Cyclosporine,DB00091,adult acute myeloid leukemia with inv(16)(p13;q22),C1541333,NCT01342887,Terminated,Phase 1/Phase 2,,cyclosporine
Pravastatin,DB00175,adult acute myeloid leukemia with inv(16)(p13;q22),C1541333,NCT01342887,Terminated,Phase 1/Phase 2,,pravastatin
Etoposide,DB00773,adult acute myeloid leukemia with inv(16)(p13;q22),C1541333,NCT01342887,Terminated,Phase 1/Phase 2,,etoposide
Mitoxantrone,DB01204,adult acute myeloid leukemia with inv(16)(p13;q22),C1541333,NCT01342887,Terminated,Phase 1/Phase 2,,mitoxantrone
Cyclosporine,DB00091,adult acute myeloid leukemia with t(16;16)(p13;q22),C1541332,NCT01342887,Terminated,Phase 1/Phase 2,,cyclosporine
Pravastatin,DB00175,adult acute myeloid leukemia with t(16;16)(p13;q22),C1541332,NCT01342887,Terminated,Phase 1/Phase 2,,pravastatin
Etoposide,DB00773,adult acute myeloid leukemia with t(16;16)(p13;q22),C1541332,NCT01342887,Terminated,Phase 1/Phase 2,,etoposide
Mitoxantrone,DB01204,adult acute myeloid leukemia with t(16;16)(p13;q22),C1541332,NCT01342887,Terminated,Phase 1/Phase 2,,mitoxantrone
Cyclosporine,DB00091,adult acute myeloid leukemia with t(8;21)(q22;q22),C1541331,NCT01342887,Terminated,Phase 1/Phase 2,,cyclosporine
Pravastatin,DB00175,adult acute myeloid leukemia with t(8;21)(q22;q22),C1541331,NCT01342887,Terminated,Phase 1/Phase 2,,pravastatin
Etoposide,DB00773,adult acute myeloid leukemia with t(8;21)(q22;q22),C1541331,NCT01342887,Terminated,Phase 1/Phase 2,,etoposide
Mitoxantrone,DB01204,adult acute myeloid leukemia with t(8;21)(q22;q22),C1541331,NCT01342887,Terminated,Phase 1/Phase 2,,mitoxantrone
Cyclosporine,DB00091,adult acute myelomonocytic leukemia (M4),C0279627,NCT01342887,Terminated,Phase 1/Phase 2,,cyclosporine
Pravastatin,DB00175,adult acute myelomonocytic leukemia (M4),C0279627,NCT01342887,Terminated,Phase 1/Phase 2,,pravastatin
Etoposide,DB00773,adult acute myelomonocytic leukemia (M4),C0279627,NCT01342887,Terminated,Phase 1/Phase 2,,etoposide
Mitoxantrone,DB01204,adult acute myelomonocytic leukemia (M4),C0279627,NCT01342887,Terminated,Phase 1/Phase 2,,mitoxantrone
Cyclosporine,DB00091,adult acute megakaryoblastic leukemia (M7),C0279632,NCT01342887,Terminated,Phase 1/Phase 2,,cyclosporine
Pravastatin,DB00175,adult acute megakaryoblastic leukemia (M7),C0279632,NCT01342887,Terminated,Phase 1/Phase 2,,pravastatin
Etoposide,DB00773,adult acute megakaryoblastic leukemia (M7),C0279632,NCT01342887,Terminated,Phase 1/Phase 2,,etoposide
Mitoxantrone,DB01204,adult acute megakaryoblastic leukemia (M7),C0279632,NCT01342887,Terminated,Phase 1/Phase 2,,mitoxantrone
Cyclosporine,DB00091,adult acute minimally differentiated myeloid leukemia (M0),C0281641,NCT01342887,Terminated,Phase 1/Phase 2,,cyclosporine
Pravastatin,DB00175,adult acute minimally differentiated myeloid leukemia (M0),C0281641,NCT01342887,Terminated,Phase 1/Phase 2,,pravastatin
Etoposide,DB00773,adult acute minimally differentiated myeloid leukemia (M0),C0281641,NCT01342887,Terminated,Phase 1/Phase 2,,etoposide
Mitoxantrone,DB01204,adult acute minimally differentiated myeloid leukemia (M0),C0281641,NCT01342887,Terminated,Phase 1/Phase 2,,mitoxantrone
Cyclosporine,DB00091,adult acute monoblastic leukemia (M5a),C0279629,NCT01342887,Terminated,Phase 1/Phase 2,,cyclosporine
Pravastatin,DB00175,adult acute monoblastic leukemia (M5a),C0279629,NCT01342887,Terminated,Phase 1/Phase 2,,pravastatin
Etoposide,DB00773,adult acute monoblastic leukemia (M5a),C0279629,NCT01342887,Terminated,Phase 1/Phase 2,,etoposide
Mitoxantrone,DB01204,adult acute monoblastic leukemia (M5a),C0279629,NCT01342887,Terminated,Phase 1/Phase 2,,mitoxantrone
Cyclosporine,DB00091,adult erythroleukemia (M6a),C1541339,NCT01342887,Terminated,Phase 1/Phase 2,,cyclosporine
Pravastatin,DB00175,adult erythroleukemia (M6a),C1541339,NCT01342887,Terminated,Phase 1/Phase 2,,pravastatin
Etoposide,DB00773,adult erythroleukemia (M6a),C1541339,NCT01342887,Terminated,Phase 1/Phase 2,,etoposide
Mitoxantrone,DB01204,adult erythroleukemia (M6a),C1541339,NCT01342887,Terminated,Phase 1/Phase 2,,mitoxantrone
Cyclosporine,DB00091,adult pure erythroid leukemia (M6b),C1541340,NCT01342887,Terminated,Phase 1/Phase 2,,cyclosporine
Pravastatin,DB00175,adult pure erythroid leukemia (M6b),C1541340,NCT01342887,Terminated,Phase 1/Phase 2,,pravastatin
Etoposide,DB00773,adult pure erythroid leukemia (M6b),C1541340,NCT01342887,Terminated,Phase 1/Phase 2,,etoposide
Mitoxantrone,DB01204,adult pure erythroid leukemia (M6b),C1541340,NCT01342887,Terminated,Phase 1/Phase 2,,mitoxantrone
Cyclosporine,DB00091,recurrent adult acute myeloid leukemia,C0278780,NCT01342887,Terminated,Phase 1/Phase 2,,cyclosporine
Pravastatin,DB00175,recurrent adult acute myeloid leukemia,C0278780,NCT01342887,Terminated,Phase 1/Phase 2,,pravastatin
Etoposide,DB00773,recurrent adult acute myeloid leukemia,C0278780,NCT01342887,Terminated,Phase 1/Phase 2,,etoposide
Mitoxantrone,DB01204,recurrent adult acute myeloid leukemia,C0278780,NCT01342887,Terminated,Phase 1/Phase 2,,mitoxantrone
Clonidine,DB00575,Neonatal Abstinence Syndrome,C0027609,NCT01360450,Terminated,Phase 2/Phase 3,The study was treminated because of low accural,clonidine
Niacin,DB00627,Primary hypercholesterolemia,C0342879,NCT01335997,Terminated,Phase 3,,niacin
Simvastatin,DB00641,Primary hypercholesterolemia,C0342879,NCT01335997,Terminated,Phase 3,,simvastatin
Nicotinamide,DB02701,Primary hypercholesterolemia,C0342879,NCT01335997,Terminated,Phase 3,,nicotinamide
Erlotinib,DB00530,recurrent metastatic squamous neck cancer with occult primary,C0279100,NCT01332279,Withdrawn,Phase 1,Pharmaceutical co. withdrew support. Study was never activated and did not accrue any    patients.,erlotinib
Sirolimus,DB00877,recurrent metastatic squamous neck cancer with occult primary,C0279100,NCT01332279,Withdrawn,Phase 1,Pharmaceutical co. withdrew support. Study was never activated and did not accrue any    patients.,sirolimus
Everolimus,DB01590,recurrent metastatic squamous neck cancer with occult primary,C0279100,NCT01332279,Withdrawn,Phase 1,Pharmaceutical co. withdrew support. Study was never activated and did not accrue any    patients.,everolimus
Erlotinib,DB00530,Recurrent Salivary Gland Cancer,C0278993,NCT01332279,Withdrawn,Phase 1,Pharmaceutical co. withdrew support. Study was never activated and did not accrue any    patients.,erlotinib
Sirolimus,DB00877,Recurrent Salivary Gland Cancer,C0278993,NCT01332279,Withdrawn,Phase 1,Pharmaceutical co. withdrew support. Study was never activated and did not accrue any    patients.,sirolimus
Everolimus,DB01590,Recurrent Salivary Gland Cancer,C0278993,NCT01332279,Withdrawn,Phase 1,Pharmaceutical co. withdrew support. Study was never activated and did not accrue any    patients.,everolimus
Erlotinib,DB00530,Squamous cell carcinoma of the hypopharynx recurrent,C0280392,NCT01332279,Withdrawn,Phase 1,Pharmaceutical co. withdrew support. Study was never activated and did not accrue any    patients.,erlotinib
Sirolimus,DB00877,Squamous cell carcinoma of the hypopharynx recurrent,C0280392,NCT01332279,Withdrawn,Phase 1,Pharmaceutical co. withdrew support. Study was never activated and did not accrue any    patients.,sirolimus
Everolimus,DB01590,Squamous cell carcinoma of the hypopharynx recurrent,C0280392,NCT01332279,Withdrawn,Phase 1,Pharmaceutical co. withdrew support. Study was never activated and did not accrue any    patients.,everolimus
Erlotinib,DB00530,Laryngeal squamous cell carcinoma recurrent,C0280401,NCT01332279,Withdrawn,Phase 1,Pharmaceutical co. withdrew support. Study was never activated and did not accrue any    patients.,erlotinib
Sirolimus,DB00877,Laryngeal squamous cell carcinoma recurrent,C0280401,NCT01332279,Withdrawn,Phase 1,Pharmaceutical co. withdrew support. Study was never activated and did not accrue any    patients.,sirolimus
Everolimus,DB01590,Laryngeal squamous cell carcinoma recurrent,C0280401,NCT01332279,Withdrawn,Phase 1,Pharmaceutical co. withdrew support. Study was never activated and did not accrue any    patients.,everolimus
Erlotinib,DB00530,recurrent squamous cell carcinoma of the lip and oral cavity,C0280363,NCT01332279,Withdrawn,Phase 1,Pharmaceutical co. withdrew support. Study was never activated and did not accrue any    patients.,erlotinib
Sirolimus,DB00877,recurrent squamous cell carcinoma of the lip and oral cavity,C0280363,NCT01332279,Withdrawn,Phase 1,Pharmaceutical co. withdrew support. Study was never activated and did not accrue any    patients.,sirolimus
Everolimus,DB01590,recurrent squamous cell carcinoma of the lip and oral cavity,C0280363,NCT01332279,Withdrawn,Phase 1,Pharmaceutical co. withdrew support. Study was never activated and did not accrue any    patients.,everolimus
Erlotinib,DB00530,Oropharyngeal squamous cell carcinoma recurrent,C0280376,NCT01332279,Withdrawn,Phase 1,Pharmaceutical co. withdrew support. Study was never activated and did not accrue any    patients.,erlotinib
Sirolimus,DB00877,Oropharyngeal squamous cell carcinoma recurrent,C0280376,NCT01332279,Withdrawn,Phase 1,Pharmaceutical co. withdrew support. Study was never activated and did not accrue any    patients.,sirolimus
Everolimus,DB01590,Oropharyngeal squamous cell carcinoma recurrent,C0280376,NCT01332279,Withdrawn,Phase 1,Pharmaceutical co. withdrew support. Study was never activated and did not accrue any    patients.,everolimus
Erlotinib,DB00530,recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity,C0280419,NCT01332279,Withdrawn,Phase 1,Pharmaceutical co. withdrew support. Study was never activated and did not accrue any    patients.,erlotinib
Sirolimus,DB00877,recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity,C0280419,NCT01332279,Withdrawn,Phase 1,Pharmaceutical co. withdrew support. Study was never activated and did not accrue any    patients.,sirolimus
Everolimus,DB01590,recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity,C0280419,NCT01332279,Withdrawn,Phase 1,Pharmaceutical co. withdrew support. Study was never activated and did not accrue any    patients.,everolimus
Erlotinib,DB00530,Laryngeal verrucous carcinoma recurrent,C0280402,NCT01332279,Withdrawn,Phase 1,Pharmaceutical co. withdrew support. Study was never activated and did not accrue any    patients.,erlotinib
Sirolimus,DB00877,Laryngeal verrucous carcinoma recurrent,C0280402,NCT01332279,Withdrawn,Phase 1,Pharmaceutical co. withdrew support. Study was never activated and did not accrue any    patients.,sirolimus
Everolimus,DB01590,Laryngeal verrucous carcinoma recurrent,C0280402,NCT01332279,Withdrawn,Phase 1,Pharmaceutical co. withdrew support. Study was never activated and did not accrue any    patients.,everolimus
Erlotinib,DB00530,Verrucous carcinoma of the oral cavity recurrent,C0280365,NCT01332279,Withdrawn,Phase 1,Pharmaceutical co. withdrew support. Study was never activated and did not accrue any    patients.,erlotinib
Sirolimus,DB00877,Verrucous carcinoma of the oral cavity recurrent,C0280365,NCT01332279,Withdrawn,Phase 1,Pharmaceutical co. withdrew support. Study was never activated and did not accrue any    patients.,sirolimus
Everolimus,DB01590,Verrucous carcinoma of the oral cavity recurrent,C0280365,NCT01332279,Withdrawn,Phase 1,Pharmaceutical co. withdrew support. Study was never activated and did not accrue any    patients.,everolimus
Erlotinib,DB00530,squamous cell carcinoma of salivary gland,C0279697,NCT01332279,Withdrawn,Phase 1,Pharmaceutical co. withdrew support. Study was never activated and did not accrue any    patients.,erlotinib
Sirolimus,DB00877,squamous cell carcinoma of salivary gland,C0279697,NCT01332279,Withdrawn,Phase 1,Pharmaceutical co. withdrew support. Study was never activated and did not accrue any    patients.,sirolimus
Everolimus,DB01590,squamous cell carcinoma of salivary gland,C0279697,NCT01332279,Withdrawn,Phase 1,Pharmaceutical co. withdrew support. Study was never activated and did not accrue any    patients.,everolimus
Letrozole,DB01006,HER-2 positive breast cancer,C1699634,NCT01361945,Withdrawn,Phase 1/Phase 2,Closed due to no enrollment,letrozole
Lapatinib,DB01259,HER-2 positive breast cancer,C1699634,NCT01361945,Withdrawn,Phase 1/Phase 2,Closed due to no enrollment,lapatinib
Ramipril,DB00178,Low density lipoprotein increased,C0549399,NCT01362218,Terminated,Phase 2,Per sponsor's decision,ramipril
Simvastatin,DB00641,Low density lipoprotein increased,C0549399,NCT01362218,Terminated,Phase 2,Per sponsor's decision,simvastatin
Salicylic acid,DB00936,Low density lipoprotein increased,C0549399,NCT01362218,Terminated,Phase 2,Per sponsor's decision,salicylic acid
Acetylsalicylic acid,DB00945,Low density lipoprotein increased,C0549399,NCT01362218,Terminated,Phase 2,Per sponsor's decision,acetylsalicylic acid
Busulfan,DB01008,Hematological Disease,C0018939,NCT01359254,Terminated,Phase 2,did not accrue enough patients.,busulfan
Melphalan,DB01042,Hematological Disease,C0018939,NCT01359254,Terminated,Phase 2,did not accrue enough patients.,melphalan
Fludarabine,DB01073,Hematological Disease,C0018939,NCT01359254,Terminated,Phase 2,did not accrue enough patients.,fludarabine
Metformin,DB00331,Squamous cell carcinoma,C0007137,NCT01333852,Terminated,Phase 2,Low accrual,metformin
Paclitaxel,DB01229,Squamous cell carcinoma,C0007137,NCT01333852,Terminated,Phase 2,Low accrual,paclitaxel
Aminolevulinic acid,DB00855,Astrocytoma,C0004114,NCT01351519,Terminated,Phase 2,Limited staff available for enrollment and limited availability of drug,aminolevulinic acid
Aminolevulinic acid,DB00855,Malignant Glioma,C0555198,NCT01351519,Terminated,Phase 2,Limited staff available for enrollment and limited availability of drug,aminolevulinic acid
Aminolevulinic acid,DB00855,Glioblastoma,C0017636,NCT01351519,Terminated,Phase 2,Limited staff available for enrollment and limited availability of drug,aminolevulinic acid
Magnesium Sulfate,DB00653,Traumatic Brain Injury,C0876926,NCT01333488,Terminated,Phase 2,Low accrual,magnesium sulfate
Cyclosporine,DB00091,Bronchiolitis Obliterans,C0006272,NCT01334892,Terminated,Phase 2/Phase 3,"Interim analysis results revealed substantial increase of patient number, with unfeasible    study prolongation.",cyclosporine
Vitamin E,DB00163,Nonalcoholic Steatohepatitis,C3241937,NCT01384578,Withdrawn,Phase 3,Lack of funds,vitamin e
Pentoxifylline,DB00806,Nonalcoholic Steatohepatitis,C3241937,NCT01384578,Withdrawn,Phase 3,Lack of funds,pentoxifylline
Vigabatrin,DB01080,"Alcoholic Intoxication, Chronic",C0001973,NCT01335867,Terminated,Phase 2,,vigabatrin
Vigabatrin,DB01080,Cocaine Dependence,C0600427,NCT01335867,Terminated,Phase 2,,vigabatrin
Sirolimus,DB00877,Non-small cell lung cancer recurrent,C0278517,NCT01383668,Withdrawn,Phase 1,lack of access to study drug,sirolimus
Everolimus,DB01590,Non-small cell lung cancer recurrent,C0278517,NCT01383668,Withdrawn,Phase 1,lack of access to study drug,everolimus
Sodium aurothiomalate,DB09276,Non-small cell lung cancer recurrent,C0278517,NCT01383668,Withdrawn,Phase 1,lack of access to study drug,sodium aurothiomalate
Sirolimus,DB00877,Non-small cell lung cancer stage IIIA,C0278983,NCT01383668,Withdrawn,Phase 1,lack of access to study drug,sirolimus
Everolimus,DB01590,Non-small cell lung cancer stage IIIA,C0278983,NCT01383668,Withdrawn,Phase 1,lack of access to study drug,everolimus
Sodium aurothiomalate,DB09276,Non-small cell lung cancer stage IIIA,C0278983,NCT01383668,Withdrawn,Phase 1,lack of access to study drug,sodium aurothiomalate
Sirolimus,DB00877,Non-small cell lung cancer metastatic,C0278987,NCT01383668,Withdrawn,Phase 1,lack of access to study drug,sirolimus
Everolimus,DB01590,Non-small cell lung cancer metastatic,C0278987,NCT01383668,Withdrawn,Phase 1,lack of access to study drug,everolimus
Sodium aurothiomalate,DB09276,Non-small cell lung cancer metastatic,C0278987,NCT01383668,Withdrawn,Phase 1,lack of access to study drug,sodium aurothiomalate
Sirolimus,DB00877,"unspecified adult solid tumor, protocol specific",C0279004,NCT01383668,Withdrawn,Phase 1,lack of access to study drug,sirolimus
Everolimus,DB01590,"unspecified adult solid tumor, protocol specific",C0279004,NCT01383668,Withdrawn,Phase 1,lack of access to study drug,everolimus
Sodium aurothiomalate,DB09276,"unspecified adult solid tumor, protocol specific",C0279004,NCT01383668,Withdrawn,Phase 1,lack of access to study drug,sodium aurothiomalate
Imatinib,DB00619,recurrent adult acute lymphoblastic leukemia,C0278785,NCT01383447,Terminated,Phase 1/Phase 2,Administratively complete.,imatinib
Vorinostat,DB02546,adult anaplastic astrocytoma,C0280483,NCT01378481,Terminated,Phase 1,,vorinostat
Vorinostat,DB02546,adult anaplastic oligodendroglioma,C0280790,NCT01378481,Terminated,Phase 1,,vorinostat
Vorinostat,DB02546,adult giant cell glioblastoma,C1541316,NCT01378481,Terminated,Phase 1,,vorinostat
Vorinostat,DB02546,adult glioblastoma,C0278878,NCT01378481,Terminated,Phase 1,,vorinostat
Vorinostat,DB02546,adult gliosarcoma,C1541317,NCT01378481,Terminated,Phase 1,,vorinostat
Vorinostat,DB02546,Adult Mixed Glioma,C3900099,NCT01378481,Terminated,Phase 1,,vorinostat
Docetaxel,DB01248,Bladder cancer stage III,C0278824,NCT01382706,Terminated,Phase 2,Trial not progressing toward scientific goals,docetaxel
Lapatinib,DB01259,Bladder cancer stage III,C0278824,NCT01382706,Terminated,Phase 2,Trial not progressing toward scientific goals,lapatinib
Sevoflurane,DB01236,Brain Injuries,C0270611,NCT01374633,Terminated,Phase 2,Sponsor decision,sevoflurane
Tadalafil,DB00820,Multiple Myeloma,C0026764,NCT01374217,Terminated,Phase 2,early stopping rule,tadalafil
Sildenafil,DB00203,Persistent Fetal Circulation Syndrome,C0031190,NCT01360671,Withdrawn,Phase 2,,sildenafil
Melphalan,DB01042,Hodgkin Disease,C0019829,NCT01350258,Terminated,Phase 1/Phase 2,Poor accrual,melphalan
Fludarabine,DB01073,Hodgkin Disease,C0019829,NCT01350258,Terminated,Phase 1/Phase 2,Poor accrual,fludarabine
Melphalan,DB01042,"Lymphoma, Non-Hodgkin",C0024305,NCT01350258,Terminated,Phase 1/Phase 2,Poor accrual,melphalan
Fludarabine,DB01073,"Lymphoma, Non-Hodgkin",C0024305,NCT01350258,Terminated,Phase 1/Phase 2,Poor accrual,fludarabine
Bortezomib,DB00188,Disorder of transplanted kidney,C1261281,NCT01349595,Terminated,Phase 2,Study halted due to lack of funding,bortezomib
Domperidone,DB01184,Gastroparesis,C0152020,NCT01378884,Withdrawn,Phase 3,,domperidone
Irinotecan,DB00762,Malignant tumor of colon,C0007102,NCT01367275,Terminated,Phase 2,Sponsor closed study,irinotecan
Irinotecan,DB00762,Adenocarcinoma of large intestine,C1319315,NCT01367275,Terminated,Phase 2,Sponsor closed study,irinotecan
Midazolam,DB00683,Traumatic Brain Injury,C0876926,NCT01402596,Withdrawn,Phase 2,"Institution decided on starting a new protocol of sedation, with another methods and that´s    why this study has not started.",midazolam
Chloral hydrate,DB01563,Traumatic Brain Injury,C0876926,NCT01402596,Withdrawn,Phase 2,"Institution decided on starting a new protocol of sedation, with another methods and that´s    why this study has not started.",chloral hydrate
Bosentan,DB00559,Persistent Fetal Circulation Syndrome,C0031190,NCT01389856,Terminated,Phase 3,To be compliant with the timelines as agreed with Paediatric Committee (PC) within the    Paediatric Investigational Plan,bosentan
Formoterol,DB00983,Chronic Obstructive Airway Disease,C0024117,NCT01351792,Terminated,Phase 3,,formoterol
Peginterferon alfa-2a,DB00008,leukemia,C0023418,NCT01392170,Terminated,Phase 2,Slow Accrual,peginterferon alfa-2a
Bortezomib,DB00188,recurrent adult diffuse large cell lymphoma,C0280188,NCT01397591,Terminated,Phase 2,Study closed by PI due to lower than expected accrual.,bortezomib
Bortezomib,DB00188,recurrent grade 1 follicular lymphoma,C0280182,NCT01397591,Terminated,Phase 2,Study closed by PI due to lower than expected accrual.,bortezomib
Bortezomib,DB00188,recurrent grade 2 follicular lymphoma,C0280183,NCT01397591,Terminated,Phase 2,Study closed by PI due to lower than expected accrual.,bortezomib
Bortezomib,DB00188,recurrent grade 3 follicular lymphoma,C0280185,NCT01397591,Terminated,Phase 2,Study closed by PI due to lower than expected accrual.,bortezomib
Bortezomib,DB00188,Mantle cell lymphoma recurrent,C0677725,NCT01397591,Terminated,Phase 2,Study closed by PI due to lower than expected accrual.,bortezomib
Oxytocin,DB00107,Dystocia,C0013418,NCT01397630,Terminated,Phase 3,"Due to budgetary concerns, the TSC decided it best to adjust sample size as there was    sufficient data to assess feasibility. Recruitment was terminated early.",oxytocin
Sunitinib,DB01268,Plexiform Neurofibroma,C0206728,NCT01402817,Suspended,Phase 2,1 patient died of uncertain cause but possibly related to drug. Regulatory currently reviewing,sunitinib
Modafinil,DB00745,Malignant Glioma,C0555198,NCT01400958,Terminated,Phase 2,"Slow Accrual, Initiating Principal Investigator (PI) left Moffitt",modafinil
Temozolomide,DB00853,Malignant Glioma,C0555198,NCT01400958,Terminated,Phase 2,"Slow Accrual, Initiating Principal Investigator (PI) left Moffitt",temozolomide
Armodafinil,DB06413,Malignant Glioma,C0555198,NCT01400958,Terminated,Phase 2,"Slow Accrual, Initiating Principal Investigator (PI) left Moffitt",armodafinil
Bevacizumab,DB00112,Malignant tumor of colon,C0007102,NCT01375816,Terminated,Phase 2,efficacy interim analysis as per protocol,bevacizumab
Leucovorin,DB00650,Malignant tumor of colon,C0007102,NCT01375816,Terminated,Phase 2,efficacy interim analysis as per protocol,leucovorin
Irinotecan,DB00762,Malignant tumor of colon,C0007102,NCT01375816,Terminated,Phase 2,efficacy interim analysis as per protocol,irinotecan
Levoleucovorin,DB11596,Malignant tumor of colon,C0007102,NCT01375816,Terminated,Phase 2,efficacy interim analysis as per protocol,levoleucovorin
Norepinephrine,DB00368,Alopecia,C0002170,NCT01367990,Terminated,Phase 1,Study site has terminated the study due to the complexity of the study,norepinephrine
Norepinephrine,DB00368,Radiodermatitis,C0034561,NCT01367990,Terminated,Phase 1,Study site has terminated the study due to the complexity of the study,norepinephrine
Testosterone,DB00624,hormone deficiency,C0599750,NCT01397500,Terminated,Phase 2,Recruitment problems due to change of patient population at site.,testosterone
Methyltestosterone,DB06710,hormone deficiency,C0599750,NCT01397500,Terminated,Phase 2,Recruitment problems due to change of patient population at site.,methyltestosterone
Dutasteride,DB01126,Adenocarcinoma of prostate,C0007112,NCT01368003,Withdrawn,Phase 2,Loss of funding.,dutasteride
Goserelin,DB00014,Oestrogen receptor positive breast cancer,C2938924,NCT01368263,Terminated,Phase 2,Due to funding source and lack of accrual,goserelin
Letrozole,DB01006,Oestrogen receptor positive breast cancer,C2938924,NCT01368263,Terminated,Phase 2,Due to funding source and lack of accrual,letrozole
Anastrozole,DB01217,Oestrogen receptor positive breast cancer,C2938924,NCT01368263,Terminated,Phase 2,Due to funding source and lack of accrual,anastrozole
Goserelin,DB00014,Breast cancer stage II,C0278486,NCT01368263,Terminated,Phase 2,Due to funding source and lack of accrual,goserelin
Letrozole,DB01006,Breast cancer stage II,C0278486,NCT01368263,Terminated,Phase 2,Due to funding source and lack of accrual,letrozole
Anastrozole,DB01217,Breast cancer stage II,C0278486,NCT01368263,Terminated,Phase 2,Due to funding source and lack of accrual,anastrozole
Niacin,DB00627,Psoriasis,C0033860,NCT01368887,Suspended,Phase 2,Sponsor seeking additional financial support before starting the study,niacin
Calcipotriol,DB02300,Psoriasis,C0033860,NCT01368887,Suspended,Phase 2,Sponsor seeking additional financial support before starting the study,calcipotriol
Nicotinamide,DB02701,Psoriasis,C0033860,NCT01368887,Suspended,Phase 2,Sponsor seeking additional financial support before starting the study,nicotinamide
Riboflavin,DB00140,Pathological Dilatation,C0012359,NCT01398839,Terminated,Phase 3,,riboflavin
Gemcitabine,DB00441,leiomyosarcoma,C0023269,NCT01418001,Terminated,Phase 1/Phase 2,Lack of accrual,gemcitabine
Docetaxel,DB01248,leiomyosarcoma,C0023269,NCT01418001,Terminated,Phase 1/Phase 2,Lack of accrual,docetaxel
Lenalidomide,DB00480,leukemia,C0023418,NCT01401322,Terminated,Phase 2,low accrual,lenalidomide
Thalidomide,DB01041,leukemia,C0023418,NCT01401322,Terminated,Phase 2,low accrual,thalidomide
Glycine,DB00145,Cystic Fibrosis,C0010674,NCT01417481,Terminated,Phase 2,Some of the researchers finished their participation in the study.,glycine
Mycophenolate mofetil,DB00688,Lupus Nephritis,C0024143,NCT01369628,Terminated,Phase 1,Please see Purpose Statement below,mycophenolate mofetil
Mycophenolic acid,DB01024,Lupus Nephritis,C0024143,NCT01369628,Terminated,Phase 1,Please see Purpose Statement below,mycophenolic acid
Methylphenidate,DB00422,Traumatic Brain Injury,C0876926,NCT01416948,Terminated,Phase 2,"The funding agency, DoD, determined that the study could not meet its enrollment numbers by    the end of the grant.",methylphenidate
Galantamine,DB00674,Traumatic Brain Injury,C0876926,NCT01416948,Terminated,Phase 2,"The funding agency, DoD, determined that the study could not meet its enrollment numbers by    the end of the grant.",galantamine
Cisplatin,DB00515,Malignant neoplasm of lung,C0242379,NCT01416961,Withdrawn,Phase 1,Neutron therapy has become unavailable,cisplatin
Etoposide,DB00773,Malignant neoplasm of lung,C0242379,NCT01416961,Withdrawn,Phase 1,Neutron therapy has become unavailable,etoposide
Rituximab,DB00073,adult nasal type extranodal NK/T-cell lymphoma,C1879279,NCT01419795,Terminated,Phase 2,Low accrual,rituximab
Lenalidomide,DB00480,adult nasal type extranodal NK/T-cell lymphoma,C1879279,NCT01419795,Terminated,Phase 2,Low accrual,lenalidomide
Thalidomide,DB01041,adult nasal type extranodal NK/T-cell lymphoma,C1879279,NCT01419795,Terminated,Phase 2,Low accrual,thalidomide
Rituximab,DB00073,Ki-1+ Anaplastic Large Cell Lymphoma,C0206180,NCT01419795,Terminated,Phase 2,Low accrual,rituximab
Lenalidomide,DB00480,Ki-1+ Anaplastic Large Cell Lymphoma,C0206180,NCT01419795,Terminated,Phase 2,Low accrual,lenalidomide
Thalidomide,DB01041,Ki-1+ Anaplastic Large Cell Lymphoma,C0206180,NCT01419795,Terminated,Phase 2,Low accrual,thalidomide
Rituximab,DB00073,Angioimmunoblastic Lymphadenopathy,C0020981,NCT01419795,Terminated,Phase 2,Low accrual,rituximab
Lenalidomide,DB00480,Angioimmunoblastic Lymphadenopathy,C0020981,NCT01419795,Terminated,Phase 2,Low accrual,lenalidomide
Thalidomide,DB01041,Angioimmunoblastic Lymphadenopathy,C0020981,NCT01419795,Terminated,Phase 2,Low accrual,thalidomide
Rituximab,DB00073,Cutaneous B-Cell Non-Hodgkin Lymphoma,C1511566,NCT01419795,Terminated,Phase 2,Low accrual,rituximab
Lenalidomide,DB00480,Cutaneous B-Cell Non-Hodgkin Lymphoma,C1511566,NCT01419795,Terminated,Phase 2,Low accrual,lenalidomide
Thalidomide,DB01041,Cutaneous B-Cell Non-Hodgkin Lymphoma,C1511566,NCT01419795,Terminated,Phase 2,Low accrual,thalidomide
Rituximab,DB00073,Mucosa-Associated Lymphoid Tissue Lymphoma,C0242647,NCT01419795,Terminated,Phase 2,Low accrual,rituximab
Lenalidomide,DB00480,Mucosa-Associated Lymphoid Tissue Lymphoma,C0242647,NCT01419795,Terminated,Phase 2,Low accrual,lenalidomide
Thalidomide,DB01041,Mucosa-Associated Lymphoid Tissue Lymphoma,C0242647,NCT01419795,Terminated,Phase 2,Low accrual,thalidomide
Rituximab,DB00073,Hepatosplenic T-cell lymphoma,C1333984,NCT01419795,Terminated,Phase 2,Low accrual,rituximab
Lenalidomide,DB00480,Hepatosplenic T-cell lymphoma,C1333984,NCT01419795,Terminated,Phase 2,Low accrual,lenalidomide
Thalidomide,DB01041,Hepatosplenic T-cell lymphoma,C1333984,NCT01419795,Terminated,Phase 2,Low accrual,thalidomide
Rituximab,DB00073,Monocytoid B-cell lymphoma,C0855139,NCT01419795,Terminated,Phase 2,Low accrual,rituximab
Lenalidomide,DB00480,Monocytoid B-cell lymphoma,C0855139,NCT01419795,Terminated,Phase 2,Low accrual,lenalidomide
Thalidomide,DB01041,Monocytoid B-cell lymphoma,C0855139,NCT01419795,Terminated,Phase 2,Low accrual,thalidomide
Rituximab,DB00073,Peripheral T-Cell Lymphoma,C0079774,NCT01419795,Terminated,Phase 2,Low accrual,rituximab
Lenalidomide,DB00480,Peripheral T-Cell Lymphoma,C0079774,NCT01419795,Terminated,Phase 2,Low accrual,lenalidomide
Thalidomide,DB01041,Peripheral T-Cell Lymphoma,C0079774,NCT01419795,Terminated,Phase 2,Low accrual,thalidomide
Rituximab,DB00073,Prolymphocytic Leukemia,C0023486,NCT01419795,Terminated,Phase 2,Low accrual,rituximab
Lenalidomide,DB00480,Prolymphocytic Leukemia,C0023486,NCT01419795,Terminated,Phase 2,Low accrual,lenalidomide
Thalidomide,DB01041,Prolymphocytic Leukemia,C0023486,NCT01419795,Terminated,Phase 2,Low accrual,thalidomide
Rituximab,DB00073,recurrent adult Burkitt's lymphoma,C0280192,NCT01419795,Terminated,Phase 2,Low accrual,rituximab
Lenalidomide,DB00480,recurrent adult Burkitt's lymphoma,C0280192,NCT01419795,Terminated,Phase 2,Low accrual,lenalidomide
Thalidomide,DB01041,recurrent adult Burkitt's lymphoma,C0280192,NCT01419795,Terminated,Phase 2,Low accrual,thalidomide
Rituximab,DB00073,recurrent adult diffuse large cell lymphoma,C0280188,NCT01419795,Terminated,Phase 2,Low accrual,rituximab
Lenalidomide,DB00480,recurrent adult diffuse large cell lymphoma,C0280188,NCT01419795,Terminated,Phase 2,Low accrual,lenalidomide
Thalidomide,DB01041,recurrent adult diffuse large cell lymphoma,C0280188,NCT01419795,Terminated,Phase 2,Low accrual,thalidomide
Rituximab,DB00073,recurrent adult diffuse mixed cell lymphoma,C0280187,NCT01419795,Terminated,Phase 2,Low accrual,rituximab
Lenalidomide,DB00480,recurrent adult diffuse mixed cell lymphoma,C0280187,NCT01419795,Terminated,Phase 2,Low accrual,lenalidomide
Thalidomide,DB01041,recurrent adult diffuse mixed cell lymphoma,C0280187,NCT01419795,Terminated,Phase 2,Low accrual,thalidomide
Rituximab,DB00073,recurrent adult diffuse small cleaved cell lymphoma,C0280186,NCT01419795,Terminated,Phase 2,Low accrual,rituximab
Lenalidomide,DB00480,recurrent adult diffuse small cleaved cell lymphoma,C0280186,NCT01419795,Terminated,Phase 2,Low accrual,lenalidomide
Thalidomide,DB01041,recurrent adult diffuse small cleaved cell lymphoma,C0280186,NCT01419795,Terminated,Phase 2,Low accrual,thalidomide
Rituximab,DB00073,recurrent grade 1 follicular lymphoma,C0280182,NCT01419795,Terminated,Phase 2,Low accrual,rituximab
Lenalidomide,DB00480,recurrent grade 1 follicular lymphoma,C0280182,NCT01419795,Terminated,Phase 2,Low accrual,lenalidomide
Thalidomide,DB01041,recurrent grade 1 follicular lymphoma,C0280182,NCT01419795,Terminated,Phase 2,Low accrual,thalidomide
Rituximab,DB00073,recurrent grade 2 follicular lymphoma,C0280183,NCT01419795,Terminated,Phase 2,Low accrual,rituximab
Lenalidomide,DB00480,recurrent grade 2 follicular lymphoma,C0280183,NCT01419795,Terminated,Phase 2,Low accrual,lenalidomide
Thalidomide,DB01041,recurrent grade 2 follicular lymphoma,C0280183,NCT01419795,Terminated,Phase 2,Low accrual,thalidomide
Rituximab,DB00073,recurrent grade 3 follicular lymphoma,C0280185,NCT01419795,Terminated,Phase 2,Low accrual,rituximab
Lenalidomide,DB00480,recurrent grade 3 follicular lymphoma,C0280185,NCT01419795,Terminated,Phase 2,Low accrual,lenalidomide
Thalidomide,DB01041,recurrent grade 3 follicular lymphoma,C0280185,NCT01419795,Terminated,Phase 2,Low accrual,thalidomide
Rituximab,DB00073,Mantle cell lymphoma recurrent,C0677725,NCT01419795,Terminated,Phase 2,Low accrual,rituximab
Lenalidomide,DB00480,Mantle cell lymphoma recurrent,C0677725,NCT01419795,Terminated,Phase 2,Low accrual,lenalidomide
Thalidomide,DB01041,Mantle cell lymphoma recurrent,C0677725,NCT01419795,Terminated,Phase 2,Low accrual,thalidomide
Rituximab,DB00073,Marginal zone lymphoma recurrent,C1541273,NCT01419795,Terminated,Phase 2,Low accrual,rituximab
Lenalidomide,DB00480,Marginal zone lymphoma recurrent,C1541273,NCT01419795,Terminated,Phase 2,Low accrual,lenalidomide
Thalidomide,DB01041,Marginal zone lymphoma recurrent,C1541273,NCT01419795,Terminated,Phase 2,Low accrual,thalidomide
Rituximab,DB00073,Mycosis fungoides/Sezary syndrome recurrent,C0862200,NCT01419795,Terminated,Phase 2,Low accrual,rituximab
Lenalidomide,DB00480,Mycosis fungoides/Sezary syndrome recurrent,C0862200,NCT01419795,Terminated,Phase 2,Low accrual,lenalidomide
Thalidomide,DB01041,Mycosis fungoides/Sezary syndrome recurrent,C0862200,NCT01419795,Terminated,Phase 2,Low accrual,thalidomide
Rituximab,DB00073,B-cell small lymphocytic lymphoma recurrent,C0855096,NCT01419795,Terminated,Phase 2,Low accrual,rituximab
Lenalidomide,DB00480,B-cell small lymphocytic lymphoma recurrent,C0855096,NCT01419795,Terminated,Phase 2,Low accrual,lenalidomide
Thalidomide,DB01041,B-cell small lymphocytic lymphoma recurrent,C0855096,NCT01419795,Terminated,Phase 2,Low accrual,thalidomide
Rituximab,DB00073,Chronic lymphocytic leukaemia refractory,C0278791,NCT01419795,Terminated,Phase 2,Low accrual,rituximab
Lenalidomide,DB00480,Chronic lymphocytic leukaemia refractory,C0278791,NCT01419795,Terminated,Phase 2,Low accrual,lenalidomide
Thalidomide,DB01041,Chronic lymphocytic leukaemia refractory,C0278791,NCT01419795,Terminated,Phase 2,Low accrual,thalidomide
Rituximab,DB00073,Hairy cell leukaemia recurrent,C0279780,NCT01419795,Terminated,Phase 2,Low accrual,rituximab
Lenalidomide,DB00480,Hairy cell leukaemia recurrent,C0279780,NCT01419795,Terminated,Phase 2,Low accrual,lenalidomide
Thalidomide,DB01041,Hairy cell leukaemia recurrent,C0279780,NCT01419795,Terminated,Phase 2,Low accrual,thalidomide
Rituximab,DB00073,Small Intestinal Lymphoma,C0278805,NCT01419795,Terminated,Phase 2,Low accrual,rituximab
Lenalidomide,DB00480,Small Intestinal Lymphoma,C0278805,NCT01419795,Terminated,Phase 2,Low accrual,lenalidomide
Thalidomide,DB01041,Small Intestinal Lymphoma,C0278805,NCT01419795,Terminated,Phase 2,Low accrual,thalidomide
Rituximab,DB00073,Splenic Marginal Zone B-Cell Lymphoma,C0349632,NCT01419795,Terminated,Phase 2,Low accrual,rituximab
Lenalidomide,DB00480,Splenic Marginal Zone B-Cell Lymphoma,C0349632,NCT01419795,Terminated,Phase 2,Low accrual,lenalidomide
Thalidomide,DB01041,Splenic Marginal Zone B-Cell Lymphoma,C0349632,NCT01419795,Terminated,Phase 2,Low accrual,thalidomide
Rituximab,DB00073,T-Cell Large Granular Lymphocyte Leukemia,C1955861,NCT01419795,Terminated,Phase 2,Low accrual,rituximab
Lenalidomide,DB00480,T-Cell Large Granular Lymphocyte Leukemia,C1955861,NCT01419795,Terminated,Phase 2,Low accrual,lenalidomide
Thalidomide,DB01041,T-Cell Large Granular Lymphocyte Leukemia,C1955861,NCT01419795,Terminated,Phase 2,Low accrual,thalidomide
Rituximab,DB00073,Malignant lymphoma of testis,C0349644,NCT01419795,Terminated,Phase 2,Low accrual,rituximab
Lenalidomide,DB00480,Malignant lymphoma of testis,C0349644,NCT01419795,Terminated,Phase 2,Low accrual,lenalidomide
Thalidomide,DB01041,Malignant lymphoma of testis,C0349644,NCT01419795,Terminated,Phase 2,Low accrual,thalidomide
Rituximab,DB00073,recurrent adult grade III lymphomatoid granulomatosis,C1541469,NCT01419795,Terminated,Phase 2,Low accrual,rituximab
Lenalidomide,DB00480,recurrent adult grade III lymphomatoid granulomatosis,C1541469,NCT01419795,Terminated,Phase 2,Low accrual,lenalidomide
Thalidomide,DB01041,recurrent adult grade III lymphomatoid granulomatosis,C1541469,NCT01419795,Terminated,Phase 2,Low accrual,thalidomide
Rituximab,DB00073,recurrent adult immunoblastic large cell lymphoma,C0280190,NCT01419795,Terminated,Phase 2,Low accrual,rituximab
Lenalidomide,DB00480,recurrent adult immunoblastic large cell lymphoma,C0280190,NCT01419795,Terminated,Phase 2,Low accrual,lenalidomide
Thalidomide,DB01041,recurrent adult immunoblastic large cell lymphoma,C0280190,NCT01419795,Terminated,Phase 2,Low accrual,thalidomide
Rituximab,DB00073,recurrent adult lymphoblastic lymphoma,C0280191,NCT01419795,Terminated,Phase 2,Low accrual,rituximab
Lenalidomide,DB00480,recurrent adult lymphoblastic lymphoma,C0280191,NCT01419795,Terminated,Phase 2,Low accrual,lenalidomide
Thalidomide,DB01041,recurrent adult lymphoblastic lymphoma,C0280191,NCT01419795,Terminated,Phase 2,Low accrual,thalidomide
Rituximab,DB00073,Adult T-cell lymphoma/leukaemia recurrent,C0280427,NCT01419795,Terminated,Phase 2,Low accrual,rituximab
Lenalidomide,DB00480,Adult T-cell lymphoma/leukaemia recurrent,C0280427,NCT01419795,Terminated,Phase 2,Low accrual,lenalidomide
Thalidomide,DB01041,Adult T-cell lymphoma/leukaemia recurrent,C0280427,NCT01419795,Terminated,Phase 2,Low accrual,thalidomide
Rituximab,DB00073,Cutaneous T-cell lymphoma recurrent,C0278580,NCT01419795,Terminated,Phase 2,Low accrual,rituximab
Lenalidomide,DB00480,Cutaneous T-cell lymphoma recurrent,C0278580,NCT01419795,Terminated,Phase 2,Low accrual,lenalidomide
Thalidomide,DB01041,Cutaneous T-cell lymphoma recurrent,C0278580,NCT01419795,Terminated,Phase 2,Low accrual,thalidomide
Sildenafil,DB00203,Respiratory Failure,C1145670,NCT01409031,Terminated,Phase 2,,sildenafil
Sildenafil,DB00203,Persistent pulmonary hypertension,C1135361,NCT01409031,Terminated,Phase 2,,sildenafil
Prednisolone,DB00860,Microscopic Polyarteritis,C2347126,NCT01408836,Terminated,Phase 2/Phase 3,Completed,prednisolone
Methylprednisolone,DB00959,Microscopic Polyarteritis,C2347126,NCT01408836,Terminated,Phase 2/Phase 3,Completed,methylprednisolone
Omeprazole,DB00338,Dyspepsia,C0013395,NCT01408849,Suspended,Phase 2,Lack of adherence and huge loss of follow up.,omeprazole
Atomoxetine,DB00289,Craving for alcohol,C0556385,NCT01408589,Terminated,Phase 1,,atomoxetine
Atomoxetine,DB00289,Mood swings,C0085633,NCT01408589,Terminated,Phase 1,,atomoxetine
Bevacizumab,DB00112,Glioblastoma,C0017636,NCT01413438,Withdrawn,Phase 2,,bevacizumab
Bevacizumab,DB00112,Brain Neoplasms,C0006118,NCT01413438,Withdrawn,Phase 2,,bevacizumab
Timolol,DB00373,Strawberry nevus of skin,C0206733,NCT01408056,Withdrawn,Phase 2,Difficulty with recruitment,timolol
Mupirocin,DB00410,Strawberry nevus of skin,C0206733,NCT01408056,Withdrawn,Phase 2,Difficulty with recruitment,mupirocin
Cisplatin,DB00515,Non-small cell lung cancer recurrent,C0278517,NCT01411098,Terminated,Phase 1,Low accrual,cisplatin
Etoposide,DB00773,Non-small cell lung cancer recurrent,C0278517,NCT01411098,Terminated,Phase 1,Low accrual,etoposide
Cisplatin,DB00515,Stage IIB Non-Small Cell Lung Carcinoma,C1336190,NCT01411098,Terminated,Phase 1,Low accrual,cisplatin
Etoposide,DB00773,Stage IIB Non-Small Cell Lung Carcinoma,C1336190,NCT01411098,Terminated,Phase 1,Low accrual,etoposide
Cisplatin,DB00515,Non-small cell lung cancer stage IIIA,C0278983,NCT01411098,Terminated,Phase 1,Low accrual,cisplatin
Etoposide,DB00773,Non-small cell lung cancer stage IIIA,C0278983,NCT01411098,Terminated,Phase 1,Low accrual,etoposide
Alitretinoin,DB00523,"Lupus Erythematosus, Cutaneous",C0024137,NCT01407679,Terminated,Phase 2,,alitretinoin
Tretinoin,DB00755,"Lupus Erythematosus, Cutaneous",C0024137,NCT01407679,Terminated,Phase 2,,tretinoin
Melphalan,DB01042,Retinoblastoma,C0035335,NCT01393769,Terminated,Phase 2,Only 5 subjects could be enrolled. The sample of 25 subjects could not be achieved due to it    is a rare disease.,melphalan
Bevacizumab,DB00112,Anaplastic astrocytoma,C0334579,NCT01386710,Suspended,Phase 1/Phase 2,In the process of transferring IRB to PI's current institution,bevacizumab
Carboplatin,DB00958,Anaplastic astrocytoma,C0334579,NCT01386710,Suspended,Phase 1/Phase 2,In the process of transferring IRB to PI's current institution,carboplatin
Anastrozole,DB01217,Oestrogen receptor positive breast cancer,C2938924,NCT01394211,Terminated,Phase 2,Slow accrual,anastrozole
Anastrozole,DB01217,Breast cancer recurrent,C0278493,NCT01394211,Terminated,Phase 2,Slow accrual,anastrozole
Anastrozole,DB01217,Breast cancer stage II,C0278486,NCT01394211,Terminated,Phase 2,Slow accrual,anastrozole
Verapamil,DB00661,Classical phenylketonuria,C0751434,NCT01395394,Terminated,Phase 2,Difficulty with recruitment and agreed with Sponsor to report completed data as case reports,verapamil
Carboplatin,DB00958,Adenocarcinoma Of Esophagus,C0279628,NCT01395537,Terminated,Phase 1/Phase 2,Research Cancelled,carboplatin
Paclitaxel,DB01229,Adenocarcinoma Of Esophagus,C0279628,NCT01395537,Terminated,Phase 1/Phase 2,Research Cancelled,paclitaxel
Lapatinib,DB01259,Adenocarcinoma Of Esophagus,C0279628,NCT01395537,Terminated,Phase 1/Phase 2,Research Cancelled,lapatinib
Carboplatin,DB00958,Adenocarcinoma of the gastroesophageal junction,C1332166,NCT01395537,Terminated,Phase 1/Phase 2,Research Cancelled,carboplatin
Paclitaxel,DB01229,Adenocarcinoma of the gastroesophageal junction,C1332166,NCT01395537,Terminated,Phase 1/Phase 2,Research Cancelled,paclitaxel
Lapatinib,DB01259,Adenocarcinoma of the gastroesophageal junction,C1332166,NCT01395537,Terminated,Phase 1/Phase 2,Research Cancelled,lapatinib
Doxycycline,DB00254,Colorectal Carcinoma,C0009402,NCT01418742,Terminated,Phase 2,Recruitement did not meet expectations. Prev. differentiation of RAS-wild-type and mutated RAS    are not in accordance with the scientific rank anymore.,doxycycline
Hydroxychloroquine,DB01611,Secondary malignant neoplasm of bone,C0153690,NCT01417403,Terminated,Phase 1,Recently published data that has shown HCQ to be safe when combined with chemo and or    radiation at even higher doses than what is used in this study.,hydroxychloroquine
Hydroxychloroquine,DB01611,"unspecified adult solid tumor, protocol specific",C0279004,NCT01417403,Terminated,Phase 1,Recently published data that has shown HCQ to be safe when combined with chemo and or    radiation at even higher doses than what is used in this study.,hydroxychloroquine
Trastuzumab,DB00072,HER-2 positive breast cancer,C1699634,NCT01388647,Terminated,Phase 1/Phase 2,Closed early due to increased hematologic toxicity and possible reduced efficacy,trastuzumab
Carboplatin,DB00958,HER-2 positive breast cancer,C1699634,NCT01388647,Terminated,Phase 1/Phase 2,Closed early due to increased hematologic toxicity and possible reduced efficacy,carboplatin
Oxaliplatin,DB00526,Nasopharyngeal carcinoma,C2931822,NCT01403259,Terminated,Phase 2,poor accrual of eligible patients,oxaliplatin
Cyclophosphamide,DB00531,Glioblastoma,C0017636,NCT01403285,Terminated,Phase 1,Due to poor accrual. This decision was taken without any safety reasons. Since beginning of    the study (June 2011) only six patients were enrolled.,cyclophosphamide
Imiquimod,DB00724,Glioblastoma,C0017636,NCT01403285,Terminated,Phase 1,Due to poor accrual. This decision was taken without any safety reasons. Since beginning of    the study (June 2011) only six patients were enrolled.,imiquimod
Tigecycline,DB00560,Dialysis Catheter Infection,C1400574,NCT01483872,Terminated,Phase 3,The study was stopped due to poor enrollment.,tigecycline
Heparin,DB01109,Dialysis Catheter Infection,C1400574,NCT01483872,Terminated,Phase 3,The study was stopped due to poor enrollment.,heparin
Milnacipran,DB04896,Irritable Bowel Syndrome,C0022104,NCT01471379,Terminated,Phase 2,Due to recruitment difficulties the study is terminated.,milnacipran
Doxorubicin,DB00997,colon cancer liver metastasis,C0742558,NCT01464593,Terminated,Phase 2,trial design contingent on RFA optimization,doxorubicin
Lansoprazole,DB00448,Eosinophilic esophagitis,C0341106,NCT01479231,Withdrawn,Phase 1/Phase 2,Souces of funding have been terminated,lansoprazole
Lansoprazole,DB00448,Deglutition Disorders,C0011168,NCT01479231,Withdrawn,Phase 1/Phase 2,Souces of funding have been terminated,lansoprazole
Pregabalin,DB00230,Neuralgia,C0027796,NCT01485094,Terminated,Phase 2,The trial was early terminated after it was concluded that there was no added benefit from    exposing further participants after an unblinded interim analysis.,pregabalin
Tenofovir,DB00300,HIV-1 infection,C2363741,NCT01489046,Terminated,Phase 2,,tenofovir
Efavirenz,DB00625,HIV-1 infection,C2363741,NCT01489046,Terminated,Phase 2,,efavirenz
Lamivudine,DB00709,HIV-1 infection,C2363741,NCT01489046,Terminated,Phase 2,,lamivudine
Tacrolimus,DB00864,Acute leukemia in remission,C0686586,NCT01488253,Terminated,Phase 2,We could not receive the support from the national medical insurance owing to the changed    policy of the government for clincal trials.,tacrolimus
Sirolimus,DB00877,Acute leukemia in remission,C0686586,NCT01488253,Terminated,Phase 2,We could not receive the support from the national medical insurance owing to the changed    policy of the government for clincal trials.,sirolimus
Everolimus,DB01590,Acute leukemia in remission,C0686586,NCT01488253,Terminated,Phase 2,We could not receive the support from the national medical insurance owing to the changed    policy of the government for clincal trials.,everolimus
Doxorubicin,DB00997,Solid tumour,C0280100,NCT01490047,Withdrawn,Phase 1,,doxorubicin
Diclofenac,DB00586,"Kidney Failure, Chronic",C0022661,NCT01481610,Terminated,Phase 2,Interim analysis shows harma to one of the study arms.,diclofenac
Lumiracoxib,DB01283,"Kidney Failure, Chronic",C0022661,NCT01481610,Terminated,Phase 2,Interim analysis shows harma to one of the study arms.,lumiracoxib
Spironolactone,DB00421,Type 2 diabetes mellitus with established diabetic nephropathy,C0837031,NCT01488877,Terminated,Phase 1,See termination reason in detailed description.,spironolactone
Paromomycin,DB01421,"Leishmaniasis, Cutaneous",C0023283,NCT01494350,Terminated,Phase 2,This study was closed prematurely due study team travel restrictions.,paromomycin
Citalopram,DB00215,Anxiety,C0003467,NCT01522092,Withdrawn,Phase 3,Study was not given ethical approval- a alternative protocol required,citalopram
Vorinostat,DB02546,"Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse",C0334634,NCT01500538,Terminated,Phase 2,Poor recruitment rate,vorinostat
Ezogabine,DB04953,Epilepsy,C0014544,NCT01494584,Terminated,Phase 2,Terminated after placing the study on hold at the request of the FDA,ezogabine
Vorinostat,DB02546,Multiple Myeloma,C0026764,NCT01501370,Withdrawn,Phase 2,,vorinostat
Ketamine,DB01221,Bipolar Disorder,C0005586,NCT01504659,Suspended,Phase 2/Phase 3,Protocol Revisions,ketamine
Atorvastatin,DB01076,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NCT01477853,Terminated,Phase 3,,atorvastatin
Bortezomib,DB00188,Malignant tumor of colon,C0007102,NCT01504477,Terminated,Phase 1/Phase 2,Low accrual--unable to meet accrual goals,bortezomib
Bexarotene,DB00307,Solid tumour,C0280100,NCT01504490,Terminated,Phase 1,Drug no longer available,bexarotene
Bexarotene,DB00307,Multiple Myeloma,C0026764,NCT01504490,Terminated,Phase 1,Drug no longer available,bexarotene
Fludarabine,DB01073,"Leukemia, Myelocytic, Acute",C0023467,NCT01478074,Withdrawn,Phase 1,The treatment planned was determined to be of low feasibility as no subject was found eligible    and able to enroll after screening over 30 subjects,fludarabine
Lidocaine,DB00281,Interstitial Cystitis,C0282488,NCT01475253,Terminated,Phase 2,This study was not enrolled completely and was terminated.,lidocaine
Sirolimus,DB00877,Endocrine Breast Diseases,C1449718,NCT01499160,Terminated,Phase 2,low accrual,sirolimus
Letrozole,DB01006,Endocrine Breast Diseases,C1449718,NCT01499160,Terminated,Phase 2,low accrual,letrozole
Lapatinib,DB01259,Endocrine Breast Diseases,C1449718,NCT01499160,Terminated,Phase 2,low accrual,lapatinib
Everolimus,DB01590,Endocrine Breast Diseases,C1449718,NCT01499160,Terminated,Phase 2,low accrual,everolimus
Sirolimus,DB00877,Neoplasm Metastasis,C0027627,NCT01499160,Terminated,Phase 2,low accrual,sirolimus
Letrozole,DB01006,Neoplasm Metastasis,C0027627,NCT01499160,Terminated,Phase 2,low accrual,letrozole
Lapatinib,DB01259,Neoplasm Metastasis,C0027627,NCT01499160,Terminated,Phase 2,low accrual,lapatinib
Everolimus,DB01590,Neoplasm Metastasis,C0027627,NCT01499160,Terminated,Phase 2,low accrual,everolimus
Bevacizumab,DB00112,Metastatic melanoma,C0278883,NCT01495988,Terminated,Phase 2,Slow accrual; toxicity; change in priorities,bevacizumab
Pravastatin,DB00175,HIV-1 infection,C2363741,NCT01515813,Withdrawn,Phase 2,"On 05/08/12, team working on revising protocol and re-open study under version 2.0",pravastatin
Tenofovir,DB00300,HIV-1 infection,C2363741,NCT01515813,Withdrawn,Phase 2,"On 05/08/12, team working on revising protocol and re-open study under version 2.0",tenofovir
Emtricitabine,DB00879,HIV-1 infection,C2363741,NCT01515813,Withdrawn,Phase 2,"On 05/08/12, team working on revising protocol and re-open study under version 2.0",emtricitabine
Irinotecan,DB00762,Neuroblastoma,C0027819,NCT01505608,Terminated,Phase 1/Phase 2,Lack of Enrollment,irinotecan
Dacarbazine,DB00851,Neuroblastoma,C0027819,NCT01505608,Terminated,Phase 1/Phase 2,Lack of Enrollment,dacarbazine
Temozolomide,DB00853,Neuroblastoma,C0027819,NCT01505608,Terminated,Phase 1/Phase 2,Lack of Enrollment,temozolomide
Bevacizumab,DB00112,Secondary malignant neoplasm of liver,C0494165,NCT01508000,Terminated,Phase 2,Low or poor accrual,bevacizumab
Cholecalciferol,DB00169,Adult Acute Myeloid Leukemia without Maturation,C0279623,NCT01521936,Terminated,Phase 2,Lack of funding,cholecalciferol
Cholecalciferol,DB00169,adult acute myeloid leukemia with 11q23 (MLL) abnormalities,C1541334,NCT01521936,Terminated,Phase 2,Lack of funding,cholecalciferol
Cholecalciferol,DB00169,adult acute myeloid leukemia with inv(16)(p13;q22),C1541333,NCT01521936,Terminated,Phase 2,Lack of funding,cholecalciferol
Cholecalciferol,DB00169,adult acute myeloid leukemia with t(16;16)(p13;q22),C1541332,NCT01521936,Terminated,Phase 2,Lack of funding,cholecalciferol
Cholecalciferol,DB00169,adult acute myeloid leukemia with t(8;21)(q22;q22),C1541331,NCT01521936,Terminated,Phase 2,Lack of funding,cholecalciferol
Cholecalciferol,DB00169,adult acute myelomonocytic leukemia (M4),C0279627,NCT01521936,Terminated,Phase 2,Lack of funding,cholecalciferol
Cholecalciferol,DB00169,adult erythroleukemia (M6a),C1541339,NCT01521936,Terminated,Phase 2,Lack of funding,cholecalciferol
Cholecalciferol,DB00169,adult pure erythroid leukemia (M6b),C1541340,NCT01521936,Terminated,Phase 2,Lack of funding,cholecalciferol
Cholecalciferol,DB00169,untreated adult acute myeloid leukemia,C0279089,NCT01521936,Terminated,Phase 2,Lack of funding,cholecalciferol
Cholecalciferol,DB00169,adult acute megakaryoblastic leukemia (M7),C0279632,NCT01521936,Terminated,Phase 2,Lack of funding,cholecalciferol
Cholecalciferol,DB00169,adult acute monoblastic leukemia (M5a),C0279629,NCT01521936,Terminated,Phase 2,Lack of funding,cholecalciferol
Cholecalciferol,DB00169,adult acute monocytic leukemia (M5b),C0280634,NCT01521936,Terminated,Phase 2,Lack of funding,cholecalciferol
Cholecalciferol,DB00169,adult acute myeloblastic leukemia with maturation (M2),C0279624,NCT01521936,Terminated,Phase 2,Lack of funding,cholecalciferol
Aripiprazole,DB01238,Bipolar Disorder,C0005586,NCT01520350,Terminated,Phase 3,recruitment issues,aripiprazole
Aripiprazole,DB01238,"Depressive episode, unspecified",C0349217,NCT01520350,Terminated,Phase 3,recruitment issues,aripiprazole
Alemtuzumab,DB00087,leukemia,C0023418,NCT01518153,Terminated,Phase 2,Objectives not met.,alemtuzumab
Methotrexate,DB00563,leukemia,C0023418,NCT01518153,Terminated,Phase 2,Objectives not met.,methotrexate
Tacrolimus,DB00864,leukemia,C0023418,NCT01518153,Terminated,Phase 2,Objectives not met.,tacrolimus
Melphalan,DB01042,leukemia,C0023418,NCT01518153,Terminated,Phase 2,Objectives not met.,melphalan
Fludarabine,DB01073,leukemia,C0023418,NCT01518153,Terminated,Phase 2,Objectives not met.,fludarabine
Azacitidine,DB00928,leukemia,C0023418,NCT01542684,Terminated,Phase 2,Slow Accrual,azacitidine
Cyclophosphamide,DB00531,Metastatic melanoma,C0278883,NCT01542255,Terminated,Phase 2,Low accrual not allowing to support statistical endpoints,cyclophosphamide
Vinblastine,DB00570,Metastatic melanoma,C0278883,NCT01542255,Terminated,Phase 2,Low accrual not allowing to support statistical endpoints,vinblastine
Vorinostat,DB02546,Multiple Myeloma,C0026764,NCT01492881,Withdrawn,Phase 2,Doxil is currently unavailable,vorinostat
Pioglitazone,DB01132,Opioid-Related Disorders,C0027412,NCT01517165,Terminated,Phase 1,,pioglitazone
Testosterone,DB00624,Multiple Sclerosis,C0026769,NCT01516554,Terminated,Phase 2,Poor recruitment,testosterone
Methyltestosterone,DB06710,Multiple Sclerosis,C0026769,NCT01516554,Terminated,Phase 2,Poor recruitment,methyltestosterone
Erlotinib,DB00530,Non-small cell lung cancer recurrent,C0278517,NCT01515969,Suspended,Phase 1,Interim analysis of PK and toxicity data,erlotinib
Erlotinib,DB00530,Non-small cell lung cancer metastatic,C0278987,NCT01515969,Suspended,Phase 1,Interim analysis of PK and toxicity data,erlotinib
Pegfilgrastim,DB00019,Multiple Myeloma,C0026764,NCT01537861,Terminated,Phase 0,Unexpected toxicity (2 early deaths),pegfilgrastim
Hydroxychloroquine,DB01611,"Kidney Failure, Chronic",C0022661,NCT01537315,Terminated,Phase 2,lack of funding,hydroxychloroquine
Penciclovir,DB00299,Meniere Disease,C0025281,NCT01526408,Terminated,Phase 3,HRI no longer conducting research.,penciclovir
Famciclovir,DB00426,Meniere Disease,C0025281,NCT01526408,Terminated,Phase 3,HRI no longer conducting research.,famciclovir
Vitamin C,DB00126,Disorder of vitamin C,C1272557,NCT01537094,Withdrawn,Phase 2,Unable to obtain funding to initiate the study. No subjects were enrolled.,vitamin c
Vitamin C,DB00126,Growth Hormone Secretion Abnormality,C3536718,NCT01537094,Withdrawn,Phase 2,Unable to obtain funding to initiate the study. No subjects were enrolled.,vitamin c
Sirolimus,DB00877,Acinar cell carcinoma of pancreas,C0279661,NCT01537107,Suspended,Phase 1,,sirolimus
Everolimus,DB01590,Acinar cell carcinoma of pancreas,C0279661,NCT01537107,Suspended,Phase 1,,everolimus
Sirolimus,DB00877,duct cell adenocarcinoma of the pancreas,C0279176,NCT01537107,Suspended,Phase 1,,sirolimus
Everolimus,DB01590,duct cell adenocarcinoma of the pancreas,C0279176,NCT01537107,Suspended,Phase 1,,everolimus
Sirolimus,DB00877,Pancreatic carcinoma recurrent,C0854777,NCT01537107,Suspended,Phase 1,,sirolimus
Everolimus,DB01590,Pancreatic carcinoma recurrent,C0854777,NCT01537107,Suspended,Phase 1,,everolimus
Sirolimus,DB00877,Stage IV Pancreatic Cancer,C1167725,NCT01537107,Suspended,Phase 1,,sirolimus
Everolimus,DB01590,Stage IV Pancreatic Cancer,C1167725,NCT01537107,Suspended,Phase 1,,everolimus
Sirolimus,DB00877,"unspecified adult solid tumor, protocol specific",C0279004,NCT01537107,Suspended,Phase 1,,sirolimus
Everolimus,DB01590,"unspecified adult solid tumor, protocol specific",C0279004,NCT01537107,Suspended,Phase 1,,everolimus
Bupivacaine,DB00297,Shoulder Pain,C0037011,NCT01538459,Withdrawn,Phase 3,,bupivacaine
Dexamethasone,DB01234,Shoulder Pain,C0037011,NCT01538459,Withdrawn,Phase 3,,dexamethasone
Bupivacaine,DB00297,Shoulder Injuries,C0149776,NCT01538459,Withdrawn,Phase 3,,bupivacaine
Dexamethasone,DB01234,Shoulder Injuries,C0149776,NCT01538459,Withdrawn,Phase 3,,dexamethasone
Bupivacaine,DB00297,Disorder of shoulder,C1290859,NCT01538459,Withdrawn,Phase 3,,bupivacaine
Dexamethasone,DB01234,Disorder of shoulder,C1290859,NCT01538459,Withdrawn,Phase 3,,dexamethasone
Bupivacaine,DB00297,Disorder of rotator cuff,C1532240,NCT01538459,Withdrawn,Phase 3,,bupivacaine
Dexamethasone,DB01234,Disorder of rotator cuff,C1532240,NCT01538459,Withdrawn,Phase 3,,dexamethasone
Bupivacaine,DB00297,Disorder of tendon of biceps,C1996944,NCT01538459,Withdrawn,Phase 3,,bupivacaine
Dexamethasone,DB01234,Disorder of tendon of biceps,C1996944,NCT01538459,Withdrawn,Phase 3,,dexamethasone
L-Carnitine,DB00583,Ulcerative Colitis,C0009324,NCT01538251,Terminated,Phase 3,Evidence of very low probability to success. No safety issues.,l-carnitine
Rituximab,DB00073,contiguous stage II adult diffuse large cell lymphoma,C0677695,NCT01539174,Withdrawn,Phase 2,No Funding Source and Competing Trials,rituximab
Cyclophosphamide,DB00531,contiguous stage II adult diffuse large cell lymphoma,C0677695,NCT01539174,Withdrawn,Phase 2,No Funding Source and Competing Trials,cyclophosphamide
Vincristine,DB00541,contiguous stage II adult diffuse large cell lymphoma,C0677695,NCT01539174,Withdrawn,Phase 2,No Funding Source and Competing Trials,vincristine
Doxorubicin,DB00997,contiguous stage II adult diffuse large cell lymphoma,C0677695,NCT01539174,Withdrawn,Phase 2,No Funding Source and Competing Trials,doxorubicin
Rituximab,DB00073,noncontiguous stage II adult diffuse large cell lymphoma,C0677709,NCT01539174,Withdrawn,Phase 2,No Funding Source and Competing Trials,rituximab
Cyclophosphamide,DB00531,noncontiguous stage II adult diffuse large cell lymphoma,C0677709,NCT01539174,Withdrawn,Phase 2,No Funding Source and Competing Trials,cyclophosphamide
Vincristine,DB00541,noncontiguous stage II adult diffuse large cell lymphoma,C0677709,NCT01539174,Withdrawn,Phase 2,No Funding Source and Competing Trials,vincristine
Doxorubicin,DB00997,noncontiguous stage II adult diffuse large cell lymphoma,C0677709,NCT01539174,Withdrawn,Phase 2,No Funding Source and Competing Trials,doxorubicin
Rituximab,DB00073,stage I adult diffuse large cell lymphoma,C0279960,NCT01539174,Withdrawn,Phase 2,No Funding Source and Competing Trials,rituximab
Cyclophosphamide,DB00531,stage I adult diffuse large cell lymphoma,C0279960,NCT01539174,Withdrawn,Phase 2,No Funding Source and Competing Trials,cyclophosphamide
Vincristine,DB00541,stage I adult diffuse large cell lymphoma,C0279960,NCT01539174,Withdrawn,Phase 2,No Funding Source and Competing Trials,vincristine
Doxorubicin,DB00997,stage I adult diffuse large cell lymphoma,C0279960,NCT01539174,Withdrawn,Phase 2,No Funding Source and Competing Trials,doxorubicin
Rituximab,DB00073,stage III adult diffuse large cell lymphoma,C0280162,NCT01539174,Withdrawn,Phase 2,No Funding Source and Competing Trials,rituximab
Cyclophosphamide,DB00531,stage III adult diffuse large cell lymphoma,C0280162,NCT01539174,Withdrawn,Phase 2,No Funding Source and Competing Trials,cyclophosphamide
Vincristine,DB00541,stage III adult diffuse large cell lymphoma,C0280162,NCT01539174,Withdrawn,Phase 2,No Funding Source and Competing Trials,vincristine
Doxorubicin,DB00997,stage III adult diffuse large cell lymphoma,C0280162,NCT01539174,Withdrawn,Phase 2,No Funding Source and Competing Trials,doxorubicin
Rituximab,DB00073,stage IV adult diffuse large cell lymphoma,C0280175,NCT01539174,Withdrawn,Phase 2,No Funding Source and Competing Trials,rituximab
Cyclophosphamide,DB00531,stage IV adult diffuse large cell lymphoma,C0280175,NCT01539174,Withdrawn,Phase 2,No Funding Source and Competing Trials,cyclophosphamide
Vincristine,DB00541,stage IV adult diffuse large cell lymphoma,C0280175,NCT01539174,Withdrawn,Phase 2,No Funding Source and Competing Trials,vincristine
Doxorubicin,DB00997,stage IV adult diffuse large cell lymphoma,C0280175,NCT01539174,Withdrawn,Phase 2,No Funding Source and Competing Trials,doxorubicin
Atorvastatin,DB01076,Psoriasis,C0033860,NCT01527097,Withdrawn,Phase 3,We strongly feel that the ability to recruit the required number of patients is very low and    thus decided to stop the study.,atorvastatin
Panobinostat,DB06603,Malignant neoplasm of stomach stage IV,C0278498,NCT01528501,Terminated,Phase 2,medical/ethical reasons,panobinostat
Bevacizumab,DB00112,colon cancer liver metastasis,C0742558,NCT01540435,Withdrawn,Phase 2,insufficient recruitment,bevacizumab
Imiquimod,DB00724,melanoma,C0025202,NCT01543464,Terminated,Phase 2,Diminished rectruitment,imiquimod
Temozolomide,DB00853,melanoma,C0025202,NCT01543464,Terminated,Phase 2,Diminished rectruitment,temozolomide
Norepinephrine,DB00368,Radiodermatitis,C0034561,NCT01544504,Withdrawn,Phase 1/Phase 2,The principal investigator withdrew from the study. The study was withdrawn because a    qualified replacement was not available.,norepinephrine
Eptifibatide,DB00063,Pneumonia,C0032285,NCT01532544,Suspended,Phase 2,,eptifibatide
Heparin,DB01109,Pneumonia,C0032285,NCT01532544,Suspended,Phase 2,,heparin
Tamsulosin,DB00706,Benign Prostatic Hyperplasia,C1704272,NCT01534351,Terminated,Phase 3,Business Reasons,tamsulosin
Finasteride,DB01216,Benign Prostatic Hyperplasia,C1704272,NCT01534351,Terminated,Phase 3,Business Reasons,finasteride
Cyclophosphamide,DB00531,leukemia,C0023418,NCT01532635,Terminated,Phase 2,Slow accrual,cyclophosphamide
Mycophenolate mofetil,DB00688,leukemia,C0023418,NCT01532635,Terminated,Phase 2,Slow accrual,mycophenolate mofetil
Tacrolimus,DB00864,leukemia,C0023418,NCT01532635,Terminated,Phase 2,Slow accrual,tacrolimus
Mycophenolic acid,DB01024,leukemia,C0023418,NCT01532635,Terminated,Phase 2,Slow accrual,mycophenolic acid
Cyclophosphamide,DB00531,Hodgkin Disease,C0019829,NCT01532635,Terminated,Phase 2,Slow accrual,cyclophosphamide
Mycophenolate mofetil,DB00688,Hodgkin Disease,C0019829,NCT01532635,Terminated,Phase 2,Slow accrual,mycophenolate mofetil
Tacrolimus,DB00864,Hodgkin Disease,C0019829,NCT01532635,Terminated,Phase 2,Slow accrual,tacrolimus
Mycophenolic acid,DB01024,Hodgkin Disease,C0019829,NCT01532635,Terminated,Phase 2,Slow accrual,mycophenolic acid
Erythromycin,DB00199,Preterm premature rupture of membranes (disorder),C0729264,NCT01556334,Withdrawn,Phase 3,Terminated before starting due to need for IND determined by FDA.,erythromycin
Cisplatin,DB00515,Multiple Myeloma,C0026764,NCT01548573,Terminated,Phase 2,Met study stopping rules,cisplatin
Etoposide,DB00773,Multiple Myeloma,C0026764,NCT01548573,Terminated,Phase 2,Met study stopping rules,etoposide
Imatinib,DB00619,Scleroderma,C0011644,NCT01545427,Terminated,Phase 2,Frequent adverse events occurred early in treatment with poor tolerability.,imatinib
Paclitaxel,DB01229,Solid tumour,C0280100,NCT01548924,Terminated,Phase 1,Drug toxicity,paclitaxel
Torasemide,DB00214,Renal Insufficiency,C1565489,NCT01558674,Terminated,Phase 1,,torasemide
Furosemide,DB00695,Renal Insufficiency,C1565489,NCT01558674,Terminated,Phase 1,,furosemide
Varenicline,DB01273,Nicotine Dependence,C0028043,NCT01560507,Terminated,Phase 2/Phase 3,Low Recruitment,varenicline
Alendronic acid,DB00630,Osteoporosis,C0029456,NCT01552122,Withdrawn,Phase 3,,alendronic acid
Calcium carbonate,DB06724,Osteoporosis,C0029456,NCT01552122,Withdrawn,Phase 3,,calcium carbonate
Acetaminophen,DB00316,Headache,C0018681,NCT01552798,Terminated,Phase 3,,acetaminophen
Salicylic acid,DB00936,Headache,C0018681,NCT01552798,Terminated,Phase 3,,salicylic acid
Acetylsalicylic acid,DB00945,Headache,C0018681,NCT01552798,Terminated,Phase 3,,acetylsalicylic acid
Loperamide,DB00836,Clostridium difficile diarrhea,C0235952,NCT01570634,Terminated,Phase 2,"Study was stopped for slow enrollment - only 2 patients, no evaluable results",loperamide
Exenatide,DB01276,Septic Shock,C0036983,NCT01573806,Withdrawn,Phase 1/Phase 2,No funding,exenatide
Exenatide,DB01276,Inflammation,C0021368,NCT01573806,Withdrawn,Phase 1/Phase 2,No funding,exenatide
Memantine,DB01043,Asperger Syndrome,C0236792,NCT01592773,Terminated,Phase 2,Terminated because primary efficacy parameter failed to demonstrate statistically significant    difference between memantine and placebo in controlled trials,memantine
Fluconazole,DB00196,CRYPTOCOCCAL INFECTION DISSEMINATED,C0742909,NCT01562132,Terminated,Phase 2,Stopped in accordance with pre-specified stopping rules for poor recruitment.,fluconazole
Flucytosine,DB01099,CRYPTOCOCCAL INFECTION DISSEMINATED,C0742909,NCT01562132,Terminated,Phase 2,Stopped in accordance with pre-specified stopping rules for poor recruitment.,flucytosine
Metformin,DB00331,Prostate carcinoma,C0600139,NCT01561482,Withdrawn,Phase 2,Study closed due to slow/low enrollment; no subjects were enrolled.,metformin
Simvastatin,DB00641,Prostate carcinoma,C0600139,NCT01561482,Withdrawn,Phase 2,Study closed due to slow/low enrollment; no subjects were enrolled.,simvastatin
Dexmedetomidine,DB00633,"Subarachnoid Hemorrhage, Aneurysmal",C0751530,NCT01565590,Terminated,Phase 3,"Slow enrollment along with new competing studies, investigators decided to stop study",dexmedetomidine
Carboplatin,DB00958,Malignant neoplasm of lung,C0242379,NCT01562301,Withdrawn,Phase 1,,carboplatin
Docetaxel,DB01248,Malignant neoplasm of lung,C0242379,NCT01562301,Withdrawn,Phase 1,,docetaxel
Carboplatin,DB00958,Chemotherapeutic Agent Toxicity,C1707372,NCT01562301,Withdrawn,Phase 1,,carboplatin
Docetaxel,DB01248,Chemotherapeutic Agent Toxicity,C1707372,NCT01562301,Withdrawn,Phase 1,,docetaxel
Cisplatin,DB00515,Non-Small Cell Lung Carcinoma,C0007131,NCT01565772,Terminated,Phase 1,Slow accrual,cisplatin
Etoposide,DB00773,Non-Small Cell Lung Carcinoma,C0007131,NCT01565772,Terminated,Phase 1,Slow accrual,etoposide
Rasburicase,DB00049,adult acute myeloid leukemia with t(16;16)(p13;q22),C1541332,NCT01564277,Terminated,Phase 2,low accrual,rasburicase
Allopurinol,DB00437,adult acute myeloid leukemia with t(16;16)(p13;q22),C1541332,NCT01564277,Terminated,Phase 2,low accrual,allopurinol
Rasburicase,DB00049,adult acute myeloid leukemia with t(8;21)(q22;q22),C1541331,NCT01564277,Terminated,Phase 2,low accrual,rasburicase
Allopurinol,DB00437,adult acute myeloid leukemia with t(8;21)(q22;q22),C1541331,NCT01564277,Terminated,Phase 2,low accrual,allopurinol
Rasburicase,DB00049,contiguous stage II adult Burkitt's lymphoma,C0677696,NCT01564277,Terminated,Phase 2,low accrual,rasburicase
Allopurinol,DB00437,contiguous stage II adult Burkitt's lymphoma,C0677696,NCT01564277,Terminated,Phase 2,low accrual,allopurinol
Rasburicase,DB00049,de novo myelodysplastic syndromes,C0280451,NCT01564277,Terminated,Phase 2,low accrual,rasburicase
Allopurinol,DB00437,de novo myelodysplastic syndromes,C0280451,NCT01564277,Terminated,Phase 2,low accrual,allopurinol
Rasburicase,DB00049,noncontiguous stage II adult Burkitt's lymphoma,C0677710,NCT01564277,Terminated,Phase 2,low accrual,rasburicase
Allopurinol,DB00437,noncontiguous stage II adult Burkitt's lymphoma,C0677710,NCT01564277,Terminated,Phase 2,low accrual,allopurinol
Rasburicase,DB00049,previously treated myelodysplastic syndromes,C0280744,NCT01564277,Terminated,Phase 2,low accrual,rasburicase
Allopurinol,DB00437,previously treated myelodysplastic syndromes,C0280744,NCT01564277,Terminated,Phase 2,low accrual,allopurinol
Rasburicase,DB00049,recurrent adult acute lymphoblastic leukemia,C0278785,NCT01564277,Terminated,Phase 2,low accrual,rasburicase
Allopurinol,DB00437,recurrent adult acute lymphoblastic leukemia,C0278785,NCT01564277,Terminated,Phase 2,low accrual,allopurinol
Rasburicase,DB00049,recurrent adult acute myeloid leukemia,C0278780,NCT01564277,Terminated,Phase 2,low accrual,rasburicase
Allopurinol,DB00437,recurrent adult acute myeloid leukemia,C0278780,NCT01564277,Terminated,Phase 2,low accrual,allopurinol
Rasburicase,DB00049,recurrent adult Burkitt's lymphoma,C0280192,NCT01564277,Terminated,Phase 2,low accrual,rasburicase
Allopurinol,DB00437,recurrent adult Burkitt's lymphoma,C0280192,NCT01564277,Terminated,Phase 2,low accrual,allopurinol
Rasburicase,DB00049,stage I adult Burkitt's lymphoma,C0279963,NCT01564277,Terminated,Phase 2,low accrual,rasburicase
Allopurinol,DB00437,stage I adult Burkitt's lymphoma,C0279963,NCT01564277,Terminated,Phase 2,low accrual,allopurinol
Rasburicase,DB00049,stage III adult Burkitt's lymphoma,C0280166,NCT01564277,Terminated,Phase 2,low accrual,rasburicase
Allopurinol,DB00437,stage III adult Burkitt's lymphoma,C0280166,NCT01564277,Terminated,Phase 2,low accrual,allopurinol
Rasburicase,DB00049,stage IV adult Burkitt's lymphoma,C0280179,NCT01564277,Terminated,Phase 2,low accrual,rasburicase
Allopurinol,DB00437,stage IV adult Burkitt's lymphoma,C0280179,NCT01564277,Terminated,Phase 2,low accrual,allopurinol
Rasburicase,DB00049,untreated adult acute lymphoblastic leukemia,C0279088,NCT01564277,Terminated,Phase 2,low accrual,rasburicase
Allopurinol,DB00437,untreated adult acute lymphoblastic leukemia,C0279088,NCT01564277,Terminated,Phase 2,low accrual,allopurinol
Rasburicase,DB00049,untreated adult acute myeloid leukemia,C0279089,NCT01564277,Terminated,Phase 2,low accrual,rasburicase
Allopurinol,DB00437,untreated adult acute myeloid leukemia,C0279089,NCT01564277,Terminated,Phase 2,low accrual,allopurinol
Rasburicase,DB00049,adult acute myeloid leukemia with 11q23 (MLL) abnormalities,C1541334,NCT01564277,Terminated,Phase 2,low accrual,rasburicase
Allopurinol,DB00437,adult acute myeloid leukemia with 11q23 (MLL) abnormalities,C1541334,NCT01564277,Terminated,Phase 2,low accrual,allopurinol
Rasburicase,DB00049,adult acute myeloid leukemia with inv(16)(p13;q22),C1541333,NCT01564277,Terminated,Phase 2,low accrual,rasburicase
Allopurinol,DB00437,adult acute myeloid leukemia with inv(16)(p13;q22),C1541333,NCT01564277,Terminated,Phase 2,low accrual,allopurinol
Rasburicase,DB00049,adult acute myeloid leukemia with t(15;17)(q22;q12),C1541335,NCT01564277,Terminated,Phase 2,low accrual,rasburicase
Allopurinol,DB00437,adult acute myeloid leukemia with t(15;17)(q22;q12),C1541335,NCT01564277,Terminated,Phase 2,low accrual,allopurinol
Ketoconazole,DB01026,Granulosa cell tumor of the ovary,C1370419,NCT01584297,Terminated,Phase 2,Insufficient recruitment rate,ketoconazole
Bupivacaine,DB00297,Chronic pain,C0150055,NCT01584947,Terminated,Phase 2,Because of a very slow patient recruitment.,bupivacaine
Adalimumab,DB00051,Inflammatory disease of mucous membrane,C0333355,NCT01562951,Terminated,Phase 3,Not enough patient population according to selection criteria to complete the study,adalimumab
L-Carnitine,DB00583,Ulcerative Colitis,C0009324,NCT01567956,Terminated,Phase 3,Evidence of very low probability to success. No safety issues,l-carnitine
Imatinib,DB00619,Pulmonary Hypertension,C0020542,NCT01568645,Withdrawn,Phase 1,,imatinib
Carvedilol,DB01136,Pulmonary Hypertension,C0020542,NCT01568645,Withdrawn,Phase 1,,carvedilol
L-Carnitine,DB00583,Postpoliomyelitis Syndrome,C0080040,NCT01549847,Withdrawn,Phase 3,Study was not approved by Health Surveillance Agency,l-carnitine
Aminolevulinic acid,DB00855,adult giant cell glioblastoma,C1541316,NCT01575275,Terminated,Phase 2,Drugs unavailable,aminolevulinic acid
Aminolevulinic acid,DB00855,adult glioblastoma,C0278878,NCT01575275,Terminated,Phase 2,Drugs unavailable,aminolevulinic acid
Aminolevulinic acid,DB00855,adult gliosarcoma,C1541317,NCT01575275,Terminated,Phase 2,Drugs unavailable,aminolevulinic acid
Aminolevulinic acid,DB00855,recurrent adult brain tumor,C0278786,NCT01575275,Terminated,Phase 2,Drugs unavailable,aminolevulinic acid
Ropivacaine,DB00296,Appendicitis,C0003615,NCT01575028,Terminated,Phase 2,The study was allowed to expire due to changes in standard care for the patient population    within the NCH institution.,ropivacaine
Tobramycin,DB00684,"Pneumonia, Bacterial",C0004626,NCT01570192,Terminated,Phase 2,NIAID terminated the study due to low subject enrollment,tobramycin
Meropenem,DB00760,"Pneumonia, Bacterial",C0004626,NCT01570192,Terminated,Phase 2,NIAID terminated the study due to low subject enrollment,meropenem
Vitamin C,DB00126,Shock,C0036974,NCT01587963,Terminated,Phase 2,PI's additional responsibilities and time commitments prevent him from completing this    clinical trial so he decided to close the study prematurely,vitamin c
Dipyridamole,DB00975,Rheumatoid Arthritis,C0003873,NCT01612377,Terminated,Phase 2,"missed endpoint of meaningful clinical benefit, compared to prednisolone 2.7mg",dipyridamole
Pentoxifylline,DB00806,"Diabetes Mellitus, Insulin-Dependent",C0011854,NCT01603121,Terminated,Phase 1/Phase 2,Unable to enroll sufficient number of subjects,pentoxifylline
Gemcitabine,DB00441,"unspecified adult solid tumor, protocol specific",C0279004,NCT01573780,Terminated,Phase 1,Sponsor did not have funds to continue study,gemcitabine
Hydrocortisone,DB00741,Phobic anxiety disorder,C0349231,NCT01574014,Terminated,Phase 2,Recruiting problems,hydrocortisone
Glucagon recombinant,DB00040,Short Bowel Syndrome,C0036992,NCT01573286,Terminated,Phase 1/Phase 2,GLP-2 Drug product stability concerns,glucagon recombinant
Zonisamide,DB00909,alcohol use disorder,C0001956,NCT01566370,Terminated,Phase 2,recruitment infeasible,zonisamide
Zonisamide,DB00909,Bipolar Disorder,C0005586,NCT01566370,Terminated,Phase 2,recruitment infeasible,zonisamide
Ganirelix,DB06785,Infertility,C0021359,NCT01599494,Withdrawn,Phase 3,,ganirelix
Rivaroxaban,DB06228,Heparin-induced thrombocytopenia,C0272285,NCT01598168,Terminated,Phase 3,slow recruitment,rivaroxaban
Folic Acid,DB00158,Pervasive Development Disorder,C0524528,NCT01602016,Terminated,Phase 2,Non-compliance,folic acid
Leucovorin,DB00650,Pervasive Development Disorder,C0524528,NCT01602016,Terminated,Phase 2,Non-compliance,leucovorin
Levoleucovorin,DB11596,Pervasive Development Disorder,C0524528,NCT01602016,Terminated,Phase 2,Non-compliance,levoleucovorin
Methamphetamine,DB01577,Methamphetamine dependence,C1533217,NCT01601717,Withdrawn,Phase 1,,methamphetamine
Methamphetamine,DB01577,Methamphetamine abuse,C1456624,NCT01601717,Withdrawn,Phase 1,,methamphetamine
Ertapenem,DB00303,Endometritis,C0014179,NCT01587495,Terminated,Phase 1,study terminated due to low subject accrual,ertapenem
Finasteride,DB01216,Retinal Diseases,C0035309,NCT01585441,Terminated,Phase 2,This study was terminated early due to lack of enrollment.,finasteride
Cetuximab,DB00002,Malignant neoplasm of stomach,C0024623,NCT01611506,Terminated,Phase 1/Phase 2,Outcome of EXPAND study (no benefit from adding cetuximab to the first-line chemotherapy in    advanced gastric cancer in the overall patient population),cetuximab
Cisplatin,DB00515,Malignant neoplasm of stomach,C0024623,NCT01611506,Terminated,Phase 1/Phase 2,Outcome of EXPAND study (no benefit from adding cetuximab to the first-line chemotherapy in    advanced gastric cancer in the overall patient population),cisplatin
Capsaicin,DB06774,Hyperalgesia,C0020429,NCT01615510,Terminated,Phase 1,,capsaicin
Capsaicin,DB06774,Allodynia,C0458247,NCT01615510,Terminated,Phase 1,,capsaicin
Capsaicin,DB06774,Pain,C0030193,NCT01615510,Terminated,Phase 1,,capsaicin
Timolol,DB00373,"Optic Neuropathy, Ischemic",C0155305,NCT01607671,Withdrawn,Phase 1,Unable to recruit participants from recruiting sites.,timolol
Timolol,DB00373,Anterior Ischemic Optic Neuropathy,C0751711,NCT01607671,Withdrawn,Phase 1,Unable to recruit participants from recruiting sites.,timolol
Letrozole,DB01006,"Medical abortion, complete or unspecified, without complication",C0495144,NCT01615211,Terminated,Phase 2,No access to study drug Trilostan. Company closed down,letrozole
Trilostane,DB01108,"Medical abortion, complete or unspecified, without complication",C0495144,NCT01615211,Terminated,Phase 2,No access to study drug Trilostan. Company closed down,trilostane
Misoprostol,DB00929,Missed abortion,C0000814,NCT01615224,Suspended,Phase 2/Phase 3,No funding,misoprostol
Mefloquine,DB00358,Malaria,C0024530,NCT01615822,Terminated,Phase 1,Decision taken to halt progression of mefloquine as a potential partner for OZ439 as a single    dose cure due to low probability of success,mefloquine
Folic Acid,DB00158,Secondary malignant neoplasm of liver,C0494165,NCT01646554,Withdrawn,Phase 2/Phase 3,,folic acid
Oxaliplatin,DB00526,Secondary malignant neoplasm of liver,C0494165,NCT01646554,Withdrawn,Phase 2/Phase 3,,oxaliplatin
Levoleucovorin,DB11596,Secondary malignant neoplasm of liver,C0494165,NCT01646554,Withdrawn,Phase 2/Phase 3,,levoleucovorin
Udenafil,DB06267,"Heart Failure, Systolic",C1135191,NCT01646515,Terminated,Phase 3,Substantial benefit was observed in the active treatment group,udenafil
Metformin,DB00331,Polycystic Ovary Syndrome,C0032460,NCT01638988,Withdrawn,Phase 3,Previous studies have been done regarding same condition,metformin
Clomifene,DB00882,Polycystic Ovary Syndrome,C0032460,NCT01638988,Withdrawn,Phase 3,Previous studies have been done regarding same condition,clomifene
Ezogabine,DB04953,Epilepsy,C0014544,NCT01648101,Terminated,Phase 3,"Registration of the medicine is no longer being pursued in South Korea, Taiwan or Vietnam",ezogabine
Gemcitabine,DB00441,anterior urethral cancer,C0279930,NCT01639521,Withdrawn,Phase 2,Lack of funding,gemcitabine
Cisplatin,DB00515,anterior urethral cancer,C0279930,NCT01639521,Withdrawn,Phase 2,Lack of funding,cisplatin
Methotrexate,DB00563,anterior urethral cancer,C0279930,NCT01639521,Withdrawn,Phase 2,Lack of funding,methotrexate
Vinblastine,DB00570,anterior urethral cancer,C0279930,NCT01639521,Withdrawn,Phase 2,Lack of funding,vinblastine
Doxorubicin,DB00997,anterior urethral cancer,C0279930,NCT01639521,Withdrawn,Phase 2,Lack of funding,doxorubicin
Gemcitabine,DB00441,Transitional cell cancer of the renal pelvis and ureter localised,C0280240,NCT01639521,Withdrawn,Phase 2,Lack of funding,gemcitabine
Cisplatin,DB00515,Transitional cell cancer of the renal pelvis and ureter localised,C0280240,NCT01639521,Withdrawn,Phase 2,Lack of funding,cisplatin
Methotrexate,DB00563,Transitional cell cancer of the renal pelvis and ureter localised,C0280240,NCT01639521,Withdrawn,Phase 2,Lack of funding,methotrexate
Vinblastine,DB00570,Transitional cell cancer of the renal pelvis and ureter localised,C0280240,NCT01639521,Withdrawn,Phase 2,Lack of funding,vinblastine
Doxorubicin,DB00997,Transitional cell cancer of the renal pelvis and ureter localised,C0280240,NCT01639521,Withdrawn,Phase 2,Lack of funding,doxorubicin
Gemcitabine,DB00441,posterior urethral cancer,C0279931,NCT01639521,Withdrawn,Phase 2,Lack of funding,gemcitabine
Cisplatin,DB00515,posterior urethral cancer,C0279931,NCT01639521,Withdrawn,Phase 2,Lack of funding,cisplatin
Methotrexate,DB00563,posterior urethral cancer,C0279931,NCT01639521,Withdrawn,Phase 2,Lack of funding,methotrexate
Vinblastine,DB00570,posterior urethral cancer,C0279931,NCT01639521,Withdrawn,Phase 2,Lack of funding,vinblastine
Doxorubicin,DB00997,posterior urethral cancer,C0279931,NCT01639521,Withdrawn,Phase 2,Lack of funding,doxorubicin
Gemcitabine,DB00441,Recurrent Urethral Cancer,C0279912,NCT01639521,Withdrawn,Phase 2,Lack of funding,gemcitabine
Cisplatin,DB00515,Recurrent Urethral Cancer,C0279912,NCT01639521,Withdrawn,Phase 2,Lack of funding,cisplatin
Methotrexate,DB00563,Recurrent Urethral Cancer,C0279912,NCT01639521,Withdrawn,Phase 2,Lack of funding,methotrexate
Vinblastine,DB00570,Recurrent Urethral Cancer,C0279912,NCT01639521,Withdrawn,Phase 2,Lack of funding,vinblastine
Doxorubicin,DB00997,Recurrent Urethral Cancer,C0279912,NCT01639521,Withdrawn,Phase 2,Lack of funding,doxorubicin
Gemcitabine,DB00441,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,C0280281,NCT01639521,Withdrawn,Phase 2,Lack of funding,gemcitabine
Cisplatin,DB00515,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,C0280281,NCT01639521,Withdrawn,Phase 2,Lack of funding,cisplatin
Methotrexate,DB00563,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,C0280281,NCT01639521,Withdrawn,Phase 2,Lack of funding,methotrexate
Vinblastine,DB00570,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,C0280281,NCT01639521,Withdrawn,Phase 2,Lack of funding,vinblastine
Doxorubicin,DB00997,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,C0280281,NCT01639521,Withdrawn,Phase 2,Lack of funding,doxorubicin
Gemcitabine,DB00441,Bladder cancer stage III,C0278824,NCT01639521,Withdrawn,Phase 2,Lack of funding,gemcitabine
Cisplatin,DB00515,Bladder cancer stage III,C0278824,NCT01639521,Withdrawn,Phase 2,Lack of funding,cisplatin
Methotrexate,DB00563,Bladder cancer stage III,C0278824,NCT01639521,Withdrawn,Phase 2,Lack of funding,methotrexate
Vinblastine,DB00570,Bladder cancer stage III,C0278824,NCT01639521,Withdrawn,Phase 2,Lack of funding,vinblastine
Doxorubicin,DB00997,Bladder cancer stage III,C0278824,NCT01639521,Withdrawn,Phase 2,Lack of funding,doxorubicin
Gemcitabine,DB00441,Malignant neoplasm of ureter,C0153619,NCT01639521,Withdrawn,Phase 2,Lack of funding,gemcitabine
Cisplatin,DB00515,Malignant neoplasm of ureter,C0153619,NCT01639521,Withdrawn,Phase 2,Lack of funding,cisplatin
Methotrexate,DB00563,Malignant neoplasm of ureter,C0153619,NCT01639521,Withdrawn,Phase 2,Lack of funding,methotrexate
Vinblastine,DB00570,Malignant neoplasm of ureter,C0153619,NCT01639521,Withdrawn,Phase 2,Lack of funding,vinblastine
Doxorubicin,DB00997,Malignant neoplasm of ureter,C0153619,NCT01639521,Withdrawn,Phase 2,Lack of funding,doxorubicin
Gemcitabine,DB00441,urethral carcinoma associated with invasive bladder cancer,C0279932,NCT01639521,Withdrawn,Phase 2,Lack of funding,gemcitabine
Cisplatin,DB00515,urethral carcinoma associated with invasive bladder cancer,C0279932,NCT01639521,Withdrawn,Phase 2,Lack of funding,cisplatin
Methotrexate,DB00563,urethral carcinoma associated with invasive bladder cancer,C0279932,NCT01639521,Withdrawn,Phase 2,Lack of funding,methotrexate
Vinblastine,DB00570,urethral carcinoma associated with invasive bladder cancer,C0279932,NCT01639521,Withdrawn,Phase 2,Lack of funding,vinblastine
Doxorubicin,DB00997,urethral carcinoma associated with invasive bladder cancer,C0279932,NCT01639521,Withdrawn,Phase 2,Lack of funding,doxorubicin
Sorafenib,DB00398,Malignant neoplasm of lung,C0242379,NCT01636921,Withdrawn,Phase 2,Terminated with slow accrual in early phase of study.,sorafenib
Vidarabine,DB00194,previously treated myelodysplastic syndromes,C0280744,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,previously treated myelodysplastic syndromes,C0280744,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,previously treated myelodysplastic syndromes,C0280744,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,previously treated myelodysplastic syndromes,C0280744,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,previously treated myelodysplastic syndromes,C0280744,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,previously treated myelodysplastic syndromes,C0280744,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,recurrent adult acute lymphoblastic leukemia,C0278785,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,recurrent adult acute lymphoblastic leukemia,C0278785,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,recurrent adult acute lymphoblastic leukemia,C0278785,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,recurrent adult acute lymphoblastic leukemia,C0278785,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,recurrent adult acute lymphoblastic leukemia,C0278785,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,recurrent adult acute lymphoblastic leukemia,C0278785,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,recurrent adult acute myeloid leukemia,C0278780,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,recurrent adult acute myeloid leukemia,C0278780,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,recurrent adult acute myeloid leukemia,C0278780,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,recurrent adult acute myeloid leukemia,C0278780,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,recurrent adult acute myeloid leukemia,C0278780,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,recurrent adult acute myeloid leukemia,C0278780,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,recurrent adult Burkitt's lymphoma,C0280192,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,recurrent adult Burkitt's lymphoma,C0280192,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,recurrent adult Burkitt's lymphoma,C0280192,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,recurrent adult Burkitt's lymphoma,C0280192,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,recurrent adult Burkitt's lymphoma,C0280192,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,recurrent adult Burkitt's lymphoma,C0280192,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,recurrent adult diffuse large cell lymphoma,C0280188,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,recurrent adult diffuse large cell lymphoma,C0280188,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,recurrent adult diffuse large cell lymphoma,C0280188,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,recurrent adult diffuse large cell lymphoma,C0280188,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,recurrent adult diffuse large cell lymphoma,C0280188,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,recurrent adult diffuse large cell lymphoma,C0280188,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,recurrent adult diffuse mixed cell lymphoma,C0280187,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,recurrent adult diffuse mixed cell lymphoma,C0280187,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,recurrent adult diffuse mixed cell lymphoma,C0280187,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,recurrent adult diffuse mixed cell lymphoma,C0280187,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,recurrent adult diffuse mixed cell lymphoma,C0280187,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,recurrent adult diffuse mixed cell lymphoma,C0280187,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,recurrent adult diffuse small cleaved cell lymphoma,C0280186,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,recurrent adult diffuse small cleaved cell lymphoma,C0280186,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,recurrent adult diffuse small cleaved cell lymphoma,C0280186,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,recurrent adult diffuse small cleaved cell lymphoma,C0280186,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,recurrent adult diffuse small cleaved cell lymphoma,C0280186,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,recurrent adult diffuse small cleaved cell lymphoma,C0280186,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,recurrent adult grade III lymphomatoid granulomatosis,C1541469,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,recurrent adult grade III lymphomatoid granulomatosis,C1541469,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,recurrent adult grade III lymphomatoid granulomatosis,C1541469,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,recurrent adult grade III lymphomatoid granulomatosis,C1541469,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,recurrent adult grade III lymphomatoid granulomatosis,C1541469,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,recurrent adult grade III lymphomatoid granulomatosis,C1541469,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,recurrent adult Hodgkin's lymphoma,C0278530,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,recurrent adult Hodgkin's lymphoma,C0278530,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,recurrent adult Hodgkin's lymphoma,C0278530,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,recurrent adult Hodgkin's lymphoma,C0278530,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,recurrent adult Hodgkin's lymphoma,C0278530,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,recurrent adult Hodgkin's lymphoma,C0278530,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,recurrent adult immunoblastic large cell lymphoma,C0280190,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,recurrent adult immunoblastic large cell lymphoma,C0280190,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,recurrent adult immunoblastic large cell lymphoma,C0280190,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,recurrent adult immunoblastic large cell lymphoma,C0280190,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,recurrent adult immunoblastic large cell lymphoma,C0280190,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,recurrent adult immunoblastic large cell lymphoma,C0280190,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,recurrent adult lymphoblastic lymphoma,C0280191,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,recurrent adult lymphoblastic lymphoma,C0280191,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,recurrent adult lymphoblastic lymphoma,C0280191,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,recurrent adult lymphoblastic lymphoma,C0280191,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,recurrent adult lymphoblastic lymphoma,C0280191,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,recurrent adult lymphoblastic lymphoma,C0280191,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,Adult T-cell lymphoma/leukaemia recurrent,C0280427,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,Adult T-cell lymphoma/leukaemia recurrent,C0280427,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,Adult T-cell lymphoma/leukaemia recurrent,C0280427,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,Adult T-cell lymphoma/leukaemia recurrent,C0280427,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,Adult T-cell lymphoma/leukaemia recurrent,C0280427,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,Adult T-cell lymphoma/leukaemia recurrent,C0280427,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,Cutaneous T-cell lymphoma recurrent,C0278580,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,Cutaneous T-cell lymphoma recurrent,C0278580,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,Cutaneous T-cell lymphoma recurrent,C0278580,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,Cutaneous T-cell lymphoma recurrent,C0278580,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,Cutaneous T-cell lymphoma recurrent,C0278580,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,Cutaneous T-cell lymphoma recurrent,C0278580,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,recurrent grade 1 follicular lymphoma,C0280182,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,recurrent grade 1 follicular lymphoma,C0280182,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,recurrent grade 1 follicular lymphoma,C0280182,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,recurrent grade 1 follicular lymphoma,C0280182,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,recurrent grade 1 follicular lymphoma,C0280182,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,recurrent grade 1 follicular lymphoma,C0280182,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,recurrent grade 2 follicular lymphoma,C0280183,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,recurrent grade 2 follicular lymphoma,C0280183,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,recurrent grade 2 follicular lymphoma,C0280183,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,recurrent grade 2 follicular lymphoma,C0280183,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,recurrent grade 2 follicular lymphoma,C0280183,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,recurrent grade 2 follicular lymphoma,C0280183,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,recurrent grade 3 follicular lymphoma,C0280185,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,recurrent grade 3 follicular lymphoma,C0280185,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,recurrent grade 3 follicular lymphoma,C0280185,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,recurrent grade 3 follicular lymphoma,C0280185,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,recurrent grade 3 follicular lymphoma,C0280185,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,recurrent grade 3 follicular lymphoma,C0280185,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,Mantle cell lymphoma recurrent,C0677725,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,Mantle cell lymphoma recurrent,C0677725,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,Mantle cell lymphoma recurrent,C0677725,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,Mantle cell lymphoma recurrent,C0677725,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,Mantle cell lymphoma recurrent,C0677725,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,Mantle cell lymphoma recurrent,C0677725,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,Marginal zone lymphoma recurrent,C1541273,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,Marginal zone lymphoma recurrent,C1541273,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,Marginal zone lymphoma recurrent,C1541273,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,Marginal zone lymphoma recurrent,C1541273,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,Marginal zone lymphoma recurrent,C1541273,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,Marginal zone lymphoma recurrent,C1541273,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,Mycosis fungoides/Sezary syndrome recurrent,C0862200,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,Mycosis fungoides/Sezary syndrome recurrent,C0862200,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,Mycosis fungoides/Sezary syndrome recurrent,C0862200,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,Mycosis fungoides/Sezary syndrome recurrent,C0862200,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,Mycosis fungoides/Sezary syndrome recurrent,C0862200,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,Mycosis fungoides/Sezary syndrome recurrent,C0862200,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,B-cell small lymphocytic lymphoma recurrent,C0855096,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,B-cell small lymphocytic lymphoma recurrent,C0855096,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,B-cell small lymphocytic lymphoma recurrent,C0855096,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,B-cell small lymphocytic lymphoma recurrent,C0855096,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,B-cell small lymphocytic lymphoma recurrent,C0855096,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,B-cell small lymphocytic lymphoma recurrent,C0855096,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,Chronic lymphocytic leukaemia refractory,C0278791,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,Chronic lymphocytic leukaemia refractory,C0278791,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,Chronic lymphocytic leukaemia refractory,C0278791,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,Chronic lymphocytic leukaemia refractory,C0278791,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,Chronic lymphocytic leukaemia refractory,C0278791,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,Chronic lymphocytic leukaemia refractory,C0278791,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,Hairy cell leukaemia recurrent,C0279780,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,Hairy cell leukaemia recurrent,C0279780,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,Hairy cell leukaemia recurrent,C0279780,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,Hairy cell leukaemia recurrent,C0279780,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,Hairy cell leukaemia recurrent,C0279780,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,Hairy cell leukaemia recurrent,C0279780,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,chronic myelogenous leukemia in relapse,C0278787,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,chronic myelogenous leukemia in relapse,C0278787,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,chronic myelogenous leukemia in relapse,C0278787,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,chronic myelogenous leukemia in relapse,C0278787,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,chronic myelogenous leukemia in relapse,C0278787,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,chronic myelogenous leukemia in relapse,C0278787,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,secondary acute myeloid leukemia,C0280449,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,secondary acute myeloid leukemia,C0280449,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,secondary acute myeloid leukemia,C0280449,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,secondary acute myeloid leukemia,C0280449,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,secondary acute myeloid leukemia,C0280449,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,secondary acute myeloid leukemia,C0280449,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,secondary myelodysplastic syndromes,C0280745,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,secondary myelodysplastic syndromes,C0280745,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,secondary myelodysplastic syndromes,C0280745,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,secondary myelodysplastic syndromes,C0280745,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,secondary myelodysplastic syndromes,C0280745,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,secondary myelodysplastic syndromes,C0280745,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,Small Intestinal Lymphoma,C0278805,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,Small Intestinal Lymphoma,C0278805,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,Small Intestinal Lymphoma,C0278805,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,Small Intestinal Lymphoma,C0278805,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,Small Intestinal Lymphoma,C0278805,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,Small Intestinal Lymphoma,C0278805,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,Splenic Marginal Zone B-Cell Lymphoma,C0349632,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,Splenic Marginal Zone B-Cell Lymphoma,C0349632,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,Splenic Marginal Zone B-Cell Lymphoma,C0349632,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,Splenic Marginal Zone B-Cell Lymphoma,C0349632,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,Splenic Marginal Zone B-Cell Lymphoma,C0349632,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,Splenic Marginal Zone B-Cell Lymphoma,C0349632,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,T-Cell Large Granular Lymphocyte Leukemia,C1955861,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,T-Cell Large Granular Lymphocyte Leukemia,C1955861,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,T-Cell Large Granular Lymphocyte Leukemia,C1955861,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,T-Cell Large Granular Lymphocyte Leukemia,C1955861,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,T-Cell Large Granular Lymphocyte Leukemia,C1955861,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,T-Cell Large Granular Lymphocyte Leukemia,C1955861,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,Malignant lymphoma of testis,C0349644,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,Malignant lymphoma of testis,C0349644,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,Malignant lymphoma of testis,C0349644,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,Malignant lymphoma of testis,C0349644,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,Malignant lymphoma of testis,C0349644,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,Malignant lymphoma of testis,C0349644,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,C1332153,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,C1332153,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,C1332153,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,C1332153,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,C1332153,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,C1332153,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,adult acute lymphoblastic leukemia in remission,C0279095,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,adult acute lymphoblastic leukemia in remission,C0279095,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,adult acute lymphoblastic leukemia in remission,C0279095,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,adult acute lymphoblastic leukemia in remission,C0279095,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,adult acute lymphoblastic leukemia in remission,C0279095,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,adult acute lymphoblastic leukemia in remission,C0279095,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,adult acute myeloid leukemia in remission,C0279094,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,adult acute myeloid leukemia in remission,C0279094,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,adult acute myeloid leukemia in remission,C0279094,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,adult acute myeloid leukemia in remission,C0279094,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,adult acute myeloid leukemia in remission,C0279094,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,adult acute myeloid leukemia in remission,C0279094,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,adult acute myeloid leukemia with 11q23 (MLL) abnormalities,C1541334,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,adult acute myeloid leukemia with 11q23 (MLL) abnormalities,C1541334,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,adult acute myeloid leukemia with 11q23 (MLL) abnormalities,C1541334,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,adult acute myeloid leukemia with 11q23 (MLL) abnormalities,C1541334,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,adult acute myeloid leukemia with 11q23 (MLL) abnormalities,C1541334,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,adult acute myeloid leukemia with 11q23 (MLL) abnormalities,C1541334,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,adult acute myeloid leukemia with inv(16)(p13;q22),C1541333,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,adult acute myeloid leukemia with inv(16)(p13;q22),C1541333,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,adult acute myeloid leukemia with inv(16)(p13;q22),C1541333,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,adult acute myeloid leukemia with inv(16)(p13;q22),C1541333,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,adult acute myeloid leukemia with inv(16)(p13;q22),C1541333,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,adult acute myeloid leukemia with inv(16)(p13;q22),C1541333,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,adult acute myeloid leukemia with t(15;17)(q22;q12),C1541335,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,adult acute myeloid leukemia with t(15;17)(q22;q12),C1541335,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,adult acute myeloid leukemia with t(15;17)(q22;q12),C1541335,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,adult acute myeloid leukemia with t(15;17)(q22;q12),C1541335,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,adult acute myeloid leukemia with t(15;17)(q22;q12),C1541335,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,adult acute myeloid leukemia with t(15;17)(q22;q12),C1541335,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,adult acute myeloid leukemia with t(16;16)(p13;q22),C1541332,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,adult acute myeloid leukemia with t(16;16)(p13;q22),C1541332,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,adult acute myeloid leukemia with t(16;16)(p13;q22),C1541332,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,adult acute myeloid leukemia with t(16;16)(p13;q22),C1541332,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,adult acute myeloid leukemia with t(16;16)(p13;q22),C1541332,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,adult acute myeloid leukemia with t(16;16)(p13;q22),C1541332,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,adult acute myeloid leukemia with t(8;21)(q22;q22),C1541331,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,adult acute myeloid leukemia with t(8;21)(q22;q22),C1541331,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,adult acute myeloid leukemia with t(8;21)(q22;q22),C1541331,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,adult acute myeloid leukemia with t(8;21)(q22;q22),C1541331,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,adult acute myeloid leukemia with t(8;21)(q22;q22),C1541331,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,adult acute myeloid leukemia with t(8;21)(q22;q22),C1541331,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,adult nasal type extranodal NK/T-cell lymphoma,C1879279,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,adult nasal type extranodal NK/T-cell lymphoma,C1879279,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,adult nasal type extranodal NK/T-cell lymphoma,C1879279,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,adult nasal type extranodal NK/T-cell lymphoma,C1879279,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,adult nasal type extranodal NK/T-cell lymphoma,C1879279,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,adult nasal type extranodal NK/T-cell lymphoma,C1879279,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,Ki-1+ Anaplastic Large Cell Lymphoma,C0206180,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,Ki-1+ Anaplastic Large Cell Lymphoma,C0206180,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,Ki-1+ Anaplastic Large Cell Lymphoma,C0206180,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,Ki-1+ Anaplastic Large Cell Lymphoma,C0206180,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,Ki-1+ Anaplastic Large Cell Lymphoma,C0206180,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,Ki-1+ Anaplastic Large Cell Lymphoma,C0206180,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,Angioimmunoblastic Lymphadenopathy,C0020981,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,Angioimmunoblastic Lymphadenopathy,C0020981,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,Angioimmunoblastic Lymphadenopathy,C0020981,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,Angioimmunoblastic Lymphadenopathy,C0020981,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,Angioimmunoblastic Lymphadenopathy,C0020981,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,Angioimmunoblastic Lymphadenopathy,C0020981,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,Cutaneous B-Cell Non-Hodgkin Lymphoma,C1511566,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,Cutaneous B-Cell Non-Hodgkin Lymphoma,C1511566,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,Cutaneous B-Cell Non-Hodgkin Lymphoma,C1511566,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,Cutaneous B-Cell Non-Hodgkin Lymphoma,C1511566,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,Cutaneous B-Cell Non-Hodgkin Lymphoma,C1511566,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,Cutaneous B-Cell Non-Hodgkin Lymphoma,C1511566,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,de novo myelodysplastic syndromes,C0280451,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,de novo myelodysplastic syndromes,C0280451,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,de novo myelodysplastic syndromes,C0280451,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,de novo myelodysplastic syndromes,C0280451,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,de novo myelodysplastic syndromes,C0280451,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,de novo myelodysplastic syndromes,C0280451,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,Mucosa-Associated Lymphoid Tissue Lymphoma,C0242647,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,Mucosa-Associated Lymphoid Tissue Lymphoma,C0242647,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,Mucosa-Associated Lymphoid Tissue Lymphoma,C0242647,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,Mucosa-Associated Lymphoid Tissue Lymphoma,C0242647,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,Mucosa-Associated Lymphoid Tissue Lymphoma,C0242647,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,Mucosa-Associated Lymphoid Tissue Lymphoma,C0242647,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,Hepatosplenic T-cell lymphoma,C1333984,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,Hepatosplenic T-cell lymphoma,C1333984,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,Hepatosplenic T-cell lymphoma,C1333984,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,Hepatosplenic T-cell lymphoma,C1333984,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,Hepatosplenic T-cell lymphoma,C1333984,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,Hepatosplenic T-cell lymphoma,C1333984,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,"Myelodysplastic/myeloproliferative neoplasm, unclassifiable",C1328061,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,"Myelodysplastic/myeloproliferative neoplasm, unclassifiable",C1328061,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,"Myelodysplastic/myeloproliferative neoplasm, unclassifiable",C1328061,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,"Myelodysplastic/myeloproliferative neoplasm, unclassifiable",C1328061,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,"Myelodysplastic/myeloproliferative neoplasm, unclassifiable",C1328061,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,"Myelodysplastic/myeloproliferative neoplasm, unclassifiable",C1328061,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,Monocytoid B-cell lymphoma,C0855139,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,Monocytoid B-cell lymphoma,C0855139,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,Monocytoid B-cell lymphoma,C0855139,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,Monocytoid B-cell lymphoma,C0855139,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,Monocytoid B-cell lymphoma,C0855139,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,Monocytoid B-cell lymphoma,C0855139,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,Peripheral T-Cell Lymphoma,C0079774,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,Peripheral T-Cell Lymphoma,C0079774,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,Peripheral T-Cell Lymphoma,C0079774,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,Peripheral T-Cell Lymphoma,C0079774,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,Peripheral T-Cell Lymphoma,C0079774,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,Peripheral T-Cell Lymphoma,C0079774,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Vidarabine,DB00194,Post-transplant lymphoproliferative disorder,C0432487,NCT01652014,Suspended,Phase 2,Funding unavailable,vidarabine
Cyclophosphamide,DB00531,Post-transplant lymphoproliferative disorder,C0432487,NCT01652014,Suspended,Phase 2,Funding unavailable,cyclophosphamide
Mycophenolate mofetil,DB00688,Post-transplant lymphoproliferative disorder,C0432487,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolate mofetil
Tacrolimus,DB00864,Post-transplant lymphoproliferative disorder,C0432487,NCT01652014,Suspended,Phase 2,Funding unavailable,tacrolimus
Mycophenolic acid,DB01024,Post-transplant lymphoproliferative disorder,C0432487,NCT01652014,Suspended,Phase 2,Funding unavailable,mycophenolic acid
Fludarabine,DB01073,Post-transplant lymphoproliferative disorder,C0432487,NCT01652014,Suspended,Phase 2,Funding unavailable,fludarabine
Etoposide,DB00773,Multiple Myeloma,C0026764,NCT01653418,Terminated,Phase 2,Due to the high rate of morbidity and mortality,etoposide
Cytarabine,DB00987,Multiple Myeloma,C0026764,NCT01653418,Terminated,Phase 2,Due to the high rate of morbidity and mortality,cytarabine
Cisplatin,DB00515,stage III squamous cell carcinoma of the lip and oral cavity,C0280353,NCT01682031,Terminated,Phase 2,Due to a lack of funding,cisplatin
Cisplatin,DB00515,Nasopharyngeal squamous cell carcinoma stage III,C0280382,NCT01682031,Terminated,Phase 2,Due to a lack of funding,cisplatin
Cisplatin,DB00515,Oropharyngeal squamous cell carcinoma stage III,C0280372,NCT01682031,Terminated,Phase 2,Due to a lack of funding,cisplatin
Cisplatin,DB00515,stage III squamous cell carcinoma of the paranasal sinus and nasal cavity,C0280411,NCT01682031,Terminated,Phase 2,Due to a lack of funding,cisplatin
Cisplatin,DB00515,Squamous cell carcinoma of the hypopharynx stage IV,C0280391,NCT01682031,Terminated,Phase 2,Due to a lack of funding,cisplatin
Cisplatin,DB00515,Laryngeal squamous cell carcinoma stage IV,C0280399,NCT01682031,Terminated,Phase 2,Due to a lack of funding,cisplatin
Cisplatin,DB00515,stage IV squamous cell carcinoma of the lip and oral cavity,C0280358,NCT01682031,Terminated,Phase 2,Due to a lack of funding,cisplatin
Cisplatin,DB00515,Chemotherapeutic Agent Toxicity,C1707372,NCT01682031,Terminated,Phase 2,Due to a lack of funding,cisplatin
Cisplatin,DB00515,Radiation Sickness,C1510432,NCT01682031,Terminated,Phase 2,Due to a lack of funding,cisplatin
Cisplatin,DB00515,Squamous cell carcinoma of the hypopharynx stage III,C0280390,NCT01682031,Terminated,Phase 2,Due to a lack of funding,cisplatin
Cisplatin,DB00515,Laryngeal squamous cell carcinoma stage III,C0280397,NCT01682031,Terminated,Phase 2,Due to a lack of funding,cisplatin
Cisplatin,DB00515,Nasopharyngeal squamous cell carcinoma stage IV,C0280384,NCT01682031,Terminated,Phase 2,Due to a lack of funding,cisplatin
Cisplatin,DB00515,stage IV squamous cell carcinoma of the oropharynx,C0280374,NCT01682031,Terminated,Phase 2,Due to a lack of funding,cisplatin
Cisplatin,DB00515,stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity,C0280415,NCT01682031,Terminated,Phase 2,Due to a lack of funding,cisplatin
Cisplatin,DB00515,Xerostomia,C0043352,NCT01682031,Terminated,Phase 2,Due to a lack of funding,cisplatin
Ketamine,DB01221,Depressive disorder,C0011581,NCT01680172,Terminated,Phase 2,Slow enrollment,ketamine
Ketamine,DB01221,Anxiety,C0003467,NCT01680172,Terminated,Phase 2,Slow enrollment,ketamine
Alemtuzumab,DB00087,Multiple Sclerosis,C0026769,NCT01679041,Terminated,Phase 2,Insufficient accruals; PI leaving site,alemtuzumab
Cyclophosphamide,DB00531,Multiple Sclerosis,C0026769,NCT01679041,Terminated,Phase 2,Insufficient accruals; PI leaving site,cyclophosphamide
Fludarabine,DB01073,Multiple Sclerosis,C0026769,NCT01679041,Terminated,Phase 2,Insufficient accruals; PI leaving site,fludarabine
Trastuzumab,DB00072,Malignant neoplasm of lung,C0242379,NCT01679743,Withdrawn,Phase 2,,trastuzumab
Bevacizumab,DB00112,Colorectal Neoplasms,C0009404,NCT01677884,Terminated,Phase 2,,bevacizumab
Citalopram,DB00215,Acute Coronary Syndrome,C0948089,NCT01667744,Withdrawn,Phase 1/Phase 2,unfunded,citalopram
Cocaine,DB00907,Cocaine Dependence,C0600427,NCT01715051,Withdrawn,Phase 2,Funding was not received,cocaine
Ezogabine,DB04953,Epilepsy,C0014544,NCT01668654,Terminated,Phase 3,FDA placed a clinical hold on the Pediatric Program requiring retigabine discontinuation in    subjects; early termination allows for timely reporting of results.,ezogabine
Dexmedetomidine,DB00633,"Sleep Apnea, Obstructive",C0520679,NCT01733043,Withdrawn,Phase 2/Phase 3,Failure to secure funding,dexmedetomidine
Prednisolone,DB00860,Ischemic reperfusion injury,C0349419,NCT01726465,Terminated,Phase 2,The first phase was completed,prednisolone
Methylprednisolone,DB00959,Ischemic reperfusion injury,C0349419,NCT01726465,Terminated,Phase 2,The first phase was completed,methylprednisolone
Acetylcysteine,DB06151,Ischemic reperfusion injury,C0349419,NCT01726465,Terminated,Phase 2,The first phase was completed,acetylcysteine
Prednisolone,DB00860,"insufficiency; hepatic, postoperative",C1401063,NCT01726465,Terminated,Phase 2,The first phase was completed,prednisolone
Methylprednisolone,DB00959,"insufficiency; hepatic, postoperative",C1401063,NCT01726465,Terminated,Phase 2,The first phase was completed,methylprednisolone
Acetylcysteine,DB06151,"insufficiency; hepatic, postoperative",C1401063,NCT01726465,Terminated,Phase 2,The first phase was completed,acetylcysteine
Carboplatin,DB00958,Small cell carcinoma of lung,C0149925,NCT01722292,Terminated,Phase 1/Phase 2,Change in clinical strategy.,carboplatin
Cisplatin,DB00515,Squamous cell carcinoma of the hypopharynx recurrent,C0280392,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,Laryngeal squamous cell carcinoma recurrent,C0280401,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,recurrent squamous cell carcinoma of the lip and oral cavity,C0280363,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,Nasopharyngeal squamous cell carcinoma recurrent,C0280386,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,Oropharyngeal squamous cell carcinoma recurrent,C0280376,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity,C0280419,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,Laryngeal verrucous carcinoma recurrent,C0280402,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,Verrucous carcinoma of the oral cavity recurrent,C0280365,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,Squamous cell carcinoma of the hypopharynx stage III,C0280390,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,Laryngeal squamous cell carcinoma stage III,C0280397,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,stage III squamous cell carcinoma of the lip and oral cavity,C0280353,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,Nasopharyngeal squamous cell carcinoma stage III,C0280382,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,Oropharyngeal squamous cell carcinoma stage III,C0280372,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,stage III squamous cell carcinoma of the paranasal sinus and nasal cavity,C0280411,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,Laryngeal verrucous carcinoma stage III,C0280398,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,Verrucous carcinoma of the oral cavity stage III,C0280355,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,Squamous cell carcinoma of the hypopharynx stage IV,C0280391,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,Nasopharyngeal squamous cell carcinoma stage IV,C0280384,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,Stage IVA Laryngeal Squamous Cell Carcinoma,C1336343,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma,C3897523,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,Stage IVA Oropharyngeal Squamous Cell Carcinoma,C1336356,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,C3897522,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,Stage IVA Laryngeal Verrucous Carcinoma,C1336344,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,Stage IVA Oral Cavity Verrucous Carcinoma,C1336354,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,Stage IVB Laryngeal Squamous Cell Carcinoma,C1336374,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma,C3897516,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,Stage IVB Oropharyngeal Squamous Cell Carcinoma,C1336387,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,C3897515,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,Stage IVB Laryngeal Verrucous Carcinoma,C1336375,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,Stage IVB Oral Cavity Verrucous Carcinoma,C1336385,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,Stage IVC Laryngeal Squamous Cell Carcinoma,C1336395,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma,C3897510,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,Stage IVC Oropharyngeal Squamous Cell Carcinoma,C1336407,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,C3897509,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,Stage IVC Laryngeal Verrucous Carcinoma,C1336396,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Cisplatin,DB00515,Stage IVC Oral Cavity Verrucous Carcinoma,C1336405,NCT01728480,Withdrawn,Phase 1,Financial Sponsor requested termination,cisplatin
Naproxen,DB00788,Headache,C0018681,NCT01726920,Withdrawn,Phase 3,"Due to budget limitations, the company decided to withdraw this study.",naproxen
Naratriptan,DB00952,Headache,C0018681,NCT01726920,Withdrawn,Phase 3,"Due to budget limitations, the company decided to withdraw this study.",naratriptan
Asenapine,DB06216,Stuttering,C0038506,NCT01684657,Suspended,Phase 3,Study transferring to another facility,asenapine
Haloperidol,DB00502,Nausea,C0027497,NCT01684969,Withdrawn,Phase 0,lack of accrual and funding is about to expire.,haloperidol
Haloperidol,DB00502,Vomiting,C0042963,NCT01684969,Withdrawn,Phase 0,lack of accrual and funding is about to expire.,haloperidol
Nitric Oxide,DB00435,Bronchopulmonary Dysplasia,C0006287,NCT01748045,Terminated,Phase 2/Phase 3,Enrollenment has been suspended due to poor enrollment,nitric oxide
Tamsulosin,DB00706,Urinary Retention,C0080274,NCT01747993,Terminated,Phase 3,low inclusion,tamsulosin
Dextroamphetamine,DB01576,Schizophrenia,C0036341,NCT01738698,Terminated,Phase 3,Study was discontinued due to non-safety related business prioritization decisions. No    subjects were randomized.,dextroamphetamine
Zinc sulfate,DB09322,Acute gastroenteritis,C0267446,NCT01737086,Terminated,Phase 2/Phase 3,Terminated due to lack of eligible patients.,zinc sulfate
Sorafenib,DB00398,Medullary carcinoma of thyroid,C0238462,NCT01736878,Withdrawn,Phase 2,Study was withdrawn due to unanticipated hassle in patient recruitment.,sorafenib
Cytarabine,DB00987,acute leukemia in relapse,C2367453,NCT01701375,Terminated,Phase 1,Material sponsor withdrew support,cytarabine
Mitoxantrone,DB01204,acute leukemia in relapse,C2367453,NCT01701375,Terminated,Phase 1,Material sponsor withdrew support,mitoxantrone
Carboplatin,DB00958,Anaplastic thyroid carcinoma,C0238461,NCT01701349,Withdrawn,Phase 3,Expected inability to recruit study participants in a reasonable amount of time.,carboplatin
Paclitaxel,DB01229,Anaplastic thyroid carcinoma,C0238461,NCT01701349,Withdrawn,Phase 3,Expected inability to recruit study participants in a reasonable amount of time.,paclitaxel
Dextroamphetamine,DB01576,Schizophrenia,C0036341,NCT01760889,Terminated,Phase 3,Study was discontinued due to non-safety related business prioritization decisions. No    subjects were randomized,dextroamphetamine
Estradiol,DB00783,Atrophy of vagina,C0241616,NCT01753102,Terminated,Phase 3,Slow recruitment,estradiol
Topiramate,DB00273,heavy drinking,C0687132,NCT01764685,Terminated,Phase 2,We terminated the study due to problems recruiting alcoholic subjects with HIV.,topiramate
Leuprolide,DB00007,Hypertensive disease,C0020538,NCT01763541,Withdrawn,Phase 0,,leuprolide
Testosterone,DB00624,Hypertensive disease,C0020538,NCT01763541,Withdrawn,Phase 0,,testosterone
Estradiol,DB00783,Hypertensive disease,C0020538,NCT01763541,Withdrawn,Phase 0,,estradiol
Anastrozole,DB01217,Hypertensive disease,C0020538,NCT01763541,Withdrawn,Phase 0,,anastrozole
Methyltestosterone,DB06710,Hypertensive disease,C0020538,NCT01763541,Withdrawn,Phase 0,,methyltestosterone
Isoniazid,DB00951,Latent Tuberculosis,C1609538,NCT01761201,Terminated,Phase 3,Recruitment rythm not sufficent to reach the simple size needed.,isoniazid
Levofloxacin,DB01137,Latent Tuberculosis,C1609538,NCT01761201,Terminated,Phase 3,Recruitment rythm not sufficent to reach the simple size needed.,levofloxacin
Ofloxacin,DB01165,Latent Tuberculosis,C1609538,NCT01761201,Terminated,Phase 3,Recruitment rythm not sufficent to reach the simple size needed.,ofloxacin
Isoniazid,DB00951,Infection in solid organ transplant recipients,C0857825,NCT01761201,Terminated,Phase 3,Recruitment rythm not sufficent to reach the simple size needed.,isoniazid
Levofloxacin,DB01137,Infection in solid organ transplant recipients,C0857825,NCT01761201,Terminated,Phase 3,Recruitment rythm not sufficent to reach the simple size needed.,levofloxacin
Ofloxacin,DB01165,Infection in solid organ transplant recipients,C0857825,NCT01761201,Terminated,Phase 3,Recruitment rythm not sufficent to reach the simple size needed.,ofloxacin
Belimumab,DB08879,Membranous glomerulonephritis,C0017665,NCT01762852,Withdrawn,Phase 2,"Withdrawn due to difficulties in to recruiting due to competing studies, changing treatment    practices, unavailability of eligible study population",belimumab
Fluoxetine,DB00472,Cerebral Hemorrhage,C2937358,NCT01737541,Terminated,Phase 3,Study recruitment was suspended due to lack of funding,fluoxetine
Rituximab,DB00073,Lupus Nephritis,C0024143,NCT01765842,Terminated,Phase 3,The recruitment period has finished without reaching sample size,rituximab
Vancomycin,DB00512,Surgical Wound Infection,C0038941,NCT01764750,Suspended,Phase 1,awaiting FDA approval for next dose group,vancomycin
Loteprednol,DB00873,Keratitis,C0022568,NCT01721694,Withdrawn,Phase 3,withdrawn by industry,loteprednol
Bevacizumab,DB00112,Malignant tumor of colon,C0007102,NCT01759238,Terminated,Phase 2,slow accrual,bevacizumab
Capecitabine,DB01101,Malignant tumor of colon,C0007102,NCT01759238,Terminated,Phase 2,slow accrual,capecitabine
Fluticasone Propionate,DB00588,Chronic Obstructive Airway Disease,C0024117,NCT01757015,Withdrawn,Phase 3,,fluticasone propionate
Salmeterol,DB00938,Chronic Obstructive Airway Disease,C0024117,NCT01757015,Withdrawn,Phase 3,,salmeterol
Oxaliplatin,DB00526,Gastric carcinoma stage IV,C0863191,NCT01748851,Terminated,Phase 3,Poor enrollment of patients,oxaliplatin
Fluorouracil,DB00544,Gastric carcinoma stage IV,C0863191,NCT01748851,Terminated,Phase 3,Poor enrollment of patients,fluorouracil
Capecitabine,DB01101,Gastric carcinoma stage IV,C0863191,NCT01748851,Terminated,Phase 3,Poor enrollment of patients,capecitabine
Omeprazole,DB00338,Laryngomalacia,C0264303,NCT01782560,Withdrawn,Phase 1,Unable to recruit a sufficient amount of subjects,omeprazole
Simvastatin,DB00641,Rhinosinusitis,C0948780,NCT01771198,Terminated,Phase 2,Lack of efficacy with one month of treatement,simvastatin
Denileukin diftitox,DB00004,Epithelial ovarian cancer,C0677886,NCT01773889,Terminated,Phase 2,Lack of funding,denileukin diftitox
Denileukin diftitox,DB00004,Fallopian Tube Carcinoma,C0238122,NCT01773889,Terminated,Phase 2,Lack of funding,denileukin diftitox
Unoprostone,DB06826,Retinitis Pigmentosa,C0035334,NCT01786395,Terminated,Phase 3,,unoprostone
Ketamine,DB01221,Chronic pain,C0150055,NCT01755169,Terminated,Phase 2,Inability to enroll sufficient patients,ketamine
Chloroquine,DB00608,Malaria,C0024530,NCT01785979,Withdrawn,Phase 3,Lack of funding,chloroquine
Prednisone,DB00635,Malaria,C0024530,NCT01785979,Withdrawn,Phase 3,Lack of funding,prednisone
Bevacizumab,DB00112,Glioblastoma,C0017636,NCT01782976,Withdrawn,Phase 2,,bevacizumab
Heparin,DB01109,Inhalation injury,C0745334,NCT01773083,Terminated,Phase 3,insufficient recruitment of patients and high costs associated with the purchase and blinding    of study medication,heparin
Nitrous oxide,DB06690,Labor Pain,C0474368,NCT01738672,Suspended,Phase 2,,nitrous oxide
Ranolazine,DB00243,Acute Coronary Syndrome,C0948089,NCT01767987,Terminated,Phase 2,Sponsor terminated study due to lack of enrollment,ranolazine
Rosuvastatin,DB01098,Influenza due to Influenza A virus subtype H1N1,C2076600,NCT01798602,Terminated,Phase 2,H1N1 pandemic concluded,rosuvastatin
Azacitidine,DB00928,"Leukemia, Myelocytic, Acute",C0023467,NCT01794169,Terminated,Phase 2,Poor recruitment,azacitidine
Theophylline,DB00277,Non-Small Cell Lung Carcinoma,C0007131,NCT01799161,Withdrawn,Phase 1,Insufficient funding,theophylline
Aminophylline,DB01223,Non-Small Cell Lung Carcinoma,C0007131,NCT01799161,Withdrawn,Phase 1,Insufficient funding,aminophylline
Theophylline,DB00277,Malignant neoplasm of lung,C0242379,NCT01799161,Withdrawn,Phase 1,Insufficient funding,theophylline
Aminophylline,DB01223,Malignant neoplasm of lung,C0242379,NCT01799161,Withdrawn,Phase 1,Insufficient funding,aminophylline
Estradiol,DB00783,Infertility,C0021359,NCT01798836,Terminated,Phase 2/Phase 3,Obtained results were not good. Protocol was proved ineffective.,estradiol
Triptorelin,DB06825,Infertility,C0021359,NCT01798836,Terminated,Phase 2/Phase 3,Obtained results were not good. Protocol was proved ineffective.,triptorelin
Clofarabine,DB00631,"Histiocytosis, Langerhans-Cell",C0019621,NCT01796405,Withdrawn,Phase 2,,clofarabine
Eplerenone,DB00700,Ascites,C0003962,NCT01801228,Withdrawn,Phase 2,difficulties to include patients,eplerenone
Hydroxychloroquine,DB01611,Antiphospholipid Syndrome,C0085278,NCT01784523,Terminated,Phase 3,low recruitment rate exacerbated by manufacturing shortage and price increase of    hydroxychloroquine.,hydroxychloroquine
Papaverine,DB01113,Schizophrenia,C0036341,NCT01813955,Terminated,Phase 0,Patient recruitment insufficient,papaverine
Metformin,DB00331,Colorectal Carcinoma,C0009402,NCT01816659,Terminated,Phase 1,Slow Accrual,metformin
Nicardipine,DB00622,Cerebral Vasospasm,C0265110,NCT01810302,Terminated,Phase 2,Unable to secure drug.,nicardipine
Ifosfamide,DB01181,adult central nervous system germ cell tumor,C0280796,NCT01808534,Terminated,Phase 2,Due to Low Accrual,ifosfamide
Ifosfamide,DB01181,Adult teratoma,C1368898,NCT01808534,Terminated,Phase 2,Due to Low Accrual,ifosfamide
Ifosfamide,DB01181,Malignant Extragonadal Germ Cell Tumor,C1334581,NCT01808534,Terminated,Phase 2,Due to Low Accrual,ifosfamide
Ifosfamide,DB01181,Malignant Extragonadal Non-Seminomatous Germ Cell Tumor,C1334582,NCT01808534,Terminated,Phase 2,Due to Low Accrual,ifosfamide
Ifosfamide,DB01181,Extragonadal Seminoma,C1333502,NCT01808534,Terminated,Phase 2,Due to Low Accrual,ifosfamide
Ifosfamide,DB01181,Testis cancer recurrent,C0278841,NCT01808534,Terminated,Phase 2,Due to Low Accrual,ifosfamide
Ifosfamide,DB01181,recurrent ovarian germ cell tumor,C0279975,NCT01808534,Terminated,Phase 2,Due to Low Accrual,ifosfamide
Ifosfamide,DB01181,Stage IV Extragonadal Non-Seminomatous Germ Cell Tumor,C1336415,NCT01808534,Terminated,Phase 2,Due to Low Accrual,ifosfamide
Ifosfamide,DB01181,Stage IV Extragonadal Seminoma,C1336416,NCT01808534,Terminated,Phase 2,Due to Low Accrual,ifosfamide
Ifosfamide,DB01181,Ovarian germ cell cancer stage IV,C0279974,NCT01808534,Terminated,Phase 2,Due to Low Accrual,ifosfamide
Sirolimus,DB00877,Eosinophilic gastroenteritis,C1262481,NCT01814059,Terminated,Phase 1,,sirolimus
Everolimus,DB01590,Eosinophilic gastroenteritis,C1262481,NCT01814059,Terminated,Phase 1,,everolimus
Sirolimus,DB00877,Eosinophilic esophagitis,C0341106,NCT01814059,Terminated,Phase 1,,sirolimus
Everolimus,DB01590,Eosinophilic esophagitis,C0341106,NCT01814059,Terminated,Phase 1,,everolimus
Ponatinib,DB08901,Thyroid Neoplasm,C0040136,NCT01838642,Terminated,Phase 2,Recruiting halted prematurely and will not resume. New study to open soon.,ponatinib
Prednisone,DB00635,Polymyalgia Rheumatica,C0032533,NCT01821040,Terminated,Phase 3,,prednisone
Cyclophosphamide,DB00531,Breast cancer stage II,C0278486,NCT01818063,Suspended,Phase 2,Lack of funding,cyclophosphamide
Carboplatin,DB00958,Breast cancer stage II,C0278486,NCT01818063,Suspended,Phase 2,Lack of funding,carboplatin
Doxorubicin,DB00997,Breast cancer stage II,C0278486,NCT01818063,Suspended,Phase 2,Lack of funding,doxorubicin
Paclitaxel,DB01229,Breast cancer stage II,C0278486,NCT01818063,Suspended,Phase 2,Lack of funding,paclitaxel
Heparin,DB01109,Bacteremia,C0004610,NCT01820962,Terminated,Phase 3,Because the inclusion rate was lower than expected.,heparin
Aluminum hydroxide,DB06723,"viral; infection, enterovirus",C1400756,NCT01812135,Withdrawn,Phase 2,"Based on the previous study results, inactivated EV71 vaccine with aluminum adjuvant was    elected to be used for the efficacy Phase III study.",aluminum hydroxide
Naltrexone,DB00704,Inflammatory Bowel Diseases,C0021390,NCT01810185,Withdrawn,Phase 2,Low patient enrollment,naltrexone
Naltrexone,DB00704,Crohn Disease,C0010346,NCT01810185,Withdrawn,Phase 2,Low patient enrollment,naltrexone
Naltrexone,DB00704,Ulcerative Colitis,C0009324,NCT01810185,Withdrawn,Phase 2,Low patient enrollment,naltrexone
Levoleucovorin,DB11596,Non-Small Cell Lung Carcinoma,C0007131,NCT01820091,Withdrawn,Phase 1,,levoleucovorin
Sulindac,DB00605,Malignant tumor of colon,C0007102,NCT01856322,Terminated,Phase 2,The trial was prematurely closed due to lack of accrual.,sulindac
Sulindac,DB00605,Adenocarcinoma of large intestine,C1319315,NCT01856322,Terminated,Phase 2,The trial was prematurely closed due to lack of accrual.,sulindac
Lidocaine,DB00281,colorectal disorders,C2103078,NCT01836614,Withdrawn,Phase 1/Phase 2,Study was closed due to recommendations of performing a PK study first.,lidocaine
Cyclophosphamide,DB00531,Metastatic melanoma,C0278883,NCT01833767,Withdrawn,Phase 2,No participants enrolled,cyclophosphamide
Mechlorethamine,DB00888,DS Stage I Plasma Cell Myeloma,C0278722,NCT01842308,Suspended,Phase 1/Phase 2,Accrual to dose level 3 (56 mg/m2 Carfilzomib; 100 mg/m2 Melphalan) has been met.,mechlorethamine
Melphalan,DB01042,DS Stage I Plasma Cell Myeloma,C0278722,NCT01842308,Suspended,Phase 1/Phase 2,Accrual to dose level 3 (56 mg/m2 Carfilzomib; 100 mg/m2 Melphalan) has been met.,melphalan
Mechlorethamine,DB00888,DS Stage II Plasma Cell Myeloma,C0278723,NCT01842308,Suspended,Phase 1/Phase 2,Accrual to dose level 3 (56 mg/m2 Carfilzomib; 100 mg/m2 Melphalan) has been met.,mechlorethamine
Melphalan,DB01042,DS Stage II Plasma Cell Myeloma,C0278723,NCT01842308,Suspended,Phase 1/Phase 2,Accrual to dose level 3 (56 mg/m2 Carfilzomib; 100 mg/m2 Melphalan) has been met.,melphalan
Mechlorethamine,DB00888,DS Stage III Plasma Cell Myeloma,C0278724,NCT01842308,Suspended,Phase 1/Phase 2,Accrual to dose level 3 (56 mg/m2 Carfilzomib; 100 mg/m2 Melphalan) has been met.,mechlorethamine
Melphalan,DB01042,DS Stage III Plasma Cell Myeloma,C0278724,NCT01842308,Suspended,Phase 1/Phase 2,Accrual to dose level 3 (56 mg/m2 Carfilzomib; 100 mg/m2 Melphalan) has been met.,melphalan
Sulindac,DB00605,"Leukemia, Myelocytic, Acute",C0023467,NCT01843179,Withdrawn,Phase 2,Lack of Funding,sulindac
Doxorubicin,DB00997,Epithelial ovarian cancer,C0677886,NCT01840943,Terminated,Phase 3,the study was terminated due to medication supply issue from current manufacturer,doxorubicin
Topotecan,DB01030,Epithelial ovarian cancer,C0677886,NCT01840943,Terminated,Phase 3,the study was terminated due to medication supply issue from current manufacturer,topotecan
Tacrolimus,DB00864,Vitiligo,C0042900,NCT01841008,Terminated,Phase 2/Phase 3,,tacrolimus
Paroxetine,DB00715,Hepatitis C,C0019196,NCT01841502,Terminated,Phase 2,"Telaprevir will not be used in NL, no more inclusions are expected.",paroxetine
Lipoic Acid,DB00166,Chronic Fatigue Syndrome,C0015674,NCT01872351,Withdrawn,Phase 1,PI left the institution,lipoic acid
Acetylcarnitine,DB08842,Chronic Fatigue Syndrome,C0015674,NCT01872351,Withdrawn,Phase 1,PI left the institution,acetylcarnitine
Ciprofloxacin,DB00537,Urolithiasis,C0451641,NCT01873690,Terminated,Phase 3,Due to the low recruitment rate and the large number lost to follow-up,ciprofloxacin
Sorafenib,DB00398,Melanoma recurrent,C0278884,NCT01851408,Withdrawn,Phase 2,No progression of Phase 1 trial to Phase 2.,sorafenib
Sirolimus,DB00877,Melanoma recurrent,C0278884,NCT01851408,Withdrawn,Phase 2,No progression of Phase 1 trial to Phase 2.,sirolimus
Everolimus,DB01590,Melanoma recurrent,C0278884,NCT01851408,Withdrawn,Phase 2,No progression of Phase 1 trial to Phase 2.,everolimus
Sorafenib,DB00398,malignant melanoma of skin stage III,C0278882,NCT01851408,Withdrawn,Phase 2,No progression of Phase 1 trial to Phase 2.,sorafenib
Sirolimus,DB00877,malignant melanoma of skin stage III,C0278882,NCT01851408,Withdrawn,Phase 2,No progression of Phase 1 trial to Phase 2.,sirolimus
Everolimus,DB01590,malignant melanoma of skin stage III,C0278882,NCT01851408,Withdrawn,Phase 2,No progression of Phase 1 trial to Phase 2.,everolimus
Lapatinib,DB01259,Breast cancer recurrent,C0278493,NCT01868503,Terminated,Phase 2,Protocol modification,lapatinib
Valproic Acid,DB00313,childhood brain tumor,C0220603,NCT01861990,Withdrawn,Phase 1,Feasibility of the trial was proven to be absent.,valproic acid
Valproic Acid,DB00313,Anaplastic astrocytoma,C0334579,NCT01861990,Withdrawn,Phase 1,Feasibility of the trial was proven to be absent.,valproic acid
Valproic Acid,DB00313,Medulloblastoma,C0025149,NCT01861990,Withdrawn,Phase 1,Feasibility of the trial was proven to be absent.,valproic acid
Valproic Acid,DB00313,Glioblastoma,C0017636,NCT01861990,Withdrawn,Phase 1,Feasibility of the trial was proven to be absent.,valproic acid
Warfarin,DB00682,primary disorders,C0277554,NCT01868243,Terminated,Phase 2/Phase 3,because a significant decrease of viable candidates for the study.,warfarin
Melatonin,DB01065,"ENCEPHALOPATHY, HYPOXIC-ISCHEMIC, NEWBORN",C0149878,NCT01904786,Withdrawn,Phase 1,Lack of enrollment of suitable candidates,melatonin
Trametinib,DB08911,recurrent adult acute myeloid leukemia,C0278780,NCT01907815,Suspended,Phase 2,Drug supply issues,trametinib
Trametinib,DB08911,untreated adult acute myeloid leukemia,C0279089,NCT01907815,Suspended,Phase 2,Drug supply issues,trametinib
Lidocaine,DB00281,Periodontitis,C0031099,NCT01878864,Terminated,Phase 2,Too slow patient inclusion and superior effect of the injection,lidocaine
Bupivacaine,DB00297,Periodontitis,C0031099,NCT01878864,Terminated,Phase 2,Too slow patient inclusion and superior effect of the injection,bupivacaine
Epinephrine,DB00668,Periodontitis,C0031099,NCT01878864,Terminated,Phase 2,Too slow patient inclusion and superior effect of the injection,epinephrine
Eslicarbazepine acetate,DB09119,Epilepsy,C0014544,NCT01878578,Terminated,Phase 1,prematurely terminated due to impossibility of recruiting the planned number of patients by    the study centre.,eslicarbazepine acetate
Asparaginase,DB00023,T-cell lymphoma recurrent,C0854826,NCT01878708,Terminated,Phase 0,Slow accrual,asparaginase
Pegaspargase,DB00059,T-cell lymphoma recurrent,C0854826,NCT01878708,Terminated,Phase 0,Slow accrual,pegaspargase
Dexamethasone,DB01234,T-cell lymphoma recurrent,C0854826,NCT01878708,Terminated,Phase 0,Slow accrual,dexamethasone
Asparaginase,DB00023,T-cell lymphoma refractory,C0854827,NCT01878708,Terminated,Phase 0,Slow accrual,asparaginase
Pegaspargase,DB00059,T-cell lymphoma refractory,C0854827,NCT01878708,Terminated,Phase 0,Slow accrual,pegaspargase
Dexamethasone,DB01234,T-cell lymphoma refractory,C0854827,NCT01878708,Terminated,Phase 0,Slow accrual,dexamethasone
Moxifloxacin,DB00218,Tuberculosis,C0041296,NCT01874314,Withdrawn,Phase 1,,moxifloxacin
Octreotide,DB00104,"Carcinoma, Neuroendocrine",C0206695,NCT01886287,Terminated,Phase 2,Slow accrual,octreotide
Gemcitabine,DB00441,duct cell adenocarcinoma of the pancreas,C0279176,NCT01893294,Terminated,Phase 1,Funding discontinued; all patients off study,gemcitabine
Fluorouracil,DB00544,duct cell adenocarcinoma of the pancreas,C0279176,NCT01893294,Terminated,Phase 1,Funding discontinued; all patients off study,fluorouracil
Gemcitabine,DB00441,Pancreatic carcinoma stage III,C1167722,NCT01893294,Terminated,Phase 1,Funding discontinued; all patients off study,gemcitabine
Fluorouracil,DB00544,Pancreatic carcinoma stage III,C1167722,NCT01893294,Terminated,Phase 1,Funding discontinued; all patients off study,fluorouracil
Gemcitabine,DB00441,Stage IV Pancreatic Cancer,C1167725,NCT01893294,Terminated,Phase 1,Funding discontinued; all patients off study,gemcitabine
Fluorouracil,DB00544,Stage IV Pancreatic Cancer,C1167725,NCT01893294,Terminated,Phase 1,Funding discontinued; all patients off study,fluorouracil
Abatacept,DB01281,Alopecia Areata,C0002171,NCT01917058,Withdrawn,Phase 2,Unfortunately we did not receive funding and therefore were not able to begin the trial.,abatacept
Mifepristone,DB00834,Pituitary-dependent Cushing's disease,C0221406,NCT01925092,Withdrawn,Phase 3,Lack of enrollment,mifepristone
Cetuximab,DB00002,Colorectal cancer metastatic,C0948380,NCT01925274,Terminated,Phase 2,Enrollment to the study was terminated on 11Nvo2014 due to slow recruitment. There were no    safety or efficacy issues that contributed to this decision.,cetuximab
Irinotecan,DB00762,Colorectal cancer metastatic,C0948380,NCT01925274,Terminated,Phase 2,Enrollment to the study was terminated on 11Nvo2014 due to slow recruitment. There were no    safety or efficacy issues that contributed to this decision.,irinotecan
Vitamin C,DB00126,Blood Coagulation Disorders,C0005779,NCT01897792,Terminated,Phase 2,Study was terminated due to inability to recruit enough patients that meet inclusion criteria.    No analysis will be done.,vitamin c
Vitamin E,DB00163,Blood Coagulation Disorders,C0005779,NCT01897792,Terminated,Phase 2,Study was terminated due to inability to recruit enough patients that meet inclusion criteria.    No analysis will be done.,vitamin e
Vitamin C,DB00126,Nosocomial pneumonia,C0949083,NCT01897792,Terminated,Phase 2,Study was terminated due to inability to recruit enough patients that meet inclusion criteria.    No analysis will be done.,vitamin c
Vitamin E,DB00163,Nosocomial pneumonia,C0949083,NCT01897792,Terminated,Phase 2,Study was terminated due to inability to recruit enough patients that meet inclusion criteria.    No analysis will be done.,vitamin e
Amitriptyline,DB00321,Sleep Initiation and Maintenance Disorders,C0021603,NCT01921296,Terminated,Phase 2,Accrual terminated early because of poor accrual,amitriptyline
Cyclobenzaprine,DB00924,Sleep Initiation and Maintenance Disorders,C0021603,NCT01921296,Terminated,Phase 2,Accrual terminated early because of poor accrual,cyclobenzaprine
Amitriptyline,DB00321,Pain,C0030193,NCT01921296,Terminated,Phase 2,Accrual terminated early because of poor accrual,amitriptyline
Cyclobenzaprine,DB00924,Pain,C0030193,NCT01921296,Terminated,Phase 2,Accrual terminated early because of poor accrual,cyclobenzaprine
Cisplatin,DB00515,Breast cancer recurrent,C0278493,NCT01918306,Terminated,Phase 1/Phase 2,company stopped production of study drug due to excessive toxicities,cisplatin
Trametinib,DB08911,malignant neoplasm of large intestine stage IIIc,C2217039,NCT01902173,Suspended,Phase 1/Phase 2,Temporarily stopped for assessment. Contact ctsucontact@westat.com for specifics,trametinib
Dabrafenib,DB08912,malignant neoplasm of large intestine stage IIIc,C2217039,NCT01902173,Suspended,Phase 1/Phase 2,Temporarily stopped for assessment. Contact ctsucontact@westat.com for specifics,dabrafenib
Trametinib,DB08911,Melanoma recurrent,C0278884,NCT01902173,Suspended,Phase 1/Phase 2,Temporarily stopped for assessment. Contact ctsucontact@westat.com for specifics,trametinib
Dabrafenib,DB08912,Melanoma recurrent,C0278884,NCT01902173,Suspended,Phase 1/Phase 2,Temporarily stopped for assessment. Contact ctsucontact@westat.com for specifics,dabrafenib
Trametinib,DB08911,Stage IIIC Skin Melanoma,C2828036,NCT01902173,Suspended,Phase 1/Phase 2,Temporarily stopped for assessment. Contact ctsucontact@westat.com for specifics,trametinib
Dabrafenib,DB08912,Stage IIIC Skin Melanoma,C2828036,NCT01902173,Suspended,Phase 1/Phase 2,Temporarily stopped for assessment. Contact ctsucontact@westat.com for specifics,dabrafenib
Paclitaxel,DB01229,Metastatic melanoma,C0278883,NCT01933061,Withdrawn,Phase 2,Strategic decision not to proceed with the opening of this study. There are no concerns over    the safety or quality of the investigational products involved.,paclitaxel
Pegfilgrastim,DB00019,Solid tumour,C0280100,NCT01940601,Withdrawn,Phase 2,,pegfilgrastim
Megestrol acetate,DB00351,Atypical Endometrial Hyperplasia,C0349579,NCT01943058,Withdrawn,Phase 2,Lack of funding,megestrol acetate
Levonorgestrel,DB00367,Atypical Endometrial Hyperplasia,C0349579,NCT01943058,Withdrawn,Phase 2,Lack of funding,levonorgestrel
Norgestrel,DB09389,Atypical Endometrial Hyperplasia,C0349579,NCT01943058,Withdrawn,Phase 2,Lack of funding,norgestrel
Megestrol acetate,DB00351,Endometrial adenocarcinoma,C1153706,NCT01943058,Withdrawn,Phase 2,Lack of funding,megestrol acetate
Levonorgestrel,DB00367,Endometrial adenocarcinoma,C1153706,NCT01943058,Withdrawn,Phase 2,Lack of funding,levonorgestrel
Norgestrel,DB09389,Endometrial adenocarcinoma,C1153706,NCT01943058,Withdrawn,Phase 2,Lack of funding,norgestrel
Megestrol acetate,DB00351,Recurrent Endometrial Cancer,C0278802,NCT01943058,Withdrawn,Phase 2,Lack of funding,megestrol acetate
Levonorgestrel,DB00367,Recurrent Endometrial Cancer,C0278802,NCT01943058,Withdrawn,Phase 2,Lack of funding,levonorgestrel
Norgestrel,DB09389,Recurrent Endometrial Cancer,C0278802,NCT01943058,Withdrawn,Phase 2,Lack of funding,norgestrel
Megestrol acetate,DB00351,Endometrial cancer stage II,C0278799,NCT01943058,Withdrawn,Phase 2,Lack of funding,megestrol acetate
Levonorgestrel,DB00367,Endometrial cancer stage II,C0278799,NCT01943058,Withdrawn,Phase 2,Lack of funding,levonorgestrel
Norgestrel,DB09389,Endometrial cancer stage II,C0278799,NCT01943058,Withdrawn,Phase 2,Lack of funding,norgestrel
Chlorhexidine,DB00878,Cerebral Hemorrhage,C2937358,NCT01933230,Terminated,Phase 1,Closed study due to issues we have encountered with meeting our enrollment goals of this study    at our site.,chlorhexidine
Carboplatin,DB00958,Solid tumour,C0280100,NCT01930292,Terminated,Phase 1,Part B was cancelled based on business decision,carboplatin
Paclitaxel,DB01229,Solid tumour,C0280100,NCT01930292,Terminated,Phase 1,Part B was cancelled based on business decision,paclitaxel
Doxycycline,DB00254,Non-ischemic cardiomyopathy,C0877438,NCT01935622,Terminated,Phase 2,End of funding,doxycycline
Sodium thiosulfate,DB09499,Calcinosis cutis,C0006664,NCT01918904,Withdrawn,Phase 2,,sodium thiosulfate
Isotretinoin,DB00982,Neuroblastoma,C0027819,NCT01916187,Withdrawn,Phase 1,drug company withdrww support following a re-examination of the benefit-risk assessment for    the investigational use of imetelstat in this population,isotretinoin
Ifosfamide,DB01181,"Liposarcoma, Dedifferentiated",C0205824,NCT01913652,Suspended,Phase 2,Major amendment - change in design,ifosfamide
Azacitidine,DB00928,"Leukemia, Myelomonocytic, Chronic",C0023480,NCT01908387,Terminated,Phase 1,Due to Slow Accrual study was terminated.,azacitidine
Azacitidine,DB00928,"Leukemia, Myelocytic, Acute",C0023467,NCT01908387,Terminated,Phase 1,Due to Slow Accrual study was terminated.,azacitidine
Azacitidine,DB00928,Multiple Myeloma,C0026764,NCT01908387,Terminated,Phase 1,Due to Slow Accrual study was terminated.,azacitidine
Deferasirox,DB01609,Iron Overload,C0282193,NCT01927913,Withdrawn,Phase 2,This study was withdrawn until the evaluation of the nonclinical rat findings is complete.,deferasirox
Deferasirox,DB01609,Iron Metabolism Disorders,C0012715,NCT01927913,Withdrawn,Phase 2,This study was withdrawn until the evaluation of the nonclinical rat findings is complete.,deferasirox
Norepinephrine,DB00368,Pure Autonomic Failure,C0393911,NCT01927055,Terminated,Phase 3,Due to potential competition with a post-marketing study requested by FDA,norepinephrine
Droxidopa,DB06262,Pure Autonomic Failure,C0393911,NCT01927055,Terminated,Phase 3,Due to potential competition with a post-marketing study requested by FDA,droxidopa
Norepinephrine,DB00368,dopamine beta hydroxylase deficiency,C0342687,NCT01927055,Terminated,Phase 3,Due to potential competition with a post-marketing study requested by FDA,norepinephrine
Droxidopa,DB06262,dopamine beta hydroxylase deficiency,C0342687,NCT01927055,Terminated,Phase 3,Due to potential competition with a post-marketing study requested by FDA,droxidopa
Gemcitabine,DB00441,Secondary malignant neoplasm of pancreas,C0346976,NCT01956812,Terminated,Phase 3,"The DSMB conducted an interim analysis on overall survival, which showed that the treatment    arm did not demonstrate a sufficient improvement in OS vs. placebo.",gemcitabine
Lidocaine,DB00281,Pain,C0030193,NCT01930877,Withdrawn,Phase 2,Withdrawn by PI,lidocaine
Abciximab,DB00054,Hb-SS disease with vasoocclusive pain,C2873760,NCT01932554,Withdrawn,Phase 2,Insufficient recruitment,abciximab
Morphine,DB00295,Hb-SS disease with vasoocclusive pain,C2873760,NCT01932554,Withdrawn,Phase 2,Insufficient recruitment,morphine
Hydromorphone,DB00327,Hb-SS disease with vasoocclusive pain,C2873760,NCT01932554,Withdrawn,Phase 2,Insufficient recruitment,hydromorphone
Fentanyl,DB00813,Hb-SS disease with vasoocclusive pain,C2873760,NCT01932554,Withdrawn,Phase 2,Insufficient recruitment,fentanyl
Ibuprofen,DB01050,Hb-SS disease with vasoocclusive pain,C2873760,NCT01932554,Withdrawn,Phase 2,Insufficient recruitment,ibuprofen
Abciximab,DB00054,Hemoglobin SS disease with vasoocclusive crisis,C2585715,NCT01932554,Withdrawn,Phase 2,Insufficient recruitment,abciximab
Morphine,DB00295,Hemoglobin SS disease with vasoocclusive crisis,C2585715,NCT01932554,Withdrawn,Phase 2,Insufficient recruitment,morphine
Hydromorphone,DB00327,Hemoglobin SS disease with vasoocclusive crisis,C2585715,NCT01932554,Withdrawn,Phase 2,Insufficient recruitment,hydromorphone
Fentanyl,DB00813,Hemoglobin SS disease with vasoocclusive crisis,C2585715,NCT01932554,Withdrawn,Phase 2,Insufficient recruitment,fentanyl
Ibuprofen,DB01050,Hemoglobin SS disease with vasoocclusive crisis,C2585715,NCT01932554,Withdrawn,Phase 2,Insufficient recruitment,ibuprofen
Abciximab,DB00054,Other sickle-cell disease with vaso-occlusive pain,C1260331,NCT01932554,Withdrawn,Phase 2,Insufficient recruitment,abciximab
Morphine,DB00295,Other sickle-cell disease with vaso-occlusive pain,C1260331,NCT01932554,Withdrawn,Phase 2,Insufficient recruitment,morphine
Hydromorphone,DB00327,Other sickle-cell disease with vaso-occlusive pain,C1260331,NCT01932554,Withdrawn,Phase 2,Insufficient recruitment,hydromorphone
Fentanyl,DB00813,Other sickle-cell disease with vaso-occlusive pain,C1260331,NCT01932554,Withdrawn,Phase 2,Insufficient recruitment,fentanyl
Ibuprofen,DB01050,Other sickle-cell disease with vaso-occlusive pain,C1260331,NCT01932554,Withdrawn,Phase 2,Insufficient recruitment,ibuprofen
Clofarabine,DB00631,"Leukemia, Myelocytic, Acute",C0023467,NCT01960387,Terminated,Phase 2,lack of accrual,clofarabine
Cisplatin,DB00515,Non-small cell lung cancer recurrent,C0278517,NCT01928160,Withdrawn,Phase 2,study not accruing,cisplatin
Erlotinib,DB00530,Non-small cell lung cancer recurrent,C0278517,NCT01928160,Withdrawn,Phase 2,study not accruing,erlotinib
Pemetrexed,DB00642,Non-small cell lung cancer recurrent,C0278517,NCT01928160,Withdrawn,Phase 2,study not accruing,pemetrexed
Carboplatin,DB00958,Non-small cell lung cancer recurrent,C0278517,NCT01928160,Withdrawn,Phase 2,study not accruing,carboplatin
Cisplatin,DB00515,Non-small cell lung cancer metastatic,C0278987,NCT01928160,Withdrawn,Phase 2,study not accruing,cisplatin
Erlotinib,DB00530,Non-small cell lung cancer metastatic,C0278987,NCT01928160,Withdrawn,Phase 2,study not accruing,erlotinib
Pemetrexed,DB00642,Non-small cell lung cancer metastatic,C0278987,NCT01928160,Withdrawn,Phase 2,study not accruing,pemetrexed
Carboplatin,DB00958,Non-small cell lung cancer metastatic,C0278987,NCT01928160,Withdrawn,Phase 2,study not accruing,carboplatin
Cisplatin,DB00515,Oropharyngeal squamous cell carcinoma stage III,C0280372,NCT01953952,Withdrawn,Phase 2,Slow accrual,cisplatin
Cisplatin,DB00515,Stage IVA Oropharyngeal Squamous Cell Carcinoma,C1336356,NCT01953952,Withdrawn,Phase 2,Slow accrual,cisplatin
Metformin,DB00331,Stage IA Pancreatic Cancer,C2981674,NCT01954732,Withdrawn,Phase 1,Slow accrual,metformin
Metformin,DB00331,Stage IB Pancreatic Cancer,C2981675,NCT01954732,Withdrawn,Phase 1,Slow accrual,metformin
Metformin,DB00331,Stage IIA Pancreatic Cancer,C2981676,NCT01954732,Withdrawn,Phase 1,Slow accrual,metformin
Metformin,DB00331,Stage IIB Pancreatic Cancer,C2981677,NCT01954732,Withdrawn,Phase 1,Slow accrual,metformin
Hydroxyurea,DB01005,Pulmonary Hypertension,C0020542,NCT01950585,Withdrawn,Phase 0,,hydroxyurea
Fluconazole,DB00196,"Leishmaniasis, Cutaneous",C0023283,NCT01953744,Terminated,Phase 3,Low cure rate in the study (fluconazole) group,fluconazole
Granisetron,DB00889,Malignant Glioma,C0555198,NCT01952886,Withdrawn,Phase 2,Lack of approval and funding from company,granisetron
Ondansetron,DB00904,Malignant Glioma,C0555198,NCT01952886,Withdrawn,Phase 2,Lack of approval and funding from company,ondansetron
Mannitol,DB00742,Acute Cerebrovascular Accidents,C0751956,NCT01954290,Withdrawn,Phase 2,Investigator is leaving the institution.,mannitol
Verapamil,DB00661,Classical phenylketonuria,C0751434,NCT01977820,Terminated,Phase 2,Recruitment challenges,verapamil
Omeprazole,DB00338,Cystic Fibrosis,C0010674,NCT01983774,Terminated,Phase 2,Closed by sponsor of the study; PI has left the institution and Columbia is now the sponsor of    the record,omeprazole
Esomeprazole,DB00736,Cystic Fibrosis,C0010674,NCT01983774,Terminated,Phase 2,Closed by sponsor of the study; PI has left the institution and Columbia is now the sponsor of    the record,esomeprazole
Hydromorphone,DB00327,Back Pain,C0004604,NCT01986946,Terminated,Phase 3,Lack of recruitment.,hydromorphone
Rituximab,DB00073,Non-Hodgkin's lymphoma of central nervous system,C2213246,NCT01973062,Terminated,Phase 2,Funding Unavailable,rituximab
Trastuzumab,DB00072,Malignant neoplasm of stomach,C0024623,NCT02005484,Terminated,Phase 2,Study terminated due to slow patient recruitment.,trastuzumab
Atomoxetine,DB00289,Nicotine Dependence,C0028043,NCT02046551,Suspended,Phase 1/Phase 2,funding lost,atomoxetine
Trastuzumab,DB00072,Cancer of Urinary Tract,C0751571,NCT02013765,Terminated,Phase 2,Trial was terminated prematurely because of recruitment difficulties.,trastuzumab
Exenatide,DB01276,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,NCT02020616,Terminated,Phase 1/Phase 2,Lack of Efficacy,exenatide
Cytarabine,DB00987,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,C1332153,NCT02029417,Terminated,Phase 2,Major revisions needed in study,cytarabine
Decitabine,DB01262,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,C1332153,NCT02029417,Terminated,Phase 2,Major revisions needed in study,decitabine
Homoharringtonine,DB04865,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,C1332153,NCT02029417,Terminated,Phase 2,Major revisions needed in study,homoharringtonine
Cytarabine,DB00987,adult acute megakaryoblastic leukemia (M7),C0279632,NCT02029417,Terminated,Phase 2,Major revisions needed in study,cytarabine
Decitabine,DB01262,adult acute megakaryoblastic leukemia (M7),C0279632,NCT02029417,Terminated,Phase 2,Major revisions needed in study,decitabine
Homoharringtonine,DB04865,adult acute megakaryoblastic leukemia (M7),C0279632,NCT02029417,Terminated,Phase 2,Major revisions needed in study,homoharringtonine
Cytarabine,DB00987,adult acute minimally differentiated myeloid leukemia (M0),C0281641,NCT02029417,Terminated,Phase 2,Major revisions needed in study,cytarabine
Decitabine,DB01262,adult acute minimally differentiated myeloid leukemia (M0),C0281641,NCT02029417,Terminated,Phase 2,Major revisions needed in study,decitabine
Homoharringtonine,DB04865,adult acute minimally differentiated myeloid leukemia (M0),C0281641,NCT02029417,Terminated,Phase 2,Major revisions needed in study,homoharringtonine
Cytarabine,DB00987,adult acute monoblastic leukemia (M5a),C0279629,NCT02029417,Terminated,Phase 2,Major revisions needed in study,cytarabine
Decitabine,DB01262,adult acute monoblastic leukemia (M5a),C0279629,NCT02029417,Terminated,Phase 2,Major revisions needed in study,decitabine
Homoharringtonine,DB04865,adult acute monoblastic leukemia (M5a),C0279629,NCT02029417,Terminated,Phase 2,Major revisions needed in study,homoharringtonine
Cytarabine,DB00987,adult acute monocytic leukemia (M5b),C0280634,NCT02029417,Terminated,Phase 2,Major revisions needed in study,cytarabine
Decitabine,DB01262,adult acute monocytic leukemia (M5b),C0280634,NCT02029417,Terminated,Phase 2,Major revisions needed in study,decitabine
Homoharringtonine,DB04865,adult acute monocytic leukemia (M5b),C0280634,NCT02029417,Terminated,Phase 2,Major revisions needed in study,homoharringtonine
Cytarabine,DB00987,adult acute myeloblastic leukemia with maturation (M2),C0279624,NCT02029417,Terminated,Phase 2,Major revisions needed in study,cytarabine
Decitabine,DB01262,adult acute myeloblastic leukemia with maturation (M2),C0279624,NCT02029417,Terminated,Phase 2,Major revisions needed in study,decitabine
Homoharringtonine,DB04865,adult acute myeloblastic leukemia with maturation (M2),C0279624,NCT02029417,Terminated,Phase 2,Major revisions needed in study,homoharringtonine
Cytarabine,DB00987,Adult Acute Myeloid Leukemia without Maturation,C0279623,NCT02029417,Terminated,Phase 2,Major revisions needed in study,cytarabine
Decitabine,DB01262,Adult Acute Myeloid Leukemia without Maturation,C0279623,NCT02029417,Terminated,Phase 2,Major revisions needed in study,decitabine
Homoharringtonine,DB04865,Adult Acute Myeloid Leukemia without Maturation,C0279623,NCT02029417,Terminated,Phase 2,Major revisions needed in study,homoharringtonine
Cytarabine,DB00987,adult acute myeloid leukemia with 11q23 (MLL) abnormalities,C1541334,NCT02029417,Terminated,Phase 2,Major revisions needed in study,cytarabine
Decitabine,DB01262,adult acute myeloid leukemia with 11q23 (MLL) abnormalities,C1541334,NCT02029417,Terminated,Phase 2,Major revisions needed in study,decitabine
Homoharringtonine,DB04865,adult acute myeloid leukemia with 11q23 (MLL) abnormalities,C1541334,NCT02029417,Terminated,Phase 2,Major revisions needed in study,homoharringtonine
Cytarabine,DB00987,adult acute myeloid leukemia with inv(16)(p13;q22),C1541333,NCT02029417,Terminated,Phase 2,Major revisions needed in study,cytarabine
Decitabine,DB01262,adult acute myeloid leukemia with inv(16)(p13;q22),C1541333,NCT02029417,Terminated,Phase 2,Major revisions needed in study,decitabine
Homoharringtonine,DB04865,adult acute myeloid leukemia with inv(16)(p13;q22),C1541333,NCT02029417,Terminated,Phase 2,Major revisions needed in study,homoharringtonine
Cytarabine,DB00987,adult acute myeloid leukemia with t(16;16)(p13;q22),C1541332,NCT02029417,Terminated,Phase 2,Major revisions needed in study,cytarabine
Decitabine,DB01262,adult acute myeloid leukemia with t(16;16)(p13;q22),C1541332,NCT02029417,Terminated,Phase 2,Major revisions needed in study,decitabine
Homoharringtonine,DB04865,adult acute myeloid leukemia with t(16;16)(p13;q22),C1541332,NCT02029417,Terminated,Phase 2,Major revisions needed in study,homoharringtonine
Cytarabine,DB00987,adult acute myeloid leukemia with t(8;21)(q22;q22),C1541331,NCT02029417,Terminated,Phase 2,Major revisions needed in study,cytarabine
Decitabine,DB01262,adult acute myeloid leukemia with t(8;21)(q22;q22),C1541331,NCT02029417,Terminated,Phase 2,Major revisions needed in study,decitabine
Homoharringtonine,DB04865,adult acute myeloid leukemia with t(8;21)(q22;q22),C1541331,NCT02029417,Terminated,Phase 2,Major revisions needed in study,homoharringtonine
Cytarabine,DB00987,adult acute myelomonocytic leukemia (M4),C0279627,NCT02029417,Terminated,Phase 2,Major revisions needed in study,cytarabine
Decitabine,DB01262,adult acute myelomonocytic leukemia (M4),C0279627,NCT02029417,Terminated,Phase 2,Major revisions needed in study,decitabine
Homoharringtonine,DB04865,adult acute myelomonocytic leukemia (M4),C0279627,NCT02029417,Terminated,Phase 2,Major revisions needed in study,homoharringtonine
Cytarabine,DB00987,adult erythroleukemia (M6a),C1541339,NCT02029417,Terminated,Phase 2,Major revisions needed in study,cytarabine
Decitabine,DB01262,adult erythroleukemia (M6a),C1541339,NCT02029417,Terminated,Phase 2,Major revisions needed in study,decitabine
Homoharringtonine,DB04865,adult erythroleukemia (M6a),C1541339,NCT02029417,Terminated,Phase 2,Major revisions needed in study,homoharringtonine
Cytarabine,DB00987,adult pure erythroid leukemia (M6b),C1541340,NCT02029417,Terminated,Phase 2,Major revisions needed in study,cytarabine
Decitabine,DB01262,adult pure erythroid leukemia (M6b),C1541340,NCT02029417,Terminated,Phase 2,Major revisions needed in study,decitabine
Homoharringtonine,DB04865,adult pure erythroid leukemia (M6b),C1541340,NCT02029417,Terminated,Phase 2,Major revisions needed in study,homoharringtonine
Cytarabine,DB00987,secondary acute myeloid leukemia,C0280449,NCT02029417,Terminated,Phase 2,Major revisions needed in study,cytarabine
Decitabine,DB01262,secondary acute myeloid leukemia,C0280449,NCT02029417,Terminated,Phase 2,Major revisions needed in study,decitabine
Homoharringtonine,DB04865,secondary acute myeloid leukemia,C0280449,NCT02029417,Terminated,Phase 2,Major revisions needed in study,homoharringtonine
Cytarabine,DB00987,untreated adult acute myeloid leukemia,C0279089,NCT02029417,Terminated,Phase 2,Major revisions needed in study,cytarabine
Decitabine,DB01262,untreated adult acute myeloid leukemia,C0279089,NCT02029417,Terminated,Phase 2,Major revisions needed in study,decitabine
Homoharringtonine,DB04865,untreated adult acute myeloid leukemia,C0279089,NCT02029417,Terminated,Phase 2,Major revisions needed in study,homoharringtonine
Ondansetron,DB00904,Vomiting,C0042963,NCT02028910,Terminated,Phase 3,,ondansetron
Ondansetron,DB00904,Gastroenteritis,C0017160,NCT02028910,Terminated,Phase 3,,ondansetron
Folic Acid,DB00158,Inflammation,C0021368,NCT02079948,Withdrawn,Phase 2,Potential participants had concerns about taking the study drug (methotrexate).,folic acid
Methotrexate,DB00563,Inflammation,C0021368,NCT02079948,Withdrawn,Phase 2,Potential participants had concerns about taking the study drug (methotrexate).,methotrexate
Trametinib,DB08911,Colorectal cancer recurrent,C0854750,NCT02079740,Suspended,Phase 1/Phase 2,Drug supply issues,trametinib
Trametinib,DB08911,Pancreatic carcinoma stage III,C1167722,NCT02079740,Suspended,Phase 1/Phase 2,Drug supply issues,trametinib
Trametinib,DB08911,Stage IIIA Colorectal Cancer,C2981401,NCT02079740,Suspended,Phase 1/Phase 2,Drug supply issues,trametinib
Trametinib,DB08911,Stage IIIB Colorectal Cancer,C2981402,NCT02079740,Suspended,Phase 1/Phase 2,Drug supply issues,trametinib
Trametinib,DB08911,Stage IIIC Colorectal Cancer,C2981403,NCT02079740,Suspended,Phase 1/Phase 2,Drug supply issues,trametinib
Trametinib,DB08911,Stage IV Pancreatic Cancer,C1167725,NCT02079740,Suspended,Phase 1/Phase 2,Drug supply issues,trametinib
Trametinib,DB08911,Stage IVA Colorectal Cancer,C2981404,NCT02079740,Suspended,Phase 1/Phase 2,Drug supply issues,trametinib
Trametinib,DB08911,Stage IVB Colorectal Cancer,C2981405,NCT02079740,Suspended,Phase 1/Phase 2,Drug supply issues,trametinib
Irinotecan,DB00762,adult anaplastic astrocytoma,C0280483,NCT02055196,Withdrawn,Phase 1,New study written,irinotecan
Irinotecan,DB00762,adult anaplastic oligodendroglioma,C0280790,NCT02055196,Withdrawn,Phase 1,New study written,irinotecan
Irinotecan,DB00762,adult giant cell glioblastoma,C1541316,NCT02055196,Withdrawn,Phase 1,New study written,irinotecan
Irinotecan,DB00762,adult glioblastoma,C0278878,NCT02055196,Withdrawn,Phase 1,New study written,irinotecan
Irinotecan,DB00762,adult gliosarcoma,C1541317,NCT02055196,Withdrawn,Phase 1,New study written,irinotecan
Irinotecan,DB00762,recurrent adult brain tumor,C0278786,NCT02055196,Withdrawn,Phase 1,New study written,irinotecan
Celecoxib,DB00482,Malignant neoplasm of lung,C0242379,NCT02054104,Suspended,Phase 1/Phase 2,,celecoxib
Cyclophosphamide,DB00531,Malignant neoplasm of lung,C0242379,NCT02054104,Suspended,Phase 1/Phase 2,,cyclophosphamide
Paclitaxel,DB01229,Squamous cell carcinoma of skin,C0553723,NCT02076243,Terminated,Phase 2,Closed by sponsor,paclitaxel
Gemcitabine,DB00441,duct cell adenocarcinoma of the pancreas,C0279176,NCT02048943,Withdrawn,Phase 1,Lack of funding,gemcitabine
Paclitaxel,DB01229,duct cell adenocarcinoma of the pancreas,C0279176,NCT02048943,Withdrawn,Phase 1,Lack of funding,paclitaxel
Gemcitabine,DB00441,Pancreatic carcinoma recurrent,C0854777,NCT02048943,Withdrawn,Phase 1,Lack of funding,gemcitabine
Paclitaxel,DB01229,Pancreatic carcinoma recurrent,C0854777,NCT02048943,Withdrawn,Phase 1,Lack of funding,paclitaxel
Gemcitabine,DB00441,"unspecified adult solid tumor, protocol specific",C0279004,NCT02048943,Withdrawn,Phase 1,Lack of funding,gemcitabine
Paclitaxel,DB01229,"unspecified adult solid tumor, protocol specific",C0279004,NCT02048943,Withdrawn,Phase 1,Lack of funding,paclitaxel
Gemcitabine,DB00441,Pancreatic carcinoma stage III,C1167722,NCT02048943,Withdrawn,Phase 1,Lack of funding,gemcitabine
Paclitaxel,DB01229,Pancreatic carcinoma stage III,C1167722,NCT02048943,Withdrawn,Phase 1,Lack of funding,paclitaxel
Gemcitabine,DB00441,Stage IV Pancreatic Cancer,C1167725,NCT02048943,Withdrawn,Phase 1,Lack of funding,gemcitabine
Paclitaxel,DB01229,Stage IV Pancreatic Cancer,C1167725,NCT02048943,Withdrawn,Phase 1,Lack of funding,paclitaxel
Milrinone,DB00235,Cardiomyopathies,C0878544,NCT02077010,Suspended,Phase 3,Drug reformulation,milrinone
Linagliptin,DB08882,Vascular inflammations,C0947751,NCT02077309,Terminated,Phase 3,"bad recruitment of suitable participants, just 4 patients in one year",linagliptin
Prasugrel,DB06209,ST segment elevation myocardial infarction,C1536220,NCT02075125,Terminated,Phase 3,Enrolling participants has halted prematurely and will not resume,prasugrel
Ticagrelor,DB08816,ST segment elevation myocardial infarction,C1536220,NCT02075125,Terminated,Phase 3,Enrolling participants has halted prematurely and will not resume,ticagrelor
Bupivacaine,DB00297,Anterior Cruciate Ligament Injuries,C1456574,NCT02075411,Terminated,Phase 3,"Difficult to enroll, parents/subjects prefer to choose type of anesthetic block.",bupivacaine
Metformin,DB00331,Ovarian epithelial cancer recurrent,C0278689,NCT02050009,Withdrawn,Phase 1,,metformin
Carboplatin,DB00958,Ovarian epithelial cancer recurrent,C0278689,NCT02050009,Withdrawn,Phase 1,,carboplatin
Paclitaxel,DB01229,Ovarian epithelial cancer recurrent,C0278689,NCT02050009,Withdrawn,Phase 1,,paclitaxel
Metformin,DB00331,recurrent ovarian germ cell tumor,C0279975,NCT02050009,Withdrawn,Phase 1,,metformin
Carboplatin,DB00958,recurrent ovarian germ cell tumor,C0279975,NCT02050009,Withdrawn,Phase 1,,carboplatin
Paclitaxel,DB01229,recurrent ovarian germ cell tumor,C0279975,NCT02050009,Withdrawn,Phase 1,,paclitaxel
Metformin,DB00331,Serous cystadenocarcinoma ovary,C0279663,NCT02050009,Withdrawn,Phase 1,,metformin
Carboplatin,DB00958,Serous cystadenocarcinoma ovary,C0279663,NCT02050009,Withdrawn,Phase 1,,carboplatin
Paclitaxel,DB01229,Serous cystadenocarcinoma ovary,C0279663,NCT02050009,Withdrawn,Phase 1,,paclitaxel
Nitrendipine,DB01054,Isolated systolic hypertension,C0745133,NCT02088450,Terminated,Phase 2,,nitrendipine
Norepinephrine,DB00368,Septic Shock,C0036983,NCT02069288,Withdrawn,Phase 3,Problems of drugs supply by the manufacturer,norepinephrine
Trametinib,DB08911,hepatic complications,C1832055,NCT02070549,Suspended,Phase 1,Drug supply issues,trametinib
Sirolimus,DB00877,Malignant neoplasm of prostate,C0376358,NCT02091531,Terminated,Phase 2,Slow accrual,sirolimus
Everolimus,DB01590,Malignant neoplasm of prostate,C0376358,NCT02091531,Terminated,Phase 2,Slow accrual,everolimus
Gemcitabine,DB00441,Gallbladder Carcinoma,C0235782,NCT02105350,Suspended,Phase 1,,gemcitabine
Oxaliplatin,DB00526,Gallbladder Carcinoma,C0235782,NCT02105350,Suspended,Phase 1,,oxaliplatin
Bevacizumab,DB00112,Hereditary hemorrhagic telangiectasia,C0039445,NCT02106520,Terminated,Phase 2/Phase 3,DSMB's decision following the first step analysis,bevacizumab
Tamoxifen,DB00675,Papillary serous cystadenocarcinoma,C0334359,NCT02101788,Suspended,Phase 2/Phase 3,Drug supply issues,tamoxifen
Doxorubicin,DB00997,Papillary serous cystadenocarcinoma,C0334359,NCT02101788,Suspended,Phase 2/Phase 3,Drug supply issues,doxorubicin
Letrozole,DB01006,Papillary serous cystadenocarcinoma,C0334359,NCT02101788,Suspended,Phase 2/Phase 3,Drug supply issues,letrozole
Topotecan,DB01030,Papillary serous cystadenocarcinoma,C0334359,NCT02101788,Suspended,Phase 2/Phase 3,Drug supply issues,topotecan
Paclitaxel,DB01229,Papillary serous cystadenocarcinoma,C0334359,NCT02101788,Suspended,Phase 2/Phase 3,Drug supply issues,paclitaxel
Trametinib,DB08911,Papillary serous cystadenocarcinoma,C0334359,NCT02101788,Suspended,Phase 2/Phase 3,Drug supply issues,trametinib
Tamoxifen,DB00675,Ovarian Serous Adenocarcinoma,C1335177,NCT02101788,Suspended,Phase 2/Phase 3,Drug supply issues,tamoxifen
Doxorubicin,DB00997,Ovarian Serous Adenocarcinoma,C1335177,NCT02101788,Suspended,Phase 2/Phase 3,Drug supply issues,doxorubicin
Letrozole,DB01006,Ovarian Serous Adenocarcinoma,C1335177,NCT02101788,Suspended,Phase 2/Phase 3,Drug supply issues,letrozole
Topotecan,DB01030,Ovarian Serous Adenocarcinoma,C1335177,NCT02101788,Suspended,Phase 2/Phase 3,Drug supply issues,topotecan
Paclitaxel,DB01229,Ovarian Serous Adenocarcinoma,C1335177,NCT02101788,Suspended,Phase 2/Phase 3,Drug supply issues,paclitaxel
Trametinib,DB08911,Ovarian Serous Adenocarcinoma,C1335177,NCT02101788,Suspended,Phase 2/Phase 3,Drug supply issues,trametinib
Tamoxifen,DB00675,Primary Peritoneal Serous Adenocarcinoma,C1514429,NCT02101788,Suspended,Phase 2/Phase 3,Drug supply issues,tamoxifen
Doxorubicin,DB00997,Primary Peritoneal Serous Adenocarcinoma,C1514429,NCT02101788,Suspended,Phase 2/Phase 3,Drug supply issues,doxorubicin
Letrozole,DB01006,Primary Peritoneal Serous Adenocarcinoma,C1514429,NCT02101788,Suspended,Phase 2/Phase 3,Drug supply issues,letrozole
Topotecan,DB01030,Primary Peritoneal Serous Adenocarcinoma,C1514429,NCT02101788,Suspended,Phase 2/Phase 3,Drug supply issues,topotecan
Paclitaxel,DB01229,Primary Peritoneal Serous Adenocarcinoma,C1514429,NCT02101788,Suspended,Phase 2/Phase 3,Drug supply issues,paclitaxel
Trametinib,DB08911,Primary Peritoneal Serous Adenocarcinoma,C1514429,NCT02101788,Suspended,Phase 2/Phase 3,Drug supply issues,trametinib
Tamoxifen,DB00675,Recurrent Primary Peritoneal Carcinoma,C3897731,NCT02101788,Suspended,Phase 2/Phase 3,Drug supply issues,tamoxifen
Doxorubicin,DB00997,Recurrent Primary Peritoneal Carcinoma,C3897731,NCT02101788,Suspended,Phase 2/Phase 3,Drug supply issues,doxorubicin
Letrozole,DB01006,Recurrent Primary Peritoneal Carcinoma,C3897731,NCT02101788,Suspended,Phase 2/Phase 3,Drug supply issues,letrozole
Topotecan,DB01030,Recurrent Primary Peritoneal Carcinoma,C3897731,NCT02101788,Suspended,Phase 2/Phase 3,Drug supply issues,topotecan
Paclitaxel,DB01229,Recurrent Primary Peritoneal Carcinoma,C3897731,NCT02101788,Suspended,Phase 2/Phase 3,Drug supply issues,paclitaxel
Trametinib,DB08911,Recurrent Primary Peritoneal Carcinoma,C3897731,NCT02101788,Suspended,Phase 2/Phase 3,Drug supply issues,trametinib
Azacitidine,DB00928,MYELODYSPLASTIC SYNDROME,C3463824,NCT02147873,Terminated,Phase 2,Study terminated due to lack of efficacy,azacitidine
Sirolimus,DB00877,Non-small cell lung cancer recurrent,C0278517,NCT02126527,Withdrawn,Phase 1,no participants enrolled,sirolimus
Auranofin,DB00995,Non-small cell lung cancer recurrent,C0278517,NCT02126527,Withdrawn,Phase 1,no participants enrolled,auranofin
Everolimus,DB01590,Non-small cell lung cancer recurrent,C0278517,NCT02126527,Withdrawn,Phase 1,no participants enrolled,everolimus
Sirolimus,DB00877,"unspecified adult solid tumor, protocol specific",C0279004,NCT02126527,Withdrawn,Phase 1,no participants enrolled,sirolimus
Auranofin,DB00995,"unspecified adult solid tumor, protocol specific",C0279004,NCT02126527,Withdrawn,Phase 1,no participants enrolled,auranofin
Everolimus,DB01590,"unspecified adult solid tumor, protocol specific",C0279004,NCT02126527,Withdrawn,Phase 1,no participants enrolled,everolimus
Oxytocin,DB00107,Noninfiltrating Intraductal Carcinoma,C0007124,NCT02127073,Suspended,Phase 0,Enrollment on hold,oxytocin
Erlotinib,DB00530,HIV Infections,C0019693,NCT02134886,Terminated,Phase 1,No Accrual,erlotinib
Erythropoietin,DB00016,Traumatic Brain Injury,C0876926,NCT02148367,Withdrawn,Phase 2,Publication of recent trials showing no effect of EPO in TBI substantially reduced equipoise    about this study.,erythropoietin
Esmolol,DB00187,Septic Shock,C0036983,NCT02120404,Suspended,Phase 2,,esmolol
Cisplatin,DB00515,Malignant neoplasm of stomach,C0024623,NCT02137343,Terminated,Phase 3,All Amgen sponsored AMG102 clinical studies were terminated following a pre-planned Data    Monitoring Committee safety review of study 20070622.,cisplatin
Nimodipine,DB00393,Acute Cerebrovascular Accidents,C0751956,NCT02165644,Withdrawn,Phase 2,The PI is leaving the University of Florida.,nimodipine
Acetazolamide,DB00819,Acute Cerebrovascular Accidents,C0751956,NCT02165644,Withdrawn,Phase 2,The PI is leaving the University of Florida.,acetazolamide
Trametinib,DB08911,Poorly Differentiated Thyroid Carcinoma,C1266050,NCT02152995,Suspended,Phase 2,Drug supply issues,trametinib
Trametinib,DB08911,Stage IVA Thyroid Gland Follicular Carcinoma,C3897519,NCT02152995,Suspended,Phase 2,Drug supply issues,trametinib
Trametinib,DB08911,Stage IVA Thyroid Gland Papillary Carcinoma,C3897518,NCT02152995,Suspended,Phase 2,Drug supply issues,trametinib
Trametinib,DB08911,Stage IVB Thyroid Gland Follicular Carcinoma,C3897512,NCT02152995,Suspended,Phase 2,Drug supply issues,trametinib
Trametinib,DB08911,Stage IVB Thyroid Gland Papillary Carcinoma,C3897511,NCT02152995,Suspended,Phase 2,Drug supply issues,trametinib
Trametinib,DB08911,Stage IVC Thyroid Gland Follicular Carcinoma,C3897507,NCT02152995,Suspended,Phase 2,Drug supply issues,trametinib
Trametinib,DB08911,Stage IVC Thyroid Gland Papillary Carcinoma,C3897506,NCT02152995,Suspended,Phase 2,Drug supply issues,trametinib
Aldesleukin,DB00041,Desmoplastic Small Round Cell Tumor,C0281508,NCT02173093,Suspended,Phase 1/Phase 2,Study on hold due to primary co-investigator leaving the institution.,aldesleukin
Aldesleukin,DB00041,Metastatic osteosarcoma,C0278512,NCT02173093,Suspended,Phase 1/Phase 2,Study on hold due to primary co-investigator leaving the institution.,aldesleukin
Aldesleukin,DB00041,Neuroblastoma recurrent,C0278695,NCT02173093,Suspended,Phase 1/Phase 2,Study on hold due to primary co-investigator leaving the institution.,aldesleukin
Aldesleukin,DB00041,Osteosarcoma recurrent,C0278779,NCT02173093,Suspended,Phase 1/Phase 2,Study on hold due to primary co-investigator leaving the institution.,aldesleukin
Eslicarbazepine acetate,DB09119,Epilepsy,C0014544,NCT02172755,Terminated,Phase 1,occurrence of a serious adverse event,eslicarbazepine acetate
Cholecalciferol,DB00169,Schizophrenia,C0036341,NCT02197286,Withdrawn,Phase 2,Personnel changes at study site.,cholecalciferol
Cholecalciferol,DB00169,Schizoaffective Disorder,C0036337,NCT02197286,Withdrawn,Phase 2,Personnel changes at study site.,cholecalciferol
Gemcitabine,DB00441,Pancreatic Ductal Adenocarcinoma,C1335302,NCT02194829,Suspended,Phase 1/Phase 2,Temporarily stopped for assessment.,gemcitabine
Paclitaxel,DB01229,Pancreatic Ductal Adenocarcinoma,C1335302,NCT02194829,Suspended,Phase 1/Phase 2,Temporarily stopped for assessment.,paclitaxel
Gemcitabine,DB00441,Pancreatic carcinoma stage III,C1167722,NCT02194829,Suspended,Phase 1/Phase 2,Temporarily stopped for assessment.,gemcitabine
Paclitaxel,DB01229,Pancreatic carcinoma stage III,C1167722,NCT02194829,Suspended,Phase 1/Phase 2,Temporarily stopped for assessment.,paclitaxel
Gemcitabine,DB00441,Stage IV Pancreatic Cancer,C1167725,NCT02194829,Suspended,Phase 1/Phase 2,Temporarily stopped for assessment.,gemcitabine
Paclitaxel,DB01229,Stage IV Pancreatic Cancer,C1167725,NCT02194829,Suspended,Phase 1/Phase 2,Temporarily stopped for assessment.,paclitaxel
Tiotropium,DB01409,Chronic Obstructive Airway Disease,C0024117,NCT02203474,Withdrawn,Phase 2,,tiotropium
Deferoxamine,DB00746,Subarachnoid Hemorrhage,C0038525,NCT02216513,Terminated,Phase 0,Principle Investigator is moving to another institution and plans to restart this proctocol in    the new location.,deferoxamine
Trametinib,DB08911,Melanoma recurrent,C0278884,NCT02196181,Suspended,Phase 2,Drug Supply Issues,trametinib
Dabrafenib,DB08912,Melanoma recurrent,C0278884,NCT02196181,Suspended,Phase 2,Drug Supply Issues,dabrafenib
Trametinib,DB08911,Stage IIIA Skin Melanoma,C2828034,NCT02196181,Suspended,Phase 2,Drug Supply Issues,trametinib
Dabrafenib,DB08912,Stage IIIA Skin Melanoma,C2828034,NCT02196181,Suspended,Phase 2,Drug Supply Issues,dabrafenib
Trametinib,DB08911,Stage IIIB Skin Melanoma,C2828035,NCT02196181,Suspended,Phase 2,Drug Supply Issues,trametinib
Dabrafenib,DB08912,Stage IIIB Skin Melanoma,C2828035,NCT02196181,Suspended,Phase 2,Drug Supply Issues,dabrafenib
Trametinib,DB08911,Stage IIIC Skin Melanoma,C2828036,NCT02196181,Suspended,Phase 2,Drug Supply Issues,trametinib
Dabrafenib,DB08912,Stage IIIC Skin Melanoma,C2828036,NCT02196181,Suspended,Phase 2,Drug Supply Issues,dabrafenib
Prednisolone,DB00860,Fever,C0015967,NCT02212210,Terminated,Phase 0,PI permanently closed accrual for the study based on FDA warning issued in April 2014. Study    remains open; PI is currently editing the manuscript.,prednisolone
Methylprednisolone,DB00959,Fever,C0015967,NCT02212210,Terminated,Phase 0,PI permanently closed accrual for the study based on FDA warning issued in April 2014. Study    remains open; PI is currently editing the manuscript.,methylprednisolone
Prednisolone,DB00860,Labor Pain,C0474368,NCT02212210,Terminated,Phase 0,PI permanently closed accrual for the study based on FDA warning issued in April 2014. Study    remains open; PI is currently editing the manuscript.,prednisolone
Methylprednisolone,DB00959,Labor Pain,C0474368,NCT02212210,Terminated,Phase 0,PI permanently closed accrual for the study based on FDA warning issued in April 2014. Study    remains open; PI is currently editing the manuscript.,methylprednisolone
Prednisolone,DB00860,"Complication of anesthesia during pregnancy, unspecified",C0495199,NCT02212210,Terminated,Phase 0,PI permanently closed accrual for the study based on FDA warning issued in April 2014. Study    remains open; PI is currently editing the manuscript.,prednisolone
Methylprednisolone,DB00959,"Complication of anesthesia during pregnancy, unspecified",C0495199,NCT02212210,Terminated,Phase 0,PI permanently closed accrual for the study based on FDA warning issued in April 2014. Study    remains open; PI is currently editing the manuscript.,methylprednisolone
Ranolazine,DB00243,Irritable bowel syndrome with diarrhea,C0348898,NCT02239926,Terminated,Phase 2/Phase 3,Difficulty in enrolling subjects,ranolazine
Ranolazine,DB00243,Diarrhoea predominant irritable bowel syndrome,C1262211,NCT02239926,Terminated,Phase 2/Phase 3,Difficulty in enrolling subjects,ranolazine
Fluorouracil,DB00544,Mucinous adenocarcinoma of colon,C0279639,NCT02235324,Withdrawn,Phase 2,Lack of funding,fluorouracil
Leucovorin,DB00650,Mucinous adenocarcinoma of colon,C0279639,NCT02235324,Withdrawn,Phase 2,Lack of funding,leucovorin
Levoleucovorin,DB11596,Mucinous adenocarcinoma of colon,C0279639,NCT02235324,Withdrawn,Phase 2,Lack of funding,levoleucovorin
Fluorouracil,DB00544,mucinous adenocarcinoma of rectum,C0279652,NCT02235324,Withdrawn,Phase 2,Lack of funding,fluorouracil
Leucovorin,DB00650,mucinous adenocarcinoma of rectum,C0279652,NCT02235324,Withdrawn,Phase 2,Lack of funding,leucovorin
Levoleucovorin,DB11596,mucinous adenocarcinoma of rectum,C0279652,NCT02235324,Withdrawn,Phase 2,Lack of funding,levoleucovorin
Fluorouracil,DB00544,Colon cancer recurrent,C0278553,NCT02235324,Withdrawn,Phase 2,Lack of funding,fluorouracil
Leucovorin,DB00650,Colon cancer recurrent,C0278553,NCT02235324,Withdrawn,Phase 2,Lack of funding,leucovorin
Levoleucovorin,DB11596,Colon cancer recurrent,C0278553,NCT02235324,Withdrawn,Phase 2,Lack of funding,levoleucovorin
Fluorouracil,DB00544,Recurrent Rectal Cancer,C0278554,NCT02235324,Withdrawn,Phase 2,Lack of funding,fluorouracil
Leucovorin,DB00650,Recurrent Rectal Cancer,C0278554,NCT02235324,Withdrawn,Phase 2,Lack of funding,leucovorin
Levoleucovorin,DB11596,Recurrent Rectal Cancer,C0278554,NCT02235324,Withdrawn,Phase 2,Lack of funding,levoleucovorin
Fluorouracil,DB00544,signet ring adenocarcinoma of the colon,C0279640,NCT02235324,Withdrawn,Phase 2,Lack of funding,fluorouracil
Leucovorin,DB00650,signet ring adenocarcinoma of the colon,C0279640,NCT02235324,Withdrawn,Phase 2,Lack of funding,leucovorin
Levoleucovorin,DB11596,signet ring adenocarcinoma of the colon,C0279640,NCT02235324,Withdrawn,Phase 2,Lack of funding,levoleucovorin
Fluorouracil,DB00544,signet ring adenocarcinoma of the rectum,C0279654,NCT02235324,Withdrawn,Phase 2,Lack of funding,fluorouracil
Leucovorin,DB00650,signet ring adenocarcinoma of the rectum,C0279654,NCT02235324,Withdrawn,Phase 2,Lack of funding,leucovorin
Levoleucovorin,DB11596,signet ring adenocarcinoma of the rectum,C0279654,NCT02235324,Withdrawn,Phase 2,Lack of funding,levoleucovorin
Fluorouracil,DB00544,Stage IVA Colon Cancer,C3897082,NCT02235324,Withdrawn,Phase 2,Lack of funding,fluorouracil
Leucovorin,DB00650,Stage IVA Colon Cancer,C3897082,NCT02235324,Withdrawn,Phase 2,Lack of funding,leucovorin
Levoleucovorin,DB11596,Stage IVA Colon Cancer,C3897082,NCT02235324,Withdrawn,Phase 2,Lack of funding,levoleucovorin
Fluorouracil,DB00544,Stage IVA Rectal Cancer,C3897520,NCT02235324,Withdrawn,Phase 2,Lack of funding,fluorouracil
Leucovorin,DB00650,Stage IVA Rectal Cancer,C3897520,NCT02235324,Withdrawn,Phase 2,Lack of funding,leucovorin
Levoleucovorin,DB11596,Stage IVA Rectal Cancer,C3897520,NCT02235324,Withdrawn,Phase 2,Lack of funding,levoleucovorin
Fluorouracil,DB00544,Stage IVB Colon Cancer,C3897517,NCT02235324,Withdrawn,Phase 2,Lack of funding,fluorouracil
Leucovorin,DB00650,Stage IVB Colon Cancer,C3897517,NCT02235324,Withdrawn,Phase 2,Lack of funding,leucovorin
Levoleucovorin,DB11596,Stage IVB Colon Cancer,C3897517,NCT02235324,Withdrawn,Phase 2,Lack of funding,levoleucovorin
Fluorouracil,DB00544,Stage IVB Rectal Cancer,C3897513,NCT02235324,Withdrawn,Phase 2,Lack of funding,fluorouracil
Leucovorin,DB00650,Stage IVB Rectal Cancer,C3897513,NCT02235324,Withdrawn,Phase 2,Lack of funding,leucovorin
Levoleucovorin,DB11596,Stage IVB Rectal Cancer,C3897513,NCT02235324,Withdrawn,Phase 2,Lack of funding,levoleucovorin
Oxycodone,DB00497,Pain,C0030193,NCT02240602,Withdrawn,Phase 3,Lack of internal resources,oxycodone
Tamoxifen,DB00675,Postmenopausal state,C0232970,NCT02322853,Suspended,Phase 2,,tamoxifen
Methylphenidate,DB00422,Conduct Disorder,C0149654,NCT02247986,Withdrawn,Phase 1/Phase 2,,methylphenidate
Ezetimibe,DB00973,Non-alcoholic Fatty Liver Disease,C0400966,NCT02244944,Terminated,Phase 2,Failure to recruit,ezetimibe
Dimethyl fumarate,DB08908,Multiple Sclerosis,C0026769,NCT02428231,Terminated,Phase 3,Sponsor decision,dimethyl fumarate
Estradiol,DB00783,Vaginal ulcer,C0566951,NCT02316249,Withdrawn,Phase 2,the study was not feasible,estradiol
Caffeine,DB00201,Dyspnea,C0013404,NCT02311088,Terminated,Phase 2,Too low enrolment rate,caffeine
Simeprevir,DB06290,Renal Insufficiency,C1565489,NCT02397395,Withdrawn,Phase 2,Trial has been cancelled due to availability of new therapeutic options for patient population,simeprevir
Oxaliplatin,DB00526,Stage IB Esophageal Adenocarcinoma,C2981371,NCT02392377,Terminated,Phase 2,Slow accrual,oxaliplatin
Fluorouracil,DB00544,Stage IB Esophageal Adenocarcinoma,C2981371,NCT02392377,Terminated,Phase 2,Slow accrual,fluorouracil
Carboplatin,DB00958,Stage IB Esophageal Adenocarcinoma,C2981371,NCT02392377,Terminated,Phase 2,Slow accrual,carboplatin
Paclitaxel,DB01229,Stage IB Esophageal Adenocarcinoma,C2981371,NCT02392377,Terminated,Phase 2,Slow accrual,paclitaxel
Levoleucovorin,DB11596,Stage IB Esophageal Adenocarcinoma,C2981371,NCT02392377,Terminated,Phase 2,Slow accrual,levoleucovorin
Oxaliplatin,DB00526,Stage IIA Esophageal Adenocarcinoma,C1336158,NCT02392377,Terminated,Phase 2,Slow accrual,oxaliplatin
Fluorouracil,DB00544,Stage IIA Esophageal Adenocarcinoma,C1336158,NCT02392377,Terminated,Phase 2,Slow accrual,fluorouracil
Carboplatin,DB00958,Stage IIA Esophageal Adenocarcinoma,C1336158,NCT02392377,Terminated,Phase 2,Slow accrual,carboplatin
Paclitaxel,DB01229,Stage IIA Esophageal Adenocarcinoma,C1336158,NCT02392377,Terminated,Phase 2,Slow accrual,paclitaxel
Levoleucovorin,DB11596,Stage IIA Esophageal Adenocarcinoma,C1336158,NCT02392377,Terminated,Phase 2,Slow accrual,levoleucovorin
Oxaliplatin,DB00526,Stage IIB Esophageal Adenocarcinoma,C1336180,NCT02392377,Terminated,Phase 2,Slow accrual,oxaliplatin
Fluorouracil,DB00544,Stage IIB Esophageal Adenocarcinoma,C1336180,NCT02392377,Terminated,Phase 2,Slow accrual,fluorouracil
Carboplatin,DB00958,Stage IIB Esophageal Adenocarcinoma,C1336180,NCT02392377,Terminated,Phase 2,Slow accrual,carboplatin
Paclitaxel,DB01229,Stage IIB Esophageal Adenocarcinoma,C1336180,NCT02392377,Terminated,Phase 2,Slow accrual,paclitaxel
Levoleucovorin,DB11596,Stage IIB Esophageal Adenocarcinoma,C1336180,NCT02392377,Terminated,Phase 2,Slow accrual,levoleucovorin
Oxaliplatin,DB00526,Stage IIIA Esophageal Adenocarcinoma,C2981372,NCT02392377,Terminated,Phase 2,Slow accrual,oxaliplatin
Fluorouracil,DB00544,Stage IIIA Esophageal Adenocarcinoma,C2981372,NCT02392377,Terminated,Phase 2,Slow accrual,fluorouracil
Carboplatin,DB00958,Stage IIIA Esophageal Adenocarcinoma,C2981372,NCT02392377,Terminated,Phase 2,Slow accrual,carboplatin
Paclitaxel,DB01229,Stage IIIA Esophageal Adenocarcinoma,C2981372,NCT02392377,Terminated,Phase 2,Slow accrual,paclitaxel
Levoleucovorin,DB11596,Stage IIIA Esophageal Adenocarcinoma,C2981372,NCT02392377,Terminated,Phase 2,Slow accrual,levoleucovorin
Oxaliplatin,DB00526,Stage IIIB Esophageal Adenocarcinoma,C2981373,NCT02392377,Terminated,Phase 2,Slow accrual,oxaliplatin
Fluorouracil,DB00544,Stage IIIB Esophageal Adenocarcinoma,C2981373,NCT02392377,Terminated,Phase 2,Slow accrual,fluorouracil
Carboplatin,DB00958,Stage IIIB Esophageal Adenocarcinoma,C2981373,NCT02392377,Terminated,Phase 2,Slow accrual,carboplatin
Paclitaxel,DB01229,Stage IIIB Esophageal Adenocarcinoma,C2981373,NCT02392377,Terminated,Phase 2,Slow accrual,paclitaxel
Levoleucovorin,DB11596,Stage IIIB Esophageal Adenocarcinoma,C2981373,NCT02392377,Terminated,Phase 2,Slow accrual,levoleucovorin
Oxaliplatin,DB00526,Stage IIIC Esophageal Adenocarcinoma,C2981374,NCT02392377,Terminated,Phase 2,Slow accrual,oxaliplatin
Fluorouracil,DB00544,Stage IIIC Esophageal Adenocarcinoma,C2981374,NCT02392377,Terminated,Phase 2,Slow accrual,fluorouracil
Carboplatin,DB00958,Stage IIIC Esophageal Adenocarcinoma,C2981374,NCT02392377,Terminated,Phase 2,Slow accrual,carboplatin
Paclitaxel,DB01229,Stage IIIC Esophageal Adenocarcinoma,C2981374,NCT02392377,Terminated,Phase 2,Slow accrual,paclitaxel
Levoleucovorin,DB11596,Stage IIIC Esophageal Adenocarcinoma,C2981374,NCT02392377,Terminated,Phase 2,Slow accrual,levoleucovorin
Vitamin E,DB00163,Hypercholesterolemia,C0020443,NCT02634606,Terminated,Phase 3,Unable to obtain supplement for this study. Unable to recruit.,vitamin e
Dimethyl fumarate,DB08908,"Multiple Sclerosis, Secondary Progressive",C0751965,NCT02430532,Terminated,Phase 3,Sponsor Decision,dimethyl fumarate
Ketamine,DB01221,Acute depression,C1386135,NCT02378415,Terminated,Phase 1,Discrepancies in medication orders,ketamine
Succinylcholine,DB00202,Multiple Myeloma,C0026764,NCT02605356,Withdrawn,Phase 1/Phase 2,,succinylcholine
Radium Ra 223 Dichloride,DB08913,Multiple Myeloma,C0026764,NCT02605356,Withdrawn,Phase 1/Phase 2,,radium ra 223 dichloride
Iloprost,DB01088,Chronic left ventricular failure,C1328381,NCT02482402,Withdrawn,Phase 2,Delay in recruitment,iloprost
Iloprost,DB01088,Pulmonary Hypertension,C0020542,NCT02482402,Withdrawn,Phase 2,Delay in recruitment,iloprost
Docetaxel,DB01248,Lung squamous cell carcinoma recurrent,C0854989,NCT02536495,Withdrawn,Phase 1/Phase 2,PI decision due to funding support,docetaxel
Docetaxel,DB01248,Lung squamous cell carcinoma stage IV,C0854994,NCT02536495,Withdrawn,Phase 1/Phase 2,PI decision due to funding support,docetaxel
Morphine,DB00295,Chronic Obstructive Airway Disease,C0024117,NCT02455362,Withdrawn,Phase 3,'Recruitment not possible given changes to trial criteria,morphine
Morphine,DB00295,Dyspnea,C0013404,NCT02455362,Withdrawn,Phase 3,'Recruitment not possible given changes to trial criteria,morphine
Sodium thiosulfate,DB09499,Calciphylaxis,C0006666,NCT02527213,Terminated,Phase 3,Company decision,sodium thiosulfate
Dacarbazine,DB00851,Glioblastoma,C0017636,NCT02661113,Withdrawn,Phase 2,Sponsor withdrew support; Study did not progress to Phase II (Phase I registration    NCT00895960),dacarbazine
Temozolomide,DB00853,Glioblastoma,C0017636,NCT02661113,Withdrawn,Phase 2,Sponsor withdrew support; Study did not progress to Phase II (Phase I registration    NCT00895960),temozolomide
Dasatinib,DB01254,Glioblastoma,C0017636,NCT02661113,Withdrawn,Phase 2,Sponsor withdrew support; Study did not progress to Phase II (Phase I registration    NCT00895960),dasatinib
Dacarbazine,DB00851,CNS disorder,C0007682,NCT02661113,Withdrawn,Phase 2,Sponsor withdrew support; Study did not progress to Phase II (Phase I registration    NCT00895960),dacarbazine
Temozolomide,DB00853,CNS disorder,C0007682,NCT02661113,Withdrawn,Phase 2,Sponsor withdrew support; Study did not progress to Phase II (Phase I registration    NCT00895960),temozolomide
Dasatinib,DB01254,CNS disorder,C0007682,NCT02661113,Withdrawn,Phase 2,Sponsor withdrew support; Study did not progress to Phase II (Phase I registration    NCT00895960),dasatinib
Dacarbazine,DB00851,Brain Diseases,C0006111,NCT02661113,Withdrawn,Phase 2,Sponsor withdrew support; Study did not progress to Phase II (Phase I registration    NCT00895960),dacarbazine
Temozolomide,DB00853,Brain Diseases,C0006111,NCT02661113,Withdrawn,Phase 2,Sponsor withdrew support; Study did not progress to Phase II (Phase I registration    NCT00895960),temozolomide
Dasatinib,DB01254,Brain Diseases,C0006111,NCT02661113,Withdrawn,Phase 2,Sponsor withdrew support; Study did not progress to Phase II (Phase I registration    NCT00895960),dasatinib